<SEC-DOCUMENT>0000886163-20-000122.txt : 20201106
<SEC-HEADER>0000886163-20-000122.hdr.sgml : 20201106
<ACCEPTANCE-DATETIME>20201106161148
ACCESSION NUMBER:		0000886163-20-000122
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201106
DATE AS OF CHANGE:		20201106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		201294533

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:015c58ab-d6da-4197-b1ca-2564dd0b9f53,g:8a625853-6817-482c-9ef8-59dc8bbafc23,d:7c5753c379194807a2081c4b5d4d13f2--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:lgnd="http://www.ligand.com/20200930" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGFibGU6OTI5MTdkZGFlMWRmNGIxNzkxMzBhMzRiMjM3MmE4ZjQvdGFibGVyYW5nZTo5MjkxN2RkYWUxZGY0YjE3OTEzMGEzNGIyMzcyYThmNF8yLTEtMS0xLTA_beace715-2e74-4915-813f-15cd0db9fabb">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGFibGU6OTI5MTdkZGFlMWRmNGIxNzkxMzBhMzRiMjM3MmE4ZjQvdGFibGVyYW5nZTo5MjkxN2RkYWUxZGY0YjE3OTEzMGEzNGIyMzcyYThmNF8zLTEtMS0xLTA_83450c1f-9a4b-44e8-bfb7-1de92ed04641">2020</ix:nonNumeric><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGFibGU6OTI5MTdkZGFlMWRmNGIxNzkxMzBhMzRiMjM3MmE4ZjQvdGFibGVyYW5nZTo5MjkxN2RkYWUxZGY0YjE3OTEzMGEzNGIyMzcyYThmNF80LTEtMS0xLTA_c0085cf5-713e-440f-ba7d-3eeeaaa15c43">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGV4dHJlZ2lvbjo4YjllM2EwNTAwMTA0NjBmOTkxOWVkNWYzZDRlYmZkMF8yNg_6833f9af-a9e5-4950-91ce-d9339bf784d6">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGV4dHJlZ2lvbjo4YjllM2EwNTAwMTA0NjBmOTkxOWVkNWYzZDRlYmZkMF8yNw_17ba234f-0c2c-43cf-bd34-8e88becbfcfe">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS0wLTEtMS0wL3RleHRyZWdpb246NDA1ODlhMzQzNDUxNGQ1MzhlMTlhOWE3ZDJkYTIxMmJfNTA_5acfac75-4ba4-4abe-a410-f94041340fdd">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80Ni9mcmFnOmNmMjIwNmE4ZjM0OTQ5MGNhZmIzZTVmNDcxYzFhNzNjL3RhYmxlOjdhMTFhMDg1ZmNkODQyYzM5ZTNkYzZlYWY2ZjYwOTFkL3RhYmxlcmFuZ2U6N2ExMWEwODVmY2Q4NDJjMzllM2RjNmVhZjZmNjA5MWRfMi0xLTEtMS0w_82eec3c8-fbc2-4dda-bf57-6d316487b25e">0.0040244</ix:nonFraction><ix:nonNumeric contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMTU4_6e2e7d5b-569a-4112-af29-1a3087e4b64c">P7Y</ix:nonNumeric><ix:nonNumeric contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjI5_55733a26-80e9-4395-8c9c-5fd85e05d7b3">P7Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i415e31ba3f934198961f14bef202c237_I20201103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40068af719eb4ea8bd60482b542bddca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9fc64f4d95b449579c5dcf83692dc2c2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff17a87c11c484c964fba70cf7a9057_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6992f512a9ea4391aba483112356a4b0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89eb246de85d4b488a38dcf7024d1c08_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4089e56d6e3f4a8887c64e185748adcb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32a628a6cc7441d2989a9bb873aa67ed_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0095c2332c5f44189e76bf00c4b53c2c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e3415613f8a40bfbe9bad5aae16a724_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d01bc1e745d4a3ab4088e5f4f2358b8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24db05f0ba7a4d77a7000833e1ed3559_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cac48edfdab44eda2c29f953e09e7d3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia893a67a4ca947ba9f3e9b7d01d18a0c_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7229001e60ff49198a53dbfbcd6d60b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa54869d40994b6aa64042e970f51be8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a859673f5404c6cbfade9e44d71e9f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a58a3c6c6448268c41dca75ca52fc7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6aea072928f4adfb9348fc0edbac316_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e26dda8ec9c45408cdc8bf9f7fe8c69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6633e74552be487692e9b132df36f4e8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aac323c2302486893f879d73f4c93e4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad5487114db84eac9bfa300064f305c6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia225c7585f734df2a5415a615cdf2097_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i390ae39298aa49b48acd3739a2084b20_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e9a32b21494264a59d8c3209cde81c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5adb4b836261437c8a079d884dd0e8ca_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd47a5e4d9a24937a102511805705f35_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9d958158dd43a293e2993c7506b393_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49e9549e37074565b41ee42b330a2e2d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a7426a780234cb098ddd5e2ad753bbc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50fc27200cc345ddab6a3d2ba7763419_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cf845807cc0448f8bb1b78321ef94bf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i033832a8e05745f8925aad29d6926388_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490f2ffbbf00499fbb82c91eb2b73aef_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib77b17a4438e4523ab9ff836080cad8f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30e1862d94954195986e08adfa6e1308_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6b07ddca2e541d7ba70100ef93c997c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia37703b7519741a7947b97bcf8cb4d32_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d9a384d5fe4b8ea0e9be04bb79c338_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if87fbb1c899e4dd3a43541865f6f3cb5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e8e2209037448496084b7cfc9433eb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id242a912b69a4ef0a5aa82c546921324_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a970afb914d41ce990cb1157db7eb2e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e121e85c66044c887bca7e02db16f42_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49bb47989637497c8b00af3bf1f16d88_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia51a45b1a9554dc4a23d19c9681b8627_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c217737a66b4aeba81beaacd79e70ec_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i234221629449487f964bc6624088b0c1_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ffdf07b1b53463498a6c354fdf3b822_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d3d78b23a9464aba33b50d534d7983_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fadbb805c68461391658b06e2708f69_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic824a6a2217044eebe4ad6f38deb865e_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifadacbb2a79244b9a4f3e6026a94394d_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13cc02644d614c5a9a285795ce36f88c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4daf159584b94905a33f5c1706489352_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37fb40383c604fa99c82bd4627415ddd_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dee39642b1441adab4e1b7f195f4820_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c4ce8565674d7cbc011bb29d51fdbc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9f29670866f470d84fbf023db043769_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43125aaaa4d745faabb5618510882e01_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c8205976c64573b1f5fafa7ee9496c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df602c5680a4955ac8de558547908d1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3192c6a0bb844fdb952e47d0f4a8a28_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife85aa33f030423e9deacf97a190c282_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ed241cfb09b46e5ba9c8968fb1b32f8_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4d3f481bad1425ca853b25afe3012d9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae80780948143b7b2da481e22963423_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d610f8e9c4740b18e5147a6ee408789_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9d5df0e1dac4e88ae8b5fb46ae522b3_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id067844f4eb4436eb363d302e57613d7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i852922b66fce4828ae182e5350dcb942_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa3f1a01a9864e59ac71fe92b7ca767d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a8257a98db24ffaa95e5892f684fd01_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79407bfe8ff44be68b660b88255cf447_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia162f6b1d4274062b41ad002117be195_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i959c4730e2da4bcdb04ef2f33d1574d7_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i953eac10432944aa918dad32003e1069_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5500183722b040e19d12c71572ccb758_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae408995adc74e3ca6339d16292d5778_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia617fcaa706e40a6a1ac062ee7d43ec4_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9de46cd3732f46198d032b4488032eaf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbb6844505d24ba0bf8408929f329456_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i631b9be815524db78231c3054bb32e61_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6adefffb5c654771b174bf3bb3a8b6bd_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32509a4fbc6a4a1582b549b4ca6df340_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c5884b82ff46d5acc051c8609beaf8_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifba8307733fc433f8ab3b039169959f0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if80024c5d7c84458b874cf41165bca20_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab25bc69dbce44049e247a4d1847a6a0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58eb2b2e375b4a358abb2a965d76fa2b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e6cef85b3c447d3aa8cdd4f781e6981_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ddd64a6c3b648bdbbbed38ab355251b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0aa285905264a199609e8e0e79eeb9e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f888f2275fa4a51a4214ceb899a5667_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41ad1b18c5f4466cb46c76831b340bf9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7b2e9c4c524632af8897ae7a9f69da_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61867bf812c848368a7dbee91070fe83_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e8662fb16b4474a6813702dcc5fbf2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32fc3b55c7ed49029b4502207f3e67b8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie13355c008834006b8d8a53974aa47bf_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7be44b2cefc0491cb1be1ab1447f7f7e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia53963dd995b43fe95834fa275cf1ab9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe3969028f3455e89611142e0bd445e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2db24569871b4483bf7e64d41e59fd8d_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if989d8f4b0444921b186d0ba5bd810f4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fdffc8317c449f881a8aa17ec02a41c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523aaf24229e4ba68a57b31257326d9a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebd966bb1d63405582633f051a4fe6cb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b59857bb5724f0db92fceca967b8a6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d0223b445c142ebbbceb1d4d5041109_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34769cb1caae46a1b085c5eb80dc24d2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieafd46562c0048748b7d5372e02d9594_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i994f5de64c0a4fbdb6c53080a3923a98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i077cb3c9fe0e483c86fb45ff23381e66_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1515ee2cbc494379a0c6d767fc8cb01e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02c7dbe217a407884f5da8e577b9510_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada23dbe678940b39476c796282a62d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i62059978ce544467b0dd531154611391_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9822c8d2a54454798b936165a57c684_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc614b30b84489b961b3be7e198cf04_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf62daa6b80444d9b1c8c7605f3061cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i458d920e4daf4b0bbb69e6db515003c0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b63e0852ede48be9e97d41d54d1fc1f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3a7b51a701f4e53aecd32502a589716_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4202a561cc0e4e888ca3864847b25542_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d220828630a41d89fbd767210960771_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie13355217b22451f86270e7501836ab5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7eb9f595411497d909c36c7b2a954d3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee0d788eb77400190e92faa6bb87523_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0100a54707e94423b27294cac36ad9cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibcbff8ebe0f84833bb1bb078e9fb983a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10d095f87a1e48e8a5b700832f2b753f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5e4fe2589b447f9a277f98db937a1f_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf7333df7984d5bbd68a862a0645e2b_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f60bf0364f848b38d48669aaccabc92_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cdccb9429b54094b52f363eef25ce9f_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3d2e8730044456d888fa8d00bb40ef6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i827adc89d29046898e0b113579222055_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ce74a6cb0394faea692955f117b0910_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eae62fa2cc244c58acbef58471706d5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcb4d6cb442c42888913360733612f6b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1cbbd30022e449b8b3b716176ea05cf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i971a95182cfc43cf993de4477741afb9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5baf6027374c4f3cb37f343379914469_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if33f5e6d2e464f5a95ee2eb981cf9859_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38b7bbf234194785adc62a7822e6c5cd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca967bf02e64cfaa352ef449e98dfb9_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22396d3cd074458826229f4aa3c94ff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic34a5542beee460cbf11a482a837b496_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i478ab1e04df3462693b4f447d123258c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f47b24008434e72b2d2b8abdd01c025_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5178294923b94ed691df5ab58c95e5ae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedc8cab80d6146938a4e96ca913b603e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f01a6768e554446859e50dd59a5f80b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49eebaf8762f41bc8e158fa2142e34c7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99eb08f38a27433e952f4df9a77b03c4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0856bf1f29e45b3ae503b85c7783f0f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78fb2997e6c149bb89d1b9405e547655_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3f212d8fb4848b7a0273c25f91e3c69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0f7b483e754043b00e42dc018f756e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f064695ce24917afeb387d23a90689_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2bcfa66308412c8f26ad4feaca4c78_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id25c3c4da77d4ea7ab8ca7b1314fdd20_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i776f577b4a88423a8d0236205bdb4fc4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830cd590ed6b4940ae325376227fbf62_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad16d307d34d4ce3a14c5cc44ab00ca9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66cf1abe6fef4052bc2a83de3d3f416a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ffefdd42a3a41f1aaa64b145eafac32_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60cb7324310c4d69b314803514b8e7b1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3493b201a94d66930f00e5b6cb91ab_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaef93f7a4c3542b39b59e3723f6abe79_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31e1ba70e57e428aa564051bda9daceb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fe44d5fc83a4e91b928eab183e2696f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1fb45159aaf459ab33f85d40561d21b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8cd383420af4806b4b998261a7844bc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1ffea26d4346d3ac80627049e44cf9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e338a0003143eca31f450081056aae_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i474b22d9f5454de2984d02f95a12bb78_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7c66fe24767491e8f06625e7c7980b6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b17dc76cb24ddf96f02602f42463a0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a210e993e749b792c4ff6feb3a58b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice47f549adc84119806f94c1746c45ec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id25da78fb55a47a9a4c833b387732860_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6fd63ec5bbe4d21b07dd199d23d7b1a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="contingentvalueright"><xbrli:measure>lgnd:contingentValueRight</xbrli:measure></xbrli:unit><xbrli:context id="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingentvaluerightseries"><xbrli:measure>lgnd:contingentValueRightSeries</xbrli:measure></xbrli:unit><xbrli:context id="ibfc313fa997f4657b35211e781b16774_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia730be76fe494ababd31b792de283e21_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d48f0e79a2a43869f2f0bd580a4753b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba69388d37546cabc299b2e1f680e46_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e64c0586051455caf1fcc537086a20a_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999aee09e45649fdb1cd9982ed98cdc2_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3375f5d3a4424dcd819ba8dc9c56b35e_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fae09558a4443b6952d5785b2692f3a_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f8208b3443c4953b951bcf2e7b70a4b_I20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e200da6ec4c46c68c9db69c0131c385_D20200909-20200909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-09</xbrli:startDate><xbrli:endDate>2020-09-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29bff9a12f464884a5afac09cb178f2b_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba4f03a76ff84cd195e9a52f4859e3e0_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b61ef8a9bb34b4a831d8fdf376d0630_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefa15c311fc64869817af666497c6c42_I20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c8ee65a89ca400999e52481a25fc8c0_D20200908-20200908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-08</xbrli:startDate><xbrli:endDate>2020-09-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf59884a0ba4125b067647bc5e8a67b_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85df3b674454d1fbeb0d47a0f94915a_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e7c4b5aaae742f5836b06830ae9422b_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i051cac9942274d55850055cf090e8f8d_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-23</xbrli:startDate><xbrli:endDate>2019-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab592e440e644d5a1ec6c7acf564453_I20190723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f34a9837f549a2b830d35fa413bbd8_I20190723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ade28714c945bdbaed7782ccd551cc_D20190723-20190723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-23</xbrli:startDate><xbrli:endDate>2019-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee3cabb8282246d9b2d4d3044cdde963_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe792e75a594433b59c93b28557b63e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5a227d490d42d182609204378ddfea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9901cc55d3a41d6a022e1bace11721c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b873c8bed16489d977cfb5d84e575a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3dda86ca5ea49ce89a56fba0b2e74eb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe5995b210642eb9ea6c816db2ac441_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1803c7b7772d48fcbcd1f7dd2fea7909_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8183957e6f4e449b8b14bffaa3391716_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id421b7a497e949c0829fd0a9cb8a9545_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>lgnd:patent</xbrli:measure></xbrli:unit><xbrli:context id="ia89ff6c0983c400999c69d63e6050433_D20191029-20191029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:LupinPatentInfringementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-29</xbrli:startDate><xbrli:endDate>2019-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civilcomplaint"><xbrli:measure>lgnd:civilComplaint</xbrli:measure></xbrli:unit><xbrli:context id="i618ff0aa526749d3ae1e702491ced1ab_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc5070ad9b82439b913a9301d0b00b65_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb2c08d52fc04211b2744d4a8b48977e_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8fa3962729945ee8b1a302fab16a100_D20201011-20201011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">lgnd:VernalisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-11</xbrli:startDate><xbrli:endDate>2020-10-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7c5753c379194807a2081c4b5d4d13f2_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8xNzI_f82aa352-c3af-44fd-96a0-3fde626e7cf8">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NTE2NWM4ZWIzMDc1NDFlYmI5NjdlYzcwOTBiYzE1NmIvdGFibGVyYW5nZTo1MTY1YzhlYjMwNzU0MWViYjk2N2VjNzA5MGJjMTU2Yl8wLTAtMS0xLTA_d02b9671-3d42-468d-a546-ff3e0131fba9">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yOTc_3837ccdb-a9c9-457d-9648-74c59f1d7cd8">September&#160;30, 2020</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6OTdhODFkYjhmNmVjNDkzNjg4NmVhZDJkZmJiM2VlZTgvdGFibGVyYW5nZTo5N2E4MWRiOGY2ZWM0OTM2ODg2ZWFkMmRmYmIzZWVlOF8wLTAtMS0xLTA_7f9bb941-ec2c-4b47-b7d2-a8cd28902337">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTkx_b2dc6ce9-e50a-4a50-963d-f4e3b10fe341">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><img src="lgnd-20200930_g1.jpg" alt="lgnd-20200930_g1.jpg" style="height:105px;width:298px;"/></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8zOTg_2fae265a-d217-4a95-8a5e-454936ec507f">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF8wLTAtMS0xLTA_c98372a2-badd-4252-9b85-62d92bddd79e">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF8wLTEtMS0xLTA_a970d3fc-e917-42b6-99d9-c5d008f25087">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF8zLTAtMS0xLTA_799db68c-6ebe-4fe5-82ae-028d4c1e4881">3911 Sorrento Valley Boulevard,  Suite 110</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF80LTAtMS0xLTA_929a1476-ef58-4689-901d-d27ced17f327">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF81LTAtMS0xLTA_b82d4b7f-882b-4e0b-9c0d-f8509d7c9445">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF81LTEtMS0xLTA_52749819-180f-4921-8532-d0dc79ab1eb9">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTky_b86f51a0-abef-49e7-ad6e-9dcfee4afb62">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTkz_3577f88e-4101-47d2-b5e2-30721e99af77">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/>Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6ZjU2MmI5ZDgzZGUyNGM1Mzg3NzliNjY1NmFmMWEyZDUvdGFibGVyYW5nZTpmNTYyYjlkODNkZTI0YzUzODc3OWI2NjU2YWYxYTJkNV8xLTAtMS0xLTA_3f378b1d-eabc-46ed-ade0-995e04487382">Common Stock , par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6ZjU2MmI5ZDgzZGUyNGM1Mzg3NzliNjY1NmFmMWEyZDUvdGFibGVyYW5nZTpmNTYyYjlkODNkZTI0YzUzODc3OWI2NjU2YWYxYTJkNV8xLTEtMS0xLTA_403a77be-bdde-4976-a299-85ee4a1b8057">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6ZjU2MmI5ZDgzZGUyNGM1Mzg3NzliNjY1NmFmMWEyZDUvdGFibGVyYW5nZTpmNTYyYjlkODNkZTI0YzUzODc3OWI2NjU2YWYxYTJkNV8xLTItMS0xLTA_1f30007d-470a-4034-b252-aeb06b2a2edc">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTk0_c58e6e87-7b5e-49e7-9d54-158b757d5740">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTg5_08bc4243-cf17-4de9-808b-b9db0e76ef62">Yes</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NmE1MTFiMjY2ZDE4NDUxOTlhNGNlN2I0MjBkNTkyY2MvdGFibGVyYW5nZTo2YTUxMWIyNjZkMTg0NTE5OWE0Y2U3YjQyMGQ1OTJjY18wLTAtMS0xLTA_66b06814-ed5c-4152-a329-2a30afbf06c9">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NmE1MTFiMjY2ZDE4NDUxOTlhNGNlN2I0MjBkNTkyY2MvdGFibGVyYW5nZTo2YTUxMWIyNjZkMTg0NTE5OWE0Y2U3YjQyMGQ1OTJjY18xLTQtMS0xLTA_1af2e9ca-9d4a-471a-90c6-242ede10fb52">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NmE1MTFiMjY2ZDE4NDUxOTlhNGNlN2I0MjBkNTkyY2MvdGFibGVyYW5nZTo2YTUxMWIyNjZkMTg0NTE5OWE0Y2U3YjQyMGQ1OTJjY18yLTEtMS0xLTA_c78e1f60-67f4-4cbc-a8e1-27af23e65ff0">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTkw_0f7f8a6f-a85f-47ed-bffc-d825906ab75c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of November&#160;3, 2020, the registrant had <ix:nonFraction unitRef="shares" contextRef="i415e31ba3f934198961f14bef202c237_I20201103" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTUy_ecfe4fc1-eb6a-416c-a657-b818cfb78caa">16,091,319</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_31">11</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_61">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_61">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_73">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_73">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_76">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_76">34</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_82">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_82">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_85">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_85">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_88">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_88">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_91">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_91">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_94">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_94">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_97">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_97">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_100">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_103">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_103">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5753c379194807a2081c4b5d4d13f2_103">38</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2019, filed with the SEC on February 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$245.0 million aggregate principal amount of convertible senior unsecured notes due 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo Med, LLC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CE</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol-enabled</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CorMatrix</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CorMatrix Cardiovascular, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CStone Pharmaceuticals (Suzhou) Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dianomi Therapeutics</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dianomi Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GRA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Glucagon receptor antagonist</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfizer Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q3 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended September 30, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q3 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Roivant</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Roivant Sciences GmbH</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Roivant License Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">License Agreement, dated March 5, 2018, between Ligand and Roivant</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Retrophin</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Retrophin, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis, SA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taurus</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Taurus Biosciences, LLC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd. and Actavis, LLC, collectively</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vernalis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vernalis plc</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited, in thousands, except par value)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMy0xLTEtMS0w_baa192a6-a77c-4b12-af16-6068dc2f0a81">456,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMy0zLTEtMS0w_b9889d29-adba-4550-83bb-dcd8c87b9700">71,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNC0xLTEtMS0w_50b08a12-c71a-48c0-8912-1015927c217a">338,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNC0zLTEtMS0w_950c045a-8189-4989-87bd-421bf90af164">998,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNS0xLTEtMS0w_bc20ba42-c6b6-416c-ba50-74d7f61d167b">32,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNS0zLTEtMS0w_68cbae97-09ff-4ebf-bd23-d18fd8b38903">30,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNi0xLTEtMS0w_0c05ea1f-3c6c-47dc-ba08-c8b8e93c33fe">13,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNi0zLTEtMS0w_420d3dfc-952f-44dc-9909-b94bc24a9f4f">7,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNy0xLTEtMS0w_5336c96e-1474-4ba7-b8c1-170b01e9cf93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNy0zLTEtMS0w_246fb812-bc55-4676-84e3-61de4a354597">11,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOC0xLTEtMS0w_364e9b53-8929-46af-828d-b258aef6a9a9">3,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOC0zLTEtMS0w_97198282-95d0-45c7-b667-86e93cd34ec5">4,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0xLTEtMS0xNjU5_3d8f0d94-4d3d-487d-8a6e-08627128d4a1">13,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0zLTEtMS0xNjYx_12057a1e-d3c8-49f6-874b-96bf7dfdd830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0xLTEtMS0w_58aef2fb-38f0-414e-a14f-5009fc0a864f">857,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0zLTEtMS0w_b27cc10b-173d-476b-990b-a9801516b781">1,123,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTAtMS0xLTEtMA_f813ce9b-a081-4231-a408-7da6a863a3bd">27,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTAtMy0xLTEtMA_2d9efd4e-20e9-4e14-8cc8-54173b1c6441">25,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTEtMS0xLTEtMA_9f505cd3-55d7-469a-94b9-db54b1315a77">224,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTEtMy0xLTEtMA_a3e9c89f-122d-47a2-b712-f0da508b7f7a">210,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTItMS0xLTEtMA_8dcac728-3464-4848-9d38-40e0e44ae4a2">102,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTItMy0xLTEtMA_1682a0b6-064c-44e3-9648-6b3215d58c80">95,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commercial license and other economic rights, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTMtMS0xLTEtMA_5c599606-e866-4f37-af96-bb6fbc8b92cd">10,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTMtMy0xLTEtMA_9a85aa4e-a918-4280-92ba-0dff9f5eeb44">20,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTQtMS0xLTEtMA_6d656a4f-d6fd-435f-98f8-7185cadb1467">7,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTQtMy0xLTEtMA_cd89f117-4931-4da6-9adf-4cd53d456cf8">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTUtMS0xLTEtMA_4881e48e-a8b6-4b93-9109-ee26ba07ef4a">4,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTUtMy0xLTEtMA_61b92d54-8d8d-4ea3-816d-0ad6033a91ba">10,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTYtMS0xLTEtMA_10515616-d1fe-437a-82f0-4a7ed19df206">13,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTYtMy0xLTEtMA_36db53c6-abc5-486d-9880-d7d5153c8e0c">2,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTctMS0xLTEtMA_f4d2b5a4-cdd7-4bf5-833f-1f23954c9135">1,247,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTctMy0xLTEtMA_99a8cdeb-eae3-48ef-993e-66ba5e756b88">1,494,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjAtMS0xLTEtMA_b9259c45-3259-44ff-aaa2-f8d9e3615203">10,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjAtMy0xLTEtMA_173dd760-94ea-4c11-b127-65277d1b2f69">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjEtMS0xLTEtMA_01e16de4-2843-423e-8032-e0b319fcd4db">14,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjEtMy0xLTEtMA_8dae7502-525a-4c85-a869-fd4d59a357e8">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMS0xLTEtMTc5Nw_65b9e76b-06ac-4f8f-b650-09bcc19703ac">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMy0xLTEtMTgwNg_d380f66b-9f12-44ef-81bf-aa42ccb2363d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjItMS0xLTEtMA_a7fb6ad7-f154-4c4e-8453-2a7f5766ab9d">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjItMy0xLTEtMA_71377992-1e64-466b-80c1-bf2e3da0fe42">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMS0xLTEtMA_016d3916-2efe-46fe-8469-f776bfb1b46a">5,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMy0xLTEtMA_d6db9b8f-140e-4b5d-abe4-b23ada2a269d">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Liabilities related to assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMS0xLTEtMTY2Ng_9304b922-a1e3-4536-b0dd-668a5072141e">10,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMy0xLTEtMTY2OA_b1fcae47-f654-4577-9c4d-af4b1ad978fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjQtMS0xLTEtMA_4d9ec782-1441-4986-970e-107b75063d48">42,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjQtMy0xLTEtMA_8930a008-6c06-4cd8-9ae4-a42e9c97d192">17,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMS0xLTEtMA_be50c45d-74f3-4565-8188-24cbe5bdb259">454,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMy0xLTEtMA_538a8b39-debc-4f28-92f2-11de2aab60d3">638,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjYtMS0xLTEtMA_1593b51d-4718-479c-8a3e-9ac8febea195">9,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:LiabilityForContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjYtMy0xLTEtMA_cec82e5f-1aee-4ad3-9868-b67b8a1c0521">6,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjctMS0xLTEtMA_c6cd5789-fd79-4dfc-a17f-4d07fb5c580f">13,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjctMy0xLTEtMA_a0a6c691-6d4e-4087-8cd5-e47ba95a90a6">32,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjgtMS0xLTEtMA_759af0db-3948-4ae0-a56c-60608819b861">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjgtMy0xLTEtMA_eae52d2c-67d0-461f-98f2-ec6843777c27">9,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjktMS0xLTEtMA_6b40231f-f71e-469d-9ce6-d8fd3b42cda7">25,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjktMy0xLTEtMA_cc479a42-96a7-414e-a223-3483d2405e72">22,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzAtMS0xLTEtMA_bd787294-7097-4abe-bed1-027035b33c84">549,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzAtMy0xLTEtMA_783503d0-2c3d-49fd-8872-fd87e499efe4">727,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzEtMS0xLTEtMA_b46bba2b-f217-4802-bc3b-e48adc6b5143"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzEtMy0xLTEtMA_a314a67b-5864-4539-b99f-522e8997d573"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzI0_72d58b7d-c195-4531-a40f-48a4adbeaaaa"><ix:nonFraction unitRef="usdPerShare" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzI0_8fb9815c-a51d-463c-8d0a-e29728603881">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzM4_5808e029-11bc-427b-b28f-9c4dcac7d42d"><ix:nonFraction unitRef="shares" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzM4_910063aa-fa77-474f-88dc-0e21d0c23cd7">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_229b20a9-59f3-4802-be4a-65b69aea8b8a"><ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_30a710cb-9d07-4de0-9cde-0580acec7a59"><ix:nonFraction unitRef="shares" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_ec08f625-8190-4f24-b90b-1a272f74ae4d"><ix:nonFraction unitRef="shares" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_f685f901-7103-4810-91da-eae673ed725c">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMS0xLTEtMA_b95bd37b-5628-415e-b05d-ca1124bd97df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMy0xLTEtMA_e68d55d1-5fbd-4c13-a5b5-9136cd4d8f96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzIx_85aadbb1-12f2-475a-a15d-ed044f82a17b"><ix:nonFraction unitRef="usdPerShare" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzIx_b6383d9d-6b8d-48fa-b837-2c2dcbd8c4e6">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzM1_141e3472-0241-4aef-960d-dd43f404afd5"><ix:nonFraction unitRef="shares" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzM1_547893a0-3f86-4b73-878e-6105b0f941fe">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzU3_08cc5cad-c9e6-4c33-93c3-e8fc3385e829"><ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzU3_297a366a-b61f-4fe1-ac8d-487d04acb2cb">16,091</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzY0_03bae9fa-9f5a-485c-8ccd-14d20a717bcb"><ix:nonFraction unitRef="shares" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzY0_98b7e3ea-f803-44ad-a9cf-9c71386d9c54">16,823</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMS0xLTEtMA_55d04b6c-fe73-4585-bae1-73dc2fa97543">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMy0xLTEtMA_aab98938-17ba-4959-9a42-5d8b22b2cbca">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzUtMS0xLTEtMA_e08c3e56-4010-43d1-a92f-4095e939f080">313,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzUtMy0xLTEtMA_1f7d8c56-fb30-401b-8488-243665b7bee5">367,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzYtMS0xLTEtMA_6d5b561c-eeb7-413e-b2ba-baf8ac9087e7">1,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzYtMy0xLTEtMA_acdd49ed-913b-42e8-814e-469fa45b8d19">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzctMS0xLTEtMA_5e2a6275-e111-492e-a7b5-a236943ad4e6">386,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzctMy0xLTEtMA_f10fd734-fe1e-410f-b6c7-0b7434092b21">400,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzgtMS0xLTEtMA_212045c0-4313-4a65-b6b3-e407998b1d6d">697,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzgtMy0xLTEtMA_f70b09a0-2a97-4333-b030-a2e765e69758">767,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzktMS0xLTEtMA_0ca9e74c-9f6e-414f-87d8-c9ce12531bdb">1,247,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzktMy0xLTEtMA_a5463944-1c7c-4ef2-906b-4f6c88cf763e">1,494,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fc64f4d95b449579c5dcf83692dc2c2_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC0xLTEtMS0w_c520a85c-936e-4ce3-a5a1-db14838e4ceb">9,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff17a87c11c484c964fba70cf7a9057_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC0zLTEtMS0w_145a46e1-6d2a-4fbd-a809-9522b81f521f">9,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992f512a9ea4391aba483112356a4b0_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC01LTEtMS0w_10e9c06e-b0a4-45b3-9b05-cfeb91ed2123">22,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89eb246de85d4b488a38dcf7024d1c08_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC03LTEtMS0w_23019184-cb43-493f-8d3b-b597d4060e5b">35,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4089e56d6e3f4a8887c64e185748adcb_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS0xLTEtMS0w_d1ce65ba-8fb5-4cbb-9b0e-c5d8ef48f166">23,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a628a6cc7441d2989a9bb873aa67ed_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS0zLTEtMS0w_ed7a52cc-39f5-4acf-a521-10eb7cde405e">6,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0095c2332c5f44189e76bf00c4b53c2c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS01LTEtMS0w_f61e3f19-290e-4309-8d9f-539c809bdd4b">68,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3415613f8a40bfbe9bad5aae16a724_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS03LTEtMS0w_a7b5d312-7182-4650-b7c3-6ff63fbad28e">24,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d01bc1e745d4a3ab4088e5f4f2358b8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy0xLTEtMS0w_bad48798-decc-4c84-ae43-23c387ec83d9">9,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24db05f0ba7a4d77a7000833e1ed3559_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy0zLTEtMS0w_a7735091-f895-4d8b-9bb9-99f050412bb8">8,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cac48edfdab44eda2c29f953e09e7d3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy01LTEtMS0w_553b2284-6b81-4072-bb4d-d61d4d8a39dd">24,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia893a67a4ca947ba9f3e9b7d01d18a0c_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy03LTEtMS0w_a213f61a-eb83-4d83-83d5-adcbf9704157">32,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC0xLTEtMS0w_c400dcc3-15db-4211-b475-f48ad01b5f94">41,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC0zLTEtMS0w_38028af1-a23d-4ec3-9b17-74aad6be3e1d">24,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC01LTEtMS0w_fa52ef54-b4a3-4709-9498-30c519d43665">116,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC03LTEtMS0w_0d14ec69-6b7a-4dbd-8836-0eeab0352f23">93,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtMS0xLTEtMA_875b8691-e781-48c5-827d-2b325b20d80a">6,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtMy0xLTEtMA_330a8730-2844-4b5e-98d9-3533189cf5d0">3,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtNS0xLTEtMA_b26d21b0-b33e-4aa7-9112-7a16650edd24">18,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostDirectMaterial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtNy0xLTEtMA_1815af3c-92e9-4b29-a698-5384126a530a">9,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtMS0xLTEtMA_56acb1da-b98f-45ef-97c4-a857b3be7f1b">3,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtMy0xLTEtMA_9aafcd51-df97-4ed3-b7ee-a965d1ecc075">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtNS0xLTEtMA_ab1cbafe-ca2d-45d4-ae9c-081543978048">11,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtNy0xLTEtMA_201251eb-adfd-4f51-9e01-649218d22630">10,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItMS0xLTEtMA_385a19f1-e016-45fb-8bd6-68029d91e695">12,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItMy0xLTEtMA_65dee77b-0215-4930-9415-f5555777637c">13,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItNS0xLTEtMA_718c73c6-7dfb-4765-a2eb-b6d01ff14d4b">37,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItNy0xLTEtMA_93cd70a6-9c55-4d53-8c87-7920270f4099">37,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtMS0xLTEtMA_fa22b0d5-4dcd-415c-b82f-f501abe6a152">15,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtMy0xLTEtMA_721e1ad2-7b37-4a13-a651-05ab7066ba79">9,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtNS0xLTEtMA_f113a88c-2b1e-4414-b247-9e6402538ce2">34,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtNy0xLTEtMA_c9e90a73-1cb1-4847-864d-2a75bae4f86a">31,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtMS0xLTEtMA_9623dd77-9b09-4580-abe8-c79733b818ca">38,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtMy0xLTEtMA_adb8a00f-59ab-405f-9144-4edbedb12b1d">29,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtNS0xLTEtMA_401fd7f8-d73a-442f-90ff-fdf0d108b9b6">101,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtNy0xLTEtMA_9725ff2e-4ede-48bd-b63d-2b52032bd9e2">88,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain from sale of Promacta license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtMS0xLTEtMA_4b36aee0-2524-4531-beee-6788ab4fcb87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtMy0xLTEtMA_7c3479fe-c1a5-4606-b56d-1c37994a8178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtNS0xLTEtMA_c5cb571b-b05c-42ae-b839-43850d7b1dd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtNy0xLTEtMA_6b27e9e6-f5f0-40c9-80b1-7c7d7618af05">812,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtMS0xLTEtMA_f3567eea-8845-41d8-b0b2-e199876cd62f">3,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtMy0xLTEtMA_2fcf1785-b46e-4e02-85e2-86e67b7993b6">5,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtNS0xLTEtMA_b2089333-37cb-4abe-8b7d-a6eedeb524b7">14,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtNy0xLTEtMA_1a0880fa-2b6c-4a60-80a5-51a65732314d">817,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Loss from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtMS0xLTEtMA_1978589f-b540-4b94-a9c4-3dd7204fc15c">9,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtMy0xLTEtMA_54c4883f-1650-45e8-a084-e66f9805d3ee">13,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtNS0xLTEtMA_668ac5b7-57a2-459b-a957-78f7b814fece">17,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtNy0xLTEtMA_229dbde7-7b30-4d64-adac-4839b2a32d42">8,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktMS0xLTEtMA_3711208a-8ddd-4195-ab2c-0366a4050e18">991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktMy0xLTEtMA_9c6de799-aafe-44ee-b1cd-b2b9dee5f80e">7,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktNS0xLTEtMA_09e499a3-a13e-4053-b18a-2fdcd13711c4">7,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktNy0xLTEtMA_7801f0c7-5a04-4e5f-a93d-509e305d01fd">22,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtMS0xLTEtMA_4a886a4c-e1f3-4234-bc81-90913338bef2">6,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtMy0xLTEtMA_026797c8-99f0-48b5-9d26-3e794b5e34f8">8,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtNS0xLTEtMA_cc6d73e5-4847-4b8f-9fcd-8d7eb01c971a">21,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtNy0xLTEtMA_3a3b84d9-c22d-4863-bfb1-f9c0b6d9dc37">26,911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtMS0xLTEtMA_7d411bbd-879d-496f-af5b-6aae587121b7">219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtMy0xLTEtMA_a6662d14-39c3-4887-a892-64422ba97158">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtNS0xLTEtMA_2b01716b-85f1-47db-ae5d-389b43417e5c">1,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtNy0xLTEtMA_f3321eff-8a2b-4ca7-a22b-54476a26b55f">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItMS0xLTEtMA_e7286be6-d6cd-461e-9247-558aef3fc63d">15,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItMy0xLTEtMA_05fae873-bc79-489c-a5e2-b160e42e02b2">14,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItNS0xLTEtMA_33371b2b-8edf-4b6f-8d83-1a2de8ba9939">28,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItNy0xLTEtMA_e5445cf0-79e2-4854-bcc4-45160dbd4274">12,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtMS0xLTEtMA_709425fb-ce63-496c-9bd3-f314db333c43">11,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtMy0xLTEtMA_680c6f03-32c8-4443-ada1-1b32045750cc">19,871</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtNS0xLTEtMA_720eea14-2010-428b-aea0-16e790ff3810">13,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtNy0xLTEtMA_4764d879-64ca-47ae-9a91-561d8ae29ab0">804,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtMS0xLTEtMA_f38672cc-bd58-4ace-8c27-512d4f499ecb">4,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtMy0xLTEtMA_8f51f371-2128-4654-841c-f6f4c11e9984">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtNS0xLTEtMA_fb40315c-6c41-44c0-b013-7012c0250875">5,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtNy0xLTEtMA_2c5f77b8-be8f-49ae-8a65-6e3fc80c4d08">168,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtMS0xLTEtMA_54082a61-e3ff-4c9b-8c83-b1344abc73ec">6,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtMy0xLTEtMA_e8ac26ca-d24c-48ab-ad4b-a0e629e14af2">15,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtNS0xLTEtMA_e1113a28-0af6-4c4d-9e0f-47bb43be9b10">8,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtNy0xLTEtMA_095a0620-fa6e-40d6-8bd4-4669910e67ec">636,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctMS0xLTEtMA_dbbd933e-037f-44bd-97a9-70dc841eade0">0.42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctMy0xLTEtMA_fd66cd48-ab72-4808-b388-47fea5a2ef04">0.81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctNS0xLTEtMA_a17943ba-f2c1-4c43-a728-3cdd079cf96a">0.54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctNy0xLTEtMA_db9076cc-b07d-4caf-8a15-982f16540bf6">32.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtMS0xLTEtMA_138b7b1f-c15d-4e57-a13d-c384759a94f5">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtMy0xLTEtMA_fd7307f1-2444-45ee-b058-04152deafa70">18,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtNS0xLTEtMA_a526d02e-e6cd-4a10-a69a-c0f74db023f8">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtNy0xLTEtMA_37cd4e29-c315-4680-b957-9a581db7643d">19,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtMS0xLTEtMA_6f709f54-d075-441c-bb11-fe4d88d50913">0.42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtMy0xLTEtMA_9df6ab79-3069-46dd-8067-fd1f231f6ea2">0.81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtNS0xLTEtMA_b467a9da-b40c-48d4-8dbe-623235a8e6ad">0.54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtNy0xLTEtMA_6ab18f95-d922-43b3-8d1f-e8b7cc765587">31.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtMS0xLTEtMA_63ffe667-e028-47ea-99b3-6536d2f20128">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtMy0xLTEtMA_2c3aa80a-6d01-4316-9a8b-0ce493517876">18,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtNS0xLTEtMA_851bb6b9-9368-4a5d-9f39-1072c7b22957">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtNy0xLTEtMA_f700b4a7-6efc-4476-84a6-089188201ac9">20,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:41.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.832%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss):</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy0xLTEtMS0w_144f415f-4138-4326-ae0d-acceabb1583e">6,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy0zLTEtMS0w_a50a42cb-317c-4dd9-8714-895b9b3fcae9">15,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy01LTEtMS0w_983ef9f8-a167-4b21-b4ed-acc32800d45c">8,746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy03LTEtMS0w_c06d9518-b390-40e1-afb8-42a6b0036404">636,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized net gain (loss) on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC0xLTEtMS0w_4ed36224-683d-40bc-bbb4-c1b80da96af6">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC0zLTEtMS0w_e4fdc719-73c9-4083-b849-300f4faca31c">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC01LTEtMS0w_f5d64c88-c9a4-4d61-a2e9-ecdc22d35f60">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC03LTEtMS0w_92fbe080-4901-45ed-835c-3e6f3142dd37">546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS0xLTEtMS0w_53d89311-1234-4e50-9293-918197d53007">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS0zLTEtMS0w_fd69eed5-aad1-4226-a6de-5a4eb663e381">764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS01LTEtMS0w_6f095f6c-c203-4078-8206-365842a7e882">1,141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS03LTEtMS0w_b6e7b1d7-ca8b-4ffb-ac88-454bd09d74b2">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy0xLTEtMS0w_dd02ea13-5135-4b38-90c2-e59c34f59d43">5,832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy0zLTEtMS0w_ddb2f789-29ed-4f9a-97e1-740eb5862587">16,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy01LTEtMS0w_0c0bbeb8-96aa-4260-bf2b-e720e3bc14d9">9,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy03LTEtMS0w_c9d0cd68-adf0-4031-9a6d-0288febef882">636,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.400%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7229001e60ff49198a53dbfbcd6d60b4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi0xLTEtMS0w_41f006f1-4187-459d-bcdd-309832502ecb">16,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7229001e60ff49198a53dbfbcd6d60b4_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi0yLTEtMS0w_bd641186-51ff-40f3-b272-a0231d5cbcbc">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa54869d40994b6aa64042e970f51be8_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi0zLTEtMS0w_0c00e062-d65f-42db-aa4b-091be4f25009">367,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a859673f5404c6cbfade9e44d71e9f2_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi00LTEtMS0w_df92112b-b59e-4b1f-94ad-2d0a29e5fc87">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a58a3c6c6448268c41dca75ca52fc7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi01LTEtMS0w_389b89e6-dd75-4e1d-bfcb-cce45bb38c85">400,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi02LTEtMS0w_a3bf9bb2-4010-4915-8746-3b15ea833979">767,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMy0xLTEtMS0w_7a87b22e-af91-4ab5-af92-e22ba4aa2ee7">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMy0zLTEtMS0w_2ed3be3c-057d-43c4-8d5a-6ae1adc6835a">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMy02LTEtMS0w_f0ffae88-1f00-49ad-8000-05145e167813">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNC0zLTEtMS0w_382af13e-c307-4751-bd72-80eb8d221eec">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNC02LTEtMS0w_fb57a90f-85c2-4d69-bbcc-e6d8c70d8386">5,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS0xLTEtMS0w_6171dd71-4cb4-4dc8-927a-dbacf1a56e15">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS0yLTEtMS0w_a33a64a6-c65e-40cf-b208-52a3a2fad226">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS0zLTEtMS0w_77547c23-9359-4e11-8b95-9a19b1208fbf">73,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS02LTEtMS0w_835c0ef1-16f1-4b6d-9c08-73108ee896ea">73,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6aea072928f4adfb9348fc0edbac316_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNi00LTEtMS0w_022bdc1f-d4b8-4929-8b27-1f113c2a1ca4">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNi02LTEtMS0w_9615f95d-190e-422e-ab41-5f5360fb48fa">2,772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6aea072928f4adfb9348fc0edbac316_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNy00LTEtMS0w_dafb5402-0577-4ed8-8d55-e4b8a1a99c22">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNy02LTEtMS0w_8b205946-a2c1-458d-b21e-c161ce410853">1,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOC0zLTEtMS0w_6e79c356-7091-4697-9d26-98fa9ab2f2a0">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOC02LTEtMS0w_62ab0cea-0dd6-463e-bd05-f63f2d4de5c1">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative-effect adjustment from adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS0wLTEtMS0wL3RleHRyZWdpb246NDA1ODlhMzQzNDUxNGQ1MzhlMTlhOWE3ZDJkYTIxMmJfNTA_5acfac75-4ba4-4abe-a410-f94041340fdd">ASU 2016-13</span>, net of tax</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e26dda8ec9c45408cdc8bf9f7fe8c69_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS01LTEtMS0w_278f7ba0-9fa5-41f5-a816-93999eb5fb7a">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6633e74552be487692e9b132df36f4e8_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS02LTEtMS0w_d8acab7e-ef67-4253-b71f-1678d004c2e0">5,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aac323c2302486893f879d73f4c93e4_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTAtNS0xLTEtMA_688b53e4-ff48-469f-ae16-04daec9b74c3">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTAtNi0xLTEtMA_74c9b218-c30e-4331-b3f6-23ce16a4c80d">24,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad5487114db84eac9bfa300064f305c6_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtMS0xLTEtMA_6f192eab-de27-4201-afec-f27d582d6c49">16,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad5487114db84eac9bfa300064f305c6_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtMi0xLTEtMA_3213cd5b-7144-4c10-9efd-2fe53e2ba510">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia225c7585f734df2a5415a615cdf2097_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtMy0xLTEtMA_c9ea0bb0-d1a3-4937-94df-862c8f9d4a68">295,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i390ae39298aa49b48acd3739a2084b20_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtNC0xLTEtMA_080b7042-90fb-4be9-bc49-0cc0a188cf63">4,867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e9a32b21494264a59d8c3209cde81c_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtNS0xLTEtMA_b5123e7d-017d-45c0-91b2-1279c9d138d3">370,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5adb4b836261437c8a079d884dd0e8ca_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtNi0xLTEtMA_580862a7-59d8-4436-be4b-5fcfeaa1f10a">661,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd47a5e4d9a24937a102511805705f35_D20200401-20200630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTItMS0xLTEtMA_21559d7b-4954-4e72-9b0c-b95abfc0ae85">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTItMy0xLTEtMA_8054b6ec-a561-4438-90c0-e877a53dc217">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTItNi0xLTEtMA_e4e777b6-f621-4e55-b3aa-0f154276b570">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTMtMy0xLTEtMA_642143cb-cd87-459a-8e50-4671b074f430">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTMtNi0xLTEtMA_d18f9b48-a80a-4a00-8aec-27dd73d73d67">7,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff9d958158dd43a293e2993c7506b393_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTQtNC0xLTEtMA_3316ed44-16d7-4408-b7fa-722aeff626b5">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTQtNi0xLTEtMA_a6f2caba-535b-431c-a627-1969f86811bd">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff9d958158dd43a293e2993c7506b393_D20200401-20200630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTUtNC0xLTEtMA_24246c1c-6a0a-4e7c-afe3-4a0558f3de74">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTUtNi0xLTEtMA_fc83e820-0c4d-4b44-b698-25bdb75d6fc8">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment on reacquisition of equity due to 2023 debt extinguishment, net of tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTYtMy0xLTEtMA_f37df607-f99a-405a-b184-170e628c150d">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTYtNi0xLTEtMA_ee2a6a45-66a2-4294-8e41-8edeb12c15ef">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e9549e37074565b41ee42b330a2e2d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTctNS0xLTEtMA_d5638c24-e7ed-4486-856d-16e42aff9671">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTctNi0xLTEtMA_ebaf3d9e-1329-43d2-ad7a-4a9736742441">22,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a7426a780234cb098ddd5e2ad753bbc_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtMS0xLTEtMA_6d23fc68-b043-4260-b3cb-1bd9117bb349">16,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7426a780234cb098ddd5e2ad753bbc_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtMi0xLTEtMA_4166a760-d571-478f-a1cb-acb30a07474c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50fc27200cc345ddab6a3d2ba7763419_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtMy0xLTEtMA_1aea0cf1-b569-49c7-b2ec-e87eec1de1fa">304,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cf845807cc0448f8bb1b78321ef94bf_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtNC0xLTEtMA_ce3c2e6e-dbf1-4b70-bc7d-2c68ee310d93">2,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033832a8e05745f8925aad29d6926388_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtNS0xLTEtMA_d859d01c-cf7a-430e-8b4d-566b5c86da4b">392,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i490f2ffbbf00499fbb82c91eb2b73aef_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtNi0xLTEtMA_03606dac-98c6-4c70-86ac-0ec16aa7aaec">695,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib77b17a4438e4523ab9ff836080cad8f_D20200701-20200930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTktMS0xLTEtMTM2MQ_750e19ab-0d6e-4f49-a075-7e851b8af7c5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e1862d94954195986e08adfa6e1308_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTktMy0xLTEtMTQyMA_80470260-93e5-4523-aba3-0963fa18eedf">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTktNi0xLTEtMTY3OQ_215d074b-57b7-447e-bb5a-15af8063e58c">910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e1862d94954195986e08adfa6e1308_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjAtMy0xLTEtMTQyNA_7ff1fdfe-1047-4421-acb1-fd1149b216ed">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjAtNi0xLTEtMTY3OQ_6f4a1385-cea4-4593-8b66-49b7f46eab94">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6b07ddca2e541d7ba70100ef93c997c_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjEtNC0xLTEtMTQ1OA_538e5f93-ec7b-4fd4-8202-c0d2caffb7f0">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjEtNi0xLTEtMTY3OQ_f94dc179-eb8b-497b-8a40-6579e98c1d85">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b07ddca2e541d7ba70100ef93c997c_D20200701-20200930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjItNC0xLTEtMTQ2Mg_a56c07e6-ab4d-4686-ad65-546a419658f3">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjItNi0xLTEtMTY3OQ_fc366d74-3efe-41b7-b30d-e13a5df7b281">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e1862d94954195986e08adfa6e1308_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtMy0xLTEtMjc5Mw_761f85c0-1b9c-454e-9eee-eddf588126f8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtNi0xLTEtMjIxNQ_512e02b0-86b9-42c8-9b2b-d46da663527c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia37703b7519741a7947b97bcf8cb4d32_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtNS0xLTEtMTQ5Ng_cf58936f-db20-4810-a57f-525f5c314a2a">6,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtNi0xLTEtMTY4MQ_bcbc10da-324e-43b4-b17e-15daa77134cf">6,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5d9a384d5fe4b8ea0e9be04bb79c338_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtMS0xLTEtMTY4MQ_ce922951-5396-4160-b768-586ec1faa01d">16,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d9a384d5fe4b8ea0e9be04bb79c338_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtMi0xLTEtMTY4MQ_94916734-393c-421c-9b64-0377f3f6fcae">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if87fbb1c899e4dd3a43541865f6f3cb5_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtMy0xLTEtMTY4MQ_bd5e8369-b226-42f8-b225-1d033151c765">313,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06e8e2209037448496084b7cfc9433eb_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtNC0xLTEtMTY4MQ_3b1dfa56-cb8a-470e-b56c-dc0fede822d2">1,441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id242a912b69a4ef0a5aa82c546921324_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtNS0xLTEtMTY4MQ_cedb34c0-ad83-4d8e-9db1-194721335e1e">386,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtNi0xLTEtMTY4MQ_ff36c6af-2d81-4a38-93b7-ae187e057126">697,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (Accumulated deficit)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a970afb914d41ce990cb1157db7eb2e_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi0xLTEtMS0w_21fffb27-5a12-4fb0-b073-05a227ddc95b">20,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a970afb914d41ce990cb1157db7eb2e_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi0yLTEtMS0w_b61bf834-532e-4f51-b290-a8d1e5329d9e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e121e85c66044c887bca7e02db16f42_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi0zLTEtMS0w_4a684270-4ffb-4400-8337-58fddb3e5342">791,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49bb47989637497c8b00af3bf1f16d88_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi00LTEtMS0w_364e64dd-2194-463a-97b3-e85b21da8585">1,024</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia51a45b1a9554dc4a23d19c9681b8627_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi01LTEtMS0w_edd6970e-0085-45e0-81b7-08beed244fe5">229,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c217737a66b4aeba81beaacd79e70ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi02LTEtMS0w_4b54ff21-3174-4283-b23e-7b991c6f428e">560,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMy0xLTEtMS0w_51839fb8-92b5-499c-a3e3-b1795f696197">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMy0zLTEtMS0w_fb7798a2-2da3-4796-a398-e7a2fb906e26">991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMy02LTEtMS0w_1069c2cd-6132-4b1d-9c48-582960ebcdc2">991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNC0zLTEtMS0w_94d45d94-efbb-46b8-9e3f-c7773a6d09c8">5,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNC02LTEtMS0w_c272d8a9-e28a-4b79-a8f9-11ad3fa6d95a">5,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS0xLTEtMS0w_803e4eff-e965-4c94-b5f4-8fe15c4f3bb7">1,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS0yLTEtMS0w_fcfdfd7c-87df-4556-ae22-ab1268d06738">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS0zLTEtMS0w_b226e773-21ed-4654-b107-75b5eefe8c26">151,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS02LTEtMS0w_dfcfb37c-af52-49df-80b3-d8101471b289">151,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234221629449487f964bc6624088b0c1_D20190101-20190331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNi00LTEtMS0w_f5705063-d13f-4818-93f6-73e93825accb">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNi02LTEtMS0w_0890211e-c0f4-4750-a5cb-4a1acfbc312a">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234221629449487f964bc6624088b0c1_D20190101-20190331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNy00LTEtMS0w_861dea3c-a793-4978-a0c0-74e5c41f6975">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNy02LTEtMS0w_35a5af3e-d9f6-4d98-9c39-462a67d98ed3">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other tax adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOC0zLTEtMS0w_4d186061-e70a-4f93-af4e-bb125e6eeb33">569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOC02LTEtMS0w_7fa0ed91-f923-407c-8d2a-4ee9ce04e2f9">569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffdf07b1b53463498a6c354fdf3b822_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOS01LTEtMS0w_234ba66e-c3c0-4687-8602-922a0b83576a">666,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOS02LTEtMS0w_12a2a368-98fa-415c-a991-89dfff80a130">666,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3d3d78b23a9464aba33b50d534d7983_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtMS0xLTEtMA_286bb99a-237f-4923-b43c-72c834034807">19,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d3d78b23a9464aba33b50d534d7983_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtMi0xLTEtMA_c35587b7-bd76-4e45-bcdf-4a941aff6007">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fadbb805c68461391658b06e2708f69_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtMy0xLTEtMA_c1c9fb66-5fc1-4787-ac82-9147bcbb7263">643,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic824a6a2217044eebe4ad6f38deb865e_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtNC0xLTEtMA_2dfb896b-17f6-4b30-a81f-3ebc17ac84f5">503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifadacbb2a79244b9a4f3e6026a94394d_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtNS0xLTEtMA_8462add6-97bf-41be-bd00-b2db367f9ed5">437,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13cc02644d614c5a9a285795ce36f88c_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtNi0xLTEtMA_978355f4-98e7-42e7-af93-d163c7a84d04">1,079,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTEtMS0xLTEtMA_63b98aad-1751-4a2c-999a-84f6e05e66a2">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTEtMy0xLTEtMA_a56e736c-d85d-4c84-b8a1-e757bb699d49">740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTEtNi0xLTEtMA_d92d7ced-23ae-4210-870e-5f7119062abc">740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTItMy0xLTEtMA_39360633-cbc1-4745-bf10-fd3b3ae8f109">6,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTItNi0xLTEtMA_bfb99c8e-0359-45b3-8af2-9d845073aea6">6,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtMS0xLTEtMA_5b3b37f1-b789-4d7f-afa0-521bf49c9fea">291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtMi0xLTEtMA_1e27b8fe-3448-4d4e-89c3-b466c89e764e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtMy0xLTEtMA_5e6cdafc-e174-4fbb-8a45-4e1ed308e45d">33,716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtNi0xLTEtMA_4afbc444-39a8-4756-a821-51055dc492d1">33,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4daf159584b94905a33f5c1706489352_D20190401-20190630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTQtNC0xLTEtMA_ed1e9d99-6c1f-4f31-aa7b-3093df297c8a">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTQtNi0xLTEtMA_2a73d2e4-0592-4689-8ba1-faf9ebbf4cc8">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4daf159584b94905a33f5c1706489352_D20190401-20190630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTUtNC0xLTEtMA_f0b728e8-a53a-4403-be0b-cca07fedcf21">542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTUtNi0xLTEtMA_07a152f6-336a-4eea-afd0-3fe5a7e64319">542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other tax adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTYtMy0xLTEtMA_3544bc6a-e1e2-4122-ac8f-ccbc4c83e32b">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTYtNi0xLTEtMA_e8344043-33e5-4aef-ab39-b75e859411ef">2,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37fb40383c604fa99c82bd4627415ddd_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTctNS0xLTEtMA_cb3304f3-ab23-479d-a94a-2dda6404bc39">14,419</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTctNi0xLTEtMA_343b2865-23ff-4386-bf83-2b3cbbffd27c">14,419</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1dee39642b1441adab4e1b7f195f4820_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtMS0xLTEtMA_61419844-52b7-4c6e-95a4-c804a923955f">19,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dee39642b1441adab4e1b7f195f4820_I20190630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtMi0xLTEtMA_4e0894fc-77d6-4da7-9405-00b282082df3">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c4ce8565674d7cbc011bb29d51fdbc_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtMy0xLTEtMA_e6180caf-414d-4e12-ba37-a0b3aa64b813">619,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9f29670866f470d84fbf023db043769_I20190630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtNC0xLTEtMA_ba994a80-8bea-43b8-9f6c-f3c2f5568c47">542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43125aaaa4d745faabb5618510882e01_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtNS0xLTEtMA_4cd8d9ad-0e5c-4970-a48e-c9c998bdbfdb">422,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c8205976c64573b1f5fafa7ee9496c_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtNi0xLTEtMA_ce4ba1d1-af8b-45dc-971f-96ed9134ecd5">1,041,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTktMS0xLTEtMTIy_7bfd165f-463b-4a73-bccf-fc5c8e97151c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTktMy0xLTEtMTM2_4509c9f0-06e8-406e-b2a7-6a2815df00fb">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTktNi0xLTEtMA_2282a911-e551-4ab7-8c57-66b56920664a">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjAtMy0xLTEtMTM2_93cfeefa-477e-4653-a08d-ff633238b542">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjAtNi0xLTEtMA_be9298ca-909b-4603-906e-bd59ac25a53e">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtMS0xLTEtMTI2_f5aa8503-2465-48a6-bde5-d62e64c97568">1,834</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtMi0xLTEtMTMx_8b86c5ba-9255-40c1-8b83-a1dc86dbf9a5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtMy0xLTEtMTM2_f3abf359-1e96-4f9b-be8c-6bb0584fc718">181,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtNi0xLTEtMA_d1ff5f7a-731d-45c2-9c6e-183796c0827b">181,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df602c5680a4955ac8de558547908d1_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjItNC0xLTEtMTQx_9f0a72a6-30c8-45a6-a21a-5b0f467e3783">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjItNi0xLTEtMA_539fd9a7-2e85-4011-902c-5edaab533e39">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df602c5680a4955ac8de558547908d1_D20190701-20190930" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjMtNC0xLTEtMTQx_713d4343-f072-4cc5-abe0-4883d4295588">764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjMtNi0xLTEtMA_196fd32f-f6cc-4896-a531-00f37ebbe4c1">764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other tax adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjQtMy0xLTEtMTM2_2c1fbf2b-7528-40fe-9ffa-ba1db2732ab1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjQtNi0xLTEtMA_e15d1ffc-a57f-4c9d-a9df-34b8b3221b1e">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3192c6a0bb844fdb952e47d0f4a8a28_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjUtNS0xLTEtMTQ2_88f2e8bc-b3c7-480e-a0cb-3b0ec3156e86">15,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzEtNi0xLTEtMA_d8ac5548-5273-48ce-b2ea-bd9e7bf096a2">15,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife85aa33f030423e9deacf97a190c282_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItMS0xLTEtMA_8a2f01d2-6a89-479e-8ae3-1ed9983e005e">17,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife85aa33f030423e9deacf97a190c282_I20190930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItMi0xLTEtMA_0db3b475-652f-4923-9120-6f4877b04c00">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ed241cfb09b46e5ba9c8968fb1b32f8_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItMy0xLTEtMA_1ea2f03a-8784-4265-a8f3-1e3250c73aae">444,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4d3f481bad1425ca853b25afe3012d9_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItNC0xLTEtMA_5f0f01e3-5e28-4ee4-9375-316825a6050d">1,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae80780948143b7b2da481e22963423_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItNS0xLTEtMA_ae6d9274-222b-4995-b054-20fbec661c97">407,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItNi0xLTEtMA_0d8b8558-fae8-482e-9414-84067162dd30">850,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, in thousands)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNC0xLTEtMS0w_ac8adb8d-f455-4496-8a43-c8b8d76cae6d">8,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNC0zLTEtMS0w_f50c8795-ed8b-4971-8b9d-21f5bc00a6d7">636,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain from sale of Promacta license</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNi0xLTEtMS0w_b069ee52-b8f5-489f-a489-094348b392ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNi0zLTEtMS0w_ede4ed5c-1b98-415f-93ad-06b6da704d99">812,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNy0xLTEtMS0w_17059c4d-3725-46c6-aa44-0f299a86ba73">397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNy0zLTEtMS0w_2949f7d2-6f41-4ddf-9500-573a2570b4ed">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOC0xLTEtMS0w_9e539517-272d-4052-8747-d04ccdd1bfd3">12,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOC0zLTEtMS0w_fc96d0ae-9c02-4bf5-af0c-4769619363f5">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of premium (discount) on investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOS0xLTEtMS0w_8e20b275-a13a-471f-bb33-099b7cc63086">1,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOS0zLTEtMS0w_7301089b-7c04-442a-843c-f24fb61a3a7c">7,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTAtMS0xLTEtMA_82307e7a-f458-405c-9b3d-2af0196825c8">17,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTAtMy0xLTEtMA_0f57184d-157a-49ec-81c5-65b8343a0b55">22,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of commercial license and other economic rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTEtMS0xLTEtMA_d49f9127-58d4-46b1-ba7c-3aa21d6a3376">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AmortizationOfOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTEtMy0xLTEtMA_8fd318eb-3a1d-4394-a4d0-d75e4951c655">10,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on debt extinguishment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTItMS0xLTEtMA_aa5904ae-9e8f-44eb-8eab-2246f2477b4d">659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTItMy0xLTEtMA_b2ab5718-b927-495d-911f-506fd1384ac8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTMtMS0xLTEtMA_e45bc4d4-86f1-47c1-baa0-efe567a03ae3">20,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTMtMy0xLTEtMA_d9c1a35c-fc29-43f2-a9a5-c5524b3f5a39">18,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTQtMS0xLTEtMA_1c03c549-4ae0-43a7-a840-576f04c10788">19,311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTQtMy0xLTEtMA_6e057a0f-462e-4e59-a57f-7a5fd452ad59">57,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTUtMS0xLTEtMA_41aaf4df-b1c7-4f22-9c32-df22c7afb41f">17,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="lgnd:GainLossOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTUtMy0xLTEtMA_938d23db-d697-4733-bf26-5b9f4684e6db">8,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTYtMS0xLTEtMA_eef180c0-0b6a-40fa-bafa-20b6c50df53d">1,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTYtMy0xLTEtMA_0a8d072f-18ff-496c-ae53-9a9a4a68d024">4,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisition:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTgtMS0xLTEtMA_dcbd1f07-5622-410a-b249-5e122e1e4d12">5,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTgtMy0xLTEtMA_028a75cb-9b17-4988-94f2-49803340bf8b">33,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTktMS0xLTEtMA_3f7d6bc8-8f71-49d8-9493-1a4b008b46ef">4,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTktMy0xLTEtMA_7de994e3-758b-465b-9945-71eec8cae579">1,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjAtMS0xLTEtMA_5be36089-5f03-4456-8767-6d4f70c56106">9,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjAtMy0xLTEtMA_386071c7-b834-4716-9a44-5b587a715e65">3,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and  payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjEtMS0xLTEtMA_8aa09bfb-8dc6-4d10-863d-cea9f281011a">12,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjEtMy0xLTEtMA_36491fd6-ca71-4866-b365-92dc5b6d5383">16,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other economic rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="lgnd:IncreaseDecreaseInOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjItMS0xLTEtMA_9f3a10f4-c544-4fd5-be98-d6845cad9dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:IncreaseDecreaseInOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjItMy0xLTEtMA_c19fdfda-4927-45a4-939b-bb80d2a49723">12,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjMtMS0xLTEtMA_24d3fac2-1cfc-41fa-9173-ffd44dd4efd7">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjMtMy0xLTEtMA_abe025e3-2ac3-4b0a-abf0-10f62427e645">2,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by (used in ) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjQtMS0xLTEtMA_84c172c6-cf9f-4572-9d13-b98af2f2f14a">54,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjQtMy0xLTEtMA_e0daed8b-a6b3-4e23-9fae-689f7afd0cc9">21,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of Promacta license</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjctMS0xLTEtMA_bbbc184d-f073-481e-b863-1f7c79d9cb9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjctMy0xLTEtMA_086f2a5f-c021-45ac-af65-be8f81c5cfeb">812,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjgtMS0xLTEtMA_9180a34c-105a-4ccf-8357-20b9858362d3">337,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjgtMy0xLTEtMA_b8d5925a-fa62-4d03-b6b3-d7d27f74ed64">1,682,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjktMS0xLTEtMA_feff3bdc-e75b-4e4d-88ed-9416350213b4">389,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjktMy0xLTEtMA_b75068be-e144-4ddb-ac3d-6177b78d6d20">144,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzAtMS0xLTEtMA_8000e5f8-5668-44f3-9c8e-6793a6635496">589,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzAtMy0xLTEtMA_d90b77ae-4e2c-4c01-9c18-7d7e49d817fe">1,274,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for acquisition, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzEtMS0xLTEtMA_30ad68f9-4bb5-49a0-a2c7-95c28aabbc43">26,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzEtMy0xLTEtMA_26a0b434-1d83-44b6-9fcf-4eedc3562eec">11,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMS0xLTEtNTg_9202e1e2-a8c0-4366-a531-2f80164a6265">500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMy0xLTEtNTI_16ee670b-7c8e-4353-bd35-7f3e41b1e016">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMS0xLTEtMA_f7c3a83a-0fdc-40ea-9045-0f26d1bc7429">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMy0xLTEtMA_92c5f9ec-4c22-460c-a9d9-8a0f3e4f9fd5">6,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzMtMS0xLTEtMA_1331a58b-bd4d-4107-b684-399833644c46">613,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzMtMy0xLTEtMA_1059f30a-d6c1-4973-a5af-57a52d4b9946">530,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d610f8e9c4740b18e5147a6ee408789_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzYtMS0xLTEtMA_9ef5e2ec-3d98-4d93-a163-69387f0ee92e">203,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d5df0e1dac4e88ae8b5fb46ae522b3_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzYtMy0xLTEtMA_9eea504c-41fd-442e-8092-6c1f91c31210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of 2019 Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id067844f4eb4436eb363d302e57613d7_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMS0xLTEtMjc2_c10a86a6-4067-4ed3-afab-628d7a401269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i852922b66fce4828ae182e5350dcb942_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMy0xLTEtNzU_01393aa0-770c-4e84-a480-3da6b5c93dcf">27,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMS0xLTEtMjc2_4f92440d-38ba-474d-9b70-0b8125079262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMy0xLTEtODM_8cb16741-ae06-4752-b064-a7727cf5a043">12,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to convertible bond holders for bond conversion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMS0xLTEtMjc2_4d0ccfc1-d175-43e2-8046-9b250fd349cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMy0xLTEtODM_e9113d8a-c5dc-457e-8e09-3ed7e5cd37f8">12,401</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzctMS0xLTEtMA_b700e635-2432-44e5-af1d-f9ecf08e8682">2,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzctMy0xLTEtMA_6a1ad7ff-3525-48bc-9c69-d9738ece8bd9">2,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMS0xLTEtMA_6c0d0af9-f2a3-420e-b619-b2ee23ea9a5a">1,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMy0xLTEtMA_7b2a4eaa-51f8-4061-9f83-d5c1352fac4e">2,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMS0xLTEtMA_5db41f9c-0d7a-4695-b285-53bee3f15482">73,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMy0xLTEtMA_8e936851-2f59-440d-a7c7-fcbee1654098">371,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMS0xLTEtMA_9e5b72af-a711-4b3a-b48c-435e33a6dfea">2,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMy0xLTEtMA_2c2f5910-86ad-4354-a70d-37cd7469792d">3,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDEtMS0xLTEtMA_668163b9-30e6-44d8-9ec1-3afdcddbc6b7">5,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDEtMy0xLTEtMA_27806624-852c-47aa-911e-a76da9a9c0f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDItMS0xLTEtMA_dc86f004-6b59-4e53-a3ef-5fad78823555">283,016</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDItMy0xLTEtMA_5a64aab6-a16e-4d1b-8845-a505bcaa44ed">401,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDMtMS0xLTEtMA_9247f320-2fc3-4498-b56d-78882cc6ad69">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDMtMy0xLTEtMA_e554d841-978a-4221-ac42-5c9445d4b4d4">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDQtMS0xLTEtMA_c884a710-34da-4b22-be21-069086e532bb">384,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDQtMy0xLTEtMA_a9390538-4135-466a-ac3d-bd486d5e3561">106,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDUtMS0xLTEtMA_0602a209-4b9b-4018-80cd-dfc4c8074cf1">72,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c217737a66b4aeba81beaacd79e70ec_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDUtMy0xLTEtMA_018d4b9d-bff5-4936-8cb4-a09de3964046">119,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDYtMS0xLTEtMA_44d350b1-fb3b-48f2-a898-072aa5f9761b">457,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDYtMy0xLTEtMA_4b5417f1-30c3-4796-93c9-0e66c8defe0c">226,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMS0xLTEtMS0w_ee012e22-7a27-48d4-93d7-3b7b4ffbd09c">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMS0zLTEtMS0w_479666d2-2c73-4568-8243-0d9d8a798573">3,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMi0xLTEtMS0w_edd17083-8728-4b2c-9b4f-58bea9042f30">2,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMi0zLTEtMS0w_ab25f8db-c3f4-4959-a382-cb98a3f353a3">93,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash in other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMy0xLTEtMS0w_83cfdb59-7dc1-40a8-94a4-2b95e52943b2">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMy0zLTEtMS0w_cf6121b6-2569-4c41-98ba-951ed64a9033">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfOS0xLTEtMS0w_6ccbcb7e-83fc-427b-b206-9c19c4f0d02a">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfOS0zLTEtMS0w_a9235602-21c1-43c1-aea1-0ad1723efbc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTEtMS0xLTEtMA_6b72e001-a3aa-4eff-802b-c34e5b2be578">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTEtMy0xLTEtMA_a9c9f8bf-2561-4f26-8783-6d017e6db6f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued financing lease payment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:AccruedLeasePurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMS0xLTEtMjMyMw_902463d0-9821-428f-8916-f186fe810990">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="lgnd:AccruedLeasePurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMy0xLTEtMjMyNw_e64c3a96-7f50-47bc-9171-e0bde1713225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain (loss) on AFS investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMS0xLTEtMA_c94fd4e7-2540-45bf-a8f2-616f75174b94">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMy0xLTEtMA_354b530d-4654-4525-bb36-f58d775b4b46">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_34"></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NTE_964b614d-4bdf-4e7a-974f-fef9872c35a7" continuedAt="ie49afb27d1b745a097ccbb218fa02d0a" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie49afb27d1b745a097ccbb218fa02d0a" continuedAt="iec51ef5559eb4686a9bd5a381ba6419d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MjE_08655880-020c-41bf-83a7-3290d01ab115" continuedAt="id769c49b9de9464aae9dd15cbd384f33" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id769c49b9de9464aae9dd15cbd384f33">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2019 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NTI_dae2178a-0f55-49ef-86af-0b191ea14860" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the second quarter of 2020, we began to include our investment in Viking in &#8220;short-term investments&#8221; in the condensed consolidated balance sheet, and present &#8220;gain (loss) from short-term investments&#8221; in the condensed consolidated statements of operations to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in &#8220;other income, net&#8221;. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and nine months ended September&#160;30, 2019 have been reclassified to conform to the current period presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of Notes to Consolidated Financial Statements in our 2019 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2Mjk_7bfcaf4b-4761-4c0e-bfd6-d149489b7596" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iec51ef5559eb4686a9bd5a381ba6419d" continuedAt="ied610ee9c88b4d5f8eec5065582393e1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead for Veklury</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (remdesivir), the first FDA-approved treatment for COVID-19 for the treatment of patients with COVID-19 requiring hospitalization and, as a result, we have extended our Captisol supply agreement with Gilead until September 2030 and worked to increase our manufacturing of Captisol to meet this increased demand. We believe our existing production capacity, together with our planned expansion, will provide adequate supply of Captisol and do not expect any significant risk or disruption to our supply chain for the foreseeable future. In addition, certain of our OmniAb and Vernalis partners have initiated antibody discovery programs for the potential treatment of COVID-19. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDY_ac7efb2f-98f9-43e4-9de0-54a6483a3872" continuedAt="i6c94846da0984861bf42c8511be53810" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. This standard includes our financial instruments, such as accounts receivable, investments that are generally of high credit quality, and commercial license rights. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The new guidance requires us to identify, analyze, document and support new methodologies for quantifying expected credit loss estimates for our financial instruments, using information such as historical experience and current economic conditions, plus the use of reasonable supportable forecast information. We adopted <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b">ASU 2016-13</span> on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance sheet of retained earnings to be recognized on the date of adoption with prior periods not restated. The cumulative-effect adjustment, net of tax, recorded on January 1, 2020, is approximately $<ix:nonFraction unitRef="usd" contextRef="i6633e74552be487692e9b132df36f4e8_I20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNzY1Mg_70d74750-57b6-4bb0-b2fd-3cf2e2fe078b">5.2</ix:nonFraction> million on our unaudited condensed consolidated balance sheet as of January 1, 2020. Results for periods after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported under previously applicable accounting standards. See additional disclosure on credit losses under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Short-term Investments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Accounts Receivable and Allowance for Credit Losses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Commercial License and Other Economic Rights&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which eliminates the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. Under the new standard the goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value, although it cannot exceed the total amount of goodwill allocated to that reporting unit. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which modifies the disclosure requirements on fair value measurements. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In November 2018, the FASB issued ASU 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements: Clarifying the Interaction between Topic 808 and Topic 606 (Topic 808)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when the counterparty is a customer for a good or service that is a distinct unit of account. The amendments also preclude entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. Depending on the amendment, adoption may be applied on a retrospective, modified retrospective or prospective basis. We adopted this standard on a prospective basis on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ied610ee9c88b4d5f8eec5065582393e1" continuedAt="if8db401229b84750a76f84ed6efdd07c"><ix:continuation id="i6c94846da0984861bf42c8511be53810"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc1OTc_3c65f1d5-bd6c-4754-af22-a2679b1edfac" continuedAt="i37bdcd82e41c4886b3b0adb5df1cc3e2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="if8db401229b84750a76f84ed6efdd07c" continuedAt="ice2f1697098b4ba58b0e846bdaabca3e"><ix:continuation id="i37bdcd82e41c4886b3b0adb5df1cc3e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTY4ODc_7aba5acc-9dd9-490c-b445-b50d6ab9d644">5.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTY4OTQ_284b7b24-9dcc-47f8-b45e-ad97370c9792">8.3</ix:nonFraction> million, respectively. During the three and nine months ended September&#160;30, 2019, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTY5OTY_ab2a93a6-835d-4cf5-81e5-98ecad6e5f69">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTcwMDM_56c60292-92e8-46cb-aa73-2489b43bdd9c">5.0</ix:nonFraction> million, respectively. We expect to satisfy the performance obligations related to long-term deferred revenue within the next <ix:nonNumeric contextRef="ifa3f1a01a9864e59ac71fe92b7ca767d_I20200930" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNDM5ODA0NjU0NzMxMw_0fbd7f6b-2e10-4a74-b660-72c96c363ebb">3</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2Mzg_bdd9ae81-cef3-4593-8bc8-b623379ec24d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:9.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.059%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8257a98db24ffaa95e5892f684fd01_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC0yLTEtMS0w_13256933-7f1c-4c6e-b9f5-d226f999532b">6,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79407bfe8ff44be68b660b88255cf447_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC00LTEtMS0w_f37edd2a-aeae-43e9-b2c6-f3ebb4bdf246">7,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia162f6b1d4274062b41ad002117be195_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC03LTEtMS0w_8d833692-00ca-438c-a2b3-3b2dcb5de104">16,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959c4730e2da4bcdb04ef2f33d1574d7_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC05LTEtMS0w_49807c87-f519-4011-a50e-a488e5a49f1d">16,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i953eac10432944aa918dad32003e1069_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS0yLTEtMS0w_0b68684a-8845-44c8-8c74-ed368a9c83d2">1,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5500183722b040e19d12c71572ccb758_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS00LTEtMS0w_e8c3b6b9-86d6-48e8-924e-184b3843d861">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae408995adc74e3ca6339d16292d5778_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS03LTEtMS0w_802d6a4e-c830-43fb-9bbe-c36ba237b0b3">4,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia617fcaa706e40a6a1ac062ee7d43ec4_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS05LTEtMS0w_962b4786-f530-4169-961a-5634795ea1f3">3,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de46cd3732f46198d032b4488032eaf_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi0yLTEtMS0w_64ef41d2-c3ed-42c3-adc6-cf9941ab68fd">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb6844505d24ba0bf8408929f329456_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi00LTEtMS0w_2da075ba-ef34-4f06-81b6-426dfdc36a76">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i631b9be815524db78231c3054bb32e61_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi03LTEtMS0w_bd4ac039-e78e-4d68-ad0c-37846f537091">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6adefffb5c654771b174bf3bb3a8b6bd_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi05LTEtMS0w_72713dc3-960d-4a6e-a308-6fcd57f3b53d">1,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Promacta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32509a4fbc6a4a1582b549b4ca6df340_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy0yLTEtMS0w_ba6babbe-8b4c-4cd6-b309-ad8f7bda3c0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c5884b82ff46d5acc051c8609beaf8_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy00LTEtMS0w_144b2c10-d1c6-4072-95e4-f3097ed227ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba8307733fc433f8ab3b039169959f0_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy03LTEtMS0w_7e1c97b6-cfa9-4416-8697-74a4918681a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if80024c5d7c84458b874cf41165bca20_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy05LTEtMS0w_cb3573ae-0237-43b6-adf9-3327801ef249">14,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fc64f4d95b449579c5dcf83692dc2c2_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC0yLTEtMS0w_8ccf3197-3f20-482f-ac54-1f15d90aa802">9,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff17a87c11c484c964fba70cf7a9057_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC00LTEtMS0w_2f8240f3-cb0d-4501-9bda-6bd8ca6fab7e">9,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6992f512a9ea4391aba483112356a4b0_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC03LTEtMS0w_4dfda0e9-2eae-45f8-b62c-1b1ccbfe10b1">22,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89eb246de85d4b488a38dcf7024d1c08_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC05LTEtMS0w_fecf5e90-205b-4f95-8a31-ab0d61d2da57">35,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4089e56d6e3f4a8887c64e185748adcb_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtMi0xLTEtMA_d1ce65ba-8fb5-4cbb-9b0e-c5d8ef48f166">23,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a628a6cc7441d2989a9bb873aa67ed_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtNC0xLTEtMA_14bfc23e-5867-42d0-96ab-df01e3c528b5">6,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0095c2332c5f44189e76bf00c4b53c2c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtNy0xLTEtMA_6d4ce6e1-f6d1-47cf-9f30-0a799e8ce9c4">68,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3415613f8a40bfbe9bad5aae16a724_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtOS0xLTEtMA_14cf9bd5-8b78-4257-9163-93f7013e0dad">24,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab25bc69dbce44049e247a4d1847a6a0_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtMi0xLTEtMTgxMw_f7d4cbb0-e5da-4b21-8f70-ed8946d60d52">7,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58eb2b2e375b4a358abb2a965d76fa2b_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtNC0xLTEtMTgxMw_cc0b559c-0886-4ecb-b841-f0e24b4241f0">4,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6cef85b3c447d3aa8cdd4f781e6981_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtNy0xLTEtMTgxMw_dcccd681-53ac-4f17-b574-4a5c2afb7541">15,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ddd64a6c3b648bdbbbed38ab355251b_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtOS0xLTEtMTgxMw_b235e4b4-6542-43af-b8f4-a8b5e19156f6">12,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0aa285905264a199609e8e0e79eeb9e_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtMi0xLTEtMA_835e0d6d-87ad-473d-816f-a39ec45dc5a8">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f888f2275fa4a51a4214ceb899a5667_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtNC0xLTEtMA_0730d605-ad38-41e7-97b5-cd1ac551382e">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ad1b18c5f4466cb46c76831b340bf9_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtNy0xLTEtMA_5cf45a7b-8400-48b5-b05f-5263582972a2">1,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7b2e9c4c524632af8897ae7a9f69da_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtOS0xLTEtMA_7f97e1af-52bb-48a9-9847-c1dcab28235b">3,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61867bf812c848368a7dbee91070fe83_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtMi0xLTEtMA_9a71fc07-5f24-4ae0-a1a4-74570564845c">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e8662fb16b4474a6813702dcc5fbf2_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtNC0xLTEtMA_28acfde1-1862-4050-b442-0964cee45d65">2,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32fc3b55c7ed49029b4502207f3e67b8_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtNy0xLTEtMA_b0ee3a3e-6aeb-4aa3-bda4-0e487bd9dc52">4,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13355c008834006b8d8a53974aa47bf_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtOS0xLTEtMA_ae1664ed-dace-4a38-b184-4ee8a4c8170e">15,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be44b2cefc0491cb1be1ab1447f7f7e_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctMi0xLTEtMA_d2a48f0c-aa5c-4707-9f8d-c01e7e76e538">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53963dd995b43fe95834fa275cf1ab9_D20190701-20190930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctNC0xLTEtMA_b3c0f30d-2490-4793-a224-db9fbadbe638">727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe3969028f3455e89611142e0bd445e_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctNy0xLTEtMA_71ecdd91-fbd5-4bed-9f3d-19e62973734d">2,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2db24569871b4483bf7e64d41e59fd8d_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctOS0xLTEtMA_42651cea-51e0-4805-bb29-20bb84c75628">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d01bc1e745d4a3ab4088e5f4f2358b8_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtMi0xLTEtMA_337017cf-c89f-45f3-a656-4f24e6cccf40">9,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24db05f0ba7a4d77a7000833e1ed3559_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtNC0xLTEtMA_eaffe1c6-3744-466d-b0cc-2849efb365c3">8,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cac48edfdab44eda2c29f953e09e7d3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtNy0xLTEtMA_61c0e4f7-a854-430f-9ac7-19186f35a6bb">24,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia893a67a4ca947ba9f3e9b7d01d18a0c_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtOS0xLTEtMA_5c498760-4c6a-484d-b01a-bf4581ba5377">32,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtMi0xLTEtMA_b92cbc3e-85e6-499a-8b96-cd553c506bf1">41,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtNC0xLTEtMA_1f72f501-7aac-4d08-89c0-5c284e67afb9">24,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtNy0xLTEtMA_44c6656d-dbb8-4430-a7bd-b6078babfbdc">116,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtOS0xLTEtMA_30974c48-b694-45f4-a1f7-e93956ebaf1a">93,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ice2f1697098b4ba58b0e846bdaabca3e" continuedAt="i925a5e50280145649695302d8622ea14"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MzU_4d72ebaa-42f0-431c-b5dd-84dff6b3fefb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments, excluding investment in Viking, consist of the following at September&#160;30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:23.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xLTEtMS0w_7d49c841-fa59-42e3-bf9e-60529e09b913">68,226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0zLTEtMS0w_3f2df77b-16a9-4df6-a7fa-bd31d1ee626c">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC01LTEtMS0w_64e57420-00e6-481f-b95c-690de2fabccf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC03LTEtMS0w_74d701c2-5611-40d8-9ff9-d6fe28c9b8f2">68,327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC05LTEtMS0w_a2d599c4-fb12-4658-bd52-5483cc0e4da8">411,690</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xMS0xLTEtMA_c77740fd-a2af-4d90-aa6f-dd0c084ef55d">188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xMy0xLTEtMA_746f2229-8a74-4595-8c2c-29ff80dc5095">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xNS0xLTEtMA_64232d50-99fa-41a9-8460-8980f6b99216">411,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xLTEtMS0w_a2d88c82-5ef2-4873-ab0c-de6549510b15">27,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0zLTEtMS0w_07e603f7-974f-41e1-b801-3374746d9b87">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS01LTEtMS0w_455dc15e-8e15-4919-9cd7-31ea3cdd72b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS03LTEtMS0w_7b462ab9-bfef-4e8b-a3bd-986b6460265e">27,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS05LTEtMS0w_e7745a5a-325d-4acc-9204-c8896dc9ba79">63,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xMS0xLTEtMA_d1fd3f2e-12c2-4116-93e7-2b872f8ecfab">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xMy0xLTEtMA_4b274d9e-1c75-4d04-ae7d-d43f5792a35a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xNS0xLTEtMA_1c109ca3-4bd0-45a2-9234-1c6105695f90">63,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xLTEtMS0w_aeb733ae-f24b-407d-b60d-57bc8029ba7d">47,943</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0zLTEtMS0w_55719c6e-e96c-42a4-90da-2b611ab3bb19">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi01LTEtMS0w_6068ed12-4cd6-4303-8263-62d0d140cf9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi03LTEtMS0w_13052b91-8a0e-495f-a0a4-5f0c41d82c5c">48,003</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi05LTEtMS0w_511d45c5-2919-472d-9111-8fa90c7c3104">210,525</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xMS0xLTEtMA_867b734c-f515-4821-ae81-e6478e63ba3c">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xMy0xLTEtMA_b5abc663-d5c0-4fd4-951a-b12af7732e48">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xNS0xLTEtMA_15cf8b09-406f-47e5-828b-69542d0f04f3">210,552</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xLTEtMS0w_66d62c84-9f4f-401f-9100-adc94169545f">4,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0zLTEtMS0w_b06d8147-bf3d-4999-a0a1-ed4870cd23d8">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy01LTEtMS0w_cb6a4509-9fc3-42ac-96ea-3485381854ee">2,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy03LTEtMS0w_d8221308-45d0-4422-9c1e-a93bc0dcd149">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy05LTEtMS0w_c6246df8-cebf-4951-971d-de5340b75054">4,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xMS0xLTEtMA_9f57a4b9-4885-4ba1-803b-657b5dce4ec9">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xMy0xLTEtMA_73a2f384-9e34-47f2-8df2-2969915da9ef">1,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xNS0xLTEtMA_3179770a-e0cb-498b-830f-07754fd5e0bf">3,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xLTEtMS0w_b95ec2ae-f8a7-4a62-8313-4335e1dd5465">151,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0zLTEtMS0w_c836e443-35ce-48da-9a90-219258574236">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC01LTEtMS0w_9b5ffcc7-f87b-42ff-87ab-d4a298beab6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC03LTEtMS0w_43488bf3-260f-4f6b-8cc8-69acf1f5ea10">151,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC05LTEtMS0w_485b5d7b-70eb-4836-a8d7-40b9b44e0140">250,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xMS0xLTEtMA_90b9265a-6e95-4cd0-9748-99b2831b52c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xMy0xLTEtMA_4c24337e-a742-44df-b1e0-5325347f1534">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xNS0xLTEtMA_f4a58500-4224-47ad-bd15-83f9b32c4635">250,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNiCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xLTEtMS0w_49cdc2c4-c57e-431a-bc5c-0f6cad3b8f8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930" decimals="-3" name="lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0zLTEtMS0w_3344fa57-e2e5-4e26-a0ea-af6e145ea8c6">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS01LTEtMS0w_822e4584-7b46-470b-971a-f1e582f106d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS03LTEtMS0w_eeae9bd7-20c3-4b60-99f9-1cef3e746871">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNiCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS05LTEtMS0w_4f111bda-c32c-45a9-806f-0081b7391169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231" decimals="-3" name="lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xMS0xLTEtMA_503b8032-bd1f-48ad-9ec0-a26387b47ad4">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xMy0xLTEtMA_64df0815-2725-44c2-8edf-a80b38ed55d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xNS0xLTEtMA_e5c398c6-1bc7-4087-aff8-5d9b70a92f21">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMS0xLTEtMA_d06634b6-92d1-427d-a501-e21f8a3f0edb">299,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMy0xLTEtMA_a55444d9-d8b9-4647-b05d-4aaefd58a46d">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtNS0xLTEtMA_bb6751d6-d50b-484e-88c2-d027d07e4531">2,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtNy0xLTEtMA_b9ef5fb1-eb26-464d-8f8b-1cbfc85ec26e">297,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtOS0xLTEtMA_1beffcf4-715f-446b-8d6b-c7954e76d8fd">941,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMTEtMS0xLTA_4fda81ad-910c-4bd6-afe8-ce5393d05ce9">933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMTMtMS0xLTA_b60b0f7c-37b1-4be1-8387-2f3c29bd22ce">2,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMTUtMS0xLTA_10c0d9bd-6f97-4613-9956-3c6bc580e114">939,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of September&#160;30, 2020 and December&#160;31, 2019, we recorded shares of Viking common stock we own at fair value of $<ix:nonFraction unitRef="usd" contextRef="ieafd46562c0048748b7d5372e02d9594_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc0MDM_8debe95d-d9f2-4d77-a41b-1424070a1e4c">33.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i994f5de64c0a4fbdb6c53080a3923a98_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc0MTA_2b08ecc4-5a9f-494f-8718-202e7fbcbeff">48.4</ix:nonFraction> million, respectively, in &#8220;Short-term investments&#8221; in our consolidated balance sheets. We also own warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="i077cb3c9fe0e483c86fb45ff23381e66_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc1MzE_cd1155b9-c8c9-4755-a8cf-5255f610dbc2">1.5</ix:nonFraction> million shares of Viking's common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1515ee2cbc494379a0c6d767fc8cb01e_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc1OTA_1dea10e1-6591-4eed-98fe-09939255f7fc">1.50</ix:nonFraction> per share. We recorded the warrants in &#8220;Short-term investments&#8221; in our consolidated balance sheet at fair value of $<ix:nonFraction unitRef="usd" contextRef="ib02c7dbe217a407884f5da8e577b9510_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc3MDg_4cdbfd7c-ff7a-4285-9456-2e2a053e5753">6.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iada23dbe678940b39476c796282a62d2_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc3MTU_50b155c7-3b1c-49a3-84d3-0bf544fd25e0">9.9</ix:nonFraction> million at September&#160;30, 2020 and December&#160;31, 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments on our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For available-for-sale debt securities with unrealized losses, the new credit losses standard (Topic 326) now requires allowances to be recorded instead of reducing the amortized cost of the investment. This standard limits the amount of credit losses to be recognized for available-for-sale debt securities to be the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the new credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MjY_c6033068-c197-481d-9df1-c6eabbfa5db6" continuedAt="ieda6ab64c6c94ab6b6500cc41a49c61e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMi0xLTEtMS0w_7b4cc7b6-0224-403c-b162-fb1133143e90">121,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMi0zLTEtMS0w_abd31d18-b728-4a4a-bf12-859f5d345c5a">121,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMy0xLTEtMS0w_ec421705-0566-45aa-ae21-a9b4266c84f2">21,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMy0zLTEtMS0w_408a4e7b-a201-4b6e-aef1-c1fe0a62f306">21,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">After five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNC0xLTEtMS0w_2f41e234-9a08-44d1-894a-e6a39c0603e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNC0zLTEtMS0w_68d194fc-fb6b-4473-abea-1a984b9924ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNS0xLTEtMS0w_94a5f4a2-10d2-40cd-b79a-847c13d11808">143,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNS0zLTEtMS0w_6a1e1593-517f-430b-8f9e-d25aafbdc1bb">143,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i925a5e50280145649695302d8622ea14" continuedAt="i0a24b0d30d604107ab719a28655a90b1"><div style="margin-bottom:6pt"><ix:continuation id="ieda6ab64c6c94ab6b6500cc41a49c61e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy0xLTEtMS0w_718feecf-6e48-42de-88fe-ec30b1701767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy0zLTEtMS0w_67f1c27b-c3ee-4003-9491-1052eea5873f">5,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy01LTEtMS0w_e522e284-811a-4357-80e1-564b280530c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy03LTEtMS0w_d79d9753-e953-45f3-a1ee-b682dddf8cd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy05LTEtMS0w_0c197948-cfc7-4775-9104-2b2f98fc90cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy0xMS0xLTEtMA_1fdae13a-bec6-4bbb-a4db-cd7dfa7353e0">5,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC0xLTEtMS0w_241f920c-1e9a-4398-b98c-6befb2156bab">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC0zLTEtMS0w_2874ff4b-bb85-4c6e-beba-57b761431737">3,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC01LTEtMS0w_b9146aa2-eee1-4d2c-a696-508d30ed2511">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC03LTEtMS0w_05126b0e-4dc8-4c69-95cb-68b6fd34dfca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC05LTEtMS0w_61211e9e-a968-4678-bea9-dd6fa79c63e0">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC0xMS0xLTEtMA_9ca6cc67-0f6d-457d-bc81-4796cd9373e7">3,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS0xLTEtMS0w_2ff120aa-88b4-4dab-b766-6d697d23d3ee">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS0zLTEtMS0w_630d7997-6b62-480d-8d41-75d4036cb9a0">8,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS01LTEtMS0w_54f6255c-6184-4090-9439-0480192e3874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS03LTEtMS0w_b65b811f-e9b2-473a-8d3c-e117478c0357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS05LTEtMS0w_21aa7ddb-4aa3-459c-a103-aef479417bac">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS0xMS0xLTEtMA_23a39899-5b3c-40d1-89b0-4881d154b6b4">8,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC0xLTEtMS0w_4f3a735f-cb8c-4c2b-80d8-b9f53884f9f3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC0zLTEtMS0w_4540e47a-c5d4-4cb7-87c0-272eae385d3a">58,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC01LTEtMS0w_90706650-77e7-45a5-9b20-f8b8b78e985e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC03LTEtMS0w_5f246861-a6cf-4ce9-a02b-866a3d3a91b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC05LTEtMS0w_bba38f26-fc21-4e04-ab21-c68a31c5954b">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC0xMS0xLTEtMA_b562e1ba-8019-4c2d-b4b7-cfb77b45c080">58,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS0xLTEtMS0w_e7a4dc19-b8ce-46b6-bc5c-6a57bea3adea">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS0zLTEtMS0w_3610fb28-afe0-4165-9511-f24333e37c53">79,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS01LTEtMS0w_4a997d8c-9e51-4c48-a047-357b548e943e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS03LTEtMS0w_7db00643-b96c-4f91-874d-e6a80c050c23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS05LTEtMS0w_6bf18376-6de9-401d-bd0c-389b1134789f">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS0xMS0xLTEtMA_f46e4c5c-35b0-453b-9955-1e4e0f01083f">79,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtMS0xLTEtMA_7be3e3d1-bcd7-49b4-8567-c99333490c7b">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtMy0xLTEtMA_567793fc-f8e4-4c16-a559-854b184a4bb9">137,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtNS0xLTEtMA_cfef728f-c708-431f-a86b-55f1272e37b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtNy0xLTEtMA_d14ce99c-d536-4d14-af48-77e4f5b32c25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtOS0xLTEtMA_dcfe22d6-661b-492f-9b96-0b30273b2aba">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtMTEtMS0xLTA_6d8c75d9-5864-4449-b7ee-00cebf368392">137,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTg5Mjc_6bca2ef9-59cf-4767-8554-b7972f0ed9fa">2</ix:nonFraction> positions which were in an unrealized loss position as of September&#160;30, 2020. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTk1MzA_0d9c3bf3-8726-4882-947b-4cfd2281564f">no</ix:nonFraction> credit losses were recognized for the three and nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2020, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the surrounding novel coronavirus (COVID-19) pandemic on our business and recorded an adjustment of $(<ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNDk0NzgwMjM1NTM3OA_a50cc032-13f1-4d15-b406-2399f5b59765">0.1</ix:nonFraction>)&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjA2MDE_17f35bb5-cf91-4100-89ac-ecb2221f7b89">0.2</ix:nonFraction>&#160;million, of allowance for credit losses, respectively, as of September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc1OTg_bb1bffc5-feab-41c2-bdd0-e84182f68fca" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.512%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMi0xLTEtMS0w_f6a6b3e6-5b1f-4d13-bce4-9e0cd55f1c2b">102,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMi0zLTEtMS0w_85ab45d6-da0d-40a0-907f-88e229199f4c">95,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62059978ce544467b0dd531154611391_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNC0xLTEtMS0w_ac4963d5-07be-4123-9f93-ceefa3eed943">257,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9822c8d2a54454798b936165a57c684_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNC0zLTEtMS0w_5d2d938c-b3d8-4ab1-8782-c4db049f95ba">242,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62059978ce544467b0dd531154611391_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNS0xLTEtMS0w_eb23ecb6-9d95-4a77-ad82-9792e0247d79">59,869</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9822c8d2a54454798b936165a57c684_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNS0zLTEtMS0w_56f45aa7-e48c-413b-b7d0-7319268c2e46">50,203</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc614b30b84489b961b3be7e198cf04_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNi0xLTEtMS0w_1306c538-cf1b-48f2-b1ea-57b68a7eb264">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf62daa6b80444d9b1c8c7605f3061cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNi0zLTEtMS0w_34cfca0c-59a2-418e-9cfb-6bde8ef25605">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacc614b30b84489b961b3be7e198cf04_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNy0xLTEtMS0w_3420c974-10bd-4a9d-9c66-7ec86c8302c4">1,279</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf62daa6b80444d9b1c8c7605f3061cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNy0zLTEtMS0w_a0be1065-578b-46af-be3b-a71cf190684b">1,180</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i458d920e4daf4b0bbb69e6db515003c0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOC0xLTEtMS0w_f71cd798-c43a-41b9-834c-59159829a9d3">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b63e0852ede48be9e97d41d54d1fc1f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOC0zLTEtMS0w_f9b442bf-b8d6-4f5a-8ccc-c1c00b731937">29,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i458d920e4daf4b0bbb69e6db515003c0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOS0xLTEtMS0w_1a7a0378-b3a7-4dce-99d2-e4ce2abfc776">14,929</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b63e0852ede48be9e97d41d54d1fc1f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOS0zLTEtMS0w_8f2d67d4-87e7-48bd-97b6-98c78e2c71b2">13,224</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMTAtMS0xLTEtMA_45f13ef8-42d3-4407-829c-05a6e90e44c2">326,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMTAtMy0xLTEtMA_e33cc0a6-0699-429a-ba17-8df2d30fcbfb">305,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1) Accumulated amortization for complete technology includes immaterial amount of foreign currency translation adjustments for the complete technology acquired from the Vernalis acquisition.<br/></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i0a24b0d30d604107ab719a28655a90b1" continuedAt="iea5793889acf4b93aa6c4c8c867b6d1f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDc_29a82fcb-5c64-43d1-9173-61f26be270a4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a7b51a701f4e53aecd32502a589716_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi0yLTEtMS0w_6ceae73d-763e-469f-b407-c94d7022011d">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a7b51a701f4e53aecd32502a589716_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi00LTEtMS0w_66bfb2e4-d3fa-4efa-983c-971d511a5f8b">9,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a7b51a701f4e53aecd32502a589716_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi02LTEtMS0w_289d3de2-7be0-49cf-9bb8-c4279ed517ad">8,052</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4202a561cc0e4e888ca3864847b25542_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi04LTEtMS0w_e41a5db7-053a-4aeb-b9c6-7c710e0f964b">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4202a561cc0e4e888ca3864847b25542_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi0xMC0xLTEtMA_b5631abf-85fa-4d95-956c-27c0cfc584f9">5,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4202a561cc0e4e888ca3864847b25542_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi0xMi0xLTEtMA_a5485d08-ed35-4103-b67f-a9567c29b24a">12,196</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Palvella</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d220828630a41d89fbd767210960771_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy0yLTEtMS0w_f3b83242-1fec-47ab-9eab-df0d4d8ae97a">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d220828630a41d89fbd767210960771_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy00LTEtMS0w_91a99297-38aa-434e-9b86-7b599790bb26">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d220828630a41d89fbd767210960771_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy02LTEtMS0w_c9037ea0-6540-4115-869f-6d4f2bb3ed7a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13355217b22451f86270e7501836ab5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy04LTEtMS0w_36d526b4-9b9e-4f71-90e6-8b80bc077704">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie13355217b22451f86270e7501836ab5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy0xMC0xLTEtMA_cc46f55d-b6cb-4b2e-9453-8cf3bbe32fd7">7,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie13355217b22451f86270e7501836ab5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy0xMi0xLTEtMA_06129704-83eb-40cc-8054-f841ecfc3ab6">2,508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC0yLTEtMS0w_d3346f25-fbcf-4956-856a-aaa575007d7f">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC00LTEtMS0w_85d284b6-0715-447e-9d22-0c80f196b774">7,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC02LTEtMS0w_26d272a2-4ff3-4aa9-a614-200167e55ce8">2,782</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7eb9f595411497d909c36c7b2a954d3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC04LTEtMS0w_6fbd52ca-2c84-4b03-8d72-2f40724a24f4">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7eb9f595411497d909c36c7b2a954d3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC0xMC0xLTEtMA_3711c355-4732-47c0-b332-2c8bcc861855">5,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7eb9f595411497d909c36c7b2a954d3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC0xMi0xLTEtMA_fc868b72-fc7c-4c95-b583-a8032e757b6a">5,386</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS0yLTEtMS0w_70098291-f638-4f0a-a26e-833f40ca0854">38,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS00LTEtMS0w_ca18c8b1-49c8-493d-81a4-d7f2e871bbce">27,464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS02LTEtMS0w_1c84ba7a-8212-425d-91d7-aaba2435644d">10,834</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0100a54707e94423b27294cac36ad9cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS04LTEtMS0w_dff53822-4880-4e77-bfc4-da46827a3c1a">38,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0100a54707e94423b27294cac36ad9cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS0xMC0xLTEtMA_e97328a5-06d5-4290-9933-bed13bd3d352">18,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0100a54707e94423b27294cac36ad9cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS0xMi0xLTEtMA_0f780933-aff7-4ab2-bd42-18306dcbae1a">20,090</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal or research and development expenses of $<ix:nonFraction unitRef="usd" contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjEyNDg_3a3ae577-8750-4ee1-bd60-d905bf1ac9d7">21.5</ix:nonFraction> million and credit loss adjustments of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$<ix:nonFraction unitRef="usd" contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930" decimals="-5" format="ixt:numdotdecimal" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjEyODQ_5798fc7a-f436-436f-9990-66f17e4b1766">6.0</ix:nonFraction> million as of September&#160;30, 2020.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal or research and development expenses as of December&#160;31, 2019.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, Palvella in December 2018, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and developments as further discussed below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of September&#160;30, 2020 is <ix:nonFraction unitRef="number" contextRef="ibcbff8ebe0f84833bb1bb078e9fb983a_D20200101-20200930" decimals="2" name="lgnd:ForecastedCashFlowsEffectiveInterestRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI0NDA_5cf342d0-9aee-4e70-861f-4d0fb55c788d">23</ix:nonFraction>%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we may receive up to $<ix:nonFraction unitRef="usd" contextRef="i10d095f87a1e48e8a5b700832f2b753f_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI3MDQ_7f882295-4289-4e89-af17-0f319e418b49">8.0</ix:nonFraction> million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congentia. In addition to the milestone payments, Palvella will pay us tiered royalties from <ix:nonFraction unitRef="number" contextRef="i1f5e4fe2589b447f9a277f98db937a1f_D20181201-20181231" decimals="INF" format="ixt:numdotdecimal" name="lgnd:CollaborationArrangementRoyaltyRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI5ODQ_6ab97849-9409-4279-a826-304bcf5ef9a6">5.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i0cf7333df7984d5bbd68a862a0645e2b_D20181201-20181231" decimals="INF" format="ixt:numdotdecimal" name="lgnd:CollaborationArrangementRoyaltyRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI5OTA_14fa3bc6-6d3d-4658-adf8-fd6ecd25c071">9.8</ix:nonFraction>% based on any aggregate annual worldwide net sales of any PTX-022 products, subject to Palvella&#8217;s right to reduce the royalty rates by making payments in certain circumstances. We paid Palvella an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i10d095f87a1e48e8a5b700832f2b753f_I20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjMyMDg_afb0c1e6-11da-418d-b39b-a176ec8e880e">10.0</ix:nonFraction> million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for the development or commercialization of PTX-022. We determined the economic rights related to Palvella should be characterized as a funded research and development arrangement, thus we account for it in accordance with ASC 730-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Research and Development Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and reduce our asset as the funds are expended by Palvella. As of September&#160;30, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, we will recognize milestones and royalties as revenue when earned. During the second quarter of 2020, we recorded a $<ix:nonFraction unitRef="usd" contextRef="i4f60bf0364f848b38d48669aaccabc92_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjM4OTI_0429f2e1-da60-4d66-a12d-6f914e29db40">3.0</ix:nonFraction>&#160;million milestone from Palvella under contract revenue, which has been included in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $<ix:nonFraction unitRef="usd" contextRef="i0cdccb9429b54094b52f363eef25ce9f_I20200101" decimals="-5" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjQwMTM_7e16f9a9-f672-4aef-847b-f0f4f3cd1eda">5.5</ix:nonFraction> million pre-tax reserve for credit losses upon adoption of the new credit losses on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the nine months ended September&#160;30, 2020, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and recorded an additional $<ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="lgnd:CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjQ4MTI_85b193e7-02a7-4b02-a00c-3679cf8f473e">0.5</ix:nonFraction> million reserve for credit losses in other expense, net, in our condensed consolidated statement of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See further detail described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, of Notes to Consolidated Financial Statements in our 2019 Annual Report.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="iea5793889acf4b93aa6c4c8c867b6d1f" continuedAt="i443b137bbc7942ef98990af003a1f3cf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNDM5ODA0NjU0NjczOA_a8d18aa5-c2af-4a69-bcfc-5615c247d3c1" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:64.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol manufacturing ramp up fee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:RampUpFeeAssetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMi0yLTEtMS0yMjI4_3ce17b55-346e-4658-b3a3-59f1edfff573">9,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:RampUpFeeAssetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMi00LTEtMS0yMjMy_e0ee7b4c-3bb3-494c-962b-fa0a33cc62f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investment receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestmentsAndReceivablesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy0yLTEtMS0yNDQ3_73d82173-6d18-4927-9a72-25dbc777905f">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermInvestmentsAndReceivablesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy00LTEtMS0yNzA4_bf84c316-2e73-47d1-bfb9-8a8d23753ee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy0yLTEtMS0yMjI4_5819b409-321e-4784-9524-b8817e492d07">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy00LTEtMS0yMjMy_6aeb5fbb-0388-424f-b0c9-68d12c805686">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:DepositsAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNC0yLTEtMS0yMjI4_a0bd9d81-e41c-4c85-a2fc-28181c9c32db">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:DepositsAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNC00LTEtMS0yMjMy_b3f3b2e3-a408-4f8b-8866-4afacf81f0e3">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNS0yLTEtMS0yMjI4_684f2a69-4bde-4b3e-9481-691f167e9643">1,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNS00LTEtMS0yMjMy_7bda7664-d6ba-4ef4-8918-8af21fda92db">1,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNi0yLTEtMS0yMjMx_a7ed047b-673b-423e-a702-2915e9e8d6f4">13,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNi00LTEtMS0yMjM2_ac895c9b-1c92-4ccd-a982-fe002ccf3053">2,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2Mjc_cb09e3bb-6096-430f-99b8-3f19eafb2d1a" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:64.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMi0yLTEtMS0w_b79e8a68-3459-4bfe-bdc4-9d92d3b1077c">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMi00LTEtMS0w_803b2aa8-c220-4b83-897a-bb11c32fca41">1,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMy0yLTEtMS0w_3d29e806-e16e-4b4a-abc3-4d23596f47d9">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMy00LTEtMS0w_47c0453c-3caa-4b0d-b126-b75d82931d9d">1,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNC0yLTEtMS0w_eada746c-da42-4516-a777-45dfe826d91b">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNC00LTEtMS0w_a98f6a37-768b-4d38-9b14-ed5b76aab398">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNS0yLTEtMS0w_42649f37-0807-4bad-9993-724bad2e3ff4">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNS00LTEtMS0w_ae12ad6b-9bfe-4e14-ab2f-730d3fad5907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNi0yLTEtMS0w_cae8fd30-f79e-4334-afda-79a84a9dcab2">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ReturnsAccrual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNi00LTEtMS0w_39433a35-b8f2-4a4a-9ba0-0672c20308bd">3,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNy0yLTEtMS0w_fb617978-eaea-4626-8ac3-5ebcd5c03217">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNy00LTEtMS0w_0d0e37a0-6b77-4dc5-8cbc-4904a1aa2fcc">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOC0yLTEtMS0w_21bc2796-5d86-4793-8b16-ba9fbc0952f9">1,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOC00LTEtMS0w_a366028e-e71c-4178-b2c1-6b8bebeef8a1">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOS0yLTEtMS0w_2890a163-0857-4cdd-b1ec-ad162cca3849">1,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOS00LTEtMS0w_24591ad7-28df-4118-81d8-dd5653b3a028">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMTAtMi0xLTEtMA_c4df2fe0-ce3b-4e7d-87ea-589efe67662c">14,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMTAtNC0xLTEtMA_a20dcfe4-e4bc-4462-ba64-db7dd06dbc0b">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDg_c43e410d-b816-42f3-bd62-b16a5b338bff" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDA_9e022ae1-4dac-4ebd-b945-7e78a27cc8cc" continuedAt="if29d32d5e9124faa9a32d87e36ba369e" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="if29d32d5e9124faa9a32d87e36ba369e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d2e8730044456d888fa8d00bb40ef6_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy0xLTEtMS0w_d4d9f0ed-5065-411b-8971-be567ecce30f">3,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827adc89d29046898e0b113579222055_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy0zLTEtMS0w_4be821b5-60ca-4dce-9b9d-21113d558bf7">2,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ce74a6cb0394faea692955f117b0910_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy01LTEtMS0w_a48a2c55-dc45-46d4-aebe-ff42036f7d50">8,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eae62fa2cc244c58acbef58471706d5_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy03LTEtMS0w_6b2463ec-17fe-4dc3-8c22-a3fd1ecd4d5d">7,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcb4d6cb442c42888913360733612f6b_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC0xLTEtMS0w_57443fba-e41c-4809-9772-8f48477a28e1">4,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1cbbd30022e449b8b3b716176ea05cf_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC0zLTEtMS0w_876e61f5-0fdc-42b0-8f96-450bbca2101f">3,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i971a95182cfc43cf993de4477741afb9_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC01LTEtMS0w_b54cf151-58a8-4264-9115-aa0a11c7fe82">12,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5baf6027374c4f3cb37f343379914469_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC03LTEtMS0w_0bc01261-74d7-48b5-a96b-90f65ba7c416">11,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS0xLTEtMS0w_535eb1d2-edad-4e2d-bd60-747e88f897ff">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS0zLTEtMS0w_0d0973fb-d05d-4c3e-ae17-f655acaca93f">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS01LTEtMS0w_3867f8dd-edbc-4212-ac42-5c8a2ad6f8a5">20,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS03LTEtMS0w_2f44dfc3-44fd-4d6d-8b6a-9a0750985fec">18,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDE_a89eb362-690c-405e-a033-3e31cfe2d76e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.380%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy0xLTEtMS0w_eca4c545-d8a1-46f5-a08d-146dda174d56">0.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy0zLTEtMS0w_59762219-f8c9-41ac-accf-30b9c136fc05">1.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy02LTEtMS0w_3d99b50e-f8f0-41dc-a781-3e077429a330">1.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy04LTEtMS0w_a6c1d50e-e287-4f37-9dd7-4efb5302d34d">2.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC0xLTEtMS0w_e7afa9fa-2546-4a08-8990-507e16b2a06e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC0zLTEtMS0w_d69c050a-8d06-4e04-91c1-4d78833ff957">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC02LTEtMS0w_3f75cec3-7134-446d-a2ee-159d4d86ce22">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC04LTEtMS0w_66e8850e-413e-4572-ba4c-a4b3a8aa9570">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS0xLTEtMS0w_81560c45-9d4c-4f45-8307-144cf35953c2">59</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS0zLTEtMS0w_6b81bf35-dff3-4390-9891-ff263f31b825">41</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS02LTEtMS0w_cbfd0656-04df-4813-bfa1-da73b377e830">55</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS04LTEtMS0w_b43e0756-afad-4d88-8e94-4967ddaff738">43</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi0xLTEtMS0w_5874aaac-95ac-4959-b5ee-e64da7d4ea9c">4.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi0zLTEtMS0w_0e02edf1-3b7a-4227-b38a-2f275d5e3ad0">5.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi02LTEtMS0w_a1f45556-5c9e-480d-912e-ddd9b8435bc8">4.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi04LTEtMS0w_9f82736c-6d64-4d95-863f-9fab0212c9ab">5.2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDU_9b533939-e154-4637-bd48-ec599ba98d20" continuedAt="i00895761b1674de1b623615a7a19d64c" escape="true">Net Income (loss) Per Share</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i443b137bbc7942ef98990af003a1f3cf"><ix:continuation id="i00895761b1674de1b623615a7a19d64c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2020, all of the <ix:nonFraction unitRef="shares" contextRef="if33f5e6d2e464f5a95ee2eb981cf9859_D20200701-20200930" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjYyMjQ_d7d5cd8e-b0b0-4b0c-8ff9-89eed43b5d80">0.70</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i38b7bbf234194785adc62a7822e6c5cd_D20200101-20200930" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTA5OTUxMTY2MzE3NA_a28bb741-f49b-4853-ac60-dca224a97a63">0.65</ix:nonFraction> million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2019, all of the <ix:nonFraction unitRef="shares" contextRef="i2ca967bf02e64cfaa352ef449e98dfb9_D20190701-20190930" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjYzNzE_9c5ce651-6727-4635-8a5f-8da86a79f123">0.70</ix:nonFraction> million weighted average shares of outstanding equity awards as of September&#160;30, 2019 were anti-dilutive due to the net loss for the period</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4 - Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6 - Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MTc_bc79f41d-c6cc-40f6-8e3f-d016785c7f56" escape="true"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDI_497b7a81-3ae0-44bf-ab6f-0dd3464c9e84" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:45.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy0xLTEtMS0w_764886a1-b6cb-42b4-a325-4e4ef03dca13">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy0zLTEtMS0w_393702f2-448a-4068-9484-bdee78e1cc10">18,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy02LTEtMS0w_00f453a4-9f29-4066-9c07-3700d773a392">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy04LTEtMS0w_87158b7f-b8c8-4307-9b95-b68412a3ee2a">19,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS0xLTEtMS0w_7c97cd5a-cf3a-49e7-a01a-e06122088368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS0zLTEtMS0w_1a091783-35ed-43b0-9881-b905c55b28a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS02LTEtMS0w_cf66652c-a8bf-4c91-9450-d2d6424f6b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS04LTEtMS0w_2905fbd6-75ac-4104-85a7-16aea0581a3a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi0xLTEtMS0w_64a41b02-8e1e-45dd-bb5b-934026676fff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi0zLTEtMS0w_0439006f-f0d1-40af-ba3f-49e23c5c9243">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi02LTEtMS0w_04eb9191-e028-4fba-b7ba-151a2155f980">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi04LTEtMS0w_930516f0-cbdb-4a08-a38f-db6efe170336">728</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy0xLTEtMS0w_546c71fc-3517-4134-9072-3902cbf578b2">16,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy0zLTEtMS0w_e42079aa-4ef4-4fb4-b0b6-3c5952736a69">18,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy02LTEtMS0w_5fc1cdec-5655-4b0a-b92e-e0c39e731518">16,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy04LTEtMS0w_bc17e550-6b60-4246-bb53-b3038ade327f">20,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC0xLTEtMS0w_eab46d94-dbf8-473a-b29e-86a2bb09aaef">7,028</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC0zLTEtMS0w_243eed63-9559-4c1c-9162-b26f00821b6d">11,549</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC02LTEtMS0w_4a3ab245-0e73-43f5-9bbb-cc30b555dd70">8,330</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC04LTEtMS0w_8604ed3a-5fe2-48f3-904b-552902b9eb3b">8,694</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfNTE2Mw_30fd3b16-b3fd-49e2-b00c-4d9f0de0e2db" continuedAt="ie0f56be8ab1b47dbbc7ae7ba9f8792b1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie0f56be8ab1b47dbbc7ae7ba9f8792b1" continuedAt="ia119c2bfd24c4a5fa5c9e64a6db35c62"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfNTE2MQ_b84f3962-704a-4fbe-aa6a-3a33d4b454ba" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0yLTEtMS0w_5980c300-0d8a-4163-9226-ca4dc3c915a3">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy00LTEtMS0w_ad118bca-b7e4-4ecb-aa3a-72c2fc3ba67f">295,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a5542beee460cbf11a482a837b496_I20200930" decimals="-3" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy02LTEtMS0w_7179505c-e7fe-45e6-ac29-54c822740845">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy04LTEtMS0w_fd68d1e6-2dd1-48d3-9122-2724bb9149be">297,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478ab1e04df3462693b4f447d123258c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xMC0xLTEtMA_820ddaff-6be8-495d-808b-55f9d3b71f96">3,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xMi0xLTEtMA_0acc7c59-2762-442f-ab4d-9812fa0b00ad">936,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231" decimals="-3" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xNC0xLTEtMA_737defa8-03ba-4f25-8d2a-556a2cc440e3">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ShortTermInvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xNi0xLTEtMA_f285b36f-4736-4e38-b6db-35458b1e2140">939,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0yLTEtMS0w_b20cfe63-81b5-4838-8109-75526a27fa79">33,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC00LTEtMS0w_ad0b0886-b2aa-4ee7-ae6b-0f4949186236">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a5542beee460cbf11a482a837b496_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC02LTEtMS0w_210060e4-bc17-4722-940c-82ae881bbbb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC04LTEtMS0w_14b171c0-16b1-41bb-b024-46511b52b0b1">33,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478ab1e04df3462693b4f447d123258c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xMC0xLTEtMA_b1c6cc81-873d-44e4-b5bf-44fe612f9b76">48,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xMi0xLTEtMA_412fc533-8f5d-4925-a22e-c098753344b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xNC0xLTEtMA_0890d712-0033-4bdb-9c8e-e3768a1efa9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xNi0xLTEtMA_afc7d724-0e0e-47c9-b1d8-afd69fc565c8">48,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0yLTEtMS0w_863a7258-fa80-4a59-8ea4-88dce5b061d7">6,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS00LTEtMS0w_a7b0fdb2-23df-4c38-bb1a-fc75065a33da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a5542beee460cbf11a482a837b496_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS02LTEtMS0w_a17ab8ea-9ded-4699-bd19-95a27cc8fe83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS04LTEtMS0w_6f5d8762-1006-4a4a-8362-32b1475d6f01">6,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478ab1e04df3462693b4f447d123258c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xMC0xLTEtMA_4d46e5a1-0c72-4595-a085-64a46a3e11f9">9,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xMi0xLTEtMA_f5854678-2530-4249-9a04-8147ee5aa015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xNC0xLTEtMA_ed4d4264-60a5-4b5e-9723-d9e93e16bdc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xNi0xLTEtMA_d239756e-5521-4c22-bb8f-f006d89104dc">9,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0yLTEtMS0w_805cecaf-5e57-4d0e-91ca-acd12aadc729">42,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi00LTEtMS0w_feb4b16f-9f29-4559-bb68-bbba6a3d8941">295,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a5542beee460cbf11a482a837b496_I20200930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi02LTEtMS0w_1dcc6764-2641-43a3-bc75-738e822e3aab">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi04LTEtMS0w_5a953960-9e58-4c8d-b75b-988c8703ed95">338,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478ab1e04df3462693b4f447d123258c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xMC0xLTEtMA_888c003a-4135-4564-9ced-3f1e6b43d269">61,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xMi0xLTEtMA_4d9c8bcb-16d0-4fee-b253-2f119c5732cc">936,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xNC0xLTEtMA_2679749f-bd3d-4a11-be23-e9445463abc3">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xNi0xLTEtMA_0820ecef-5922-47a6-a64d-27ca27cde6ea">998,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc8cab80d6146938a4e96ca913b603e_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0yLTEtMS0w_8b047a00-d0e6-43fd-a4cc-6aaa676d816b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f01a6768e554446859e50dd59a5f80b_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC00LTEtMS0w_2c7ff095-4d7d-4e90-a7ec-9ff1ceaaa070">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49eebaf8762f41bc8e158fa2142e34c7_I20200930" decimals="-3" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC02LTEtMS0w_dbf21548-8c7a-4da9-9d90-391d8ac7bbf1">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99eb08f38a27433e952f4df9a77b03c4_I20200930" decimals="-3" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC04LTEtMS0w_71ecb05d-21f9-4c75-b181-062253c18480">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0856bf1f29e45b3ae503b85c7783f0f_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xMC0xLTEtMA_d738aa0c-4d79-4a16-ab39-c11604fc67f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78fb2997e6c149bb89d1b9405e547655_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xMi0xLTEtMA_d5743b73-d0ac-4d80-9e6a-81727a39f3b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3f212d8fb4848b7a0273c25f91e3c69_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xNC0xLTEtMA_325670c1-65e1-42df-be1c-96a47cb6d5f4">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c0f7b483e754043b00e42dc018f756e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xNi0xLTEtMA_369543ff-3b14-4c32-9966-3b5c7a98b478">2,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f064695ce24917afeb387d23a90689_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0yLTEtMS0w_94fc418c-ff0d-40a7-8b2b-91a0145a2f6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2bcfa66308412c8f26ad4feaca4c78_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS00LTEtMS0w_66125712-f448-481c-9adb-f5d746832764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25c3c4da77d4ea7ab8ca7b1314fdd20_I20200930" decimals="-3" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS02LTEtMS0w_f526508b-697e-4feb-bda2-3703de77a046">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i776f577b4a88423a8d0236205bdb4fc4_I20200930" decimals="-3" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS04LTEtMS0w_385ce17c-b61a-4c5a-988a-be7979714969">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830cd590ed6b4940ae325376227fbf62_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xMC0xLTEtMA_147edbd8-36a6-4af7-9423-0fa8ed5a55dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad16d307d34d4ce3a14c5cc44ab00ca9_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xMi0xLTEtMA_d78badbf-5028-41ae-afc4-b9fa79411731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66cf1abe6fef4052bc2a83de3d3f416a_I20191231" decimals="-3" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xNC0xLTEtMA_a3af102e-29ab-46cb-b390-3920f6189d3d">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ffefdd42a3a41f1aaa64b145eafac32_I20191231" decimals="-3" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xNi0xLTEtMA_4b8c6890-3e4f-40ca-959a-47fcefd38ca6">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60cb7324310c4d69b314803514b8e7b1_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMi0xLTEtMA_73cc331a-c8ad-4326-9c60-20e779fb5ab9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3493b201a94d66930f00e5b6cb91ab_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtNC0xLTEtMA_927e802e-0ef9-4f8e-aff1-8712d2295674">4,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef93f7a4c3542b39b59e3723f6abe79_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtNi0xLTEtMA_3e2353be-8d85-4c22-8c9a-b35c487708b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e1ba70e57e428aa564051bda9daceb_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtOC0xLTEtMA_10209cb6-f744-45e7-bdad-0a4abc6f9bae">4,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe44d5fc83a4e91b928eab183e2696f_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTAtMS0xLTA_1aa9ec4e-3f1f-4145-9150-d7f80d35abc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1fb45159aaf459ab33f85d40561d21b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTItMS0xLTA_64b7a0cf-c04d-4305-9661-19c5126da0b6">5,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8cd383420af4806b4b998261a7844bc_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTQtMS0xLTA_39f14dbd-2a4c-48f9-9bb0-0a5d3602e26b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1ffea26d4346d3ac80627049e44cf9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTYtMS0xLTA_309b9c6b-686e-4762-baca-dc5682c53986">5,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e338a0003143eca31f450081056aae_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMi0xLTEtMA_94d32042-da30-4eab-bc55-c4ebad15f418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474b22d9f5454de2984d02f95a12bb78_I20200930" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtNC0xLTEtMA_a3d2ddd4-fd57-49db-97d1-6d3727a14833">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c66fe24767491e8f06625e7c7980b6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtNi0xLTEtMA_2e00f83c-16f7-425c-a33f-4064b16e1340">4,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b17dc76cb24ddf96f02602f42463a0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtOC0xLTEtMA_cec11e69-cfb5-48be-9e45-3255882914a4">4,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a210e993e749b792c4ff6feb3a58b4_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTAtMS0xLTA_abefa89f-567f-4375-b7c0-05bec6c7c73c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice47f549adc84119806f94c1746c45ec_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTItMS0xLTA_40981edc-41be-4f87-be7c-78a1cd0f1250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25da78fb55a47a9a4c833b387732860_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTQtMS0xLTA_9611a1e9-d79c-40da-8554-e11c28672b25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6fd63ec5bbe4d21b07dd199d23d7b1a_I20191231" decimals="-3" format="ixt:zerodash" name="lgnd:ContingentLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTYtMS0xLTA_d878696f-75b9-43d2-b8e9-5ca7ed73c3f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMi0xLTEtMA_f7d102d4-afa8-4d1b-aeeb-58c87b486dbc">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItNC0xLTEtMA_dfd1350c-8fb8-44a3-aa9d-9fe6d4910ee6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a5542beee460cbf11a482a837b496_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItNi0xLTEtMA_57b58255-6239-4a4e-81c7-688a1c1a508f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItOC0xLTEtMA_9fc59fbc-7718-4fb6-9770-829f69f6365a">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478ab1e04df3462693b4f447d123258c_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTAtMS0xLTA_7d798997-9495-47fe-81b5-14d62d138462">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTItMS0xLTA_e1281319-6973-4fd5-8a39-9a7409a6d23c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTQtMS0xLTA_e6319ed5-e6fb-4be5-8148-7181f1c7e087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTYtMS0xLTA_f1c0510a-7eda-486b-8918-daceda631d6b">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMi0xLTEtMA_fc05db6f-da9c-4fcf-afa3-4d586623ba03">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtNC0xLTEtMA_1f447a2a-b2c7-4d41-8692-8199cf63b640">4,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a5542beee460cbf11a482a837b496_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtNi0xLTEtMA_c5b38c9f-7e0a-4372-b28e-8ae323bb121e">5,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtOC0xLTEtMA_e602acd6-937f-4977-a757-3fb45c284a28">10,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i478ab1e04df3462693b4f447d123258c_I20191231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTAtMS0xLTA_fa782bf2-cb68-496b-adb1-24dd7a5aeae0">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTItMS0xLTA_49330f1f-6064-4d11-aeb7-2c4e5412521d">5,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTQtMS0xLTA_d8ca3d2a-dcaf-4a60-9809-feb59c3cb9c6">3,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTYtMS0xLTA_58e19930-72f6-4dd4-afa8-6bea292bb3f0">9,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the first quarter of 2020, we paid a $<ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjM2NQ_54951681-9af2-455d-af6c-8445577f2134">1.8</ix:nonFraction>&#160;million contingent liability on development milestones to former Crystal shareholders. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingentvalueright" contextRef="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjU0Ng_84b3cb5f-612f-4f5c-a6fe-d1458d28b8a5">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingentvalueright" contextRef="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjU2NA_20ba2828-52da-423d-b982-e304d9453414">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingentvaluerightseries" contextRef="ibfc313fa997f4657b35211e781b16774_D20100101-20100131" decimals="INF" format="ixt-sec:numwordsen" name="lgnd:NumberOfContingentValueRightsSeries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjU4NA_398dffe3-5cc2-4108-a5f4-05b928c03cd8">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131" format="ixt-sec:durwordsen" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjcxOQ_d201438c-6d2c-4214-94f2-df72480712ec">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="ia730be76fe494ababd31b792de283e21_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMzUyMQ_453015b5-3d78-41a5-985f-f663366153a9">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i4d48f0e79a2a43869f2f0bd580a4753b_I20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMzYzNg_2104c0c8-b3f5-42b8-ba35-b1e6623cbdcd">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the third quarter of 2020, we paid a $<ix:nonFraction unitRef="usd" contextRef="i7ba69388d37546cabc299b2e1f680e46_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfNDk0NzgwMjMzMDIwNg_072a3381-eb86-4fad-ab98-02aebf0a5bd0">0.5</ix:nonFraction>&#160;million contingent liability based on revenue milestones to Icagen.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ia119c2bfd24c4a5fa5c9e64a6db35c62" continuedAt="i366c2eeadfe24beab6883b55d8719c8c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i366c2eeadfe24beab6883b55d8719c8c">There were no triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three and nine months ended September&#160;30, 2020.</ix:continuation> </span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODI0NjMzNzIxOTIwNg_daab69d1-8c5a-49e3-86df-01839288b85f" continuedAt="i604be09cf5a542a0887efd8f2861d5e2" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i604be09cf5a542a0887efd8f2861d5e2" continuedAt="i11cde2180fc84994bcc8e15c217ba462"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTgxNw_89e0a531-4469-4e35-a05f-8441401c4fc5">5.1</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzU2MA_cbc58bf1-0710-4428-9676-d2cfa79febd2">4.6</ix:nonFraction> million in cash, and a $<ix:nonFraction unitRef="usd" contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTM1Mg_3875f5b7-de7f-41cd-8db1-2b7b59ca420c">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $<ix:nonFraction unitRef="usd" contextRef="i9e64c0586051455caf1fcc537086a20a_I20200909" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzU3Nw_aa6e2492-4df9-4b48-b63e-20e9314ec1a3">4.5</ix:nonFraction> million tied to partnered and internal research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="i999aee09e45649fdb1cd9982ed98cdc2_I20200909" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzU5Ng_32121f16-4f1f-4942-94db-316f50d74617">25.0</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i3375f5d3a4424dcd819ba8dc9c56b35e_D20200909-20200909" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzYxNA_cad57825-082f-4f60-b7f2-33a2c021437a">25</ix:nonFraction>% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTg2MA_50bcc02e-24d5-42ab-aba1-4115a9ac99c2">5.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="i8fae09558a4443b6952d5785b2692f3a_I20200909" decimals="-4" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNTkwOQ_ab4464c5-02b5-4ac0-ba39-00ada7811fa2">0.05</ix:nonFraction> million of tangible assets acquired, and (2) $<ix:nonFraction unitRef="usd" contextRef="i8f8208b3443c4953b951bcf2e7b70a4b_I20200909" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNTk5Mg_58e8e943-291f-4417-a636-f7c975e38410">5.0</ix:nonFraction> million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i9e200da6ec4c46c68c9db69c0131c385_D20200909-20200909" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzODY0Nw_cba95ee4-e704-4525-bb9e-61204db6f957">10</ix:nonNumeric> years. We account for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="i8fae09558a4443b6952d5785b2692f3a_I20200909" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDM5ODA0NjUyMzAyMQ_195dd196-8220-49b3-a64e-4b1e3c5a91f8">None</ix:nonFraction> of the CVRs are recognized as of the acquisition date. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $<ix:nonFraction unitRef="usd" contextRef="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzYyMA_5a172058-f847-4044-a29d-1c515c0cb637">7.1</ix:nonFraction> million in cash (including a $<ix:nonFraction unitRef="usd" contextRef="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationConsiderationTransferredHoldback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTUyMg_e833a85a-9321-4f1e-a32c-2e9c4b518937">0.5</ix:nonFraction> million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $<ix:nonFraction unitRef="usd" contextRef="i29bff9a12f464884a5afac09cb178f2b_I20200908" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzYzNw_4743a703-d3be-4d32-9f75-a09bcd61c115">5.0</ix:nonFraction> million tied to our use of the xCella technology for partnered research and development and for up to $<ix:nonFraction unitRef="usd" contextRef="iba4f03a76ff84cd195e9a52f4859e3e0_I20200908" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzY1NA_6463a13b-5827-4919-9edc-1008ddb28ea2">25.75</ix:nonFraction> million as a <ix:nonFraction unitRef="number" contextRef="i5b61ef8a9bb34b4a831d8fdf376d0630_D20200908-20200908" decimals="INF" name="lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzY3NQ_67fcbbe3-c722-4b0e-ada9-47f7d09d9cc8">25</ix:nonFraction>% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $<ix:nonFraction unitRef="usd" contextRef="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjQwNg_c13e7720-2ac6-4ba7-90af-ec7978cb2667">7.1</ix:nonFraction> million consideration transferred, we recognized (1) $<ix:nonFraction unitRef="usd" contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjIyOQ_fe214e19-2c45-40b9-b3b4-2c89124a7f44">0.2</ix:nonFraction> million of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjI3MA_6ac53a82-8bf0-4337-a3e0-ea8c9851408c">0.1</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="iefa15c311fc64869817af666497c6c42_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjMxMA_302a3c55-dd6e-4430-8bef-4330becf782d">7.8</ix:nonFraction> million of core completed technology acquired, and (4) $(<ix:nonFraction unitRef="usd" contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjk2Nw_78693110-fb33-4ebb-9985-0007eec0e1b6">0.8</ix:nonFraction>) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i3c8ee65a89ca400999e52481a25fc8c0_D20200908-20200908" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzODUzNg_582a5e85-9b37-41e6-bb70-1e80e5d57e8e">15</ix:nonNumeric> years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. <ix:nonFraction unitRef="usd" contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDM5ODA0NjUyMzAzMA_6bb415ff-58e0-490a-8afe-1393cae56fe5">None</ix:nonFraction> of the earnout rights are recognized as of the acquisition date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did <ix:nonFraction unitRef="usd" contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODI0NjMzNzIxOTIyNQ_5b54a1de-c131-4910-a00f-a5979d4d6139">no</ix:nonFraction>t incur any material acquisition related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNjU0_267850ec-3ee6-41cd-babc-51a2885db81c">19.9</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNjY2_ec667a51-4e2b-4152-94ab-048cfd0f4ac3">15.1</ix:nonFraction> million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNzU0_5ba086f4-2ce5-408f-b373-e5d15d0468e7">25.0</ix:nonFraction>&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODQy_8ec14208-220d-4ffb-8742-b07ee708a4fa">4.8</ix:nonFraction> million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i11cde2180fc84994bcc8e15c217ba462" continuedAt="i8710ca9b2f3b486a888f236a2d1afe84"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. There was no change in the fair value of the continent liabilities during the second quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary allocation of the purchase price consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTk3MA_05ff3079-999f-4e54-984d-bfde8bc34f26">1.8</ix:nonFraction> million of fair value of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjAyMQ_1c373628-6cd5-452d-b877-f9107fdd6323">0.8</ix:nonFraction>) million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjA1Mg_3036df45-671b-4dd8-b703-a45af069d491">12.8</ix:nonFraction> million of acquired intangibles, (4) $(<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjA4NA_cdd3b77e-2c85-4b62-8edc-b2989c01a5ea">3.7</ix:nonFraction>) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $<ix:nonFraction unitRef="usd" contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjE5NQ_fdb515af-91ec-4791-8475-73b3ee6406d7">0.8</ix:nonFraction> million of deferred tax asset associated with the deferred revenue, and (6) $<ix:nonFraction unitRef="usd" contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjI2Ng_199e30a0-f23d-475b-af7d-9a159b9ee75b">9.0</ix:nonFraction> million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $<ix:nonFraction unitRef="usd" contextRef="iedf59884a0ba4125b067647bc5e8a67b_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjM2Nw_56deef56-e424-4617-9170-8a0b9c92c037">11.1</ix:nonFraction> million of customer relationships and $<ix:nonFraction unitRef="usd" contextRef="if85df3b674454d1fbeb0d47a0f94915a_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjQwMA_3c0ebdfb-0fad-4e4a-b5b8-f20b97b4fa93">1.7</ix:nonFraction> million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i7e7c4b5aaae742f5836b06830ae9422b_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjY5NQ_9eeb266d-e158-4c99-86b0-1a398b6c64fa">17</ix:nonFraction>%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of <ix:nonNumeric contextRef="i7e7c4b5aaae742f5836b06830ae9422b_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjgzOQ_1096676a-79c0-4119-a30b-1abac6d43e0c">9.6</ix:nonNumeric> years The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i051cac9942274d55850055cf090e8f8d_D20200401-20200401" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMzE3OQ_24aeaa1e-18ff-4679-9e8e-cc610a954011">17</ix:nonFraction>%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="i051cac9942274d55850055cf090e8f8d_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMzI5OQ_32159562-8b2b-4f11-b4ca-d99d5bea79b9">10</ix:nonNumeric> years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMzQxOQ_052eebc9-8950-46fe-beb9-1112d66a2c4f">9.7</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Ab Initio Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 23, 2019, we acquired privately-held Ab Initio Biotherapeutics, Inc., an antigen-discovery company located in South San Francisco, California. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did <ix:nonFraction unitRef="usd" contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODI0NjMzNzIxOTIxNw_10e48b19-8f52-4daf-98f9-bbd09ae51f37">no</ix:nonFraction>t incur any material acquisition related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $<ix:nonFraction unitRef="usd" contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDAxOQ_75b94de2-467a-4c1a-a970-e6820aa3ec4e">12.0</ix:nonFraction> million included $<ix:nonFraction unitRef="usd" contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDAzMQ_885fbe0d-5891-4d17-9720-d364420ba546">11.86</ix:nonFraction> million cash consideration paid upon acquisition, net of cash acquired, and $<ix:nonFraction unitRef="usd" contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDEwMg_def0085a-0a4c-434d-9970-d435379a368e">0.15</ix:nonFraction> million cash holdback for potential indemnification claims, which was paid during the third quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Ab Initio have been included in our results of operations since the date of acquisition. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i8710ca9b2f3b486a888f236a2d1afe84">The allocation of the purchase price consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723" decimals="-4" format="ixt:numdotdecimal" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDQyNA_be966c6f-9a3b-4c87-b4e6-13862396f087">0.03</ix:nonFraction> million of fair value of tangible assets acquired, (2) $(<ix:nonFraction unitRef="usd" contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDQ3NQ_ed26d631-c410-4b9a-a802-f00a60a3398e">0.08</ix:nonFraction>)&#160;million of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="i14f34a9837f549a2b830d35fa413bbd8_I20190723" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDUwNg_439029ca-62ac-4f7b-b8ae-60b1de0f185d">7.40</ix:nonFraction>&#160;million of acquired technologies, (4) $(<ix:nonFraction unitRef="usd" contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDUzOQ_d9dc354f-d931-44dd-b7d3-755134bf68a4">0.15</ix:nonFraction>)&#160;million of deferred tax liability in connection with the acquired intangibles, and (5) $<ix:nonFraction unitRef="usd" contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723" decimals="-4" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDYyMQ_70e96daf-ab7d-4448-8baf-4f2da85dd75f">4.81</ix:nonFraction>&#160;million of goodwill, none of which is deductible for tax purposes. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of <ix:nonFraction unitRef="number" contextRef="i98ade28714c945bdbaed7782ccd551cc_D20190723-20190723" decimals="INF" name="lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNTAxNA_902d24f9-14cf-4ad5-9696-be69118ed836">12</ix:nonFraction>%. The fair value of the core technology is being amortized on a straight-line basis over the weighted average estimated useful life of the approximately <ix:nonNumeric contextRef="i98ade28714c945bdbaed7782ccd551cc_D20190723-20190723" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNTE2OQ_a649f171-5b94-47a7-a31a-e2cead90a55a">20</ix:nonNumeric> years.</ix:continuation> </span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTk3Ng_beaef0a9-ba0b-4455-a247-6ac01425c1fe" continuedAt="i2b480d3f10184e0dab3b368a67816507" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2b480d3f10184e0dab3b368a67816507" continuedAt="ic1f8fa9a2ff641899bb8f2c0ecf219f3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTAw_61c0b64a-2fdc-4685-b638-bc91fec771af">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTMz_2593a00a-a152-4faa-b63c-f523bc6bcdb9">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjg5_e6550d0b-348e-406c-b96f-5d9808843b33">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNjEw_676837e5-c22f-4fd5-ab6a-f4418a5237cb">248.48</ix:nonFraction> per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ic1f8fa9a2ff641899bb8f2c0ecf219f3" continuedAt="ic0730adc7242488fab389d38ee677c91"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfOTQz_72ff901c-a9e4-4e21-8075-4e4d74619bbf">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfOTk5_73425219-0c1d-444b-b140-c7578a1e28f9">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTE5NA_98701c00-27c3-467c-a28a-63935e3252c9">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTI1OQ_3846cee0-eb0a-4f2a-bf66-3d56254934fe">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTMwOA_2d15bcf6-e0ce-43c7-b365-f67dbcd6b09a">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTQxNw_40cf97c9-20d9-463a-b87f-19d7fda5dad1">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTg0MQ_1ec238a6-e1db-47a0-afc7-420396cc5877">248.48</ix:nonFraction>. As of September&#160;30, 2020, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTk5OA_98f0b200-706b-4afc-9ca1-4413ffb15732">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $<ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjE3MQ_8f3f2f3c-104f-4e94-8bd5-5a837e54d8cb">13.7</ix:nonFraction> million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we repurchased $<ix:nonFraction unitRef="usd" contextRef="ibfe792e75a594433b59c93b28557b63e_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjU4OA_41e1edef-fc6a-4ab5-886c-813c33ef51c5">234.4</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjYyNg_c3a70746-58c4-4240-9a08-22b41fc4476a">203.8</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjY2OA_53dd1a64-8f55-475c-ade0-8b59bd9f4b55">0.6</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted (1) a gain of $<ix:nonFraction unitRef="usd" contextRef="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjc1OQ_bd943571-9d46-445a-bfaf-863dcfa68b2d">0.7</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2020; (2) a $<ix:nonFraction unitRef="usd" contextRef="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="lgnd:IncreaseDecreaseInDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjg3OQ_77dedc4b-1750-464c-b641-a310b83dbe52">32.7</ix:nonFraction> million reduction in debt discount, and (3) a $<ix:nonFraction unitRef="usd" contextRef="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjkyMA_93920833-f67f-4569-97bf-2f19595822f3">2.7</ix:nonFraction>&#160;million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of September&#160;30, 2020. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzEyMA_38543cd4-73aa-494c-a05b-22e38e13b81c">515.6</ix:nonFraction>&#160;million in principal amount of the 2023 Notes remain outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzM0OA_d8da5981-546a-4be4-bb6c-b42fc4fb6a5c">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzYyMg_35d2d31c-38f0-4095-b4cc-ba9c62763731">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="lgnd:PaymentsForConvertibleBondHedges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzcwNQ_293a56a8-d1c6-4e54-92a5-922b109d6862">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNDYwNQ_c0d7f8ef-4a89-4491-8dea-b6e056e31782">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNDY3MQ_b214d613-03d7-4636-9136-099babe371da">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNDcyOQ_afa42ed5-669f-409f-8222-3cef823c1fda">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="ibfe792e75a594433b59c93b28557b63e_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTM1Ng_41e1edef-fc6a-4ab5-886c-813c33ef51c5">234.4</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTM5NA_c3a70746-58c4-4240-9a08-22b41fc4476a">203.8</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTQzNg_53dd1a64-8f55-475c-ade0-8b59bd9f4b55">0.6</ix:nonFraction>&#160;million, during the quarter ended March 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic0730adc7242488fab389d38ee677c91"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTk3NQ_b0eff3f5-e5b0-4006-ab2a-8108a48ec72e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.885%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMS0xLTEtMS0w_5aefa71a-eabe-40c5-9ac3-c903d388f537">515,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5a227d490d42d182609204378ddfea_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMS0zLTEtMS0w_e8e90a96-d4a2-4e76-a250-09d3c1f23657">750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMi0xLTEtMS0w_a304d846-7398-4489-a598-e1c3ae22460f">60,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief5a227d490d42d182609204378ddfea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMi0zLTEtMS0w_2520dc7f-830b-49e1-af74-3280849f417c">111,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMy0xLTEtMS0w_6b003448-fd2e-46ed-86ab-62975112debb">454,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5a227d490d42d182609204378ddfea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMy0zLTEtMS0w_bb9ab3f5-a52c-41ae-9737-88fd70244a43">638,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNS0xLTEtMS0w_51b39e3d-2dc2-4090-bd87-1aae5cf47a31">55,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5a227d490d42d182609204378ddfea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNS0zLTEtMS0w_b40cff0d-5186-4aaa-acb7-ffbf29de5b6c">101,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNi0xLTEtMS0w_cbbeed90-eb18-455a-be16-c697f9c841a1">464,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5a227d490d42d182609204378ddfea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNi0zLTEtMS0w_ff6e9cf0-60ae-4d4d-9963-f467943d0671">647,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfMTAzOA_1912ba78-704d-46c2-9941-d5962d9c5256" continuedAt="iae09bb99ba95464db51d67abe88e0b1c" escape="true">Income Tax</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="iae09bb99ba95464db51d67abe88e0b1c">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2020 was <ix:nonFraction unitRef="number" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfNDI5_e66e0d8d-269e-4fa9-934c-ba594db1508b">42.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfNDM2_65414a58-44ad-4ae2-9976-7c2cafe5cfa0">37.1</ix:nonFraction>%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. and tax deductions related to stock award activities offset by tax deductions related to foreign derived intangible income tax credits. The effective tax rate for the three and nine months ended September&#160;30, 2019 was <ix:nonFraction unitRef="number" contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfODIw_c219bb9e-4482-43cf-8cf1-dc0a7dd14375">23.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930" decimals="3" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfODI3_d546ceb8-19a8-42e9-ae17-5660cd44c58a">20.9</ix:nonFraction>%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three months ended September&#160;30, 2019 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory tax rates than the U.S..</ix:continuation></span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTcwMA_ad792cef-b5e3-4595-a987-738fe19c14ce" continuedAt="ia17ce2b75ce741bdadc96a03af522927" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia17ce2b75ce741bdadc96a03af522927" continuedAt="i4a5e58958c6942dc88c96b97bb1eac94"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of Notes to Consolidated Financial Statements in our 2019 Annual Report.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTcwMw_1e4af673-502a-4753-a997-9e353c24c503" escape="true"><ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTcwNA_a0e6d6c4-4896-4656-afa4-ee1ec9a1d71a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:40.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9901cc55d3a41d6a022e1bace11721c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi0xLTEtMS0w_04f51d08-dfc5-4c1a-9703-449b1a38313f">1,956,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9901cc55d3a41d6a022e1bace11721c_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi0zLTEtMS0w_e7286db5-fad1-4c1b-8437-0ced04227c9c">77.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b873c8bed16489d977cfb5d84e575a4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi01LTEtMS0w_22d75977-588c-41eb-9065-e96b075e2da5">147,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b873c8bed16489d977cfb5d84e575a4_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi03LTEtMS0w_65926dd1-f30e-439e-9b61-dc7f353b0949">125.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy0xLTEtMS0w_86debad1-fcdf-4378-b657-1d6b5c267996">480,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy0zLTEtMS0w_44f6ae7f-0edd-499e-8a52-4dd132674720">90.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy01LTEtMS0w_bb654887-961e-4c70-b2ad-00e775dba90c">104,306</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy03LTEtMS0w_68ac0d99-e228-4ae3-bc81-d6c55dde40c7">89.58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC0xLTEtMS0w_52d611e5-bb29-4da8-b554-9681e2f4c0e2">113,107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC0zLTEtMS0w_c78fe98f-c219-4d18-b806-2234a70b1bc6">23.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC01LTEtMS0w_125a89a6-492d-4ae4-a030-01c12a4d04d9">50,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC03LTEtMS0w_7a529006-d55e-4169-985e-ef9e241a2d9d">122.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS0xLTEtMS0w_4905f497-df5f-41cb-a05f-ee33e3951208">10,200</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS0zLTEtMS0w_e55d1280-4a18-4fe0-b9c7-b48c24194eff">72.01</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS01LTEtMS0w_5a8533fb-0626-4906-96d6-6d194de9f537">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS03LTEtMS0w_80c387e9-f74e-4137-bc63-6b9d3eb18e53">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia3dda86ca5ea49ce89a56fba0b2e74eb_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi0xLTEtMS0w_492b1ebb-44c4-46f1-bcbf-59f7faf463e9">2,313,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia3dda86ca5ea49ce89a56fba0b2e74eb_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi0zLTEtMS0w_a6bf5d56-3ee2-4246-ada3-3337b6aae509">82.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fe5995b210642eb9ea6c816db2ac441_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi01LTEtMS0w_30998c90-b233-44e8-b718-19bf8a3249e3">201,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fe5995b210642eb9ea6c816db2ac441_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi03LTEtMS0w_f326a587-9e08-48b1-ab6b-5da492d0a08f">107.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfNDQ3_14bd9a86-dfaf-4320-8dae-3b23f91a7d1d">1.6</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="2" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfNTI2_e16a69e8-47fb-43f2-bc1d-07e710afe74e">72.60</ix:nonFraction>.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i1803c7b7772d48fcbcd1f7dd2fea7909_D20200101-20200930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfNjc1_ee44b5fe-5551-4b64-b656-6e17a4834e49">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2020, <ix:nonFraction unitRef="shares" contextRef="i1803c7b7772d48fcbcd1f7dd2fea7909_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfODAy_302ced40-9220-4ed3-9e66-5dd8ed65b692">56,079</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfOTMz_2f68a19c-57ef-4692-81f5-17d7e1f56188">73.3</ix:nonFraction> million of our common stock under our stock repurchase programs as discussed below. We did <ix:nonFraction unitRef="usd" contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTAxOQ_0c6c81f2-b7d2-4e93-aad7-b74286b708cb"><ix:nonFraction unitRef="usd" contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTAxOQ_1749fb28-f1e7-426a-ae4c-df8f462d1a6d">no</ix:nonFraction></ix:nonFraction>t have any share repurchases during the second and third quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i8183957e6f4e449b8b14bffaa3391716_I20190911" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTIyNQ_20d1d0fa-11ba-483f-b871-d975e98a1bf2">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="id421b7a497e949c0829fd0a9cb8a9545_D20190911-20190911" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTI4MA_98dd06fd-7962-479f-89d6-a75dbfef1bb6">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4a5e58958c6942dc88c96b97bb1eac94">repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTY0Nw_0be41d40-71da-45bd-850c-44a27f7f5729">253.5</ix:nonFraction> million of our common stock remained available as of September&#160;30, 2020.</ix:continuation> </span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNTExNg_fdd521fd-f565-48c3-8322-7b1e2d93162d" continuedAt="i3900a72284654fdfacff84a8654c2d42" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3900a72284654fdfacff84a8654c2d42"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2019, CyDex received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#8220;Alembic&#8221;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&#174; prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or U.S. Patent No. 10,040,872 (&#8220;the &#8217;872 patent&#8221;), and alleging that these patents, each of which relates to Captisol&#174;, are invalid, unenforceable, and/or would not be infringed by Alembic&#8217;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#8217;s ANDA constitutes infringement of each of the &#8217;088 patent and the &#8217;582 patent. On July 29, 2019, Alembic filed an answer and counterclaims seeking declarations of non-infringement and invalidity as to each of the asserted patents and, on August 19, 2019, CyDex filed an answer to Alembic&#8217;s counterclaims. On April 7, 2020, the Court ordered that the Scheduling Order be amended such that, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter alia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the fact discovery cut off was set for November 2, 2020, the close of expect discovery was set for March 22, 2021, and that May 17, 2021 would remain the first day of a five-to-six-day bench trial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#8220;Lupin&#8221;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&#174; prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or the &#8217;872 patent, and alleging that these patents, each of which relates to Captisol&#174;, are invalid, unenforceable, and/or would not be infringed by Lupin&#8217;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all <ix:nonFraction unitRef="patent" contextRef="ia89ff6c0983c400999c69d63e6050433_D20191029-20191029" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNDE3OA_ee7e2519-c41a-4ad5-a377-ae2c8179a2d6">four</ix:nonFraction> patents and CyDex filed its answer to Lupin&#8217;s counterclaims on January 2, 2020. Fact discovery is ongoing. The Court&#8217;s scheduling order sets close of discovery on May 7, 2021 and a five day bench trial starting on December 13, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civilcomplaint" contextRef="i618ff0aa526749d3ae1e702491ced1ab_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNDQyMQ_305b80bc-c496-4b14-bf06-7a04b24b3e16">three</ix:nonFraction> civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civilcomplaint" contextRef="i618ff0aa526749d3ae1e702491ced1ab_D20191031-20191031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNTAwNg_0de8b2b8-165d-4f51-941d-873c056874cf">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div></ix:continuation><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjIyOQ_2a196c7b-3776-4b96-ba53-762fad0e79ca" continuedAt="i89640dcb07994efa9b486c2629550b61" escape="true">Leases</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i89640dcb07994efa9b486c2629550b61" continuedAt="i7df67fd5b80d40828bed0c3183f46ef7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMTU4_6e2e7d5b-569a-4112-af29-1a3087e4b64c">seven</span> years, some of which include options to extend the leases for up to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjI5_55733a26-80e9-4395-8c9c-5fd85e05d7b3">seven</span> years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. For leases with a term of 12 months or less, we elected to not recognize lease assets and lease liabilities and expense the leases over a straight-line basis for the term of those leases.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i7df67fd5b80d40828bed0c3183f46ef7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div></ix:continuation><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_481"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90ZXh0cmVnaW9uOjk2MWYxNmY1ZTRiYjRhNDFhMGQyYzg1NmZkZTBiNDU1XzQzOTgwNDY1MTI2MDA_aaaf7ee6-4ef0-4d82-8436-0a4ae0d26df8" continuedAt="i4cae7077220642a4b9535ac4738fea9a" escape="true">Assets Held for Sale</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4cae7077220642a4b9535ac4738fea9a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 10 - Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we entered into an agreement to divest Vernalis (R&amp;D) Limited in October 2020. As a result of meeting the criteria to classify the disposal group as held for sale under generally accepted accounting principles, Vernalis (R&amp;D) Limited was classified as held for sale as of September&#160;30, 2020. Assets classified as held for sale are recorded at the lower of their carrying amount or fair value less costs to sell and are not depreciated or amortized. Classification of our disposal group held for sale occurs when sufficient authority to sell the disposal group has been obtained, the disposal group is available for immediate sale and its sale is probable within one year. If at any time these criteria are no longer met, the disposal group would be reclassified as held and used. We evaluate the held for sale classification during each reporting period. The disposal group did not meet the requirements for presentation as discontinued operations and are included in income from continuing operations for the three and nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="usd" contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90ZXh0cmVnaW9uOjk2MWYxNmY1ZTRiYjRhNDFhMGQyYzg1NmZkZTBiNDU1XzQzOTgwNDY1MTI2MDY_2eb1cb77-3309-4597-a7f5-6a7004ce6c4a">no</ix:nonFraction>t have any assets held for sale as of December&#160;31, 2019. <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90ZXh0cmVnaW9uOjk2MWYxNmY1ZTRiYjRhNDFhMGQyYzg1NmZkZTBiNDU1XzQzOTgwNDY1MTI2MDE_c75455eb-abfe-4bc1-afe9-53acfb75745c" continuedAt="i0982ddefddb84115a7e6279dcc2a1f97" escape="true">The following table presents the carrying amounts of major classes of assets and liabilities related to assets held for sale with respect to the Vernalis (R&amp;D) Limited divestiture as of September&#160;30, 2020.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="i0982ddefddb84115a7e6279dcc2a1f97"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:75.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzItMi0xLTEtMTU4Ng_8e950a6a-bf5d-4e1f-b7c1-ea370319db53">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzMtMi0xLTEtMTU4Ng_7403a720-62b7-427a-a005-892531789ee9">2,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzQtMi0xLTEtMTYwNw_dcc7dff4-affb-46ba-971b-e0607e5f435a">2,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzQtMi0xLTEtMTU4Ng_20a8829d-2a37-46c0-ad93-bae069705245">5,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzYtMi0xLTEtMTcwOQ_21cf7d8c-2c07-4182-88c6-563a2700218a">13,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzktMi0xLTEtMTU5MA_0a90a6f9-76eb-4fde-b8e8-f5b3be87e921">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzEwLTItMS0xLTE1OTA_c123bd6f-187e-49ac-9183-dd7d266c4dc3">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzExLTItMS0xLTE1OTA_b0b9a1a2-f491-49db-9936-d871a41413cb">2,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzEyLTItMS0xLTE1OTA_1af731be-81a9-4ff5-9b0a-d6eac84a8685">5,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzEzLTItMS0xLTE2MTU_fc522b2c-d8ae-4593-a29f-c99fe5cb5bfb">653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities related to assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzE0LTItMS0xLTE3MTE_26762d94-6a32-47df-adfb-3ef70b211d72">10,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_462"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTEyNzM_f192d11b-25e9-4b81-8647-e676acb4d582" continuedAt="iacd22bbbdf3349db9b2851f1c198797f" escape="true">Subsequent Events</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iacd22bbbdf3349db9b2851f1c198797f" continuedAt="i9c9a1081f7fb4b0d905f3abefa99b46d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, we completed the acquisition of Pfenex for $<ix:nonFraction unitRef="usd" contextRef="ibc5070ad9b82439b913a9301d0b00b65_D20201001-20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTQ2Mzk_283c0990-56e9-40eb-ae23-91a6fc20e8cb">437.5</ix:nonFraction>&#160;million in cash, plus one non-transferable CVR per share representing the right to receive an aggregate contingent payment of $<ix:nonFraction unitRef="usd" contextRef="ibb2c08d52fc04211b2744d4a8b48977e_I20201001" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTQ2NTU_b650cdd4-e7a9-4bc3-b46e-a115e00b3075">78</ix:nonFraction>&#160;million in cash if a certain specified milestone is achieved. The acquisition was funded using cash on hand. We are currently evaluating the accounting impact of this transaction and anticipate using ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, but the initial purchase price allocation is not yet complete.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Vernalis Research Operations</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i9c9a1081f7fb4b0d905f3abefa99b46d">On October 11, 2020, we and our wholly-owned subsidary Vernalis Limited, a company incorporated in England (&#8220;Seller&#8221;), entered into an Agreement for the Sale and Purchase of the Entire Issued Share Capital of Vernalis (R&amp;D) Limited (the &#8220;Purchase and Sale Agreement&#8221;) with HitGen UK Ltd, a company incorporated in England (&#8220;Buyer&#8221;), and HitGen Inc., a company incorporated in China (&#8220;HitGen&#8221;), pursuant to which Ligand and Seller agreed to sell the entire issued share capital of Vernalis (R&amp;D) Limited, a company incorporated in England and a wholly-owned subsidiary of Seller (&#8220;Vernalis&#8221;), which constitutes the sale of the Vernalis business operations including the Vernalis Design Platform.  Under the terms of the Purchase and Sale Agreement, at the closing of the transaction, Buyer will pay $<ix:nonFraction unitRef="usd" contextRef="ia8fa3962729945ee8b1a302fab16a100_D20201011-20201011" decimals="-5" format="ixt:numdotdecimal" name="lgnd:ExpectedProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTQ2Njk_50e431df-b100-474d-be0a-da3432e8b991">25.0</ix:nonFraction>&#160;million in cash, subject to a working capital adjustment. In addition, Buyer will pay to Ligand any net receipts pursuant to completed collaboration licenses and a share of any net receipts pursuant to ongoing research collaboration agreements. The closing is expected to occur in the fourth quarter of 2020.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A: "Risk Factors."  This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis, and other product royalty revenues, the impact of COVID-19, product returns, and product development. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market, or that the closing conditions of the transaction to divest the Vernalis business will be satisfied. Ligand may not achieve the growth prospects and synergies expected from its acquisitions of Pfenex, xCella and Taurus, and may experience delays, challenges and expenses associated with integrating the related businesses. In addition, ongoing or future arbitration, or litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our trademarks, trade names and service marks referenced herein include Ligand. Each other trademark, trade name or service mark appearing in this quarterly report belongs to its owner.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a revenue generating biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, structure-based drug design, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 120 pharmaceutical and biotechnology companies. Over 200 different programs are in various stages of commercialization and development and fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others. Our collaboration partners and licensees have programs currently in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. We have over 1,400 issued patents worldwide.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled our large portfolio of fully-funded programs either by licensing our own proprietary drug development programs, licensing our platform technologies such as Captisol or OmniAb to partners for use with their proprietary programs, or acquiring existing partnered programs from other companies. Fully-funded programs, which we refer to as &#8220;shots on goal,&#8221; are those for which our partners pay all of the development and commercialization costs. For our internal programs, we generally plan to advance drug candidates through early-stage drug development or clinical proof-of-concept and then seek partners to continue development and potential commercialization.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. We believe that focusing on discovery and early-stage drug development while benefiting from our partners&#8217; development and commercialization expertise will reduce our internal expenses and allow us to have a larger number of drug candidates progress to later stages of drug development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from: royalties on sales of products commercialized by our partners, sale of Captisol material, and contract revenue which consists of service revenue for contracted R&amp;D services performed for our customers over </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time, license fees, contingent milestone payments and other payments. In addition to discovering and developing our own proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see impact of COVID-19 pandemic described in Item 1. Condensed Consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. For additional information on the various risks posed by COVID-19 pandemic, please read </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this report.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Program Updates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:95%">OmniAb&#174; Platform Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb is our multi-species antibody platform for the discovery of mono- and bi-specific therapeutic human antibodies.  As of the third quarter of 2020, more than 8,500 clinical subjects have been or are planned to be treated by partners in clinical trials with OmniAb-derived antibodies. New clinical programs are pending at Johnson &amp; Johnson and Merck, among others.  Ligand expects the first regulatory submission for OmniAb-derived antibodies in 2021, with potential for as many as 10 approvals expected by 2025.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the OmniAb platform, we recently announced OmniTaur&#8482;, featuring Ultralong CDR-H3 humanized binding domains recently acquired from Taurus Biosciences. The OmniAb platform also includes the ultra-high resolution, high-speed automated antibody selection technology acquired from xCella Biosciences.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Multiple OmniAb partners reported clinical or regulatory progression with OmniAb-derived antibodies during the third quarter of 2020.  Additionally, three of our partners (Takeda, Immunoprecise and Genovac) are pursuing development of therapeutic antibodies for the treatment of COVID-19 that were discovered with OmniAb.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CStone Pharmaceuticals announced the formation of a $480 million strategic collaboration that encompasses a $200 million equity investment by Pfizer Hong Kong in CStone, collaboration between CStone and Pfizer Investment for the development and commercialization of CStone&#8217;s PD-L1 antibody sugemalimab (CS1001) in mainland China and a framework between CStone and Pfizer Investment to bring additional oncology assets to the Greater China market. CStone announced updated results from two clinical studies of sugemalimab at the 2020 Chinese Society of Clinical Oncology Annual Meeting.  CStone announced that sugemalimab met the primary endpoint as first-line treatment in stage IV squamous and non-squamous non-small cell lung cancer.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immunovant announced positive topline results from a multicenter, placebo-controlled Phase 2a trial (ASCEND MG) of IMVT-1401, a novel investigational anti-FcRn antibody delivered by subcutaneous injection, in patients with myasthenia gravis (MG).  A registration-enabling Phase 3 MG trial is expected to initiate in the first half of 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol&#174; Business Updates </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date in 2020, we have entered into more than 120 Captisol research use agreements and eight clinical and/or commercial license agreements. This is the highest number of use agreements to be signed in a single year since the invention of Captisol.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Captisol is utilized in the formulation of Gilead Sciences&#8217; Veklury&#174; (remdesivir), which on October 22, 2020 received U.S. FDA approval for the treatment of patients with COVID-19 requiring hospitalization. The product has regulatory approvals for the treatment of moderate or severe COVID-19 in over 50 countries and is included in more than 30 ongoing clinical trials. We are supplying Captisol to Gilead under a recently signed 10-year supply agreement. We are also supplying Captisol to Gilead&#8217;s voluntary licensing generic partners who are manufacturing remdesivir for 127 low- and middle-income countries.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Partner Marinus was recently awarded a BARDA contract by the U.S. government to develop Captisol-enabled IV ganaxolone for the treatment of refractory status epilepticus (RSE) caused by nerve agent exposure. Marinus also announced it had satisfied the FDA protocol-specific questions for the registrational Phase 3 trial (the RAISE trial) in RSE, allowing the company to begin patient enrollment in October. Topline data are anticipated in the first half of 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to initiate a potentially pivotal trial for CE-Iohexol in December 2020.  CE-Iohexol is an iodine-based contrast agent for hospital-based imaging procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protein Expression Technology Platform Updates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, we closed the previously announced acquisition of Pfenex, Inc. Pfenex brings to us a proprietary protein expression technology, as well as major collaborations with Jazz Pharmaceuticals, Merck, Serum Institute of India and Alvogen, each of which has potential to contribute meaningfully to our royalty revenue. Our partner Merck announced positive data from two Phase 3 studies with V114, which uses the protein expression technology, evaluating the safety, tolerability and immunogenicity of the investigational 15-valent pneumococcal conjugate vaccine with plans for global regulatory licensure applications in the fourth quarter 2020. Also using the platform, Jazz Pharmaceutical&#8217;s Erwinaze supply challenges due to issues with their manufacturer were solved, resulting in a robust process showing manufacturing consistency and efficiency.  The program was completed from commencement to projected first BLA filing in approximately four years.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a new 10-year CRM197 supply agreement with a global multi-national pharmaceutical partner focused on vaccine development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:99%">Other Business Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We announced the sale of our Vernalis research operations and internal programs to HitGen Inc. for $25 million in cash.  Under the terms of the agreement, we will retain economic rights on completed collaboration licenses as well as a share of the economic rights on current research collaboration contracts. The transaction is expected to close in the fourth quarter of 2020, subject to customary closing conditions.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several partners also had significant regulatory, financing and business updates during the third quarter of 2020:  Verona Pharma announced initiation of its ENHANCE Phase 3 trials, Retrophin announced enrollment of the first 280 patients in the pivotal Phase 3 PROTECT study of sparsentan in IgA nephropathy, and Sermonix Pharmaceuticals announced a collaboration with Eli Lilly to study lasofoxifene in combination with Lilly&#8217;s CDK 4 and 6 inhibitor abemaciclib in metastatic breast cancer. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:14pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:18.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,005</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(762)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,180)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">23,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">68,966</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,454</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">24,712</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41,848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,040&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">116,429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93,279&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. On March 6, 2019, we sold all of our rights, title and interest in and to the Promacta license to Royalty Pharma; therefore, the royalty revenue for Promacta only reflected the revenue prior to the sale. Subsequent to March 6, 2019, we no longer recognize revenue related to Promacta. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables represent royalty revenue by program:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2019 Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2019 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">277.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">0.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">331.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">337.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019 Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">832.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">778.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">132.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Promacta</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">225.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">987.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,163.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q3 2020 vs. Q3 2019</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $17.0 million, or 69%, to $41.8 million in Q3 2020 compared to $24.8 million in Q3 2019 mainly driven by an increase in Captisol material sales during Q3 2020 attributable to an increased demand from Gilead for remdesivir.  See additional remdesivir updates in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Portfolio Program Update</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">YTD 2020 vs. YTD 2019</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $23.2 million, or 25%, to $116.4 million in the YTD 2020 compared to $93.3 million in the same period last year mainly driven by an increase in Captisol material sales during the YTD 2020 attributable to an increased demand from Gilead for remdesivir as mentioned above. The increases were partially offset by our no longer recognizing royalties related to Promacta since the sale of Promacta in March 2019 and the decreased contract revenue due to the disruption from COVID-19 as some partners delay starting clinical trials or paused patient enrollment in ongoing trials.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,353</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,875</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,853</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15,020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">38,101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,966&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">101,794</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q3 2020 vs. Q3 2019</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses increased by $8.1 million or 27%. Cost of Captisol increased primarily due to higher Captisol sales during Q3 2020 as mentioned above. General and administrative expenses increased primarily due to acquisition integration related costs as well as additional expenses from the Icagen acquisition in April 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">YTD 2020 vs. YTD 2019</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating costs and expenses increased by $13.0 million or 15%. Cost of Captisol increased primarily due to higher Captisol sales during the YTD 2020 as mentioned above. General and administrative expenses increased primarily due to acquisition integration related costs as well as additional expenses from the Icagen acquisition in April 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(9,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,297)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(17,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,524)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,619)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">991</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,405)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,690</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,590&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,900)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6,269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(21,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(219)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(400)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,940</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15,359)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,713)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(646)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(28,543)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,102)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and warrants. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decreases over the prior periods were due to the decrease in our short-term investment balance resulting from the proceeds used in share repurchases, the 2023 Notes repurchase during the second quarter of 2020 and the acquisition of Icagen, xCella and Taurus during the nine months ended September&#160;30, 2020.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the three and nine months ended September&#160;30, 2020. The decreases over the prior periods were primarily due to lower average debt outstanding balance during the current periods as compared to the prior periods. The 2019 Notes were paid off upon the maturity date in August 2019. In March 2020, we repurchased $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4 - Convertible Senior Notes.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net, for the nine months ended September&#160;30, 2020 increased as compared to the same period last year. The increases were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to a $1.9 million gain on an asset sale during the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(11,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,871)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(13,908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">804,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(818,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,911</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(168,147)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(6,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,251)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(8,746)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">636,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(645,413)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.3&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three and nine months ended September&#160;30, 2020 was 42.3% and 37.1%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with higher statutory rates than the U.S. and tax deductions related to stock award activities, offset by tax deductions related to foreign derived intangible income tax credits. The effective tax rate for the three and nine months ended September&#160;30, 2019 was 23.2% and 20.9%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three months ended September&#160;30, 2019 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory tax rates than the U.S.</span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  As of September&#160;30, 2020, our cash, cash equivalents, and marketable securities totaled $795.1 million, which were decreased by $274.8&#160;million from the end of last year, due to factors described in the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; below. This amount excludes our cash payment of $437.5&#160;million million at the closing of our acquisition of Pfenex on October 1, 2020. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 5.8 million shares of common stock in Viking.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. In conjunction of the 2023 Notes offering, we used a portion of the proceeds from such issuance totaling $49.7 million to repurchase 260,000 shares of our common stock. In March 2020, we repurchased $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million. After the repurchases, $515.6&#160;million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plan to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of September&#160;30, 2020. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4 - Convertible Senior Notes.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions  and may enter into Rule 10b5-1 trading plans to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. During the first quarter of 2020, we repurchased $73.3 million of our common stock under our stock repurchase programs as discussed below. We did not have any share repurchases during the second and third quarter of 2020. Authorization to repurchase $253.5 million of our common stock remained available as of September&#160;30, 2020. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we had $10.8 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases and Off-Balance Sheet Arrangements</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease our office facilities under operating lease arrangements with varying terms through September 2026. The agreements provide for increases in annual rents based on changes in the Consumer Price Index or fixed percentage increases of 3.0%. See further information in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8, Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no off-balance sheet arrangements at September&#160;30, 2020 and December&#160;31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:71.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.152%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,997)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">613,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">530,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(283,016)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(401,479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the nine months ended September&#160;30, 2020, we repurchased $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million; paid $15.1 million in cash for the Icagen acquisition, $11.6 million in cash for xCella and Taurus acquisitions, and used $73.3 million to repurchase our common stock. During the nine months ended September&#160;30, 2019, we generated $827 million from the sale of Promacta license (including $14.2 million recorded to revenue related to the Promacta royalty for the period between January 1, 2019 and March 6, 2019), used cash for net purchases of short-term investments, used $371.1 million to repurchase our common stock, used $93.8 million to pay federal and state estimated income taxes, paid off the remaining balance of the 2019 Notes in the amount of $27.3 million, paid $12.0 million for the purchase of Novan economic rights and paid $11.8 million for the Ab Initio acquisition (net of cash acquired).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Contractual Obligations</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes outside the ordinary course of business to the &#8220;Contractual Obligations&#8221; table set forth in our 2019 Annual Report, other than our purchase obligations under our agreements with Hovione for Captisol purchases and equipment investment increased by approximately $69 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2019 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed Consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1, "Basis of Presentation and Summary of Significant Accounting Policies,"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> related to allowance for credit losses.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_73"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the three and nine months ended September&#160;30, 2020, when compared to the disclosures in Item 7A of our 2019 Annual Report.</span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_76"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of September&#160;30, 2020 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_79"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For information that updates the disclosures set forth under Part I, Item 3, &#8220;Legal Proceedings&#8221; in our 2019 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to the Condensed Consolidated Financial Statements contained in Part I, Item 1 of this report.</span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_85"></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There have been no material changes to the risk factors included in &#8220;Item 1A.  Risk Factors&#8221; in our 2019 Annual Report, other than as set forth below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:95%">Our business is subject to risks arising from epidemic diseases, such as the recent COVID-19 pandemic, which has impacted and could continue to impact our business.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions are taking actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues. As the COVID-19 pandemic continues to spread around the globe, we may experience disruptions that could severely impact our business, drug manufacturing and supply chain, nonclinical activities and clinical trials and our partners&#8217; business may be impacted in similar ways, including due to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or difficulties in enrolling patients in clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or difficulties in clinical site initiation, including difficulties in recruiting or supporting clinical site investigators and clinical site staff;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as clinical trial sites and hospital staff supporting the conduct of clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of key clinical trial activities, such as clinical trial site monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures, which may impact the integrity of subject data and clinical study endpoints;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption or delays in the operations of the FDA or other regulatory authorities, which may impact review and approval timelines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of, or delays in receiving, supplies of Captisol or other product or product candidates from contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems, which may result in cancellations of Captisol orders or refunds if we fail to deliver Captisol timely;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in clinical sites receiving the supplies and materials needed to conduct clinical trials and interruption in global shipping that may affect the transport of clinical trial materials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruptions in nonclinical studies due to restricted or limited operations at laboratory facility or those of outsourced service providers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on employee resources that would otherwise be focused on the conduct of nonclinical studies or clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in receiving approval from local regulatory authorities to initiate planned clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in local regulations as part of a response to COVID-19 which may require us to change the ways in which clinical trials are conducted, which may result in unexpected costs, or to discontinue the clinical trials altogether;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations in employee resources or forced furlough of government employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal of the FDA to accept data from clinical trials in affected geographies outside the United States; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption or delays to discovery and development pipelines; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties launching or commercializing products, including due to reduced access to doctors as a result of social distancing protocols. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if COVID-19 infects our genetically modified animals which form the basis of our OmniAb platform, or if there is an outbreak among our employees who maintain and care for these animals, we and our partners may be unable to produce antibodies for development. Further, the spread of COVID-19 has had and may continue to severely impact the trading price of shares of our common stock and could further severely impact our ability to raise additional capital on a timely basis or at all.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The extent to which the COVID-19 may impact our business, including our drug manufacturing and supply chain, nonclinical activities, clinical trials and financial condition, including due to impacts on our partners&#8217; businesses, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, the duration of the pandemic, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other countries to contain and treat the disease.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in this section and in the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; section of our 2019 Annual Report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Future revenue from sales of Captisol material to our license partners may be lower than expected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of Captisol material to our collaborative partners, including Amgen and Gilead, represent a significant portion of our current revenues. Any setback that may occur with respect to Captisol could significantly impair our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating results and/or reduce the market price of our stock. Setbacks for Captisol could include problems with shipping, distribution, manufacturing, product safety, marketing, government regulation or reimbursement, licenses and approvals, intellectual property rights, competition with existing or new products and physician or patient acceptance of the products using Captisol. In addition, revenue from Captisol sales related to remdesivir may not continue or materially increase due to a number of factors, including: if remdesivir is later shown to not be effective or safe for the treatment of COVID-19; the FDA revises or revokes its approval of remdesivir; if alternative therapies or vaccines are approved; or the risk of COVID-19 infection significantly diminishes, in which case the commercial opportunity could be materially and adversely affected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If products or product candidates incorporating Captisol material were to cause any unexpected adverse events, the perception of Captisol safety could be seriously harmed. If this were to occur, we may not be able to sell Captisol unless and until we are able to demonstrate that the adverse event was unrelated to Captisol, which we may not be able to do. Further, the FDA could require us to submit additional information for regulatory review or approval, including data from extensive safety testing or clinical testing of products using Captisol. This would be expensive and it may delay the marketing of Captisol-enabled products and receipt of revenue related to those products, which could significantly impair our operating results and/or reduce the market price of our stock.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain Captisol from Hovione, our third party manufacturer, primarily at Hovione&#8217;s facilities in Portugal and Ireland.   If Hovione were to cease to be able, for any reason, to supply Captisol to us in the amounts we require, or decline to supply Captisol to us, we would be required to seek an alternative source, which could potentially take a considerable length of time and impact our revenue and customer relationships. In the event of a Captisol supply interruption, we are permitted to designate and, with Hovione&#8217;s assistance, qualify one or more alternate suppliers, although there is no assurance that we could do so timely or at an acceptable costs, if at all. In addition to manufacturing at Hovione&#8217;s facilities in Ireland and Portugal, we have now added final step processing capacity for Captisol in both the United States and England.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain inventory of Captisol, which has a five year shelf life, at three geographically dispersed storage locations in the United States and Europe. If we were to encounter problems maintaining our inventory, such as natural disasters, at one or more of these locations, it could lead to supply interruptions. In addition, we will rely on Hovione to expand manufacturing capacity of Captisol and any failure by Hovione to timely implement such increased capacity could adversely affect our ability to supply Captisol to our partners. While we believe we maintain adequate inventory of Captisol to meet our current partner needs, and our planned expansion of Captisol capacity will be sufficient to meet future partner needs, our estimates and projections for Captisol demand may not be correct and any supply interruptions could materially adversely impact our operating results. In addition, our plan to invest additional capital for the expansion of Captisol manufacturing capacity may not yield a return on investment if future Captisol sales fall below our expectations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently depend on our arrangements with our partners and licensees to sell products using our Captisol technology. These agreements generally provide that our partners may terminate the agreements at will. If our partners discontinue sales of products using Captisol, fail to obtain regulatory approval for products using Captisol, fail to satisfy their obligations under their agreements with us, or choose to utilize a competing product, or if we are unable to establish new licensing and marketing relationships, our financial results and growth prospects would be materially affected. Furthermore, we maintain significant accounts receivable balances with certain customers purchasing Captisol materials, which may result in the concentration of credit risk. We generally do not require any collateral from our customers to secure payment of these accounts receivable. If any of our major customers were to default in the payment of their obligations to us, our business, operating results and cash flows could be adversely affected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under most of our Captisol outlicenses, the amount of royalties we receive will be reduced or will cease when the relevant patent expires. Our low-chloride patents and foreign equivalents are not expected to expire until 2033, our high purity patents and foreign equivalents, are not expected to expire until 2029 and our morphology patents and foreign equivalents, are not expected to expire until 2025, but the initially filed patents relating to Captisol expired starting in 2010 in the United States and in 2016 in most countries outside the United States. If our other intellectual property rights are not sufficient to prevent a generic form of Captisol from coming to market and if in such case our partners choose to terminate their agreements with us, our Captisol revenue may decrease significantly.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our OmniAb antibody platform faces specific risks, including the fact that no product using antibodies from the platform has been approved by the FDA or similar regulatory agency.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our collaboration partners using our OmniAb antibody platform have received approval from the FDA or similar regulatory agency to market a product discovered based on our platform. In addition, only a few of our collaboration partners&#8217; product candidates based on the platform have been tested in late stage clinical trials. If one of our OmniAb collaboration </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partners&#8217; product candidates fails during preclinical studies or clinical trials, our other OmniAb collaboration partners may decide to abandon product candidates using antibodies generated from the OmniAb platform, whether or not such failure is attributable to the platform. All of our OmniAb collaboration partners may terminate their programs at any time without penalty. In addition, our OmniRat and OmniFlic platforms, which we consider the most promising, are covered by six patents within the U.S. and three patents in the European Union and are subject to the same risks as our patent portfolio discussed elsewhere in this report and our 2019 Annual Report, including the risk that our patents may infringe on third party patent rights or that our patents may be invalidated. As of a result of these factors, the future revenue generated from this platform may be materially lower than what we currently anticipate. Further, we face significant competition from other companies selling human antibody-generating rodents, especially mice which compete with our OmniMouse platform, including the VelocImmune mouse, the AlivaMab mouse, the Trianni mouse and the Kymouse. Many of our competitors have greater financial, technical and human resources than we do and may be better equipped to develop, manufacture and market competing antibody platforms. Our competitors may render our OmniAb antibody platform obsolete, or limit the commercial value of any product candidates developed using our platform, by advances in existing technological approaches or the development of new or different approaches, potentially eliminating the advantages that we believe our platform offers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our recent strategic acquisitions and announced dispositions may adversely affect our stock price, operating results and results of operations. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recently acquired Pfenex, as well as Taurus and xCella. We may not be able to integrate these acquired business successfully, achieve the expected growth prospects and synergies, expected royalties and other economics or operate such businesses profitably.  In addition, such acquisitions may disrupt our current plans and operations, we may not be able to retain key personnel or preserve existing business relationships following such acquisitions, and may incur unexpected costs, charges or expenses resulting from completion of the acquisitions. Further, many of the risks we disclose for our programs and our existing partners&#8217; programs in &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1A.  Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our 2019 Annual Report would also apply these acquired companies and businesses.  For example, the platform we acquired from Pfenex faces many of the same risks that face our OmniAb platform, including that we are entirely dependent on our partners' efforts to develop and commercial products based on the platform.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also recently announced the disposition of Vernalis (R&amp;D) Limited. We cannot assure you that the closing of this transaction will occur on our expected timeframe or at all, whether as a result of the failure to meet closing conditions or otherwise, including the requirement that required governmental approvals may not obtained or may be delayed. Furthermore, we may not realize expected future benefits from the Vernalis transaction, including from retained licenses and collaboration economics and as a result of indemnification claims under the Vernalis Purchase Agreement and our retention of certain liabilities associated with the Vernalis business. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to realize the expected benefits from these acquisitions and our proposed Vernalis disposition, our business, results of operations and financial condition could be adversely affected.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_88"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_91"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_94"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_97"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i7c5753c379194807a2081c4b5d4d13f2_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312520215346/d79922dex21.htm">2.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of August 10, 2020, by and among Pfenex, Inc., Ligand Pharmaceuticals Incorporated and Pelican Acquisition Sub, Inc. (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 11, 2020).</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000101/a101ligandxcellaagreem.htm">2.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated September 8, 2020, among Ligand Pharmaceuticals Incorporated, xCella Biosciences, Inc. and other persons (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 10, 2020).</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000101/a102ligandtaurusagreem.htm">2.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated September 9, 2020, among Ligand Pharmaceuticals Incorporated, Taurus Biosciences, LLC and other persons (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 10, 2020).</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000101/a103ligandtauruscvragr.htm">2.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Value Rights Agreement, dated September 9, 2020, between Ligand Pharmaceuticals Incorporated and Vaughn Smider, as Members' Representative (regarding Taurus Biosciences, LLC acquisition) (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 10, 2020).</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit25ligand-cvragr.htm">2.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contingent Value Rights Agreement, dated as of September 30, 2020, by and between Ligand Pharmaceuticals Incorporated and American Stock Transfer &amp; Trust Company, LLC.*</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000108/exhibit21vineyard-spae.htm">2.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreement for the Sale and Purchase of the Entire Issued Share Capital of Vernalis (R&amp;D) Limited, dated as of October 11, 2020, by and among Ligand Pharmaceuticals Incorporated, Vernalis Limited, HitGen UK Ltd and HitGen Inc. (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on October 13, 2020).</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000101/a104ligandtaurusminota.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial License Agreement, dated September 9, 2020, between Taurus Biosciences, LLC and Minotaur Therapeutics, Inc. (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 10, 2020).</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102ligandcydexg.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amendment to Supply Agreement, dated September 21, 2020, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc., which amends that certain Supply Agreement, dated December 2, 2015, by and between Cydex Pharmaceuticals, Inc. and Gilead Sciences, Inc.*</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_93020exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_93020exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lgnd_93020exhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2020, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.*</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2020, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Filed herewith.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="i7c5753c379194807a2081c4b5d4d13f2_103"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.5
<SEQUENCE>2
<FILENAME>exhibit25ligand-cvragr.htm
<DESCRIPTION>EX-2.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia7c9df4c8ab9481c94cc233ba68c20b4_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 2.5</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">CONTINGENT VALUE RIGHTS AGREEMENT</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">This CONTINGENT VALUE RIGHTS AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), dated September&#160;30, 2020, is by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;) and American Stock Transfer &#38; Trust Company, LLC, a New York limited liability trust company, as rights agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Rights Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">RECITALS </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">A.  Pfenex Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), Parent and Pelican Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Acquisition Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;) have entered into an Agreement and Plan of Merger, dated as of August 10, 2020 (as it may be amended or supplemented from time to time pursuant to the terms thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Merger Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;).  Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to them in the Merger Agreement.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">B. Pursuant to the Merger Agreement, Acquisition Sub (a) has agreed to commence a tender offer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;) to acquire all of the outstanding shares of Company Common Stock and (b) will, following consummation of the Offer, merge with and into the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), with the Company surviving the Merger as a wholly owned subsidiary of Parent. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">C. Pursuant to the Merger Agreement, and in accordance with the terms and conditions thereof, Parent has agreed to provide the Holders (as defined below) certain contingent value rights upon the achievement of a certain milestone as hereinafter described in accordance with the terms of this Agreement and of the Merger Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">D. The Rights Agent is willing to act in connection with the issuance, transfer, exchange and payment of such contingent value rights as provided herein. </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">AGREEMENT</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">The parties to this Agreement therefore agree as follows&#58;</font></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE I</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">CONTINGENT VALUE RIGHTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Holders of CVRs&#59; Appointment of Rights Agent</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Pursuant to the terms of the Merger Agreement, as of the Effective Time (i) each holder of any shares of Company Common Stock that is converted into the right to receive the Merger Consideration shall, as part of such Merger Consideration, be entitled to one CVR for each such share of Company Common Stock, and (ii) each holder of any In-the-Money Company Option that is cancelled in exchange for the right to receive the excess of the Merger Consideration over the per share exercise price of each such In-the-Money Company Option shall, as part of such Merger Consideration, be entitled to receive one CVR for each share of Company Common Stock underlying each such In-the-Money Company Option. For the avoidance of doubt, no CVR shall be issued with respect to any Out-of-the-Money Company Options or any portion of In-the-Money Company Options that vest based on performance that do not vest in accordance with Section 2.8(d) of the Merger Agreement.  The initial Holders shall be determined pursuant to the terms of the Merger Agreement and this Agreement, and a list of the initial Holders shall be furnished to the Rights Agent by or on behalf of Parent in accordance with Section 3.1 hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Parent hereby appoints the Rights Agent to act as rights agent for Parent in accordance with the express terms and conditions set forth in this Agreement, and the Rights Agent hereby accepts such appointment. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Nontransferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. CVRs may not be sold, assigned, transferred, pledged, encumbered or disposed of in any other manner, in whole or in part, other than pursuant to a Permitted Transfer, and, in the case of a Permitted Transfer, only in accordance with Section 1.3(c) hereof. Any attempted sale, assignment, transfer, pledge, encumbrance or disposition of CVRs, in whole or in part, in violation of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> shall be void </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%">ab initio </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and of no effect.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">No Certificate&#59; Registration&#59; Registration of Transfer&#59; Change of Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;CVRs shall not be evidenced by a certificate or other instrument. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;The Rights Agent shall keep a register (the &#8220;CVR Register&#8221;) for the purposes of (i) identifying the Holders of CVRs and (ii) documenting CVRs and Permitted Transfers thereof, which CVR Register may be amended from time to time by the Rights Agent to reflect any changes to Holders or applicable number of CVRs as permitted hereunder, including to reflect any repurchases by Parent of CVRs. The CVR Register will initially show one position for Cede &#38; Co. representing all of the CVRs that are issued to the former holders of shares of Company Common Stock held by DTC on behalf of the former street holders of the shares of Company Common Stock. With respect to any payments to be made under Section 1.4 below, the Rights Agent will accomplish such payment to any former street name holders of the shares of Common Stock by sending such payments to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street name holders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Without limiting the restriction on transferability set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer and other requested documentation in form reasonably satisfactory to the Rights Agent, duly executed by the registered Holder or Holders thereof, or by the duly appointed legal representative, personal representative or survivor of such Holder or Holders, setting forth in reasonable detail the circumstances relating to the transfer demonstrating that such proposed transfer is a Permitted Transfer.  Upon receipt of such written notice, the Rights Agent shall promptly notify Parent in writing that it has received such written notice.  Upon receipt of such notice from the Rights Agent, Parent shall in good faith reasonably determine whether the transfer is a Permitted Transfer and otherwise complies with the other terms and conditions of this Agreement, and if Parent so reasonably determines that such transfer does so comply, Parent shall instruct the Rights Agent in writing to register the transfer of the applicable CVRs in the CVR Register.  All duly transferred CVRs registered in the CVR Register shall be the valid obligations of Parent, evidencing the same right, and entitling the transferee to the same benefits and rights under this Agreement, as those held by the transferor.  No transfer of a CVR shall be valid until registered in the CVR Register in accordance with this Agreement. The CVR Register shall be conclusive absent manifest error.  Any transfer or assignment of CVRs shall be without charge (other than the cost of any transfer Tax or similar Tax or charge) to the applicable Holder.  Parent and the Rights Agent may require payment from the applicable Holder or recipient of the applicable CVR of a sum sufficient to cover any stamp or other Tax or charge that is imposed in connection with any such registration of transfer and&#47;or may require the applicable Holder or recipient of the applicable CVR to establish to the satisfaction of Parent and the Rights Agent that such stamp or other Tax or charge has been paid or is otherwise not payable. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register.  Such written request must be duly executed by such Holder.  Upon receipt of such written request, the Rights Agent shall promptly record the change of address in the CVR Register. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If the CVR Payment Milestone has been achieved on or prior to December 31, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), then the Milestone Payments shall become due and payable. In such event, Parent or its designee shall provide prompt (and in no event later than ten Business Days after receipt of the FDA TE Achievement Notice) notice to the Rights Agent of the occurrence of the CVR Payment Milestone (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Milestone Occurrence Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), which notice shall (i)&#160;indicate that the FDA TE Achievement Notice has been received and (ii) specify a payment date for the Milestone Payment, no later than 60 days after the date of the FDA TE Achievement Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;). For the avoidance of doubt, the Milestone Payment shall only be paid, if at all, one time under this Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;On or before the Payment Date, Parent shall deliver to the Rights Agent an amount in cash equal to the aggregate Milestone Payment with respect to the CVRs held by all Holders, other than that portion payable to the Equity Award Holders, which aggregate amount shall be retained by Parent for payment pursuant to Section 1.4(d) below. The Rights Agent shall promptly (and in no event later than five Business Days after receipt thereof by the Rights Agent) send to each Holder at its address set forth in the CVR Register a copy of the Milestone Occurrence Notice and any letter of instruction reasonably required by the Rights Agent, and, other than with respect to Equity Award Holders, an amount in cash equal to the Milestone Payment with respect to each CVR held by such Holder. If the CVR Payment Milestone does not occur by 5&#58;00 p.m. Eastern time on the Expiration Date, then the Holders shall have no right to receive the Milestone Payment with respect to their CVRs</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Parent or its designee shall provide prompt (and in no event later than ten Business Days after receipt of the FDA TE Non-Achievement Notice) notice to the Rights Agent a certificate (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Non-Occurrence Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;) which notice shall (i) indicate that the FDA TE Non-Achievement Notice has been received and (ii) indicate that the Milestone Payment will not be paid. The Rights Agent shall promptly (and in no event later than five Business Days after receipt thereof by the Rights Agent) send to each Holder at its address set forth in the CVR Register a copy of the Non-Occurrence Notice. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;With respect to the Milestone Payment that is payable pursuant to this Agreement to Holders other than Equity Award Holders, the Rights Agent shall pay the applicable amount to each of the Holders (the amount to which each Holder is entitled to receive will be based on the number of CVRs held by such Holder as reflected on the CVR Register) by check mailed to the address of each Holder as reflected on the CVR Register as of the close of business on the last Business Day prior to such payment date.  With respect to any Milestone Payment that is payable to Equity Award Holders, Parent shall, within 10 days following the Payment Date, pay, or cause the Company to pay, each such Holder the applicable amount (the amount to which each Equity Award Holder is entitled to receive will be based on the number of CVRs held by such Holder as reflected on the CVR Register) through the Company&#8217;s payroll system (subject to any applicable Tax withholding).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e) &#160;&#160;&#160;&#160;Each of the Rights Agent, Parent, Acquisition Sub, any Affiliate of Parent and the Surviving Corporation shall be entitled to deduct and withhold from any amounts payable pursuant to this Agreement and pay to the applicable Taxing Authority, such amounts that each of the Rights Agent, Parent, Acquisition Sub, any Affiliate of Parent and the Surviving Corporation is required to deduct or withhold with respect to the making of such payment under the Code or any other provision of applicable Tax Laws. To the extent that such amounts are so deducted and withheld, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of in respect of whom such deduction and withholding was made.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f) &#160;&#160;&#160;&#160;The Rights Agent shall hold, as agent for Parent, any cash held by it for payment to the Holders in a non-interest bearing account at such commercial bank as Parent instructs the Rights Agent.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary herein, Parent shall be responsible for providing the Rights Agent with sufficient funds to satisfy its payment obligations to Holders.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g) &#160;&#160;&#160;&#160;Any cash that remains undistributed to the Holders of CVRs 12 months after such payment is due (including by means of uncashed checks or invalid addresses on the CVR Register) in accordance with the terms of this Agreement, shall be delivered to Parent or its designee, within five Business Days following the expiration of such 12 month period and shall be held in trust by Parent for the benefit of the Holders.  Any Holders of CVRs who have not theretofore received cash with respect to such CVRs shall thereafter look only to Parent for payment of their claim therefor (subject to abandoned property, escheat or similar Laws).  Notwithstanding any other provisions of this Agreement, any portion of the cash provided by Parent to the Rights Agent that remains unclaimed after termination of this Agreement in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> (or such earlier date immediately prior to such time as such amounts would otherwise escheat to, or become property of, any Governmental Authority) shall, to the extent permitted by Law, become the property of Parent free and clear of any claims or interest of any Person previously entitled thereto.  Neither Parent, the Rights Agent nor any of their Affiliates shall be liable to any Holder for any payments delivered to a public official pursuant to any abandoned property, escheat or other similar Law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(h) &#160;&#160;&#160;&#160;The Rights Agent shall keep copies of this Agreement available for inspection by the Holders during normal business hours at its office.   </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.5 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">No Voting, Dividends or Interest&#59; No Equity or Ownership Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;CVRs shall not have any voting or dividend or consent rights, and, shall not entitle the Holders to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of Parent or any or any other matter, or any other rights of any kind or nature whatsoever as a stockholder of Parent, either at Law or in equity. Except as set forth in this Agreement, interest shall not accrue on any amounts payable in respect of CVRs.(b) &#160;&#160;&#160;&#160;CVRs shall not represent any equity or ownership interest in Parent, any constituent company to the Merger or any of their respective Affiliates. The rights of a Holder in respect of the CVRs are limited to those expressed in this Agreement and the Merger Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">1.6 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Ability to Abandon CVRs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  A Holder may at any time, at such Holder&#8217;s option, abandon all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to Parent or its Affiliates without consideration therefor.  Nothing in this Agreement shall prohibit Parent or any of its Affiliates from offering to acquire or acquiring any CVRs for consideration from the Holders, in private transactions or otherwise, in its sole discretion.  Any CVRs acquired by Parent or any of its Affiliates shall be automatically deemed extinguished and no longer outstanding for purposes of the definition of Acting Holders. </font></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE II</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">THE RIGHTS AGENT</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Duties and Responsibilities of the Rights Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;The Rights Agent shall not have any liability for any actions taken or not taken in connection with this Agreement, except to the extent such liability arises as a result of the willful misconduct, bad faith, gross negligence or fraud of the Rights Agent. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;The Acting Holders may direct the Rights Agent to act on behalf of the Holders in enforcing any of their rights hereunder.  All rights of action of any or all Holders under this Agreement may be enforced by the Rights Agent, and any action, suit or proceeding instituted by the Rights Agent shall be brought in its name as the Rights Agent and any recovery in connection therewith shall be for the proportionate benefit of all the Holders, as their respective rights or interests may appear. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Rights of the Rights Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;The Rights Agent may rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document believed by it in good faith to be genuine and to have been signed or presented by the proper party or parties. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;The Rights Agent may engage and consult with counsel of its reasonable selection and the written advice or opinion of such outside counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d) &#160;&#160;&#160;&#160;Any permissive rights of the Rights Agent hereunder shall not be construed as a duty. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of such powers. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(f) &#160;&#160;&#160;&#160;Parent agrees to indemnify the Rights Agent for, and to hold the Rights Agent harmless from and against, any loss, liability, damage or expense (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;) suffered or incurred by the Rights Agent arising out of or in connection with the Rights Agent&#8217;s performance of its obligations under this Agreement, including the reasonable costs and expenses of defending the Rights Agent against any claims, charges, demands, actions or suits arising out of or in connection with such performance, except to the extent such Loss shall have been determined by a court of competent jurisdiction to have resulted from the Rights Agent&#8217;s gross negligence, bad faith, willful misconduct or fraud.  Parent&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> to indemnify the Rights Agent shall survive the resignation or removal of any Rights Agent and the termination of this Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(g) &#160;&#160;&#160;&#160;In addition to the indemnification provided under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, but without duplication, Parent agrees (i) to pay the fees of the Rights Agent in connection with the Rights Agent&#8217;s performance of its obligations hereunder, as agreed upon in writing by the Rights Agent and Parent on or prior to the date of this Agreement, and (ii) to reimburse the Rights Agent for all reasonable and documented out-of-pocket expenses, including all Taxes (other than income, receipt, franchise or similar Taxes) and governmental charges, incurred by the Rights Agent in the performance of its obligations under this Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Resignation and Removal&#59; Appointment of Successor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;The Rights Agent may resign at any time by giving written notice thereof to Parent and the Holders specifying a date when such resignation shall take effect, which notice shall be sent at least 60 days prior to the date so specified but in no event shall such resignation become effective until a successor Rights Agent has been appointed and accepted such appointment. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Parent shall have the right to remove the Rights Agent at any time by specifying a date when such removal shall take effect.  Notice of such removal shall be given by Parent to the Rights Agent, which notice shall be sent at least 60 days prior to the date so specified. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;If the Rights Agent shall resign, be removed or become incapable of acting, Parent shall promptly appoint a qualified successor Rights Agent.  The successor Rights Agent so appointed shall, forthwith upon its acceptance of such appointment in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, become the Rights Agent for all purposes hereunder. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Parent shall give notice of each resignation or removal of the Rights Agent and each appointment of a successor Rights Agent through the facilities of DTC in accordance with DTC&#8217;s procedures and&#47;or by mailing written notice of such event by first-class mail, postage prepaid, to the Holders as their names and addresses appear in the CVR Register.  Each notice shall include the name and address of the successor Rights Agent.  If Parent fails to send such notice within 10 Business Days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent shall cause the notice to be mailed at the expense of Parent. Failure to give any notice provided for in this Section 2.3, however, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the case may be.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Acceptance of Appointment by Successor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Every successor Rights Agent appointed hereunder shall, at or prior to such appointment, execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the Rights Agent&#59; provided that upon the request of Parent or the successor Rights Agent, such resigning or removed Rights Agent shall execute and deliver an instrument transferring to such successor Rights Agent all the rights, powers and trusts of such resigning or removed Rights Agent. </font></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE III</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">COVENANTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">List of Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Parent shall furnish or cause to be furnished to the Rights Agent the names and addresses of the Holders within 30 Business Days following the Effective Time.  The CVRs shall, in the case of the holders of Company Common Stock, be registered in the names and addresses of the holder as set forth in the applicable letter of transmittal accompanying the Company Common Stock surrendered by the holder thereof in connection with the Offer pursuant to the Merger Agreement and in a denomination equal to the number of Company Common Stock so surrendered, and in the case of In-the-Money Company Options, be registered in the name and address of the holder set forth in the books and records of the Company at the Effective Time and in a denomination computed in accordance with the terms of the Merger Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Efforts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Parent shall, during the period from and after the Closing Date through the later of the delivery of the Non-Occurrence Notice or Milestone Occurrence Notice to the Rights Agent, exercise commercially reasonable efforts to cause the occurrence of the CVR Payment Milestone. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, &#8220;commercially reasonable efforts&#8221; means, with respect to the CVR Payment Milestone event, the efforts and resources customarily applied by similarly situated pharmaceutical companies of comparable size and resources to secure the occurrence of such event for a product of similar potential (including commercial potential) and in similar stages of development, taking into account all relevant technical, commercial, legal, scientific and&#47;or medical factors, including its proprietary position and profitability (including pricing and reimbursement status), issues of safety and efficacy, anticipated or actual product profile, difficulty in product development or manufacturing, anticipated or actual cost and time to develop, anticipated or actual market conditions and economic return potential, anticipated or actual competitiveness of alternative products in the marketplace, the nature and extent of anticipated or actual market exclusivity (including patent coverage and regulatory exclusivity), the regulatory environment, including regulatory requirements involved and the reasonably expected likelihood of regulatory approval, anticipated or actual amounts of marketing and promotional expenditures required, other relevant technical, commercial, legal, scientific and&#47;or medical factors. </font></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE IV</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">AMENDMENTS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments Without Consent of Holders or Rights Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Parent, at any time or from time to time, may unilaterally enter into one or more amendments hereto for any of the following purposes, without the consent of any of the Holders or the Rights Agent, so long as, in the cases of clauses (ii) through (iv), such amendments do not, individually or in the aggregate, adversely affect the interests of the Holders&#58; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i) &#160;&#160;&#160;&#160;to evidence the appointment of another Person as a successor Rights Agent and the assumption by any successor Rights Agent of the covenants and obligations of the Rights Agent hereof in accordance with the provisions of this Agreement&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii) &#160;&#160;&#160;&#160;to add to the covenants of Parent such further covenants, restrictions, conditions or provisions as Parent shall determine to be for the protection of the Holders&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iii) &#160;&#160;&#160;&#160;to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(iv) &#160;&#160;&#160;&#160;as may be necessary or appropriate to ensure that CVRs are not subject to registration under the Securities Act or the Exchange Act&#59; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(v) &#160;&#160;&#160;&#160;to evidence the assignment of this Agreement by Parent as provided in Section 5.4&#59; or </font></div><div style="margin-top:12pt;text-align:justify;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(vi) &#160;&#160;&#160;&#160;any other amendment hereto which would provide any additional rights or benefits to the Holders or that does not adversely affect the legal rights under this Agreement of any such Holder. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Promptly after the execution by Parent of any amendment pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, Parent shall mail (or cause the Rights Agent to mail) a notice thereof through the facilities of DTC in accordance with DTC&#8217;s procedures and&#47;or by first class mail to the Holders at their addresses as set forth on the CVR Register, setting forth in general terms the substance of such amendment. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments with Consent of Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;In addition to any amendments to this Agreement that may be made by Parent without the consent of any Holder or the Rights Agent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, with the consent of the Holders of not less than a majority of the outstanding CVRs, whether evidenced in writing or taken at a meeting of the Holders, Parent and the Rights Agent may enter into one or more amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is adverse to the interests of the Holders. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;Promptly after the execution by Parent and the Rights Agent of any amendment pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> (but prior to the effectiveness of such amendment), Parent shall mail (or cause the Rights Agent to mail) a notice thereof through the facilities of DTC in accordance with DTC&#8217;s procedures and&#47;or by first class mail to the Holders at their addresses as set forth on the CVR Register, setting forth in general terms the substance of such amendment.  Any amendment to this Agreement made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> shall become effective 15 Business Days following the mailing of such notice. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments Affecting Rights Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, powers, trusts, privileges, covenants or duties under this Agreement or otherwise. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">4.4 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Effect of Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Upon the execution of any amendment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">ARTICLE IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, this Agreement shall be modified in accordance therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby. </font></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE V</font></div><div style="margin-top:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">MISCELLANEOUS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Notices to Rights Agent and Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  All notices and other communications under this Agreement shall be in writing and shall be deemed to have been duly delivered and received (i) four Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid, (ii)&#160;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service, (iii) immediately upon delivery by hand or (iv) on the date sent by email (except that notice given by email will not be effective unless either (A)&#160;a duplicate copy of such email notice is promptly given by one of the other methods described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or (B)&#160;the receiving party delivers a written confirmation of receipt of such notice either by email or any other method described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> (excluding &#8220;out of office&#8221; or other automated replies)), in each case to the intended recipient as set forth below&#58; </font></div><div style="margin-top:12pt;padding-left:126pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(i) &#160;&#160;&#160;&#160;if to Parent, to&#58;</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">3911 Sorrento Valley Boulevard, Suite 110</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">San Diego, CA 92121</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Attention&#58; Charles S. Berkman</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">E-mail&#58; cberkman&#64;ligand.com</font></div><div style="padding-left:108pt;text-indent:36pt"><font><br></font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">with a copy (which shall not constitute notice) to&#58;</font></div><div style="padding-left:108pt;text-indent:36pt"><font><br></font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Latham &#38; Watkins LLP</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">12670 High Bluff Drive</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">San Diego, CA 92130</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Attention&#58; Matt Bush&#59; R. Scott Shean</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">E-mail&#58; matt.bush&#64;lw.com&#59; scott.shean&#64;lw.com</font></div><div style="padding-left:108pt;text-indent:36pt"><font><br></font></div><div style="margin-top:0.12pt;padding-left:126pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(ii) &#160;&#160;&#160;&#160;if to the Rights Agent, to&#58;</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">American Stock Transfer &#38; Trust Company, LLC</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">6201 15th Avenue</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Brooklyn, New York 11219</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Attn&#58; Corporate Actions</font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Tel&#58; (718) 921-8200</font></div><div style="margin-top:12pt;padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">with a copy (which shall not constitute notice) to&#58;</font></div><div style="padding-left:126pt"><font><br></font></div><div style="padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Wilson Sonsini Goodrich &#38; Rosati</font></div><div style="margin-top:0.12pt;padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Professional Corporation</font></div><div style="margin-top:0.12pt;padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">12235 El Camino Real</font></div><div style="margin-top:0.12pt;padding-left:126pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">San Diego, California 92130</font></div><div style="margin-top:0.12pt;padding-left:135pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">Attention&#58; Dan Koeppen, Zachary Myers and Ethan Lutske</font></div><div style="padding-left:162pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">E-mail&#58; &#160;&#160;&#160;&#160;dkoeppen&#64;wsgr.com, zmyers&#64;wsgr.com and elutske&#64;wsgr.com</font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Notice to Holders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  All notices, requests and communications required to be given to the Holders shall be sufficiently given (unless otherwise herein expressly provided) if in writing and transmitted through </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">the facilities of DTC in accordance with DTC&#8217;s procedures and&#47;or mailed, first-class postage prepaid, to each Holder affected by such event, at his, her or its address set forth in the CVR Register, not later than the latest date, and not earlier than the earliest date, prescribed for the giving of such notice.  In any case where notice to the Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder shall affect the sufficiency of such notice with respect to other Holders. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  This Agreement, the Confidentiality Agreement and the Merger Agreement represent the entire understanding of Parent and the Company with reference to the CVRs, and this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement and the Confidentiality Agreement. This Agreement represents the entire understanding of the Rights Agent with reference to the CVRs, and this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement and the Confidentiality Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Parent may assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to one or more its Affiliates (that are wholly owned direct or indirect Subsidiaries of Parent) (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;) and any such Assignee may thereafter assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations set forth hereunder to one or more additional Assignees&#59; provided, however, that in connection with any assignment to an Assignee, Parent shall agree to remain liable for the performance by Parent of its obligations hereunder.  This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties to this Agreement and their respective successors and assigns.  The Rights Agent may not assign this Agreement without Parent&#8217;s consent.  This Agreement shall not restrict Parent&#8217;s or any successor&#8217;s ability to merge or consolidate or enter into or consummate any Change of Control&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">, that in the event of a Change of Control, Parent shall cause the acquirer to assume Parent&#8217;s obligations, duties and covenants under this Agreement.  Any attempted assignment of this Agreement or any of such rights in violation of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> shall be void </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%">ab initio </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">and of no effect. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Benefits of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Nothing in this Agreement, express or implied, shall give to any Person (other than the parties to this Agreement, the Holders and their permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the parties to this Agreement, the Holders and their permitted successors and assigns.  The Holders shall have no rights hereunder except as are expressly set forth herein. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of law thereof. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.7 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Consent to Jurisdiction&#59; Service of Process&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Each of the parties to this Agreement (a) irrevocably consents to the service of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the transactions contemplated by this Agreement, for and on behalf of itself or any of its properties or assets, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> or in such other manner as may be permitted by applicable Law, but nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> shall affect the right of any parties to this Agreement to serve legal process in any other manner permitted by applicable Law&#59; (b) irrevocably and unconditionally consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive jurisdiction of the Chosen Courts in the event any dispute or controversy arises out of this Agreement or the transactions contemplated in this Agreement, or for recognition and enforcement of any judgment in respect thereof&#59; (c) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any Chosen Court&#59; (d) agrees that any Legal Proceedings arising in connection with this Agreement or the transactions contemplated in this Agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">shall be brought, tried and determined only in the Chosen Courts&#59; (e) waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient court and agrees not to plead or claim the same&#59; and (f) agrees that it will not bring any Legal Proceeding relating to this Agreement or the transactions contemplated hereby or thereby in any court other than the Chosen Courts.  Each of parties to this Agreement agrees that a final judgment in any Legal Proceeding in the Chosen Courts shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  EACH PARTY TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY TO THIS AGREEMENT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT ACKNOWLEDGES AND AGREES THAT (A)&#160;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY TO THIS AGREEMENT HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER&#59; (B)&#160;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER&#59; (C)&#160;IT MAKES THIS WAIVER VOLUNTARILY&#59; AND (D)&#160;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">SECTION&#160;5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  Subject to the provisions of this Agreement, the parties to this Agreement will, from time to time, do all acts and things and execute and deliver all such further documents and instruments, as the other parties to this Agreement may reasonably require to effectively carry out or better evidence or perfect the full intent and meaning of this Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties to this Agreement.  The parties to this Agreement further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  The headings and table of contents contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  This Agreement and any amendments to this Agreement may be executed in one or more textually identical counterparts, all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties to this Agreement and delivered to the other parties to this Agreement, it being understood that all parties to this Agreement need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#8221;), will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party to this Agreement may raise the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each party to this Agreement forever waives any such defense, except to the extent such defense relates to lack of authenticity. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  This Agreement shall be terminated and of no force or effect, and the parties to this Agreement shall have no liability hereunder (other than to the extent of any obligations which expressly survive or provide for performance following termination), upon the earliest to occur of (a) the full payment of the Milestone Payment and (b) Parent&#8217;s delivery of the Non-Occurrence Notice. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Holidays</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  In the event that the day on which any Milestone Payment is due shall not be a Business Day, then, notwithstanding any provision of this Agreement to the contrary, any payment required to be made in respect of the CVRs shall be made on the next succeeding Business Day with the same force and effect as if made on the last day on which such Milestone Payment is due. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">.  When a reference is made in this Agreement to an Article, Annex or Section, such reference shall be to an Article, Annex or Section of this Agreement unless otherwise indicated.  Whenever the words &#8220;include,&#8221; &#8220;includes&#8221; or &#8220;including&#8221; are used in this Agreement, they shall be deemed to be followed by the words &#8220;without limitation.&#8221; The words &#8220;hereof,&#8221; &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement.  All terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant of this Agreement unless otherwise defined therein.  The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term.  Any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein.  References to a Person are also to its permitted successors and assigns.  References to clauses without a cross-reference to a Section or subsection are references to clauses within the same Section or, if more specific, subsection.  References from or through any date means, unless otherwise specified, from and including or through and including, respectively.  The symbol &#8220;$&#8221; refers to United States Dollars. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">5.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">No Fiduciary Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">. Each of Parent and the Rights Agent acknowledges and agrees that the other party, its Affiliates and their respective officers, directors and controlling Persons do not owe any fiduciary duties to the first party or any of its respective Affiliates, officers, directors or controlling Persons. The only obligations of Parent and the Rights Agent to each other and their Affiliates and their respective officers, directors and controlling Persons arising out of this Agreement are the contractual obligations expressly set forth in this Agreement.</font></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:120%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.&#93; </font></div><div style="margin-top:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="ia7c9df4c8ab9481c94cc233ba68c20b4_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed by their respective duly authorized officers to be effective as of the date first above written. </font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Charles S. Berkman&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; &#160;&#160;&#160;&#160;Charles S. Berkman&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; &#160;&#160;&#160;&#160;Senior Vice President, General Counsel and Secretary </font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMERICAN STOCK TRANSFER &#38; &#160;&#160;&#160;&#160;TRUST COMPANY, LLC </font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Michael Legregin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Michael Legregin </font></div><div style="margin-top:12pt;padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Senior Vice President </font></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page to Contingent Value Rights Agreement&#93;</font></div><div><font><br></font></div></div></div><div id="ia7c9df4c8ab9481c94cc233ba68c20b4_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Annex A</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN DEFINED TERMS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Acting Holder(s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#8221; means any Holder or Holders of at least thirty-five percent (35%) of the outstanding CVRs as set forth on the CVR Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any day, other than a Saturday, Sunday and any day which is a legal holiday under the Laws of the State of California or is a day on which banking institutions located in the State of California are authorized or required by Law or other governmental action to close.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means (i) a sale or other disposition of all or substantially all of the assets of Parent on a consolidated basis (other than to any direct or indirect wholly owned subsidiary of Parent), (ii) a merger or consolidation involving Parent in which it is not the surviving entity, and (iii) any other transaction involving Parent in which it is the surviving entity but in which the stockholders of Parent immediately prior to such transaction own less than fifty percent (50%) of the surviving entity&#8217;s voting power immediately after the transaction, other than any bona fide equity financing transaction solely related to the continued financing of the operations of Parent and its subsidiaries.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Chosen Courts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, if the Court of Chancery of the State of Delaware does not have subject matter jurisdiction (but only in such event), the United States District Court for the District of Delaware or, if jurisdiction is not then available in the United States District Court for the District of Delaware (but only in such event), then any Delaware state court). </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVR(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the rights of Holders to receive contingent cash payments pursuant to the Merger Agreement and this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVR Payment Milestone</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, with respect to Company&#8217;s teriparatide injection product (also referred to as PF708 or Bonsity&#8482;) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVR Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the receipt of written notice from the U.S. Food and Drug Administration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) indicating that the FDA has determined the CVR Product to be therapeutically equivalent to the listed product, FORTEO&#174; (teriparatide injection) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORTEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and that the FDA has assigned the CVR Product a therapeutic equivalence code that begins with an &#8220;A&#8221; in the FDA publication, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Approved Drug Products with Therapeutic Equivalence Evaluations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Orange Book</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with respect to FORTEO (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FDA TE Achievement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">DTC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means The Depository Trust Company or any successor entity thereto.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Equity Award Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Holders of CVRs granted with respect to In-the-Money Options.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FDA TE Non-Achievement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means with respect to the CVR Product, the receipt of written notice from the FDA indicating that the FDA has determined that the CVR Product is not therapeutically equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to FORTEO, such that the CVR Product will not be assigned a therapeutic equivalence code that begins with an &#8220;A&#8221; in the Orange Book with respect to FORTEO.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any government, any governmental or regulatory entity or body, department, commission, board, agency, instrumentality, legislature, Taxing Authority, political subdivision, bureau, official and any self-regulatory organization (including NYSE American) and any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">court, tribunal, judicial body, arbitrator or arbitration panel, in each case whether federal, state, county, provincial, and whether local, foreign or multinational.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, at the relevant time, a Person in whose name a CVR is registered in the CVR Register.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any and all applicable federal, state, local, municipal, foreign, multinational or other law, statute, constitution, principle of common law, ordinance, code, rule, regulation, ruling, order or other legal requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by law under the authority of any Governmental Authority.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Legal Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any civil, criminal or administrative actions, demands, countersuits, proceedings suits, claims, charges, arbitrations, oppositions, investigations, reexaminations, lawsuits, litigations or other proceedings brought by or pending before any Governmental Authority.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Milestone Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means an amount equal to $2.00 per CVR, payable in cash, without interest thereon and subject to reduction for any applicable withholding Taxes in respect thereof. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Permitted Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a transfer of one or more CVRs (a) upon death by will or intestacy&#59; (b) by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee&#59; (c) made pursuant to a court order&#59; (d) made by operation of Law (including a consolidation or merger) or without consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity&#59; (e) in the case of CVRs payable to a nominee, from a nominee to a beneficial owner (and, if applicable, through an intermediary) or from such nominee to another nominee for the same beneficial owner, in each case as allowable by DTC&#59; or (f) as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-2</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102ligandcydexg.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iabbde36cfbef49a79a1c8343fea05479_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">AMENDMENT TO SUPPLY AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">This Amendment to Supply Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made as of September 21, 2020 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) between CyDex Pharmaceuticals,&#160;Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CyDex</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and Gilead Sciences, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Gilead</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  It amends the Supply Agreement dated December 22, 2015 between CyDex and Gilead (as previously amended to date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Original Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  The Original Agreement, as amended hereby, is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#8221;  Defined terms used in this Amendment but not defined herein shall have the meanings set forth in the Original Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In consideration of the following mutual promises and other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the parties, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt">Exhibit A-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Original Agreement is hereby amended prospectively to read in full as set forth in Exhibit A-1 to this Amendment. </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt">Exhibit A-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Original Agreement is hereby amended prospectively to read in full as set forth in Exhibit A-2 to this Amendment.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Section 2(b) of the Original Agreement is hereby amended prospectively to read in full as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">i. Forecasts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Before the first day of each calendar quarter starting on Oct 1, 2020, Gilead (on behalf of itself and its Affiliates) shall provide to CyDex a rolling forecast detailing the quantities for the delivery of Product for the next twelve (12) calendar months of the Term (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forecast</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Each Forecast beginning with the Forecast covering the four (4) calendar quarters beginning October 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2020 shall be &#91;***&#93;.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ii. Binding Purchase Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  CyDex agrees to supply ordered Product in a quantity up to a maximum of 150% (per calendar quarter) of the quantity specified in the Forecast and shall also utilize commercially reasonable efforts to supply any requested additional Product in excess of those (150%) quantities in the timeline requested by Gilead. Gilead shall from time to time provide CyDex purchase orders for the Product quantity required to meet Gilead&#8217;s production schedule, and each such purchase order shall constitute a firm and binding commitment by Gilead to purchase from CyDex such ordered quantities.  For each such purchase order, CyDex shall be required to deliver at least the minimum monthly delivery quantities set forth under &#8220;Product Delivery&#8221; of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit A-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> during the corresponding delivery window. If Gilead requests more than the quantities set forth for each delivery window in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit A-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, CyDex shall have fourteen (14) days from the receipt of a purchase order from Gilead to provide Gilead written confirmation of its receipt and acceptance or rejection (to the extent provided herein) of such purchase order.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">iii. Take or Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If Gilead fails to order for &#91;***&#93; of any Forecast a quantity of Product to be delivered during such &#91;***&#93; that is equal to or greater than 100% of the quantity of Product Gilead is obligated to purchase in &#91;***&#93; pursuant to the applicable Forecast (the  difference  between the quantity of Product Gilead is obligated to  purchase </font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.339%"><tr><td style="width:1.0%"></td><td style="width:67.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Certain Confidential Information Omitted.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in &#91;***&#93; pursuant to the applicable Forecast and the amount of Product that Gilead actually orders for delivery in &#91;***&#93;, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Shortfall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), then within 30 days after the end of &#91;***&#93; Gilead shall pay CyDex &#91;***&#93; of the purchase price hereunder for the Shortfall amount and in such case shall not be entitled to receive delivery of such Shortfall amount.   If the delivery of any quantity of Product is delayed 30 days beyond the delivery date set forth in the Purchase Order and in consideration of Section 2(d) of the Agreement Gilead accepts and does not cancel such delayed Product, CyDex shall discount the price of the Product by &#91;***&#93; as to such applicable delivery.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Section 6 of the Original Agreement is hereby amended prospectively to read in full as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Unless otherwise agreed to by the Parties in writing, CYDEX shall deliver all shipments of Product ordered through December 31, 2020 to Gilead DDP (Incoterms 2010) to the facility designated in the accepted Purchase Order.  Title and risk of loss, damage or destruction to the Product shall remain with CYDEX until final delivery of the Product to Gilead at the named place of destination on the accepted Purchase Order.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Unless otherwise agreed to by the Parties in writing, CYDEX shall deliver all shipments of Product ordered after December 31, 2020 to Gilead FCA (Incoterms 2020) CyDex&#8217;s location of manufacture&#59; provided, that the Parties agree to cooperate with one another and use reasonable efforts to legitimately mitigate or reduce any value added taxes, or other duties, as permitted by applicable law.  Title and risk of loss, damage or destruction to the Product shall remain with CYDEX until final delivery of the Product to Gilead at CyDex&#8217;s location of manufacture.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">CYDEX shall package and label the Product for delivery in accordance with Gilead&#8217;s packaging and labeling requirements.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Section 15 of the Original Agreement is hereby amended to provide that the Agreement shall have a term lasting until the 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> anniversary of the Amendment Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Section 20 of the Original Agreement is amended prospectively to change the address for notice to CyDex to&#58;  CyDex Pharmaceuticals, Inc., c&#47;o Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard, Suite 110, San Diego, California 92121, USA, Attention&#58; Senior Vice President and Secretary&#59; with a copy to Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard, Suite 110, San Diego, California 92121, USA, Attention&#58; General Counsel.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Except as expressly set forth in this Amendment, the Original Agreement remains unchanged and in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.339%"><tr><td style="width:1.0%"></td><td style="width:67.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Certain Confidential Information Omitted.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the parties have executed this Amendment to Supply Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CYDEX PHARMACEUTICALS, INC.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:45.032%"><tr><td style="width:1.0%"></td><td style="width:20.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Charles S. Berkman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles S. Berkman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SVP, General Counsel and Secretary</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GILEAD SCIENCES, INC. </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:45.032%"><tr><td style="width:1.0%"></td><td style="width:20.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Reza Oliyai</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reza Oliyai</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SVP, PBO</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Exhibit A-1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Product</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Product&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Captisol&#174; Betadex Sulfobutyl Ether Sodium, Sulfobutylether &#7838; (beta) cyclodextrin, sodium salt (Clinical Grade or Commercial Grade, as specified for Gilead&#8217;s proposed use and supplied by&#47;for CYDEX).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Captisol which (a)&#160;has been manufactured in accordance with the Specifications under cGMP conditions, (b)&#160;is intended for use in humans, and (c)&#160;is intended for use in the manufacture of quantities of Licensed Products that are to be offered for clinical use or commercial sale or otherwise introduced into commerce (e.g., humanitarian or charitable use).  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Specifications&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.339%"><tr><td style="width:1.0%"></td><td style="width:67.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Certain Confidential Information Omitted.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Exhibit A-2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Commercial Provisions</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.339%"><tr><td style="width:1.0%"></td><td style="width:67.023%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">***</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Certain Confidential Information Omitted.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>lgnd_93020exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ic7e235faff2c464c923312da49bbda66_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;November&#160;6, 2020 </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>lgnd_93020exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i05b02d6fa13941ac84e14a64df6e2dd8_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Matthew Korenberg, certify that&#58;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;November&#160;6, 2020 </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>lgnd_93020exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i2acce97028114ba3870e492cdb1491c6_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr style="height:13pt"><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 6, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew Korenberg<br>Executive Vice President, Finance and Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lgnd-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:015c58ab-d6da-4197-b1ca-2564dd0b9f53,g:8a625853-6817-482c-9ef8-59dc8bbafc23-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ligand.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails">
        <link:definition>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
        <link:definition>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails">
        <link:definition>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>2414411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>2415412 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>2116102 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>2317302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2418413 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.ligand.com/role/Acquisitions">
        <link:definition>2119103 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2420414 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>2121104 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2322303 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>2423415 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>2424416 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>2125105 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxNarrativeDetails" roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails">
        <link:definition>2426417 - Disclosure - Income Tax - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>2127106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>2328304 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>2429418 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2430419 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>2131107 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsNarrativeDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails">
        <link:definition>2432420 - Disclosure - Commitment and Contingencies: Legal Proceedings - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ligand.com/role/Leases">
        <link:definition>2133108 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ligand.com/role/LeasesNarrativeDetails">
        <link:definition>2434421 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSale" roleURI="http://www.ligand.com/role/AssetsHeldforSale">
        <link:definition>2135109 - Disclosure - Assets Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleTables" roleURI="http://www.ligand.com/role/AssetsHeldforSaleTables">
        <link:definition>2336305 - Disclosure - Assets Held for Sale (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetsHeldforSaleSummaryDetails" roleURI="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails">
        <link:definition>2437422 - Disclosure - Assets Held for Sale - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.ligand.com/role/SubsequentEvent">
        <link:definition>2138110 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.ligand.com/role/SubsequentEventDetails">
        <link:definition>2439423 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_PfenexIncMember" abstract="true" name="PfenexIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" abstract="false" name="ForecastedCashFlowsEffectiveInterestRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" abstract="true" name="ContingentValueRightForInternalResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" abstract="false" name="LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInOtherEconomicRights" abstract="false" name="IncreaseDecreaseInOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lgnd_ExpectedProceedsFromDivestitureOfBusinesses" abstract="false" name="ExpectedProceedsFromDivestitureOfBusinesses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2019Member" abstract="true" name="ConvertibleSeniorNotesDue2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_PromactaMember" abstract="true" name="PromactaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_AmortizationOfOtherEconomicRights" abstract="false" name="AmortizationOfOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_AccruedLeasePurchases" abstract="false" name="AccruedLeasePurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_LupinPatentInfringementMember" abstract="true" name="LupinPatentInfringementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CollaborationArrangementRoyaltyRate" abstract="false" name="CollaborationArrangementRoyaltyRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_VernalisMember" abstract="true" name="VernalisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" abstract="true" name="LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_AziyoMember" abstract="true" name="AziyoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" abstract="false" name="EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ContingentValueRightOnProductRevenuesMember" abstract="true" name="ContingentValueRightOnProductRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" abstract="false" name="CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_TaurusBiosciencesLLCMember" abstract="true" name="TaurusBiosciencesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_PalvellaMember" abstract="true" name="PalvellaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_RampUpFeeAssetNoncurrent" abstract="false" name="RampUpFeeAssetNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" abstract="false" name="CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" abstract="false" name="PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_ContingentLiabilitiesFairValueDisclosure" abstract="false" name="ContingentLiabilitiesFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" abstract="false" name="EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_IcagenMember" abstract="true" name="IcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AbInitioBiotherapeuticsIncMember" abstract="true" name="AbInitioBiotherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ShortTermInvestmentsFairValueDisclosure" abstract="false" name="ShortTermInvestmentsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_MilestonePaymentsMember" abstract="true" name="MilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationConsiderationTransferredHoldback" abstract="false" name="BusinessCombinationConsiderationTransferredHoldback" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" abstract="true" name="CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>lgnd-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:015c58ab-d6da-4197-b1ca-2564dd0b9f53,g:8a625853-6817-482c-9ef8-59dc8bbafc23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b8265281-0fee-4643-8b6f-7e3138caf836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2b0bf580-606d-4963-9414-280d6630d1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b8265281-0fee-4643-8b6f-7e3138caf836" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2b0bf580-606d-4963-9414-280d6630d1c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9cf2ce15-52ae-4720-9a2b-110b35f72cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b8265281-0fee-4643-8b6f-7e3138caf836" xlink:to="loc_us-gaap_CommonStockValue_9cf2ce15-52ae-4720-9a2b-110b35f72cb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_44fbdd08-69c0-43cd-8ae3-0a68ba4e35b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b8265281-0fee-4643-8b6f-7e3138caf836" xlink:to="loc_us-gaap_AdditionalPaidInCapital_44fbdd08-69c0-43cd-8ae3-0a68ba4e35b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_60307de5-766a-44d9-a94a-95b0b95012a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b8265281-0fee-4643-8b6f-7e3138caf836" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_60307de5-766a-44d9-a94a-95b0b95012a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_24d83fba-7298-4663-91c8-0de48f9a6f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b8265281-0fee-4643-8b6f-7e3138caf836" xlink:to="loc_us-gaap_PreferredStockValue_24d83fba-7298-4663-91c8-0de48f9a6f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3707817d-4139-4da1-9f08-24ba5f8b93bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3707817d-4139-4da1-9f08-24ba5f8b93bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_d30414e2-9e3b-4380-bc6e-3acd823695b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_ShortTermInvestments_d30414e2-9e3b-4380-bc6e-3acd823695b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7c341b5f-a81c-4610-8bbf-5ff19e97bbe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7c341b5f-a81c-4610-8bbf-5ff19e97bbe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ad642e30-b2ee-4d89-a0a7-b387a0444637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_InventoryNet_ad642e30-b2ee-4d89-a0a7-b387a0444637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_2bd802bb-0087-4d4e-a50d-e9fb192025c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_IncomeTaxesReceivable_2bd802bb-0087-4d4e-a50d-e9fb192025c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e919c5d8-c4f7-4e8b-910c-5f3decd5a4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_OtherAssetsCurrent_e919c5d8-c4f7-4e8b-910c-5f3decd5a4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fb348e79-f58e-4196-9a97-f218a3b39070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d585ddc5-729b-4efb-b319-74fc4a9034c4" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fb348e79-f58e-4196-9a97-f218a3b39070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_68dfefaf-26ce-41d8-b46b-f43b9872421a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_50f17b58-e799-4465-ae10-213d7822d689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68dfefaf-26ce-41d8-b46b-f43b9872421a" xlink:to="loc_us-gaap_Liabilities_50f17b58-e799-4465-ae10-213d7822d689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cc5c79ab-f6f2-478f-a83a-24d982fb4fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68dfefaf-26ce-41d8-b46b-f43b9872421a" xlink:to="loc_us-gaap_StockholdersEquity_cc5c79ab-f6f2-478f-a83a-24d982fb4fa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0f10d0cd-2203-4065-82aa-7b962cd32f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68dfefaf-26ce-41d8-b46b-f43b9872421a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0f10d0cd-2203-4065-82aa-7b962cd32f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_22651926-0329-4b86-8335-a69fd6033664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:to="loc_us-gaap_AccountsPayableCurrent_22651926-0329-4b86-8335-a69fd6033664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ff93f1d4-7870-4d7b-9f70-780426fc2fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ff93f1d4-7870-4d7b-9f70-780426fc2fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e00a693c-b4e7-4f64-ab7e-d466c2c82966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:to="loc_us-gaap_TaxesPayableCurrent_e00a693c-b4e7-4f64-ab7e-d466c2c82966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_abbb4cde-5976-40c2-a467-d41751d13ad9" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_abbb4cde-5976-40c2-a467-d41751d13ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bb81fe00-04bc-4a6f-ae9b-6857f435ce8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bb81fe00-04bc-4a6f-ae9b-6857f435ce8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_4716e3c8-720e-49dd-ad13-59c07b249140" xlink:href="lgnd-20200930.xsd#lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d47a644-b466-4567-9694-11443f2f37e7" xlink:to="loc_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_4716e3c8-720e-49dd-ad13-59c07b249140" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1cbd46ee-535d-44cc-9671-9d3575e23ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_AssetsCurrent_1cbd46ee-535d-44cc-9671-9d3575e23ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_819c9c25-5500-4a4e-8078-25e0b43ac152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_819c9c25-5500-4a4e-8078-25e0b43ac152" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_781a2e08-220a-4bf6-a8eb-0bd7d18858b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_781a2e08-220a-4bf6-a8eb-0bd7d18858b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_95a998dd-ab10-4a2c-8637-56c21fc2554a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_Goodwill_95a998dd-ab10-4a2c-8637-56c21fc2554a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_0a9e7690-ed43-47b2-abcb-8d6cf47850ca" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_lgnd_CommercialLicenseRights_0a9e7690-ed43-47b2-abcb-8d6cf47850ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a0ec3187-cb26-4f3b-a2df-447422499c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a0ec3187-cb26-4f3b-a2df-447422499c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bac33c09-6cc4-4485-88d7-188ae3718312" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bac33c09-6cc4-4485-88d7-188ae3718312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_312721f8-25bf-483c-9a5a-aa5d57e627d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd860e19-91a5-402a-8e6a-b277a56b2a20" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_312721f8-25bf-483c-9a5a-aa5d57e627d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_810c8650-587c-4fff-9299-54054644ab83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:to="loc_us-gaap_LiabilitiesCurrent_810c8650-587c-4fff-9299-54054644ab83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_8f992efa-e4b5-470f-b3f2-5ff28bf91918" xlink:href="lgnd-20200930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:to="loc_lgnd_LiabilityForContingentValueRights_8f992efa-e4b5-470f-b3f2-5ff28bf91918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ef85a500-cea7-46de-a30d-154bec4db762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ef85a500-cea7-46de-a30d-154bec4db762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_1bb9326d-69ea-4b29-83fa-d499402f9494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_1bb9326d-69ea-4b29-83fa-d499402f9494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e73e7afd-b8ab-44e0-afe9-9092c14f62df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e73e7afd-b8ab-44e0-afe9-9092c14f62df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cedee5fe-0191-49aa-ba3d-85e6aace07ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_058fa4b9-1b63-43a5-981e-20bc59e0f086" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cedee5fe-0191-49aa-ba3d-85e6aace07ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8803b673-8411-466f-815c-784c9e4c28ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_e27253c7-a59c-48a5-952a-c564408a21f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8803b673-8411-466f-815c-784c9e4c28ec" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_e27253c7-a59c-48a5-952a-c564408a21f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_cec01305-4514-4683-a98a-44ef79ae7243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8803b673-8411-466f-815c-784c9e4c28ec" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_cec01305-4514-4683-a98a-44ef79ae7243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_4228ed64-e0da-4f02-91e2-d4a71f2c146f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8803b673-8411-466f-815c-784c9e4c28ec" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_4228ed64-e0da-4f02-91e2-d4a71f2c146f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_64bb39eb-a685-4789-935e-a28ae0417ea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7e264ada-4982-480f-8065-fd080928db49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_64bb39eb-a685-4789-935e-a28ae0417ea8" xlink:to="loc_us-gaap_OperatingIncomeLoss_7e264ada-4982-480f-8065-fd080928db49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_03bf3507-9d49-4aa1-a5fa-e3e0611351a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_64bb39eb-a685-4789-935e-a28ae0417ea8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_03bf3507-9d49-4aa1-a5fa-e3e0611351a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_208f98b0-d9cd-4616-a29b-56eebc2f4107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8de6759f-cbb1-46ad-9308-85c7c429ee23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_208f98b0-d9cd-4616-a29b-56eebc2f4107" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8de6759f-cbb1-46ad-9308-85c7c429ee23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9e9a10d8-a087-4b36-a0cb-9ee9c2fa9f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_208f98b0-d9cd-4616-a29b-56eebc2f4107" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9e9a10d8-a087-4b36-a0cb-9ee9c2fa9f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_238558fa-ef43-40e3-b3eb-6d0321cae76a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_a35210d5-7a4e-403f-a493-a51397e37756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_238558fa-ef43-40e3-b3eb-6d0321cae76a" xlink:to="loc_us-gaap_GainLossOnInvestments_a35210d5-7a4e-403f-a493-a51397e37756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8b21964f-9010-42b0-bdde-66ac4b275918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_238558fa-ef43-40e3-b3eb-6d0321cae76a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8b21964f-9010-42b0-bdde-66ac4b275918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_58c1ddf6-e5f1-46ee-9f69-dfb4efa62e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_238558fa-ef43-40e3-b3eb-6d0321cae76a" xlink:to="loc_us-gaap_InterestExpense_58c1ddf6-e5f1-46ee-9f69-dfb4efa62e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_53bfe833-48e9-4faa-b1cf-007b9c7e15e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_238558fa-ef43-40e3-b3eb-6d0321cae76a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_53bfe833-48e9-4faa-b1cf-007b9c7e15e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_618b3f68-50e6-4201-b0e5-a1f29317556c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_55c625c3-e4cf-44a9-b59f-342da5dcd684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_618b3f68-50e6-4201-b0e5-a1f29317556c" xlink:to="loc_us-gaap_CostDirectMaterial_55c625c3-e4cf-44a9-b59f-342da5dcd684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_a6700fd9-aede-4196-bd7a-47277b6a806d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_618b3f68-50e6-4201-b0e5-a1f29317556c" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_a6700fd9-aede-4196-bd7a-47277b6a806d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_38bc1f89-b40c-4aef-b5ce-b580e1e6f1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_618b3f68-50e6-4201-b0e5-a1f29317556c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_38bc1f89-b40c-4aef-b5ce-b580e1e6f1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3cb8d940-0ccd-46bf-ad91-53d2690592da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_618b3f68-50e6-4201-b0e5-a1f29317556c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3cb8d940-0ccd-46bf-ad91-53d2690592da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5126e4ed-a21a-4a62-9fd2-d5a000d13f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f4fb4d7-7c75-47f9-8175-dba09dbaa77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5126e4ed-a21a-4a62-9fd2-d5a000d13f5f" xlink:to="loc_us-gaap_NetIncomeLoss_4f4fb4d7-7c75-47f9-8175-dba09dbaa77e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b1cb3ca8-63f0-4780-955f-de5bed2a39ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5126e4ed-a21a-4a62-9fd2-d5a000d13f5f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b1cb3ca8-63f0-4780-955f-de5bed2a39ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_16acebc2-8010-47a5-be19-78c52466417a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5126e4ed-a21a-4a62-9fd2-d5a000d13f5f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_16acebc2-8010-47a5-be19-78c52466417a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_a7adb92f-fea4-47ed-83c7-a886f4a58ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_a7adb92f-fea4-47ed-83c7-a886f4a58ca9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_144485f1-cdb3-4205-92f7-7a8f6b7ceb60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_144485f1-cdb3-4205-92f7-7a8f6b7ceb60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7a42be5a-344f-4ec0-8af0-74f8a0326f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7a42be5a-344f-4ec0-8af0-74f8a0326f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3cd49ef4-656f-4b2c-9a4d-f644af172ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3cd49ef4-656f-4b2c-9a4d-f644af172ccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e8448b0-5aaf-4dd5-ad05-c6b7f8818159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e8448b0-5aaf-4dd5-ad05-c6b7f8818159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_49bff2c0-c4ad-430c-b870-0554b65f3791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_49bff2c0-c4ad-430c-b870-0554b65f3791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f39a2e4-5170-4a7f-87a3-b759cd9c894e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_83ccaf39-b463-443b-957f-b5a747631cde" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2f39a2e4-5170-4a7f-87a3-b759cd9c894e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b5f72a66-e421-4793-a772-22999c74b7ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0b7027dc-fabe-4c5b-b42b-6a2bedf0da73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b5f72a66-e421-4793-a772-22999c74b7ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0b7027dc-fabe-4c5b-b42b-6a2bedf0da73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5905db89-15d1-4a4e-8573-53c5d6e8dfb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b5f72a66-e421-4793-a772-22999c74b7ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5905db89-15d1-4a4e-8573-53c5d6e8dfb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc8a55dc-905a-4a62-aead-d1a4b96c923a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b5f72a66-e421-4793-a772-22999c74b7ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc8a55dc-905a-4a62-aead-d1a4b96c923a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4338d62c-3846-47eb-9d49-55330a9c3e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b5f72a66-e421-4793-a772-22999c74b7ae" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4338d62c-3846-47eb-9d49-55330a9c3e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cce41286-59fb-4503-a54a-a8b2b0541ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_ProfitLoss_cce41286-59fb-4503-a54a-a8b2b0541ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_4bfe4dd5-c371-489d-ba95-f3e288ecf54d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_4bfe4dd5-c371-489d-ba95-f3e288ecf54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_144b4c10-5ebc-47cf-8775-b89a63993cc5" xlink:href="lgnd-20200930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_144b4c10-5ebc-47cf-8775-b89a63993cc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0cd6113b-e5c8-4050-83be-4f8bf9662e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0cd6113b-e5c8-4050-83be-4f8bf9662e51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cff9ca2c-5d8f-42ed-be69-e3d398e7dd26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cff9ca2c-5d8f-42ed-be69-e3d398e7dd26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c329d9d7-5821-444f-ac39-6d1b9b929576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c329d9d7-5821-444f-ac39-6d1b9b929576" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_852e93e2-c47a-484d-b746-afae8259bfab" xlink:href="lgnd-20200930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_852e93e2-c47a-484d-b746-afae8259bfab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_427a1a61-bba2-420f-b3cc-3d186bb0eb45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_427a1a61-bba2-420f-b3cc-3d186bb0eb45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8a0dccfa-7bf9-41bb-8a5a-388b6d93e842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_ShareBasedCompensation_8a0dccfa-7bf9-41bb-8a5a-388b6d93e842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_cea96a36-55eb-4699-a05e-447dfc586575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_cea96a36-55eb-4699-a05e-447dfc586575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_d6d5378e-e221-4455-b847-bb0fe00f35f1" xlink:href="lgnd-20200930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_d6d5378e-e221-4455-b847-bb0fe00f35f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e0898454-72a8-4715-a79e-7acf6de72eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e0898454-72a8-4715-a79e-7acf6de72eac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_318e7865-c3cd-41a5-a6b3-b4e700cecd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_318e7865-c3cd-41a5-a6b3-b4e700cecd0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_24908221-f847-4ed4-87d5-b8a3ea8f4ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_24908221-f847-4ed4-87d5-b8a3ea8f4ded" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_72af62d4-7a2c-4206-8340-6524747e48ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_72af62d4-7a2c-4206-8340-6524747e48ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1e2d3d88-f7fc-481f-965a-4b860594cb57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1e2d3d88-f7fc-481f-965a-4b860594cb57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInOtherEconomicRights_6c3d04fe-aad3-40c8-90df-a2702952104c" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInOtherEconomicRights"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_lgnd_IncreaseDecreaseInOtherEconomicRights_6c3d04fe-aad3-40c8-90df-a2702952104c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_54e0b928-e099-4171-83be-c941d3932a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2aa88de0-143c-429a-a948-cc149247f023" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_54e0b928-e099-4171-83be-c941d3932a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0e6fed27-5c8b-468a-bc01-fcfeba5fa9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0e6fed27-5c8b-468a-bc01-fcfeba5fa9d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_a9e7a115-d021-4a85-983d-9364ceb44d82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_a9e7a115-d021-4a85-983d-9364ceb44d82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_dd409735-db9b-42aa-a56a-4ba83115d4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_dd409735-db9b-42aa-a56a-4ba83115d4d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_fa8d1c1b-e308-4407-9490-772eb5990a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_fa8d1c1b-e308-4407-9490-772eb5990a90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b940097b-f5f0-41dc-9ca6-83546b82fae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b940097b-f5f0-41dc-9ca6-83546b82fae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_93f83260-2d38-4ff8-896b-dea2e6d0baa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_93f83260-2d38-4ff8-896b-dea2e6d0baa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_c68ef28b-705a-4fef-9c7e-521aedc9e3bf" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_c68ef28b-705a-4fef-9c7e-521aedc9e3bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b51c6fcf-25d0-424f-9d6d-efa68d810b6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39750d6d-dae6-4c2e-8da4-e0f4e8a9cb45" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b51c6fcf-25d0-424f-9d6d-efa68d810b6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_ffea84a2-d64a-4bb1-b6bd-b5e762345c53" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2c62b4c1-7519-43dd-9416-de4e9ba0fa33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_ffea84a2-d64a-4bb1-b6bd-b5e762345c53" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2c62b4c1-7519-43dd-9416-de4e9ba0fa33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_8840ac37-0ad3-4ad6-96cc-8a1a41c06df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_ffea84a2-d64a-4bb1-b6bd-b5e762345c53" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_8840ac37-0ad3-4ad6-96cc-8a1a41c06df7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0ca89284-c1b5-482e-80de-0d7ae9917f49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0ce22847-d36b-4379-a470-19e1963f93c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0ca89284-c1b5-482e-80de-0d7ae9917f49" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0ce22847-d36b-4379-a470-19e1963f93c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4973ed33-fb26-4968-8787-e1f65e5362f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0ca89284-c1b5-482e-80de-0d7ae9917f49" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4973ed33-fb26-4968-8787-e1f65e5362f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b56fb2a7-cf0b-4338-9f97-01a30c050088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_0ca89284-c1b5-482e-80de-0d7ae9917f49" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b56fb2a7-cf0b-4338-9f97-01a30c050088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_69d091b9-71e4-4138-9a96-7afc101a254e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_0da10631-37ac-4ed3-a47c-8338fde40e98" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost_69d091b9-71e4-4138-9a96-7afc101a254e" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_0da10631-37ac-4ed3-a47c-8338fde40e98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_9f6dfc89-5bba-4bda-96f3-7d2320dc239e" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost_69d091b9-71e4-4138-9a96-7afc101a254e" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_9f6dfc89-5bba-4bda-96f3-7d2320dc239e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_79761f33-4ffb-492e-acb9-74c0bae52ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost_69d091b9-71e4-4138-9a96-7afc101a254e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_79761f33-4ffb-492e-acb9-74c0bae52ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_1da6b6b1-0187-44f8-b0d2-c5e8fb137875" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_6c90233f-bee3-4f7d-b38d-ac22a64e5023" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_1da6b6b1-0187-44f8-b0d2-c5e8fb137875" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_6c90233f-bee3-4f7d-b38d-ac22a64e5023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5a6c7bea-9fbb-41c6-ac3e-207dc65ed431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_1da6b6b1-0187-44f8-b0d2-c5e8fb137875" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5a6c7bea-9fbb-41c6-ac3e-207dc65ed431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_68f3ef09-92e2-4d01-970b-5acb160c05eb" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_becea6fd-b41c-4b8b-b796-d52b87bc1890" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_68f3ef09-92e2-4d01-970b-5acb160c05eb" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_becea6fd-b41c-4b8b-b796-d52b87bc1890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_64df0621-ed7c-4bc5-8a24-95283232e117" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_68f3ef09-92e2-4d01-970b-5acb160c05eb" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_64df0621-ed7c-4bc5-8a24-95283232e117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_b31b9ac6-5df0-482a-9e04-d961342d4fd6" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_68f3ef09-92e2-4d01-970b-5acb160c05eb" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_b31b9ac6-5df0-482a-9e04-d961342d4fd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_84978c24-b59a-4d39-9ace-f9865610ae15" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_0328a461-18d3-4e37-96df-d8a1fc95a0ce" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_84978c24-b59a-4d39-9ace-f9865610ae15" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_0328a461-18d3-4e37-96df-d8a1fc95a0ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d80cc42a-a692-456d-accf-cf648e351ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_84978c24-b59a-4d39-9ace-f9865610ae15" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d80cc42a-a692-456d-accf-cf648e351ccc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_490d74dc-297e-4dcb-a077-d2c0f362cf1a" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_45f2a236-cb74-4c4c-b892-fc3439d8ead2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_490d74dc-297e-4dcb-a077-d2c0f362cf1a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_45f2a236-cb74-4c4c-b892-fc3439d8ead2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_5ebaedf1-67eb-4ef9-8981-1c3c8cf4ae8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_490d74dc-297e-4dcb-a077-d2c0f362cf1a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_5ebaedf1-67eb-4ef9-8981-1c3c8cf4ae8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_ce3ac6eb-11db-46fe-a3f5-c29b0495afae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_57e2d2cd-a2c4-4d9c-86d3-d9ed6321656a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_ce3ac6eb-11db-46fe-a3f5-c29b0495afae" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_57e2d2cd-a2c4-4d9c-86d3-d9ed6321656a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e361b712-5bb8-486a-8080-33ba5d835a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_ce3ac6eb-11db-46fe-a3f5-c29b0495afae" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e361b712-5bb8-486a-8080-33ba5d835a00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_bbc19c60-f2ef-45a2-9ae3-6d41e7087832" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_ce3ac6eb-11db-46fe-a3f5-c29b0495afae" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_bbc19c60-f2ef-45a2-9ae3-6d41e7087832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_810688b0-2fe0-487f-9760-f728d9a87034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_51f1ac12-7f89-4bf0-aa1c-e49ef2559a6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_810688b0-2fe0-487f-9760-f728d9a87034" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_51f1ac12-7f89-4bf0-aa1c-e49ef2559a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_ecb5848c-fbb2-477c-8112-7e09aa9ed70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_810688b0-2fe0-487f-9760-f728d9a87034" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_ecb5848c-fbb2-477c-8112-7e09aa9ed70f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_b13a7451-2c0f-4c93-9c9c-4867251c90f9" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_810688b0-2fe0-487f-9760-f728d9a87034" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_b13a7451-2c0f-4c93-9c9c-4867251c90f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_54a29c08-4444-4a02-95ce-13b4b0ed42e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4d4e5c84-972c-4378-b1a9-a8cc0eea93a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_54a29c08-4444-4a02-95ce-13b4b0ed42e8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_4d4e5c84-972c-4378-b1a9-a8cc0eea93a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_157fa300-464d-4d8e-95fd-23c94054539e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_54a29c08-4444-4a02-95ce-13b4b0ed42e8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_157fa300-464d-4d8e-95fd-23c94054539e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_43627e7d-4481-4827-b0c7-7574dc132cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_374bbee6-aa08-407a-a9bd-c5ccff404ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_43627e7d-4481-4827-b0c7-7574dc132cb9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_374bbee6-aa08-407a-a9bd-c5ccff404ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1504fc7f-ce15-4702-9076-c77593be988b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_43627e7d-4481-4827-b0c7-7574dc132cb9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1504fc7f-ce15-4702-9076-c77593be988b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9324d1c3-3073-43ba-8b47-c03a8f836589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d1ad0edc-cc09-43d1-929c-2d8de2cf76f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9324d1c3-3073-43ba-8b47-c03a8f836589" xlink:to="loc_us-gaap_Goodwill_d1ad0edc-cc09-43d1-929c-2d8de2cf76f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_df1696c4-52a3-49b0-a619-52da3dac47d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9324d1c3-3073-43ba-8b47-c03a8f836589" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_df1696c4-52a3-49b0-a619-52da3dac47d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_666aeede-14ae-4073-9b57-a36f87365449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_9324d1c3-3073-43ba-8b47-c03a8f836589" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_666aeede-14ae-4073-9b57-a36f87365449" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_818475aa-9c44-4b44-8738-3f9e1eaeb104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_47aea581-87f2-413e-82e1-00669418f689" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_818475aa-9c44-4b44-8738-3f9e1eaeb104" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_47aea581-87f2-413e-82e1-00669418f689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0baf53a9-26a5-4e8f-b2f4-4d2ef491160f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_818475aa-9c44-4b44-8738-3f9e1eaeb104" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0baf53a9-26a5-4e8f-b2f4-4d2ef491160f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_507b23b4-6957-4236-9f1e-f4b8dbd10335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RampUpFeeAssetNoncurrent_c23e6db4-4c42-4095-9bd9-087a7182286d" xlink:href="lgnd-20200930.xsd#lgnd_RampUpFeeAssetNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_507b23b4-6957-4236-9f1e-f4b8dbd10335" xlink:to="loc_lgnd_RampUpFeeAssetNoncurrent_c23e6db4-4c42-4095-9bd9-087a7182286d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAndReceivablesNet_2efd85b2-eeaa-4745-ba63-5a852ee2ab53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_507b23b4-6957-4236-9f1e-f4b8dbd10335" xlink:to="loc_us-gaap_LongTermInvestmentsAndReceivablesNet_2efd85b2-eeaa-4745-ba63-5a852ee2ab53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d4cfc9e6-b297-4cf0-b9bb-f74f8be08ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_507b23b4-6957-4236-9f1e-f4b8dbd10335" xlink:to="loc_us-gaap_EquityMethodInvestments_d4cfc9e6-b297-4cf0-b9bb-f74f8be08ae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_4d48e00e-b875-4101-aee2-5a55549d63ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_507b23b4-6957-4236-9f1e-f4b8dbd10335" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_4d48e00e-b875-4101-aee2-5a55549d63ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_08ca10d5-f91d-4167-9c82-0bda5158a302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_507b23b4-6957-4236-9f1e-f4b8dbd10335" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_08ca10d5-f91d-4167-9c82-0bda5158a302" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6eb61c2d-0d4b-4ed7-8684-b2d9994f1bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6eb61c2d-0d4b-4ed7-8684-b2d9994f1bed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_09d95214-3999-44aa-b58e-bbdd6a14c3c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_09d95214-3999-44aa-b58e-bbdd6a14c3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_d21d9890-f5c5-4382-9f93-c0f668520a9c" xlink:href="lgnd-20200930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_lgnd_LicenseeAccrualCurrent_d21d9890-f5c5-4382-9f93-c0f668520a9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_b3cf90b8-e990-4013-898b-e4cedc407706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_b3cf90b8-e990-4013-898b-e4cedc407706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_db033011-9649-4f59-baad-0f59b21a6dd3" xlink:href="lgnd-20200930.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_lgnd_ReturnsAccrual_db033011-9649-4f59-baad-0f59b21a6dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_807fe2c5-10aa-40bc-a225-9819a1d824b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_807fe2c5-10aa-40bc-a225-9819a1d824b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_0e48db21-e491-49af-bef3-d0c090621e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_us-gaap_InterestPayableCurrent_0e48db21-e491-49af-bef3-d0c090621e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9be1b956-f431-4f37-af4e-3425e3b35e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2becc3a3-ca19-47cf-87eb-cf836d9a12c3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9be1b956-f431-4f37-af4e-3425e3b35e33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1c601c4-f512-464d-9153-7583a751ab80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b7110069-18ce-4587-8443-a9884e5933df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1c601c4-f512-464d-9153-7583a751ab80" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b7110069-18ce-4587-8443-a9884e5933df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_328ca71c-2102-4cb5-be37-fcd05903afab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1c601c4-f512-464d-9153-7583a751ab80" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_328ca71c-2102-4cb5-be37-fcd05903afab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_65c45a9b-694d-4956-9c0c-48ee03a0e057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1c601c4-f512-464d-9153-7583a751ab80" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_65c45a9b-694d-4956-9c0c-48ee03a0e057" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_91c0d331-45f7-4325-b026-b1f9d8441609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_7a3884cc-b390-466b-9a2f-c390e9ea0d93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_91c0d331-45f7-4325-b026-b1f9d8441609" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_7a3884cc-b390-466b-9a2f-c390e9ea0d93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesFairValueDisclosure_6b88a1d5-77ab-4007-bc35-7f9f1f0b63bb" xlink:href="lgnd-20200930.xsd#lgnd_ContingentLiabilitiesFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_91c0d331-45f7-4325-b026-b1f9d8441609" xlink:to="loc_lgnd_ContingentLiabilitiesFairValueDisclosure_6b88a1d5-77ab-4007-bc35-7f9f1f0b63bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_222d90d0-1888-40f6-bfc7-5a741224ba11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1cf34419-3e57-4b35-9aac-0f24bfc443d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_222d90d0-1888-40f6-bfc7-5a741224ba11" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1cf34419-3e57-4b35-9aac-0f24bfc443d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShortTermInvestmentsFairValueDisclosure_fa28fe97-456c-4d26-a7f3-73241b558c00" xlink:href="lgnd-20200930.xsd#lgnd_ShortTermInvestmentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_222d90d0-1888-40f6-bfc7-5a741224ba11" xlink:to="loc_lgnd_ShortTermInvestmentsFairValueDisclosure_fa28fe97-456c-4d26-a7f3-73241b558c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_1bbfbb58-32ce-4bed-953f-a0c4ff12bae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_222d90d0-1888-40f6-bfc7-5a741224ba11" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_1bbfbb58-32ce-4bed-953f-a0c4ff12bae8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20200930.xsd#Acquisitions"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AcquisitionsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotes"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_4420b888-af48-44da-bcfc-e8c9b2445b98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f9fc696b-b957-42af-af77-283ca622be40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_4420b888-af48-44da-bcfc-e8c9b2445b98" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f9fc696b-b957-42af-af77-283ca622be40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ca077ced-39fc-4385-8a01-7d60a20657de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_4420b888-af48-44da-bcfc-e8c9b2445b98" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ca077ced-39fc-4385-8a01-7d60a20657de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20200930.xsd#IncomeTax"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#IncomeTaxNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CommitmentandContingenciesLegalProceedingsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20200930.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSale" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSale"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AssetsHeldforSale" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSaleTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSaleTables"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AssetsHeldforSaleTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSaleSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fc65b760-2049-426b-8a48-aa0af7db1f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_dd73a5a8-7580-4215-b747-eab37c3fc739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fc65b760-2049-426b-8a48-aa0af7db1f2d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_dd73a5a8-7580-4215-b747-eab37c3fc739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_7defa404-39c1-41ab-8527-77cba7042d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fc65b760-2049-426b-8a48-aa0af7db1f2d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_7defa404-39c1-41ab-8527-77cba7042d92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_e9e26622-4329-47cc-a680-322bd5075d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fc65b760-2049-426b-8a48-aa0af7db1f2d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_e9e26622-4329-47cc-a680-322bd5075d77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_7de0c9d3-7cf5-428e-a92f-3765f5211a97" xlink:href="lgnd-20200930.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_fc65b760-2049-426b-8a48-aa0af7db1f2d" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_7de0c9d3-7cf5-428e-a92f-3765f5211a97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a548bdc6-1bc5-41e2-980f-96b66a1bdef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_e5844ffc-3a78-4d70-860e-06683cbd38e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a548bdc6-1bc5-41e2-980f-96b66a1bdef9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_e5844ffc-3a78-4d70-860e-06683cbd38e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_f33debe8-e03a-4ea8-99a1-1bcc403325b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a548bdc6-1bc5-41e2-980f-96b66a1bdef9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_f33debe8-e03a-4ea8-99a1-1bcc403325b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_8e48488a-cab6-4665-ad89-01f608d82f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a548bdc6-1bc5-41e2-980f-96b66a1bdef9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_8e48488a-cab6-4665-ad89-01f608d82f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_a025616f-8a03-42e2-bb73-588b23d7ff01" xlink:href="lgnd-20200930.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a548bdc6-1bc5-41e2-980f-96b66a1bdef9" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_a025616f-8a03-42e2-bb73-588b23d7ff01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_e133f815-bfea-4770-80b2-fe20514c1324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_a548bdc6-1bc5-41e2-980f-96b66a1bdef9" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_e133f815-bfea-4770-80b2-fe20514c1324" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEvent" xlink:type="simple" xlink:href="lgnd-20200930.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#SubsequentEventDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>lgnd-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:015c58ab-d6da-4197-b1ca-2564dd0b9f53,g:8a625853-6817-482c-9ef8-59dc8bbafc23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended" id="i722c19cb88f64a13873e063f048a24b8_CoverPage"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i71bbc62431064da5bfc5abf551a50d5e_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i9704c67ed63c49a1a4e1c2b35a94ed71_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i33275a3f49cb4e588de70bbf44b1ebf9_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_82c07a80-e5bf-4511-863d-64ecf07f4347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_RevenuesAbstract_82c07a80-e5bf-4511-863d-64ecf07f4347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3eb9be29-4dad-4373-b838-26fbd9fced86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_82c07a80-e5bf-4511-863d-64ecf07f4347" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3eb9be29-4dad-4373-b838-26fbd9fced86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_a701cd05-8567-40f9-ab08-ed41103156b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_CostDirectMaterial_a701cd05-8567-40f9-ab08-ed41103156b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_bc1dc59a-d6cd-450f-8570-e688917bf440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_bc1dc59a-d6cd-450f-8570-e688917bf440" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3a13db90-761b-4197-9f68-afda55670ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3a13db90-761b-4197-9f68-afda55670ddf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1cd2c903-4dcc-4896-9cbb-7f73348da4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1cd2c903-4dcc-4896-9cbb-7f73348da4b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_1a133c3d-3d28-4f4e-b36b-3c0ff9dc3be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_1a133c3d-3d28-4f4e-b36b-3c0ff9dc3be1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_2836753f-2a75-4852-84be-532e5f610a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_2836753f-2a75-4852-84be-532e5f610a6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ee6a91a-c7c6-4dc7-b761-e71e3b9d5cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_OperatingIncomeLoss_7ee6a91a-c7c6-4dc7-b761-e71e3b9d5cba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f9e4ad77-c4d5-4f4a-9675-fbcf5dc3ec71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_GainLossOnInvestments_f9e4ad77-c4d5-4f4a-9675-fbcf5dc3ec71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_986873ae-6992-472e-9537-dc774b7cc9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_986873ae-6992-472e-9537-dc774b7cc9d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_361fd7e6-bb5e-4a04-9874-3421840970d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_InterestExpense_361fd7e6-bb5e-4a04-9874-3421840970d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_817e526b-886d-44ed-b9c2-98bbcca4b3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_817e526b-886d-44ed-b9c2-98bbcca4b3c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3e04b0b8-3246-4c1a-9982-d5eb2790ecd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3e04b0b8-3246-4c1a-9982-d5eb2790ecd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8a79c502-300d-48b1-b936-aa616d7b0357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8a79c502-300d-48b1-b936-aa616d7b0357" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7ff49690-ecc4-4067-a0cf-3494dc92f57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7ff49690-ecc4-4067-a0cf-3494dc92f57a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ae6adae0-f84a-4b00-82f9-626e76c48a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_NetIncomeLoss_ae6adae0-f84a-4b00-82f9-626e76c48a5b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_23717912-3faa-4a85-b3e9-ebc3cd74337f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_EarningsPerShareBasic_23717912-3faa-4a85-b3e9-ebc3cd74337f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd008ab7-c318-4991-b7bd-89b4e7b82fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd008ab7-c318-4991-b7bd-89b4e7b82fa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f9d7fb8c-0aee-4c08-b9e0-4a66df3cab1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f9d7fb8c-0aee-4c08-b9e0-4a66df3cab1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_678765b3-65c4-4afa-8c07-ff3b6a8db8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_678765b3-65c4-4afa-8c07-ff3b6a8db8e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:to="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7dc989d1-c34f-4547-875d-3b0ee52d98a1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:to="loc_srt_ProductsAndServicesDomain_7dc989d1-c34f-4547-875d-3b0ee52d98a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:to="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_e387c34e-f4c2-4678-abef-7a3f3409a55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:to="loc_us-gaap_RoyaltyMember_e387c34e-f4c2-4678-abef-7a3f3409a55a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_78967ecf-ef72-4115-8305-fe2ddda4a32e" xlink:href="lgnd-20200930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_78967ecf-ef72-4115-8305-fe2ddda4a32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_6edcb724-d41e-46ec-bd0b-39f533831161" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:to="loc_lgnd_ContractRevenueMember_6edcb724-d41e-46ec-bd0b-39f533831161" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="ic50313021f6b4b72824af9bdc78138c8_CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="ie9d89174c63c4580827f713406811140_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2bc6ab4f-9820-4bd8-989c-f618b6c19db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2bc6ab4f-9820-4bd8-989c-f618b6c19db6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_47915a6a-8414-4879-a257-4b5681ffce5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_SharesIssued_47915a6a-8414-4879-a257-4b5681ffce5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2626c257-101c-4c41-8e72-1946792333b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockholdersEquity_2626c257-101c-4c41-8e72-1946792333b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9ea58678-3654-4ac0-9077-296b32032eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9ea58678-3654-4ac0-9077-296b32032eca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_05f25614-d8fa-4f08-ab38-5f829ce753cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_05f25614-d8fa-4f08-ab38-5f829ce753cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e271bb78-f31c-4291-aa46-17224872b206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e271bb78-f31c-4291-aa46-17224872b206" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_bf567355-7089-4bbe-ac36-b769fe38eee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_bf567355-7089-4bbe-ac36-b769fe38eee4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_72df04d1-4a68-42c7-8a2f-fe665caa16ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_72df04d1-4a68-42c7-8a2f-fe665caa16ec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4ac45515-ef7a-43fc-abdb-a8c726b00bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4ac45515-ef7a-43fc-abdb-a8c726b00bf4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_aa570f91-f989-41af-b695-48e12f68a238" xlink:href="lgnd-20200930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_aa570f91-f989-41af-b695-48e12f68a238" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2e3bc253-6c18-4c73-85b2-5c5c4d4ef8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2e3bc253-6c18-4c73-85b2-5c5c4d4ef8e0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_36295b03-44b1-4a87-8a2b-ddb9d89b7001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_36295b03-44b1-4a87-8a2b-ddb9d89b7001" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_64e3d484-1cc3-462f-b39a-4c77da3d739c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockholdersEquityOther_64e3d484-1cc3-462f-b39a-4c77da3d739c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_03ae6635-fd06-4be2-9df9-8f5c9ad181e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_NetIncomeLoss_03ae6635-fd06-4be2-9df9-8f5c9ad181e3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d5cbc560-8c1e-4848-8ff3-cc53e810dfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_05df3ec6-7148-48d3-a15e-cf1d433fbdda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:to="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ad55365-0c60-43ac-8242-c88245441ba1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:to="loc_us-gaap_EquityComponentDomain_3ad55365-0c60-43ac-8242-c88245441ba1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:to="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2dbd2623-4598-437f-a338-8569bcac79e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_CommonStockMember_2dbd2623-4598-437f-a338-8569bcac79e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_42ec63af-ca4d-4bdf-9575-6b3cd3515f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_42ec63af-ca4d-4bdf-9575-6b3cd3515f3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04d40b63-74a7-4eac-bb0e-680bcbe9c4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04d40b63-74a7-4eac-bb0e-680bcbe9c4c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_97be589d-04d1-48d6-b6ab-7bd6ca0f81f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_RetainedEarningsMember_97be589d-04d1-48d6-b6ab-7bd6ca0f81f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_58e5801e-1c24-40a6-a2b9-1b82d883b2bc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_58e5801e-1c24-40a6-a2b9-1b82d883b2bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5174eda-b86c-466b-a608-28451f708966" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5174eda-b86c-466b-a608-28451f708966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3106f75f-c7ec-42ea-936b-3aad55260e34" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5174eda-b86c-466b-a608-28451f708966" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3106f75f-c7ec-42ea-936b-3aad55260e34" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="iedeb2b29505740a4b9a841da3e9c35cb_CondensedConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a271a981-6074-4c34-b036-000950fa0349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_ProfitLoss_a271a981-6074-4c34-b036-000950fa0349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_011bea2f-9f10-4d38-adb0-d9e9bd9c2a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_011bea2f-9f10-4d38-adb0-d9e9bd9c2a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_f175a0e5-c9f3-4c74-86e8-5180ccd4f723" xlink:href="lgnd-20200930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_f175a0e5-c9f3-4c74-86e8-5180ccd4f723" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4d05a516-7526-4de2-9004-059775a38302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4d05a516-7526-4de2-9004-059775a38302" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f54576cf-9a4a-4c27-9922-71c1610b1f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f54576cf-9a4a-4c27-9922-71c1610b1f1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_448de8dc-c422-492b-af72-f7e23a82e52c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_448de8dc-c422-492b-af72-f7e23a82e52c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_f707f762-525e-4406-974b-8cb39c160bfe" xlink:href="lgnd-20200930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_f707f762-525e-4406-974b-8cb39c160bfe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9df01388-5d3f-4946-b1a6-61d3f7e06f61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9df01388-5d3f-4946-b1a6-61d3f7e06f61" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b945246a-498e-44f4-bab0-902334c84fac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_ShareBasedCompensation_b945246a-498e-44f4-bab0-902334c84fac" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5f3acbff-d8b1-4879-815b-a53daa210510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5f3acbff-d8b1-4879-815b-a53daa210510" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_b260d9b6-aaeb-4099-a046-abfaeee324a7" xlink:href="lgnd-20200930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_b260d9b6-aaeb-4099-a046-abfaeee324a7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_eadc36ad-aadb-4ab2-beb2-684c85c25aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_eadc36ad-aadb-4ab2-beb2-684c85c25aa7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b23727b3-1936-41d2-9897-f537a5858daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b23727b3-1936-41d2-9897-f537a5858daf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6e10c55-2a04-45f6-900e-cb601f72e3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6e10c55-2a04-45f6-900e-cb601f72e3b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b84f683-9304-436e-b4b0-1c3bfa874769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b84f683-9304-436e-b4b0-1c3bfa874769" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6670b159-3a24-4332-83c9-094bc79e6b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6670b159-3a24-4332-83c9-094bc79e6b0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInOtherEconomicRights_f7458476-9136-4be6-81b0-95e25010ad59" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInOtherEconomicRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_lgnd_IncreaseDecreaseInOtherEconomicRights_f7458476-9136-4be6-81b0-95e25010ad59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_643d7661-e3b0-42f0-8fc6-adff15adbe0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_643d7661-e3b0-42f0-8fc6-adff15adbe0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_392d7755-5782-4457-bbfd-069d7b558f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_392d7755-5782-4457-bbfd-069d7b558f6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_59e9fc41-6999-45f3-9b49-8c4b2d25ed13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_59e9fc41-6999-45f3-9b49-8c4b2d25ed13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_12baca2f-b517-4389-a723-124d8d5f6d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_12baca2f-b517-4389-a723-124d8d5f6d85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_b1d98fcf-5570-4a6f-bcc5-6bbb9e6e9b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_b1d98fcf-5570-4a6f-bcc5-6bbb9e6e9b73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_567cce5e-0f77-47a2-80fd-c5c76f0e94f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_567cce5e-0f77-47a2-80fd-c5c76f0e94f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_464bcd8f-c66e-40cf-b73b-df2abc2e5428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_464bcd8f-c66e-40cf-b73b-df2abc2e5428" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_eb0fcc97-a89a-44a8-b1cb-e5d7bc4869d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_eb0fcc97-a89a-44a8-b1cb-e5d7bc4869d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e98e013b-c79e-4ea1-9238-e52589d59e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e98e013b-c79e-4ea1-9238-e52589d59e95" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b98a1991-110f-4abb-b72c-6fcd71866602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b98a1991-110f-4abb-b72c-6fcd71866602" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4e6b7ba9-39b6-445e-bd25-5c12942b9657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4e6b7ba9-39b6-445e-bd25-5c12942b9657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_81d33522-1c04-4c03-858c-230d48b6799f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_81d33522-1c04-4c03-858c-230d48b6799f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_21886089-f1a6-4ff2-9205-c6ffe2473ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_21886089-f1a6-4ff2-9205-c6ffe2473ba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_bb1add11-6b3b-4447-bd49-56dad3212dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_bb1add11-6b3b-4447-bd49-56dad3212dff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_588077ec-cf6e-4b69-a9e3-d3aed1001d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_588077ec-cf6e-4b69-a9e3-d3aed1001d16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6269083c-6801-4735-ad42-ab7e176d2291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6269083c-6801-4735-ad42-ab7e176d2291" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_07f93f95-3079-49bc-a8cd-d7d74e5a0f6d" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_07f93f95-3079-49bc-a8cd-d7d74e5a0f6d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e553e842-972b-4825-b987-33711f80b398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e553e842-972b-4825-b987-33711f80b398" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8bc4dedc-b266-4df1-bf75-1c32ea66141e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8bc4dedc-b266-4df1-bf75-1c32ea66141e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44527d0e-be90-40ba-8758-8e45eae50b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44527d0e-be90-40ba-8758-8e45eae50b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3511f065-7f09-485e-bdd6-52b75aa3c2d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3511f065-7f09-485e-bdd6-52b75aa3c2d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76f86f35-a6f7-4e28-88e8-10cd301367cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76f86f35-a6f7-4e28-88e8-10cd301367cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1411b802-44e2-4837-92d9-6648a06006be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f3dbdf15-4f0a-49cc-a8c5-78ee3a5707a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:to="loc_us-gaap_InterestPaidNet_f3dbdf15-4f0a-49cc-a8c5-78ee3a5707a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_c7c93e10-2858-416d-8d68-7e7ccf938a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:to="loc_us-gaap_IncomeTaxesPaid_c7c93e10-2858-416d-8d68-7e7ccf938a34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_c4284b51-a48f-46cf-a435-9ed74531b1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:to="loc_us-gaap_RestrictedCashCurrent_c4284b51-a48f-46cf-a435-9ed74531b1d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_47862015-f8f9-40fa-b255-fcb7ad9a7d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_47862015-f8f9-40fa-b255-fcb7ad9a7d70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_801500cd-a2b1-4083-9af6-a9702a6b1a00" xlink:href="lgnd-20200930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_lgnd_AccruedInventoryPurchases_801500cd-a2b1-4083-9af6-a9702a6b1a00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedLeasePurchases_286365a2-8715-4652-8fe6-ed49fe204ce4" xlink:href="lgnd-20200930.xsd#lgnd_AccruedLeasePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_lgnd_AccruedLeasePurchases_286365a2-8715-4652-8fe6-ed49fe204ce4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_7627d287-9b21-4035-97cb-ecbd84cafcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_7627d287-9b21-4035-97cb-ecbd84cafcd3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:to="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_98bc7ac3-b96d-416c-96b0-eb8efcdecff4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_98bc7ac3-b96d-416c-96b0-eb8efcdecff4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_62e3a272-fbb3-4a5d-9ab0-f9c506b22260" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_62e3a272-fbb3-4a5d-9ab0-f9c506b22260" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2019Member_0d5a128d-5ade-4d2f-927f-61a5e14e80cf" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2019Member_0d5a128d-5ade-4d2f-927f-61a5e14e80cf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended" id="iec5c3b4ef5d94174ae9debe94e3333c1_BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i6f2090c56aca4beba591d28bee562aaf_BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="i72168870893b4cf1b7349da67535a612_BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ief56eff5d22143a48db2c07a11f24499_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_36006eec-ea1c-4dbf-8209-ec29799085ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_36006eec-ea1c-4dbf-8209-ec29799085ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_50beadf6-e297-4fb0-a5fd-3f1c0c1516f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_50beadf6-e297-4fb0-a5fd-3f1c0c1516f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7308479-77e2-41ff-bdd4-d904f497bb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7308479-77e2-41ff-bdd4-d904f497bb1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_798c4d1d-3e6a-4f66-840c-74c6e703fcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_798c4d1d-3e6a-4f66-840c-74c6e703fcff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_fd7e61a9-0e30-4dcf-95e0-c0ba641c6e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_fd7e61a9-0e30-4dcf-95e0-c0ba641c6e48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dab5ddce-44b7-4882-9d4f-2ac9cf81044a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dab5ddce-44b7-4882-9d4f-2ac9cf81044a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376f6f4c-82ac-4e0c-9e5d-ab8931f79f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376f6f4c-82ac-4e0c-9e5d-ab8931f79f38" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0860b38d-4635-4545-b4c9-5e954d2431bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0860b38d-4635-4545-b4c9-5e954d2431bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95ac505b-7170-4a21-a9c6-72f583aab610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95ac505b-7170-4a21-a9c6-72f583aab610" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_5745683a-31f4-458f-a9f5-c09d2f306edc" xlink:href="lgnd-20200930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_5745683a-31f4-458f-a9f5-c09d2f306edc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_de01ed7a-a64a-4a19-9dfb-7d307b655dac" xlink:href="lgnd-20200930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_de01ed7a-a64a-4a19-9dfb-7d307b655dac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_12089933-1ccd-4ed3-b751-0f8a8c43f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_12089933-1ccd-4ed3-b751-0f8a8c43f6e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CollaborationArrangementRoyaltyRate_c07eb2b5-9ef1-4a14-922d-90e7b028a087" xlink:href="lgnd-20200930.xsd#lgnd_CollaborationArrangementRoyaltyRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CollaborationArrangementRoyaltyRate_c07eb2b5-9ef1-4a14-922d-90e7b028a087" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f261cf7-f47e-49e1-9f8e-a30587c3bb9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f261cf7-f47e-49e1-9f8e-a30587c3bb9e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_fcbdcf31-cc32-4b0c-ac26-ca4a84bc1d79" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_fcbdcf31-cc32-4b0c-ac26-ca4a84bc1d79" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_4907edd6-e049-4589-85bb-3b1b9ab8ae76" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_4907edd6-e049-4589-85bb-3b1b9ab8ae76" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78f76334-ac96-4bfe-a2d9-99a074e92079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78f76334-ac96-4bfe-a2d9-99a074e92079" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:to="loc_srt_RangeMember_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:to="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eadce923-5b68-437c-83ad-6ef12d3715f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:to="loc_srt_MinimumMember_eadce923-5b68-437c-83ad-6ef12d3715f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_919eef7e-e0ba-47b0-80e8-4f629df58e4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:to="loc_srt_MaximumMember_919eef7e-e0ba-47b0-80e8-4f629df58e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46e1f815-3108-4ade-a435-b3f1440e3210_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46e1f815-3108-4ade-a435-b3f1440e3210_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_19f50278-5096-4cf3-95a3-4299aaff7132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_19f50278-5096-4cf3-95a3-4299aaff7132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_5d2b2ff2-6e67-4ad1-8dea-45263e5e3f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:to="loc_us-gaap_LicensingAgreementsMember_5d2b2ff2-6e67-4ad1-8dea-45263e5e3f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e5363f16-67c6-48aa-8e17-936fe580b106_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e5363f16-67c6-48aa-8e17-936fe580b106_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_b039b280-2560-4cfa-8880-80b797fa4819" xlink:href="lgnd-20200930.xsd#lgnd_AziyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:to="loc_lgnd_AziyoMember_b039b280-2560-4cfa-8880-80b797fa4819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaMember_74bac7cf-55ef-4160-a0de-64c0f2418147" xlink:href="lgnd-20200930.xsd#lgnd_PalvellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:to="loc_lgnd_PalvellaMember_74bac7cf-55ef-4160-a0de-64c0f2418147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d8beceaa-cd13-47ef-a53e-f7613ff54d96_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:to="loc_us-gaap_RelatedPartyDomain_d8beceaa-cd13-47ef-a53e-f7613ff54d96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:to="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_32959629-992e-41cd-b8ee-a04ddbce9424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_32959629-992e-41cd-b8ee-a04ddbce9424" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4efc4c29-8433-42fa-b4ac-0605c9c1987a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4efc4c29-8433-42fa-b4ac-0605c9c1987a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abca0e8b-a322-473e-ab81-e1e1d24982ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abca0e8b-a322-473e-ab81-e1e1d24982ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_82c83619-0851-4712-9c6f-805ede9dff2b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_82c83619-0851-4712-9c6f-805ede9dff2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_79aafbe1-12fe-406c-a254-f9172509153e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:to="loc_us-gaap_StockCompensationPlanMember_79aafbe1-12fe-406c-a254-f9172509153e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fbf24441-da15-4c03-9186-254580d74234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:to="loc_us-gaap_WarrantMember_fbf24441-da15-4c03-9186-254580d74234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_50d8eb5e-866b-4716-810a-b7112da2fa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:to="loc_us-gaap_CommonStockMember_50d8eb5e-866b-4716-810a-b7112da2fa4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_541aef99-bec4-4bfb-8526-1c85c4ac2ab2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_541aef99-bec4-4bfb-8526-1c85c4ac2ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e677c218-1d8d-4b9f-b20d-840de60fc3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e677c218-1d8d-4b9f-b20d-840de60fc3e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_142b1418-cf22-49a3-971e-8cb5d0c7cba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_142b1418-cf22-49a3-971e-8cb5d0c7cba1" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" xlink:type="extended" id="ib0a4c7bb4027497686eea938ee7ec834_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_36006eec-ea1c-4dbf-8209-ec29799085ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_36006eec-ea1c-4dbf-8209-ec29799085ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_50beadf6-e297-4fb0-a5fd-3f1c0c1516f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_50beadf6-e297-4fb0-a5fd-3f1c0c1516f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7308479-77e2-41ff-bdd4-d904f497bb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7308479-77e2-41ff-bdd4-d904f497bb1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_798c4d1d-3e6a-4f66-840c-74c6e703fcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_798c4d1d-3e6a-4f66-840c-74c6e703fcff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_fd7e61a9-0e30-4dcf-95e0-c0ba641c6e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_fd7e61a9-0e30-4dcf-95e0-c0ba641c6e48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dab5ddce-44b7-4882-9d4f-2ac9cf81044a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dab5ddce-44b7-4882-9d4f-2ac9cf81044a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376f6f4c-82ac-4e0c-9e5d-ab8931f79f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376f6f4c-82ac-4e0c-9e5d-ab8931f79f38" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0860b38d-4635-4545-b4c9-5e954d2431bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0860b38d-4635-4545-b4c9-5e954d2431bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95ac505b-7170-4a21-a9c6-72f583aab610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95ac505b-7170-4a21-a9c6-72f583aab610" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_5745683a-31f4-458f-a9f5-c09d2f306edc" xlink:href="lgnd-20200930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_5745683a-31f4-458f-a9f5-c09d2f306edc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_de01ed7a-a64a-4a19-9dfb-7d307b655dac" xlink:href="lgnd-20200930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_de01ed7a-a64a-4a19-9dfb-7d307b655dac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_12089933-1ccd-4ed3-b751-0f8a8c43f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_12089933-1ccd-4ed3-b751-0f8a8c43f6e6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CollaborationArrangementRoyaltyRate_c07eb2b5-9ef1-4a14-922d-90e7b028a087" xlink:href="lgnd-20200930.xsd#lgnd_CollaborationArrangementRoyaltyRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CollaborationArrangementRoyaltyRate_c07eb2b5-9ef1-4a14-922d-90e7b028a087" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f261cf7-f47e-49e1-9f8e-a30587c3bb9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f261cf7-f47e-49e1-9f8e-a30587c3bb9e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_fcbdcf31-cc32-4b0c-ac26-ca4a84bc1d79" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_fcbdcf31-cc32-4b0c-ac26-ca4a84bc1d79" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_4907edd6-e049-4589-85bb-3b1b9ab8ae76" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_4907edd6-e049-4589-85bb-3b1b9ab8ae76" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78f76334-ac96-4bfe-a2d9-99a074e92079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78f76334-ac96-4bfe-a2d9-99a074e92079" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:to="loc_srt_RangeMember_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:to="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eadce923-5b68-437c-83ad-6ef12d3715f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:to="loc_srt_MinimumMember_eadce923-5b68-437c-83ad-6ef12d3715f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_919eef7e-e0ba-47b0-80e8-4f629df58e4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:to="loc_srt_MaximumMember_919eef7e-e0ba-47b0-80e8-4f629df58e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46e1f815-3108-4ade-a435-b3f1440e3210_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_46e1f815-3108-4ade-a435-b3f1440e3210_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_19f50278-5096-4cf3-95a3-4299aaff7132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_19f50278-5096-4cf3-95a3-4299aaff7132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_5d2b2ff2-6e67-4ad1-8dea-45263e5e3f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:to="loc_us-gaap_LicensingAgreementsMember_5d2b2ff2-6e67-4ad1-8dea-45263e5e3f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e5363f16-67c6-48aa-8e17-936fe580b106_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e5363f16-67c6-48aa-8e17-936fe580b106_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_b039b280-2560-4cfa-8880-80b797fa4819" xlink:href="lgnd-20200930.xsd#lgnd_AziyoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:to="loc_lgnd_AziyoMember_b039b280-2560-4cfa-8880-80b797fa4819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaMember_74bac7cf-55ef-4160-a0de-64c0f2418147" xlink:href="lgnd-20200930.xsd#lgnd_PalvellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:to="loc_lgnd_PalvellaMember_74bac7cf-55ef-4160-a0de-64c0f2418147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d8beceaa-cd13-47ef-a53e-f7613ff54d96_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:to="loc_us-gaap_RelatedPartyDomain_d8beceaa-cd13-47ef-a53e-f7613ff54d96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:to="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_32959629-992e-41cd-b8ee-a04ddbce9424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_32959629-992e-41cd-b8ee-a04ddbce9424" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4efc4c29-8433-42fa-b4ac-0605c9c1987a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4efc4c29-8433-42fa-b4ac-0605c9c1987a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abca0e8b-a322-473e-ab81-e1e1d24982ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abca0e8b-a322-473e-ab81-e1e1d24982ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_82c83619-0851-4712-9c6f-805ede9dff2b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_82c83619-0851-4712-9c6f-805ede9dff2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_79aafbe1-12fe-406c-a254-f9172509153e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:to="loc_us-gaap_StockCompensationPlanMember_79aafbe1-12fe-406c-a254-f9172509153e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fbf24441-da15-4c03-9186-254580d74234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:to="loc_us-gaap_WarrantMember_fbf24441-da15-4c03-9186-254580d74234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_50d8eb5e-866b-4716-810a-b7112da2fa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:to="loc_us-gaap_CommonStockMember_50d8eb5e-866b-4716-810a-b7112da2fa4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_541aef99-bec4-4bfb-8526-1c85c4ac2ab2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_541aef99-bec4-4bfb-8526-1c85c4ac2ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e677c218-1d8d-4b9f-b20d-840de60fc3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e677c218-1d8d-4b9f-b20d-840de60fc3e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="ie6edbb2b78fc460c8241d11b0f3eb340_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b61b9db0-7648-4a5e-8dd2-0717f206c7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_af75c758-f70d-4569-be7f-f106fe0cb5c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b61b9db0-7648-4a5e-8dd2-0717f206c7e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_af75c758-f70d-4569-be7f-f106fe0cb5c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b61b9db0-7648-4a5e-8dd2-0717f206c7e7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:to="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:to="loc_srt_ProductsAndServicesDomain_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:to="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:to="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_4a84d331-c2cc-49cb-bbce-d11af82612a9" xlink:href="lgnd-20200930.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_KyprolisMember_4a84d331-c2cc-49cb-bbce-d11af82612a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_ae2ef542-3d1a-46bc-9f3e-1ac40ce1c1e1" xlink:href="lgnd-20200930.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_EvomelaMember_ae2ef542-3d1a-46bc-9f3e-1ac40ce1c1e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_b40b0c99-7261-4f64-a873-22164acac7b2" xlink:href="lgnd-20200930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_RoyaltyOtherMember_b40b0c99-7261-4f64-a873-22164acac7b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PromactaMember_fbb70567-4abf-4a04-ae2e-8fe3ae6b569f" xlink:href="lgnd-20200930.xsd#lgnd_PromactaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_PromactaMember_fbb70567-4abf-4a04-ae2e-8fe3ae6b569f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_91424f12-ebc7-45ce-bed9-7b843df72a27" xlink:href="lgnd-20200930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_91424f12-ebc7-45ce-bed9-7b843df72a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:to="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_785cfdfa-cd66-47cd-ad1c-f5727f736fb9" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_ContractRevenueServiceMember_785cfdfa-cd66-47cd-ad1c-f5727f736fb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_e1c59603-aed3-4efb-8353-df4e62810ccc" xlink:href="lgnd-20200930.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_LicenseFeesMember_e1c59603-aed3-4efb-8353-df4e62810ccc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_9000f982-e51c-4e46-9bde-0fb94ccaa1af" xlink:href="lgnd-20200930.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_MilestoneMember_9000f982-e51c-4e46-9bde-0fb94ccaa1af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_0db8e1dd-d4e3-4608-8389-7ee0c32a266d" xlink:href="lgnd-20200930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_0db8e1dd-d4e3-4608-8389-7ee0c32a266d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="iffabb8c810e14abeb76ef42a01266efc_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04ad80e2-98c3-420f-9e3a-da4442d5ccff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04ad80e2-98c3-420f-9e3a-da4442d5ccff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_314bb92d-5e26-4289-a53e-ca1379a3bd3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_314bb92d-5e26-4289-a53e-ca1379a3bd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_64e44e9d-b87e-40e5-ae2f-ee9307c09318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_64e44e9d-b87e-40e5-ae2f-ee9307c09318" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeed8229-f306-4319-8c3a-47e99a4f1bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeed8229-f306-4319-8c3a-47e99a4f1bb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_6525f764-5b20-469d-a1c5-7084009795da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_6525f764-5b20-469d-a1c5-7084009795da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_b5546fc7-b804-4ca3-9d6a-f9c52a4ab609" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_b5546fc7-b804-4ca3-9d6a-f9c52a4ab609" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_76326d59-f2c6-4a70-b100-2194c59ce9eb" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_76326d59-f2c6-4a70-b100-2194c59ce9eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_22daa239-76e7-41e5-a175-992915378334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_22daa239-76e7-41e5-a175-992915378334" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_e72da02e-2678-4d9d-8e5e-645452e57c21" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_e72da02e-2678-4d9d-8e5e-645452e57c21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_d5792e05-1756-4f33-93b6-2ca2de68338a" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_d5792e05-1756-4f33-93b6-2ca2de68338a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_e70d5b68-ef17-49fd-97d1-201c353d061f" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_e70d5b68-ef17-49fd-97d1-201c353d061f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_e63019eb-c5e3-41cd-a9ab-616a19379861" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_e63019eb-c5e3-41cd-a9ab-616a19379861" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b817d3af-0001-4736-9829-b350856c0651_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b817d3af-0001-4736-9829-b350856c0651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_c31cb9b1-ced8-4494-ac26-949c4e4b2f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_DemandDepositsMember_c31cb9b1-ced8-4494-ac26-949c4e4b2f1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e0a1f35e-ea25-415d-a052-57b564cc3fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e0a1f35e-ea25-415d-a052-57b564cc3fe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1538721e-c36a-47cd-b07f-10ac7921355e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_CommercialPaperMember_1538721e-c36a-47cd-b07f-10ac7921355e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4c8b5e0d-8a3d-41c9-ab10-e10bd1e96579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_EquitySecuritiesMember_4c8b5e0d-8a3d-41c9-ab10-e10bd1e96579" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_a48055c4-76ee-4d07-a7d8-e0960416a8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_MutualFundMember_a48055c4-76ee-4d07-a7d8-e0960416a8ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_9711b4fe-cf82-45ca-a0e2-18d6ce41eaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_WarrantMember_9711b4fe-cf82-45ca-a0e2-18d6ce41eaa2" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="if884b04844ca4755a7a88d4ac44b7e61_BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended" id="i399b8170c4db421b86728530704d1e9f_BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bb05bfcf-6d48-4d17-8e87-0d1bf4548acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bb05bfcf-6d48-4d17-8e87-0d1bf4548acd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_06631bf6-c2cb-491c-83d5-8a634074da0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_06631bf6-c2cb-491c-83d5-8a634074da0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_66133dba-d7f2-40e2-a7c6-785d1df5dd73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_66133dba-d7f2-40e2-a7c6-785d1df5dd73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3c6b3473-8f31-4a32-832b-2127760763cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3c6b3473-8f31-4a32-832b-2127760763cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_23cf9bbf-7e02-43a3-88d3-670f543bcc81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_23cf9bbf-7e02-43a3-88d3-670f543bcc81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d50baba7-be1a-48bc-8513-624d5c13e0b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d50baba7-be1a-48bc-8513-624d5c13e0b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6aa596a-bae7-4d28-9c53-6cef87360af7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6aa596a-bae7-4d28-9c53-6cef87360af7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_266058ef-52b2-4d82-a216-a7bdeb86c83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:to="loc_us-gaap_DemandDepositsMember_266058ef-52b2-4d82-a216-a7bdeb86c83b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6bd9e087-917f-4acc-adaa-6f2f6a7bec0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6bd9e087-917f-4acc-adaa-6f2f6a7bec0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4b22b505-5b72-4b9c-b0b1-6cca3baa23d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:to="loc_us-gaap_CommercialPaperMember_4b22b505-5b72-4b9c-b0b1-6cca3baa23d8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="idd6e7f9fd7204cd298d261ca19246e57_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c57f6d45-b4a0-4c45-871d-bbd9290ebae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c57f6d45-b4a0-4c45-871d-bbd9290ebae8" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebb69cf7-1768-4e1f-aa6d-5039573e2797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_Goodwill_ebb69cf7-1768-4e1f-aa6d-5039573e2797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f19189ff-fc59-46ff-b1f6-9e9ed2ad4f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f19189ff-fc59-46ff-b1f6-9e9ed2ad4f83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dcc824e7-5878-4451-98fd-ba6e58153749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dcc824e7-5878-4451-98fd-ba6e58153749" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f27df8e1-135f-4db6-ab8e-4f2e017ac93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f27df8e1-135f-4db6-ab8e-4f2e017ac93c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c57f6d45-b4a0-4c45-871d-bbd9290ebae8" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_531239b0-abdf-4272-9931-59000a1bda1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_531239b0-abdf-4272-9931-59000a1bda1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_7c2a4697-9a04-4725-a290-412285bc779d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_PatentedTechnologyMember_7c2a4697-9a04-4725-a290-412285bc779d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a767b091-79d6-406c-b898-cf4432ea0b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_TradeNamesMember_a767b091-79d6-406c-b898-cf4432ea0b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3851043c-4601-406a-9650-815a3cd842fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3851043c-4601-406a-9650-815a3cd842fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_caaf2d17-bafe-444d-b480-0dd0c65759cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_LicensingAgreementsMember_caaf2d17-bafe-444d-b480-0dd0c65759cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:to="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a0f19a4-6126-43ef-b58a-8e0ae33da696_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2a0f19a4-6126-43ef-b58a-8e0ae33da696_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77ea50bc-2518-48e6-aa2e-f27702dc249b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77ea50bc-2518-48e6-aa2e-f27702dc249b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_2add5b7a-8c32-43ea-a6ca-2de178c09b0e" xlink:href="lgnd-20200930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77ea50bc-2518-48e6-aa2e-f27702dc249b" xlink:to="loc_lgnd_SelexisAndDianomiMember_2add5b7a-8c32-43ea-a6ca-2de178c09b0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended" id="i8c876c27a40c4edbaf2e89f7f36739cd_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_26dbf029-e6cd-4664-8ca8-ca3e99de0360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_26dbf029-e6cd-4664-8ca8-ca3e99de0360" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_74284dbc-cae7-42ae-a523-70488ffaa4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_74284dbc-cae7-42ae-a523-70488ffaa4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_be55682e-bbee-40ab-99c2-a1c87269e6a1" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_be55682e-bbee-40ab-99c2-a1c87269e6a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5ace89a-454c-4ebb-a863-b0719a54259f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5ace89a-454c-4ebb-a863-b0719a54259f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d0d3119-797f-4d4b-8f07-8293c95022b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d0d3119-797f-4d4b-8f07-8293c95022b0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_a739d83d-0ef7-4798-b5a8-f92fd07447da" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_a739d83d-0ef7-4798-b5a8-f92fd07447da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_26dbf029-e6cd-4664-8ca8-ca3e99de0360" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d14d3c8c-f167-4292-893d-a0aa17d4048d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d14d3c8c-f167-4292-893d-a0aa17d4048d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb096ca-3938-4b3a-a9f9-3a10d82ac2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb096ca-3938-4b3a-a9f9-3a10d82ac2e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_81007103-9efe-4b6b-848d-59eef9323445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb096ca-3938-4b3a-a9f9-3a10d82ac2e1" xlink:to="loc_us-gaap_LicensingAgreementsMember_81007103-9efe-4b6b-848d-59eef9323445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:to="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5cf155e-eecf-4cac-b42c-7141e7131ea4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5cf155e-eecf-4cac-b42c-7141e7131ea4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_4f0c6f13-1554-40bd-8edc-df86cd2ef45d" xlink:href="lgnd-20200930.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_4f0c6f13-1554-40bd-8edc-df86cd2ef45d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaMember_1401d8d7-d64c-42b5-8c91-3e9d7ce4a508" xlink:href="lgnd-20200930.xsd#lgnd_PalvellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:to="loc_lgnd_PalvellaMember_1401d8d7-d64c-42b5-8c91-3e9d7ce4a508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_bca1c904-565a-4a3c-b15f-68dfca99a3f6" xlink:href="lgnd-20200930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:to="loc_lgnd_SelexisAndDianomiMember_bca1c904-565a-4a3c-b15f-68dfca99a3f6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="extended" id="ia4898ae9350948cfbed4991b175f45df_BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended" id="icb4f89bc8e994ed08808ce7617151485_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="ifb3d446993c14d2d979d4711b5b5e448_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_45861a76-7040-44f0-94e7-e3c24d8c34b5" xlink:href="lgnd-20200930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cf0c6b07-230c-4c74-9483-67173fb17000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_45861a76-7040-44f0-94e7-e3c24d8c34b5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cf0c6b07-230c-4c74-9483-67173fb17000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:href="lgnd-20200930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_45861a76-7040-44f0-94e7-e3c24d8c34b5" xlink:to="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_71117dfb-ecee-4906-be73-9e8baf6cd6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_71117dfb-ecee-4906-be73-9e8baf6cd6cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5112ba76-1e1a-442f-a270-fe69092145b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5112ba76-1e1a-442f-a270-fe69092145b3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended" id="if41ce1531b7141d0b4be1f411b6a29fc_BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended" id="ic748d988100347b9842956b1818d85b6_BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended" id="iea86d45bf3b740189d82853826b2c74a_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i5793a8e855a14b9ea30331b63b70cf0d_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i97a7b918b7de4fb3a220e45b74b37a48_FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShortTermInvestmentsFairValueDisclosure_2b3b7381-5700-4812-b52d-3cf5177ee985" xlink:href="lgnd-20200930.xsd#lgnd_ShortTermInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_lgnd_ShortTermInvestmentsFairValueDisclosure_2b3b7381-5700-4812-b52d-3cf5177ee985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_563766bc-d045-414f-ab39-418536b4ad2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_563766bc-d045-414f-ab39-418536b4ad2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_28c7722e-063e-414f-bb8a-00418522b4d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_28c7722e-063e-414f-bb8a-00418522b4d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7ccbe389-a9dc-4c55-b8c0-494a1bf10e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7ccbe389-a9dc-4c55-b8c0-494a1bf10e84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesFairValueDisclosure_5b928b2d-26cf-4b78-8026-22da0b39ef1f" xlink:href="lgnd-20200930.xsd#lgnd_ContingentLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:to="loc_lgnd_ContingentLiabilitiesFairValueDisclosure_5b928b2d-26cf-4b78-8026-22da0b39ef1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_ed39f039-2f8f-4e7d-a516-6b2e978408c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_ed39f039-2f8f-4e7d-a516-6b2e978408c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_66ddffc9-990f-4e51-bfa7-52f8bbb8c7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_66ddffc9-990f-4e51-bfa7-52f8bbb8c7c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_47d021ce-76cc-4908-95a2-a70d4f03bc53" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_47d021ce-76cc-4908-95a2-a70d4f03bc53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_cba8af87-afc6-4d2f-a273-f236c65eb7b9" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_cba8af87-afc6-4d2f-a273-f236c65eb7b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f7960c6a-3e55-428e-a140-c8045beed89a" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f7960c6a-3e55-428e-a140-c8045beed89a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_63c32f9d-24ac-47dc-b30a-506461a2d623" xlink:href="lgnd-20200930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_63c32f9d-24ac-47dc-b30a-506461a2d623" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_34401fa9-7612-4db8-9c9f-153d9d056df6" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_34401fa9-7612-4db8-9c9f-153d9d056df6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9a7bb347-5f7d-45b4-9b54-685f88ac4130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_Investments_9a7bb347-5f7d-45b4-9b54-685f88ac4130" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_8d6879c0-d7b8-4d55-9987-b89764ba8f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_8d6879c0-d7b8-4d55-9987-b89764ba8f24" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0a992c35-72eb-444a-b517-1a267afc9984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0a992c35-72eb-444a-b517-1a267afc9984" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ada775f2-cb6e-4e73-ba27-e9a345803072_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ada775f2-cb6e-4e73-ba27-e9a345803072_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_47f1c365-d228-4b53-937c-fdbaff9e540c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_47f1c365-d228-4b53-937c-fdbaff9e540c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0595438c-9db5-40e9-827c-3d0ad08f5963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0595438c-9db5-40e9-827c-3d0ad08f5963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b9b59c57-5d28-473e-8c90-2eccf7e610db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b9b59c57-5d28-473e-8c90-2eccf7e610db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember_0eaf0359-dc1b-4a27-b050-cb3b5c3b6683" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember_0eaf0359-dc1b-4a27-b050-cb3b5c3b6683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember_e7b3855c-decc-4806-b584-d4a65e622c75" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember_e7b3855c-decc-4806-b584-d4a65e622c75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember_b4d280ea-9baa-4d74-bd2c-f69a9b6e0f71" xlink:href="lgnd-20200930.xsd#lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember_b4d280ea-9baa-4d74-bd2c-f69a9b6e0f71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_013d7c28-a8cb-4055-b1eb-fa952c048a25" xlink:href="lgnd-20200930.xsd#lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_013d7c28-a8cb-4055-b1eb-fa952c048a25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad880d03-3d90-4d8c-8e85-9dc648de70dc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:to="loc_srt_RangeMember_ad880d03-3d90-4d8c-8e85-9dc648de70dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b014a0cd-51e6-4cfa-b1f0-ba55b419d678" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:to="loc_srt_RangeMember_b014a0cd-51e6-4cfa-b1f0-ba55b419d678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c48fbdf6-ac20-44ed-8fdc-5469a6c3ed6a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b014a0cd-51e6-4cfa-b1f0-ba55b419d678" xlink:to="loc_srt_MaximumMember_c48fbdf6-ac20-44ed-8fdc-5469a6c3ed6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_76eef4ae-f532-4188-9aa6-6ae42e47601d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_76eef4ae-f532-4188-9aa6-6ae42e47601d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2a0b3d3a-b078-4c24-8013-125d0558dcfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2a0b3d3a-b078-4c24-8013-125d0558dcfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_9703c0b2-5607-4f7c-beeb-b88758f167b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2a0b3d3a-b078-4c24-8013-125d0558dcfa" xlink:to="loc_us-gaap_TransferredOverTimeMember_9703c0b2-5607-4f7c-beeb-b88758f167b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:to="loc_srt_ProductsAndServicesDomain_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:to="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_66809785-0b9e-488a-b7aa-332fb2d825cf" xlink:href="lgnd-20200930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_66809785-0b9e-488a-b7aa-332fb2d825cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_7b7b0f53-99a2-4664-8293-4ac327cfc01c" xlink:href="lgnd-20200930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_7b7b0f53-99a2-4664-8293-4ac327cfc01c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f2600f07-9e67-43b1-907a-fb04b115e694_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f2600f07-9e67-43b1-907a-fb04b115e694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b1c2e4-a696-4cfa-a7ad-51be01108f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b1c2e4-a696-4cfa-a7ad-51be01108f12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_f2252557-1b29-4790-aaf2-81d4cca8ebac" xlink:href="lgnd-20200930.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b1c2e4-a696-4cfa-a7ad-51be01108f12" xlink:to="loc_lgnd_MetabasisMember_f2252557-1b29-4790-aaf2-81d4cca8ebac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20200930.xsd#Acquisitions"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended" id="i9bca48565606410ebcaaa2dd03b05d93_Acquisitions"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="ic20c21f4bb2f446ab9d3385daefe3e73_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a1366ff8-ea06-4bed-8ea3-9bd6e71533e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a1366ff8-ea06-4bed-8ea3-9bd6e71533e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c4bc1e4-c99e-4770-b711-d296ad08827e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c4bc1e4-c99e-4770-b711-d296ad08827e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_2a961c8e-907b-4982-877d-4ef9067d60dc" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_2a961c8e-907b-4982-877d-4ef9067d60dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0ef8e8-cba1-4cb2-81c0-592fdd512508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0ef8e8-cba1-4cb2-81c0-592fdd512508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_7c3337fd-bce5-4c1b-a1ba-6d60f4d7b303" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_7c3337fd-bce5-4c1b-a1ba-6d60f4d7b303" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_5cce33ce-371a-40e0-a9dd-3f8cf83f6b7f" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_5cce33ce-371a-40e0-a9dd-3f8cf83f6b7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f21eb79f-868e-49c8-b361-bc4db023ea0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f21eb79f-868e-49c8-b361-bc4db023ea0d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72f0d3ce-49a6-4e35-80b3-1686c98ebac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72f0d3ce-49a6-4e35-80b3-1686c98ebac3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ace7e2c9-9a08-4e02-8b60-6d771ac21644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ace7e2c9-9a08-4e02-8b60-6d771ac21644" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5863b111-835f-4a1b-ba4c-2adb5857644b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5863b111-835f-4a1b-ba4c-2adb5857644b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a3905a42-0d07-4063-b3c3-109bd1afab59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a3905a42-0d07-4063-b3c3-109bd1afab59" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_7384cdea-dc1f-40d8-8dc3-052203d5c12b" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_7384cdea-dc1f-40d8-8dc3-052203d5c12b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_228b6c30-a10e-4fe7-b2bf-97b51039c5b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_228b6c30-a10e-4fe7-b2bf-97b51039c5b7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd3c5515-c82c-4320-afd8-c04fd67988e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd3c5515-c82c-4320-afd8-c04fd67988e6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f5d0f911-d3a9-41f9-b3ef-f9694bd951fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f5d0f911-d3a9-41f9-b3ef-f9694bd951fa" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_95de1f0f-c651-4c28-8a23-b235f7e3907e" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_95de1f0f-c651-4c28-8a23-b235f7e3907e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cf85f414-9060-46c8-966e-9f6e4f666db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cf85f414-9060-46c8-966e-9f6e4f666db3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d282030-7864-4002-900f-27d8818274fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d282030-7864-4002-900f-27d8818274fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_a24950bb-97ba-4457-9f84-299a0abd83fd" xlink:href="lgnd-20200930.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_a24950bb-97ba-4457-9f84-299a0abd83fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_60b6bcf7-849d-4263-afc2-66594e160be5" xlink:href="lgnd-20200930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_60b6bcf7-849d-4263-afc2-66594e160be5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_f08ff688-095e-4c27-a7cb-2eb3fe1942cb" xlink:href="lgnd-20200930.xsd#lgnd_IcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_IcagenMember_f08ff688-095e-4c27-a7cb-2eb3fe1942cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AbInitioBiotherapeuticsIncMember_4b93b0d2-1cf1-4f10-bc14-6c7675a73a1a" xlink:href="lgnd-20200930.xsd#lgnd_AbInitioBiotherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_AbInitioBiotherapeuticsIncMember_4b93b0d2-1cf1-4f10-bc14-6c7675a73a1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_111ba9e2-4d01-4ab8-9360-beedee5e03b6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_111ba9e2-4d01-4ab8-9360-beedee5e03b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ab9771c2-ed81-4afa-b2bb-b3beae21b8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ab9771c2-ed81-4afa-b2bb-b3beae21b8c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4c14312d-e41b-41bb-a66a-d39ab79cc421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4c14312d-e41b-41bb-a66a-d39ab79cc421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_ca719647-a253-47bb-b0f5-9bd7f597b19d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_ca719647-a253-47bb-b0f5-9bd7f597b19d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_86386f54-260b-4c3c-b1d6-edf12e013f92" xlink:href="lgnd-20200930.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_86386f54-260b-4c3c-b1d6-edf12e013f92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_218a28bc-fc59-4d8e-8daf-3c6f1205d724" xlink:href="lgnd-20200930.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_218a28bc-fc59-4d8e-8daf-3c6f1205d724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_0626a4f7-459f-4bbd-af13-5a04abf29cf3" xlink:href="lgnd-20200930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_0626a4f7-459f-4bbd-af13-5a04abf29cf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_44d1b41b-73fc-49a1-aadc-9bb3814831e1" xlink:href="lgnd-20200930.xsd#lgnd_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_MilestonePaymentsMember_44d1b41b-73fc-49a1-aadc-9bb3814831e1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotes"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended" id="i933971e400b045c5b9fda958906bd99c_ConvertibleSeniorNotes"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended" id="ia417f996c3c442939a1ca55d0f154848_ConvertibleSeniorNotesTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i15da45f75ade4fb98a89855c500689b8_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9b79d99d-c5d4-4394-a78e-8e72e7932ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9b79d99d-c5d4-4394-a78e-8e72e7932ffd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cb3f4a6b-cfcf-46ca-a42f-50d5cc765991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cb3f4a6b-cfcf-46ca-a42f-50d5cc765991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c68b6be1-4ec7-4b86-9d60-19a50a92d07d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c68b6be1-4ec7-4b86-9d60-19a50a92d07d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bf91a89-f81c-4555-be50-eaa141ac4536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bf91a89-f81c-4555-be50-eaa141ac4536" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f715e083-fd12-48cc-9387-9390ac593ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f715e083-fd12-48cc-9387-9390ac593ca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_08defb4a-a705-4056-86fe-f9b2e6216eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_08defb4a-a705-4056-86fe-f9b2e6216eb9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c58ffb6c-6a4b-48e3-ba61-fc10ecfbb86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c58ffb6c-6a4b-48e3-ba61-fc10ecfbb86f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9060c41d-3ca0-4d70-8930-e427d344b18a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9060c41d-3ca0-4d70-8930-e427d344b18a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_cda1fb98-4c3b-4180-ab17-72548756c124" xlink:href="lgnd-20200930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_cda1fb98-4c3b-4180-ab17-72548756c124" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_d7f50094-32e8-4389-b00d-be70ed4ce0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_d7f50094-32e8-4389-b00d-be70ed4ce0f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_f8b64062-6f88-4c30-af95-f35fef9c99b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_f8b64062-6f88-4c30-af95-f35fef9c99b7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2d2d59ec-227e-4232-aa15-2230685918d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_LongTermDebt_2d2d59ec-227e-4232-aa15-2230685918d2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_f7dacac7-21fe-40e6-8341-032b66c09f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_f7dacac7-21fe-40e6-8341-032b66c09f39" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_bb58ebf9-bcf6-4fcb-ba4e-a0acf86a5257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_bb58ebf9-bcf6-4fcb-ba4e-a0acf86a5257" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3976ef45-5bf6-4063-8cf5-7e9f54c677dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3976ef45-5bf6-4063-8cf5-7e9f54c677dc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_2b196749-278e-4d03-bf5a-7c2b6fbf3b33" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_2b196749-278e-4d03-bf5a-7c2b6fbf3b33" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_ae0eaeea-8d50-459a-b5a5-6d752f5d6132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_ae0eaeea-8d50-459a-b5a5-6d752f5d6132" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f31acab2-8a5b-481d-8fe0-65d13b39fdbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f31acab2-8a5b-481d-8fe0-65d13b39fdbb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_c9879b5f-8c0a-429f-8d57-b8c462d6fa37" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_c9879b5f-8c0a-429f-8d57-b8c462d6fa37" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b23a47e-a093-43cf-b658-48e670aa7452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b23a47e-a093-43cf-b658-48e670aa7452" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea2bee10-04cd-4974-86aa-421520624fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea2bee10-04cd-4974-86aa-421520624fed" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f5913c8-4671-463a-8887-3b1142a1f1db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f5913c8-4671-463a-8887-3b1142a1f1db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_27fe31b7-4492-469b-9e2d-18678c136363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6f5913c8-4671-463a-8887-3b1142a1f1db" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_27fe31b7-4492-469b-9e2d-18678c136363" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_735bca27-2105-4a37-8749-74d99f3dbdee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_735bca27-2105-4a37-8749-74d99f3dbdee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_bde36598-5180-4767-8f65-39032b95a9d2" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_735bca27-2105-4a37-8749-74d99f3dbdee" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_bde36598-5180-4767-8f65-39032b95a9d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3a1d3d3f-c564-4291-bbfa-36979fe8efc4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3a1d3d3f-c564-4291-bbfa-36979fe8efc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_fad8e415-ba39-4fea-b211-70e96da9a0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_fad8e415-ba39-4fea-b211-70e96da9a0cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_915aecfb-c8cf-4555-a5ea-ea60da26bd3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_915aecfb-c8cf-4555-a5ea-ea60da26bd3c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="ibbd281fb55934ae7969f7149f04a154a_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_376a0d30-51ba-4cd1-a65e-453fa6699f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_376a0d30-51ba-4cd1-a65e-453fa6699f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5665f202-7b6d-4a77-bec8-fe0984bb7a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5665f202-7b6d-4a77-bec8-fe0984bb7a8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_0c7797f0-2c95-4079-b32b-ab2018aceb5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:to="loc_us-gaap_LongTermNotesPayable_0c7797f0-2c95-4079-b32b-ab2018aceb5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_334bbf99-de6a-4785-9b6d-9717cc0492c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_334bbf99-de6a-4785-9b6d-9717cc0492c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_115f338d-06de-4b37-ace5-45290161fea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_115f338d-06de-4b37-ace5-45290161fea8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b92a3106-cc30-47cd-b0ce-93d5e3a6411a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b92a3106-cc30-47cd-b0ce-93d5e3a6411a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_463a7c5e-59b6-4f8d-8249-c4c4b872702c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_463a7c5e-59b6-4f8d-8249-c4c4b872702c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_9c263027-952f-4731-a545-ac112f55190f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_463a7c5e-59b6-4f8d-8249-c4c4b872702c" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_9c263027-952f-4731-a545-ac112f55190f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:to="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_449b077c-3b8d-479b-8b3c-b115992d6f63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_449b077c-3b8d-479b-8b3c-b115992d6f63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de5033d5-01bd-4914-94d2-2a737c0afc78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de5033d5-01bd-4914-94d2-2a737c0afc78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0076dbd0-9a81-49fd-899f-803eafc6fcaf" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de5033d5-01bd-4914-94d2-2a737c0afc78" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0076dbd0-9a81-49fd-899f-803eafc6fcaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20200930.xsd#IncomeTax"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended" id="ib675ea1d920841278ff9add5d9b4d9ed_IncomeTax"/>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#IncomeTaxNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="extended" id="icf39b60d47c7475fb304d12f1bc1aca8_IncomeTaxNarrativeDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended" id="i5f6027d9237d4c1a90ffb8773e99dab6_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended" id="i7cad5266a04348cc81d88ad6c863d1eb_StockholdersEquityTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="idd4ed249c64a42aba2702f7079d99de3_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d654555d-1c70-4e22-9f8e-c219a1f3e866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d654555d-1c70-4e22-9f8e-c219a1f3e866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_09fde424-69a9-44ca-bb14-81863452fdb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_09fde424-69a9-44ca-bb14-81863452fdb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6811851-2582-44a5-958a-41a17dc96813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6811851-2582-44a5-958a-41a17dc96813" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c08c794-9377-4ed8-b230-ce53517d3d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c08c794-9377-4ed8-b230-ce53517d3d52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cf2976ea-8b3b-40c3-b9d7-1399080a85b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7199fe8a-eff7-43ae-ba1e-c3b5b563253c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7199fe8a-eff7-43ae-ba1e-c3b5b563253c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5e8769ad-dd17-4d1e-b262-fe04073e297b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5e8769ad-dd17-4d1e-b262-fe04073e297b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_00066953-fc22-4215-80c3-b9224541f471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_00066953-fc22-4215-80c3-b9224541f471" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_233067a7-f3cf-47e8-919c-7594d7566b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_233067a7-f3cf-47e8-919c-7594d7566b01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1f38e98-f6a3-48d2-8d4f-7694bc8bb028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_218038a4-e963-4b03-99fe-683156312520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_218038a4-e963-4b03-99fe-683156312520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fc31927-7a17-45d8-a2bf-5de067d1f50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fc31927-7a17-45d8-a2bf-5de067d1f50a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d093e39-ec09-4a7f-8660-8877d56ba27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d093e39-ec09-4a7f-8660-8877d56ba27c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9f7de826-ffa8-421c-ab58-68d9e643f394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9f7de826-ffa8-421c-ab58-68d9e643f394" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5cdc61d8-cd94-4f8c-93a2-b3ba0bc074db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c1a6617-222a-46f7-ac01-eb95c65da30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c1a6617-222a-46f7-ac01-eb95c65da30a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d518e95-033e-4f7f-ade6-9e5298e5fb8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d518e95-033e-4f7f-ade6-9e5298e5fb8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2af8b2fd-6f55-46c3-beb6-54ded094c6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2af8b2fd-6f55-46c3-beb6-54ded094c6bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_79c84672-5c11-4814-b44d-3e444b82fe94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_79c84672-5c11-4814-b44d-3e444b82fe94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14fb4423-253a-48f0-be24-cd40a6cd2d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:to="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_45594e26-efad-48c0-880a-008ddcbebe2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_45594e26-efad-48c0-880a-008ddcbebe2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_26006515-e4d3-4eda-b09f-51dffb59173a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:to="loc_us-gaap_RestrictedStockMember_26006515-e4d3-4eda-b09f-51dffb59173a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i501b3682a8f549209b725749fdf61fdb_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4eefcd4-f07e-43d6-a0bf-38c1eb8ac26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4eefcd4-f07e-43d6-a0bf-38c1eb8ac26b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_17622ad1-5122-40f3-8ae0-6f006e6e5646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_17622ad1-5122-40f3-8ae0-6f006e6e5646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:href="lgnd-20200930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_db236442-a947-4ff8-acad-92a662cdb582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_db236442-a947-4ff8-acad-92a662cdb582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_323ba12f-79ab-4139-8b10-a5d1679fe532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_323ba12f-79ab-4139-8b10-a5d1679fe532" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_30c03353-1612-4451-869b-17fcb47d361b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_30c03353-1612-4451-869b-17fcb47d361b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50ea36cc-28c5-4fb5-bcd8-09875cb65a83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50ea36cc-28c5-4fb5-bcd8-09875cb65a83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_9d9f8beb-ff1b-4b28-bba0-278d8473157e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_9d9f8beb-ff1b-4b28-bba0-278d8473157e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_fe51b269-fd8a-4f4a-862f-7a88f85b415c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_fe51b269-fd8a-4f4a-862f-7a88f85b415c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:to="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_55545e6f-b4ce-4476-987f-dee3d16b884b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:to="loc_us-gaap_PlanNameDomain_55545e6f-b4ce-4476-987f-dee3d16b884b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_704d9286-fd91-450c-912b-c21f43dcedc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:to="loc_us-gaap_PlanNameDomain_704d9286-fd91-450c-912b-c21f43dcedc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_dd99b4db-e88e-43ce-90b4-42b13ca90f43" xlink:href="lgnd-20200930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_704d9286-fd91-450c-912b-c21f43dcedc3" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_dd99b4db-e88e-43ce-90b4-42b13ca90f43" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended" id="iad4ed299ebd04ce193bf6a29c0b23ef4_CommitmentandContingenciesLegalProceedings"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CommitmentandContingenciesLegalProceedingsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="extended" id="i3c61613eee2f45bab9706ce97d970e1c_CommitmentandContingenciesLegalProceedingsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_407bef7a-0056-4809-946d-975c6504ab8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_407bef7a-0056-4809-946d-975c6504ab8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_458f41c4-76fb-4bb8-984b-02f8064dbcdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_458f41c4-76fb-4bb8-984b-02f8064dbcdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:to="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:to="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:to="loc_srt_LitigationCaseTypeDomain_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:to="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember_1659663c-cf6d-4af3-933c-a4614b8d6acc" xlink:href="lgnd-20200930.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:to="loc_lgnd_LupinPatentInfringementMember_1659663c-cf6d-4af3-933c-a4614b8d6acc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_4b06cb78-2700-4c40-95c5-9bcdf83bd0e9" xlink:href="lgnd-20200930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_4b06cb78-2700-4c40-95c5-9bcdf83bd0e9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20200930.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended" id="i53acc1854efd4693b3ec00004c717112_Leases"/>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i3d28bab16c944819b267c8f7777377ce_LeasesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSale" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSale"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AssetsHeldforSale" xlink:type="extended" id="i672b1f91df024e1bbe19d5b082c1628d_AssetsHeldforSale"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSaleTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSaleTables"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AssetsHeldforSaleTables" xlink:type="extended" id="ia60a4b9e68d643909eafe2ad378b5b3d_AssetsHeldforSaleTables"/>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSaleSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails" xlink:type="extended" id="i110584d617324589abcb0ecdfd126b94_AssetsHeldforSaleSummaryDetails"/>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEvent" xlink:type="simple" xlink:href="lgnd-20200930.xsd#SubsequentEvent"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SubsequentEvent" xlink:type="extended" id="i988e5bcdf9a748ed9db3907878834cb7_SubsequentEvent"/>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended" id="id8d03c96004d45599831b6b67c1b00c2_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_20290937-3f48-4f41-860e-27fbfb047122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_20290937-3f48-4f41-860e-27fbfb047122" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_6c3124c2-c0f5-47ad-9f69-04139e7885e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_6c3124c2-c0f5-47ad-9f69-04139e7885e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_8d2290e7-ae2f-4860-985b-ee700e31b4af" xlink:href="lgnd-20200930.xsd#lgnd_ExpectedProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_8d2290e7-ae2f-4860-985b-ee700e31b4af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_579a5fd8-f84d-49b9-9a66-49cab3876fc5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_579a5fd8-f84d-49b9-9a66-49cab3876fc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0193b72a-5253-48f2-805f-4e9c1e4f39c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0193b72a-5253-48f2-805f-4e9c1e4f39c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dc130757-4eef-48db-a810-eb80a8ca164a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0193b72a-5253-48f2-805f-4e9c1e4f39c1" xlink:to="loc_us-gaap_SubsequentEventMember_dc130757-4eef-48db-a810-eb80a8ca164a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0bd6a5d3-ba62-4c6f-bac9-6c538407135d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0bd6a5d3-ba62-4c6f-bac9-6c538407135d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a80ca6b-16bb-4f3e-9212-546facd597d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a80ca6b-16bb-4f3e-9212-546facd597d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexIncMember_f6bae57d-94e4-4f3f-bfc5-1a253c63073b" xlink:href="lgnd-20200930.xsd#lgnd_PfenexIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a80ca6b-16bb-4f3e-9212-546facd597d8" xlink:to="loc_lgnd_PfenexIncMember_f6bae57d-94e4-4f3f-bfc5-1a253c63073b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e32af219-75a8-450f-9db2-ab04f99097b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e32af219-75a8-450f-9db2-ab04f99097b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75bd7b15-9b54-40c5-b4ae-d26cf28839a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75bd7b15-9b54-40c5-b4ae-d26cf28839a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VernalisMember_6894fdab-5656-4df5-8326-cd3bbe1645e5" xlink:href="lgnd-20200930.xsd#lgnd_VernalisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75bd7b15-9b54-40c5-b4ae-d26cf28839a8" xlink:to="loc_lgnd_VernalisMember_6894fdab-5656-4df5-8326-cd3bbe1645e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_87e8bdec-06b9-4914-aa23-d4b9e5fdc9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_87e8bdec-06b9-4914-aa23-d4b9e5fdc9c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d8fc4a05-385c-4aef-8e72-f68f1cc50934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_87e8bdec-06b9-4914-aa23-d4b9e5fdc9c1" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d8fc4a05-385c-4aef-8e72-f68f1cc50934" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>lgnd-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:015c58ab-d6da-4197-b1ca-2564dd0b9f53,g:8a625853-6817-482c-9ef8-59dc8bbafc23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d17b261c-8dcf-47fe-a87d-4c5d40f60d34_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_e4fc4cd3-d60e-4564-b618-6d84af506f35_terseLabel_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate for forecasted cash flows (as a percent)</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_label_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:label id="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_documentation_en-US" xlink:label="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecasted Cash Flows, Effective Interest Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:href="lgnd-20200930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:to="lab_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_77d3841d-5cce-4ba4-8766-3438602a58e0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember_906f1a2e-7d76-4c27-b4d3-2c7d89707e61_terseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Crystal contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember_label_en-US" xlink:label="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" xlink:to="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9bb28325-e294-47cb-95fc-dc78c7794226_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_82c4fec5-1701-4160-b02c-a751a338f063_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_b5d860ae-1ecb-4158-8017-25f09de45041_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_528a10af-5379-4ca1-b72f-0f3df16fbc8d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4cc6b94b-ac13-48ae-9b62-5b56965a6de3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_da4d9bd4-5521-4ca6-82ec-94ebd84f5ea8_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability acquired in connection with the acquired intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_94d8d1be-089e-4fac-8bb4-c90f1f5d62fa_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patents allegedly infringed upon</link:label>
    <link:label id="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_label_en-US" xlink:label="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Patents Allegedly Infringed upon, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:to="lab_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_97d88b82-adc3-4509-b2f8-39577a03f7d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_46b00410-8bd0-49f2-a4f7-facaf5cffd7c_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_21a995e7-29d9-476e-a98f-4b8940673e54_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_57c32267-e8f9-43f0-99f9-f7bbad56c29e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_22d9e0ad-6307-4213-921f-f736ffc603ef_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_1487313c-c409-46a3-86a2-73060b4da035_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_6416a8a0-c32f-4958-bca1-0306cc1f87a0_negatedLabel_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_label_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Accumulated Gross Unrealized Loss</link:label>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_documentation_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Accumulated Gross Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" xlink:to="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_350ac19c-3150-47e7-afdb-249f0fa5dd44_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_83fc30b2-5f27-4c0e-863c-79827aace18b_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_95091c13-17e9-4242-9a91-62e402a14bae_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5e081d8-2434-4594-ba1f-cab069527416_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_00137f50-adfe-45d4-aa54-d5f8fbf692d9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_bc28a121-fc19-4161-9ffe-ee375e080a25_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_85a27c39-e413-4107-8860-041bde92da3a_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid in capital, equity component of convertible debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4d0b0e2a-2684-47fe-bdc4-f868e2c5f65f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f135b1fd-c6fb-4e9f-9c5f-5ed937378f81_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_557366a0-8ea2-4804-9f03-c024a57ee2d7_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_e63561d0-30b0-4811-aa38-04f7fd678674_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ef9e10ea-0ac7-47d0-9410-59e91fb19aa1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3b000380-f071-459c-90dd-d45f951a077c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_35b503ae-cba8-45b3-84b3-4360a1c0aae3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_f8b37cd8-1e1e-459b-b9e3-ae9ab906dc3b_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6dbbcf61-8a21-4ccc-ad70-efb14dc0e4cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_070cf649-5795-4f07-9af7-33104c77a686_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_68cf699f-d3b1-40b3-b72a-503585136ab7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b3dd4f92-ae22-46ea-8c13-a6fec2d17ccd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_19c91862-6a99-4c32-9d4b-64d570970764_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a33d5595-2f3b-4bce-b2c5-a6f5e1d5034b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_eb52a605-2b00-4026-b264-589a51d415c1_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_16bf6352-7f00-442a-876c-1805a64e4365_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_ffc73db6-b18b-4b40-ad7a-15c20a1a69cc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_02529b06-13a9-4fc3-9926-a03d153a1dba_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_40e73fea-a0a0-4389-9139-84336267ceb1_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ecb17d17-6982-4f38-aec2-c78baf47709e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e4b4fe04-fd1e-4d11-ba60-8c406a3fed90_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0659db1e-adac-4dee-ba43-e4a018b3958d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_9e65073f-8de7-406c-9074-610e2b102723_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1af7bd3a-262f-4828-a0ed-15d526383b6b_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c0bc741e-3274-4cbb-aecd-a23394bb6d32_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_6fa817bf-af3a-47be-87a3-c4c83b29b63c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_5fd03650-42e3-44ef-8a7d-6e1a3174aac9_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2549650d-2056-46ae-94f2-ed6ad8b6be6f_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CollaborationArrangementRoyaltyRate_5753ebd4-2959-4270-b9c0-447314859051_terseLabel_en-US" xlink:label="lab_lgnd_CollaborationArrangementRoyaltyRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty rate (as a percent)</link:label>
    <link:label id="lab_lgnd_CollaborationArrangementRoyaltyRate_label_en-US" xlink:label="lab_lgnd_CollaborationArrangementRoyaltyRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Royalty Rate</link:label>
    <link:label id="lab_lgnd_CollaborationArrangementRoyaltyRate_documentation_en-US" xlink:label="lab_lgnd_CollaborationArrangementRoyaltyRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Royalty Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CollaborationArrangementRoyaltyRate" xlink:href="lgnd-20200930.xsd#lgnd_CollaborationArrangementRoyaltyRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CollaborationArrangementRoyaltyRate" xlink:to="lab_lgnd_CollaborationArrangementRoyaltyRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b7907856-de9a-41f8-bc8e-35e1bb78a8f6_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average estimated useful life of finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_1e0cc324-f637-473f-9619-a64746fb089a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ab9e3e0f-d273-4a34-b43f-ad19dfddb37b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1e0c52a6-42dd-49c7-8262-a6d6d298090f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_ff2775fb-2db2-4090-b49b-3fabeae73839_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_acbb0eac-9787-45cf-91b7-bdb2f2dfdcba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_90b4e2fc-3e49-4156-96cb-5dd09081c091_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible assets acquired</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b53240c4-a98f-4bba-9885-267ad9e6faf8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_85aef239-bdb5-4886-85b5-05a7eadc03ec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_29d38fdd-a7ed-4078-b18a-c94fdcaf7146_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of contingent earn-out payment</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_6c5c7397-dcb0-4f10-802c-5c3e4eba7d5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_96f81ca2-b996-4482-8806-398d33ebffe3_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5c2438bc-8f36-454b-8271-02e6c0ad6cdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2a4fc554-ea4b-4335-a971-7d4e8aa71415_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShortTermInvestmentsFairValueDisclosure_65782417-766a-4c58-8777-f4563d95a6bd_terseLabel_en-US" xlink:label="lab_lgnd_ShortTermInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments, excluding Viking</link:label>
    <link:label id="lab_lgnd_ShortTermInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_ShortTermInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_ShortTermInvestmentsFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_ShortTermInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShortTermInvestmentsFairValueDisclosure" xlink:href="lgnd-20200930.xsd#lgnd_ShortTermInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShortTermInvestmentsFairValueDisclosure" xlink:to="lab_lgnd_ShortTermInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_e6216b9b-5f08-4b5c-b358-9cba60c09ae7_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20200930.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_4970dfad-a9d0-4678-a138-c81a4d15df47_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_f66a673a-9cd2-4083-80ee-3fd65227f170_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d5b6b623-6596-43fb-8476-d20370e0722f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_cd2b6627-54ff-4124-8b2b-f8844d90c23d_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_a4b19802-4030-43a0-80af-6fbd0e0a47bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8022c1af-95f1-43c6-abe7-f454bb872867_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_2b9b344d-fdbd-4916-b111-cd8dfdb2a464_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12c733c8-498a-45ea-8900-1c18eea82df9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_27c85eaf-d7c5-4fb1-8126-d7cd9cb6d4ef_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_74dcd51e-e9db-4ab2-bbe5-e07182a7a1ab_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInOtherEconomicRights_0a4cd3b3-8d75-4c5a-8b2f-12ff15a103e8_negatedTerseLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInOtherEconomicRights" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other economic rights</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Economic Rights</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInOtherEconomicRights" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInOtherEconomicRights" xlink:to="lab_lgnd_IncreaseDecreaseInOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_be47aef7-71d0-42fe-aae1-9ae8e7421575_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_1f4b904e-6f21-4960-9062-d1ae8de67a8d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_66c70131-2f20-4a6e-a0e8-e688de2770ac_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20200930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_e3d713be-17b4-4dca-9a9f-3a5b205c5abc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_a209bde8-f961-43af-8e36-011d622b7d71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5dd40547-b005-4103-82ad-f5fc62c28850_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_04fced87-4eb4-409e-8fce-9673ee356ef3_terseLabel_en-US" xlink:label="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected proceeds from divestiture of business</link:label>
    <link:label id="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_documentation_en-US" xlink:label="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExpectedProceedsFromDivestitureOfBusinesses" xlink:href="lgnd-20200930.xsd#lgnd_ExpectedProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ExpectedProceedsFromDivestitureOfBusinesses" xlink:to="lab_lgnd_ExpectedProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_73e1556c-4429-48b8-bec7-f32bc591f245_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20200930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_af9bdd44-3819-42e5-8ed0-20fb49131c0a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0e24afab-8a99-490b-b329-9a5473da0e82_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fb03aaeb-9635-422d-8e64-271eaa0c79a4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of computation of basic and diluted net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_ecc95898-4714-40e5-806a-36d100b9f089_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_97dfac8b-b563-462f-983b-ebb1addb9254_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_26e49a46-9a74-460f-8da4-77989a1a2419_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bffd07e4-0f93-45b6-8370-9f11a004bdb6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_2e20b866-ce99-4625-b36c-89b058fea0a9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_c62e473d-e369-4c0f-bb0b-895b1dfe4b47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_352d00ad-1140-4cca-9386-e19d3991cc97_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_47d0f249-3322-472c-b183-f068d7016062_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20200930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d7516f02-8209-4c59-9256-1729a158f770_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_b8ab5b33-6726-4495-9289-2f47e5b036c4_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right for Internal Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:href="lgnd-20200930.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:to="lab_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_8755e00c-588e-4276-b0bd-8fea164aca94_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_91723e8b-6e5f-43c5-b804-40fb3c1a3da7_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_4fe87e31-4333-4a35-8097-c284a3a8a265_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20200930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c2801b70-8a7f-4c54-b7a0-6972a590218d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_d4888c82-77fb-43b1-bd6d-18cb4014ce07_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ff1f3f0-a67f-4297-be55-5b8a6a23f16d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_6e473ae6-ba4b-44af-86b0-6191d9189eb9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_9145e9c6-2db9-42b1-a29c-c45789b70c6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_021eab41-6801-4788-bae3-27c3dce5f083_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f10539aa-01b2-4d8d-a6cd-b74a4b2d7471_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_00fac696-ddae-49a2-8010-5336303bb740_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_52a3d506-bd9c-4438-98e5-c4ae7b473a47_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_81f28caf-5a42-4806-99c2-8cdab1d15ad8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cd803fec-da61-40d3-8b82-04ceed7b77b3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_dc8a41c8-7574-40ab-96af-bbcad3c2fb4d_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_af88e96a-854b-40bb-b5c4-e169371586ed_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20200930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5792aaa4-aa52-4516-80c5-6534cdcd57f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in ) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_7adf9ef2-9e10-4556-84f6-f6cce8891ea4_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoMember_27237e7a-f22e-4651-b57b-3bdc693f3516_terseLabel_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo</link:label>
    <link:label id="lab_lgnd_AziyoMember_label_en-US" xlink:label="lab_lgnd_AziyoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AziyoMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember" xlink:href="lgnd-20200930.xsd#lgnd_AziyoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoMember" xlink:to="lab_lgnd_AziyoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_b86fbbb7-e326-4cec-864c-dcaa83999142_terseLabel_en-US" xlink:label="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen contingent liabilities</link:label>
    <link:label id="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_label_en-US" xlink:label="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LongTermPortionofLiabilityForContingentValueRightsCompanyIcagen [Member]</link:label>
    <link:label id="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_documentation_en-US" xlink:label="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LongTermPortionofLiabilityForContingentValueRightsCompanyIcagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" xlink:href="lgnd-20200930.xsd#lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" xlink:to="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8a403cde-e5d5-407d-8668-4a78fb36cdeb_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dade3fb8-2176-417e-bb16-aae5e90e4eaa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_b40833eb-fce4-49a0-85e8-618d1c33982f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_966f6618-3c57-42d8-88c5-b775b58b39fa_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_22e6525d-3ce7-4de8-b4f0-1bbfe0d403a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember_372285de-ce7f-4618-84e1-3517456dfac0_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_00a0f175-5be9-4840-b083-3d4d98f77f67_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_586a385e-8966-4ad2-905c-39bcac147af4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember_1e2edce6-77ee-47fb-a50b-5af29037c04a_terseLabel_en-US" xlink:label="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis contingent liabilities</link:label>
    <link:label id="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20200930.xsd#lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedLeasePurchases_53b4c247-0619-4a8e-9582-7d11552a6ad0_terseLabel_en-US" xlink:label="lab_lgnd_AccruedLeasePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued financing lease payment</link:label>
    <link:label id="lab_lgnd_AccruedLeasePurchases_label_en-US" xlink:label="lab_lgnd_AccruedLeasePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Lease Purchases</link:label>
    <link:label id="lab_lgnd_AccruedLeasePurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedLeasePurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Lease Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedLeasePurchases" xlink:href="lgnd-20200930.xsd#lgnd_AccruedLeasePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedLeasePurchases" xlink:to="lab_lgnd_AccruedLeasePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_72952a4a-4737-4bbc-8167-7bdcf7678c0e_terseLabel_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_label_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Accumulated Gross Unrealized Gain</link:label>
    <link:label id="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_documentation_en-US" xlink:label="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Accumulated Gross Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" xlink:to="lab_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4db31a8e-a566-4ed5-9663-26bc92fd472c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_847dbf0c-4d8a-4042-908f-a5c3ea699447_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3c3b2a26-bb53-4d84-8cbb-85317427e670_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_ce56f12b-7fbc-4cfd-b410-fdcb63ed8ba1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_e15499da-258b-4c08-96bd-e6c3b7e8a3ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5d1a96d0-0e8a-4100-a33f-239a82628bb0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5c7e5287-9183-4c23-b76d-f8ef1d5e1f4d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_f25b8562-24d1-494c-a7d7-3082751ffa2d_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20200930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_df1a37fd-7f6b-4075-86ea-80b826805e62_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_33d55988-8d24-4225-af8a-5e8a345d1850_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20200930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3de2a520-2f37-40c6-ba6a-9d3ae21039fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_72248dbd-b8cd-47e3-b6a2-150eb7e0746a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_49b7219a-5c02-4b64-b3f0-2ee79baf7a3c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_8df9d28f-d79c-431a-9639-2374223c3d87_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate used to value intangible assets acquired (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_label_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:label id="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:to="lab_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_c5f90cda-e8eb-4446-aa0e-7b409fdeddbc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e2b663f7-cd9c-429f-9bf4-47579383dcd2_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_dc5be434-375e-4dbc-9cf5-6afcf4ea44f9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_6ed17e4b-4e82-4c94-9401-2f3fd919729b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PalvellaMember_52065cef-037b-426e-b33c-3719e813d1f6_terseLabel_en-US" xlink:label="lab_lgnd_PalvellaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palvella</link:label>
    <link:label id="lab_lgnd_PalvellaMember_label_en-US" xlink:label="lab_lgnd_PalvellaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palvella [Member]</link:label>
    <link:label id="lab_lgnd_PalvellaMember_documentation_en-US" xlink:label="lab_lgnd_PalvellaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Palvella</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaMember" xlink:href="lgnd-20200930.xsd#lgnd_PalvellaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PalvellaMember" xlink:to="lab_lgnd_PalvellaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bf544d37-278e-49a8-b182-117ce2f3a4cc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3758983c-2fb7-49ee-b12a-9ac5a7e75f02_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_d0f11263-2dac-47f4-893a-161d87bc4a1e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_099e7a85-5a67-4d87-af62-df9a1a9bb9cc_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_5b366bb1-e9ef-4b0b-a240-f195bc714a09_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_9bf87e00-4f3d-49ae-b9c5-5f5d968091a7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_4c613d27-29dc-463b-9664-27a5366bd068_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_30fd9fed-7710-4cb7-ad78-10b205935248_totalLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c8bc9a71-5bb4-4cd8-a1b5-7a5e8ca76bff_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PromactaMember_aae19bae-22b7-4419-bc3e-a4e622636cb6_terseLabel_en-US" xlink:label="lab_lgnd_PromactaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promacta</link:label>
    <link:label id="lab_lgnd_PromactaMember_label_en-US" xlink:label="lab_lgnd_PromactaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promacta [Member]</link:label>
    <link:label id="lab_lgnd_PromactaMember_documentation_en-US" xlink:label="lab_lgnd_PromactaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promacta</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PromactaMember" xlink:href="lgnd-20200930.xsd#lgnd_PromactaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PromactaMember" xlink:to="lab_lgnd_PromactaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_ce673e82-5a65-4870-af08-b74e5ca6ab16_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_ff1752ee-4afe-4b82-b289-131118e717fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_7b17df57-9380-4925-832d-eba71884f8f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_52703644-8357-4394-8bdf-d4d3c465c776_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_abd14f78-667f-43e8-8d8c-29190f394a75_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_7a30e019-5abd-42c9-a8be-79fa23feffae_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4fc20712-df84-49d3-bfef-da8b8df9e9ea_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_774f088f-9f01-435c-86ca-94092b5d8ac5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_c3f6f5b1-5477-4c7d-bc96-9e80c01b78c7_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_62254c0b-5b9b-4b73-9b62-7717c499d787_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_98ca057b-0b0a-4604-9902-e44961312e24_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_5829ad5f-6ac5-4fc3-bff2-c2de791d7bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_ac18441e-f4ae-40b4-a6c1-72f1f7ef8f11_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d2aae7c1-4fa5-4d91-82ad-fa08b35126d2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from milestone method revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1a3e3ad1-5055-4499-97e3-88a5ff6073bd_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RampUpFeeAssetNoncurrent_3256105d-8e7a-41aa-810b-e7f76ee18de5_terseLabel_en-US" xlink:label="lab_lgnd_RampUpFeeAssetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol manufacturing ramp up fee</link:label>
    <link:label id="lab_lgnd_RampUpFeeAssetNoncurrent_label_en-US" xlink:label="lab_lgnd_RampUpFeeAssetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramp-up Fee Asset, Noncurrent</link:label>
    <link:label id="lab_lgnd_RampUpFeeAssetNoncurrent_documentation_en-US" xlink:label="lab_lgnd_RampUpFeeAssetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramp-up Fee Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RampUpFeeAssetNoncurrent" xlink:href="lgnd-20200930.xsd#lgnd_RampUpFeeAssetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RampUpFeeAssetNoncurrent" xlink:to="lab_lgnd_RampUpFeeAssetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_98d678c0-76e0-4d5c-b649-d0f9e1141f02_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_90d25667-1ec6-4fee-b9d0-7b65bf7de81e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_16d31007-7f77-4609-bb1c-3f14e22764c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_603e0bcd-1b53-41ef-bf09-605fd33266c9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_8c8aab80-209d-4841-8208-e15e67c8617a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbcabb9c-7b22-480e-8c17-44722948e741_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a40efc67-7677-47f1-bff8-0fa65177acd7_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_20bb6b65-43f4-4b4f-a091-e1de28750900_terseLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Amortized Cost</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_904bae2c-acb0-408c-80be-c9cceb92cc75_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4cdec83b-6807-4071-803f-d2ed38185bba_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_07b14ed9-110d-4484-816c-39b3c04f249e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_56e16c47-95fb-48a5-8587-b572824e7a47_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_6ee32ed4-f29d-404d-ad31-2173d2d68045_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_5881e51e-97b8-4e0d-8b1b-22dc1592a3b0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_ad3dc8fe-cb35-44db-bf8b-5723fb1e83eb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_99ece2d4-cd43-4dc2-a7e6-0eaa93f8a5c6_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_2520b5f7-cd3d-44bc-a6ac-e91a8462a89c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_845c4cce-ee52-43d1-a690-f4f8dff16d6a_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_fb4cf67c-ca6c-4e03-b51e-5b7c28b6b7bd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_afefce81-bd51-47a6-9960-e0d1df6a48b4_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7250f3a8-f181-4883-a0ba-2edef978b4a3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e081e6dd-fae6-4973-8679-37bb7887228e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_a6a968cc-9d09-4524-9c71-e5d1e3cb8ef6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract" xlink:to="lab_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cc945a63-8509-4462-a60b-5b502e546e53_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_a375037c-0886-40d3-9732-62ba69df7cbc_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_ea66545c-fde8-4b95-a1b9-ee38575a29c1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_4063a606-85ee-47f4-b554-cb07ba7d4c84_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_7975d600-327c-46ea-bc5f-26f61e9388aa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2749d902-8d7e-4cb6-8e18-3dcad3890399_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_993c3c54-8968-482a-9881-f680ae44e1d5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_74b36bd4-0456-464f-a2cf-397947b4fa94_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications and Prior Period Immaterial Error</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_f1c67115-aa56-4592-9201-dcac3dc4099a_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_31256463-66c7-4e0f-85ef-1de5783579ca_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6c8424c4-3427-45b3-b4ab-ead222948e82_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_7be8dcf6-8597-4376-a296-501fadae6830_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20200930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_23398210-d75b-4270-a969-4360c94012e2_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_9b7c3837-2a51-4b69-bcff-bd51f9a4d11f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestonePaymentsMember_578c87b8-a37b-433b-aff5-b159eeb4f556_terseLabel_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_label_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments [Member]</link:label>
    <link:label id="lab_lgnd_MilestonePaymentsMember_documentation_en-US" xlink:label="lab_lgnd_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember" xlink:href="lgnd-20200930.xsd#lgnd_MilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestonePaymentsMember" xlink:to="lab_lgnd_MilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_4a8d5f0b-5f52-4d17-a876-9334f1b82423_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20200930.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_f6052c24-29f0-4c1d-84fd-2ae79519c1c6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_ad771a11-bbbf-41fa-84d9-c385dda6dc02_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20200930.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_544cf7ff-6f08-483f-8f05-213b3495bdf6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_679a8155-6b28-4e9a-8956-36fe75d27b13_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_28a23425-dfed-4d7e-b269-0e54d4af9635_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_06416aef-9e59-4b01-98e4-74b7dd98c5d8_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of Promacta license</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_557ea2f3-bf83-420f-899c-9f4c6be5e323_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_862c049a-67d9-4fa9-b134-666b5b5625a4_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_4f4aab60-95b4-47ea-ad96-caa5641e8e74_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_96b45e5e-3b26-431c-ab15-b95dcfd042b8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_8f698789-db20-4e21-8db3-a0e842abbac1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_45035f9e-7eca-45ad-97aa-0680e38aabbc_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_758de12a-e2ce-4005-b5b7-6cd8f2d5715a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1956295f-cd22-4774-b96c-5364bddcbc38_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_a0148c3c-fa04-42de-b031-ee461543f41b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_1c3eb032-23d0-4fb9-ab73-7769543fe1ae_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportion of milestone payments (as a percent)</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_e6f95761-6fb9-45f2-8211-c1ff0635c1de_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_cb95c896-c352-4616-88e0-7f7d2dc021be_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_f0ed52e5-dda7-436c-b84c-31742ea9bde2_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_66eee1ca-bf2a-4a85-8680-5c6cda222797_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9370d012-3eb2-49aa-b3e3-6a32eed5636d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_7665e2d2-9019-4f24-b6d7-6d0aa4dc553d_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d6aa2500-c221-490d-8d60-90c7a401999c_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_da7e764a-9f9c-4a5a-b2f7-46c5029979df_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_31b25e55-27f2-4ca6-8b35-e7aa476b070e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_ccaaee25-7ed9-4eb5-b65c-2ecc2cd6ce3f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8445a359-1b64-47c5-a332-d39de65ffbfd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_1faa34a2-83c9-48b5-8ca3-c9b00196e5ce_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ba1ecfa4-8acd-45a3-8ac1-351a94e8a4e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_dc44e95d-2b39-479d-8e74-cca0370687ee_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_258df06e-9b47-4f5a-b70a-26eb7bda44e6_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20200930.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_37953fe1-26ec-4d52-895e-1e086dad2774_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3ffd61f8-54c9-4b9a-990b-08490da36321_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_09f66bac-ee72-4c14-9970-212da5bc9490_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract_d2a12bf4-ba02-4e7d-b38f-bd98c0d3445c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_083d0aa4-9701-448b-9fb6-099061c9b1f7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_b0786dd1-3c29-4690-9b6f-718422e06b35_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_681bbea0-3121-4133-b211-10ed8e98a6a4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_72df0e0b-b1e4-4212-9eb5-7158ad98dc6b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_d2e9fc8e-e8d3-4fa4-adc8-9b8f71bb13b9_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_cae699cd-8afb-4e6b-8998-6df55bb84c03_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_8b6506f6-9278-40ff-aa14-a8e9aba67ad3_netLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_17ab3f7f-0ccf-414d-8828-4d5ebb1a8857_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_5fb86c28-9db8-47bd-8a99-77b0c603df2b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in warrants</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_b09bea9c-f9c5-4057-818a-bfeaef03fb25_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements</link:label>
    <link:label id="lab_us-gaap_RoyaltyAgreementsMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyAgreementsMember" xlink:to="lab_us-gaap_RoyaltyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AbInitioBiotherapeuticsIncMember_ab378255-41b6-43cf-8057-14ba8758a248_terseLabel_en-US" xlink:label="lab_lgnd_AbInitioBiotherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ab Initio</link:label>
    <link:label id="lab_lgnd_AbInitioBiotherapeuticsIncMember_label_en-US" xlink:label="lab_lgnd_AbInitioBiotherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ab Initio Biotherapeutics, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_AbInitioBiotherapeuticsIncMember_documentation_en-US" xlink:label="lab_lgnd_AbInitioBiotherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ab Initio Biotherapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AbInitioBiotherapeuticsIncMember" xlink:href="lgnd-20200930.xsd#lgnd_AbInitioBiotherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AbInitioBiotherapeuticsIncMember" xlink:to="lab_lgnd_AbInitioBiotherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fa8497d2-f6fc-4f99-87b9-0df0f5d34fdb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_10498830-cd11-4e06-98a4-135cfcb830b2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_71497e9f-a02c-48af-868d-132ac8d89cdc_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_4ada9886-d38e-46a4-974a-1c3b64f6acec_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_3f77bfca-0708-4cc2-8392-a447140d8316_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_e4cc946d-e169-482d-b58f-717b2a549e4b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking Therapeutics, Inc.</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_077dde1e-329b-4278-ac6b-2ba8f42c85c9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_59aab299-5323-490d-81a6-ae26b10f0183_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_be6a0252-b39c-467f-b007-cf462401e230_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_e06558b1-7029-46e0-8540-ecd4c3201e8f_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b4a52147-65e5-4d2c-9a10-c38e84d7fabc_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium (discount) on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2aec48ee-9844-41e3-b00b-572bd25779ee_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1db0f21c-63fe-4fd2-b41a-3d5ebe7a852c_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1248ce1d-6472-46d6-96af-cdf1dd64f134_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_35f5081d-2dee-46b2-8431-eee110480b6b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dbfd0c6b-7334-4038-981f-7b8c689737ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e07c26ca-a6f4-48fb-9882-8f4e9bbc254f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_895ae364-1ce7-47f6-8275-6a95369b0fae_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_08c6e933-05d9-49bc-a506-cadb4c29bdca_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_5545366c-ee67-4115-8d36-71bf05cdbc17_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1c38dcc9-2020-4cd5-94aa-72d010a6e96d_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_76b644be-44e6-4dca-a67e-e490b61c5975_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_c6b7c2e6-45a1-45d9-aabc-0958c5c5b230_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4cbb69b3-6678-4701-a799-613f28c4f5c7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_60c3937b-7bd0-4f70-b2f9-377ea7b2daae_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_d142a6f7-bd8b-4b61-97a8-224000dc28b4_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20200930.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_a7bf22b5-de07-4b47-bb06-ad728755d4e7_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license and other economic rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommercialLicenseRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_dad95941-6ffc-4f52-beb2-a0f747e512e0_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20200930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_e177e530-50f6-415c-ab58-c61f8fe148a9_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20200930.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_06e11126-b629-4a04-9cd9-df609fd3a70b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1050b669-8a1c-476e-a732-900f8d577ceb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_f95427c9-1bfa-44b5-b262-9d452c85185b_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_95cb3e49-058e-4d76-a04c-d7f0a95dc5f3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_c3600fcc-6ca1-479f-8699-615b82be6b34_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cf1e28fb-cb57-4d35-8c46-28691db2ba30_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cbe1e1f2-8d89-415e-8ff8-51852943bff0_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_85d52cea-9d4f-4cff-9742-43bbe41ccb0d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_7a894bb5-d87f-46e4-9ab3-49103a0c043f_terseLabel_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement</link:label>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_label_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement [Member]</link:label>
    <link:label id="lab_lgnd_LupinPatentInfringementMember_documentation_en-US" xlink:label="lab_lgnd_LupinPatentInfringementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lupin Patent Infringement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember" xlink:href="lgnd-20200930.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LupinPatentInfringementMember" xlink:to="lab_lgnd_LupinPatentInfringementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_fcb5200c-96bc-4d6d-9f7c-a4f4e8565105_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of related party debt</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders and Other Contingency Payments, Investing Activities</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders and Other Contingency Payments, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_71011b8a-0b06-4589-84a1-26492ae6044e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_f591dbec-27aa-4c1a-9997-cfc78fa00e92_terseLabel_en-US" xlink:label="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities related to assets held for sale</link:label>
    <link:label id="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_label_en-US" xlink:label="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Related to Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:label id="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_documentation_en-US" xlink:label="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Related to Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:href="lgnd-20200930.xsd#lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="lab_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1998ecc3-eb42-44af-938b-be78a49f9cd4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_c977f54c-d972-4150-bf6e-e3bce34610d8_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:href="lgnd-20200930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_c813b270-69a3-40d6-91ae-cf17bf9e645d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_fa2cb3dd-3991-4984-9587-d3d31c01a1f8_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20200930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_7aa1874d-cea5-4b9d-9513-73a11de16f36_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_19a5ff5b-b860-4b64-8a65-8abfc5efff30_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_60a9c9a3-c4f0-42eb-8957-610d2ede8978_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_3e9d3c90-7642-437e-8463-1017afae0de8_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_330f2e64-b3c3-45a9-a077-a57cef3d4c0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash holdback for potential indemnification claims</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Indemnification Assets, Amount as of Acquisition Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:to="lab_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_29d8119a-a259-4181-964d-d7541941996f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_78b8b54f-dbea-4ef6-98ed-19d69f2bcdaa_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b5f1e767-af1d-4af3-a0d0-0182d8201b79_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_de1afaaa-adc7-470a-bdf2-4420b335a907_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_091d7d44-f3ef-44de-869d-d7e9608c659c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_c1f22f22-bf03-469b-a5fb-5af9fc5351ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_5d0f3f09-3c1d-489a-be83-c5d95b4d7fbf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other tax adjustments</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_66edc821-55fd-4d0d-a966-f023d0b23ae0_verboseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20200930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_a5dafa71-f665-4ad0-899e-e6d1b259998f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_91d6cf95-0606-4246-bc30-aed81ef23904_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_e8aca18e-c4b5-4ced-9145-c72934f597a3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_0f62da8a-aacf-4947-9a05-6c6ae35c1d41_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20200930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_910f1295-db08-4e0f-8af5-5848ba4d6dae_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d9e7ee8b-990a-44cf-9d65-e2a186af4c0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_93a789ca-2653-4251-93d8-9f55a7b40cc0_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional allowance for credit losses recorded related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20200930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e29e26ce-8933-4986-8867-c66f23358e4c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentLiabilitiesFairValueDisclosure_4d6b2bbd-ec95-4430-ae17-8dd660f3f5a0_terseLabel_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_lgnd_ContingentLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_ContingentLiabilitiesFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesFairValueDisclosure" xlink:href="lgnd-20200930.xsd#lgnd_ContingentLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentLiabilitiesFairValueDisclosure" xlink:to="lab_lgnd_ContingentLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_1724e23d-8cf5-4142-a912-b5a8cde08ddb_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_683c5433-660e-4345-820a-a4dd46836b44_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b86cdd14-982e-45ab-a54a-a912e8dfcf48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_6c06ffc0-23b7-4467-adfa-374b8b72c5ef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of Promacta license</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_9bd460b2-8efd-4d9f-9947-e8c3794e44c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a76ea36d-b2b1-4fc4-9cc7-6fcedf939652_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or greater</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_16f81914-f154-44df-ae2e-a4b875b2250a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_338160e9-5d18-48a3-b7a9-8c851051340b_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_bbd0d909-29db-4ecb-b893-469fca3bfa19_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3ed9ad88-9c53-4d76-b8a1-ca67bf478f0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_29c4800f-e647-49e9-94c0-102a898b74af_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20200930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_04622d48-0b54-4039-84ee-d549f633f934_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for bond conversion</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d5238ccd-d2cd-4dbb-92fe-1a88225cc56d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_576b6467-c289-4382-b42c-2ed56f17cba5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3f606ddb-f0e8-4b0a-87b8-654443096692_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PfenexIncMember_3d1cc223-1132-4a58-969d-87911719f6d5_terseLabel_en-US" xlink:label="lab_lgnd_PfenexIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex Inc.</link:label>
    <link:label id="lab_lgnd_PfenexIncMember_label_en-US" xlink:label="lab_lgnd_PfenexIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex Inc. [Member]</link:label>
    <link:label id="lab_lgnd_PfenexIncMember_documentation_en-US" xlink:label="lab_lgnd_PfenexIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexIncMember" xlink:href="lgnd-20200930.xsd#lgnd_PfenexIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexIncMember" xlink:to="lab_lgnd_PfenexIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_fbecc7db-3741-4a4d-9fba-720c40abe7b3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_8bc77f3a-e24f-4d5d-94f8-8d7c2d0ef525_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_177e5c64-032a-4ef9-b74c-da269aab2e59_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20200930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_aad286a4-a8b7-42e5-aca5-e0b80a2487dc_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_5cb3dc7f-f542-43e0-9339-4ecb6825483b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_3eda63eb-4d6b-4116-aee4-09ca7767f020_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_5c1866ca-ae8b-41ad-a3c2-b4a8c9116705_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_da954951-850a-4235-b87a-04db523f8f96_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_30c1294d-819c-4a30-9168-02206556baea_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_c33bf838-2d10-4fc5-9834-4dd924c2ab8b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_c8c9ef8b-25b9-4c08-a1f6-8f5830d20d3f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4b18fd4f-76db-44f0-8e6e-72ffa356abfc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_f3ec3a42-0780-4579-9cb1-96b410b594e1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_9ca25861-4df7-4b07-a596-15f829bb1255_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_998ec84f-e508-44f7-8020-c642d55aaf76_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_8c1cc7fb-f988-4681-a83a-2b2dc0f9c4ad_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_8a828a3f-aa11-4cb7-bdd0-68ea4ddcb461_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_8684b218-e904-4a09-b6b5-4544e3f6778e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_91149ce7-b4e3-4bf3-b62d-f81e6c959020_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e94fbbf7-fef4-47b2-9d70-abc8f1859ac8_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_bbadd148-24f6-4900-b148-c7dd4a74061a_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_acbc6fdd-d6e2-4c3d-94b8-a6ea9ac97cbe_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_5e72b7d5-d121-41f5-ab78-20f904cc1d61_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b75fac56-9411-41cd-887f-9b6c3ec4913d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1b4f2f97-5afb-4daf-9b1a-edec8edc8ba8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_08d249c5-8c65-4ab5-8e9e-22e3d03546eb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c6de7659-4807-4575-a2a7-4c4aff92cce2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_c57c3beb-dd14-48e9-b880-8276cb8626ad_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_228181cb-4a6c-4687-b145-3b2971185fd2_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI, Amortized Cost</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_e9d719ed-711b-426f-9b93-e947b44bda03_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_7a56cf95-562b-4fda-8a51-3c2bc99074c6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_03384465-eecc-46ae-9a4d-025277a34798_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_bd4e700c-b2cb-420f-b0ed-469ab33ab5a3_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase/ Repayment of Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_38103e3d-cb4e-4f0b-b99d-beaaa448beda_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant derivative in connection with Notes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_06bea6c0-7e76-42ce-9ecc-959c74339a94_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9048d744-5ead-48f6-98e1-7d6cc17db612_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_df838cd0-dca8-4d51-aad3-c2c6ce4ca882_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_840320fb-bc71-4306-81ca-0f83b0752ba1_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a02c387d-5829-4405-b1e8-8d3b61067d41_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,091 and 16,823 shares issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_589305c9-bfcf-47b8-9f46-c874a52980d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5c3d3419-a88b-417e-b515-84a04f710680_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2f6aad39-1591-48ef-9a97-a990f9a8b275_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_de5615f6-60cd-49c5-8a49-7ab1ad81ce87_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_2d943208-a08a-4774-bfd0-73a355ce6585_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20200930.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_6e3df669-5217-420b-89b7-aa2091a1f062_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_f1b8b8c2-089e-42df-8857-c20bc609b614_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_e1952df4-ee2f-4e2a-9b54-e712c963914f_negatedTotalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_0452cf8f-2995-4d8a-9ce8-fe9d46583ea0_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20200930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_fdab9583-713d-4a1d-92ef-c6305c0d38bc_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_2021e578-596a-4582-ad65-f215e513fc3d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_ac91079e-4e9b-485a-b4e9-027525498215_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5632dd10-8ad6-42da-acc4-02db222c4aa1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_35ae8de2-b1d4-41f8-9df3-afc7e97618bd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_898b79be-9490-4eb7-9de0-1e8f193cbf7f_terseLabel_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_label_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC [Member]</link:label>
    <link:label id="lab_lgnd_TaurusBiosciencesLLCMember_documentation_en-US" xlink:label="lab_lgnd_TaurusBiosciencesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taurus Biosciences, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember" xlink:href="lgnd-20200930.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TaurusBiosciencesLLCMember" xlink:to="lab_lgnd_TaurusBiosciencesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_46ece7ed-6b40-48b2-af88-3161e3cb9d13_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f9362046-3e9d-4e9d-8fcf-605f58b6ad1d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6dbac500-6ceb-48fc-bbbf-314b32ad7ae0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd59932a-1edd-41e7-9d49-b4bff7df6e8a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0761dfb0-9e1e-49a5-b7cf-04bc439d4060_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_e264da18-4527-4fe8-b049-99cae145f536_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_01e4d0c1-4c49-480b-b3e5-ab617b6f6c2b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_eef8697b-f708-4467-85de-15d9e495d78d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0745b4a5-4fec-4bdf-821f-124e3a79ce01_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2c93b4fb-32a1-41c1-9561-1d15ef92015d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_63d170ad-20f5-4fa7-a498-214bbb0f51e3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities related to assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_34b52bc3-09b5-4ead-9752-d4cafe305de6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0649224b-5b8d-4158-af44-ff27c992520f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_32c60065-eb7f-44d4-9b11-3c60c5fe887c_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="lgnd-20200930.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5467772e-cf4c-437c-bf93-8befc5249752_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_10a47f8a-c556-41ad-8d02-a9155c5aff86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e0e33c83-1c95-45a9-80d9-bffa370dc88b_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1aa72e79-885d-48d5-a88b-ffb5c3093ee7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_4a106e76-711a-4bbb-90ac-decb7299df51_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_3f536377-5281-44c8-976b-8f71cbc66f31_terseLabel_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_label_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues [Member]</link:label>
    <link:label id="lab_lgnd_ContingentValueRightOnProductRevenuesMember_documentation_en-US" xlink:label="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Right on Product Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:href="lgnd-20200930.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:to="lab_lgnd_ContingentValueRightOnProductRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_56f838e6-d477-418b-be5b-032fafba6ce8_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_f39a5968-1544-4577-ba47-90a47a4cbbae_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_6eac65ff-9d2b-4c38-8c15-fb8223e482f9_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8089c0bc-9d3f-4649-adab-f22dbc2867d5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_2cd07692-bff1-46f8-ac50-e7bdaf31d554_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license and other economic rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:href="lgnd-20200930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_8e277a24-5317-43d8-90ec-bea5ae6c324a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_63dbbe74-d2bb-482d-b334-a9c078802e38_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b12be10f-fd77-4685-bb7f-be7a15703bef_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_60398c3f-a420-4793-9f58-4d524a94819c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_dfaed934-6194-4805-9482-0ea20a0f7028_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d1aa50f5-9457-49a9-9226-6f42c3403b19_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d34d516c-6b18-4925-ad66-22e060221f7d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_218a4026-8441-4535-92e0-51f31d76b760_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e4157ea8-0b4b-4c09-b241-ddf5c9dc7529_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c28f54af-2d54-4fcf-bfdd-0769ba56edab_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dad429c0-5183-4a27-8e14-07fbb8e0f560_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fa769eaa-e39e-4324-be15-86abf89b7e8b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquisition:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_651f9aa4-2b53-4280-b1fb-609fc51a004b_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20200930.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_390c3bd4-e30e-492b-8bed-605f267a4b7a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of equity component of the 2023 Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_47f0571c-ad1f-4ec6-b7ac-c48fed9513f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_57554c41-bb5b-4664-acf1-9b936d0de302_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_5d28aa1d-97ce-455a-b2f7-e75556a240f4_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) to allowance for credit loss during period</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Increase (Decrease) to Allowance for Credit Loss during Period</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights, Increase (Decrease) to Allowance for Credit Loss during Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_a2bca167-9c6e-4ef4-bf61-572d18b2d2cb_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2b8b5ff3-e9e9-4048-aefb-aee1fdf97e8e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_06d52a6e-d023-49d0-adff-1b43567b8ed3_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0d14afc6-873c-4ff9-bb4e-791ca0e5ae09_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_24259b55-3453-474a-b245-c66664718231_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_6dae349f-b710-4581-88cf-775ea8e37ba8_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_2c5a469c-8802-424d-9b1a-30c22e0d512d_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20200930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_66ea5a2b-f6be-408d-bd37-28e934319d77_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding warrants to purchase shares of Viking's common stock (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_157bc639-51f8-46a8-bcd4-1a7656bd4df5_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_871be1f6-0c76-401f-9f81-7ab815e7c635_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4a110e13-dc06-4927-8977-36ea32fd6f60_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_d7e48c8c-79b3-43c2-8bd6-eaea783d5b43_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_VernalisMember_941f4def-a9d3-4869-99a4-759be475da37_terseLabel_en-US" xlink:label="lab_lgnd_VernalisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vernalis</link:label>
    <link:label id="lab_lgnd_VernalisMember_label_en-US" xlink:label="lab_lgnd_VernalisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vernalis [Member]</link:label>
    <link:label id="lab_lgnd_VernalisMember_documentation_en-US" xlink:label="lab_lgnd_VernalisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vernalis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VernalisMember" xlink:href="lgnd-20200930.xsd#lgnd_VernalisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_VernalisMember" xlink:to="lab_lgnd_VernalisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_1a12f180-847c-4396-8874-0ee2d86b5869_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_804aacd0-f4b0-4bf1-aada-9eb27b96ba57_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_1dd3c10b-d3c9-4991-b78a-cea531cc68b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationAsset_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4f4589cc-5f28-4f07-b83a-971c462b5ae5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_8bde3f58-404b-43f0-9f27-74cdf76d108a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_3214668d-547e-4512-b2ac-71b7a4a32aeb_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_aa6469d6-d172-44d2-99af-58964827a0ca_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_396b4540-200d-4807-8ed2-db32388aee45_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_01445090-c57c-4017-84d1-a0cc711f8e6a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4220f10e-016a-40ac-9438-5077346cfe2a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_d231922a-f415-4e7a-98a1-962b46d33bf7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_23490009-0677-4275-807a-954842d43954_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_72d3486c-2c25-4475-a4a4-2e1ad4c6be59_terseLabel_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_label_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Current</link:label>
    <link:label id="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_documentation_en-US" xlink:label="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:href="lgnd-20200930.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:to="lab_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ae1d18ad-382f-4bd5-9951-196b9bc5118d_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_66d9e641-477d-4b6a-ae64-07921ea30a95_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_74c7e7a6-9fb4-4bbb-931d-7e6f13a052a3_terseLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Fair Value</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_68812c34-f182-4995-b5eb-ead77120e7f0_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20200930.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_3e625039-a0ec-4762-b79f-360bd1183718_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback from acquisition</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_label_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:label id="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:to="lab_lgnd_BusinessCombinationConsiderationTransferredHoldback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ff7ec7ce-335c-4801-95a1-5a46822520c6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-front payment</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_1990c8c8-1cbc-45cb-9571-0079600b0b9d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ea97813a-e443-4882-9aca-7dc5d194c313_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_29df5b31-b5f5-4a8e-aa5e-2d0ba7994ec9_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20200930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_98815b76-8b47-4772-90e8-eed2a0f25448_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c9b2a127-d315-4a28-80bb-382a8f142728_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e2243956-5c6e-4e64-9230-ffe552399cc9_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1acd720b-adb2-4765-ae23-2180ef0e078a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected timing of satisfaction of remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_f3f3a31a-d31f-450e-93a0-782ba841fd9b_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_eb5e8e15-6395-4c36-9bfb-59682b9449e3_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0ef05763-9241-42e3-9273-b0f72e01d4d4_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_af3ebf29-a1e6-4a77-a8de-d55b3a0a945f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_121ecfe0-495d-4a11-895b-7b1acd96871d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_bf3288d7-3eb7-4f6b-ab18-c578b3235c48_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cd92e0fa-920d-4598-ae8a-1ddb724eb10d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d8192e0d-4014-49f4-8063-1b1c1d15a705_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_428df085-390b-49c8-b669-4bd4c09922ed_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_89ff35ee-b9ea-4c0c-be8a-422a91a09608_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_36afafde-88be-4b2f-b957-0e9c14133c8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7b96ba54-b9b7-430f-a117-224d769a05b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0910b7c4-fd2b-4864-907b-a0cd98984f45_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_730193c3-15ed-4471-ac03-3db029078a17_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_ee3aa0e7-cfde-4a99-b3e2-e74bb479fc1d_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_72a5e7f7-7bef-4c42-aae7-501955faf9e0_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20200930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7e43604e-0575-407f-931a-c54876db3ccb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_dd279671-dc77-4be9-852e-00276a85da90_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_e261dece-7933-4d80-8783-7b27c81cc345_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of Promacta license</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9b822ade-c087-40c5-ac67-1b7f5df0182a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_ae82cd06-19cd-4648-9ff2-687f3ac67407_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_2ee87f38-06cc-425e-ac74-26040e9801b1_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1ee0caf4-7d67-4829-b7f6-e63c6e2578b3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative-effect adjustment from adoption of ASU 2016-13, net of tax</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_37e7f77f-a538-4f1d-bed4-2d9b21938850_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_27a3b6a6-b3e7-45cf-9271-074c1aa0cad7_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7d470718-b561-4ab2-8d07-813b7de3adce_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_a4af3617-829c-4c1c-871d-aea25d4b5329_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_129ceb5c-ef9d-403b-ac34-d3b2dd627840_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f59e1a74-3bbf-4d0f-955e-0e676da418ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_d383a1a7-ddf1-4594-a163-bc7a5b5a19fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_acf8115e-1ee4-4f19-a2a1-3cc126b6d981_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5900c7aa-7bb1-4bab-8cec-976fa18e068e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_8b973738-72e9-4f15-8078-e3c4335a9e38_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f32a5cd1-0c8a-41c2-932c-e816c4b53205_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestmentsAndReceivablesNet_89e69880-6aef-4f31-93b8-ffa27f230e2a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investment receivable</link:label>
    <link:label id="lab_us-gaap_LongTermInvestmentsAndReceivablesNet_label_en-US" xlink:label="lab_us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments and Receivables, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:to="lab_us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_961f0367-938f-4199-b725-1ab27d44c932_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20200930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_7d30cdbd-4e69-4311-a246-d05d7d1d78e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_fcb29eb3-eac7-4625-9d13-08f4b5c185fc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_6e30c504-f48d-48b2-8dc3-593403f512f2_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20200930.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_af692b91-8fde-4c35-abc9-163e0245e2e2_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_c2253a14-b331-427a-b9b6-3ec9103f6e08_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_7c2a6db7-cc2e-407d-b975-1900a3c27afe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_b9476bef-05fb-4c4b-95f8-09d4c0a77c78_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_d41d31f5-a7fe-4deb-99d9-087ff0bed596_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c38606bc-d6e4-4171-a71e-0cb1b080369f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_a0b98a0c-e38e-41f4-a1f1-0681ed31f1f7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_79807368-72a1-4ca6-9af3-46d0f25aa42f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IcagenMember_a04b7d80-e5b9-4ca8-84cd-3fcf927fde6a_terseLabel_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:label id="lab_lgnd_IcagenMember_label_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen [Member]</link:label>
    <link:label id="lab_lgnd_IcagenMember_documentation_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember" xlink:href="lgnd-20200930.xsd#lgnd_IcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IcagenMember" xlink:to="lab_lgnd_IcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_25d841a0-57e5-44fc-b190-ad4ce51904b9_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5baa15d4-4d93-4382-8090-f6330ed4869a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_10ac2b59-d0a5-45bf-bf6b-824f7021e0c5_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a7684f02-995d-4495-b8c4-0edad7e953e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_684fb8da-f0b2-44ee-8cbd-9ce3993a5e0e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_af2c1e40-ae6f-4255-8b77-5f34051241e7_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2ab9df89-70db-429f-bf38-7327fc7c1612_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_b3b44e9f-ee47-423b-9944-07a92619b2e3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_2441085f-2b34-43d4-87b2-ab4cd2496cdf_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_64ac8667-c1ff-4960-97e5-5e61c2d64c6a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_edc30750-f57b-44cd-9675-683653caa3bf_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d2dc2002-5385-4ce4-8234-4784660b6b23_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b1180c0e-bccf-4437-a538-80ed21fb6a3a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent liability</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_87148c4e-b648-4f1e-ae7d-fc59a8046cc8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_59e20d1e-9d36-4e6d-bf6c-e7c13a1fbd09_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58e97a29-af54-44f7-9360-36220b2105d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ff030874-6a7a-4e68-ae18-9f9d671745a3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_1be0bb3b-2c5f-4e5e-8091-0f3fd6277520_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a2d77268-3d91-46b1-9525-f51875431271_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_025072ec-45b0-410f-9c36-52d7607ab053_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_80549c01-33ea-4dd1-885a-0ce9f925aec7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_5421b18e-32f4-4c30-8797-d336d013757c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2019Member_4cf17396-9ef0-4f17-a601-9b66785478de_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2019Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2019 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2019Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2019Member" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2019Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f3963764-68d3-4181-b910-181164a8d517_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_70295d0e-6372-423c-86e9-1a82024b8ac5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_86f916f0-2d9a-4312-8be9-2556535b9869_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_961a99a7-1431-4a85-aeb5-424baafc5e19_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20200930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_e3a249f4-e72a-448c-a337-d55dea07e8a2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_c5aa14a9-e6da-47e4-bfa6-b4c01efeba6e_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a160230d-198d-4e6d-87a4-57edbf6fbf7b_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available for Sale and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0c5cccf3-079e-41d5-bce7-b994e3c2a80d_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_9c6789c7-96e6-46c8-8848-5a06f0ade174_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0223d28f-e3cf-446e-851d-16dfc0f05cc8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_3877e189-76a7-4dc0-b88a-3a226d370fb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>lgnd-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:015c58ab-d6da-4197-b1ca-2564dd0b9f53,g:8a625853-6817-482c-9ef8-59dc8bbafc23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2e0ac4c5-a502-4ab8-99e2-b9281f364bb2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_DocumentType_2e0ac4c5-a502-4ab8-99e2-b9281f364bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_702ceb55-cf2b-4b8c-9bca-00788fbac5a0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_DocumentQuarterlyReport_702ceb55-cf2b-4b8c-9bca-00788fbac5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4b109b36-a234-41a6-83f4-cdf76e22948e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_DocumentPeriodEndDate_4b109b36-a234-41a6-83f4-cdf76e22948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a1c7082b-a2b4-4c95-9ea3-f488921058f3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_DocumentTransitionReport_a1c7082b-a2b4-4c95-9ea3-f488921058f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5c2f5b16-3ebb-4480-b22f-9a5cb46a85fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityFileNumber_5c2f5b16-3ebb-4480-b22f-9a5cb46a85fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f992d66a-6276-4f67-911c-a17ecbe88bd2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityRegistrantName_f992d66a-6276-4f67-911c-a17ecbe88bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c74e483c-4371-4c17-817b-c52f3f359806" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c74e483c-4371-4c17-817b-c52f3f359806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_14838c51-cb3c-4b29-8e8c-e48153fc5209" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityTaxIdentificationNumber_14838c51-cb3c-4b29-8e8c-e48153fc5209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_50e9fc28-0d9c-4d5f-b3a7-4060b5c341da" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityAddressAddressLine1_50e9fc28-0d9c-4d5f-b3a7-4060b5c341da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_06c47d68-99a1-47c0-8606-416f4ec89ca9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityAddressCityOrTown_06c47d68-99a1-47c0-8606-416f4ec89ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2b60a895-7ccc-442d-8427-56721ff00148" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityAddressStateOrProvince_2b60a895-7ccc-442d-8427-56721ff00148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8baaed6f-81f4-4aff-8628-4d3e0a2b2485" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityAddressPostalZipCode_8baaed6f-81f4-4aff-8628-4d3e0a2b2485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5f0363a8-824b-4a73-8b72-1125a2ea33fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_CityAreaCode_5f0363a8-824b-4a73-8b72-1125a2ea33fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ab880a58-1160-4d75-8c39-5cff5ae06412" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_LocalPhoneNumber_ab880a58-1160-4d75-8c39-5cff5ae06412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_62b91ec1-b530-464a-bf2a-e9b5239a91fe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_Security12bTitle_62b91ec1-b530-464a-bf2a-e9b5239a91fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b7bd6490-b3c9-404c-b885-7897966e61ea" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_TradingSymbol_b7bd6490-b3c9-404c-b885-7897966e61ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_977fd71a-3a4c-400c-8b0e-466ef39e5307" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_SecurityExchangeName_977fd71a-3a4c-400c-8b0e-466ef39e5307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b3a1230e-247e-4263-9852-745eed084441" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityCurrentReportingStatus_b3a1230e-247e-4263-9852-745eed084441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e5a4e722-b541-41d0-b418-1bbe8563128d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityInteractiveDataCurrent_e5a4e722-b541-41d0-b418-1bbe8563128d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_93dd7056-5bf1-4081-89ad-ab40ff6bb580" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityFilerCategory_93dd7056-5bf1-4081-89ad-ab40ff6bb580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c6115b34-95cb-4d4f-82b4-f00b2df2b4ed" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntitySmallBusiness_c6115b34-95cb-4d4f-82b4-f00b2df2b4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b300aab8-9a59-4d76-a0d6-b828d8ad9ee5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityEmergingGrowthCompany_b300aab8-9a59-4d76-a0d6-b828d8ad9ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8afc3075-f808-4fd9-92b9-eb76d0a04fcc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityShellCompany_8afc3075-f808-4fd9-92b9-eb76d0a04fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fe9191ba-49b8-4391-97c0-f7e949032e1f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fe9191ba-49b8-4391-97c0-f7e949032e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_12b8a0f3-1ee5-4d3a-9868-d37958d4b452" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_AmendmentFlag_12b8a0f3-1ee5-4d3a-9868-d37958d4b452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_09b3ad5d-e275-498c-8ef4-d1b8dd8853ea" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_DocumentFiscalYearFocus_09b3ad5d-e275-498c-8ef4-d1b8dd8853ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_04d01d6b-8327-438d-afc6-0b982c4aee33" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_04d01d6b-8327-438d-afc6-0b982c4aee33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a2f0c3f9-6271-4532-826d-0e6628bc8f9d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_EntityCentralIndexKey_a2f0c3f9-6271-4532-826d-0e6628bc8f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3c770efa-2d7e-4452-8bcf-fe615f6d9a35" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9960b976-9e4a-4b3c-8a62-2241dd7635d2" xlink:to="loc_dei_CurrentFiscalYearEndDate_3c770efa-2d7e-4452-8bcf-fe615f6d9a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_23cbd438-945e-48ae-9354-2a11b5d7626b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23cbd438-945e-48ae-9354-2a11b5d7626b" xlink:to="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b310d50d-e915-4108-81b8-1c1142d1c6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b310d50d-e915-4108-81b8-1c1142d1c6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_2bd6250b-23e2-4dd1-8209-7945fee145b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_ShortTermInvestments_2bd6250b-23e2-4dd1-8209-7945fee145b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c2de61ce-af5c-48d5-b543-277162c8559a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c2de61ce-af5c-48d5-b543-277162c8559a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a560f8a2-eec1-46c2-8774-01619d0226c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_InventoryNet_a560f8a2-eec1-46c2-8774-01619d0226c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b4033419-007d-4a24-a826-f3deec501776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b4033419-007d-4a24-a826-f3deec501776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_05d68af7-337c-423e-9c2f-aef60545c6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_OtherAssetsCurrent_05d68af7-337c-423e-9c2f-aef60545c6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_de3eb250-96d9-42b0-ac65-17c98967b9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_de3eb250-96d9-42b0-ac65-17c98967b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_95c8b6a5-9f44-465c-850c-b7ef89d512fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_7ec4720e-e0d8-41a5-ad96-90dbdf8c8eae" xlink:to="loc_us-gaap_AssetsCurrent_95c8b6a5-9f44-465c-850c-b7ef89d512fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4972944a-711c-48a0-94ad-de056e0c9828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4972944a-711c-48a0-94ad-de056e0c9828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bf3239db-eec1-4f88-a9be-c8f51b66ec8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bf3239db-eec1-4f88-a9be-c8f51b66ec8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3cbebe45-8ecd-41e8-944f-65c57281ae3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_Goodwill_3cbebe45-8ecd-41e8-944f-65c57281ae3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_e7cae4ae-bef3-41ff-b4a6-6d3678697e88" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_lgnd_CommercialLicenseRights_e7cae4ae-bef3-41ff-b4a6-6d3678697e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9d42d291-f2df-4e45-b29a-ede824545154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9d42d291-f2df-4e45-b29a-ede824545154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_66e23d9c-4ef5-41a7-a938-e81e06d57559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_66e23d9c-4ef5-41a7-a938-e81e06d57559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0f37c073-a8f8-4c9a-9209-37e6ac39e240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0f37c073-a8f8-4c9a-9209-37e6ac39e240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e08b33e4-298c-49d2-921c-8b010c2d8408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f2970a1f-b939-40fb-9b60-6fed64638b58" xlink:to="loc_us-gaap_Assets_e08b33e4-298c-49d2-921c-8b010c2d8408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23cbd438-945e-48ae-9354-2a11b5d7626b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_9737f924-80fd-4913-b0ac-680e2494c004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_us-gaap_AccountsPayableCurrent_9737f924-80fd-4913-b0ac-680e2494c004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0d9a14aa-d816-413d-ae01-db2b1990fcee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0d9a14aa-d816-413d-ae01-db2b1990fcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_3de5e3be-96f4-4ddb-a44e-868c6e08ba26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_us-gaap_TaxesPayableCurrent_3de5e3be-96f4-4ddb-a44e-868c6e08ba26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_c280ec4a-57ac-4389-90ee-a38581d12512" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_c280ec4a-57ac-4389-90ee-a38581d12512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7d5b3a6d-e7a7-4da6-b667-9b7fdecab9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7d5b3a6d-e7a7-4da6-b667-9b7fdecab9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_6badfaf5-5abc-4a87-8c63-606ffb5e24ff" xlink:href="lgnd-20200930.xsd#lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent_6badfaf5-5abc-4a87-8c63-606ffb5e24ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_63759667-0db9-4ea7-a533-732efabf7a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_181994fa-15cd-438e-b7d4-8951a030c9b7" xlink:to="loc_us-gaap_LiabilitiesCurrent_63759667-0db9-4ea7-a533-732efabf7a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_bac6e2bc-53e1-4884-a625-2a3d2e8ce6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_bac6e2bc-53e1-4884-a625-2a3d2e8ce6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_38e749ba-d98b-475b-9820-2728078a8582" xlink:href="lgnd-20200930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_lgnd_LiabilityForContingentValueRights_38e749ba-d98b-475b-9820-2728078a8582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3ea314fc-7c7f-43a9-a861-0db4fc8d56f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3ea314fc-7c7f-43a9-a861-0db4fc8d56f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c7eb1e8-7894-4304-8f2a-7de0249dfc49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c7eb1e8-7894-4304-8f2a-7de0249dfc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_60dab06e-f07b-4d48-b954-84f1b53697dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_60dab06e-f07b-4d48-b954-84f1b53697dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4d46a548-9ad4-4f2b-a64b-8517a3ee49d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_Liabilities_4d46a548-9ad4-4f2b-a64b-8517a3ee49d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_270c3cb4-c9f4-4012-b20f-a6e9dbc268c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_CommitmentsAndContingencies_270c3cb4-c9f4-4012-b20f-a6e9dbc268c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7ffd63a2-b83b-4b6a-8d94-8fd1a138ca43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:to="loc_us-gaap_PreferredStockValue_7ffd63a2-b83b-4b6a-8d94-8fd1a138ca43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5a58fa98-8718-453f-b173-0061608e7662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:to="loc_us-gaap_CommonStockValue_5a58fa98-8718-453f-b173-0061608e7662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0d77fe40-0152-4141-aaa3-943d049d2538" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0d77fe40-0152-4141-aaa3-943d049d2538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8dfa9be4-e2f1-46ee-a6b3-ed0a2d4307d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8dfa9be4-e2f1-46ee-a6b3-ed0a2d4307d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f0ee36b4-56f7-46c7-8a3a-705dd201c5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f0ee36b4-56f7-46c7-8a3a-705dd201c5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1f425d19-8ebf-48a8-ba58-a8227686f2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b0f614de-f1de-4a2b-822c-b22f60a167eb" xlink:to="loc_us-gaap_StockholdersEquity_1f425d19-8ebf-48a8-ba58-a8227686f2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd9195cb-297e-47d8-8bae-836a50265f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3bae2d50-d427-4110-bc7a-5dc46c5d2b08" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bd9195cb-297e-47d8-8bae-836a50265f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_eb06d982-34df-4efa-96cf-f8aa7d3bb83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_eb06d982-34df-4efa-96cf-f8aa7d3bb83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_bd091a09-92ad-4563-a0de-f4a638c5e46e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_bd091a09-92ad-4563-a0de-f4a638c5e46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_032574df-1a3b-45c3-a323-ed48eff036a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_PreferredStockSharesIssued_032574df-1a3b-45c3-a323-ed48eff036a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_60880bc1-f4f0-47c8-aae0-d3e963cb1c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_60880bc1-f4f0-47c8-aae0-d3e963cb1c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_5b9ac7d7-bd82-491d-84c7-591fa19fdbd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_5b9ac7d7-bd82-491d-84c7-591fa19fdbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_643d99e5-7cdf-4360-a005-65a42f219cf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_643d99e5-7cdf-4360-a005-65a42f219cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_36d5b870-e0c4-454d-95a8-55e92f245c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_CommonStockSharesIssued_36d5b870-e0c4-454d-95a8-55e92f245c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5ec9e88d-a651-4b5f-a7ef-4e6e56615c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a2fd0b6-f027-43d2-b219-c89bc6e44d28" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5ec9e88d-a651-4b5f-a7ef-4e6e56615c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e4ed415a-1828-4f17-be7f-b9ebe7f562d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e4ed415a-1828-4f17-be7f-b9ebe7f562d3" xlink:to="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:to="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7dc989d1-c34f-4547-875d-3b0ee52d98a1" xlink:to="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_e387c34e-f4c2-4678-abef-7a3f3409a55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:to="loc_us-gaap_RoyaltyMember_e387c34e-f4c2-4678-abef-7a3f3409a55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_78967ecf-ef72-4115-8305-fe2ddda4a32e" xlink:href="lgnd-20200930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_78967ecf-ef72-4115-8305-fe2ddda4a32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_6edcb724-d41e-46ec-bd0b-39f533831161" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f5ad2f05-bb69-4f40-85da-e50a158e5d1f" xlink:to="loc_lgnd_ContractRevenueMember_6edcb724-d41e-46ec-bd0b-39f533831161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_48b33c25-5518-475a-b814-d35ff4b151af" xlink:to="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_82c07a80-e5bf-4511-863d-64ecf07f4347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_RevenuesAbstract_82c07a80-e5bf-4511-863d-64ecf07f4347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3eb9be29-4dad-4373-b838-26fbd9fced86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_82c07a80-e5bf-4511-863d-64ecf07f4347" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3eb9be29-4dad-4373-b838-26fbd9fced86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_a701cd05-8567-40f9-ab08-ed41103156b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_CostDirectMaterial_a701cd05-8567-40f9-ab08-ed41103156b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_bc1dc59a-d6cd-450f-8570-e688917bf440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_bc1dc59a-d6cd-450f-8570-e688917bf440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3a13db90-761b-4197-9f68-afda55670ddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3a13db90-761b-4197-9f68-afda55670ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1cd2c903-4dcc-4896-9cbb-7f73348da4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1cd2c903-4dcc-4896-9cbb-7f73348da4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_1a133c3d-3d28-4f4e-b36b-3c0ff9dc3be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_202ba78a-c994-4d7f-a669-d96b8c0d44ff" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_1a133c3d-3d28-4f4e-b36b-3c0ff9dc3be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_2836753f-2a75-4852-84be-532e5f610a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_2836753f-2a75-4852-84be-532e5f610a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ee6a91a-c7c6-4dc7-b761-e71e3b9d5cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_OperatingIncomeLoss_7ee6a91a-c7c6-4dc7-b761-e71e3b9d5cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_f9e4ad77-c4d5-4f4a-9675-fbcf5dc3ec71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_GainLossOnInvestments_f9e4ad77-c4d5-4f4a-9675-fbcf5dc3ec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_986873ae-6992-472e-9537-dc774b7cc9d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_986873ae-6992-472e-9537-dc774b7cc9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_361fd7e6-bb5e-4a04-9874-3421840970d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_InterestExpense_361fd7e6-bb5e-4a04-9874-3421840970d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_817e526b-886d-44ed-b9c2-98bbcca4b3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_817e526b-886d-44ed-b9c2-98bbcca4b3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3e04b0b8-3246-4c1a-9982-d5eb2790ecd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b64b15d-cd53-4fd0-9db7-524481db9fe0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_3e04b0b8-3246-4c1a-9982-d5eb2790ecd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8a79c502-300d-48b1-b936-aa616d7b0357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8a79c502-300d-48b1-b936-aa616d7b0357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7ff49690-ecc4-4067-a0cf-3494dc92f57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7ff49690-ecc4-4067-a0cf-3494dc92f57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ae6adae0-f84a-4b00-82f9-626e76c48a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_NetIncomeLoss_ae6adae0-f84a-4b00-82f9-626e76c48a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fbe14bf9-a874-4aab-b4af-7eb0313bb6bf" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_23717912-3faa-4a85-b3e9-ebc3cd74337f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_EarningsPerShareBasic_23717912-3faa-4a85-b3e9-ebc3cd74337f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd008ab7-c318-4991-b7bd-89b4e7b82fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd008ab7-c318-4991-b7bd-89b4e7b82fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f9d7fb8c-0aee-4c08-b9e0-4a66df3cab1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f9d7fb8c-0aee-4c08-b9e0-4a66df3cab1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_678765b3-65c4-4afa-8c07-ff3b6a8db8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6d12a3-3d64-4942-b709-277571f741a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_678765b3-65c4-4afa-8c07-ff3b6a8db8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fba1a93a-865c-4cee-9387-ffbbb4e8e426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6ba33d31-d3f8-4d88-bcfe-cdbb48117e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fba1a93a-865c-4cee-9387-ffbbb4e8e426" xlink:to="loc_us-gaap_NetIncomeLoss_6ba33d31-d3f8-4d88-bcfe-cdbb48117e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a24ae2c5-f907-431c-a16d-42b753bfd4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fba1a93a-865c-4cee-9387-ffbbb4e8e426" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a24ae2c5-f907-431c-a16d-42b753bfd4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82f9d894-3765-43d6-ba25-c4fee898aa08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fba1a93a-865c-4cee-9387-ffbbb4e8e426" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82f9d894-3765-43d6-ba25-c4fee898aa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_52182fa4-d0b9-4eee-9657-40091b2230a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fba1a93a-865c-4cee-9387-ffbbb4e8e426" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_52182fa4-d0b9-4eee-9657-40091b2230a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0576d7e6-f62a-4e12-b524-87170144cdb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0576d7e6-f62a-4e12-b524-87170144cdb3" xlink:to="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3ad55365-0c60-43ac-8242-c88245441ba1" xlink:to="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2dbd2623-4598-437f-a338-8569bcac79e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_CommonStockMember_2dbd2623-4598-437f-a338-8569bcac79e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_42ec63af-ca4d-4bdf-9575-6b3cd3515f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_42ec63af-ca4d-4bdf-9575-6b3cd3515f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04d40b63-74a7-4eac-bb0e-680bcbe9c4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_04d40b63-74a7-4eac-bb0e-680bcbe9c4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_97be589d-04d1-48d6-b6ab-7bd6ca0f81f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e14a1a01-f81d-4ab8-af7c-a23a26b7de54" xlink:to="loc_us-gaap_RetainedEarningsMember_97be589d-04d1-48d6-b6ab-7bd6ca0f81f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5174eda-b86c-466b-a608-28451f708966" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_58e5801e-1c24-40a6-a2b9-1b82d883b2bc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5174eda-b86c-466b-a608-28451f708966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3106f75f-c7ec-42ea-936b-3aad55260e34" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e5174eda-b86c-466b-a608-28451f708966" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3106f75f-c7ec-42ea-936b-3aad55260e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b5f6cba5-a669-4759-a5eb-344f7f6a5139" xlink:to="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2bc6ab4f-9820-4bd8-989c-f618b6c19db6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_2bc6ab4f-9820-4bd8-989c-f618b6c19db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e85ffd8c-6ef8-4989-b33a-99f05bd44cba" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_47915a6a-8414-4879-a257-4b5681ffce5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_SharesIssued_47915a6a-8414-4879-a257-4b5681ffce5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2626c257-101c-4c41-8e72-1946792333b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockholdersEquity_2626c257-101c-4c41-8e72-1946792333b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9ea58678-3654-4ac0-9077-296b32032eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9ea58678-3654-4ac0-9077-296b32032eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_05f25614-d8fa-4f08-ab38-5f829ce753cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_05f25614-d8fa-4f08-ab38-5f829ce753cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e271bb78-f31c-4291-aa46-17224872b206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e271bb78-f31c-4291-aa46-17224872b206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_bf567355-7089-4bbe-ac36-b769fe38eee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_bf567355-7089-4bbe-ac36-b769fe38eee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_72df04d1-4a68-42c7-8a2f-fe665caa16ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_72df04d1-4a68-42c7-8a2f-fe665caa16ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4ac45515-ef7a-43fc-abdb-a8c726b00bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4ac45515-ef7a-43fc-abdb-a8c726b00bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_aa570f91-f989-41af-b695-48e12f68a238" xlink:href="lgnd-20200930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment_aa570f91-f989-41af-b695-48e12f68a238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2e3bc253-6c18-4c73-85b2-5c5c4d4ef8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_2e3bc253-6c18-4c73-85b2-5c5c4d4ef8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_36295b03-44b1-4a87-8a2b-ddb9d89b7001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_36295b03-44b1-4a87-8a2b-ddb9d89b7001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_64e3d484-1cc3-462f-b39a-4c77da3d739c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockholdersEquityOther_64e3d484-1cc3-462f-b39a-4c77da3d739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_03ae6635-fd06-4be2-9df9-8f5c9ad181e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_NetIncomeLoss_03ae6635-fd06-4be2-9df9-8f5c9ad181e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_d5cbc560-8c1e-4848-8ff3-cc53e810dfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_SharesIssued_d5cbc560-8c1e-4848-8ff3-cc53e810dfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_05df3ec6-7148-48d3-a15e-cf1d433fbdda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_da918151-cb85-4d17-9db0-ddcd8fe46a1c" xlink:to="loc_us-gaap_StockholdersEquity_05df3ec6-7148-48d3-a15e-cf1d433fbdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_182652f7-8b84-486b-a066-f312b1564e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_182652f7-8b84-486b-a066-f312b1564e96" xlink:to="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:to="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_98bc7ac3-b96d-416c-96b0-eb8efcdecff4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_62e3a272-fbb3-4a5d-9ab0-f9c506b22260" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_62e3a272-fbb3-4a5d-9ab0-f9c506b22260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2019Member_0d5a128d-5ade-4d2f-927f-61a5e14e80cf" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_11944d5b-110d-446b-be2e-95b60c80389f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2019Member_0d5a128d-5ade-4d2f-927f-61a5e14e80cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f1d11b35-d3be-4cec-affb-328f295545ba" xlink:to="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a271a981-6074-4c34-b036-000950fa0349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_ProfitLoss_a271a981-6074-4c34-b036-000950fa0349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_011bea2f-9f10-4d38-adb0-d9e9bd9c2a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_011bea2f-9f10-4d38-adb0-d9e9bd9c2a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_f175a0e5-c9f3-4c74-86e8-5180ccd4f723" xlink:href="lgnd-20200930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_f175a0e5-c9f3-4c74-86e8-5180ccd4f723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4d05a516-7526-4de2-9004-059775a38302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4d05a516-7526-4de2-9004-059775a38302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f54576cf-9a4a-4c27-9922-71c1610b1f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f54576cf-9a4a-4c27-9922-71c1610b1f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_448de8dc-c422-492b-af72-f7e23a82e52c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_448de8dc-c422-492b-af72-f7e23a82e52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfOtherEconomicRights_f707f762-525e-4406-974b-8cb39c160bfe" xlink:href="lgnd-20200930.xsd#lgnd_AmortizationOfOtherEconomicRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_lgnd_AmortizationOfOtherEconomicRights_f707f762-525e-4406-974b-8cb39c160bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9df01388-5d3f-4946-b1a6-61d3f7e06f61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9df01388-5d3f-4946-b1a6-61d3f7e06f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b945246a-498e-44f4-bab0-902334c84fac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_ShareBasedCompensation_b945246a-498e-44f4-bab0-902334c84fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5f3acbff-d8b1-4879-815b-a53daa210510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5f3acbff-d8b1-4879-815b-a53daa210510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_b260d9b6-aaeb-4099-a046-abfaeee324a7" xlink:href="lgnd-20200930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_b260d9b6-aaeb-4099-a046-abfaeee324a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_eadc36ad-aadb-4ab2-beb2-684c85c25aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0622d4bc-4e24-4e28-a0b2-aad09168629c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_eadc36ad-aadb-4ab2-beb2-684c85c25aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b23727b3-1936-41d2-9897-f537a5858daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b23727b3-1936-41d2-9897-f537a5858daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6e10c55-2a04-45f6-900e-cb601f72e3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6e10c55-2a04-45f6-900e-cb601f72e3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b84f683-9304-436e-b4b0-1c3bfa874769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b84f683-9304-436e-b4b0-1c3bfa874769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6670b159-3a24-4332-83c9-094bc79e6b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6670b159-3a24-4332-83c9-094bc79e6b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInOtherEconomicRights_f7458476-9136-4be6-81b0-95e25010ad59" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_lgnd_IncreaseDecreaseInOtherEconomicRights_f7458476-9136-4be6-81b0-95e25010ad59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_643d7661-e3b0-42f0-8fc6-adff15adbe0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7fa3baea-d24a-4b56-bbb6-b55e514a726e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_643d7661-e3b0-42f0-8fc6-adff15adbe0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_392d7755-5782-4457-bbfd-069d7b558f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_af5d8a92-e29b-46b5-9d98-d40a9ed94988" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_392d7755-5782-4457-bbfd-069d7b558f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_59e9fc41-6999-45f3-9b49-8c4b2d25ed13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_59e9fc41-6999-45f3-9b49-8c4b2d25ed13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_12baca2f-b517-4389-a723-124d8d5f6d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_12baca2f-b517-4389-a723-124d8d5f6d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_b1d98fcf-5570-4a6f-bcc5-6bbb9e6e9b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_b1d98fcf-5570-4a6f-bcc5-6bbb9e6e9b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_567cce5e-0f77-47a2-80fd-c5c76f0e94f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_567cce5e-0f77-47a2-80fd-c5c76f0e94f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_464bcd8f-c66e-40cf-b73b-df2abc2e5428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_464bcd8f-c66e-40cf-b73b-df2abc2e5428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_eb0fcc97-a89a-44a8-b1cb-e5d7bc4869d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_eb0fcc97-a89a-44a8-b1cb-e5d7bc4869d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e98e013b-c79e-4ea1-9238-e52589d59e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e98e013b-c79e-4ea1-9238-e52589d59e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b98a1991-110f-4abb-b72c-6fcd71866602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2a05ff1b-cf18-4e67-a777-600e71a78f6a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b98a1991-110f-4abb-b72c-6fcd71866602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4e6b7ba9-39b6-445e-bd25-5c12942b9657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4e6b7ba9-39b6-445e-bd25-5c12942b9657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_81d33522-1c04-4c03-858c-230d48b6799f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_81d33522-1c04-4c03-858c-230d48b6799f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_21886089-f1a6-4ff2-9205-c6ffe2473ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_21886089-f1a6-4ff2-9205-c6ffe2473ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_bb1add11-6b3b-4447-bd49-56dad3212dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_bb1add11-6b3b-4447-bd49-56dad3212dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_588077ec-cf6e-4b69-a9e3-d3aed1001d16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_588077ec-cf6e-4b69-a9e3-d3aed1001d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6269083c-6801-4735-ad42-ab7e176d2291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6269083c-6801-4735-ad42-ab7e176d2291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_07f93f95-3079-49bc-a8cd-d7d74e5a0f6d" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_07f93f95-3079-49bc-a8cd-d7d74e5a0f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e553e842-972b-4825-b987-33711f80b398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_e553e842-972b-4825-b987-33711f80b398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8bc4dedc-b266-4df1-bf75-1c32ea66141e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d1f81051-06a4-43da-bcaa-40efbb82e65a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8bc4dedc-b266-4df1-bf75-1c32ea66141e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44527d0e-be90-40ba-8758-8e45eae50b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44527d0e-be90-40ba-8758-8e45eae50b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3511f065-7f09-485e-bdd6-52b75aa3c2d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3511f065-7f09-485e-bdd6-52b75aa3c2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76f86f35-a6f7-4e28-88e8-10cd301367cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76f86f35-a6f7-4e28-88e8-10cd301367cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1411b802-44e2-4837-92d9-6648a06006be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1411b802-44e2-4837-92d9-6648a06006be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f3dbdf15-4f0a-49cc-a8c5-78ee3a5707a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:to="loc_us-gaap_InterestPaidNet_f3dbdf15-4f0a-49cc-a8c5-78ee3a5707a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_c7c93e10-2858-416d-8d68-7e7ccf938a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:to="loc_us-gaap_IncomeTaxesPaid_c7c93e10-2858-416d-8d68-7e7ccf938a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_c4284b51-a48f-46cf-a435-9ed74531b1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_506992c9-2cf6-4c8b-be6f-0652840ae3dd" xlink:to="loc_us-gaap_RestrictedCashCurrent_c4284b51-a48f-46cf-a435-9ed74531b1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_237f5802-02f8-483d-8b20-9d695a6dd836" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_47862015-f8f9-40fa-b255-fcb7ad9a7d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_47862015-f8f9-40fa-b255-fcb7ad9a7d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_801500cd-a2b1-4083-9af6-a9702a6b1a00" xlink:href="lgnd-20200930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_lgnd_AccruedInventoryPurchases_801500cd-a2b1-4083-9af6-a9702a6b1a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedLeasePurchases_286365a2-8715-4652-8fe6-ed49fe204ce4" xlink:href="lgnd-20200930.xsd#lgnd_AccruedLeasePurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_lgnd_AccruedLeasePurchases_286365a2-8715-4652-8fe6-ed49fe204ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_7627d287-9b21-4035-97cb-ecbd84cafcd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_ffb5f82e-e6d7-437a-a9b4-b39d0ecfcdaf" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_7627d287-9b21-4035-97cb-ecbd84cafcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4dd27b94-a0b6-4c35-a567-8c62adf4094f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_4f92dc5f-0b1f-4e5c-954c-e32e5bf8a5f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4dd27b94-a0b6-4c35-a567-8c62adf4094f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_4f92dc5f-0b1f-4e5c-954c-e32e5bf8a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a2474539-9b51-47a8-809a-81b93b0a0a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a2474539-9b51-47a8-809a-81b93b0a0a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_40388c64-532a-4272-8f34-1e9a0689fb00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_40388c64-532a-4272-8f34-1e9a0689fb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_2719729a-de33-4b0e-88c1-01ab168576e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_UseOfEstimates_2719729a-de33-4b0e-88c1-01ab168576e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_65fefd6e-78c0-458b-acdd-2cab12a4e401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_65fefd6e-78c0-458b-acdd-2cab12a4e401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4b6f50ed-80f3-49df-9571-406d7a206738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4b6f50ed-80f3-49df-9571-406d7a206738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_79fc9223-4b35-4a2b-ba94-793784811445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_79fc9223-4b35-4a2b-ba94-793784811445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_83303924-fbb3-4239-9939-81f61bd669b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6f882ec3-2ac0-4a6e-94e4-2ca6654920f0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_83303924-fbb3-4239-9939-81f61bd669b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a3b63b68-fb92-487e-b1fd-35f3a202f041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a3b63b68-fb92-487e-b1fd-35f3a202f041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_f79890b8-c799-429e-82f5-981454374d21" xlink:href="lgnd-20200930.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_f79890b8-c799-429e-82f5-981454374d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_43efa4f2-1448-4878-8a01-f8d62ce7b1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_43efa4f2-1448-4878-8a01-f8d62ce7b1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_bfe2d9bf-4a2c-4f07-b704-49ffd910ca3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_bfe2d9bf-4a2c-4f07-b704-49ffd910ca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_ef5e1e29-8d40-432e-b811-c7417aa6205f" xlink:href="lgnd-20200930.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_ef5e1e29-8d40-432e-b811-c7417aa6205f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_e1a28212-3719-478d-a8dc-c26f5f1aa2f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_e1a28212-3719-478d-a8dc-c26f5f1aa2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_977fc315-cd69-4b06-86e8-40e320d1787a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_977fc315-cd69-4b06-86e8-40e320d1787a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_d9434fda-3b90-4263-ab1c-12e0c5222b86" xlink:href="lgnd-20200930.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_d9434fda-3b90-4263-ab1c-12e0c5222b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_4d4dc972-d698-4675-9754-9fac3b8e3946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_4d4dc972-d698-4675-9754-9fac3b8e3946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6722fff7-6eff-4088-82a2-b375cf2e7d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7f2bbd8a-2293-41bb-a2c0-129b691e4444" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6722fff7-6eff-4088-82a2-b375cf2e7d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ab51e681-e6cc-4b83-a36b-f5cee2587c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ab51e681-e6cc-4b83-a36b-f5cee2587c31" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_052a5cc3-5c26-4e9a-b99f-fd2fa9c0ab1a" xlink:to="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eadce923-5b68-437c-83ad-6ef12d3715f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:to="loc_srt_MinimumMember_eadce923-5b68-437c-83ad-6ef12d3715f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_919eef7e-e0ba-47b0-80e8-4f629df58e4a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1bfb3e04-e40f-4234-83f4-06fe24c3c929" xlink:to="loc_srt_MaximumMember_919eef7e-e0ba-47b0-80e8-4f629df58e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_46e1f815-3108-4ade-a435-b3f1440e3210" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyAgreementsMember_19f50278-5096-4cf3-95a3-4299aaff7132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:to="loc_us-gaap_RoyaltyAgreementsMember_19f50278-5096-4cf3-95a3-4299aaff7132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_5d2b2ff2-6e67-4ad1-8dea-45263e5e3f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50343448-3842-4072-8233-97fd020d0621" xlink:to="loc_us-gaap_LicensingAgreementsMember_5d2b2ff2-6e67-4ad1-8dea-45263e5e3f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e5363f16-67c6-48aa-8e17-936fe580b106" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoMember_b039b280-2560-4cfa-8880-80b797fa4819" xlink:href="lgnd-20200930.xsd#lgnd_AziyoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:to="loc_lgnd_AziyoMember_b039b280-2560-4cfa-8880-80b797fa4819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaMember_74bac7cf-55ef-4160-a0de-64c0f2418147" xlink:href="lgnd-20200930.xsd#lgnd_PalvellaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_db06762a-bef7-41a8-bd08-af4e9b091404" xlink:to="loc_lgnd_PalvellaMember_74bac7cf-55ef-4160-a0de-64c0f2418147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_d8beceaa-cd13-47ef-a53e-f7613ff54d96" xlink:to="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_32959629-992e-41cd-b8ee-a04ddbce9424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4742edc4-f983-4e66-b013-333c13d647fc" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_32959629-992e-41cd-b8ee-a04ddbce9424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_4efc4c29-8433-42fa-b4ac-0605c9c1987a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abca0e8b-a322-473e-ab81-e1e1d24982ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_72f1573c-3734-4792-baba-9367d64fdc27" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_abca0e8b-a322-473e-ab81-e1e1d24982ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82c83619-0851-4712-9c6f-805ede9dff2b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_79aafbe1-12fe-406c-a254-f9172509153e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0dfd14c6-dd99-4c0e-8413-1b5b08cdb966" xlink:to="loc_us-gaap_StockCompensationPlanMember_79aafbe1-12fe-406c-a254-f9172509153e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a46f0bdc-6fce-4ef7-8f73-7ff6be220d69" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fbf24441-da15-4c03-9186-254580d74234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:to="loc_us-gaap_WarrantMember_fbf24441-da15-4c03-9186-254580d74234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_50d8eb5e-866b-4716-810a-b7112da2fa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_97014411-5745-420e-8689-28dd24f61200" xlink:to="loc_us-gaap_CommonStockMember_50d8eb5e-866b-4716-810a-b7112da2fa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_541aef99-bec4-4bfb-8526-1c85c4ac2ab2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e677c218-1d8d-4b9f-b20d-840de60fc3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1632714a-b29c-4569-83b1-80ca157254ae" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e677c218-1d8d-4b9f-b20d-840de60fc3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_142b1418-cf22-49a3-971e-8cb5d0c7cba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_142b1418-cf22-49a3-971e-8cb5d0c7cba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79c87759-635b-48d6-885b-72066a5217da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_36006eec-ea1c-4dbf-8209-ec29799085ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_36006eec-ea1c-4dbf-8209-ec29799085ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_50beadf6-e297-4fb0-a5fd-3f1c0c1516f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_50beadf6-e297-4fb0-a5fd-3f1c0c1516f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7308479-77e2-41ff-bdd4-d904f497bb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d7308479-77e2-41ff-bdd4-d904f497bb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_798c4d1d-3e6a-4f66-840c-74c6e703fcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_798c4d1d-3e6a-4f66-840c-74c6e703fcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_fd7e61a9-0e30-4dcf-95e0-c0ba641c6e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_fd7e61a9-0e30-4dcf-95e0-c0ba641c6e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dab5ddce-44b7-4882-9d4f-2ac9cf81044a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_dab5ddce-44b7-4882-9d4f-2ac9cf81044a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376f6f4c-82ac-4e0c-9e5d-ab8931f79f38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376f6f4c-82ac-4e0c-9e5d-ab8931f79f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0860b38d-4635-4545-b4c9-5e954d2431bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0860b38d-4635-4545-b4c9-5e954d2431bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95ac505b-7170-4a21-a9c6-72f583aab610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_95ac505b-7170-4a21-a9c6-72f583aab610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_5745683a-31f4-458f-a9f5-c09d2f306edc" xlink:href="lgnd-20200930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_5745683a-31f4-458f-a9f5-c09d2f306edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_de01ed7a-a64a-4a19-9dfb-7d307b655dac" xlink:href="lgnd-20200930.xsd#lgnd_ForecastedCashFlowsEffectiveInterestRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent_de01ed7a-a64a-4a19-9dfb-7d307b655dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_12089933-1ccd-4ed3-b751-0f8a8c43f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_12089933-1ccd-4ed3-b751-0f8a8c43f6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CollaborationArrangementRoyaltyRate_c07eb2b5-9ef1-4a14-922d-90e7b028a087" xlink:href="lgnd-20200930.xsd#lgnd_CollaborationArrangementRoyaltyRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CollaborationArrangementRoyaltyRate_c07eb2b5-9ef1-4a14-922d-90e7b028a087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f261cf7-f47e-49e1-9f8e-a30587c3bb9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9f261cf7-f47e-49e1-9f8e-a30587c3bb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_fcbdcf31-cc32-4b0c-ac26-ca4a84bc1d79" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss_fcbdcf31-cc32-4b0c-ac26-ca4a84bc1d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_4907edd6-e049-4589-85bb-3b1b9ab8ae76" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod_4907edd6-e049-4589-85bb-3b1b9ab8ae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78f76334-ac96-4bfe-a2d9-99a074e92079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_083a1514-9eed-4947-8694-d43b8700d5a3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78f76334-ac96-4bfe-a2d9-99a074e92079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_08d03cab-f61f-4b75-8f2c-bd093f3f1732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_08d03cab-f61f-4b75-8f2c-bd093f3f1732" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:to="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_dfc86ea9-fe12-4253-a2eb-e90467bcc4f0" xlink:to="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:to="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_4a84d331-c2cc-49cb-bbce-d11af82612a9" xlink:href="lgnd-20200930.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_KyprolisMember_4a84d331-c2cc-49cb-bbce-d11af82612a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_ae2ef542-3d1a-46bc-9f3e-1ac40ce1c1e1" xlink:href="lgnd-20200930.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_EvomelaMember_ae2ef542-3d1a-46bc-9f3e-1ac40ce1c1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_b40b0c99-7261-4f64-a873-22164acac7b2" xlink:href="lgnd-20200930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_RoyaltyOtherMember_b40b0c99-7261-4f64-a873-22164acac7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PromactaMember_fbb70567-4abf-4a04-ae2e-8fe3ae6b569f" xlink:href="lgnd-20200930.xsd#lgnd_PromactaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_6f77d56d-64d8-4337-9c42-913543dac9d1" xlink:to="loc_lgnd_PromactaMember_fbb70567-4abf-4a04-ae2e-8fe3ae6b569f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_91424f12-ebc7-45ce-bed9-7b843df72a27" xlink:href="lgnd-20200930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_91424f12-ebc7-45ce-bed9-7b843df72a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3771add5-e4ad-43fd-97f0-0a542a077a9e" xlink:to="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_785cfdfa-cd66-47cd-ad1c-f5727f736fb9" xlink:href="lgnd-20200930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_ContractRevenueServiceMember_785cfdfa-cd66-47cd-ad1c-f5727f736fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_e1c59603-aed3-4efb-8353-df4e62810ccc" xlink:href="lgnd-20200930.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_LicenseFeesMember_e1c59603-aed3-4efb-8353-df4e62810ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_9000f982-e51c-4e46-9bde-0fb94ccaa1af" xlink:href="lgnd-20200930.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_MilestoneMember_9000f982-e51c-4e46-9bde-0fb94ccaa1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_0db8e1dd-d4e3-4608-8389-7ee0c32a266d" xlink:href="lgnd-20200930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_b4ff3b60-b217-4db2-ad24-ef45bf535577" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_0db8e1dd-d4e3-4608-8389-7ee0c32a266d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b61b9db0-7648-4a5e-8dd2-0717f206c7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f3620edc-1c4d-48db-a91f-72f336959339" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_b61b9db0-7648-4a5e-8dd2-0717f206c7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_af75c758-f70d-4569-be7f-f106fe0cb5c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b61b9db0-7648-4a5e-8dd2-0717f206c7e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_af75c758-f70d-4569-be7f-f106fe0cb5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7e5e49e-47b3-41a6-af7b-348cba90eca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7e5e49e-47b3-41a6-af7b-348cba90eca6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b817d3af-0001-4736-9829-b350856c0651" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_c31cb9b1-ced8-4494-ac26-949c4e4b2f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_DemandDepositsMember_c31cb9b1-ced8-4494-ac26-949c4e4b2f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e0a1f35e-ea25-415d-a052-57b564cc3fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e0a1f35e-ea25-415d-a052-57b564cc3fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_1538721e-c36a-47cd-b07f-10ac7921355e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_CommercialPaperMember_1538721e-c36a-47cd-b07f-10ac7921355e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4c8b5e0d-8a3d-41c9-ab10-e10bd1e96579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_EquitySecuritiesMember_4c8b5e0d-8a3d-41c9-ab10-e10bd1e96579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_a48055c4-76ee-4d07-a7d8-e0960416a8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_MutualFundMember_a48055c4-76ee-4d07-a7d8-e0960416a8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_9711b4fe-cf82-45ca-a0e2-18d6ce41eaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a447473e-e8d4-4002-929a-4e044debbda0" xlink:to="loc_us-gaap_WarrantMember_9711b4fe-cf82-45ca-a0e2-18d6ce41eaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_a440bc01-06bd-4874-8ca3-7766bf563b37" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04ad80e2-98c3-420f-9e3a-da4442d5ccff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_04ad80e2-98c3-420f-9e3a-da4442d5ccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_314bb92d-5e26-4289-a53e-ca1379a3bd3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_314bb92d-5e26-4289-a53e-ca1379a3bd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_64e44e9d-b87e-40e5-ae2f-ee9307c09318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_64e44e9d-b87e-40e5-ae2f-ee9307c09318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeed8229-f306-4319-8c3a-47e99a4f1bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eeed8229-f306-4319-8c3a-47e99a4f1bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLossAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_6525f764-5b20-469d-a1c5-7084009795da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_6525f764-5b20-469d-a1c5-7084009795da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_b5546fc7-b804-4ca3-9d6a-f9c52a4ab609" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain_b5546fc7-b804-4ca3-9d6a-f9c52a4ab609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_76326d59-f2c6-4a70-b100-2194c59ce9eb" xlink:href="lgnd-20200930.xsd#lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss_76326d59-f2c6-4a70-b100-2194c59ce9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_22daa239-76e7-41e5-a175-992915378334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLossAbstract_145ef979-35f1-4237-b317-44b6f769e6a9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_22daa239-76e7-41e5-a175-992915378334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_987778b8-c469-48f4-b69f-8209f48c5d6a" xlink:to="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_e72da02e-2678-4d9d-8e5e-645452e57c21" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost_e72da02e-2678-4d9d-8e5e-645452e57c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_d5792e05-1756-4f33-93b6-2ca2de68338a" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax_d5792e05-1756-4f33-93b6-2ca2de68338a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_e70d5b68-ef17-49fd-97d1-201c353d061f" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax_e70d5b68-ef17-49fd-97d1-201c353d061f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_e63019eb-c5e3-41cd-a9ab-616a19379861" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract_f4146ef6-ea0e-4159-8da5-57eac4741a9d" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_e63019eb-c5e3-41cd-a9ab-616a19379861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5024496b-25ed-4e3d-9194-1a0196244042" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_2f51c302-6fdb-45db-98d6-9005b91e754b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5024496b-25ed-4e3d-9194-1a0196244042" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_2f51c302-6fdb-45db-98d6-9005b91e754b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_5a535d20-6a28-48bd-8222-4016a7f7bb49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_2f51c302-6fdb-45db-98d6-9005b91e754b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_5a535d20-6a28-48bd-8222-4016a7f7bb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_950b5efb-ad92-458e-9770-c4e98f2eda57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_2f51c302-6fdb-45db-98d6-9005b91e754b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_950b5efb-ad92-458e-9770-c4e98f2eda57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_eee5d71b-b928-4686-a658-6e1eb7c153a3" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_2f51c302-6fdb-45db-98d6-9005b91e754b" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost_eee5d71b-b928-4686-a658-6e1eb7c153a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_ec4f75b3-732b-4b39-a40e-63273c872f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_2f51c302-6fdb-45db-98d6-9005b91e754b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_ec4f75b3-732b-4b39-a40e-63273c872f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_4f70b0b4-e48e-44a6-b423-0aa5248a360f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5024496b-25ed-4e3d-9194-1a0196244042" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_4f70b0b4-e48e-44a6-b423-0aa5248a360f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_6984409e-e123-4f3c-9fa1-1697d3d34373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_4f70b0b4-e48e-44a6-b423-0aa5248a360f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_6984409e-e123-4f3c-9fa1-1697d3d34373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_a433bf4e-0a05-4a3f-93c3-5afe84efe27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_4f70b0b4-e48e-44a6-b423-0aa5248a360f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_a433bf4e-0a05-4a3f-93c3-5afe84efe27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_4ffc9948-1900-4d8b-b43b-2790f980c9aa" xlink:href="lgnd-20200930.xsd#lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_4f70b0b4-e48e-44a6-b423-0aa5248a360f" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue_4ffc9948-1900-4d8b-b43b-2790f980c9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_6797a367-0e35-4023-8cdd-f0bd609ec0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_4f70b0b4-e48e-44a6-b423-0aa5248a360f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_6797a367-0e35-4023-8cdd-f0bd609ec0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ef9f57da-464e-4fc1-b389-013d8198b026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ef9f57da-464e-4fc1-b389-013d8198b026" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e6aa596a-bae7-4d28-9c53-6cef87360af7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_266058ef-52b2-4d82-a216-a7bdeb86c83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:to="loc_us-gaap_DemandDepositsMember_266058ef-52b2-4d82-a216-a7bdeb86c83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_6bd9e087-917f-4acc-adaa-6f2f6a7bec0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_6bd9e087-917f-4acc-adaa-6f2f6a7bec0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4b22b505-5b72-4b9c-b0b1-6cca3baa23d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_84b5e668-42cc-42b5-aa04-efcfd67bc445" xlink:to="loc_us-gaap_CommercialPaperMember_4b22b505-5b72-4b9c-b0b1-6cca3baa23d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_55cd7f48-d07d-46dd-889e-5f171c922175" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bb05bfcf-6d48-4d17-8e87-0d1bf4548acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_bb05bfcf-6d48-4d17-8e87-0d1bf4548acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_06631bf6-c2cb-491c-83d5-8a634074da0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_06631bf6-c2cb-491c-83d5-8a634074da0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_66133dba-d7f2-40e2-a7c6-785d1df5dd73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_b0f90475-9393-4f64-b0db-9d4296c43d96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_66133dba-d7f2-40e2-a7c6-785d1df5dd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_612ad5c8-7ad7-4040-ad4f-3bc96174ccfa" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3c6b3473-8f31-4a32-832b-2127760763cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_3c6b3473-8f31-4a32-832b-2127760763cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_23cf9bbf-7e02-43a3-88d3-670f543bcc81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_23cf9bbf-7e02-43a3-88d3-670f543bcc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d50baba7-be1a-48bc-8513-624d5c13e0b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_c8dd713e-b10b-4158-81e2-201188106a3d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d50baba7-be1a-48bc-8513-624d5c13e0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cbed8d96-e46b-4c5a-b159-27e4111a2a77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cbed8d96-e46b-4c5a-b159-27e4111a2a77" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_531239b0-abdf-4272-9931-59000a1bda1d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_7c2a4697-9a04-4725-a290-412285bc779d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_PatentedTechnologyMember_7c2a4697-9a04-4725-a290-412285bc779d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a767b091-79d6-406c-b898-cf4432ea0b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_TradeNamesMember_a767b091-79d6-406c-b898-cf4432ea0b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3851043c-4601-406a-9650-815a3cd842fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3851043c-4601-406a-9650-815a3cd842fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_caaf2d17-bafe-444d-b480-0dd0c65759cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ce2cb6e2-0ebd-4386-a9ad-15da24468274" xlink:to="loc_us-gaap_LicensingAgreementsMember_caaf2d17-bafe-444d-b480-0dd0c65759cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:to="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77ea50bc-2518-48e6-aa2e-f27702dc249b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2a0f19a4-6126-43ef-b58a-8e0ae33da696" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77ea50bc-2518-48e6-aa2e-f27702dc249b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_2add5b7a-8c32-43ea-a6ca-2de178c09b0e" xlink:href="lgnd-20200930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_77ea50bc-2518-48e6-aa2e-f27702dc249b" xlink:to="loc_lgnd_SelexisAndDianomiMember_2add5b7a-8c32-43ea-a6ca-2de178c09b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c57f6d45-b4a0-4c45-871d-bbd9290ebae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3c97b88b-c57e-412b-b363-9e78e73f7aa2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c57f6d45-b4a0-4c45-871d-bbd9290ebae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c57f6d45-b4a0-4c45-871d-bbd9290ebae8" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebb69cf7-1768-4e1f-aa6d-5039573e2797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_Goodwill_ebb69cf7-1768-4e1f-aa6d-5039573e2797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f19189ff-fc59-46ff-b1f6-9e9ed2ad4f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f19189ff-fc59-46ff-b1f6-9e9ed2ad4f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dcc824e7-5878-4451-98fd-ba6e58153749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dcc824e7-5878-4451-98fd-ba6e58153749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f27df8e1-135f-4db6-ab8e-4f2e017ac93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_7db8cd07-54d5-4b91-b441-6f3a9fd28117" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_f27df8e1-135f-4db6-ab8e-4f2e017ac93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_601fd21a-26b3-49e0-a189-6bf3a9f5c4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_601fd21a-26b3-49e0-a189-6bf3a9f5c4d7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb096ca-3938-4b3a-a9f9-3a10d82ac2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d14d3c8c-f167-4292-893d-a0aa17d4048d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb096ca-3938-4b3a-a9f9-3a10d82ac2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_81007103-9efe-4b6b-848d-59eef9323445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb096ca-3938-4b3a-a9f9-3a10d82ac2e1" xlink:to="loc_us-gaap_LicensingAgreementsMember_81007103-9efe-4b6b-848d-59eef9323445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:to="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a5cf155e-eecf-4cac-b42c-7141e7131ea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_4f0c6f13-1554-40bd-8edc-df86cd2ef45d" xlink:href="lgnd-20200930.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_4f0c6f13-1554-40bd-8edc-df86cd2ef45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PalvellaMember_1401d8d7-d64c-42b5-8c91-3e9d7ce4a508" xlink:href="lgnd-20200930.xsd#lgnd_PalvellaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:to="loc_lgnd_PalvellaMember_1401d8d7-d64c-42b5-8c91-3e9d7ce4a508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_bca1c904-565a-4a3c-b15f-68dfca99a3f6" xlink:href="lgnd-20200930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_aca87240-0c3c-4f63-a2c7-f43daf173e3c" xlink:to="loc_lgnd_SelexisAndDianomiMember_bca1c904-565a-4a3c-b15f-68dfca99a3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_26dbf029-e6cd-4664-8ca8-ca3e99de0360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_56228cc9-e91c-462c-b22e-e7ee11424c85" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_26dbf029-e6cd-4664-8ca8-ca3e99de0360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:href="lgnd-20200930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_26dbf029-e6cd-4664-8ca8-ca3e99de0360" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_74284dbc-cae7-42ae-a523-70488ffaa4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_74284dbc-cae7-42ae-a523-70488ffaa4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_be55682e-bbee-40ab-99c2-a1c87269e6a1" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_be55682e-bbee-40ab-99c2-a1c87269e6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5ace89a-454c-4ebb-a863-b0719a54259f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5ace89a-454c-4ebb-a863-b0719a54259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d0d3119-797f-4d4b-8f07-8293c95022b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1d0d3119-797f-4d4b-8f07-8293c95022b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_a739d83d-0ef7-4798-b5a8-f92fd07447da" xlink:href="lgnd-20200930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_054665cb-91c7-457c-9b90-3676d99a0098" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_a739d83d-0ef7-4798-b5a8-f92fd07447da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RampUpFeeAssetNoncurrent_bdd34979-f027-4220-92e1-a89c71fca2c7" xlink:href="lgnd-20200930.xsd#lgnd_RampUpFeeAssetNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:to="loc_lgnd_RampUpFeeAssetNoncurrent_bdd34979-f027-4220-92e1-a89c71fca2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestmentsAndReceivablesNet_0ff4a86b-567b-49d4-a536-9c8dade7da27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:to="loc_us-gaap_LongTermInvestmentsAndReceivablesNet_0ff4a86b-567b-49d4-a536-9c8dade7da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_31429a22-d4d6-4d48-9bbc-560aebc2e6ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:to="loc_us-gaap_EquityMethodInvestments_31429a22-d4d6-4d48-9bbc-560aebc2e6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_77729e0d-6085-4ec2-9e7b-ecf2afdfd578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_77729e0d-6085-4ec2-9e7b-ecf2afdfd578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_389fc79a-0043-4b4f-adc6-955105e7d40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_389fc79a-0043-4b4f-adc6-955105e7d40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_31738adf-59d9-4bea-9d74-b7706c515749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_575f02b4-5908-4b5a-a102-1c82a62150c7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_31738adf-59d9-4bea-9d74-b7706c515749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed9b641c-2820-4e05-86e9-b8de4abf63f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ed9b641c-2820-4e05-86e9-b8de4abf63f8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5ac00913-9cab-40f2-8ac5-09e0e031f29b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5ac00913-9cab-40f2-8ac5-09e0e031f29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_c075adf2-8c05-4845-aca1-89f9f5cce11e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_c075adf2-8c05-4845-aca1-89f9f5cce11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_caf95e80-6cae-4ff2-872d-29106607607a" xlink:href="lgnd-20200930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_lgnd_LicenseeAccrualCurrent_caf95e80-6cae-4ff2-872d-29106607607a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_c300e28f-58cc-493f-b8c3-996908d7cef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_c300e28f-58cc-493f-b8c3-996908d7cef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_837e7270-8fbc-41fb-b8bd-40b8ec86f1c7" xlink:href="lgnd-20200930.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_lgnd_ReturnsAccrual_837e7270-8fbc-41fb-b8bd-40b8ec86f1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_fa5917e9-b159-4e0e-ae03-8c38ed765f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_fa5917e9-b159-4e0e-ae03-8c38ed765f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_0ff8c2d7-d7b8-4020-85bf-d5dbfa958c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_InterestPayableCurrent_0ff8c2d7-d7b8-4020-85bf-d5dbfa958c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8c627ff8-5b48-4e58-98d1-60ba0d3b4211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8c627ff8-5b48-4e58-98d1-60ba0d3b4211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8c2f7e2b-5ef5-48d1-b531-89a6ffcf0a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_f04ad4e7-6850-42b6-91f9-59ac26a7c12b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8c2f7e2b-5ef5-48d1-b531-89a6ffcf0a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7b46bdc-f2f4-4abe-a155-bab9c7f7e55e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:href="lgnd-20200930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f7b46bdc-f2f4-4abe-a155-bab9c7f7e55e" xlink:to="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16e5c883-3fbe-48cf-acf0-3cc3d70bdf6c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_71117dfb-ecee-4906-be73-9e8baf6cd6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_71117dfb-ecee-4906-be73-9e8baf6cd6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5112ba76-1e1a-442f-a270-fe69092145b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_90380688-a7c7-44bd-b534-b607f46f9c71" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5112ba76-1e1a-442f-a270-fe69092145b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_45861a76-7040-44f0-94e7-e3c24d8c34b5" xlink:href="lgnd-20200930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_ab473761-7902-4bee-bcf3-483ecc3aa2b5" xlink:to="loc_lgnd_BasisOfPresentationLineItems_45861a76-7040-44f0-94e7-e3c24d8c34b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cf0c6b07-230c-4c74-9483-67173fb17000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_45861a76-7040-44f0-94e7-e3c24d8c34b5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_cf0c6b07-230c-4c74-9483-67173fb17000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe5cd815-0440-4494-884f-9999cccf1d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_933b78b2-3b1b-4490-b27d-0b7caa8e975b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe5cd815-0440-4494-884f-9999cccf1d75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_933b78b2-3b1b-4490-b27d-0b7caa8e975b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b8e8f7dd-3dee-4a56-93d2-c8349325b01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe5cd815-0440-4494-884f-9999cccf1d75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b8e8f7dd-3dee-4a56-93d2-c8349325b01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d68dfb5e-263e-4f6f-988d-d4a045dd7c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe5cd815-0440-4494-884f-9999cccf1d75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d68dfb5e-263e-4f6f-988d-d4a045dd7c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8e7740c1-c4ab-4ddd-9c73-87222eff2a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fe5cd815-0440-4494-884f-9999cccf1d75" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8e7740c1-c4ab-4ddd-9c73-87222eff2a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0f8da7c8-ddb1-47e4-b353-1ed3cb75a364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2156fbe4-e30f-4dd0-95cb-47f8eb1e024c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0f8da7c8-ddb1-47e4-b353-1ed3cb75a364" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2156fbe4-e30f-4dd0-95cb-47f8eb1e024c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_142bf496-ef93-435e-85a9-8face93f4211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2156fbe4-e30f-4dd0-95cb-47f8eb1e024c" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_142bf496-ef93-435e-85a9-8face93f4211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_909d52ba-2d9b-4566-82cf-79a01214755e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2156fbe4-e30f-4dd0-95cb-47f8eb1e024c" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_909d52ba-2d9b-4566-82cf-79a01214755e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_9f68aea1-49cc-4322-ab5d-bbf57cd1f0cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_909d52ba-2d9b-4566-82cf-79a01214755e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_9f68aea1-49cc-4322-ab5d-bbf57cd1f0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0d58dd9c-2e81-4483-bf47-649f26221587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_909d52ba-2d9b-4566-82cf-79a01214755e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0d58dd9c-2e81-4483-bf47-649f26221587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_45066b89-ce4f-4d87-8403-5cb74d17867a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_909d52ba-2d9b-4566-82cf-79a01214755e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_45066b89-ce4f-4d87-8403-5cb74d17867a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b4e91127-2663-4947-bcaf-6423d0609997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_2156fbe4-e30f-4dd0-95cb-47f8eb1e024c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b4e91127-2663-4947-bcaf-6423d0609997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2e48227d-5f30-4c7f-8d01-9a8545e6d6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5515410e-fc34-4f5c-95e2-b8dd4e0c6bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2e48227d-5f30-4c7f-8d01-9a8545e6d6e3" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5515410e-fc34-4f5c-95e2-b8dd4e0c6bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_020f480b-e46c-4352-b687-ed4cbb25a97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_be8ad1e3-782a-45cc-8594-014129643e32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_020f480b-e46c-4352-b687-ed4cbb25a97c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_be8ad1e3-782a-45cc-8594-014129643e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_95067cf5-aaaf-4a76-aecf-8ac815f3ab7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_95067cf5-aaaf-4a76-aecf-8ac815f3ab7a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ada775f2-cb6e-4e73-ba27-e9a345803072" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_47f1c365-d228-4b53-937c-fdbaff9e540c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_47f1c365-d228-4b53-937c-fdbaff9e540c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0595438c-9db5-40e9-827c-3d0ad08f5963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0595438c-9db5-40e9-827c-3d0ad08f5963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b9b59c57-5d28-473e-8c90-2eccf7e610db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e97594c0-48de-4255-9190-9cbe56381ed5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b9b59c57-5d28-473e-8c90-2eccf7e610db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_dfdf9fb1-5b8b-48b6-9bf4-b955fcab885b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember_0eaf0359-dc1b-4a27-b050-cb3b5c3b6683" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember_0eaf0359-dc1b-4a27-b050-cb3b5c3b6683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember_e7b3855c-decc-4806-b584-d4a65e622c75" xlink:href="lgnd-20200930.xsd#lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember_e7b3855c-decc-4806-b584-d4a65e622c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember_b4d280ea-9baa-4d74-bd2c-f69a9b6e0f71" xlink:href="lgnd-20200930.xsd#lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember_b4d280ea-9baa-4d74-bd2c-f69a9b6e0f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_013d7c28-a8cb-4055-b1eb-fa952c048a25" xlink:href="lgnd-20200930.xsd#lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6456d13b-d0e8-4a48-86e8-a8ccc9a83493" xlink:to="loc_lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember_013d7c28-a8cb-4055-b1eb-fa952c048a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b014a0cd-51e6-4cfa-b1f0-ba55b419d678" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ad880d03-3d90-4d8c-8e85-9dc648de70dc" xlink:to="loc_srt_RangeMember_b014a0cd-51e6-4cfa-b1f0-ba55b419d678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c48fbdf6-ac20-44ed-8fdc-5469a6c3ed6a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b014a0cd-51e6-4cfa-b1f0-ba55b419d678" xlink:to="loc_srt_MaximumMember_c48fbdf6-ac20-44ed-8fdc-5469a6c3ed6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2a0b3d3a-b078-4c24-8013-125d0558dcfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_76eef4ae-f532-4188-9aa6-6ae42e47601d" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2a0b3d3a-b078-4c24-8013-125d0558dcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_9703c0b2-5607-4f7c-beeb-b88758f167b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_2a0b3d3a-b078-4c24-8013-125d0558dcfa" xlink:to="loc_us-gaap_TransferredOverTimeMember_9703c0b2-5607-4f7c-beeb-b88758f167b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5dbafd28-4e9c-428d-a6cc-7197ff3d7d57" xlink:to="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_66809785-0b9e-488a-b7aa-332fb2d825cf" xlink:href="lgnd-20200930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_66809785-0b9e-488a-b7aa-332fb2d825cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_7b7b0f53-99a2-4664-8293-4ac327cfc01c" xlink:href="lgnd-20200930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d160cc6c-d085-4136-a32b-17838ba3dae5" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_7b7b0f53-99a2-4664-8293-4ac327cfc01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b1c2e4-a696-4cfa-a7ad-51be01108f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f2600f07-9e67-43b1-907a-fb04b115e694" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b1c2e4-a696-4cfa-a7ad-51be01108f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_f2252557-1b29-4790-aaf2-81d4cca8ebac" xlink:href="lgnd-20200930.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8b1c2e4-a696-4cfa-a7ad-51be01108f12" xlink:to="loc_lgnd_MetabasisMember_f2252557-1b29-4790-aaf2-81d4cca8ebac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_31bbec15-5a0a-43e9-8846-59122ab4eec4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShortTermInvestmentsFairValueDisclosure_2b3b7381-5700-4812-b52d-3cf5177ee985" xlink:href="lgnd-20200930.xsd#lgnd_ShortTermInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_lgnd_ShortTermInvestmentsFairValueDisclosure_2b3b7381-5700-4812-b52d-3cf5177ee985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_563766bc-d045-414f-ab39-418536b4ad2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_563766bc-d045-414f-ab39-418536b4ad2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_28c7722e-063e-414f-bb8a-00418522b4d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_28c7722e-063e-414f-bb8a-00418522b4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7ccbe389-a9dc-4c55-b8c0-494a1bf10e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_4f1cb7ce-4b74-4ee6-905c-6b7e4dbe75d4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7ccbe389-a9dc-4c55-b8c0-494a1bf10e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesFairValueDisclosure_5b928b2d-26cf-4b78-8026-22da0b39ef1f" xlink:href="lgnd-20200930.xsd#lgnd_ContingentLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:to="loc_lgnd_ContingentLiabilitiesFairValueDisclosure_5b928b2d-26cf-4b78-8026-22da0b39ef1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_ed39f039-2f8f-4e7d-a516-6b2e978408c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_ed39f039-2f8f-4e7d-a516-6b2e978408c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_66ddffc9-990f-4e51-bfa7-52f8bbb8c7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1561a05a-f97c-47d9-a393-c15d67394d7e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_66ddffc9-990f-4e51-bfa7-52f8bbb8c7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_47d021ce-76cc-4908-95a2-a70d4f03bc53" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities_47d021ce-76cc-4908-95a2-a70d4f03bc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_cba8af87-afc6-4d2f-a273-f236c65eb7b9" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_cba8af87-afc6-4d2f-a273-f236c65eb7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f7960c6a-3e55-428e-a140-c8045beed89a" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_f7960c6a-3e55-428e-a140-c8045beed89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_63c32f9d-24ac-47dc-b30a-506461a2d623" xlink:href="lgnd-20200930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_63c32f9d-24ac-47dc-b30a-506461a2d623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_34401fa9-7612-4db8-9c9f-153d9d056df6" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_34401fa9-7612-4db8-9c9f-153d9d056df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9a7bb347-5f7d-45b4-9b54-685f88ac4130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_Investments_9a7bb347-5f7d-45b4-9b54-685f88ac4130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_8d6879c0-d7b8-4d55-9987-b89764ba8f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_8d6879c0-d7b8-4d55-9987-b89764ba8f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0a992c35-72eb-444a-b517-1a267afc9984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_41c8da80-4d18-467f-9789-8d67c35baff2" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_0a992c35-72eb-444a-b517-1a267afc9984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Acquisitions" xlink:type="simple" xlink:href="lgnd-20200930.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d66d1137-0728-479c-86d4-9785325684e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_10cda553-d755-4bb6-a652-75bb416b442e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d66d1137-0728-479c-86d4-9785325684e1" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_10cda553-d755-4bb6-a652-75bb416b442e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_00b5ba80-49c6-42b1-a4c4-2d2fbe3f2a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_00b5ba80-49c6-42b1-a4c4-2d2fbe3f2a8f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d282030-7864-4002-900f-27d8818274fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TaurusBiosciencesLLCMember_a24950bb-97ba-4457-9f84-299a0abd83fd" xlink:href="lgnd-20200930.xsd#lgnd_TaurusBiosciencesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_TaurusBiosciencesLLCMember_a24950bb-97ba-4457-9f84-299a0abd83fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_60b6bcf7-849d-4263-afc2-66594e160be5" xlink:href="lgnd-20200930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_60b6bcf7-849d-4263-afc2-66594e160be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_f08ff688-095e-4c27-a7cb-2eb3fe1942cb" xlink:href="lgnd-20200930.xsd#lgnd_IcagenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_IcagenMember_f08ff688-095e-4c27-a7cb-2eb3fe1942cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AbInitioBiotherapeuticsIncMember_4b93b0d2-1cf1-4f10-bc14-6c7675a73a1a" xlink:href="lgnd-20200930.xsd#lgnd_AbInitioBiotherapeuticsIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77764fb6-1d9c-4631-9d27-db4f36c4222f" xlink:to="loc_lgnd_AbInitioBiotherapeuticsIncMember_4b93b0d2-1cf1-4f10-bc14-6c7675a73a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_111ba9e2-4d01-4ab8-9360-beedee5e03b6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ab9771c2-ed81-4afa-b2bb-b3beae21b8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_ab9771c2-ed81-4afa-b2bb-b3beae21b8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4c14312d-e41b-41bb-a66a-d39ab79cc421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a3817df8-85cc-401d-838f-dc2de2964c74" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4c14312d-e41b-41bb-a66a-d39ab79cc421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ca719647-a253-47bb-b0f5-9bd7f597b19d" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_86386f54-260b-4c3c-b1d6-edf12e013f92" xlink:href="lgnd-20200930.xsd#lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember_86386f54-260b-4c3c-b1d6-edf12e013f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentValueRightOnProductRevenuesMember_218a28bc-fc59-4d8e-8daf-3c6f1205d724" xlink:href="lgnd-20200930.xsd#lgnd_ContingentValueRightOnProductRevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_ContingentValueRightOnProductRevenuesMember_218a28bc-fc59-4d8e-8daf-3c6f1205d724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_0626a4f7-459f-4bbd-af13-5a04abf29cf3" xlink:href="lgnd-20200930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_0626a4f7-459f-4bbd-af13-5a04abf29cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestonePaymentsMember_44d1b41b-73fc-49a1-aadc-9bb3814831e1" xlink:href="lgnd-20200930.xsd#lgnd_MilestonePaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_68d721cb-9111-4452-8087-3549ce05b040" xlink:to="loc_lgnd_MilestonePaymentsMember_44d1b41b-73fc-49a1-aadc-9bb3814831e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_99421566-607f-422f-9257-bb668ac28a46" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a1366ff8-ea06-4bed-8ea3-9bd6e71533e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a1366ff8-ea06-4bed-8ea3-9bd6e71533e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c4bc1e4-c99e-4770-b711-d296ad08827e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9c4bc1e4-c99e-4770-b711-d296ad08827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_2a961c8e-907b-4982-877d-4ef9067d60dc" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationConsiderationTransferredHoldback"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationConsiderationTransferredHoldback_2a961c8e-907b-4982-877d-4ef9067d60dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0ef8e8-cba1-4cb2-81c0-592fdd512508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7c0ef8e8-cba1-4cb2-81c0-592fdd512508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_7c3337fd-bce5-4c1b-a1ba-6d60f4d7b303" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues_7c3337fd-bce5-4c1b-a1ba-6d60f4d7b303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_5cce33ce-371a-40e0-a9dd-3f8cf83f6b7f" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_5cce33ce-371a-40e0-a9dd-3f8cf83f6b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f21eb79f-868e-49c8-b361-bc4db023ea0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f21eb79f-868e-49c8-b361-bc4db023ea0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72f0d3ce-49a6-4e35-80b3-1686c98ebac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72f0d3ce-49a6-4e35-80b3-1686c98ebac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ace7e2c9-9a08-4e02-8b60-6d771ac21644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ace7e2c9-9a08-4e02-8b60-6d771ac21644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5863b111-835f-4a1b-ba4c-2adb5857644b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5863b111-835f-4a1b-ba4c-2adb5857644b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a3905a42-0d07-4063-b3c3-109bd1afab59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a3905a42-0d07-4063-b3c3-109bd1afab59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_7384cdea-dc1f-40d8-8dc3-052203d5c12b" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_7384cdea-dc1f-40d8-8dc3-052203d5c12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_228b6c30-a10e-4fe7-b2bf-97b51039c5b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_228b6c30-a10e-4fe7-b2bf-97b51039c5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd3c5515-c82c-4320-afd8-c04fd67988e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_dd3c5515-c82c-4320-afd8-c04fd67988e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f5d0f911-d3a9-41f9-b3ef-f9694bd951fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f5d0f911-d3a9-41f9-b3ef-f9694bd951fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_95de1f0f-c651-4c28-8a23-b235f7e3907e" xlink:href="lgnd-20200930.xsd#lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate_95de1f0f-c651-4c28-8a23-b235f7e3907e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cf85f414-9060-46c8-966e-9f6e4f666db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_325435fa-0030-43dc-8075-9aef9d4fde9c" xlink:to="loc_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate_cf85f414-9060-46c8-966e-9f6e4f666db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dd3331da-c77b-44c9-8f82-678fdbcda1fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_e25eb6e8-4c60-4130-bde7-ca90e90af767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dd3331da-c77b-44c9-8f82-678fdbcda1fd" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_e25eb6e8-4c60-4130-bde7-ca90e90af767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fff57f1c-9ac7-425f-9478-b60940ef467b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_27822e20-a874-4b10-8b1f-4a3449611b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fff57f1c-9ac7-425f-9478-b60940ef467b" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_27822e20-a874-4b10-8b1f-4a3449611b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6c498f2a-28d6-45f3-8203-014ada30101e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6c498f2a-28d6-45f3-8203-014ada30101e" xlink:to="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f5913c8-4671-463a-8887-3b1142a1f1db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1fe3be4-cac3-4a9a-8054-c4a3e1382eb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f5913c8-4671-463a-8887-3b1142a1f1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_27fe31b7-4492-469b-9e2d-18678c136363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6f5913c8-4671-463a-8887-3b1142a1f1db" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_27fe31b7-4492-469b-9e2d-18678c136363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_735bca27-2105-4a37-8749-74d99f3dbdee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef4065f5-3b47-41ec-9361-d5d9ee68f9ef" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_735bca27-2105-4a37-8749-74d99f3dbdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_bde36598-5180-4767-8f65-39032b95a9d2" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_735bca27-2105-4a37-8749-74d99f3dbdee" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_bde36598-5180-4767-8f65-39032b95a9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3a1d3d3f-c564-4291-bbfa-36979fe8efc4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_fad8e415-ba39-4fea-b211-70e96da9a0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_fad8e415-ba39-4fea-b211-70e96da9a0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_915aecfb-c8cf-4555-a5ea-ea60da26bd3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_536712cd-c8f6-4a12-b042-4ae66dba59de" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_915aecfb-c8cf-4555-a5ea-ea60da26bd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_89a04e65-0857-4665-a10e-72dce72f2949" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_9b79d99d-c5d4-4394-a78e-8e72e7932ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_9b79d99d-c5d4-4394-a78e-8e72e7932ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cb3f4a6b-cfcf-46ca-a42f-50d5cc765991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cb3f4a6b-cfcf-46ca-a42f-50d5cc765991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c68b6be1-4ec7-4b86-9d60-19a50a92d07d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_c68b6be1-4ec7-4b86-9d60-19a50a92d07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bf91a89-f81c-4555-be50-eaa141ac4536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1bf91a89-f81c-4555-be50-eaa141ac4536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f715e083-fd12-48cc-9387-9390ac593ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f715e083-fd12-48cc-9387-9390ac593ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_08defb4a-a705-4056-86fe-f9b2e6216eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_08defb4a-a705-4056-86fe-f9b2e6216eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c58ffb6c-6a4b-48e3-ba61-fc10ecfbb86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c58ffb6c-6a4b-48e3-ba61-fc10ecfbb86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9060c41d-3ca0-4d70-8930-e427d344b18a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_9060c41d-3ca0-4d70-8930-e427d344b18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_cda1fb98-4c3b-4180-ab17-72548756c124" xlink:href="lgnd-20200930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_cda1fb98-4c3b-4180-ab17-72548756c124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_d7f50094-32e8-4389-b00d-be70ed4ce0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_d7f50094-32e8-4389-b00d-be70ed4ce0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_f8b64062-6f88-4c30-af95-f35fef9c99b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_f8b64062-6f88-4c30-af95-f35fef9c99b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2d2d59ec-227e-4232-aa15-2230685918d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_LongTermDebt_2d2d59ec-227e-4232-aa15-2230685918d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_f7dacac7-21fe-40e6-8341-032b66c09f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_f7dacac7-21fe-40e6-8341-032b66c09f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_bb58ebf9-bcf6-4fcb-ba4e-a0acf86a5257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_bb58ebf9-bcf6-4fcb-ba4e-a0acf86a5257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3976ef45-5bf6-4063-8cf5-7e9f54c677dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3976ef45-5bf6-4063-8cf5-7e9f54c677dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_2b196749-278e-4d03-bf5a-7c2b6fbf3b33" xlink:href="lgnd-20200930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_2b196749-278e-4d03-bf5a-7c2b6fbf3b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_ae0eaeea-8d50-459a-b5a5-6d752f5d6132" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_ae0eaeea-8d50-459a-b5a5-6d752f5d6132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f31acab2-8a5b-481d-8fe0-65d13b39fdbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f31acab2-8a5b-481d-8fe0-65d13b39fdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_c9879b5f-8c0a-429f-8d57-b8c462d6fa37" xlink:href="lgnd-20200930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_c9879b5f-8c0a-429f-8d57-b8c462d6fa37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b23a47e-a093-43cf-b658-48e670aa7452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8b23a47e-a093-43cf-b658-48e670aa7452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea2bee10-04cd-4974-86aa-421520624fed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6335d958-f0f6-4998-b9df-98bcf7a0200f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea2bee10-04cd-4974-86aa-421520624fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e844528b-fb44-4bc0-b323-9e0e2eacbff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e844528b-fb44-4bc0-b323-9e0e2eacbff6" xlink:to="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_463a7c5e-59b6-4f8d-8249-c4c4b872702c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b92a3106-cc30-47cd-b0ce-93d5e3a6411a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_463a7c5e-59b6-4f8d-8249-c4c4b872702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_9c263027-952f-4731-a545-ac112f55190f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_463a7c5e-59b6-4f8d-8249-c4c4b872702c" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_9c263027-952f-4731-a545-ac112f55190f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:to="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de5033d5-01bd-4914-94d2-2a737c0afc78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_449b077c-3b8d-479b-8b3c-b115992d6f63" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de5033d5-01bd-4914-94d2-2a737c0afc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0076dbd0-9a81-49fd-899f-803eafc6fcaf" xlink:href="lgnd-20200930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_de5033d5-01bd-4914-94d2-2a737c0afc78" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_0076dbd0-9a81-49fd-899f-803eafc6fcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ec37b9dc-3f4b-42bd-aff1-5ae0df6a5ffa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_376a0d30-51ba-4cd1-a65e-453fa6699f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_376a0d30-51ba-4cd1-a65e-453fa6699f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5665f202-7b6d-4a77-bec8-fe0984bb7a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5665f202-7b6d-4a77-bec8-fe0984bb7a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_0c7797f0-2c95-4079-b32b-ab2018aceb5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_a9b7a0da-20e9-451d-8497-f45d37621b16" xlink:to="loc_us-gaap_LongTermNotesPayable_0c7797f0-2c95-4079-b32b-ab2018aceb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_334bbf99-de6a-4785-9b6d-9717cc0492c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_334bbf99-de6a-4785-9b6d-9717cc0492c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_115f338d-06de-4b37-ace5-45290161fea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8d188c84-93ad-4087-a462-fcc5cd80cb1f" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_115f338d-06de-4b37-ace5-45290161fea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20200930.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e351fba2-8af6-471c-92c4-9dc2cbaf82a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_442a38ee-576e-4b68-946e-dc945e707f17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e351fba2-8af6-471c-92c4-9dc2cbaf82a0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_442a38ee-576e-4b68-946e-dc945e707f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#IncomeTaxNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_35de0ddf-9250-41fc-baf0-53fab9cec243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b550be4b-1f6c-4a1b-824f-f72d8e177da8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_35de0ddf-9250-41fc-baf0-53fab9cec243" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b550be4b-1f6c-4a1b-824f-f72d8e177da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c5437043-e816-440a-9019-27c6a5888014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f963974-b835-4dd6-af27-15e6cd8cee2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c5437043-e816-440a-9019-27c6a5888014" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f963974-b835-4dd6-af27-15e6cd8cee2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_62c4674a-9bf9-4ec5-b9c0-c52eaae864c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca39121c-c17f-483e-af1b-66bb3fbe1ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_62c4674a-9bf9-4ec5-b9c0-c52eaae864c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ca39121c-c17f-483e-af1b-66bb3fbe1ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7f6a7325-c71e-4bd2-8e2c-f322141d645c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_62c4674a-9bf9-4ec5-b9c0-c52eaae864c7" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_7f6a7325-c71e-4bd2-8e2c-f322141d645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9a7d8625-3a78-435a-b183-18ac48b38672" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9a7d8625-3a78-435a-b183-18ac48b38672" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:to="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bca05ba7-cfba-4cfb-ae1f-3b52627a22e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_45594e26-efad-48c0-880a-008ddcbebe2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_45594e26-efad-48c0-880a-008ddcbebe2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_26006515-e4d3-4eda-b09f-51dffb59173a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a206031a-106a-4019-8715-b3a25f9c61bb" xlink:to="loc_us-gaap_RestrictedStockMember_26006515-e4d3-4eda-b09f-51dffb59173a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_74555756-a39d-40c8-8e5f-1de93a93e33b" xlink:to="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d654555d-1c70-4e22-9f8e-c219a1f3e866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d654555d-1c70-4e22-9f8e-c219a1f3e866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_09fde424-69a9-44ca-bb14-81863452fdb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_09fde424-69a9-44ca-bb14-81863452fdb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6811851-2582-44a5-958a-41a17dc96813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6811851-2582-44a5-958a-41a17dc96813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c08c794-9377-4ed8-b230-ce53517d3d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8c08c794-9377-4ed8-b230-ce53517d3d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cf2976ea-8b3b-40c3-b9d7-1399080a85b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f4e957ec-2cf2-4478-92a0-d72f48203d2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_cf2976ea-8b3b-40c3-b9d7-1399080a85b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7199fe8a-eff7-43ae-ba1e-c3b5b563253c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7199fe8a-eff7-43ae-ba1e-c3b5b563253c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5e8769ad-dd17-4d1e-b262-fe04073e297b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5e8769ad-dd17-4d1e-b262-fe04073e297b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_00066953-fc22-4215-80c3-b9224541f471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_00066953-fc22-4215-80c3-b9224541f471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_233067a7-f3cf-47e8-919c-7594d7566b01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_233067a7-f3cf-47e8-919c-7594d7566b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1f38e98-f6a3-48d2-8d4f-7694bc8bb028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3c44097-3aa6-48d5-9de2-c312fe65f33e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e1f38e98-f6a3-48d2-8d4f-7694bc8bb028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_218038a4-e963-4b03-99fe-683156312520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_218038a4-e963-4b03-99fe-683156312520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fc31927-7a17-45d8-a2bf-5de067d1f50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1fc31927-7a17-45d8-a2bf-5de067d1f50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d093e39-ec09-4a7f-8660-8877d56ba27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d093e39-ec09-4a7f-8660-8877d56ba27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9f7de826-ffa8-421c-ab58-68d9e643f394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9f7de826-ffa8-421c-ab58-68d9e643f394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5cdc61d8-cd94-4f8c-93a2-b3ba0bc074db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9d66d0d0-96ba-47c8-88a3-0d5f27a68032" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5cdc61d8-cd94-4f8c-93a2-b3ba0bc074db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_84e47448-b7fd-482b-be1a-cdb9f17e42c5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c1a6617-222a-46f7-ac01-eb95c65da30a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2c1a6617-222a-46f7-ac01-eb95c65da30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d518e95-033e-4f7f-ade6-9e5298e5fb8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d518e95-033e-4f7f-ade6-9e5298e5fb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2af8b2fd-6f55-46c3-beb6-54ded094c6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2af8b2fd-6f55-46c3-beb6-54ded094c6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_79c84672-5c11-4814-b44d-3e444b82fe94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_79c84672-5c11-4814-b44d-3e444b82fe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14fb4423-253a-48f0-be24-cd40a6cd2d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_05982417-588a-490f-8839-3a088a84b026" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_14fb4423-253a-48f0-be24-cd40a6cd2d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9754bd62-f98d-4113-a116-6a17df958b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9754bd62-f98d-4113-a116-6a17df958b02" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:to="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_704d9286-fd91-450c-912b-c21f43dcedc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_55545e6f-b4ce-4476-987f-dee3d16b884b" xlink:to="loc_us-gaap_PlanNameDomain_704d9286-fd91-450c-912b-c21f43dcedc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_dd99b4db-e88e-43ce-90b4-42b13ca90f43" xlink:href="lgnd-20200930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_704d9286-fd91-450c-912b-c21f43dcedc3" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_dd99b4db-e88e-43ce-90b4-42b13ca90f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc0604bd-03d4-4e3a-a9ec-6acc920e2a85" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4eefcd4-f07e-43d6-a0bf-38c1eb8ac26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c4eefcd4-f07e-43d6-a0bf-38c1eb8ac26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_17622ad1-5122-40f3-8ae0-6f006e6e5646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_17622ad1-5122-40f3-8ae0-6f006e6e5646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:href="lgnd-20200930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_db236442-a947-4ff8-acad-92a662cdb582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_db236442-a947-4ff8-acad-92a662cdb582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_323ba12f-79ab-4139-8b10-a5d1679fe532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_08689638-f123-4d34-873b-ea2e70b660b3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_323ba12f-79ab-4139-8b10-a5d1679fe532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_30c03353-1612-4451-869b-17fcb47d361b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_30c03353-1612-4451-869b-17fcb47d361b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50ea36cc-28c5-4fb5-bcd8-09875cb65a83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_50ea36cc-28c5-4fb5-bcd8-09875cb65a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_9d9f8beb-ff1b-4b28-bba0-278d8473157e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_9d9f8beb-ff1b-4b28-bba0-278d8473157e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_fe51b269-fd8a-4f4a-862f-7a88f85b415c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0410e820-19d6-485c-bb1a-694bc9a1975b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_fe51b269-fd8a-4f4a-862f-7a88f85b415c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_40bbae13-c30d-42a9-adb8-5cddc2c5385b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0698c630-4803-4011-b77d-02ff17f912d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_40bbae13-c30d-42a9-adb8-5cddc2c5385b" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0698c630-4803-4011-b77d-02ff17f912d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#CommitmentandContingenciesLegalProceedingsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a791bc6a-e0bd-4a68-8a6d-2c724f7bcf04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a791bc6a-e0bd-4a68-8a6d-2c724f7bcf04" xlink:to="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:to="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_c7a1f0b1-fcc9-42f9-91bb-16fafa8f58be" xlink:to="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LupinPatentInfringementMember_1659663c-cf6d-4af3-933c-a4614b8d6acc" xlink:href="lgnd-20200930.xsd#lgnd_LupinPatentInfringementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:to="loc_lgnd_LupinPatentInfringementMember_1659663c-cf6d-4af3-933c-a4614b8d6acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_4b06cb78-2700-4c40-95c5-9bcdf83bd0e9" xlink:href="lgnd-20200930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_604334c7-a89f-4c61-a125-551f62e2d062" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_4b06cb78-2700-4c40-95c5-9bcdf83bd0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_e1da96b7-10c8-4bc2-8054-ddeda1dc3ecc" xlink:to="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_407bef7a-0056-4809-946d-975c6504ab8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:to="loc_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber_407bef7a-0056-4809-946d-975c6504ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_458f41c4-76fb-4bb8-984b-02f8064dbcdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_80db50b9-c1f6-435d-9ff1-4892b563f13c" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_458f41c4-76fb-4bb8-984b-02f8064dbcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20200930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b53ef702-7555-4d14-a79c-34cb29253edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ddfda1a9-ffbe-49ce-9630-f90eb34e98c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b53ef702-7555-4d14-a79c-34cb29253edf" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_ddfda1a9-ffbe-49ce-9630-f90eb34e98c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_035d4143-1274-4594-9460-87d3f2abb100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_f1abea6b-2791-4ca1-a3c3-1755dfc70b65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_035d4143-1274-4594-9460-87d3f2abb100" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_f1abea6b-2791-4ca1-a3c3-1755dfc70b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1c9e5e7f-945f-459b-bc13-e4694c362d11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_035d4143-1274-4594-9460-87d3f2abb100" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1c9e5e7f-945f-459b-bc13-e4694c362d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSale" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSale"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AssetsHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2e4f4f86-fd69-4d31-bbf5-1af37c547659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_123f984b-b93e-404d-9ba5-d1e8f0cbc0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2e4f4f86-fd69-4d31-bbf5-1af37c547659" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_123f984b-b93e-404d-9ba5-d1e8f0cbc0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSaleTables" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AssetsHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c24a557a-b588-424d-a563-2123d1702f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_13356e41-0216-46b0-82ff-37488dfa9774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_c24a557a-b588-424d-a563-2123d1702f87" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_13356e41-0216-46b0-82ff-37488dfa9774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#AssetsHeldforSaleSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_699dc045-55da-428e-aaab-8f248e5a0474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_699dc045-55da-428e-aaab-8f248e5a0474" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_8f708d86-f061-444c-89b0-820e2d11ddb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_8f708d86-f061-444c-89b0-820e2d11ddb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_0f100949-849c-46ab-81fd-e47fc4be1ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_0f100949-849c-46ab-81fd-e47fc4be1ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_bfe74317-8e78-47ba-88f8-a8072f8d5f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_bfe74317-8e78-47ba-88f8-a8072f8d5f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_04a8a50a-a266-45a5-99c1-ad4d0b850700" xlink:href="lgnd-20200930.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_04a8a50a-a266-45a5-99c1-ad4d0b850700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_88d645e7-1242-4aa1-bba7-6adb32b8b902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_a8747783-27ba-4072-8d98-ad3a3a01aafd" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_88d645e7-1242-4aa1-bba7-6adb32b8b902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_699dc045-55da-428e-aaab-8f248e5a0474" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_3791787d-b956-4967-802a-f8f69b19b536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_3791787d-b956-4967-802a-f8f69b19b536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_5b185d92-49dc-4e62-ab81-f3891f8162e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_5b185d92-49dc-4e62-ab81-f3891f8162e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_bb2fc014-1295-4f21-89b5-564b86a47f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent_bb2fc014-1295-4f21-89b5-564b86a47f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_035f2e42-b447-4ea9-b512-0458fecee771" xlink:href="lgnd-20200930.xsd#lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:to="loc_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_035f2e42-b447-4ea9-b512-0458fecee771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_ee4a7ec5-c944-4550-ae11-4417b47f83ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_ee4a7ec5-c944-4550-ae11-4417b47f83ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3262a802-8fce-46c3-a889-6f24105ef4ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_6ba81ce6-4d7a-419f-87aa-00866795f973" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_3262a802-8fce-46c3-a889-6f24105ef4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEvent" xlink:type="simple" xlink:href="lgnd-20200930.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_408ad465-b815-4e22-a0c2-851716e59a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_a244d605-a944-47be-9c8b-f250bf799879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_408ad465-b815-4e22-a0c2-851716e59a35" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_a244d605-a944-47be-9c8b-f250bf799879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20200930.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_777e1bb8-e582-4b3c-8e09-eff6a43a43cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_777e1bb8-e582-4b3c-8e09-eff6a43a43cc" xlink:to="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0193b72a-5253-48f2-805f-4e9c1e4f39c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_579a5fd8-f84d-49b9-9a66-49cab3876fc5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0193b72a-5253-48f2-805f-4e9c1e4f39c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_dc130757-4eef-48db-a810-eb80a8ca164a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0193b72a-5253-48f2-805f-4e9c1e4f39c1" xlink:to="loc_us-gaap_SubsequentEventMember_dc130757-4eef-48db-a810-eb80a8ca164a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a80ca6b-16bb-4f3e-9212-546facd597d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0bd6a5d3-ba62-4c6f-bac9-6c538407135d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a80ca6b-16bb-4f3e-9212-546facd597d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexIncMember_f6bae57d-94e4-4f3f-bfc5-1a253c63073b" xlink:href="lgnd-20200930.xsd#lgnd_PfenexIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9a80ca6b-16bb-4f3e-9212-546facd597d8" xlink:to="loc_lgnd_PfenexIncMember_f6bae57d-94e4-4f3f-bfc5-1a253c63073b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75bd7b15-9b54-40c5-b4ae-d26cf28839a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e32af219-75a8-450f-9db2-ab04f99097b9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75bd7b15-9b54-40c5-b4ae-d26cf28839a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_VernalisMember_6894fdab-5656-4df5-8326-cd3bbe1645e5" xlink:href="lgnd-20200930.xsd#lgnd_VernalisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_75bd7b15-9b54-40c5-b4ae-d26cf28839a8" xlink:to="loc_lgnd_VernalisMember_6894fdab-5656-4df5-8326-cd3bbe1645e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_87e8bdec-06b9-4914-aa23-d4b9e5fdc9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_e71c9c52-d0f4-4ffc-ac46-ebcb23de1ee8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_87e8bdec-06b9-4914-aa23-d4b9e5fdc9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d8fc4a05-385c-4aef-8e72-f68f1cc50934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_87e8bdec-06b9-4914-aa23-d4b9e5fdc9c1" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d8fc4a05-385c-4aef-8e72-f68f1cc50934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1ab77b71-47e3-4a62-b3d7-d58f50eca681" xlink:to="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_20290937-3f48-4f41-860e-27fbfb047122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_20290937-3f48-4f41-860e-27fbfb047122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_6c3124c2-c0f5-47ad-9f69-04139e7885e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationAsset_6c3124c2-c0f5-47ad-9f69-04139e7885e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_8d2290e7-ae2f-4860-985b-ee700e31b4af" xlink:href="lgnd-20200930.xsd#lgnd_ExpectedProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_265df043-9a74-4abc-955f-3615a3a88b04" xlink:to="loc_lgnd_ExpectedProceedsFromDivestitureOfBusinesses_8d2290e7-ae2f-4860-985b-ee700e31b4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>lgnd-20200930_g1.jpg
<TEXT>
begin 644 lgnd-20200930_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#X17AI9@  34T *@    @ ! $[  (
M   /   (2H=I  0    !   (6IR=  $    >   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $UI8V%E;&$N
M3&ET=&QE    !9 #  (    4   0J) $  (    4   0O)*1  (    #-C,
M )*2  (    #-C,  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         #(P,3DZ,#4Z,#8@,3$Z-3 Z,CD ,C Q.3HP
M-3HP-B Q,3HU,#HR.0   $T :0!C &$ 90!L &$ +@!, &D = !T &P 90
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" !I 2H# 2(  A$! Q$!_\0 'P
M 04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0
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M $ 5\V5])Z#_ ,BYIO\ UZ1?^@"A@7Z***0!1110 4444 %9?B?_ )%'6/\
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M_,+>$'/DQ'<[=._0=QZUZO:VL-E:Q6UK&L4,2A$11PH% $C,$4LY"JHR23@
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MRE5/M<A0+$<;2Q*XQVP17O6CPO;Z'8PS*5DCMHT93V(4 BA@7****0!1110
M4444 %%%% !1110 4444 %%%% '/>/;F:T\":I);XWM$(SD9^5V"M^C&O%/"
MRVS^+-+%\0(/M2;LC(// /L3@'VKZ%OK.+4-/N+.Y!,5Q&T;X.#@C!Q[UX+X
ME\&:IX<NW$D+SVN?W=PBY4CGKZ'BF@/H&BO!]-^(_B+3;58%N4N$7 4SIN(
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M_H#P?FW^-=!10!4L]*L-/5196<,&U=H*( <>F>M6Z** "BBB@ HHHH ****
C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>lgnd-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20200930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20200930.xsd" xlink:type="simple"/>
    <context id="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i415e31ba3f934198961f14bef202c237_I20201103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i40068af719eb4ea8bd60482b542bddca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9fc64f4d95b449579c5dcf83692dc2c2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icff17a87c11c484c964fba70cf7a9057_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6992f512a9ea4391aba483112356a4b0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i89eb246de85d4b488a38dcf7024d1c08_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4089e56d6e3f4a8887c64e185748adcb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i32a628a6cc7441d2989a9bb873aa67ed_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0095c2332c5f44189e76bf00c4b53c2c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2e3415613f8a40bfbe9bad5aae16a724_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0d01bc1e745d4a3ab4088e5f4f2358b8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i24db05f0ba7a4d77a7000833e1ed3559_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3cac48edfdab44eda2c29f953e09e7d3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia893a67a4ca947ba9f3e9b7d01d18a0c_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7229001e60ff49198a53dbfbcd6d60b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa54869d40994b6aa64042e970f51be8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2a859673f5404c6cbfade9e44d71e9f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i70a58a3c6c6448268c41dca75ca52fc7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i007cb72b91db4bc690515877028df7e9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia6aea072928f4adfb9348fc0edbac316_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3e26dda8ec9c45408cdc8bf9f7fe8c69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6633e74552be487692e9b132df36f4e8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5aac323c2302486893f879d73f4c93e4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iad5487114db84eac9bfa300064f305c6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia225c7585f734df2a5415a615cdf2097_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i390ae39298aa49b48acd3739a2084b20_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i98e9a32b21494264a59d8c3209cde81c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5adb4b836261437c8a079d884dd0e8ca_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idd47a5e4d9a24937a102511805705f35_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iff9d958158dd43a293e2993c7506b393_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i49e9549e37074565b41ee42b330a2e2d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1a7426a780234cb098ddd5e2ad753bbc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i50fc27200cc345ddab6a3d2ba7763419_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5cf845807cc0448f8bb1b78321ef94bf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i033832a8e05745f8925aad29d6926388_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i490f2ffbbf00499fbb82c91eb2b73aef_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib77b17a4438e4523ab9ff836080cad8f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i30e1862d94954195986e08adfa6e1308_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if6b07ddca2e541d7ba70100ef93c997c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia37703b7519741a7947b97bcf8cb4d32_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib5d9a384d5fe4b8ea0e9be04bb79c338_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if87fbb1c899e4dd3a43541865f6f3cb5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i06e8e2209037448496084b7cfc9433eb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id242a912b69a4ef0a5aa82c546921324_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7a970afb914d41ce990cb1157db7eb2e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7e121e85c66044c887bca7e02db16f42_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i49bb47989637497c8b00af3bf1f16d88_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia51a45b1a9554dc4a23d19c9681b8627_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7c217737a66b4aeba81beaacd79e70ec_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i234221629449487f964bc6624088b0c1_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i8ffdf07b1b53463498a6c354fdf3b822_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic3d3d78b23a9464aba33b50d534d7983_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i5fadbb805c68461391658b06e2708f69_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic824a6a2217044eebe4ad6f38deb865e_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ifadacbb2a79244b9a4f3e6026a94394d_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i13cc02644d614c5a9a285795ce36f88c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4daf159584b94905a33f5c1706489352_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i37fb40383c604fa99c82bd4627415ddd_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1dee39642b1441adab4e1b7f195f4820_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib4c4ce8565674d7cbc011bb29d51fdbc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id9f29670866f470d84fbf023db043769_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i43125aaaa4d745faabb5618510882e01_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if7c8205976c64573b1f5fafa7ee9496c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2df602c5680a4955ac8de558547908d1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic3192c6a0bb844fdb952e47d0f4a8a28_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ife85aa33f030423e9deacf97a190c282_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i3ed241cfb09b46e5ba9c8968fb1b32f8_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie4d3f481bad1425ca853b25afe3012d9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5ae80780948143b7b2da481e22963423_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i1d610f8e9c4740b18e5147a6ee408789_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic9d5df0e1dac4e88ae8b5fb46ae522b3_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id067844f4eb4436eb363d302e57613d7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i852922b66fce4828ae182e5350dcb942_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifa3f1a01a9864e59ac71fe92b7ca767d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-10-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4a8257a98db24ffaa95e5892f684fd01_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i79407bfe8ff44be68b660b88255cf447_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia162f6b1d4274062b41ad002117be195_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i959c4730e2da4bcdb04ef2f33d1574d7_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i953eac10432944aa918dad32003e1069_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5500183722b040e19d12c71572ccb758_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iae408995adc74e3ca6339d16292d5778_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia617fcaa706e40a6a1ac062ee7d43ec4_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9de46cd3732f46198d032b4488032eaf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idbb6844505d24ba0bf8408929f329456_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i631b9be815524db78231c3054bb32e61_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6adefffb5c654771b174bf3bb3a8b6bd_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i32509a4fbc6a4a1582b549b4ca6df340_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i91c5884b82ff46d5acc051c8609beaf8_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifba8307733fc433f8ab3b039169959f0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if80024c5d7c84458b874cf41165bca20_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:PromactaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iab25bc69dbce44049e247a4d1847a6a0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i58eb2b2e375b4a358abb2a965d76fa2b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3e6cef85b3c447d3aa8cdd4f781e6981_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2ddd64a6c3b648bdbbbed38ab355251b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia0aa285905264a199609e8e0e79eeb9e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0f888f2275fa4a51a4214ceb899a5667_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i41ad1b18c5f4466cb46c76831b340bf9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a7b2e9c4c524632af8897ae7a9f69da_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i61867bf812c848368a7dbee91070fe83_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie8e8662fb16b4474a6813702dcc5fbf2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i32fc3b55c7ed49029b4502207f3e67b8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie13355c008834006b8d8a53974aa47bf_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7be44b2cefc0491cb1be1ab1447f7f7e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia53963dd995b43fe95834fa275cf1ab9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1fe3969028f3455e89611142e0bd445e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2db24569871b4483bf7e64d41e59fd8d_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if989d8f4b0444921b186d0ba5bd810f4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5a2a7519e6c341a38f6401cd9723ed03_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3fdffc8317c449f881a8aa17ec02a41c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i523aaf24229e4ba68a57b31257326d9a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iebd966bb1d63405582633f051a4fe6cb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i2b59857bb5724f0db92fceca967b8a6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d0223b445c142ebbbceb1d4d5041109_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34769cb1caae46a1b085c5eb80dc24d2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieafd46562c0048748b7d5372e02d9594_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i994f5de64c0a4fbdb6c53080a3923a98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i077cb3c9fe0e483c86fb45ff23381e66_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1515ee2cbc494379a0c6d767fc8cb01e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib02c7dbe217a407884f5da8e577b9510_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iada23dbe678940b39476c796282a62d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i62059978ce544467b0dd531154611391_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic9822c8d2a54454798b936165a57c684_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacc614b30b84489b961b3be7e198cf04_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf62daa6b80444d9b1c8c7605f3061cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i458d920e4daf4b0bbb69e6db515003c0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3b63e0852ede48be9e97d41d54d1fc1f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3a7b51a701f4e53aecd32502a589716_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4202a561cc0e4e888ca3864847b25542_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d220828630a41d89fbd767210960771_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie13355217b22451f86270e7501836ab5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id7eb9f595411497d909c36c7b2a954d3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ee0d788eb77400190e92faa6bb87523_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0100a54707e94423b27294cac36ad9cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibcbff8ebe0f84833bb1bb078e9fb983a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i10d095f87a1e48e8a5b700832f2b753f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1f5e4fe2589b447f9a277f98db937a1f_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0cf7333df7984d5bbd68a862a0645e2b_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4f60bf0364f848b38d48669aaccabc92_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:PalvellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0cdccb9429b54094b52f363eef25ce9f_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ic3d2e8730044456d888fa8d00bb40ef6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i827adc89d29046898e0b113579222055_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6ce74a6cb0394faea692955f117b0910_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9eae62fa2cc244c58acbef58471706d5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="idcb4d6cb442c42888913360733612f6b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1cbbd30022e449b8b3b716176ea05cf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i971a95182cfc43cf993de4477741afb9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5baf6027374c4f3cb37f343379914469_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if33f5e6d2e464f5a95ee2eb981cf9859_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i38b7bbf234194785adc62a7822e6c5cd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2ca967bf02e64cfaa352ef449e98dfb9_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib22396d3cd074458826229f4aa3c94ff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic34a5542beee460cbf11a482a837b496_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i478ab1e04df3462693b4f447d123258c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f47b24008434e72b2d2b8abdd01c025_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5178294923b94ed691df5ab58c95e5ae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iedc8cab80d6146938a4e96ca913b603e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3f01a6768e554446859e50dd59a5f80b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i49eebaf8762f41bc8e158fa2142e34c7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i99eb08f38a27433e952f4df9a77b03c4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie0856bf1f29e45b3ae503b85c7783f0f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i78fb2997e6c149bb89d1b9405e547655_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3f212d8fb4848b7a0273c25f91e3c69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c0f7b483e754043b00e42dc018f756e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84f064695ce24917afeb387d23a90689_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0b2bcfa66308412c8f26ad4feaca4c78_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id25c3c4da77d4ea7ab8ca7b1314fdd20_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i776f577b4a88423a8d0236205bdb4fc4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i830cd590ed6b4940ae325376227fbf62_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iad16d307d34d4ce3a14c5cc44ab00ca9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i66cf1abe6fef4052bc2a83de3d3f416a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2ffefdd42a3a41f1aaa64b145eafac32_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i60cb7324310c4d69b314803514b8e7b1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5d3493b201a94d66930f00e5b6cb91ab_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaef93f7a4c3542b39b59e3723f6abe79_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i31e1ba70e57e428aa564051bda9daceb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8fe44d5fc83a4e91b928eab183e2696f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id1fb45159aaf459ab33f85d40561d21b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8cd383420af4806b4b998261a7844bc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ife1ffea26d4346d3ac80627049e44cf9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i76e338a0003143eca31f450081056aae_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i474b22d9f5454de2984d02f95a12bb78_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id7c66fe24767491e8f06625e7c7980b6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie7b17dc76cb24ddf96f02602f42463a0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i30a210e993e749b792c4ff6feb3a58b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice47f549adc84119806f94c1746c45ec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id25da78fb55a47a9a4c833b387732860_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id6fd63ec5bbe4d21b07dd199d23d7b1a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ibfc313fa997f4657b35211e781b16774_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ia730be76fe494ababd31b792de283e21_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d48f0e79a2a43869f2f0bd580a4753b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7ba69388d37546cabc299b2e1f680e46_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i9e64c0586051455caf1fcc537086a20a_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightForInternalResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i999aee09e45649fdb1cd9982ed98cdc2_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i3375f5d3a4424dcd819ba8dc9c56b35e_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:ContingentValueRightOnProductRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="i8fae09558a4443b6952d5785b2692f3a_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i8f8208b3443c4953b951bcf2e7b70a4b_I20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-09</instant>
        </period>
    </context>
    <context id="i9e200da6ec4c46c68c9db69c0131c385_D20200909-20200909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:TaurusBiosciencesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-09</startDate>
            <endDate>2020-09-09</endDate>
        </period>
    </context>
    <context id="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i29bff9a12f464884a5afac09cb178f2b_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="iba4f03a76ff84cd195e9a52f4859e3e0_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i5b61ef8a9bb34b4a831d8fdf376d0630_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:MilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="iefa15c311fc64869817af666497c6c42_I20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-08</instant>
        </period>
    </context>
    <context id="i3c8ee65a89ca400999e52481a25fc8c0_D20200908-20200908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-08</startDate>
            <endDate>2020-09-08</endDate>
        </period>
    </context>
    <context id="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i2fe5fef198d34ce288dab72b45d25f2a_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="iedf59884a0ba4125b067647bc5e8a67b_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="if85df3b674454d1fbeb0d47a0f94915a_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i7e7c4b5aaae742f5836b06830ae9422b_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i051cac9942274d55850055cf090e8f8d_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-23</startDate>
            <endDate>2019-07-23</endDate>
        </period>
    </context>
    <context id="ieab592e440e644d5a1ec6c7acf564453_I20190723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="i14f34a9837f549a2b830d35fa413bbd8_I20190723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="i98ade28714c945bdbaed7782ccd551cc_D20190723-20190723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:AbInitioBiotherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-23</startDate>
            <endDate>2019-07-23</endDate>
        </period>
    </context>
    <context id="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="iee3cabb8282246d9b2d4d3044cdde963_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibfe792e75a594433b59c93b28557b63e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ief5a227d490d42d182609204378ddfea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib9901cc55d3a41d6a022e1bace11721c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2b873c8bed16489d977cfb5d84e575a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3dda86ca5ea49ce89a56fba0b2e74eb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5fe5995b210642eb9ea6c816db2ac441_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1803c7b7772d48fcbcd1f7dd2fea7909_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8183957e6f4e449b8b14bffaa3391716_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="id421b7a497e949c0829fd0a9cb8a9545_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="ia89ff6c0983c400999c69d63e6050433_D20191029-20191029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:LupinPatentInfringementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-29</startDate>
            <endDate>2019-10-29</endDate>
        </period>
    </context>
    <context id="i618ff0aa526749d3ae1e702491ced1ab_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ibc5070ad9b82439b913a9301d0b00b65_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="ibb2c08d52fc04211b2744d4a8b48977e_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="ia8fa3962729945ee8b1a302fab16a100_D20201011-20201011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">lgnd:VernalisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-11</startDate>
            <endDate>2020-10-11</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contingentvalueright">
        <measure>lgnd:contingentValueRight</measure>
    </unit>
    <unit id="contingentvaluerightseries">
        <measure>lgnd:contingentValueRightSeries</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="patent">
        <measure>lgnd:patent</measure>
    </unit>
    <unit id="civilcomplaint">
        <measure>lgnd:civilComplaint</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGFibGU6OTI5MTdkZGFlMWRmNGIxNzkxMzBhMzRiMjM3MmE4ZjQvdGFibGVyYW5nZTo5MjkxN2RkYWUxZGY0YjE3OTEzMGEzNGIyMzcyYThmNF8yLTEtMS0xLTA_beace715-2e74-4915-813f-15cd0db9fabb">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGFibGU6OTI5MTdkZGFlMWRmNGIxNzkxMzBhMzRiMjM3MmE4ZjQvdGFibGVyYW5nZTo5MjkxN2RkYWUxZGY0YjE3OTEzMGEzNGIyMzcyYThmNF8zLTEtMS0xLTA_83450c1f-9a4b-44e8-bfb7-1de92ed04641">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGFibGU6OTI5MTdkZGFlMWRmNGIxNzkxMzBhMzRiMjM3MmE4ZjQvdGFibGVyYW5nZTo5MjkxN2RkYWUxZGY0YjE3OTEzMGEzNGIyMzcyYThmNF80LTEtMS0xLTA_c0085cf5-713e-440f-ba7d-3eeeaaa15c43">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGV4dHJlZ2lvbjo4YjllM2EwNTAwMTA0NjBmOTkxOWVkNWYzZDRlYmZkMF8yNg_6833f9af-a9e5-4950-91ce-d9339bf784d6">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80L2ZyYWc6OGI5ZTNhMDUwMDEwNDYwZjk5MTllZDVmM2Q0ZWJmZDAvdGV4dHJlZ2lvbjo4YjllM2EwNTAwMTA0NjBmOTkxOWVkNWYzZDRlYmZkMF8yNw_17ba234f-0c2c-43cf-bd34-8e88becbfcfe">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS0wLTEtMS0wL3RleHRyZWdpb246NDA1ODlhMzQzNDUxNGQ1MzhlMTlhOWE3ZDJkYTIxMmJfNTA_5acfac75-4ba4-4abe-a410-f94041340fdd">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80Ni9mcmFnOmNmMjIwNmE4ZjM0OTQ5MGNhZmIzZTVmNDcxYzFhNzNjL3RhYmxlOjdhMTFhMDg1ZmNkODQyYzM5ZTNkYzZlYWY2ZjYwOTFkL3RhYmxlcmFuZ2U6N2ExMWEwODVmY2Q4NDJjMzllM2RjNmVhZjZmNjA5MWRfMi0xLTEtMS0w_82eec3c8-fbc2-4dda-bf57-6d316487b25e"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMTU4_6e2e7d5b-569a-4112-af29-1a3087e4b64c">P7Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjI5_55733a26-80e9-4395-8c9c-5fd85e05d7b3">P7Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dei:DocumentType
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8xNzI_f82aa352-c3af-44fd-96a0-3fde626e7cf8">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NTE2NWM4ZWIzMDc1NDFlYmI5NjdlYzcwOTBiYzE1NmIvdGFibGVyYW5nZTo1MTY1YzhlYjMwNzU0MWViYjk2N2VjNzA5MGJjMTU2Yl8wLTAtMS0xLTA_d02b9671-3d42-468d-a546-ff3e0131fba9">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yOTc_3837ccdb-a9c9-457d-9648-74c59f1d7cd8">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6OTdhODFkYjhmNmVjNDkzNjg4NmVhZDJkZmJiM2VlZTgvdGFibGVyYW5nZTo5N2E4MWRiOGY2ZWM0OTM2ODg2ZWFkMmRmYmIzZWVlOF8wLTAtMS0xLTA_7f9bb941-ec2c-4b47-b7d2-a8cd28902337">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTkx_b2dc6ce9-e50a-4a50-963d-f4e3b10fe341">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8zOTg_2fae265a-d217-4a95-8a5e-454936ec507f">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF8wLTAtMS0xLTA_c98372a2-badd-4252-9b85-62d92bddd79e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF8wLTEtMS0xLTA_a970d3fc-e917-42b6-99d9-c5d008f25087">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF8zLTAtMS0xLTA_799db68c-6ebe-4fe5-82ae-028d4c1e4881">3911 Sorrento Valley Boulevard,  Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF80LTAtMS0xLTA_929a1476-ef58-4689-901d-d27ced17f327">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF81LTAtMS0xLTA_b82d4b7f-882b-4e0b-9c0d-f8509d7c9445">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6M2M3YWQ0YWU0YmFlNDE4Yjg3NGM1MDUzMGE4YmMyMzgvdGFibGVyYW5nZTozYzdhZDRhZTRiYWU0MThiODc0YzUwNTMwYThiYzIzOF81LTEtMS0xLTA_52749819-180f-4921-8532-d0dc79ab1eb9">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTky_b86f51a0-abef-49e7-ad6e-9dcfee4afb62">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTkz_3577f88e-4101-47d2-b5e2-30721e99af77">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6ZjU2MmI5ZDgzZGUyNGM1Mzg3NzliNjY1NmFmMWEyZDUvdGFibGVyYW5nZTpmNTYyYjlkODNkZTI0YzUzODc3OWI2NjU2YWYxYTJkNV8xLTAtMS0xLTA_3f378b1d-eabc-46ed-ade0-995e04487382">Common Stock , par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6ZjU2MmI5ZDgzZGUyNGM1Mzg3NzliNjY1NmFmMWEyZDUvdGFibGVyYW5nZTpmNTYyYjlkODNkZTI0YzUzODc3OWI2NjU2YWYxYTJkNV8xLTEtMS0xLTA_403a77be-bdde-4976-a299-85ee4a1b8057">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6ZjU2MmI5ZDgzZGUyNGM1Mzg3NzliNjY1NmFmMWEyZDUvdGFibGVyYW5nZTpmNTYyYjlkODNkZTI0YzUzODc3OWI2NjU2YWYxYTJkNV8xLTItMS0xLTA_1f30007d-470a-4034-b252-aeb06b2a2edc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTk0_c58e6e87-7b5e-49e7-9d54-158b757d5740">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTg5_08bc4243-cf17-4de9-808b-b9db0e76ef62">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NmE1MTFiMjY2ZDE4NDUxOTlhNGNlN2I0MjBkNTkyY2MvdGFibGVyYW5nZTo2YTUxMWIyNjZkMTg0NTE5OWE0Y2U3YjQyMGQ1OTJjY18wLTAtMS0xLTA_66b06814-ed5c-4152-a329-2a30afbf06c9">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NmE1MTFiMjY2ZDE4NDUxOTlhNGNlN2I0MjBkNTkyY2MvdGFibGVyYW5nZTo2YTUxMWIyNjZkMTg0NTE5OWE0Y2U3YjQyMGQ1OTJjY18xLTQtMS0xLTA_1af2e9ca-9d4a-471a-90c6-242ede10fb52">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGFibGU6NmE1MTFiMjY2ZDE4NDUxOTlhNGNlN2I0MjBkNTkyY2MvdGFibGVyYW5nZTo2YTUxMWIyNjZkMTg0NTE5OWE0Y2U3YjQyMGQ1OTJjY18yLTEtMS0xLTA_c78e1f60-67f4-4cbc-a8e1-27af23e65ff0">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTkw_0f7f8a6f-a85f-47ed-bffc-d825906ab75c">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i415e31ba3f934198961f14bef202c237_I20201103"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xL2ZyYWc6ZGU4YzQ1MTU0Mjc0NDg3MGJhNGZmNDY4NDFhN2U2MDgvdGV4dHJlZ2lvbjpkZThjNDUxNTQyNzQ0ODcwYmE0ZmY0Njg0MWE3ZTYwOF8yMTUy_ecfe4fc1-eb6a-416c-a657-b818cfb78caa"
      unitRef="shares">16091319</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMy0xLTEtMS0w_baa192a6-a77c-4b12-af16-6068dc2f0a81"
      unitRef="usd">456916000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMy0zLTEtMS0w_b9889d29-adba-4550-83bb-dcd8c87b9700"
      unitRef="usd">71543000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNC0xLTEtMS0w_50b08a12-c71a-48c0-8912-1015927c217a"
      unitRef="usd">338154000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNC0zLTEtMS0w_950c045a-8189-4989-87bd-421bf90af164"
      unitRef="usd">998324000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNS0xLTEtMS0w_bc20ba42-c6b6-416c-ba50-74d7f61d167b"
      unitRef="usd">32907000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNS0zLTEtMS0w_68cbae97-09ff-4ebf-bd23-d18fd8b38903"
      unitRef="usd">30387000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNi0xLTEtMS0w_0c05ea1f-3c6c-47dc-ba08-c8b8e93c33fe"
      unitRef="usd">13430000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNi0zLTEtMS0w_420d3dfc-952f-44dc-9909-b94bc24a9f4f"
      unitRef="usd">7296000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNy0xLTEtMS0w_5336c96e-1474-4ba7-b8c1-170b01e9cf93"
      unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfNy0zLTEtMS0w_246fb812-bc55-4676-84e3-61de4a354597"
      unitRef="usd">11361000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOC0xLTEtMS0w_364e9b53-8929-46af-828d-b258aef6a9a9"
      unitRef="usd">3191000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOC0zLTEtMS0w_97198282-95d0-45c7-b667-86e93cd34ec5"
      unitRef="usd">4734000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0xLTEtMS0xNjU5_3d8f0d94-4d3d-487d-8a6e-08627128d4a1"
      unitRef="usd">13143000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0zLTEtMS0xNjYx_12057a1e-d3c8-49f6-874b-96bf7dfdd830"
      unitRef="usd">0</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0xLTEtMS0w_58aef2fb-38f0-414e-a14f-5009fc0a864f"
      unitRef="usd">857741000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfOS0zLTEtMS0w_b27cc10b-173d-476b-990b-a9801516b781"
      unitRef="usd">1123645000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTAtMS0xLTEtMA_f813ce9b-a081-4231-a408-7da6a863a3bd"
      unitRef="usd">27026000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTAtMy0xLTEtMA_2d9efd4e-20e9-4e14-8cc8-54173b1c6441"
      unitRef="usd">25608000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTEtMS0xLTEtMA_9f505cd3-55d7-469a-94b9-db54b1315a77"
      unitRef="usd">224582000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTEtMy0xLTEtMA_a3e9c89f-122d-47a2-b712-f0da508b7f7a"
      unitRef="usd">210448000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTItMS0xLTEtMA_8dcac728-3464-4848-9d38-40e0e44ae4a2"
      unitRef="usd">102136000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTItMy0xLTEtMA_1682a0b6-064c-44e3-9648-6b3215d58c80"
      unitRef="usd">95229000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTMtMS0xLTEtMA_5c599606-e866-4f37-af96-bb6fbc8b92cd"
      unitRef="usd">10834000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTMtMy0xLTEtMA_9a85aa4e-a918-4280-92ba-0dff9f5eeb44"
      unitRef="usd">20090000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTQtMS0xLTEtMA_6d656a4f-d6fd-435f-98f8-7185cadb1467"
      unitRef="usd">7157000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTQtMy0xLTEtMA_cd89f117-4931-4da6-9adf-4cd53d456cf8"
      unitRef="usd">7185000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTUtMS0xLTEtMA_4881e48e-a8b6-4b93-9109-ee26ba07ef4a"
      unitRef="usd">4269000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTUtMy0xLTEtMA_61b92d54-8d8d-4ea3-816d-0ad6033a91ba"
      unitRef="usd">10353000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTYtMS0xLTEtMA_10515616-d1fe-437a-82f0-4a7ed19df206"
      unitRef="usd">13704000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTYtMy0xLTEtMA_36db53c6-abc5-486d-9880-d7d5153c8e0c"
      unitRef="usd">2357000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTctMS0xLTEtMA_f4d2b5a4-cdd7-4bf5-833f-1f23954c9135"
      unitRef="usd">1247449000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMTctMy0xLTEtMA_99a8cdeb-eae3-48ef-993e-66ba5e756b88"
      unitRef="usd">1494915000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjAtMS0xLTEtMA_b9259c45-3259-44ff-aaa2-f8d9e3615203"
      unitRef="usd">10169000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjAtMy0xLTEtMA_173dd760-94ea-4c11-b127-65277d1b2f69"
      unitRef="usd">2420000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjEtMS0xLTEtMA_01e16de4-2843-423e-8032-e0b319fcd4db"
      unitRef="usd">14498000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjEtMy0xLTEtMA_8dae7502-525a-4c85-a869-fd4d59a357e8"
      unitRef="usd">9836000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMS0xLTEtMTc5Nw_65b9e76b-06ac-4f8f-b650-09bcc19703ac"
      unitRef="usd">674000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMy0xLTEtMTgwNg_d380f66b-9f12-44ef-81bf-aa42ccb2363d"
      unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjItMS0xLTEtMA_a7fb6ad7-f154-4c4e-8453-2a7f5766ab9d"
      unitRef="usd">1194000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjItMy0xLTEtMA_71377992-1e64-466b-80c1-bf2e3da0fe42"
      unitRef="usd">2607000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMS0xLTEtMA_016d3916-2efe-46fe-8469-f776bfb1b46a"
      unitRef="usd">5404000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjMtMy0xLTEtMA_d6db9b8f-140e-4b5d-abe4-b23ada2a269d"
      unitRef="usd">2139000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <lgnd:LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMS0xLTEtMTY2Ng_9304b922-a1e3-4536-b0dd-668a5072141e"
      unitRef="usd">10361000</lgnd:LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <lgnd:LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMy0xLTEtMTY2OA_b1fcae47-f654-4577-9c4d-af4b1ad978fc"
      unitRef="usd">0</lgnd:LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjQtMS0xLTEtMA_4d9ec782-1441-4986-970e-107b75063d48"
      unitRef="usd">42300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjQtMy0xLTEtMA_8930a008-6c06-4cd8-9ae4-a42e9c97d192"
      unitRef="usd">17002000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMS0xLTEtMA_be50c45d-74f3-4565-8188-24cbe5bdb259"
      unitRef="usd">454973000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjUtMy0xLTEtMA_538a8b39-debc-4f28-92f2-11de2aab60d3"
      unitRef="usd">638959000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjYtMS0xLTEtMA_1593b51d-4718-479c-8a3e-9ac8febea195"
      unitRef="usd">9604000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjYtMy0xLTEtMA_cec82e5f-1aee-4ad3-9868-b67b8a1c0521"
      unitRef="usd">6335000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjctMS0xLTEtMA_c6cd5789-fd79-4dfc-a17f-4d07fb5c580f"
      unitRef="usd">13508000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjctMy0xLTEtMA_a0a6c691-6d4e-4087-8cd5-e47ba95a90a6"
      unitRef="usd">32937000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjgtMS0xLTEtMA_759af0db-3948-4ae0-a56c-60608819b861"
      unitRef="usd">3920000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjgtMy0xLTEtMA_eae52d2c-67d0-461f-98f2-ec6843777c27"
      unitRef="usd">9970000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjktMS0xLTEtMA_6b40231f-f71e-469d-9ce6-d8fd3b42cda7"
      unitRef="usd">25320000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMjktMy0xLTEtMA_cc479a42-96a7-414e-a223-3483d2405e72"
      unitRef="usd">22480000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzAtMS0xLTEtMA_bd787294-7097-4abe-bed1-027035b33c84"
      unitRef="usd">549625000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzAtMy0xLTEtMA_783503d0-2c3d-49fd-8872-fd87e499efe4"
      unitRef="usd">727683000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzEtMS0xLTEtMA_b46bba2b-f217-4802-bc3b-e48adc6b5143"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzEtMy0xLTEtMA_a314a67b-5864-4539-b99f-522e8997d573"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzI0_72d58b7d-c195-4531-a40f-48a4adbeaaaa"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzI0_8fb9815c-a51d-463c-8d0a-e29728603881"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzM4_5808e029-11bc-427b-b28f-9c4dcac7d42d"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzM4_910063aa-fa77-474f-88dc-0e21d0c23cd7"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_229b20a9-59f3-4802-be4a-65b69aea8b8a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_30a710cb-9d07-4de0-9cde-0580acec7a59"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_ec08f625-8190-4f24-b90b-1a272f74ae4d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc0NjFhMDhhNjZkOTQ2NTg4NGI1MDcxMTJkN2RjOWI2XzYw_f685f901-7103-4810-91da-eae673ed725c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMS0xLTEtMA_b95bd37b-5628-415e-b05d-ca1124bd97df"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzMtMy0xLTEtMA_e68d55d1-5fbd-4c13-a5b5-9136cd4d8f96"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzIx_85aadbb1-12f2-475a-a15d-ed044f82a17b"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzIx_b6383d9d-6b8d-48fa-b837-2c2dcbd8c4e6"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzM1_141e3472-0241-4aef-960d-dd43f404afd5"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzM1_547893a0-3f86-4b73-878e-6105b0f941fe"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzU3_08cc5cad-c9e6-4c33-93c3-e8fc3385e829"
      unitRef="shares">16091000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzU3_297a366a-b61f-4fe1-ac8d-487d04acb2cb"
      unitRef="shares">16091000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzY0_03bae9fa-9f5a-485c-8ccd-14d20a717bcb"
      unitRef="shares">16823000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjg2ZTgzMjcxNDdiOTRlZjk4MDJhMzUxMDE1N2I1Y2ViXzY0_98b7e3ea-f803-44ad-a9cf-9c71386d9c54"
      unitRef="shares">16823000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMS0xLTEtMA_55d04b6c-fe73-4585-bae1-73dc2fa97543"
      unitRef="usd">16000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzQtMy0xLTEtMA_aab98938-17ba-4959-9a42-5d8b22b2cbca"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzUtMS0xLTEtMA_e08c3e56-4010-43d1-a92f-4095e939f080"
      unitRef="usd">313057000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzUtMy0xLTEtMA_1f7d8c56-fb30-401b-8488-243665b7bee5"
      unitRef="usd">367326000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzYtMS0xLTEtMA_6d5b561c-eeb7-413e-b2ba-baf8ac9087e7"
      unitRef="usd">-1441000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzYtMy0xLTEtMA_acdd49ed-913b-42e8-814e-469fa45b8d19"
      unitRef="usd">-216000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzctMS0xLTEtMA_5e2a6275-e111-492e-a7b5-a236943ad4e6"
      unitRef="usd">386192000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzctMy0xLTEtMA_f10fd734-fe1e-410f-b6c7-0b7434092b21"
      unitRef="usd">400105000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzgtMS0xLTEtMA_212045c0-4313-4a65-b6b3-e407998b1d6d"
      unitRef="usd">697824000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzgtMy0xLTEtMA_f70b09a0-2a97-4333-b030-a2e765e69758"
      unitRef="usd">767232000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzktMS0xLTEtMA_0ca9e74c-9f6e-414f-87d8-c9ce12531bdb"
      unitRef="usd">1247449000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xNi9mcmFnOjRjYzY1ODI1NGIzZDQyN2FhNThiODRlYmRiMWJjMTNjL3RhYmxlOjgyZjIwODgzN2FhNTQ3NjViOTk5YjJiYzBiMTJhYzZmL3RhYmxlcmFuZ2U6ODJmMjA4ODM3YWE1NDc2NWI5OTliMmJjMGIxMmFjNmZfMzktMy0xLTEtMA_a5463944-1c7c-4ef2-906b-4f6c88cf763e"
      unitRef="usd">1494915000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9fc64f4d95b449579c5dcf83692dc2c2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC0xLTEtMS0w_c520a85c-936e-4ce3-a5a1-db14838e4ceb"
      unitRef="usd">9005000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icff17a87c11c484c964fba70cf7a9057_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC0zLTEtMS0w_145a46e1-6d2a-4fbd-a809-9522b81f521f"
      unitRef="usd">9767000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6992f512a9ea4391aba483112356a4b0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC01LTEtMS0w_10e9c06e-b0a4-45b3-9b05-cfeb91ed2123"
      unitRef="usd">22751000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i89eb246de85d4b488a38dcf7024d1c08_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNC03LTEtMS0w_23019184-cb43-493f-8d3b-b597d4060e5b"
      unitRef="usd">35931000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4089e56d6e3f4a8887c64e185748adcb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS0xLTEtMS0w_d1ce65ba-8fb5-4cbb-9b0e-c5d8ef48f166"
      unitRef="usd">23389000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i32a628a6cc7441d2989a9bb873aa67ed_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS0zLTEtMS0w_ed7a52cc-39f5-4acf-a521-10eb7cde405e"
      unitRef="usd">6849000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0095c2332c5f44189e76bf00c4b53c2c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS01LTEtMS0w_f61e3f19-290e-4309-8d9f-539c809bdd4b"
      unitRef="usd">68966000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2e3415613f8a40bfbe9bad5aae16a724_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNS03LTEtMS0w_a7b5d312-7182-4650-b7c3-6ff63fbad28e"
      unitRef="usd">24357000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0d01bc1e745d4a3ab4088e5f4f2358b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy0xLTEtMS0w_bad48798-decc-4c84-ae43-23c387ec83d9"
      unitRef="usd">9454000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i24db05f0ba7a4d77a7000833e1ed3559_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy0zLTEtMS0w_a7735091-f895-4d8b-9bb9-99f050412bb8"
      unitRef="usd">8192000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3cac48edfdab44eda2c29f953e09e7d3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy01LTEtMS0w_553b2284-6b81-4072-bb4d-d61d4d8a39dd"
      unitRef="usd">24712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia893a67a4ca947ba9f3e9b7d01d18a0c_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfNy03LTEtMS0w_a213f61a-eb83-4d83-83d5-adcbf9704157"
      unitRef="usd">32991000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC0xLTEtMS0w_c400dcc3-15db-4211-b475-f48ad01b5f94"
      unitRef="usd">41848000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC0zLTEtMS0w_38028af1-a23d-4ec3-9b17-74aad6be3e1d"
      unitRef="usd">24808000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC01LTEtMS0w_fa52ef54-b4a3-4709-9498-30c519d43665"
      unitRef="usd">116429000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfOC03LTEtMS0w_0d14ec69-6b7a-4dbd-8836-0eeab0352f23"
      unitRef="usd">93279000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtMS0xLTEtMA_875b8691-e781-48c5-827d-2b325b20d80a"
      unitRef="usd">6353000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtMy0xLTEtMA_330a8730-2844-4b5e-98d9-3533189cf5d0"
      unitRef="usd">3147000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtNS0xLTEtMA_b26d21b0-b33e-4aa7-9112-7a16650edd24"
      unitRef="usd">18680000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTAtNy0xLTEtMA_1815af3c-92e9-4b29-a698-5384126a530a"
      unitRef="usd">9410000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtMS0xLTEtMA_56acb1da-b98f-45ef-97c4-a857b3be7f1b"
      unitRef="usd">3875000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtMy0xLTEtMA_9aafcd51-df97-4ed3-b7ee-a965d1ecc075"
      unitRef="usd">3552000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtNS0xLTEtMA_ab1cbafe-ca2d-45d4-ae9c-081543978048"
      unitRef="usd">11285000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTEtNy0xLTEtMA_201251eb-adfd-4f51-9e01-649218d22630"
      unitRef="usd">10560000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItMS0xLTEtMA_385a19f1-e016-45fb-8bd6-68029d91e695"
      unitRef="usd">12853000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItMy0xLTEtMA_65dee77b-0215-4930-9415-f5555777637c"
      unitRef="usd">13742000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItNS0xLTEtMA_718c73c6-7dfb-4765-a2eb-b6d01ff14d4b"
      unitRef="usd">37476000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTItNy0xLTEtMA_93cd70a6-9c55-4d53-8c87-7920270f4099"
      unitRef="usd">37244000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtMS0xLTEtMA_fa22b0d5-4dcd-415c-b82f-f501abe6a152"
      unitRef="usd">15020000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtMy0xLTEtMA_721e1ad2-7b37-4a13-a651-05ab7066ba79"
      unitRef="usd">9525000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtNS0xLTEtMA_f113a88c-2b1e-4414-b247-9e6402538ce2"
      unitRef="usd">34353000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTMtNy0xLTEtMA_c9e90a73-1cb1-4847-864d-2a75bae4f86a"
      unitRef="usd">31607000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtMS0xLTEtMA_9623dd77-9b09-4580-abe8-c79733b818ca"
      unitRef="usd">38101000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtMy0xLTEtMA_adb8a00f-59ab-405f-9144-4edbedb12b1d"
      unitRef="usd">29966000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtNS0xLTEtMA_401fd7f8-d73a-442f-90ff-fdf0d108b9b6"
      unitRef="usd">101794000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTQtNy0xLTEtMA_9725ff2e-4ede-48bd-b63d-2b52032bd9e2"
      unitRef="usd">88821000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtMS0xLTEtMA_4b36aee0-2524-4531-beee-6788ab4fcb87"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtMy0xLTEtMA_7c3479fe-c1a5-4606-b56d-1c37994a8178"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtNS0xLTEtMA_c5cb571b-b05c-42ae-b839-43850d7b1dd7"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTUtNy0xLTEtMA_6b27e9e6-f5f0-40c9-80b1-7c7d7618af05"
      unitRef="usd">812797000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtMS0xLTEtMA_f3567eea-8845-41d8-b0b2-e199876cd62f"
      unitRef="usd">3747000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtMy0xLTEtMA_2fcf1785-b46e-4e02-85e2-86e67b7993b6"
      unitRef="usd">-5158000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtNS0xLTEtMA_b2089333-37cb-4abe-8b7d-a6eedeb524b7"
      unitRef="usd">14635000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTYtNy0xLTEtMA_1a0880fa-2b6c-4a60-80a5-51a65732314d"
      unitRef="usd">817255000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtMS0xLTEtMA_1978589f-b540-4b94-a9c4-3dd7204fc15c"
      unitRef="usd">-9862000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtMy0xLTEtMA_54c4883f-1650-45e8-a084-e66f9805d3ee"
      unitRef="usd">-13297000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtNS0xLTEtMA_668ac5b7-57a2-459b-a957-78f7b814fece"
      unitRef="usd">-17143000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTgtNy0xLTEtMA_229dbde7-7b30-4d64-adac-4839b2a32d42"
      unitRef="usd">-8524000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktMS0xLTEtMA_3711208a-8ddd-4195-ab2c-0366a4050e18"
      unitRef="usd">991000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktMy0xLTEtMA_9c6de799-aafe-44ee-b1cd-b2b9dee5f80e"
      unitRef="usd">7396000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktNS0xLTEtMA_09e499a3-a13e-4053-b18a-2fdcd13711c4"
      unitRef="usd">7690000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMTktNy0xLTEtMA_7801f0c7-5a04-4e5f-a93d-509e305d01fd"
      unitRef="usd">22590000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtMS0xLTEtMA_4a886a4c-e1f3-4234-bc81-90913338bef2"
      unitRef="usd">6269000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtMy0xLTEtMA_026797c8-99f0-48b5-9d26-3e794b5e34f8"
      unitRef="usd">8993000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtNS0xLTEtMA_cc6d73e5-4847-4b8f-9fcd-8d7eb01c971a"
      unitRef="usd">21030000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjAtNy0xLTEtMA_3a3b84d9-c22d-4863-bfb1-f9c0b6d9dc37"
      unitRef="usd">26911000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtMS0xLTEtMA_7d411bbd-879d-496f-af5b-6aae587121b7"
      unitRef="usd">-219000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtMy0xLTEtMA_a6662d14-39c3-4887-a892-64422ba97158"
      unitRef="usd">181000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtNS0xLTEtMA_2b01716b-85f1-47db-ae5d-389b43417e5c"
      unitRef="usd">1940000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjEtNy0xLTEtMA_f3321eff-8a2b-4ca7-a22b-54476a26b55f"
      unitRef="usd">404000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItMS0xLTEtMA_e7286be6-d6cd-461e-9247-558aef3fc63d"
      unitRef="usd">-15359000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItMy0xLTEtMA_05fae873-bc79-489c-a5e2-b160e42e02b2"
      unitRef="usd">-14713000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItNS0xLTEtMA_33371b2b-8edf-4b6f-8d83-1a2de8ba9939"
      unitRef="usd">-28543000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjItNy0xLTEtMA_e5445cf0-79e2-4854-bcc4-45160dbd4274"
      unitRef="usd">-12441000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtMS0xLTEtMA_709425fb-ce63-496c-9bd3-f314db333c43"
      unitRef="usd">-11612000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtMy0xLTEtMA_680c6f03-32c8-4443-ada1-1b32045750cc"
      unitRef="usd">-19871000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtNS0xLTEtMA_720eea14-2010-428b-aea0-16e790ff3810"
      unitRef="usd">-13908000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjMtNy0xLTEtMA_4764d879-64ca-47ae-9a91-561d8ae29ab0"
      unitRef="usd">804814000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtMS0xLTEtMA_f38672cc-bd58-4ace-8c27-512d4f499ecb"
      unitRef="usd">-4911000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtMy0xLTEtMA_8f51f371-2128-4654-841c-f6f4c11e9984"
      unitRef="usd">-4620000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtNS0xLTEtMA_fb40315c-6c41-44c0-b013-7012c0250875"
      unitRef="usd">-5162000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjQtNy0xLTEtMA_2c5f77b8-be8f-49ae-8a65-6e3fc80c4d08"
      unitRef="usd">168147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtMS0xLTEtMA_54082a61-e3ff-4c9b-8c83-b1344abc73ec"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtMy0xLTEtMA_e8ac26ca-d24c-48ab-ad4b-a0e629e14af2"
      unitRef="usd">-15251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtNS0xLTEtMA_e1113a28-0af6-4c4d-9e0f-47bb43be9b10"
      unitRef="usd">-8746000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjUtNy0xLTEtMA_095a0620-fa6e-40d6-8bd4-4669910e67ec"
      unitRef="usd">636667000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctMS0xLTEtMA_dbbd933e-037f-44bd-97a9-70dc841eade0"
      unitRef="usdPerShare">-0.42</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctMy0xLTEtMA_fd66cd48-ab72-4808-b388-47fea5a2ef04"
      unitRef="usdPerShare">-0.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctNS0xLTEtMA_a17943ba-f2c1-4c43-a728-3cdd079cf96a"
      unitRef="usdPerShare">-0.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjctNy0xLTEtMA_db9076cc-b07d-4caf-8a15-982f16540bf6"
      unitRef="usdPerShare">32.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtMS0xLTEtMA_138b7b1f-c15d-4e57-a13d-c384759a94f5"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtMy0xLTEtMA_fd7307f1-2444-45ee-b058-04152deafa70"
      unitRef="shares">18770000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtNS0xLTEtMA_a526d02e-e6cd-4a10-a69a-c0f74db023f8"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMjgtNy0xLTEtMA_37cd4e29-c315-4680-b957-9a581db7643d"
      unitRef="shares">19586000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtMS0xLTEtMA_6f709f54-d075-441c-bb11-fe4d88d50913"
      unitRef="usdPerShare">-0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtMy0xLTEtMA_9df6ab79-3069-46dd-8067-fd1f231f6ea2"
      unitRef="usdPerShare">-0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtNS0xLTEtMA_b467a9da-b40c-48d4-8dbe-623235a8e6ad"
      unitRef="usdPerShare">-0.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzAtNy0xLTEtMA_6ab18f95-d922-43b3-8d1f-e8b7cc765587"
      unitRef="usdPerShare">31.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtMS0xLTEtMA_63ffe667-e028-47ea-99b3-6536d2f20128"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtMy0xLTEtMA_2c3aa80a-6d01-4316-9a8b-0ce493517876"
      unitRef="shares">18770000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtNS0xLTEtMA_851bb6b9-9368-4a5d-9f39-1072c7b22957"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8xOS9mcmFnOjU0OWY0NzljNzAzYjRiOTg4MTNjNThiNzUzNjgzNGY4L3RhYmxlOmEzNmNhOGQyY2VmYjRhNjE5YTE0NGY0OWIyY2U3MGZkL3RhYmxlcmFuZ2U6YTM2Y2E4ZDJjZWZiNGE2MTlhMTQ0ZjQ5YjJjZTcwZmRfMzEtNy0xLTEtMA_f700b4a7-6efc-4476-84a6-089188201ac9"
      unitRef="shares">20349000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy0xLTEtMS0w_144f415f-4138-4326-ae0d-acceabb1583e"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy0zLTEtMS0w_a50a42cb-317c-4dd9-8714-895b9b3fcae9"
      unitRef="usd">-15251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy01LTEtMS0w_983ef9f8-a167-4b21-b4ed-acc32800d45c"
      unitRef="usd">-8746000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfMy03LTEtMS0w_c06d9518-b390-40e1-afb8-42a6b0036404"
      unitRef="usd">636667000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC0xLTEtMS0w_4ed36224-683d-40bc-bbb4-c1b80da96af6"
      unitRef="usd">-54000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC0zLTEtMS0w_e4fdc719-73c9-4083-b849-300f4faca31c"
      unitRef="usd">-187000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC01LTEtMS0w_f5d64c88-c9a4-4d61-a2e9-ecdc22d35f60"
      unitRef="usd">-84000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNC03LTEtMS0w_92fbe080-4901-45ed-835c-3e6f3142dd37"
      unitRef="usd">546000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS0xLTEtMS0w_53d89311-1234-4e50-9293-918197d53007"
      unitRef="usd">923000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS0zLTEtMS0w_fd69eed5-aad1-4226-a6de-5a4eb663e381"
      unitRef="usd">-764000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS01LTEtMS0w_6f095f6c-c203-4078-8206-365842a7e882"
      unitRef="usd">-1141000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNS03LTEtMS0w_b6e7b1d7-ca8b-4ffb-ac88-454bd09d74b2"
      unitRef="usd">-1015000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy0xLTEtMS0w_dd02ea13-5135-4b38-90c2-e59c34f59d43"
      unitRef="usd">-5832000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy0zLTEtMS0w_ddb2f789-29ed-4f9a-97e1-740eb5862587"
      unitRef="usd">-16202000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy01LTEtMS0w_0c0bbeb8-96aa-4260-bf2b-e720e3bc14d9"
      unitRef="usd">-9971000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yMi9mcmFnOjhkNDI3MGQ5NmU1MTQ2MWE4YTg4YTgyODI3YWJlYTkzL3RhYmxlOjRhNmRiN2U3MGY1NjQ4OWI4NDYyYjljNjZjNjRkODkwL3RhYmxlcmFuZ2U6NGE2ZGI3ZTcwZjU2NDg5Yjg0NjJiOWM2NmM2NGQ4OTBfNy03LTEtMS0w_c9d0cd68-adf0-4031-9a6d-0288febef882"
      unitRef="usd">636198000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i7229001e60ff49198a53dbfbcd6d60b4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi0xLTEtMS0w_41f006f1-4187-459d-bcdd-309832502ecb"
      unitRef="shares">16823000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7229001e60ff49198a53dbfbcd6d60b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi0yLTEtMS0w_bd641186-51ff-40f3-b272-a0231d5cbcbc"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifa54869d40994b6aa64042e970f51be8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi0zLTEtMS0w_0c00e062-d65f-42db-aa4b-091be4f25009"
      unitRef="usd">367326000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a859673f5404c6cbfade9e44d71e9f2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi00LTEtMS0w_df92112b-b59e-4b1f-94ad-2d0a29e5fc87"
      unitRef="usd">-216000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70a58a3c6c6448268c41dca75ca52fc7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi01LTEtMS0w_389b89e6-dd75-4e1d-bfcb-cce45bb38c85"
      unitRef="usd">400105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMi02LTEtMS0w_a3bf9bb2-4010-4915-8746-3b15ea833979"
      unitRef="usd">767232000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMy0xLTEtMS0w_7a87b22e-af91-4ab5-af92-e22ba4aa2ee7"
      unitRef="shares">105000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMy0zLTEtMS0w_2ed3be3c-057d-43c4-8d5a-6ae1adc6835a"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMy02LTEtMS0w_f0ffae88-1f00-49ad-8000-05145e167813"
      unitRef="usd">-1008000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNC0zLTEtMS0w_382af13e-c307-4751-bd72-80eb8d221eec"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNC02LTEtMS0w_fb57a90f-85c2-4d69-bbcc-e6d8c70d8386"
      unitRef="usd">5653000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS0xLTEtMS0w_6171dd71-4cb4-4dc8-927a-dbacf1a56e15"
      unitRef="shares">878000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i93b6a7a57a26471bbca3ba63cc1f2b18_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS0yLTEtMS0w_a33a64a6-c65e-40cf-b208-52a3a2fad226"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS0zLTEtMS0w_77547c23-9359-4e11-8b95-9a19b1208fbf"
      unitRef="usd">73286000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNS02LTEtMS0w_835c0ef1-16f1-4b6d-9c08-73108ee896ea"
      unitRef="usd">73287000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ia6aea072928f4adfb9348fc0edbac316_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNi00LTEtMS0w_022bdc1f-d4b8-4929-8b27-1f113c2a1ca4"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNi02LTEtMS0w_9615f95d-190e-422e-ab41-5f5360fb48fa"
      unitRef="usd">-2772000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="ia6aea072928f4adfb9348fc0edbac316_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNy00LTEtMS0w_dafb5402-0577-4ed8-8d55-e4b8a1a99c22"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfNy02LTEtMS0w_8b205946-a2c1-458d-b21e-c161ce410853"
      unitRef="usd">-1879000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i1be3328391d64804a9f96dd3d094589e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOC0zLTEtMS0w_6e79c356-7091-4697-9d26-98fa9ab2f2a0"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOC02LTEtMS0w_62ab0cea-0dd6-463e-bd05-f63f2d4de5c1"
      unitRef="usd">-2745000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:StockholdersEquity
      contextRef="i3e26dda8ec9c45408cdc8bf9f7fe8c69_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS01LTEtMS0w_278f7ba0-9fa5-41f5-a816-93999eb5fb7a"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6633e74552be487692e9b132df36f4e8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfOS02LTEtMS0w_d8acab7e-ef67-4253-b71f-1678d004c2e0"
      unitRef="usd">-5167000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i5aac323c2302486893f879d73f4c93e4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTAtNS0xLTEtMA_688b53e4-ff48-469f-ae16-04daec9b74c3"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTAtNi0xLTEtMA_74c9b218-c30e-4331-b3f6-23ce16a4c80d"
      unitRef="usd">-24131000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="iad5487114db84eac9bfa300064f305c6_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtMS0xLTEtMA_6f192eab-de27-4201-afec-f27d582d6c49"
      unitRef="shares">16050000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iad5487114db84eac9bfa300064f305c6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtMi0xLTEtMA_3213cd5b-7144-4c10-9efd-2fe53e2ba510"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia225c7585f734df2a5415a615cdf2097_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtMy0xLTEtMA_c9ea0bb0-d1a3-4937-94df-862c8f9d4a68"
      unitRef="usd">295940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i390ae39298aa49b48acd3739a2084b20_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtNC0xLTEtMA_080b7042-90fb-4be9-bc49-0cc0a188cf63"
      unitRef="usd">-4867000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i98e9a32b21494264a59d8c3209cde81c_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtNS0xLTEtMA_b5123e7d-017d-45c0-91b2-1279c9d138d3"
      unitRef="usd">370807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5adb4b836261437c8a079d884dd0e8ca_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTEtNi0xLTEtMA_580862a7-59d8-4436-be4b-5fcfeaa1f10a"
      unitRef="usd">661896000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="idd47a5e4d9a24937a102511805705f35_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTItMS0xLTEtMA_21559d7b-4954-4e72-9b0c-b95abfc0ae85"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTItMy0xLTEtMA_8054b6ec-a561-4438-90c0-e877a53dc217"
      unitRef="usd">1128000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTItNi0xLTEtMA_e4e777b6-f621-4e55-b3aa-0f154276b570"
      unitRef="usd">1128000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTMtMy0xLTEtMA_642143cb-cd87-459a-8e50-4671b074f430"
      unitRef="usd">7359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTMtNi0xLTEtMA_d18f9b48-a80a-4a00-8aec-27dd73d73d67"
      unitRef="usd">7359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="iff9d958158dd43a293e2993c7506b393_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTQtNC0xLTEtMA_3316ed44-16d7-4408-b7fa-722aeff626b5"
      unitRef="usd">2742000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTQtNi0xLTEtMA_a6f2caba-535b-431c-a627-1969f86811bd"
      unitRef="usd">2742000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="iff9d958158dd43a293e2993c7506b393_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTUtNC0xLTEtMA_24246c1c-6a0a-4e7c-afe3-4a0558f3de74"
      unitRef="usd">-185000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTUtNi0xLTEtMA_fc83e820-0c4d-4b44-b698-25bdb75d6fc8"
      unitRef="usd">-185000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i792ad4d2405b4adfbbfd4fd6501c99a2_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTYtMy0xLTEtMA_f37df607-f99a-405a-b184-170e628c150d"
      unitRef="usd">-23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTYtNi0xLTEtMA_ee2a6a45-66a2-4294-8e41-8edeb12c15ef"
      unitRef="usd">-23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:NetIncomeLoss
      contextRef="i49e9549e37074565b41ee42b330a2e2d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTctNS0xLTEtMA_d5638c24-e7ed-4486-856d-16e42aff9671"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTctNi0xLTEtMA_ebaf3d9e-1329-43d2-ad7a-4a9736742441"
      unitRef="usd">22086000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i1a7426a780234cb098ddd5e2ad753bbc_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtMS0xLTEtMA_6d23fc68-b043-4260-b3cb-1bd9117bb349"
      unitRef="shares">16071000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1a7426a780234cb098ddd5e2ad753bbc_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtMi0xLTEtMA_4166a760-d571-478f-a1cb-acb30a07474c"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50fc27200cc345ddab6a3d2ba7763419_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtMy0xLTEtMA_1aea0cf1-b569-49c7-b2ec-e87eec1de1fa"
      unitRef="usd">304404000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5cf845807cc0448f8bb1b78321ef94bf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtNC0xLTEtMA_ce3c2e6e-dbf1-4b70-bc7d-2c68ee310d93"
      unitRef="usd">-2310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i033832a8e05745f8925aad29d6926388_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtNS0xLTEtMA_d859d01c-cf7a-430e-8b4d-566b5c86da4b"
      unitRef="usd">392893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i490f2ffbbf00499fbb82c91eb2b73aef_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTgtNi0xLTEtMA_03606dac-98c6-4c70-86ac-0ec16aa7aaec"
      unitRef="usd">695003000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib77b17a4438e4523ab9ff836080cad8f_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTktMS0xLTEtMTM2MQ_750e19ab-0d6e-4f49-a075-7e851b8af7c5"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i30e1862d94954195986e08adfa6e1308_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTktMy0xLTEtMTQyMA_80470260-93e5-4523-aba3-0963fa18eedf"
      unitRef="usd">910000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMTktNi0xLTEtMTY3OQ_215d074b-57b7-447e-bb5a-15af8063e58c"
      unitRef="usd">910000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i30e1862d94954195986e08adfa6e1308_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjAtMy0xLTEtMTQyNA_7ff1fdfe-1047-4421-acb1-fd1149b216ed"
      unitRef="usd">7740000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjAtNi0xLTEtMTY3OQ_6f4a1385-cea4-4593-8b66-49b7f46eab94"
      unitRef="usd">7740000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="if6b07ddca2e541d7ba70100ef93c997c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjEtNC0xLTEtMTQ1OA_538e5f93-ec7b-4fd4-8202-c0d2caffb7f0"
      unitRef="usd">-54000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjEtNi0xLTEtMTY3OQ_f94dc179-eb8b-497b-8a40-6579e98c1d85"
      unitRef="usd">-54000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="if6b07ddca2e541d7ba70100ef93c997c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjItNC0xLTEtMTQ2Mg_a56c07e6-ab4d-4686-ad65-546a419658f3"
      unitRef="usd">923000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjItNi0xLTEtMTY3OQ_fc366d74-3efe-41b7-b30d-e13a5df7b281"
      unitRef="usd">923000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:StockholdersEquityOther
      contextRef="i30e1862d94954195986e08adfa6e1308_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtMy0xLTEtMjc5Mw_761f85c0-1b9c-454e-9eee-eddf588126f8"
      unitRef="usd">-3000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtNi0xLTEtMjIxNQ_512e02b0-86b9-42c8-9b2b-d46da663527c"
      unitRef="usd">-3000</us-gaap:StockholdersEquityOther>
    <us-gaap:NetIncomeLoss
      contextRef="ia37703b7519741a7947b97bcf8cb4d32_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtNS0xLTEtMTQ5Ng_cf58936f-db20-4810-a57f-525f5c314a2a"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjMtNi0xLTEtMTY4MQ_bcbc10da-324e-43b4-b17e-15daa77134cf"
      unitRef="usd">-6701000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ib5d9a384d5fe4b8ea0e9be04bb79c338_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtMS0xLTEtMTY4MQ_ce922951-5396-4160-b768-586ec1faa01d"
      unitRef="shares">16091000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib5d9a384d5fe4b8ea0e9be04bb79c338_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtMi0xLTEtMTY4MQ_94916734-393c-421c-9b64-0377f3f6fcae"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if87fbb1c899e4dd3a43541865f6f3cb5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtMy0xLTEtMTY4MQ_bd5e8369-b226-42f8-b225-1d033151c765"
      unitRef="usd">313057000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i06e8e2209037448496084b7cfc9433eb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtNC0xLTEtMTY4MQ_3b1dfa56-cb8a-470e-b56c-dc0fede822d2"
      unitRef="usd">-1441000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id242a912b69a4ef0a5aa82c546921324_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtNS0xLTEtMTY4MQ_cedb34c0-ad83-4d8e-9db1-194721335e1e"
      unitRef="usd">386192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOmFhNzhmM2VkOGJlYTRlZjU4Yjg4NDgzZmYyZTY1ZGRkL3RhYmxlcmFuZ2U6YWE3OGYzZWQ4YmVhNGVmNThiODg0ODNmZjJlNjVkZGRfMjQtNi0xLTEtMTY4MQ_ff36c6af-2d81-4a38-93b7-ae187e057126"
      unitRef="usd">697824000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i7a970afb914d41ce990cb1157db7eb2e_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi0xLTEtMS0w_21fffb27-5a12-4fb0-b073-05a227ddc95b"
      unitRef="shares">20765000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7a970afb914d41ce990cb1157db7eb2e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi0yLTEtMS0w_b61bf834-532e-4f51-b290-a8d1e5329d9e"
      unitRef="usd">21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e121e85c66044c887bca7e02db16f42_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi0zLTEtMS0w_4a684270-4ffb-4400-8337-58fddb3e5342"
      unitRef="usd">791114000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i49bb47989637497c8b00af3bf1f16d88_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi00LTEtMS0w_364e64dd-2194-463a-97b3-e85b21da8585"
      unitRef="usd">-1024000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia51a45b1a9554dc4a23d19c9681b8627_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi01LTEtMS0w_edd6970e-0085-45e0-81b7-08beed244fe5"
      unitRef="usd">-229197000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c217737a66b4aeba81beaacd79e70ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMi02LTEtMS0w_4b54ff21-3174-4283-b23e-7b991c6f428e"
      unitRef="usd">560914000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMy0xLTEtMS0w_51839fb8-92b5-499c-a3e3-b1795f696197"
      unitRef="shares">135000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMy0zLTEtMS0w_fb7798a2-2da3-4796-a398-e7a2fb906e26"
      unitRef="usd">-991000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMy02LTEtMS0w_1069c2cd-6132-4b1d-9c48-582960ebcdc2"
      unitRef="usd">-991000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNC0zLTEtMS0w_94d45d94-efbb-46b8-9e3f-c7773a6d09c8"
      unitRef="usd">5347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNC02LTEtMS0w_c272d8a9-e28a-4b79-a8f9-11ad3fa6d95a"
      unitRef="usd">5347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS0xLTEtMS0w_803e4eff-e965-4c94-b5f4-8fe15c4f3bb7"
      unitRef="shares">1236000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS0yLTEtMS0w_fcfdfd7c-87df-4556-ae22-ab1268d06738"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS0zLTEtMS0w_b226e773-21ed-4654-b107-75b5eefe8c26"
      unitRef="usd">151584000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNS02LTEtMS0w_dfcfb37c-af52-49df-80b3-d8101471b289"
      unitRef="usd">151585000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i234221629449487f964bc6624088b0c1_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNi00LTEtMS0w_f5705063-d13f-4818-93f6-73e93825accb"
      unitRef="usd">230000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNi02LTEtMS0w_0890211e-c0f4-4750-a5cb-4a1acfbc312a"
      unitRef="usd">230000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i234221629449487f964bc6624088b0c1_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNy00LTEtMS0w_861dea3c-a793-4978-a0c0-74e5c41f6975"
      unitRef="usd">291000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfNy02LTEtMS0w_35a5af3e-d9f6-4d98-9c39-462a67d98ed3"
      unitRef="usd">291000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ia9bd65fdc5f84b1496704c0128e5a070_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOC0zLTEtMS0w_4d186061-e70a-4f93-af4e-bb125e6eeb33"
      unitRef="usd">-569000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOC02LTEtMS0w_7fa0ed91-f923-407c-8d2a-4ee9ce04e2f9"
      unitRef="usd">-569000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="i8ffdf07b1b53463498a6c354fdf3b822_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOS01LTEtMS0w_234ba66e-c3c0-4687-8602-922a0b83576a"
      unitRef="usd">666337000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i23d3bfe7404945179b76d09c7fa9b744_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfOS02LTEtMS0w_12a2a368-98fa-415c-a991-89dfff80a130"
      unitRef="usd">666337000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ic3d3d78b23a9464aba33b50d534d7983_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtMS0xLTEtMA_286bb99a-237f-4923-b43c-72c834034807"
      unitRef="shares">19664000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic3d3d78b23a9464aba33b50d534d7983_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtMi0xLTEtMA_c35587b7-bd76-4e45-bcdf-4a941aff6007"
      unitRef="usd">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fadbb805c68461391658b06e2708f69_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtMy0xLTEtMA_c1c9fb66-5fc1-4787-ac82-9147bcbb7263"
      unitRef="usd">643317000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic824a6a2217044eebe4ad6f38deb865e_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtNC0xLTEtMA_2dfb896b-17f6-4b30-a81f-3ebc17ac84f5"
      unitRef="usd">-503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifadacbb2a79244b9a4f3e6026a94394d_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtNS0xLTEtMA_8462add6-97bf-41be-bd00-b2db367f9ed5"
      unitRef="usd">437140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i13cc02644d614c5a9a285795ce36f88c_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTAtNi0xLTEtMA_978355f4-98e7-42e7-af93-d163c7a84d04"
      unitRef="usd">1079974000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTEtMS0xLTEtMA_63b98aad-1751-4a2c-999a-84f6e05e66a2"
      unitRef="shares">17000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTEtMy0xLTEtMA_a56e736c-d85d-4c84-b8a1-e757bb699d49"
      unitRef="usd">740000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTEtNi0xLTEtMA_d92d7ced-23ae-4210-870e-5f7119062abc"
      unitRef="usd">740000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTItMy0xLTEtMA_39360633-cbc1-4745-bf10-fd3b3ae8f109"
      unitRef="usd">6571000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTItNi0xLTEtMA_bfb99c8e-0359-45b3-8af2-9d845073aea6"
      unitRef="usd">6571000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtMS0xLTEtMA_5b3b37f1-b789-4d7f-afa0-521bf49c9fea"
      unitRef="shares">291000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iddd96e6198334ac5a3cf12440840750d_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtMi0xLTEtMA_1e27b8fe-3448-4d4e-89c3-b466c89e764e"
      unitRef="usd">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtMy0xLTEtMA_5e6cdafc-e174-4fbb-8a45-4e1ed308e45d"
      unitRef="usd">33716000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTMtNi0xLTEtMA_4afbc444-39a8-4756-a821-51055dc492d1"
      unitRef="usd">33717000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i4daf159584b94905a33f5c1706489352_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTQtNC0xLTEtMA_ed1e9d99-6c1f-4f31-aa7b-3093df297c8a"
      unitRef="usd">503000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTQtNi0xLTEtMA_2a73d2e4-0592-4689-8ba1-faf9ebbf4cc8"
      unitRef="usd">503000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i4daf159584b94905a33f5c1706489352_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTUtNC0xLTEtMA_f0b728e8-a53a-4403-be0b-cca07fedcf21"
      unitRef="usd">-542000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTUtNi0xLTEtMA_07a152f6-336a-4eea-afd0-3fe5a7e64319"
      unitRef="usd">-542000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i497ab0804fae4fe48647682e1e4ced5a_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTYtMy0xLTEtMA_3544bc6a-e1e2-4122-ac8f-ccbc4c83e32b"
      unitRef="usd">2343000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTYtNi0xLTEtMA_e8344043-33e5-4aef-ab39-b75e859411ef"
      unitRef="usd">2343000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="i37fb40383c604fa99c82bd4627415ddd_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTctNS0xLTEtMA_cb3304f3-ab23-479d-a94a-2dda6404bc39"
      unitRef="usd">-14419000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifb1965ddd9ab43c2b7db581e54e7b96c_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTctNi0xLTEtMA_343b2865-23ff-4386-bf83-2b3cbbffd27c"
      unitRef="usd">-14419000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i1dee39642b1441adab4e1b7f195f4820_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtMS0xLTEtMA_61419844-52b7-4c6e-95a4-c804a923955f"
      unitRef="shares">19390000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1dee39642b1441adab4e1b7f195f4820_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtMi0xLTEtMA_4e0894fc-77d6-4da7-9405-00b282082df3"
      unitRef="usd">19000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4c4ce8565674d7cbc011bb29d51fdbc_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtMy0xLTEtMA_e6180caf-414d-4e12-ba37-a0b3aa64b813"
      unitRef="usd">619255000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9f29670866f470d84fbf023db043769_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtNC0xLTEtMA_ba994a80-8bea-43b8-9f6c-f3c2f5568c47"
      unitRef="usd">-542000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i43125aaaa4d745faabb5618510882e01_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtNS0xLTEtMA_4cd8d9ad-0e5c-4970-a48e-c9c998bdbfdb"
      unitRef="usd">422721000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if7c8205976c64573b1f5fafa7ee9496c_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTgtNi0xLTEtMA_ce4ba1d1-af8b-45dc-971f-96ed9134ecd5"
      unitRef="usd">1041453000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTktMS0xLTEtMTIy_7bfd165f-463b-4a73-bccf-fc5c8e97151c"
      unitRef="shares">7000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTktMy0xLTEtMTM2_4509c9f0-06e8-406e-b2a7-6a2815df00fb"
      unitRef="usd">199000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMTktNi0xLTEtMA_2282a911-e551-4ab7-8c57-66b56920664a"
      unitRef="usd">199000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjAtMy0xLTEtMTM2_93cfeefa-477e-4653-a08d-ff633238b542"
      unitRef="usd">6297000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjAtNi0xLTEtMA_be9298ca-909b-4603-906e-bd59ac25a53e"
      unitRef="usd">6297000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtMS0xLTEtMTI2_f5aa8503-2465-48a6-bde5-d62e64c97568"
      unitRef="shares">1834000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i2549cf4adff94d2dbeebf5fc531c6bfd_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtMi0xLTEtMTMx_8b86c5ba-9255-40c1-8b83-a1dc86dbf9a5"
      unitRef="usd">2000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtMy0xLTEtMTM2_f3abf359-1e96-4f9b-be8c-6bb0584fc718"
      unitRef="usd">181186000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjEtNi0xLTEtMA_d1ff5f7a-731d-45c2-9c6e-183796c0827b"
      unitRef="usd">181188000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i2df602c5680a4955ac8de558547908d1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjItNC0xLTEtMTQx_9f0a72a6-30c8-45a6-a21a-5b0f467e3783"
      unitRef="usd">-187000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjItNi0xLTEtMA_539fd9a7-2e85-4011-902c-5edaab533e39"
      unitRef="usd">-187000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="i2df602c5680a4955ac8de558547908d1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjMtNC0xLTEtMTQx_713d4343-f072-4cc5-abe0-4883d4295588"
      unitRef="usd">-764000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjMtNi0xLTEtMA_196fd32f-f6cc-4896-a531-00f37ebbe4c1"
      unitRef="usd">-764000</lgnd:AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ia77697fddf3c4cfd95d7ff8e73c041f1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjQtMy0xLTEtMTM2_2c1fbf2b-7528-40fe-9ffa-ba1db2732ab1"
      unitRef="usd">22000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjQtNi0xLTEtMA_e15d1ffc-a57f-4c9d-a9df-34b8b3221b1e"
      unitRef="usd">22000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="ic3192c6a0bb844fdb952e47d0f4a8a28_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMjUtNS0xLTEtMTQ2_88f2e8bc-b3c7-480e-a0cb-3b0ec3156e86"
      unitRef="usd">-15251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzEtNi0xLTEtMA_d8ac5548-5273-48ce-b2ea-bd9e7bf096a2"
      unitRef="usd">-15251000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ife85aa33f030423e9deacf97a190c282_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItMS0xLTEtMA_8a2f01d2-6a89-479e-8ae3-1ed9983e005e"
      unitRef="shares">17563000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ife85aa33f030423e9deacf97a190c282_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItMi0xLTEtMA_0db3b475-652f-4923-9120-6f4877b04c00"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3ed241cfb09b46e5ba9c8968fb1b32f8_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItMy0xLTEtMA_1ea2f03a-8784-4265-a8f3-1e3250c73aae"
      unitRef="usd">444587000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4d3f481bad1425ca853b25afe3012d9_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItNC0xLTEtMA_5f0f01e3-5e28-4ee4-9375-316825a6050d"
      unitRef="usd">-1493000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ae80780948143b7b2da481e22963423_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItNS0xLTEtMA_ae6d9274-222b-4995-b054-20fbec661c97"
      unitRef="usd">407470000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yNS9mcmFnOjA3MWRlNGQ4NmEzNTQ4NTdiYmRiNjFjOTA3ZDEyN2M0L3RhYmxlOjFhYjUxM2JhN2QwMjQ4NTViMDQwOGUzNTQzMTE0NGY2L3RhYmxlcmFuZ2U6MWFiNTEzYmE3ZDAyNDg1NWIwNDA4ZTM1NDMxMTQ0ZjZfMzItNi0xLTEtMA_0d8b8558-fae8-482e-9414-84067162dd30"
      unitRef="usd">850581000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNC0xLTEtMS0w_ac8adb8d-f455-4496-8a43-c8b8d76cae6d"
      unitRef="usd">-8746000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNC0zLTEtMS0w_f50c8795-ed8b-4971-8b9d-21f5bc00a6d7"
      unitRef="usd">636667000</us-gaap:ProfitLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNi0xLTEtMS0w_b069ee52-b8f5-489f-a489-094348b392ee"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNi0zLTEtMS0w_ede4ed5c-1b98-415f-93ad-06b6da704d99"
      unitRef="usd">812797000</us-gaap:GainLossOnDispositionOfAssets1>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNy0xLTEtMS0w_17059c4d-3725-46c6-aa44-0f299a86ba73"
      unitRef="usd">397000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNy0zLTEtMS0w_2949f7d2-6f41-4ddf-9500-573a2570b4ed"
      unitRef="usd">-762000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOC0xLTEtMS0w_9e539517-272d-4052-8747-d04ccdd1bfd3"
      unitRef="usd">12645000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOC0zLTEtMS0w_fc96d0ae-9c02-4bf5-af0c-4769619363f5"
      unitRef="usd">11648000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOS0xLTEtMS0w_8e20b275-a13a-471f-bb33-099b7cc63086"
      unitRef="usd">-1507000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfOS0zLTEtMS0w_7301089b-7c04-442a-843c-f24fb61a3a7c"
      unitRef="usd">7477000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTAtMS0xLTEtMA_82307e7a-f458-405c-9b3d-2af0196825c8"
      unitRef="usd">17743000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTAtMy0xLTEtMA_0f57184d-157a-49ec-81c5-65b8343a0b55"
      unitRef="usd">22562000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTEtMS0xLTEtMA_d49f9127-58d4-46b1-ba7c-3aa21d6a3376"
      unitRef="usd">2505000</lgnd:AmortizationOfOtherEconomicRights>
    <lgnd:AmortizationOfOtherEconomicRights
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTEtMy0xLTEtMA_8fd318eb-3a1d-4394-a4d0-d75e4951c655"
      unitRef="usd">10047000</lgnd:AmortizationOfOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTItMS0xLTEtMA_aa5904ae-9e8f-44eb-8eab-2246f2477b4d"
      unitRef="usd">659000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTItMy0xLTEtMA_b2ab5718-b927-495d-911f-506fd1384ac8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTMtMS0xLTEtMA_e45bc4d4-86f1-47c1-baa0-efe567a03ae3"
      unitRef="usd">20752000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTMtMy0xLTEtMA_d9c1a35c-fc29-43f2-a9a5-c5524b3f5a39"
      unitRef="usd">18215000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTQtMS0xLTEtMA_1c03c549-4ae0-43a7-a840-576f04c10788"
      unitRef="usd">19311000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTQtMy0xLTEtMA_6e057a0f-462e-4e59-a57f-7a5fd452ad59"
      unitRef="usd">-57766000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTUtMS0xLTEtMA_41aaf4df-b1c7-4f22-9c32-df22c7afb41f"
      unitRef="usd">-17143000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTUtMy0xLTEtMA_938d23db-d697-4733-bf26-5b9f4684e6db"
      unitRef="usd">-8524000</lgnd:GainLossOnShortTermInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTYtMS0xLTEtMA_eef180c0-0b6a-40fa-bafa-20b6c50df53d"
      unitRef="usd">-1525000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTYtMy0xLTEtMA_0a8d072f-18ff-496c-ae53-9a9a4a68d024"
      unitRef="usd">-4253000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTgtMS0xLTEtMA_dcbd1f07-5622-410a-b249-5e122e1e4d12"
      unitRef="usd">5080000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTgtMy0xLTEtMA_028a75cb-9b17-4988-94f2-49803340bf8b"
      unitRef="usd">-33892000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTktMS0xLTEtMA_3f7d6bc8-8f71-49d8-9493-1a4b008b46ef"
      unitRef="usd">4914000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMTktMy0xLTEtMA_7de994e3-758b-465b-9945-71eec8cae579"
      unitRef="usd">1500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjAtMS0xLTEtMA_5be36089-5f03-4456-8767-6d4f70c56106"
      unitRef="usd">9894000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjAtMy0xLTEtMA_386071c7-b834-4716-9a44-5b587a715e65"
      unitRef="usd">-3302000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjEtMS0xLTEtMA_8aa09bfb-8dc6-4d10-863d-cea9f281011a"
      unitRef="usd">12026000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjEtMy0xLTEtMA_36491fd6-ca71-4866-b365-92dc5b6d5383"
      unitRef="usd">16571000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <lgnd:IncreaseDecreaseInOtherEconomicRights
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjItMS0xLTEtMA_9f3a10f4-c544-4fd5-be98-d6845cad9dc7"
      unitRef="usd">0</lgnd:IncreaseDecreaseInOtherEconomicRights>
    <lgnd:IncreaseDecreaseInOtherEconomicRights
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjItMy0xLTEtMA_c19fdfda-4927-45a4-939b-bb80d2a49723"
      unitRef="usd">12000000</lgnd:IncreaseDecreaseInOtherEconomicRights>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjMtMS0xLTEtMA_24d3fac2-1cfc-41fa-9173-ffd44dd4efd7"
      unitRef="usd">466000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjMtMy0xLTEtMA_abe025e3-2ac3-4b0a-abf0-10f62427e645"
      unitRef="usd">2678000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjQtMS0xLTEtMA_84c172c6-cf9f-4572-9d13-b98af2f2f14a"
      unitRef="usd">54049000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjQtMy0xLTEtMA_e0daed8b-a6b3-4e23-9fae-689f7afd0cc9"
      unitRef="usd">-21997000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjctMS0xLTEtMA_bbbc184d-f073-481e-b863-1f7c79d9cb9f"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjctMy0xLTEtMA_086f2a5f-c021-45ac-af65-be8f81c5cfeb"
      unitRef="usd">812797000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjgtMS0xLTEtMA_9180a34c-105a-4ccf-8357-20b9858362d3"
      unitRef="usd">337016000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjgtMy0xLTEtMA_b8d5925a-fa62-4d03-b6b3-d7d27f74ed64"
      unitRef="usd">1682586000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjktMS0xLTEtMA_feff3bdc-e75b-4e4d-88ed-9416350213b4"
      unitRef="usd">389296000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMjktMy0xLTEtMA_b75068be-e144-4ddb-ac3d-6177b78d6d20"
      unitRef="usd">144182000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzAtMS0xLTEtMA_8000e5f8-5668-44f3-9c8e-6793a6635496"
      unitRef="usd">589155000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzAtMy0xLTEtMA_d90b77ae-4e2c-4c01-9c18-7d7e49d817fe"
      unitRef="usd">1274851000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzEtMS0xLTEtMA_30ad68f9-4bb5-49a0-a2c7-95c28aabbc43"
      unitRef="usd">26857000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzEtMy0xLTEtMA_26a0b434-1d83-44b6-9fcf-4eedc3562eec"
      unitRef="usd">11840000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMS0xLTEtNTg_9202e1e2-a8c0-4366-a531-2f80164a6265"
      unitRef="usd">500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMy0xLTEtNTI_16ee670b-7c8e-4353-bd35-7f3e41b1e016"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMS0xLTEtMA_f7c3a83a-0fdc-40ea-9045-0f26d1bc7429"
      unitRef="usd">228000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzItMy0xLTEtMA_92c5f9ec-4c22-460c-a9d9-8a0f3e4f9fd5"
      unitRef="usd">6307000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzMtMS0xLTEtMA_1331a58b-bd4d-4107-b684-399833644c46"
      unitRef="usd">613850000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzMtMy0xLTEtMA_1059f30a-d6c1-4973-a5af-57a52d4b9946"
      unitRef="usd">530097000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1d610f8e9c4740b18e5147a6ee408789_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzYtMS0xLTEtMA_9ef5e2ec-3d98-4d93-a163-69387f0ee92e"
      unitRef="usd">203210000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic9d5df0e1dac4e88ae8b5fb46ae522b3_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzYtMy0xLTEtMA_9eea504c-41fd-442e-8092-6c1f91c31210"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id067844f4eb4436eb363d302e57613d7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMS0xLTEtMjc2_c10a86a6-4067-4ed3-afab-628d7a401269"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i852922b66fce4828ae182e5350dcb942_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMy0xLTEtNzU_01393aa0-770c-4e84-a480-3da6b5c93dcf"
      unitRef="usd">27323000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMS0xLTEtMjc2_4f92440d-38ba-474d-9b70-0b8125079262"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMy0xLTEtODM_8cb16741-ae06-4752-b064-a7727cf5a043"
      unitRef="usd">12401000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMS0xLTEtMjc2_4d0ccfc1-d175-43e2-8046-9b250fd349cc"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMy0xLTEtODM_e9113d8a-c5dc-457e-8e09-3ed7e5cd37f8"
      unitRef="usd">12401000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzctMS0xLTEtMA_b700e635-2432-44e5-af1d-f9ecf08e8682"
      unitRef="usd">2459000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzctMy0xLTEtMA_6a1ad7ff-3525-48bc-9c69-d9738ece8bd9"
      unitRef="usd">2856000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMS0xLTEtMA_6c0d0af9-f2a3-420e-b619-b2ee23ea9a5a"
      unitRef="usd">1429000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzgtMy0xLTEtMA_7b2a4eaa-51f8-4061-9f83-d5c1352fac4e"
      unitRef="usd">2906000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMS0xLTEtMA_5db41f9c-0d7a-4695-b285-53bee3f15482"
      unitRef="usd">73287000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfMzktMy0xLTEtMA_8e936851-2f59-440d-a7c7-fcbee1654098"
      unitRef="usd">371106000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMS0xLTEtMA_9e5b72af-a711-4b3a-b48c-435e33a6dfea"
      unitRef="usd">2325000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDAtMy0xLTEtMA_2c2f5910-86ad-4354-a70d-37cd7469792d"
      unitRef="usd">3000000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDEtMS0xLTEtMA_668163b9-30e6-44d8-9ec1-3afdcddbc6b7"
      unitRef="usd">-5224000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDEtMy0xLTEtMA_27806624-852c-47aa-911e-a76da9a9c0f7"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDItMS0xLTEtMA_dc86f004-6b59-4e53-a3ef-5fad78823555"
      unitRef="usd">-283016000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDItMy0xLTEtMA_5a64aab6-a16e-4d1b-8845-a505bcaa44ed"
      unitRef="usd">-401479000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDMtMS0xLTEtMA_9247f320-2fc3-4498-b56d-78882cc6ad69"
      unitRef="usd">-50000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDMtMy0xLTEtMA_e554d841-978a-4221-ac42-5c9445d4b4d4"
      unitRef="usd">-88000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDQtMS0xLTEtMA_c884a710-34da-4b22-be21-069086e532bb"
      unitRef="usd">384833000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDQtMy0xLTEtMA_a9390538-4135-466a-ac3d-bd486d5e3561"
      unitRef="usd">106533000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDUtMS0xLTEtMA_0602a209-4b9b-4018-80cd-dfc4c8074cf1"
      unitRef="usd">72273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7c217737a66b4aeba81beaacd79e70ec_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDUtMy0xLTEtMA_018d4b9d-bff5-4936-8cb4-a09de3964046"
      unitRef="usd">119780000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDYtMS0xLTEtMA_44d350b1-fb3b-48f2-a898-072aa5f9761b"
      unitRef="usd">457106000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjJlZTUxZGE2OTU5NzRiNTZhMTg5ZTc5YjY2MmNkNjNlL3RhYmxlcmFuZ2U6MmVlNTFkYTY5NTk3NGI1NmExODllNzliNjYyY2Q2M2VfNDYtMy0xLTEtMA_4b5417f1-30c3-4796-93c9-0e66c8defe0c"
      unitRef="usd">226313000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMS0xLTEtMS0w_ee012e22-7a27-48d4-93d7-3b7b4ffbd09c"
      unitRef="usd">2531000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMS0zLTEtMS0w_479666d2-2c73-4568-8243-0d9d8a798573"
      unitRef="usd">3015000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMi0xLTEtMS0w_edd17083-8728-4b2c-9b4f-58bea9042f30"
      unitRef="usd">2130000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMi0zLTEtMS0w_ab25f8db-c3f4-4959-a382-cb98a3f353a3"
      unitRef="usd">93817000</us-gaap:IncomeTaxesPaid>
    <us-gaap:RestrictedCashCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMy0xLTEtMS0w_83cfdb59-7dc1-40a8-94a4-2b95e52943b2"
      unitRef="usd">190000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i8c213e8cbfdd41b88a06453b76bd15e6_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMy0zLTEtMS0w_cf6121b6-2569-4c41-98ba-951ed64a9033"
      unitRef="usd">1011000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfOS0xLTEtMS0w_6ccbcb7e-83fc-427b-b206-9c19c4f0d02a"
      unitRef="usd">381000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfOS0zLTEtMS0w_a9235602-21c1-43c1-aea1-0ad1723efbc3"
      unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTEtMS0xLTEtMA_6b72e001-a3aa-4eff-802b-c34e5b2be578"
      unitRef="usd">1390000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTEtMy0xLTEtMA_a9c9f8bf-2561-4f26-8783-6d017e6db6f9"
      unitRef="usd">0</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedLeasePurchases
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMS0xLTEtMjMyMw_902463d0-9821-428f-8916-f186fe810990"
      unitRef="usd">2500000</lgnd:AccruedLeasePurchases>
    <lgnd:AccruedLeasePurchases
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMy0xLTEtMjMyNw_e64c3a96-7f50-47bc-9171-e0bde1713225"
      unitRef="usd">0</lgnd:AccruedLeasePurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMS0xLTEtMA_c94fd4e7-2540-45bf-a8f2-616f75174b94"
      unitRef="usd">-109000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8yOC9mcmFnOmFkZGZlZjE0OGViMTQ5ZGQ4ZTc5ZmQ0NjU2MWViYjQ0L3RhYmxlOjQwYzY3N2RhMTJjYTQxMzg4NzNkYzkzOTAyMGNhMTRmL3RhYmxlcmFuZ2U6NDBjNjc3ZGExMmNhNDEzODg3M2RjOTM5MDIwY2ExNGZfMTItMy0xLTEtMA_354b530d-4654-4525-bb36-f58d775b4b46"
      unitRef="usd">699000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NTE_964b614d-4bdf-4e7a-974f-fef9872c35a7">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2019 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the second quarter of 2020, we began to include our investment in Viking in &#x201c;short-term investments&#x201d; in the condensed consolidated balance sheet, and present &#x201c;gain (loss) from short-term investments&#x201d; in the condensed consolidated statements of operations to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in &#x201c;other income, net&#x201d;. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and nine months ended September&#160;30, 2019 have been reclassified to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of Notes to Consolidated Financial Statements in our 2019 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impact of COVID-19 Pandemic&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#x201c;stay-at-home&#x201d; orders, and restricting business functions outside of one&#x2019;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead for Veklury&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (remdesivir), the first FDA-approved treatment for COVID-19 for the treatment of patients with COVID-19 requiring hospitalization and, as a result, we have extended our Captisol supply agreement with Gilead until September 2030 and worked to increase our manufacturing of Captisol to meet this increased demand. We believe our existing production capacity, together with our planned expansion, will provide adequate supply of Captisol and do not expect any significant risk or disruption to our supply chain for the foreseeable future. In addition, certain of our OmniAb and Vernalis partners have initiated antibody discovery programs for the potential treatment of COVID-19. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, and the economic impact on local, regional, national and international markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. This standard includes our financial instruments, such as accounts receivable, investments that are generally of high credit quality, and commercial license rights. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The new guidance requires us to identify, analyze, document and support new methodologies for quantifying expected credit loss estimates for our financial instruments, using information such as historical experience and current economic conditions, plus the use of reasonable supportable forecast information. We adopted &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b"&gt;ASU 2016-13&lt;/span&gt; on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance sheet of retained earnings to be recognized on the date of adoption with prior periods not restated. The cumulative-effect adjustment, net of tax, recorded on January 1, 2020, is approximately $5.2 million on our unaudited condensed consolidated balance sheet as of January 1, 2020. Results for periods after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported under previously applicable accounting standards. See additional disclosure on credit losses under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Short-term Investments&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Accounts Receivable and Allowance for Credit Losses&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Commercial License and Other Economic Rights&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill Impairment Testing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In January 2017, the FASB issued ASU 2017-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Test for Goodwill Impairment, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which eliminates the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. Under the new standard the goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value, although it cannot exceed the total amount of goodwill allocated to that reporting unit. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In August 2018, the FASB issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement: Disclosure Framework&#x2014;Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which modifies the disclosure requirements on fair value measurements. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In November 2018, the FASB issued ASU 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements: Clarifying the Interaction between Topic 808 and Topic 606 (Topic 808)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, when the counterparty is a customer for a good or service that is a distinct unit of account. The amendments also preclude entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. Depending on the amendment, adoption may be applied on a retrospective, modified retrospective or prospective basis. We adopted this standard on a prospective basis on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $5.8 million and $8.3 million, respectively. During the three and nine months ended September&#160;30, 2019, the amount recognized as revenue that was previously deferred was $1.0 million and $5.0 million, respectively. We expect to satisfy the performance obligations related to long-term deferred revenue within the next 3 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Promacta&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments, excluding investment in Viking, consist of the following at September&#160;30, 2020 and December 31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;411,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;411,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;210,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;210,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;151,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;151,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;297,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;941,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;939,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as of September&#160;30, 2020 and December&#160;31, 2019, we recorded shares of Viking common stock we own at fair value of $33.9 million and $48.4 million, respectively, in &#x201c;Short-term investments&#x201d; in our consolidated balance sheets. We also own warrants to purchase up to 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. We recorded the warrants in &#x201c;Short-term investments&#x201d; in our consolidated balance sheet at fair value of $6.6 million and $9.9 million at September&#160;30, 2020 and December&#160;31, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments on our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For available-for-sale debt securities with unrealized losses, the new credit losses standard (Topic 326) now requires allowances to be recorded instead of reducing the amortized cost of the investment. This standard limits the amount of credit losses to be recognized for available-for-sale debt securities to be the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the new credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;After five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;79,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;79,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 2 positions which were in an unrealized loss position as of September&#160;30, 2020. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2020, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the surrounding novel coronavirus (COVID-19) pandemic on our business and recorded an adjustment of $(0.1)&#160;million and $0.2&#160;million, of allowance for credit losses, respectively, as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;95,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(50,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;305,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1) Accumulated amortization for complete technology includes immaterial amount of foreign currency translation adjustments for the complete technology acquired from the Vernalis acquisition.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial License and Other Economic Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,052&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Palvella&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,508&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,834&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;20,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal or research and development expenses of $21.5 million and credit loss adjustments of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$6.0 million as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal or research and development expenses as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, Palvella in December 2018, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and developments as further discussed below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of September&#160;30, 2020 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we may receive up to $8.0 million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congentia. In addition to the milestone payments, Palvella will pay us tiered royalties from 5.0% to 9.8% based on any aggregate annual worldwide net sales of any PTX-022 products, subject to Palvella&#x2019;s right to reduce the royalty rates by making payments in certain circumstances. We paid Palvella an upfront payment of $10.0 million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for the development or commercialization of PTX-022. We determined the economic rights related to Palvella should be characterized as a funded research and development arrangement, thus we account for it in accordance with ASC 730-20, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Research and Development Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, and reduce our asset as the funds are expended by Palvella. As of September&#160;30, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, we will recognize milestones and royalties as revenue when earned. During the second quarter of 2020, we recorded a $3.0&#160;million milestone from Palvella under contract revenue, which has been included in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the new credit losses on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the nine months ended September&#160;30, 2020, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and recorded an additional $0.5 million reserve for credit losses in other expense, net, in our condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;See further detail described in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, of Notes to Consolidated Financial Statements in our 2019 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Captisol manufacturing ramp up fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term investment receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2020, all of the 0.70 million and 0.65 million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2019, all of the 0.70 million weighted average shares of outstanding equity awards as of September&#160;30, 2019 were anti-dilutive due to the net loss for the period&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4 - Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6 - Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MjE_08655880-020c-41bf-83a7-3290d01ab115">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2019 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NTI_dae2178a-0f55-49ef-86af-0b191ea14860">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the second quarter of 2020, we began to include our investment in Viking in &#x201c;short-term investments&#x201d; in the condensed consolidated balance sheet, and present &#x201c;gain (loss) from short-term investments&#x201d; in the condensed consolidated statements of operations to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in &#x201c;other income, net&#x201d;. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and nine months ended September&#160;30, 2019 have been reclassified to conform to the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2Mjk_7bfcaf4b-4761-4c0e-bfd6-d149489b7596">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDY_ac7efb2f-98f9-43e4-9de0-54a6483a3872">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. This standard includes our financial instruments, such as accounts receivable, investments that are generally of high credit quality, and commercial license rights. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The new guidance requires us to identify, analyze, document and support new methodologies for quantifying expected credit loss estimates for our financial instruments, using information such as historical experience and current economic conditions, plus the use of reasonable supportable forecast information. We adopted &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b"&gt;ASU 2016-13&lt;/span&gt; on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance sheet of retained earnings to be recognized on the date of adoption with prior periods not restated. The cumulative-effect adjustment, net of tax, recorded on January 1, 2020, is approximately $5.2 million on our unaudited condensed consolidated balance sheet as of January 1, 2020. Results for periods after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported under previously applicable accounting standards. See additional disclosure on credit losses under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Short-term Investments&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Accounts Receivable and Allowance for Credit Losses&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Commercial License and Other Economic Rights&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill Impairment Testing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In January 2017, the FASB issued ASU 2017-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Test for Goodwill Impairment, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which eliminates the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. Under the new standard the goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value, although it cannot exceed the total amount of goodwill allocated to that reporting unit. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In August 2018, the FASB issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement: Disclosure Framework&#x2014;Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which modifies the disclosure requirements on fair value measurements. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - In November 2018, the FASB issued ASU 2018-18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements: Clarifying the Interaction between Topic 808 and Topic 606 (Topic 808)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new standard clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, when the counterparty is a customer for a good or service that is a distinct unit of account. The amendments also preclude entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. Depending on the amendment, adoption may be applied on a retrospective, modified retrospective or prospective basis. We adopted this standard on a prospective basis on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#x2019;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6633e74552be487692e9b132df36f4e8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNzY1Mg_70d74750-57b6-4bb0-b2fd-3cf2e2fe078b"
      unitRef="usd">-5200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc1OTc_3c65f1d5-bd6c-4754-af22-a2679b1edfac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $5.8 million and $8.3 million, respectively. During the three and nine months ended September&#160;30, 2019, the amount recognized as revenue that was previously deferred was $1.0 million and $5.0 million, respectively. We expect to satisfy the performance obligations related to long-term deferred revenue within the next 3 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTY4ODc_7aba5acc-9dd9-490c-b445-b50d6ab9d644"
      unitRef="usd">5800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTY4OTQ_284b7b24-9dcc-47f8-b45e-ad97370c9792"
      unitRef="usd">8300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTY5OTY_ab2a93a6-835d-4cf5-81e5-98ecad6e5f69"
      unitRef="usd">1000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTcwMDM_56c60292-92e8-46cb-aa73-2489b43bdd9c"
      unitRef="usd">5000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ifa3f1a01a9864e59ac71fe92b7ca767d_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNDM5ODA0NjU0NzMxMw_0fbd7f6b-2e10-4a74-b660-72c96c363ebb">P3Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2Mzg_bdd9ae81-cef3-4593-8bc8-b623379ec24d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.059%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Promacta&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4a8257a98db24ffaa95e5892f684fd01_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC0yLTEtMS0w_13256933-7f1c-4c6e-b9f5-d226f999532b"
      unitRef="usd">6923000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i79407bfe8ff44be68b660b88255cf447_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC00LTEtMS0w_f37edd2a-aeae-43e9-b2c6-f3ebb4bdf246"
      unitRef="usd">7602000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia162f6b1d4274062b41ad002117be195_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC03LTEtMS0w_8d833692-00ca-438c-a2b3-3b2dcb5de104"
      unitRef="usd">16809000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i959c4730e2da4bcdb04ef2f33d1574d7_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNC05LTEtMS0w_49807c87-f519-4011-a50e-a488e5a49f1d"
      unitRef="usd">16317000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i953eac10432944aa918dad32003e1069_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS0yLTEtMS0w_0b68684a-8845-44c8-8c74-ed368a9c83d2"
      unitRef="usd">1802000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5500183722b040e19d12c71572ccb758_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS00LTEtMS0w_e8c3b6b9-86d6-48e8-924e-184b3843d861"
      unitRef="usd">1515000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iae408995adc74e3ca6339d16292d5778_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS03LTEtMS0w_802d6a4e-c830-43fb-9bbe-c36ba237b0b3"
      unitRef="usd">4577000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia617fcaa706e40a6a1ac062ee7d43ec4_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNS05LTEtMS0w_962b4786-f530-4169-961a-5634795ea1f3"
      unitRef="usd">3570000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9de46cd3732f46198d032b4488032eaf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi0yLTEtMS0w_64ef41d2-c3ed-42c3-adc6-cf9941ab68fd"
      unitRef="usd">280000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idbb6844505d24ba0bf8408929f329456_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi00LTEtMS0w_2da075ba-ef34-4f06-81b6-426dfdc36a76"
      unitRef="usd">650000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i631b9be815524db78231c3054bb32e61_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi03LTEtMS0w_bd4ac039-e78e-4d68-ad0c-37846f537091"
      unitRef="usd">1365000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6adefffb5c654771b174bf3bb3a8b6bd_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNi05LTEtMS0w_72713dc3-960d-4a6e-a308-6fcd57f3b53d"
      unitRef="usd">1851000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i32509a4fbc6a4a1582b549b4ca6df340_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy0yLTEtMS0w_ba6babbe-8b4c-4cd6-b309-ad8f7bda3c0f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i91c5884b82ff46d5acc051c8609beaf8_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy00LTEtMS0w_144b2c10-d1c6-4072-95e4-f3097ed227ec"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifba8307733fc433f8ab3b039169959f0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy03LTEtMS0w_7e1c97b6-cfa9-4416-8697-74a4918681a7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if80024c5d7c84458b874cf41165bca20_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfNy05LTEtMS0w_cb3573ae-0237-43b6-adf9-3327801ef249"
      unitRef="usd">14193000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9fc64f4d95b449579c5dcf83692dc2c2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC0yLTEtMS0w_8ccf3197-3f20-482f-ac54-1f15d90aa802"
      unitRef="usd">9005000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icff17a87c11c484c964fba70cf7a9057_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC00LTEtMS0w_2f8240f3-cb0d-4501-9bda-6bd8ca6fab7e"
      unitRef="usd">9767000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6992f512a9ea4391aba483112356a4b0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC03LTEtMS0w_4dfda0e9-2eae-45f8-b62c-1b1ccbfe10b1"
      unitRef="usd">22751000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i89eb246de85d4b488a38dcf7024d1c08_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfOC05LTEtMS0w_fecf5e90-205b-4f95-8a31-ab0d61d2da57"
      unitRef="usd">35931000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4089e56d6e3f4a8887c64e185748adcb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtMi0xLTEtMA_d1ce65ba-8fb5-4cbb-9b0e-c5d8ef48f166"
      unitRef="usd">23389000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i32a628a6cc7441d2989a9bb873aa67ed_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtNC0xLTEtMA_14bfc23e-5867-42d0-96ab-df01e3c528b5"
      unitRef="usd">6849000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0095c2332c5f44189e76bf00c4b53c2c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtNy0xLTEtMA_6d4ce6e1-f6d1-47cf-9f30-0a799e8ce9c4"
      unitRef="usd">68966000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2e3415613f8a40bfbe9bad5aae16a724_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTAtOS0xLTEtMA_14cf9bd5-8b78-4257-9163-93f7013e0dad"
      unitRef="usd">24357000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iab25bc69dbce44049e247a4d1847a6a0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtMi0xLTEtMTgxMw_f7d4cbb0-e5da-4b21-8f70-ed8946d60d52"
      unitRef="usd">7341000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i58eb2b2e375b4a358abb2a965d76fa2b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtNC0xLTEtMTgxMw_cc0b559c-0886-4ecb-b841-f0e24b4241f0"
      unitRef="usd">4548000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3e6cef85b3c447d3aa8cdd4f781e6981_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtNy0xLTEtMTgxMw_dcccd681-53ac-4f17-b574-4a5c2afb7541"
      unitRef="usd">15280000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2ddd64a6c3b648bdbbbed38ab355251b_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTMtOS0xLTEtMTgxMw_b235e4b4-6542-43af-b8f4-a8b5e19156f6"
      unitRef="usd">12990000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia0aa285905264a199609e8e0e79eeb9e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtMi0xLTEtMA_835e0d6d-87ad-473d-816f-a39ec45dc5a8"
      unitRef="usd">158000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0f888f2275fa4a51a4214ceb899a5667_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtNC0xLTEtMA_0730d605-ad38-41e7-97b5-cd1ac551382e"
      unitRef="usd">243000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i41ad1b18c5f4466cb46c76831b340bf9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtNy0xLTEtMA_5cf45a7b-8400-48b5-b05f-5263582972a2"
      unitRef="usd">1793000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6a7b2e9c4c524632af8897ae7a9f69da_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTUtOS0xLTEtMA_7f97e1af-52bb-48a9-9847-c1dcab28235b"
      unitRef="usd">3083000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i61867bf812c848368a7dbee91070fe83_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtMi0xLTEtMA_9a71fc07-5f24-4ae0-a1a4-74570564845c"
      unitRef="usd">960000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie8e8662fb16b4474a6813702dcc5fbf2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtNC0xLTEtMA_28acfde1-1862-4050-b442-0964cee45d65"
      unitRef="usd">2674000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i32fc3b55c7ed49029b4502207f3e67b8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtNy0xLTEtMA_b0ee3a3e-6aeb-4aa3-bda4-0e487bd9dc52"
      unitRef="usd">4766000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie13355c008834006b8d8a53974aa47bf_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTYtOS0xLTEtMA_ae1664ed-dace-4a38-b184-4ee8a4c8170e"
      unitRef="usd">15425000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7be44b2cefc0491cb1be1ab1447f7f7e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctMi0xLTEtMA_d2a48f0c-aa5c-4707-9f8d-c01e7e76e538"
      unitRef="usd">995000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia53963dd995b43fe95834fa275cf1ab9_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctNC0xLTEtMA_b3c0f30d-2490-4793-a224-db9fbadbe638"
      unitRef="usd">727000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1fe3969028f3455e89611142e0bd445e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctNy0xLTEtMA_71ecdd91-fbd5-4bed-9f3d-19e62973734d"
      unitRef="usd">2873000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2db24569871b4483bf7e64d41e59fd8d_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTctOS0xLTEtMA_42651cea-51e0-4805-bb29-20bb84c75628"
      unitRef="usd">1493000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0d01bc1e745d4a3ab4088e5f4f2358b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtMi0xLTEtMA_337017cf-c89f-45f3-a656-4f24e6cccf40"
      unitRef="usd">9454000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i24db05f0ba7a4d77a7000833e1ed3559_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtNC0xLTEtMA_eaffe1c6-3744-466d-b0cc-2849efb365c3"
      unitRef="usd">8192000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3cac48edfdab44eda2c29f953e09e7d3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtNy0xLTEtMA_61c0e4f7-a854-430f-9ac7-19186f35a6bb"
      unitRef="usd">24712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia893a67a4ca947ba9f3e9b7d01d18a0c_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMTgtOS0xLTEtMA_5c498760-4c6a-484d-b01a-bf4581ba5377"
      unitRef="usd">32991000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtMi0xLTEtMA_b92cbc3e-85e6-499a-8b96-cd553c506bf1"
      unitRef="usd">41848000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtNC0xLTEtMA_1f72f501-7aac-4d08-89c0-5c284e67afb9"
      unitRef="usd">24808000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtNy0xLTEtMA_44c6656d-dbb8-4430-a7bd-b6078babfbdc"
      unitRef="usd">116429000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjZkMjgzNDk5Y2UzZjQ0ZjRiN2VkZTAxMDY5NGM3ZDdmL3RhYmxlcmFuZ2U6NmQyODM0OTljZTNmNDRmNGI3ZWRlMDEwNjk0YzdkN2ZfMjAtOS0xLTEtMA_30974c48-b694-45f4-a1f7-e93956ebaf1a"
      unitRef="usd">93279000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MzU_4d72ebaa-42f0-431c-b5dd-84dff6b3fefb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investments, excluding investment in Viking, consist of the following at September&#160;30, 2020 and December 31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:13pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;411,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;411,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;47,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;210,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;210,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;151,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;151,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;250,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;297,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;941,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;939,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xLTEtMS0w_7d49c841-fa59-42e3-bf9e-60529e09b913"
      unitRef="usd">68226000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0zLTEtMS0w_3f2df77b-16a9-4df6-a7fa-bd31d1ee626c"
      unitRef="usd">101000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC01LTEtMS0w_64e57420-00e6-481f-b95c-690de2fabccf"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC03LTEtMS0w_74d701c2-5611-40d8-9ff9-d6fe28c9b8f2"
      unitRef="usd">68327000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC05LTEtMS0w_a2d599c4-fb12-4658-bd52-5483cc0e4da8"
      unitRef="usd">411690000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xMS0xLTEtMA_c77740fd-a2af-4d90-aa6f-dd0c084ef55d"
      unitRef="usd">188000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xMy0xLTEtMA_746f2229-8a74-4595-8c2c-29ff80dc5095"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNC0xNS0xLTEtMA_64232d50-99fa-41a9-8460-8980f6b99216"
      unitRef="usd">411875000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xLTEtMS0w_a2d88c82-5ef2-4873-ab0c-de6549510b15"
      unitRef="usd">27125000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0zLTEtMS0w_07e603f7-974f-41e1-b801-3374746d9b87"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS01LTEtMS0w_455dc15e-8e15-4919-9cd7-31ea3cdd72b1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS03LTEtMS0w_7b462ab9-bfef-4e8b-a3bd-986b6460265e"
      unitRef="usd">27227000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS05LTEtMS0w_e7745a5a-325d-4acc-9204-c8896dc9ba79"
      unitRef="usd">63818000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xMS0xLTEtMA_d1fd3f2e-12c2-4116-93e7-2b872f8ecfab"
      unitRef="usd">161000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xMy0xLTEtMA_4b274d9e-1c75-4d04-ae7d-d43f5792a35a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fdffc8317c449f881a8aa17ec02a41c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNS0xNS0xLTEtMA_1c109ca3-4bd0-45a2-9234-1c6105695f90"
      unitRef="usd">63979000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xLTEtMS0w_aeb733ae-f24b-407d-b60d-57bc8029ba7d"
      unitRef="usd">47943000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0zLTEtMS0w_55719c6e-e96c-42a4-90da-2b611ab3bb19"
      unitRef="usd">60000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi01LTEtMS0w_6068ed12-4cd6-4303-8263-62d0d140cf9e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i523aaf24229e4ba68a57b31257326d9a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi03LTEtMS0w_13052b91-8a0e-495f-a0a4-5f0c41d82c5c"
      unitRef="usd">48003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi05LTEtMS0w_511d45c5-2919-472d-9111-8fa90c7c3104"
      unitRef="usd">210525000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xMS0xLTEtMA_867b734c-f515-4821-ae81-e6478e63ba3c"
      unitRef="usd">43000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xMy0xLTEtMA_b5abc663-d5c0-4fd4-951a-b12af7732e48"
      unitRef="usd">16000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNi0xNS0xLTEtMA_15cf8b09-406f-47e5-828b-69542d0f04f3"
      unitRef="usd">210552000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xLTEtMS0w_66d62c84-9f4f-401f-9100-adc94169545f"
      unitRef="usd">4484000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0zLTEtMS0w_b06d8147-bf3d-4999-a0a1-ed4870cd23d8"
      unitRef="usd">415000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy01LTEtMS0w_cb6a4509-9fc3-42ac-96ea-3485381854ee"
      unitRef="usd">2624000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iebd966bb1d63405582633f051a4fe6cb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy03LTEtMS0w_d8221308-45d0-4422-9c1e-a93bc0dcd149"
      unitRef="usd">2275000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy05LTEtMS0w_c6246df8-cebf-4951-971d-de5340b75054"
      unitRef="usd">4506000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xMS0xLTEtMA_9f57a4b9-4885-4ba1-803b-657b5dce4ec9"
      unitRef="usd">416000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xMy0xLTEtMA_73a2f384-9e34-47f2-8df2-2969915da9ef"
      unitRef="usd">1850000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b59857bb5724f0db92fceca967b8a6f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfNy0xNS0xLTEtMA_3179770a-e0cb-498b-830f-07754fd5e0bf"
      unitRef="usd">3072000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xLTEtMS0w_b95ec2ae-f8a7-4a62-8313-4335e1dd5465"
      unitRef="usd">151513000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0zLTEtMS0w_c836e443-35ce-48da-9a90-219258574236"
      unitRef="usd">204000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC01LTEtMS0w_9b5ffcc7-f87b-42ff-87ab-d4a298beab6a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05e7c1cc6c3c41398f1a68c23fd6bd82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC03LTEtMS0w_43488bf3-260f-4f6b-8cc8-69acf1f5ea10"
      unitRef="usd">151717000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC05LTEtMS0w_485b5d7b-70eb-4836-a8d7-40b9b44e0140"
      unitRef="usd">250635000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xMS0xLTEtMA_90b9265a-6e95-4cd0-9748-99b2831b52c3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xMy0xLTEtMA_4c24337e-a742-44df-b1e0-5325347f1534"
      unitRef="usd">249000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d0223b445c142ebbbceb1d4d5041109_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOC0xNS0xLTEtMA_f4a58500-4224-47ad-bd15-83f9b32c4635"
      unitRef="usd">250386000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xLTEtMS0w_49cdc2c4-c57e-431a-bc5c-0f6cad3b8f8e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCost>
    <lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain
      contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0zLTEtMS0w_3344fa57-e2e5-4e26-a0ea-af6e145ea8c6"
      unitRef="usd">155000</lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain>
    <lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss
      contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS01LTEtMS0w_822e4584-7b46-470b-971a-f1e582f106d8"
      unitRef="usd">0</lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i34769cb1caae46a1b085c5eb80dc24d2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS03LTEtMS0w_eeae9bd7-20c3-4b60-99f9-1cef3e746871"
      unitRef="usd">155000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS05LTEtMS0w_4f111bda-c32c-45a9-806f-0081b7391169"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiCost>
    <lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain
      contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xMS0xLTEtMA_503b8032-bd1f-48ad-9ec0-a26387b47ad4"
      unitRef="usd">125000</lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain>
    <lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss
      contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xMy0xLTEtMA_64df0815-2725-44c2-8edf-a80b38ed55d6"
      unitRef="usd">0</lgnd:EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i816ea3fa0dc84cbc89dc030d7627ef53_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfOS0xNS0xLTEtMA_e5c398c6-1bc7-4087-aff8-5d9b70a92f21"
      unitRef="usd">125000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMS0xLTEtMA_d06634b6-92d1-427d-a501-e21f8a3f0edb"
      unitRef="usd">299291000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMy0xLTEtMA_a55444d9-d8b9-4647-b05d-4aaefd58a46d"
      unitRef="usd">1037000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtNS0xLTEtMA_bb6751d6-d50b-484e-88c2-d027d07e4531"
      unitRef="usd">2624000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtNy0xLTEtMA_b9ef5fb1-eb26-464d-8f8b-1cbfc85ec26e"
      unitRef="usd">297704000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtOS0xLTEtMA_1beffcf4-715f-446b-8d6b-c7954e76d8fd"
      unitRef="usd">941174000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMTEtMS0xLTA_4fda81ad-910c-4bd6-afe8-ce5393d05ce9"
      unitRef="usd">933000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMTMtMS0xLTA_b60b0f7c-37b1-4be1-8387-2f3c29bd22ce"
      unitRef="usd">2118000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmFmNzg3NDNmODYwMTQ3NmFiYjAzYWFlNzhkMTliMzFmL3RhYmxlcmFuZ2U6YWY3ODc0M2Y4NjAxNDc2YWJiMDNhYWU3OGQxOWIzMWZfMTAtMTUtMS0xLTA_10c0d9bd-6f97-4613-9956-3c6bc580e114"
      unitRef="usd">939989000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ieafd46562c0048748b7d5372e02d9594_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc0MDM_8debe95d-d9f2-4d77-a41b-1424070a1e4c"
      unitRef="usd">33900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i994f5de64c0a4fbdb6c53080a3923a98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc0MTA_2b08ecc4-5a9f-494f-8718-202e7fbcbeff"
      unitRef="usd">48400000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i077cb3c9fe0e483c86fb45ff23381e66_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc1MzE_cd1155b9-c8c9-4755-a8cf-5255f610dbc2"
      unitRef="shares">1500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i1515ee2cbc494379a0c6d767fc8cb01e_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc1OTA_1dea10e1-6591-4eed-98fe-09939255f7fc"
      unitRef="usdPerShare">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib02c7dbe217a407884f5da8e577b9510_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc3MDg_4cdbfd7c-ff7a-4285-9456-2e2a053e5753"
      unitRef="usd">6600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iada23dbe678940b39476c796282a62d2_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTc3MTU_50b155c7-3b1c-49a3-84d3-0bf544fd25e0"
      unitRef="usd">9900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MjY_c6033068-c197-481d-9df1-c6eabbfa5db6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.574%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;After five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;79,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;79,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMi0xLTEtMS0w_7b4cc7b6-0224-403c-b162-fb1133143e90"
      unitRef="usd">121452000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMi0zLTEtMS0w_abd31d18-b728-4a4a-bf12-859f5d345c5a"
      unitRef="usd">121610000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMy0xLTEtMS0w_ec421705-0566-45aa-ae21-a9b4266c84f2"
      unitRef="usd">21842000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfMy0zLTEtMS0w_408a4e7b-a201-4b6e-aef1-c1fe0a62f306"
      unitRef="usd">21947000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <lgnd:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNC0xLTEtMS0w_2f41e234-9a08-44d1-894a-e6a39c0603e1"
      unitRef="usd">0</lgnd:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost>
    <lgnd:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNC0zLTEtMS0w_68d194fc-fb6b-4473-abea-1a984b9924ba"
      unitRef="usd">0</lgnd:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNS0xLTEtMS0w_94a5f4a2-10d2-40cd-b79a-847c13d11808"
      unitRef="usd">143294000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmI0YjNlZGIyZjFjZjQ1ZmRhNzg3YjU3Y2VkM2MwYzc5L3RhYmxlcmFuZ2U6YjRiM2VkYjJmMWNmNDVmZGE3ODdiNTdjZWQzYzBjNzlfNS0zLTEtMS0w_6a1e1593-517f-430b-8f9e-d25aafbdc1bb"
      unitRef="usd">143557000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy0xLTEtMS0w_718feecf-6e48-42de-88fe-ec30b1701767"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy0zLTEtMS0w_67f1c27b-c3ee-4003-9491-1052eea5873f"
      unitRef="usd">5011000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy01LTEtMS0w_e522e284-811a-4357-80e1-564b280530c7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy03LTEtMS0w_d79d9753-e953-45f3-a1ee-b682dddf8cd4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy05LTEtMS0w_0c197948-cfc7-4775-9104-2b2f98fc90cb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if989d8f4b0444921b186d0ba5bd810f4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMy0xMS0xLTEtMA_1fdae13a-bec6-4bbb-a4db-cd7dfa7353e0"
      unitRef="usd">5011000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC0xLTEtMS0w_241f920c-1e9a-4398-b98c-6befb2156bab"
      unitRef="usd">400</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC0zLTEtMS0w_2874ff4b-bb85-4c6e-beba-57b761431737"
      unitRef="usd">3007000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC01LTEtMS0w_b9146aa2-eee1-4d2c-a696-508d30ed2511"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC03LTEtMS0w_05126b0e-4dc8-4c69-95cb-68b6fd34dfca"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC05LTEtMS0w_61211e9e-a968-4678-bea9-dd6fa79c63e0"
      unitRef="usd">400</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5a2a7519e6c341a38f6401cd9723ed03_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNC0xMS0xLTEtMA_9ca6cc67-0f6d-457d-bc81-4796cd9373e7"
      unitRef="usd">3007000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS0xLTEtMS0w_2ff120aa-88b4-4dab-b766-6d697d23d3ee"
      unitRef="usd">400</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS0zLTEtMS0w_630d7997-6b62-480d-8d41-75d4036cb9a0"
      unitRef="usd">8018000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS01LTEtMS0w_54f6255c-6184-4090-9439-0480192e3874"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS03LTEtMS0w_b65b811f-e9b2-473a-8d3c-e117478c0357"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS05LTEtMS0w_21aa7ddb-4aa3-459c-a103-aef479417bac"
      unitRef="usd">400</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfNS0xMS0xLTEtMA_23a39899-5b3c-40d1-89b0-4881d154b6b4"
      unitRef="usd">8018000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC0xLTEtMS0w_4f3a735f-cb8c-4c2b-80d8-b9f53884f9f3"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC0zLTEtMS0w_4540e47a-c5d4-4cb7-87c0-272eae385d3a"
      unitRef="usd">58584000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC01LTEtMS0w_90706650-77e7-45a5-9b20-f8b8b78e985e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC03LTEtMS0w_5f246861-a6cf-4ce9-a02b-866a3d3a91b8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC05LTEtMS0w_bba38f26-fc21-4e04-ab21-c68a31c5954b"
      unitRef="usd">3000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id9a9d4b03b4b41a9b0045d7006341f1c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOC0xMS0xLTEtMA_b562e1ba-8019-4c2d-b4b7-cfb77b45c080"
      unitRef="usd">58584000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS0xLTEtMS0w_e7a4dc19-b8ce-46b6-bc5c-6a57bea3adea"
      unitRef="usd">16000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS0zLTEtMS0w_3610fb28-afe0-4165-9511-f24333e37c53"
      unitRef="usd">79363000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS01LTEtMS0w_4a997d8c-9e51-4c48-a047-357b548e943e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS03LTEtMS0w_7db00643-b96c-4f91-874d-e6a80c050c23"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS05LTEtMS0w_6bf18376-6de9-401d-bd0c-389b1134789f"
      unitRef="usd">16000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2270a0a4d5334ef2afc04cfa740c2e42_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfOS0xMS0xLTEtMA_f46e4c5c-35b0-453b-9955-1e4e0f01083f"
      unitRef="usd">79363000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtMS0xLTEtMA_7be3e3d1-bcd7-49b4-8567-c99333490c7b"
      unitRef="usd">19000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtMy0xLTEtMA_567793fc-f8e4-4c16-a559-854b184a4bb9"
      unitRef="usd">137947000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtNS0xLTEtMA_cfef728f-c708-431f-a86b-55f1272e37b5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtNy0xLTEtMA_d14ce99c-d536-4d14-af48-77e4f5b32c25"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtOS0xLTEtMA_dcfe22d6-661b-492f-9b96-0b30273b2aba"
      unitRef="usd">19000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjRlNWQ3YWE3MTFhMzRlMjdiZGQxOWIxOTNiNDU4MzJlL3RhYmxlcmFuZ2U6NGU1ZDdhYTcxMWEzNGUyN2JkZDE5YjE5M2I0NTgzMmVfMTAtMTEtMS0xLTA_6d8c75d9-5864-4449-b7ee-00cebf368392"
      unitRef="usd">137947000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTg5Mjc_6bca2ef9-59cf-4767-8554-b7972f0ed9fa"
      unitRef="position">2</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTk1MzA_0d9c3bf3-8726-4882-947b-4cfd2281564f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNDk0NzgwMjM1NTM3OA_a50cc032-13f1-4d15-b406-2399f5b59765"
      unitRef="usd">-100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjA2MDE_17f35bb5-cf91-4100-89ac-ecb2221f7b89"
      unitRef="usd">200000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc1OTg_bb1bffc5-feab-41c2-bdd0-e84182f68fca">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.509%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;95,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;242,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(50,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;305,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1) Accumulated amortization for complete technology includes immaterial amount of foreign currency translation adjustments for the complete technology acquired from the Vernalis acquisition.&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMi0xLTEtMS0w_f6a6b3e6-5b1f-4d13-bce4-9e0cd55f1c2b"
      unitRef="usd">102136000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMi0zLTEtMS0w_85ab45d6-da0d-40a0-907f-88e229199f4c"
      unitRef="usd">95229000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i62059978ce544467b0dd531154611391_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNC0xLTEtMS0w_ac4963d5-07be-4123-9f93-ceefa3eed943"
      unitRef="usd">257317000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic9822c8d2a54454798b936165a57c684_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNC0zLTEtMS0w_5d2d938c-b3d8-4ab1-8782-c4db049f95ba"
      unitRef="usd">242813000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i62059978ce544467b0dd531154611391_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNS0xLTEtMS0w_eb23ecb6-9d95-4a77-ad82-9792e0247d79"
      unitRef="usd">59869000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic9822c8d2a54454798b936165a57c684_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNS0zLTEtMS0w_56f45aa7-e48c-413b-b7d0-7319268c2e46"
      unitRef="usd">50203000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iacc614b30b84489b961b3be7e198cf04_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNi0xLTEtMS0w_1306c538-cf1b-48f2-b1ea-57b68a7eb264"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icf62daa6b80444d9b1c8c7605f3061cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNi0zLTEtMS0w_34cfca0c-59a2-418e-9cfb-6bde8ef25605"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iacc614b30b84489b961b3be7e198cf04_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNy0xLTEtMS0w_3420c974-10bd-4a9d-9c66-7ec86c8302c4"
      unitRef="usd">1279000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icf62daa6b80444d9b1c8c7605f3061cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfNy0zLTEtMS0w_a0be1065-578b-46af-be3b-a71cf190684b"
      unitRef="usd">1180000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i458d920e4daf4b0bbb69e6db515003c0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOC0xLTEtMS0w_f71cd798-c43a-41b9-834c-59159829a9d3"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3b63e0852ede48be9e97d41d54d1fc1f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOC0zLTEtMS0w_f9b442bf-b8d6-4f5a-8ccc-c1c00b731937"
      unitRef="usd">29600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i458d920e4daf4b0bbb69e6db515003c0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOS0xLTEtMS0w_1a7a0378-b3a7-4dce-99d2-e4ce2abfc776"
      unitRef="usd">14929000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3b63e0852ede48be9e97d41d54d1fc1f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfOS0zLTEtMS0w_8f2d67d4-87e7-48bd-97b6-98c78e2c71b2"
      unitRef="usd">13224000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMTAtMS0xLTEtMA_45f13ef8-42d3-4407-829c-05a6e90e44c2"
      unitRef="usd">326718000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmY4MGE2ZmUwZTYzZjRlYzI4MzE0ZTNjM2JhMDI1NzY0L3RhYmxlcmFuZ2U6ZjgwYTZmZTBlNjNmNGVjMjgzMTRlM2MzYmEwMjU3NjRfMTAtMy0xLTEtMA_e33cc0a6-0699-429a-ba17-8df2d30fcbfb"
      unitRef="usd">305677000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDc_29a82fcb-5c64-43d1-9173-61f26be270a4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license and other economic rights consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;8,052&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12,196&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Palvella&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,508&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2,782&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;5,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;10,834&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;20,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal or research and development expenses of $21.5 million and credit loss adjustments of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$6.0 million as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal or research and development expenses as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic3a7b51a701f4e53aecd32502a589716_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi0yLTEtMS0w_6ceae73d-763e-469f-b407-c94d7022011d"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ic3a7b51a701f4e53aecd32502a589716_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi00LTEtMS0w_66bfb2e4-d3fa-4efa-983c-971d511a5f8b"
      unitRef="usd">9644000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic3a7b51a701f4e53aecd32502a589716_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi02LTEtMS0w_289d3de2-7be0-49cf-9bb8-c4279ed517ad"
      unitRef="usd">8052000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4202a561cc0e4e888ca3864847b25542_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi04LTEtMS0w_e41a5db7-053a-4aeb-b9c6-7c710e0f964b"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i4202a561cc0e4e888ca3864847b25542_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi0xMC0xLTEtMA_b5631abf-85fa-4d95-956c-27c0cfc584f9"
      unitRef="usd">5500000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4202a561cc0e4e888ca3864847b25542_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMi0xMi0xLTEtMA_a5485d08-ed35-4103-b67f-a9567c29b24a"
      unitRef="usd">12196000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d220828630a41d89fbd767210960771_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy0yLTEtMS0w_f3b83242-1fec-47ab-9eab-df0d4d8ae97a"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i9d220828630a41d89fbd767210960771_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy00LTEtMS0w_91a99297-38aa-434e-9b86-7b599790bb26"
      unitRef="usd">10000000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9d220828630a41d89fbd767210960771_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy02LTEtMS0w_c9037ea0-6540-4115-869f-6d4f2bb3ed7a"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie13355217b22451f86270e7501836ab5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy04LTEtMS0w_36d526b4-9b9e-4f71-90e6-8b80bc077704"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ie13355217b22451f86270e7501836ab5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy0xMC0xLTEtMA_cc46f55d-b6cb-4b2e-9453-8cf3bbe32fd7"
      unitRef="usd">7492000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie13355217b22451f86270e7501836ab5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfMy0xMi0xLTEtMA_06129704-83eb-40cc-8054-f841ecfc3ab6"
      unitRef="usd">2508000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC0yLTEtMS0w_d3346f25-fbcf-4956-856a-aaa575007d7f"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC00LTEtMS0w_85d284b6-0715-447e-9d22-0c80f196b774"
      unitRef="usd">7820000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5c2bd2d2dbcd4c169347a7c8c5ed44e4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC02LTEtMS0w_26d272a2-4ff3-4aa9-a614-200167e55ce8"
      unitRef="usd">2782000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id7eb9f595411497d909c36c7b2a954d3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC04LTEtMS0w_6fbd52ca-2c84-4b03-8d72-2f40724a24f4"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="id7eb9f595411497d909c36c7b2a954d3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC0xMC0xLTEtMA_3711c355-4732-47c0-b332-2c8bcc861855"
      unitRef="usd">5216000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id7eb9f595411497d909c36c7b2a954d3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNC0xMi0xLTEtMA_fc868b72-fc7c-4c95-b583-a8032e757b6a"
      unitRef="usd">5386000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS0yLTEtMS0w_70098291-f638-4f0a-a26e-833f40ca0854"
      unitRef="usd">38298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS00LTEtMS0w_ca18c8b1-49c8-493d-81a4-d7f2e871bbce"
      unitRef="usd">27464000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS02LTEtMS0w_1c84ba7a-8212-425d-91d7-aaba2435644d"
      unitRef="usd">10834000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0100a54707e94423b27294cac36ad9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS04LTEtMS0w_dff53822-4880-4e77-bfc4-da46827a3c1a"
      unitRef="usd">38298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i0100a54707e94423b27294cac36ad9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS0xMC0xLTEtMA_e97328a5-06d5-4290-9933-bed13bd3d352"
      unitRef="usd">18208000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0100a54707e94423b27294cac36ad9cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjYyNTY5MTY4ODFiOTRjMjE4NTIxNmE4NGRhN2ZiNjRkL3RhYmxlcmFuZ2U6NjI1NjkxNjg4MWI5NGMyMTg1MjE2YTg0ZGE3ZmI2NGRfNS0xMi0xLTEtMA_0f780933-aff7-4ab2-bd42-18306dcbae1a"
      unitRef="usd">20090000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjEyNDg_3a3ae577-8750-4ee1-bd60-d905bf1ac9d7"
      unitRef="usd">21500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i0ee0d788eb77400190e92faa6bb87523_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjEyODQ_5798fc7a-f436-436f-9990-66f17e4b1766"
      unitRef="usd">6000000.0</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <lgnd:ForecastedCashFlowsEffectiveInterestRatePercent
      contextRef="ibcbff8ebe0f84833bb1bb078e9fb983a_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI0NDA_5cf342d0-9aee-4e70-861f-4d0fb55c788d"
      unitRef="number">0.23</lgnd:ForecastedCashFlowsEffectiveInterestRatePercent>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i10d095f87a1e48e8a5b700832f2b753f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI3MDQ_7f882295-4289-4e89-af17-0f319e418b49"
      unitRef="usd">8000000.0</us-gaap:ContractWithCustomerAssetNet>
    <lgnd:CollaborationArrangementRoyaltyRate
      contextRef="i1f5e4fe2589b447f9a277f98db937a1f_D20181201-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI5ODQ_6ab97849-9409-4279-a826-304bcf5ef9a6"
      unitRef="number">0.050</lgnd:CollaborationArrangementRoyaltyRate>
    <lgnd:CollaborationArrangementRoyaltyRate
      contextRef="i0cf7333df7984d5bbd68a862a0645e2b_D20181201-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjI5OTA_14fa3bc6-6d3d-4658-adf8-fd6ecd25c071"
      unitRef="number">0.098</lgnd:CollaborationArrangementRoyaltyRate>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i10d095f87a1e48e8a5b700832f2b753f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjMyMDg_afb0c1e6-11da-418d-b39b-a176ec8e880e"
      unitRef="usd">10000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i4f60bf0364f848b38d48669aaccabc92_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjM4OTI_0429f2e1-da60-4d66-a12d-6f914e29db40"
      unitRef="usd">3000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss
      contextRef="i0cdccb9429b54094b52f363eef25ce9f_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjQwMTM_7e16f9a9-f672-4aef-847b-f0f4f3cd1eda"
      unitRef="usd">5500000</lgnd:CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss>
    <lgnd:CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjQ4MTI_85b193e7-02a7-4b02-a00c-3679cf8f473e"
      unitRef="usd">500000</lgnd:CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfNDM5ODA0NjU0NjczOA_a8d18aa5-c2af-4a69-bcfc-5615c247d3c1">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Captisol manufacturing ramp up fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term investment receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <lgnd:RampUpFeeAssetNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMi0yLTEtMS0yMjI4_3ce17b55-346e-4658-b3a3-59f1edfff573"
      unitRef="usd">9215000</lgnd:RampUpFeeAssetNoncurrent>
    <lgnd:RampUpFeeAssetNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMi00LTEtMS0yMjMy_e0ee7b4c-3bb3-494c-962b-fa0a33cc62f6"
      unitRef="usd">0</lgnd:RampUpFeeAssetNoncurrent>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy0yLTEtMS0yNDQ3_73d82173-6d18-4927-9a72-25dbc777905f"
      unitRef="usd">2000000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy00LTEtMS0yNzA4_bf84c316-2e73-47d1-bfb9-8a8d23753ee0"
      unitRef="usd">0</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:EquityMethodInvestments
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy0yLTEtMS0yMjI4_5819b409-321e-4784-9524-b8817e492d07"
      unitRef="usd">813000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfMy00LTEtMS0yMjMy_6aeb5fbb-0388-424f-b0c9-68d12c805686"
      unitRef="usd">750000</us-gaap:EquityMethodInvestments>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNC0yLTEtMS0yMjI4_a0bd9d81-e41c-4c85-a2fc-28181c9c32db"
      unitRef="usd">138000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNC00LTEtMS0yMjMy_b3f3b2e3-a408-4f8b-8866-4afacf81f0e3"
      unitRef="usd">219000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNS0yLTEtMS0yMjI4_684f2a69-4bde-4b3e-9481-691f167e9643"
      unitRef="usd">1538000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNS00LTEtMS0yMjMy_7bda7664-d6ba-4ef4-8918-8af21fda92db"
      unitRef="usd">1388000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNi0yLTEtMS0yMjMx_a7ed047b-673b-423e-a702-2915e9e8d6f4"
      unitRef="usd">13704000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjU1NDY5ZTRmOWExMDRmYmE4N2NmNDliY2UzMGNmZDQzL3RhYmxlcmFuZ2U6NTU0NjllNGY5YTEwNGZiYTg3Y2Y0OWJjZTMwY2ZkNDNfNi00LTEtMS0yMjM2_ac895c9b-1c92-4ccd-a982-fe002ccf3053"
      unitRef="usd">2357000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2Mjc_cb09e3bb-6096-430f-99b8-3f19eafb2d1a">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMi0yLTEtMS0w_b79e8a68-3459-4bfe-bdc4-9d92d3b1077c"
      unitRef="usd">4840000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMi00LTEtMS0w_803b2aa8-c220-4b83-897a-bb11c32fca41"
      unitRef="usd">1986000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMy0yLTEtMS0w_3d29e806-e16e-4b4a-abc3-4d23596f47d9"
      unitRef="usd">1226000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMy00LTEtMS0w_47c0453c-3caa-4b0d-b126-b75d82931d9d"
      unitRef="usd">1135000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNC0yLTEtMS0w_eada746c-da42-4516-a777-45dfe826d91b"
      unitRef="usd">407000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNC00LTEtMS0w_a98f6a37-768b-4d38-9b14-ed5b76aab398"
      unitRef="usd">381000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNS0yLTEtMS0w_42649f37-0807-4bad-9993-724bad2e3ff4"
      unitRef="usd">805000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNS00LTEtMS0w_ae12ad6b-9bfe-4e14-ab2f-730d3fad5907"
      unitRef="usd">0</us-gaap:AccruedRoyaltiesCurrent>
    <lgnd:ReturnsAccrual
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNi0yLTEtMS0w_cae8fd30-f79e-4334-afda-79a84a9dcab2"
      unitRef="usd">2835000</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNi00LTEtMS0w_39433a35-b8f2-4a4a-9ba0-0672c20308bd"
      unitRef="usd">3027000</lgnd:ReturnsAccrual>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNy0yLTEtMS0w_fb617978-eaea-4626-8ac3-5ebcd5c03217"
      unitRef="usd">1029000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfNy00LTEtMS0w_0d0e37a0-6b77-4dc5-8cbc-4904a1aa2fcc"
      unitRef="usd">1242000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOC0yLTEtMS0w_21bc2796-5d86-4793-8b16-ba9fbc0952f9"
      unitRef="usd">1437000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOC00LTEtMS0w_a366028e-e71c-4178-b2c1-6b8bebeef8a1"
      unitRef="usd">690000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOS0yLTEtMS0w_2890a163-0857-4cdd-b1ec-ad162cca3849"
      unitRef="usd">1919000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfOS00LTEtMS0w_24591ad7-28df-4118-81d8-dd5653b3a028"
      unitRef="usd">1375000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMTAtMi0xLTEtMA_c4df2fe0-ce3b-4e7d-87ea-589efe67662c"
      unitRef="usd">14498000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg5ZGU1MTcxYWU3NTQzZWE5MjA0YWY1NmJmYTA0YjNmL3RhYmxlcmFuZ2U6ODlkZTUxNzFhZTc1NDNlYTkyMDRhZjU2YmZhMDRiM2ZfMTAtNC0xLTEtMA_a20dcfe4-e4bc-4462-ba64-db7dd06dbc0b"
      unitRef="usd">9836000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDg_c43e410d-b816-42f3-bd62-b16a5b338bff">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDA_9e022ae1-4dac-4ebd-b945-7e78a27cc8cc">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic3d2e8730044456d888fa8d00bb40ef6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy0xLTEtMS0w_d4d9f0ed-5065-411b-8971-be567ecce30f"
      unitRef="usd">3094000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i827adc89d29046898e0b113579222055_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy0zLTEtMS0w_4be821b5-60ca-4dce-9b9d-21113d558bf7"
      unitRef="usd">2481000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i6ce74a6cb0394faea692955f117b0910_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy01LTEtMS0w_a48a2c55-dc45-46d4-aebe-ff42036f7d50"
      unitRef="usd">8510000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i9eae62fa2cc244c58acbef58471706d5_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfMy03LTEtMS0w_6b2463ec-17fe-4dc3-8c22-a3fd1ecd4d5d"
      unitRef="usd">7136000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="idcb4d6cb442c42888913360733612f6b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC0xLTEtMS0w_57443fba-e41c-4809-9772-8f48477a28e1"
      unitRef="usd">4646000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ia1cbbd30022e449b8b3b716176ea05cf_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC0zLTEtMS0w_876e61f5-0fdc-42b0-8f96-450bbca2101f"
      unitRef="usd">3816000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i971a95182cfc43cf993de4477741afb9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC01LTEtMS0w_b54cf151-58a8-4264-9115-aa0a11c7fe82"
      unitRef="usd">12242000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i5baf6027374c4f3cb37f343379914469_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNC03LTEtMS0w_0bc01261-74d7-48b5-a96b-90f65ba7c416"
      unitRef="usd">11079000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS0xLTEtMS0w_535eb1d2-edad-4e2d-bd60-747e88f897ff"
      unitRef="usd">7740000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS0zLTEtMS0w_0d0973fb-d05d-4c3e-ae17-f655acaca93f"
      unitRef="usd">6297000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS01LTEtMS0w_3867f8dd-edbc-4212-ac42-5c8a2ad6f8a5"
      unitRef="usd">20752000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjQ0NmZlZGIyZjhkNzRkZDFhNDIzMGUwY2NmZDViNjVkL3RhYmxlcmFuZ2U6NDQ2ZmVkYjJmOGQ3NGRkMWE0MjMwZTBjY2ZkNWI2NWRfNS03LTEtMS0w_2f44dfc3-44fd-4d6d-8b6a-9a0750985fec"
      unitRef="usd">18215000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDE_a89eb362-690c-405e-a033-3e31cfe2d76e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy0xLTEtMS0w_eca4c545-d8a1-46f5-a08d-146dda174d56"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy0zLTEtMS0w_59762219-f8c9-41ac-accf-30b9c136fc05"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy02LTEtMS0w_3d99b50e-f8f0-41dc-a781-3e077429a330"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfMy04LTEtMS0w_a6c1d50e-e287-4f37-9dd7-4efb5302d34d"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC0xLTEtMS0w_e7afa9fa-2546-4a08-8990-507e16b2a06e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC0zLTEtMS0w_d69c050a-8d06-4e04-91c1-4d78833ff957"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC02LTEtMS0w_3f75cec3-7134-446d-a2ee-159d4d86ce22"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNC04LTEtMS0w_66e8850e-413e-4572-ba4c-a4b3a8aa9570"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS0xLTEtMS0w_81560c45-9d4c-4f45-8307-144cf35953c2"
      unitRef="number">0.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS0zLTEtMS0w_6b81bf35-dff3-4390-9891-ff263f31b825"
      unitRef="number">0.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS02LTEtMS0w_cbfd0656-04df-4813-bfa1-da73b377e830"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNS04LTEtMS0w_b43e0756-afad-4d88-8e94-4967ddaff738"
      unitRef="number">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi0xLTEtMS0w_5874aaac-95ac-4959-b5ee-e64da7d4ea9c">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi0zLTEtMS0w_0e02edf1-3b7a-4227-b38a-2f275d5e3ad0">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi02LTEtMS0w_a1f45556-5c9e-480d-912e-ddd9b8435bc8">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOjg2ODc0ZWNiZjg2YzRjNGY4MTEyYjhmNWNiNGQ1NmVmL3RhYmxlcmFuZ2U6ODY4NzRlY2JmODZjNGM0ZjgxMTJiOGY1Y2I0ZDU2ZWZfNi04LTEtMS0w_9f82736c-6d64-4d95-863f-9fab0212c9ab">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDU_9b533939-e154-4637-bd48-ec599ba98d20">Net Income (loss) Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September&#160;30, 2020, all of the 0.70 million and 0.65 million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2019, all of the 0.70 million weighted average shares of outstanding equity awards as of September&#160;30, 2019 were anti-dilutive due to the net loss for the period&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4 - Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6 - Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if33f5e6d2e464f5a95ee2eb981cf9859_D20200701-20200930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjYyMjQ_d7d5cd8e-b0b0-4b0c-8ff9-89eed43b5d80"
      unitRef="shares">700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i38b7bbf234194785adc62a7822e6c5cd_D20200101-20200930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMTA5OTUxMTY2MzE3NA_a28bb741-f49b-4853-ac60-dca224a97a63"
      unitRef="shares">650000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2ca967bf02e64cfaa352ef449e98dfb9_D20190701-20190930"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjYzNzE_9c5ce651-6727-4635-8a5f-8da86a79f123"
      unitRef="shares">700000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MTc_bc79f41d-c6cc-40f6-8e3f-d016785c7f56">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2NDI_497b7a81-3ae0-44bf-ab6f-0dd3464c9e84">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.061%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy0xLTEtMS0w_764886a1-b6cb-42b4-a325-4e4ef03dca13"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy0zLTEtMS0w_393702f2-448a-4068-9484-bdee78e1cc10"
      unitRef="shares">18770000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy02LTEtMS0w_00f453a4-9f29-4066-9c07-3700d773a392"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfMy04LTEtMS0w_87158b7f-b8c8-4307-9b95-b68412a3ee2a"
      unitRef="shares">19586000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS0xLTEtMS0w_7c97cd5a-cf3a-49e7-a01a-e06122088368"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS0zLTEtMS0w_1a091783-35ed-43b0-9881-b905c55b28a0"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS02LTEtMS0w_cf66652c-a8bf-4c91-9450-d2d6424f6b86"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNS04LTEtMS0w_2905fbd6-75ac-4104-85a7-16aea0581a3a"
      unitRef="shares">35000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi0xLTEtMS0w_64a41b02-8e1e-45dd-bb5b-934026676fff"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi0zLTEtMS0w_0439006f-f0d1-40af-ba3f-49e23c5c9243"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi02LTEtMS0w_04eb9191-e028-4fba-b7ba-151a2155f980"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNi04LTEtMS0w_930516f0-cbdb-4a08-a38f-db6efe170336"
      unitRef="shares">728000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy0xLTEtMS0w_546c71fc-3517-4134-9072-3902cbf578b2"
      unitRef="shares">16082000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy0zLTEtMS0w_e42079aa-4ef4-4fb4-b0b6-3c5952736a69"
      unitRef="shares">18770000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy02LTEtMS0w_5fc1cdec-5655-4b0a-b92e-e0c39e731518"
      unitRef="shares">16222000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfNy04LTEtMS0w_bc17e550-6b60-4246-bb53-b3038ade327f"
      unitRef="shares">20349000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC0xLTEtMS0w_eab46d94-dbf8-473a-b29e-86a2bb09aaef"
      unitRef="shares">7028000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC0zLTEtMS0w_243eed63-9559-4c1c-9162-b26f00821b6d"
      unitRef="shares">11549000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC02LTEtMS0w_4a3ab245-0e73-43f5-9bbb-cc30b555dd70"
      unitRef="shares">8330000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RhYmxlOmE2YmI1YTM2ODE4YTQ4NWFhMzljMDY0YWY5MzI1OGFlL3RhYmxlcmFuZ2U6YTZiYjVhMzY4MThhNDg1YWEzOWMwNjRhZjkzMjU4YWVfOC04LTEtMS0w_8604ed3a-5fe2-48f3-904b-552902b9eb3b"
      unitRef="shares">8694000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfNTE2Mw_30fd3b16-b3fd-49e2-b00c-4d9f0de0e2db">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;297,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;936,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;939,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;338,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;936,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the first quarter of 2020, we paid a $1.8&#160;million contingent liability on development milestones to former Crystal shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the third quarter of 2020, we paid a $0.5&#160;million contingent liability based on revenue milestones to Icagen.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;There were no triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three and nine months ended September&#160;30, 2020.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfNTE2MQ_b84f3962-704a-4fbe-aa6a-3a33d4b454ba">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;297,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;936,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;939,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;48,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;338,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;936,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;998,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Crystal contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Investment in warrants, which we received as a result of Viking&#x2019;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the first quarter of 2020, we paid a $1.8&#160;million contingent liability on development milestones to former Crystal shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the third quarter of 2020, we paid a $0.5&#160;million contingent liability based on revenue milestones to Icagen.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0yLTEtMS0w_5980c300-0d8a-4163-9226-ca4dc3c915a3"
      unitRef="usd">2274000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy00LTEtMS0w_ad118bca-b7e4-4ecb-aa3a-72c2fc3ba67f"
      unitRef="usd">295275000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="ic34a5542beee460cbf11a482a837b496_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy02LTEtMS0w_7179505c-e7fe-45e6-ac29-54c822740845"
      unitRef="usd">155000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy04LTEtMS0w_fd68d1e6-2dd1-48d3-9122-2724bb9149be"
      unitRef="usd">297704000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="i478ab1e04df3462693b4f447d123258c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xMC0xLTEtMA_820ddaff-6be8-495d-808b-55f9d3b71f96"
      unitRef="usd">3073000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xMi0xLTEtMA_0acc7c59-2762-442f-ab4d-9812fa0b00ad"
      unitRef="usd">936791000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xNC0xLTEtMA_737defa8-03ba-4f25-8d2a-556a2cc440e3"
      unitRef="usd">125000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <lgnd:ShortTermInvestmentsFairValueDisclosure
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMy0xNi0xLTEtMA_f285b36f-4736-4e38-b6db-35458b1e2140"
      unitRef="usd">939989000</lgnd:ShortTermInvestmentsFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0yLTEtMS0w_b20cfe63-81b5-4838-8109-75526a27fa79"
      unitRef="usd">33869000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC00LTEtMS0w_ad0b0886-b2aa-4ee7-ae6b-0f4949186236"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="ic34a5542beee460cbf11a482a837b496_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC02LTEtMS0w_210060e4-bc17-4722-940c-82ae881bbbb2"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC04LTEtMS0w_14b171c0-16b1-41bb-b024-46511b52b0b1"
      unitRef="usd">33869000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i478ab1e04df3462693b4f447d123258c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xMC0xLTEtMA_b1c6cc81-873d-44e4-b5bf-44fe612f9b76"
      unitRef="usd">48425000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xMi0xLTEtMA_412fc533-8f5d-4925-a22e-c098753344b4"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xNC0xLTEtMA_0890d712-0033-4bdb-9c8e-e3768a1efa9d"
      unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNC0xNi0xLTEtMA_afc7d724-0e0e-47c9-b1d8-afd69fc565c8"
      unitRef="usd">48425000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0yLTEtMS0w_863a7258-fa80-4a59-8ea4-88dce5b061d7"
      unitRef="usd">6581000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS00LTEtMS0w_a7b0fdb2-23df-4c38-bb1a-fc75065a33da"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic34a5542beee460cbf11a482a837b496_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS02LTEtMS0w_a17ab8ea-9ded-4699-bd19-95a27cc8fe83"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS04LTEtMS0w_6f5d8762-1006-4a4a-8362-32b1475d6f01"
      unitRef="usd">6581000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i478ab1e04df3462693b4f447d123258c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xMC0xLTEtMA_4d46e5a1-0c72-4595-a085-64a46a3e11f9"
      unitRef="usd">9910000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xMi0xLTEtMA_f5854678-2530-4249-9a04-8147ee5aa015"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xNC0xLTEtMA_ed4d4264-60a5-4b5e-9723-d9e93e16bdc6"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNS0xNi0xLTEtMA_d239756e-5521-4c22-bb8f-f006d89104dc"
      unitRef="usd">9910000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0yLTEtMS0w_805cecaf-5e57-4d0e-91ca-acd12aadc729"
      unitRef="usd">42724000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi00LTEtMS0w_feb4b16f-9f29-4559-bb68-bbba6a3d8941"
      unitRef="usd">295275000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic34a5542beee460cbf11a482a837b496_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi02LTEtMS0w_1dcc6764-2641-43a3-bc75-738e822e3aab"
      unitRef="usd">155000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi04LTEtMS0w_5a953960-9e58-4c8d-b75b-988c8703ed95"
      unitRef="usd">338154000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i478ab1e04df3462693b4f447d123258c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xMC0xLTEtMA_888c003a-4135-4564-9ced-3f1e6b43d269"
      unitRef="usd">61408000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xMi0xLTEtMA_4d9c8bcb-16d0-4fee-b253-2f119c5732cc"
      unitRef="usd">936791000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xNC0xLTEtMA_2679749f-bd3d-4a11-be23-e9445463abc3"
      unitRef="usd">125000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfNi0xNi0xLTEtMA_0820ecef-5922-47a6-a64d-27ca27cde6ea"
      unitRef="usd">998324000</us-gaap:AssetsFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="iedc8cab80d6146938a4e96ca913b603e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0yLTEtMS0w_8b047a00-d0e6-43fd-a4cc-6aaa676d816b"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i3f01a6768e554446859e50dd59a5f80b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC00LTEtMS0w_2c7ff095-4d7d-4e90-a7ec-9ff1ceaaa070"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i49eebaf8762f41bc8e158fa2142e34c7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC02LTEtMS0w_dbf21548-8c7a-4da9-9d90-391d8ac7bbf1"
      unitRef="usd">800000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i99eb08f38a27433e952f4df9a77b03c4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC04LTEtMS0w_71ecb05d-21f9-4c75-b181-062253c18480"
      unitRef="usd">800000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="ie0856bf1f29e45b3ae503b85c7783f0f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xMC0xLTEtMA_d738aa0c-4d79-4a16-ab39-c11604fc67f4"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i78fb2997e6c149bb89d1b9405e547655_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xMi0xLTEtMA_d5743b73-d0ac-4d80-9e6a-81727a39f3b1"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="ic3f212d8fb4848b7a0273c25f91e3c69_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xNC0xLTEtMA_325670c1-65e1-42df-be1c-96a47cb6d5f4"
      unitRef="usd">2659000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i9c0f7b483e754043b00e42dc018f756e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOC0xNi0xLTEtMA_369543ff-3b14-4c32-9966-3b5c7a98b478"
      unitRef="usd">2659000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i84f064695ce24917afeb387d23a90689_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0yLTEtMS0w_94fc418c-ff0d-40a7-8b2b-91a0145a2f6c"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i0b2bcfa66308412c8f26ad4feaca4c78_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS00LTEtMS0w_66125712-f448-481c-9adb-f5d746832764"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="id25c3c4da77d4ea7ab8ca7b1314fdd20_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS02LTEtMS0w_f526508b-697e-4feb-bda2-3703de77a046"
      unitRef="usd">509000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i776f577b4a88423a8d0236205bdb4fc4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS04LTEtMS0w_385ce17c-b61a-4c5a-988a-be7979714969"
      unitRef="usd">509000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i830cd590ed6b4940ae325376227fbf62_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xMC0xLTEtMA_147edbd8-36a6-4af7-9423-0fa8ed5a55dc"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="iad16d307d34d4ce3a14c5cc44ab00ca9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xMi0xLTEtMA_d78badbf-5028-41ae-afc4-b9fa79411731"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i66cf1abe6fef4052bc2a83de3d3f416a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xNC0xLTEtMA_a3af102e-29ab-46cb-b390-3920f6189d3d"
      unitRef="usd">348000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i2ffefdd42a3a41f1aaa64b145eafac32_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfOS0xNi0xLTEtMA_4b8c6890-3e4f-40ca-959a-47fcefd38ca6"
      unitRef="usd">348000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i60cb7324310c4d69b314803514b8e7b1_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMi0xLTEtMA_73cc331a-c8ad-4326-9c60-20e779fb5ab9"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i5d3493b201a94d66930f00e5b6cb91ab_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtNC0xLTEtMA_927e802e-0ef9-4f8e-aff1-8712d2295674"
      unitRef="usd">4985000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="iaef93f7a4c3542b39b59e3723f6abe79_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtNi0xLTEtMA_3e2353be-8d85-4c22-8c9a-b35c487708b1"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i31e1ba70e57e428aa564051bda9daceb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtOC0xLTEtMA_10209cb6-f744-45e7-bdad-0a4abc6f9bae"
      unitRef="usd">4985000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i8fe44d5fc83a4e91b928eab183e2696f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTAtMS0xLTA_1aa9ec4e-3f1f-4145-9150-d7f80d35abc6"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="id1fb45159aaf459ab33f85d40561d21b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTItMS0xLTA_64b7a0cf-c04d-4305-9661-19c5126da0b6"
      unitRef="usd">5935000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="if8cd383420af4806b4b998261a7844bc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTQtMS0xLTA_39f14dbd-2a4c-48f9-9bb0-0a5d3602e26b"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="ife1ffea26d4346d3ac80627049e44cf9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTAtMTYtMS0xLTA_309b9c6b-686e-4762-baca-dc5682c53986"
      unitRef="usd">5935000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i76e338a0003143eca31f450081056aae_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMi0xLTEtMA_94d32042-da30-4eab-bc55-c4ebad15f418"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i474b22d9f5454de2984d02f95a12bb78_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtNC0xLTEtMA_a3d2ddd4-fd57-49db-97d1-6d3727a14833"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="id7c66fe24767491e8f06625e7c7980b6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtNi0xLTEtMA_2e00f83c-16f7-425c-a33f-4064b16e1340"
      unitRef="usd">4504000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="ie7b17dc76cb24ddf96f02602f42463a0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtOC0xLTEtMA_cec11e69-cfb5-48be-9e45-3255882914a4"
      unitRef="usd">4504000</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="i30a210e993e749b792c4ff6feb3a58b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTAtMS0xLTA_abefa89f-567f-4375-b7c0-05bec6c7c73c"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="ice47f549adc84119806f94c1746c45ec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTItMS0xLTA_40981edc-41be-4f87-be7c-78a1cd0f1250"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="id25da78fb55a47a9a4c833b387732860_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTQtMS0xLTA_9611a1e9-d79c-40da-8554-e11c28672b25"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <lgnd:ContingentLiabilitiesFairValueDisclosure
      contextRef="id6fd63ec5bbe4d21b07dd199d23d7b1a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTEtMTYtMS0xLTA_d878696f-75b9-43d2-b8e9-5ca7ed73c3f1"
      unitRef="usd">0</lgnd:ContingentLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMi0xLTEtMA_f7d102d4-afa8-4d1b-aeeb-58c87b486dbc"
      unitRef="usd">71000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItNC0xLTEtMA_dfd1350c-8fb8-44a3-aa9d-9fe6d4910ee6"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="ic34a5542beee460cbf11a482a837b496_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItNi0xLTEtMA_57b58255-6239-4a4e-81c7-688a1c1a508f"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItOC0xLTEtMA_9fc59fbc-7718-4fb6-9770-829f69f6365a"
      unitRef="usd">71000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i478ab1e04df3462693b4f447d123258c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTAtMS0xLTA_7d798997-9495-47fe-81b5-14d62d138462"
      unitRef="usd">75000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTItMS0xLTA_e1281319-6973-4fd5-8a39-9a7409a6d23c"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTQtMS0xLTA_e6319ed5-e6fb-4be5-8148-7181f1c7e087"
      unitRef="usd">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTItMTYtMS0xLTA_f1c0510a-7eda-486b-8918-daceda631d6b"
      unitRef="usd">75000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib22396d3cd074458826229f4aa3c94ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMi0xLTEtMA_fc05db6f-da9c-4fcf-afa3-4d586623ba03"
      unitRef="usd">71000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5b6aaa8ac3bb46b39974b3d5c99408ee_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtNC0xLTEtMA_1f447a2a-b2c7-4d41-8692-8199cf63b640"
      unitRef="usd">4985000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic34a5542beee460cbf11a482a837b496_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtNi0xLTEtMA_c5b38c9f-7e0a-4372-b28e-8ae323bb121e"
      unitRef="usd">5813000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtOC0xLTEtMA_e602acd6-937f-4977-a757-3fb45c284a28"
      unitRef="usd">10869000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i478ab1e04df3462693b4f447d123258c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTAtMS0xLTA_fa782bf2-cb68-496b-adb1-24dd7a5aeae0"
      unitRef="usd">75000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8f47b24008434e72b2d2b8abdd01c025_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTItMS0xLTA_49330f1f-6064-4d11-aeb7-2c4e5412521d"
      unitRef="usd">5935000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5178294923b94ed691df5ab58c95e5ae_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTQtMS0xLTA_d8ca3d2a-dcaf-4a60-9809-feb59c3cb9c6"
      unitRef="usd">3007000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RhYmxlOmMxYmY0ZjYyOGYwZTQ3NDc4ZDYxNmU0M2MwOWNkNDIxL3RhYmxlcmFuZ2U6YzFiZjRmNjI4ZjBlNDc0NzhkNjE2ZTQzYzA5Y2Q0MjFfMTMtMTYtMS0xLTA_58e19930-72f6-4dd4-afa8-6bea292bb3f0"
      unitRef="usd">9017000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjM2NQ_54951681-9af2-455d-af6c-8445577f2134"
      unitRef="usd">1800000</lgnd:PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjU0Ng_84b3cb5f-612f-4f5c-a6fe-d1458d28b8a5"
      unitRef="contingentvalueright">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjU2NA_20ba2828-52da-423d-b982-e304d9453414"
      unitRef="contingentvalueright">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="ibfc313fa997f4657b35211e781b16774_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjU4NA_398dffe3-5cc2-4108-a5f4-05b928c03cd8"
      unitRef="contingentvaluerightseries">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="ifd4ad4fbc7854cc3a753abc4113dd6d8_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMjcxOQ_d201438c-6d2c-4214-94f2-df72480712ec">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="ia730be76fe494ababd31b792de283e21_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMzUyMQ_453015b5-3d78-41a5-985f-f663366153a9"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i4d48f0e79a2a43869f2f0bd580a4753b_I20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfMzYzNg_2104c0c8-b3f5-42b8-ba35-b1e6623cbdcd"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i7ba69388d37546cabc299b2e1f680e46_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNy9mcmFnOmEzZTEyM2NjOGNjYjRmZTdhYzU1NTJmY2E5YjQxZWNlL3RleHRyZWdpb246YTNlMTIzY2M4Y2NiNGZlN2FjNTU1MmZjYTliNDFlY2VfNDk0NzgwMjMzMDIwNg_072a3381-eb86-4fad-ab98-02aebf0a5bd0"
      unitRef="usd">500000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODI0NjMzNzIxOTIwNg_daab69d1-8c5a-49e3-86df-01839288b85f">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Taurus Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account for the CVRs in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;xCella Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Icagen Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition related costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 2, Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, for &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. There was no change in the fair value of the continent liabilities during the second quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The preliminary allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Ab Initio Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 23, 2019, we acquired privately-held Ab Initio Biotherapeutics, Inc., an antigen-discovery company located in South San Francisco, California. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition related costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The purchase price of $12.0 million included $11.86 million cash consideration paid upon acquisition, net of cash acquired, and $0.15 million cash holdback for potential indemnification claims, which was paid during the third quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Ab Initio have been included in our results of operations since the date of acquisition. &lt;/span&gt;&lt;/div&gt;The allocation of the purchase price consisted of (1) $0.03 million of fair value of tangible assets acquired, (2) $(0.08)&#160;million of liabilities assumed, (3) $7.40&#160;million of acquired technologies, (4) $(0.15)&#160;million of deferred tax liability in connection with the acquired intangibles, and (5) $4.81&#160;million of goodwill, none of which is deductible for tax purposes. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 12%. The fair value of the core technology is being amortized on a straight-line basis over the weighted average estimated useful life of the approximately 20 years.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTgxNw_89e0a531-4469-4e35-a05f-8441401c4fc5"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzU2MA_cbc58bf1-0710-4428-9676-d2cfa79febd2"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTM1Mg_3875f5b7-de7f-41cd-8db1-2b7b59ca420c"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9e64c0586051455caf1fcc537086a20a_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzU3Nw_aa6e2492-4df9-4b48-b63e-20e9314ec1a3"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i999aee09e45649fdb1cd9982ed98cdc2_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzU5Ng_32121f16-4f1f-4942-94db-316f50d74617"
      unitRef="usd">25000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i3375f5d3a4424dcd819ba8dc9c56b35e_D20200909-20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzYxNA_cad57825-082f-4f60-b7f2-33a2c021437a"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTg2MA_50bcc02e-24d5-42ab-aba1-4115a9ac99c2"
      unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i8fae09558a4443b6952d5785b2692f3a_I20200909"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNTkwOQ_ab4464c5-02b5-4ac0-ba39-00ada7811fa2"
      unitRef="usd">50000.00</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8f8208b3443c4953b951bcf2e7b70a4b_I20200909"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNTk5Mg_58e8e943-291f-4417-a636-f7c975e38410"
      unitRef="usd">5000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9e200da6ec4c46c68c9db69c0131c385_D20200909-20200909"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzODY0Nw_cba95ee4-e704-4525-bb9e-61204db6f957">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8fae09558a4443b6952d5785b2692f3a_I20200909"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDM5ODA0NjUyMzAyMQ_195dd196-8220-49b3-a64e-4b1e3c5a91f8"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzYyMA_5a172058-f847-4044-a29d-1c515c0cb637"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationConsiderationTransferredHoldback
      contextRef="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzOTUyMg_e833a85a-9321-4f1e-a32c-2e9c4b518937"
      unitRef="usd">500000</lgnd:BusinessCombinationConsiderationTransferredHoldback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i29bff9a12f464884a5afac09cb178f2b_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzYzNw_4743a703-d3be-4d32-9f75-a09bcd61c115"
      unitRef="usd">5000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iba4f03a76ff84cd195e9a52f4859e3e0_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzY1NA_6463a13b-5827-4919-9edc-1008ddb28ea2"
      unitRef="usd">25750000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues
      contextRef="i5b61ef8a9bb34b4a831d8fdf376d0630_D20200908-20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzNzY3NQ_67fcbbe3-c722-4b0e-ada9-47f7d09d9cc8"
      unitRef="number">0.25</lgnd:BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibc3329ce8164404b96f67397945d7abf_D20200908-20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjQwNg_c13e7720-2ac6-4ba7-90af-ec7978cb2667"
      unitRef="usd">7100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjIyOQ_fe214e19-2c45-40b9-b3b4-2c89124a7f44"
      unitRef="usd">200000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjI3MA_6ac53a82-8bf0-4337-a3e0-ea8c9851408c"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iefa15c311fc64869817af666497c6c42_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjMxMA_302a3c55-dd6e-4430-8bef-4330becf782d"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDk0NzgwMjMzNjk2Nw_78693110-fb33-4ebb-9985-0007eec0e1b6"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3c8ee65a89ca400999e52481a25fc8c0_D20200908-20200908"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTA5OTUxMTYzODUzNg_582a5e85-9b37-41e6-bb70-1e80e5d57e8e">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4d8f016fb52a4bafa215f7babc6e3f45_I20200908"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDM5ODA0NjUyMzAzMA_6bb415ff-58e0-490a-8afe-1393cae56fe5"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODI0NjMzNzIxOTIyNQ_5b54a1de-c131-4910-a00f-a5979d4d6139"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNjU0_267850ec-3ee6-41cd-babc-51a2885db81c"
      unitRef="usd">19900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNjY2_ec667a51-4e2b-4152-94ab-048cfd0f4ac3"
      unitRef="usd">15100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNzU0_5ba086f4-2ce5-408f-b373-e5d15d0468e7"
      unitRef="usd">25000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODQy_8ec14208-220d-4ffb-8742-b07ee708a4fa"
      unitRef="usd">4800000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMTk3MA_05ff3079-999f-4e54-984d-bfde8bc34f26"
      unitRef="usd">1800000</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjAyMQ_1c373628-6cd5-452d-b877-f9107fdd6323"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjA1Mg_3036df45-671b-4dd8-b703-a45af069d491"
      unitRef="usd">12800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjA4NA_cdd3b77e-2c85-4b62-8edc-b2989c01a5ea"
      unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i2fe5fef198d34ce288dab72b45d25f2a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjE5NQ_fdb515af-91ec-4791-8475-73b3ee6406d7"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjI2Ng_199e30a0-f23d-475b-af7d-9a159b9ee75b"
      unitRef="usd">9000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iedf59884a0ba4125b067647bc5e8a67b_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjM2Nw_56deef56-e424-4617-9170-8a0b9c92c037"
      unitRef="usd">11100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if85df3b674454d1fbeb0d47a0f94915a_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjQwMA_3c0ebdfb-0fad-4e4a-b5b8-f20b97b4fa93"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i7e7c4b5aaae742f5836b06830ae9422b_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjY5NQ_9eeb266d-e158-4c99-86b0-1a398b6c64fa"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7e7c4b5aaae742f5836b06830ae9422b_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMjgzOQ_1096676a-79c0-4119-a30b-1abac6d43e0c">P9Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i051cac9942274d55850055cf090e8f8d_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMzE3OQ_24aeaa1e-18ff-4679-9e8e-cc610a954011"
      unitRef="number">0.17</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i051cac9942274d55850055cf090e8f8d_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMzI5OQ_32159562-8b2b-4f11-b4ca-d99d5bea79b9">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia09122bddb1b400f832b31da0a0ea112_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfMzQxOQ_052eebc9-8950-46fe-beb9-1112d66a2c4f">P9Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfODI0NjMzNzIxOTIxNw_10e48b19-8f52-4daf-98f9-bbd09ae51f37"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDAxOQ_75b94de2-467a-4c1a-a970-e6820aa3ec4e"
      unitRef="usd">12000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDAzMQ_885fbe0d-5891-4d17-9720-d364420ba546"
      unitRef="usd">11860000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
      contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDEwMg_def0085a-0a4c-434d-9970-d435379a368e"
      unitRef="usd">150000</us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDQyNA_be966c6f-9a3b-4c87-b4e6-13862396f087"
      unitRef="usd">30000.00</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDQ3NQ_ed26d631-c410-4b9a-a802-f00a60a3398e"
      unitRef="usd">80000.00</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i14f34a9837f549a2b830d35fa413bbd8_I20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDUwNg_439029ca-62ac-4f7b-b8ae-60b1de0f185d"
      unitRef="usd">7400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ieab592e440e644d5a1ec6c7acf564453_I20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDUzOQ_d9dc354f-d931-44dd-b7d3-755134bf68a4"
      unitRef="usd">150000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i620650f07d414c4db4440a9363fe6d74_D20190723-20190723"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNDYyMQ_70e96daf-ab7d-4448-8baf-4f2da85dd75f"
      unitRef="usd">4810000</us-gaap:GoodwillAcquiredDuringPeriod>
    <lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate
      contextRef="i98ade28714c945bdbaed7782ccd551cc_D20190723-20190723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNTAxNA_902d24f9-14cf-4ad5-9696-be69118ed836"
      unitRef="number">0.12</lgnd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i98ade28714c945bdbaed7782ccd551cc_D20190723-20190723"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80MC9mcmFnOjc5NWMwNGZhZjBhNjRlZWJhODJkYmI1NTI3ZWEzNDU4L3RleHRyZWdpb246Nzk1YzA0ZmFmMGE2NGVlYmE4MmRiYjU1MjdlYTM0NThfNTE2OQ_a649f171-5b94-47a7-a31a-e2cead90a55a">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTk3Ng_beaef0a9-ba0b-4455-a247-6ac01425c1fe">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of September&#160;30, 2020, the &#x201c;if-converted value&#x201d; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, we repurchased $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted (1) a gain of $0.7&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2020; (2) a $32.7 million reduction in debt discount, and (3) a $2.7&#160;million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of September&#160;30, 2020. After the repurchases, approximately $515.6&#160;million in principal amount of the 2023 Notes remain outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, in connection with the repurchases of $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million, during the quarter ended March 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;515,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;454,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTAw_61c0b64a-2fdc-4685-b638-bc91fec771af"
      unitRef="usd">750000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTMz_2593a00a-a152-4faa-b63c-f523bc6bcdb9"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjg5_e6550d0b-348e-406c-b96f-5d9808843b33"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNjEw_676837e5-c22f-4fd5-ab6a-f4418a5237cb"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfOTQz_72ff901c-a9e4-4e21-8075-4e4d74619bbf"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfOTk5_73425219-0c1d-444b-b140-c7578a1e28f9"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i3fdd6a5c0c934742b54efa1803d5a810_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTE5NA_98701c00-27c3-467c-a28a-63935e3252c9"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTI1OQ_3846cee0-eb0a-4f2a-bf66-3d56254934fe"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTMwOA_2d15bcf6-e0ce-43c7-b365-f67dbcd6b09a"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="i0e05720f202b4d1a8478bee5e5c3a22b_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTQxNw_40cf97c9-20d9-463a-b87f-19d7fda5dad1"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTg0MQ_1ec238a6-e1db-47a0-afc7-420396cc5877"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMTk5OA_98f0b200-706b-4afc-9ca1-4413ffb15732"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjE3MQ_8f3f2f3c-104f-4e94-8bd5-5a837e54d8cb"
      unitRef="usd">13700000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt
      contextRef="ibfe792e75a594433b59c93b28557b63e_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjU4OA_41e1edef-fc6a-4ab5-886c-813c33ef51c5"
      unitRef="usd">234400000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjYyNg_c3a70746-58c4-4240-9a08-22b41fc4476a"
      unitRef="usd">203800000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjY2OA_53dd1a64-8f55-475c-ade0-8b59bd9f4b55"
      unitRef="usd">600000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjc1OQ_bd943571-9d46-445a-bfaf-863dcfa68b2d"
      unitRef="usd">700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjg3OQ_77dedc4b-1750-464c-b641-a310b83dbe52"
      unitRef="usd">-32700000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="ic4c98d33cfa0477d8ee8bcf530622477_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMjkyMA_93920833-f67f-4569-97bf-2f19595822f3"
      unitRef="usd">-2700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:LongTermDebt
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzEyMA_38543cd4-73aa-494c-a05b-22e38e13b81c"
      unitRef="usd">515600000</us-gaap:LongTermDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzM0OA_d8da5981-546a-4be4-bb6c-b42fc4fb6a5c"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzYyMg_35d2d31c-38f0-4095-b4cc-ba9c62763731"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfMzcwNQ_293a56a8-d1c6-4e54-92a5-922b109d6862"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNDYwNQ_c0d7f8ef-4a89-4491-8dea-b6e056e31782"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNDY3MQ_b214d613-03d7-4636-9136-099babe371da"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i8665c7c51114413eb80fe4dbef1197d3_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNDcyOQ_afa42ed5-669f-409f-8222-3cef823c1fda"
      unitRef="usd">90000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:LongTermDebt
      contextRef="ibfe792e75a594433b59c93b28557b63e_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTM1Ng_41e1edef-fc6a-4ab5-886c-813c33ef51c5"
      unitRef="usd">234400000</us-gaap:LongTermDebt>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTM5NA_c3a70746-58c4-4240-9a08-22b41fc4476a"
      unitRef="usd">203800000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="ie1bdc4bc69f3498c95362a40cda13edb_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTQzNg_53dd1a64-8f55-475c-ade0-8b59bd9f4b55"
      unitRef="usd">600000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RleHRyZWdpb246MDk4NGVhYjhkMGZkNGZiODliYWVhYmFiNzM1ZTJmMzdfNTk3NQ_b0eff3f5-e5b0-4006-ab2a-8108a48ec72e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;515,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;454,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying value of equity component of the 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;464,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMS0xLTEtMS0w_5aefa71a-eabe-40c5-9ac3-c903d388f537"
      unitRef="usd">515560000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ief5a227d490d42d182609204378ddfea_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMS0zLTEtMS0w_e8e90a96-d4a2-4e76-a250-09d3c1f23657"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMi0xLTEtMS0w_a304d846-7398-4489-a598-e1c3ae22460f"
      unitRef="usd">60587000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ief5a227d490d42d182609204378ddfea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMi0zLTEtMS0w_2520dc7f-830b-49e1-af74-3280849f417c"
      unitRef="usd">111041000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermNotesPayable
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMy0xLTEtMS0w_6b003448-fd2e-46ed-86ab-62975112debb"
      unitRef="usd">454973000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="ief5a227d490d42d182609204378ddfea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfMy0zLTEtMS0w_bb9ab3f5-a52c-41ae-9737-88fd70244a43"
      unitRef="usd">638959000</us-gaap:LongTermNotesPayable>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNS0xLTEtMS0w_51b39e3d-2dc2-4090-bd87-1aae5cf47a31"
      unitRef="usd">55339000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="ief5a227d490d42d182609204378ddfea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNS0zLTEtMS0w_b40cff0d-5186-4aaa-acb7-ffbf29de5b6c"
      unitRef="usd">101422000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="iee3cabb8282246d9b2d4d3044cdde963_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNi0xLTEtMS0w_cbbeed90-eb18-455a-be16-c697f9c841a1"
      unitRef="usd">464958000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ief5a227d490d42d182609204378ddfea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80My9mcmFnOjA5ODRlYWI4ZDBmZDRmYjg5YmFlYWJhYjczNWUyZjM3L3RhYmxlOjE4NzU3ZDNjNzI3NTQyZjk5MGU0ODgyNDA3MmNjY2UxL3RhYmxlcmFuZ2U6MTg3NTdkM2M3Mjc1NDJmOTkwZTQ4ODI0MDcyY2NjZTFfNi0zLTEtMS0w_ff6e9cf0-60ae-4d4d-9963-f467943d0671"
      unitRef="usd">647280000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfMTAzOA_1912ba78-704d-46c2-9941-d5962d9c5256">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2020 was 42.3% and 37.1%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. and tax deductions related to stock award activities offset by tax deductions related to foreign derived intangible income tax credits. The effective tax rate for the three and nine months ended September&#160;30, 2019 was 23.2% and 20.9%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three months ended September&#160;30, 2019 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory tax rates than the U.S..</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfNDI5_e66e0d8d-269e-4fa9-934c-ba594db1508b"
      unitRef="number">0.423</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfNDM2_65414a58-44ad-4ae2-9976-7c2cafe5cfa0"
      unitRef="number">0.371</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibf01760fe7f246eea8e00384efae729a_D20190701-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfODIw_c219bb9e-4482-43cf-8cf1-dc0a7dd14375"
      unitRef="number">0.232</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i42740aaab7d44544bcbf167dbaccdf6e_D20190101-20190930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80OS9mcmFnOmZiYzhhY2UxOTY0NjRkMTZiMDYzNDc5ZmZlNzAxMDY0L3RleHRyZWdpb246ZmJjOGFjZTE5NjQ2NGQxNmIwNjM0NzlmZmU3MDEwNjRfODI3_d546ceb8-19a8-42e9-ae17-5660cd44c58a"
      unitRef="number">0.209</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTcwMA_ad792cef-b5e3-4595-a987-738fe19c14ce">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of Notes to Consolidated Financial Statements in our 2019 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,313,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, outstanding options to purchase 1.6 million shares were exercisable with a weighted average exercise price per share of $72.60.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2020, 56,079 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2020, we repurchased $73.3 million of our common stock under our stock repurchase programs as discussed below. We did not have any share repurchases during the second and third quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market &lt;/span&gt;&lt;/div&gt;repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $253.5 million of our common stock remained available as of September&#160;30, 2020.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTcwMw_1e4af673-502a-4753-a997-9e353c24c503">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,313,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTcwNA_a0e6d6c4-4896-4656-afa4-ee1ec9a1d71a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(113,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,313,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;201,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib9901cc55d3a41d6a022e1bace11721c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi0xLTEtMS0w_04f51d08-dfc5-4c1a-9703-449b1a38313f"
      unitRef="shares">1956379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib9901cc55d3a41d6a022e1bace11721c_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi0zLTEtMS0w_e7286db5-fad1-4c1b-8437-0ced04227c9c"
      unitRef="usdPerShare">77.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2b873c8bed16489d977cfb5d84e575a4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi01LTEtMS0w_22d75977-588c-41eb-9065-e96b075e2da5"
      unitRef="shares">147259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2b873c8bed16489d977cfb5d84e575a4_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMi03LTEtMS0w_65926dd1-f30e-439e-9b61-dc7f353b0949"
      unitRef="usdPerShare">125.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy0xLTEtMS0w_86debad1-fcdf-4378-b657-1d6b5c267996"
      unitRef="shares">480250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy0zLTEtMS0w_44f6ae7f-0edd-499e-8a52-4dd132674720"
      unitRef="usdPerShare">90.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy01LTEtMS0w_bb654887-961e-4c70-b2ad-00e775dba90c"
      unitRef="shares">104306</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfMy03LTEtMS0w_68ac0d99-e228-4ae3-bc81-d6c55dde40c7"
      unitRef="usdPerShare">89.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC0xLTEtMS0w_52d611e5-bb29-4da8-b554-9681e2f4c0e2"
      unitRef="shares">113107</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC0zLTEtMS0w_c78fe98f-c219-4d18-b806-2234a70b1bc6"
      unitRef="usdPerShare">23.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC01LTEtMS0w_125a89a6-492d-4ae4-a030-01c12a4d04d9"
      unitRef="shares">50053</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNC03LTEtMS0w_7a529006-d55e-4169-985e-ef9e241a2d9d"
      unitRef="usdPerShare">122.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS0xLTEtMS0w_4905f497-df5f-41cb-a05f-ee33e3951208"
      unitRef="shares">10200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ia3ec1e7306a74ebb92bafa9d1368c8ea_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS0zLTEtMS0w_e55d1280-4a18-4fe0-b9c7-b48c24194eff"
      unitRef="usdPerShare">72.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS01LTEtMS0w_5a8533fb-0626-4906-96d6-6d194de9f537"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibeda4f81019d442fa01c713f1d0d7894_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNS03LTEtMS0w_80c387e9-f74e-4137-bc63-6b9d3eb18e53"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia3dda86ca5ea49ce89a56fba0b2e74eb_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi0xLTEtMS0w_492b1ebb-44c4-46f1-bcbf-59f7faf463e9"
      unitRef="shares">2313322</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia3dda86ca5ea49ce89a56fba0b2e74eb_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi0zLTEtMS0w_a6bf5d56-3ee2-4246-ada3-3337b6aae509"
      unitRef="usdPerShare">82.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5fe5995b210642eb9ea6c816db2ac441_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi01LTEtMS0w_30998c90-b233-44e8-b718-19bf8a3249e3"
      unitRef="shares">201512</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5fe5995b210642eb9ea6c816db2ac441_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RhYmxlOjUyODNmODc2YmM2YzQ3MjFiM2E3NmNiMDQ3YTNjMWI0L3RhYmxlcmFuZ2U6NTI4M2Y4NzZiYzZjNDcyMWIzYTc2Y2IwNDdhM2MxYjRfNi03LTEtMS0w_f326a587-9e08-48b1-ab6b-5da492d0a08f"
      unitRef="usdPerShare">107.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfNDQ3_14bd9a86-dfaf-4320-8dae-3b23f91a7d1d"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfNTI2_e16a69e8-47fb-43f2-bc1d-07e710afe74e"
      unitRef="usdPerShare">72.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i1803c7b7772d48fcbcd1f7dd2fea7909_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfNjc1_ee44b5fe-5551-4b64-b656-6e17a4834e49"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i1803c7b7772d48fcbcd1f7dd2fea7909_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfODAy_302ced40-9220-4ed3-9e66-5dd8ed65b692"
      unitRef="shares">56079</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i007cb72b91db4bc690515877028df7e9_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfOTMz_2f68a19c-57ef-4692-81f5-17d7e1f56188"
      unitRef="usd">73300000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTAxOQ_0c6c81f2-b7d2-4e93-aad7-b74286b708cb"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie819e34ca1664cf1b664f2a48decbbb7_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTAxOQ_1749fb28-f1e7-426a-ae4c-df8f462d1a6d"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i8183957e6f4e449b8b14bffaa3391716_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTIyNQ_20d1d0fa-11ba-483f-b871-d975e98a1bf2"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="id421b7a497e949c0829fd0a9cb8a9545_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTI4MA_98dd06fd-7962-479f-89d6-a75dbfef1bb6">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81Mi9mcmFnOjUxYmJhNDQxNTQ2NzRmN2NiYjYyMDA2MjY1NzI5Y2Q5L3RleHRyZWdpb246NTFiYmE0NDE1NDY3NGY3Y2JiNjIwMDYyNjU3MjljZDlfMTY0Nw_0be41d40-71da-45bd-850c-44a27f7f5729"
      unitRef="usd">253500000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNTExNg_fdd521fd-f565-48c3-8322-7b1e2d93162d">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 9, 2019, CyDex received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#x201c;Alembic&#x201d;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&#xae; prior to the expiration of any of the &#x2019;077 patent; the &#x2019;088 patent, the &#x2019;582 patent, or U.S. Patent No. 10,040,872 (&#x201c;the &#x2019;872 patent&#x201d;), and alleging that these patents, each of which relates to Captisol&#xae;, are invalid, unenforceable, and/or would not be infringed by Alembic&#x2019;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#x2019;s ANDA constitutes infringement of each of the &#x2019;088 patent and the &#x2019;582 patent. On July 29, 2019, Alembic filed an answer and counterclaims seeking declarations of non-infringement and invalidity as to each of the asserted patents and, on August 19, 2019, CyDex filed an answer to Alembic&#x2019;s counterclaims. On April 7, 2020, the Court ordered that the Scheduling Order be amended such that, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter alia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the fact discovery cut off was set for November 2, 2020, the close of expect discovery was set for March 22, 2021, and that May 17, 2021 would remain the first day of a five-to-six-day bench trial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#x201c;Lupin&#x201d;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&#xae; prior to the expiration of any of the &#x2019;077 patent; the &#x2019;088 patent, the &#x2019;582 patent, or the &#x2019;872 patent, and alleging that these patents, each of which relates to Captisol&#xae;, are invalid, unenforceable, and/or would not be infringed by Lupin&#x2019;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all four patents and CyDex filed its answer to Lupin&#x2019;s counterclaims on January 2, 2020. Fact discovery is ongoing. The Court&#x2019;s scheduling order sets close of discovery on May 7, 2021 and a five day bench trial starting on December 13, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber
      contextRef="ia89ff6c0983c400999c69d63e6050433_D20191029-20191029"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNDE3OA_ee7e2519-c41a-4ad5-a377-ae2c8179a2d6"
      unitRef="patent">4</us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i618ff0aa526749d3ae1e702491ced1ab_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNDQyMQ_305b80bc-c496-4b14-bf06-7a04b24b3e16"
      unitRef="civilcomplaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i618ff0aa526749d3ae1e702491ced1ab_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81NS9mcmFnOmEwOGMwYzE5YTJmNzQzZjViZjU1MzI5ZjYwNmZmYzEyL3RleHRyZWdpb246YTA4YzBjMTlhMmY3NDNmNWJmNTUzMjlmNjA2ZmZjMTJfNTAwNg_0de8b2b8-165d-4f51-941d-873c056874cf"
      unitRef="civilcomplaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjIyOQ_2a196c7b-3776-4b96-ba53-762fad0e79ca">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMTU4_6e2e7d5b-569a-4112-af29-1a3087e4b64c"&gt;seven&lt;/span&gt; years, some of which include options to extend the leases for up to &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjI5_55733a26-80e9-4395-8c9c-5fd85e05d7b3"&gt;seven&lt;/span&gt; years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. For leases with a term of 12 months or less, we elected to not recognize lease assets and lease liabilities and expense the leases over a straight-line basis for the term of those leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90ZXh0cmVnaW9uOjk2MWYxNmY1ZTRiYjRhNDFhMGQyYzg1NmZkZTBiNDU1XzQzOTgwNDY1MTI2MDA_aaaf7ee6-4ef0-4d82-8436-0a4ae0d26df8">Assets Held for Sale&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 10 - Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, we entered into an agreement to divest Vernalis (R&amp;amp;D) Limited in October 2020. As a result of meeting the criteria to classify the disposal group as held for sale under generally accepted accounting principles, Vernalis (R&amp;amp;D) Limited was classified as held for sale as of September&#160;30, 2020. Assets classified as held for sale are recorded at the lower of their carrying amount or fair value less costs to sell and are not depreciated or amortized. Classification of our disposal group held for sale occurs when sufficient authority to sell the disposal group has been obtained, the disposal group is available for immediate sale and its sale is probable within one year. If at any time these criteria are no longer met, the disposal group would be reclassified as held and used. We evaluate the held for sale classification during each reporting period. The disposal group did not meet the requirements for presentation as discontinued operations and are included in income from continuing operations for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any assets held for sale as of December&#160;31, 2019. The following table presents the carrying amounts of major classes of assets and liabilities related to assets held for sale with respect to the Vernalis (R&amp;amp;D) Limited divestiture as of September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities related to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i40068af719eb4ea8bd60482b542bddca_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90ZXh0cmVnaW9uOjk2MWYxNmY1ZTRiYjRhNDFhMGQyYzg1NmZkZTBiNDU1XzQzOTgwNDY1MTI2MDY_2eb1cb77-3309-4597-a7f5-6a7004ce6c4a"
      unitRef="usd">0</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90ZXh0cmVnaW9uOjk2MWYxNmY1ZTRiYjRhNDFhMGQyYzg1NmZkZTBiNDU1XzQzOTgwNDY1MTI2MDE_c75455eb-abfe-4bc1-afe9-53acfb75745c">The following table presents the carrying amounts of major classes of assets and liabilities related to assets held for sale with respect to the Vernalis (R&amp;amp;D) Limited divestiture as of September&#160;30, 2020.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.675%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities related to assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzItMi0xLTEtMTU4Ng_8e950a6a-bf5d-4e1f-b7c1-ea370319db53"
      unitRef="usd">2581000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzMtMi0xLTEtMTU4Ng_7403a720-62b7-427a-a005-892531789ee9"
      unitRef="usd">2871000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzQtMi0xLTEtMTYwNw_dcc7dff4-affb-46ba-971b-e0607e5f435a"
      unitRef="usd">2445000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzQtMi0xLTEtMTU4Ng_20a8829d-2a37-46c0-ad93-bae069705245"
      unitRef="usd">5246000</lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzYtMi0xLTEtMTcwOQ_21cf7d8c-2c07-4182-88c6-563a2700218a"
      unitRef="usd">13143000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzktMi0xLTEtMTU5MA_0a90a6f9-76eb-4fde-b8e8-f5b3be87e921"
      unitRef="usd">463000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzEwLTItMS0xLTE1OTA_c123bd6f-187e-49ac-9183-dd7d266c4dc3"
      unitRef="usd">1697000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzExLTItMS0xLTE1OTA_b0b9a1a2-f491-49db-9936-d871a41413cb"
      unitRef="usd">2464000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent>
    <lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzEyLTItMS0xLTE1OTA_1af731be-81a9-4ff5-9b0a-d6eac84a8685"
      unitRef="usd">5084000</lgnd:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzEzLTItMS0xLTE2MTU_fc522b2c-d8ae-4593-a29f-c99fe5cb5bfb"
      unitRef="usd">653000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80ODEvZnJhZzo5NjFmMTZmNWU0YmI0YTQxYTBkMmM4NTZmZGUwYjQ1NS90YWJsZTplYTY0NTMzZDJhMWU0OGNlYWFkYjNjMTRmYzU1OWQ5Zi90YWJsZXJhbmdlOmVhNjQ1MzNkMmExZTQ4Y2VhYWRiM2MxNGZjNTU5ZDlmXzE0LTItMS0xLTE3MTE_26762d94-6a32-47df-adfb-3ef70b211d72"
      unitRef="usd">10361000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i084c958f709b4a00b5002d47e6069f43_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTEyNzM_f192d11b-25e9-4b81-8647-e676acb4d582">Subsequent Events&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pfenex Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2020, we completed the acquisition of Pfenex for $437.5&#160;million in cash, plus one non-transferable CVR per share representing the right to receive an aggregate contingent payment of $78&#160;million in cash if a certain specified milestone is achieved. The acquisition was funded using cash on hand. We are currently evaluating the accounting impact of this transaction and anticipate using ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, but the initial purchase price allocation is not yet complete.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Vernalis Research Operations&lt;/span&gt;&lt;/div&gt;On October 11, 2020, we and our wholly-owned subsidary Vernalis Limited, a company incorporated in England (&#x201c;Seller&#x201d;), entered into an Agreement for the Sale and Purchase of the Entire Issued Share Capital of Vernalis (R&amp;amp;D) Limited (the &#x201c;Purchase and Sale Agreement&#x201d;) with HitGen UK Ltd, a company incorporated in England (&#x201c;Buyer&#x201d;), and HitGen Inc., a company incorporated in China (&#x201c;HitGen&#x201d;), pursuant to which Ligand and Seller agreed to sell the entire issued share capital of Vernalis (R&amp;amp;D) Limited, a company incorporated in England and a wholly-owned subsidiary of Seller (&#x201c;Vernalis&#x201d;), which constitutes the sale of the Vernalis business operations including the Vernalis Design Platform.  Under the terms of the Purchase and Sale Agreement, at the closing of the transaction, Buyer will pay $25.0&#160;million in cash, subject to a working capital adjustment. In addition, Buyer will pay to Ligand any net receipts pursuant to completed collaboration licenses and a share of any net receipts pursuant to ongoing research collaboration agreements. The closing is expected to occur in the fourth quarter of 2020.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ibc5070ad9b82439b913a9301d0b00b65_D20201001-20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTQ2Mzk_283c0990-56e9-40eb-ae23-91a6fc20e8cb"
      unitRef="usd">437500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="ibb2c08d52fc04211b2744d4a8b48977e_I20201001"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTQ2NTU_b650cdd4-e7a9-4bc3-b46e-a115e00b3075"
      unitRef="usd">78000000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <lgnd:ExpectedProceedsFromDivestitureOfBusinesses
      contextRef="ia8fa3962729945ee8b1a302fab16a100_D20201011-20201011"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl80NjIvZnJhZzozNzlkZGUzMWRhODE0NTVlYmU1ZGE4NzMwYWM2MTM3MC90ZXh0cmVnaW9uOjM3OWRkZTMxZGE4MTQ1NWViZTVkYTg3MzBhYzYxMzcwXzQzOTgwNDY1MTQ2Njk_50e431df-b100-474d-be0a-da3432e8b991"
      unitRef="usd">25000000.0</lgnd:ExpectedProceedsFromDivestitureOfBusinesses>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198441440312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard,  Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock , par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,091,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434679160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 456,916,000<span></span>
</td>
<td class="nump">$ 71,543,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">338,154,000<span></span>
</td>
<td class="nump">998,324,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">32,907,000<span></span>
</td>
<td class="nump">30,387,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">13,430,000<span></span>
</td>
<td class="nump">7,296,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,361,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">3,191,000<span></span>
</td>
<td class="nump">4,734,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Assets held for sale</a></td>
<td class="nump">13,143,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">857,741,000<span></span>
</td>
<td class="nump">1,123,645,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">27,026,000<span></span>
</td>
<td class="nump">25,608,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">224,582,000<span></span>
</td>
<td class="nump">210,448,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">102,136,000<span></span>
</td>
<td class="nump">95,229,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license and other economic rights, net</a></td>
<td class="nump">10,834,000<span></span>
</td>
<td class="nump">20,090,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,157,000<span></span>
</td>
<td class="nump">7,185,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">4,269,000<span></span>
</td>
<td class="nump">10,353,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">13,704,000<span></span>
</td>
<td class="nump">2,357,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,247,449,000<span></span>
</td>
<td class="nump">1,494,915,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,169,000<span></span>
</td>
<td class="nump">2,420,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">14,498,000<span></span>
</td>
<td class="nump">9,836,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">674,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">1,194,000<span></span>
</td>
<td class="nump">2,607,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">5,404,000<span></span>
</td>
<td class="nump">2,139,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Liabilities related to assets held for sale</a></td>
<td class="nump">10,361,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">42,300,000<span></span>
</td>
<td class="nump">17,002,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">454,973,000<span></span>
</td>
<td class="nump">638,959,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">9,604,000<span></span>
</td>
<td class="nump">6,335,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">13,508,000<span></span>
</td>
<td class="nump">32,937,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">3,920,000<span></span>
</td>
<td class="nump">9,970,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">25,320,000<span></span>
</td>
<td class="nump">22,480,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">549,625,000<span></span>
</td>
<td class="nump">727,683,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,091 and 16,823 shares issued and outstanding at September&#160;30, 2020 and December&#160;31, 2019, respectively</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">313,057,000<span></span>
</td>
<td class="nump">367,326,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,441,000)<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">386,192,000<span></span>
</td>
<td class="nump">400,105,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">697,824,000<span></span>
</td>
<td class="nump">767,232,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,247,449,000<span></span>
</td>
<td class="nump">$ 1,494,915,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities Related to Assets Held-for-sale, Not Part of Disposal Group, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121558832&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198441342776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,091,000<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,091,000<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434641384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 41,848<span></span>
</td>
<td class="nump">$ 24,808<span></span>
</td>
<td class="nump">$ 116,429<span></span>
</td>
<td class="nump">$ 93,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">6,353<span></span>
</td>
<td class="nump">3,147<span></span>
</td>
<td class="nump">18,680<span></span>
</td>
<td class="nump">9,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">11,285<span></span>
</td>
<td class="nump">10,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">12,853<span></span>
</td>
<td class="nump">13,742<span></span>
</td>
<td class="nump">37,476<span></span>
</td>
<td class="nump">37,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">15,020<span></span>
</td>
<td class="nump">9,525<span></span>
</td>
<td class="nump">34,353<span></span>
</td>
<td class="nump">31,607<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">38,101<span></span>
</td>
<td class="nump">29,966<span></span>
</td>
<td class="nump">101,794<span></span>
</td>
<td class="nump">88,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain from sale of Promacta license</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">812,797<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">3,747<span></span>
</td>
<td class="num">(5,158)<span></span>
</td>
<td class="nump">14,635<span></span>
</td>
<td class="nump">817,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Loss from short-term investments</a></td>
<td class="num">(9,862)<span></span>
</td>
<td class="num">(13,297)<span></span>
</td>
<td class="num">(17,143)<span></span>
</td>
<td class="num">(8,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">991<span></span>
</td>
<td class="nump">7,396<span></span>
</td>
<td class="nump">7,690<span></span>
</td>
<td class="nump">22,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6,269)<span></span>
</td>
<td class="num">(8,993)<span></span>
</td>
<td class="num">(21,030)<span></span>
</td>
<td class="num">(26,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(219)<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">1,940<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss), net</a></td>
<td class="num">(15,359)<span></span>
</td>
<td class="num">(14,713)<span></span>
</td>
<td class="num">(28,543)<span></span>
</td>
<td class="num">(12,441)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="num">(11,612)<span></span>
</td>
<td class="num">(19,871)<span></span>
</td>
<td class="num">(13,908)<span></span>
</td>
<td class="nump">804,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">4,911<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="nump">5,162<span></span>
</td>
<td class="num">(168,147)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (6,701)<span></span>
</td>
<td class="num">$ (15,251)<span></span>
</td>
<td class="num">$ (8,746)<span></span>
</td>
<td class="nump">$ 636,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.81)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="nump">$ 32.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (shares)</a></td>
<td class="nump">16,082,000<span></span>
</td>
<td class="nump">18,770,000<span></span>
</td>
<td class="nump">16,222,000<span></span>
</td>
<td class="nump">19,586,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="num">$ (0.42)<span></span>
</td>
<td class="num">$ (0.81)<span></span>
</td>
<td class="num">$ (0.54)<span></span>
</td>
<td class="nump">$ 31.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (shares)</a></td>
<td class="nump">16,082,000<span></span>
</td>
<td class="nump">18,770,000<span></span>
</td>
<td class="nump">16,222,000<span></span>
</td>
<td class="nump">20,349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9,005<span></span>
</td>
<td class="nump">$ 9,767<span></span>
</td>
<td class="nump">$ 22,751<span></span>
</td>
<td class="nump">$ 35,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">23,389<span></span>
</td>
<td class="nump">6,849<span></span>
</td>
<td class="nump">68,966<span></span>
</td>
<td class="nump">24,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9,454<span></span>
</td>
<td class="nump">$ 8,192<span></span>
</td>
<td class="nump">$ 24,712<span></span>
</td>
<td class="nump">$ 32,991<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198441389704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss):</a></td>
<td class="num">$ (6,701)<span></span>
</td>
<td class="num">$ (15,251)<span></span>
</td>
<td class="num">$ (8,746)<span></span>
</td>
<td class="nump">$ 636,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">923<span></span>
</td>
<td class="num">(764)<span></span>
</td>
<td class="num">(1,141)<span></span>
</td>
<td class="num">(1,015)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (5,832)<span></span>
</td>
<td class="num">$ (16,202)<span></span>
</td>
<td class="num">$ (9,971)<span></span>
</td>
<td class="nump">$ 636,198<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198357773496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2018</a></td>
<td class="nump">$ 560,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">$ 791,114,000<span></span>
</td>
<td class="num">$ (1,024,000)<span></span>
</td>
<td class="num">$ (229,197,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="num">(991,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(991,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,236,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(151,585,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(151,584,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="nump">291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other tax adjustments</a></td>
<td class="num">(569,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(569,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">666,337,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">666,337,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2019</a></td>
<td class="nump">1,079,974,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">643,317,000<span></span>
</td>
<td class="num">(503,000)<span></span>
</td>
<td class="nump">437,140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2018</a></td>
<td class="nump">560,914,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">791,114,000<span></span>
</td>
<td class="num">(1,024,000)<span></span>
</td>
<td class="num">(229,197,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">636,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,563,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2019</a></td>
<td class="nump">850,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">444,587,000<span></span>
</td>
<td class="num">(1,493,000)<span></span>
</td>
<td class="nump">407,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2019</a></td>
<td class="nump">1,079,974,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">643,317,000<span></span>
</td>
<td class="num">(503,000)<span></span>
</td>
<td class="nump">437,140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">6,571,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,571,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(291,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(33,717,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(33,716,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="nump">503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(542,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(542,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other tax adjustments</a></td>
<td class="nump">2,343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,343,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(14,419,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,419,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2019</a></td>
<td class="nump">1,041,453,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="nump">619,255,000<span></span>
</td>
<td class="num">(542,000)<span></span>
</td>
<td class="nump">422,721,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">6,297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,297,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,834,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(181,188,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,000)<span></span>
</td>
<td class="num">(181,186,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(187,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(764,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(764,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other tax adjustments</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(15,251,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,251,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,563,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2019</a></td>
<td class="nump">850,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">444,587,000<span></span>
</td>
<td class="num">(1,493,000)<span></span>
</td>
<td class="nump">407,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">367,326,000<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="nump">400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(878,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(73,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">(73,286,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,772,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,745,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,131,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">$ 661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 767,232,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">367,326,000<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="nump">400,105,000<span></span>
</td>
<td class="num">$ (5,167,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(8,746,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">697,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">313,057,000<span></span>
</td>
<td class="num">(1,441,000)<span></span>
</td>
<td class="nump">386,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="nump">661,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">295,940,000<span></span>
</td>
<td class="num">(4,867,000)<span></span>
</td>
<td class="nump">370,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">1,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="nump">2,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="num">(185,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(185,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">22,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,086,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="nump">695,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">304,404,000<span></span>
</td>
<td class="num">(2,310,000)<span></span>
</td>
<td class="nump">392,893,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net</a></td>
<td class="nump">910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">7,740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(54,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment', window );">Foreign currency translation adjustment</a></td>
<td class="nump">923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(6,701,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,701,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,091,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2020</a></td>
<td class="nump">$ 697,824,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 313,057,000<span></span>
</td>
<td class="num">$ (1,441,000)<span></span>
</td>
<td class="nump">$ 386,192,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198432976472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (8,746)<span></span>
</td>
<td class="nump">$ 636,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain from sale of Promacta license</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(812,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(397)<span></span>
</td>
<td class="nump">762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">12,645<span></span>
</td>
<td class="nump">11,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium (discount) on investments, net</a></td>
<td class="nump">1,507<span></span>
</td>
<td class="num">(7,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">17,743<span></span>
</td>
<td class="nump">22,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AmortizationOfOtherEconomicRights', window );">Amortization of commercial license and other economic rights</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="nump">10,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on debt extinguishment</a></td>
<td class="num">(659)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">20,752<span></span>
</td>
<td class="nump">18,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(19,311)<span></span>
</td>
<td class="nump">57,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss from short-term investments</a></td>
<td class="nump">17,143<span></span>
</td>
<td class="nump">8,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="num">(1,525)<span></span>
</td>
<td class="num">(4,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(5,080)<span></span>
</td>
<td class="nump">33,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(4,914)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">9,894<span></span>
</td>
<td class="num">(3,302)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="nump">12,026<span></span>
</td>
<td class="nump">16,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInOtherEconomicRights', window );">Other economic rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">2,678<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in ) operating activities</a></td>
<td class="nump">54,049<span></span>
</td>
<td class="num">(21,997)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Proceeds from sale of Promacta license</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">812,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(337,016)<span></span>
</td>
<td class="num">(1,682,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">389,296<span></span>
</td>
<td class="nump">144,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">589,155<span></span>
</td>
<td class="nump">1,274,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition, net of cash acquired</a></td>
<td class="num">(26,857)<span></span>
</td>
<td class="num">(11,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="num">(500)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(6,307)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">613,850<span></span>
</td>
<td class="nump">530,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for bond conversion</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">2,459<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(1,429)<span></span>
</td>
<td class="num">(2,906)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchase</a></td>
<td class="num">(73,287)<span></span>
</td>
<td class="num">(371,106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(2,325)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(5,224)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(283,016)<span></span>
</td>
<td class="num">(401,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">384,833<span></span>
</td>
<td class="nump">106,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">72,273<span></span>
</td>
<td class="nump">119,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">457,106<span></span>
</td>
<td class="nump">226,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">2,130<span></span>
</td>
<td class="nump">93,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash in other current assets</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">1,390<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedLeasePurchases', window );">Accrued financing lease payment</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain (loss) on AFS investments</a></td>
<td class="num">(109)<span></span>
</td>
<td class="nump">699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member', window );">2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase/ Repayment of Notes</a></td>
<td class="num">(203,210)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2019Member', window );">2019 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase/ Repayment of Notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (27,323)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedLeasePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Lease Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedLeasePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198429866440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2019 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the second quarter of 2020, we began to include our investment in Viking in &#8220;short-term investments&#8221; in the condensed consolidated balance sheet, and present &#8220;gain (loss) from short-term investments&#8221; in the condensed consolidated statements of operations to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in &#8220;other income, net&#8221;. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and nine months ended September&#160;30, 2019 have been reclassified to conform to the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of Notes to Consolidated Financial Statements in our 2019 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 Pandemic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees and partners, patients, communities and business operations, as well as the U.S. and global economy and financial markets. International and U.S. governmental authorities in impacted regions have taken actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have restricted in-person access to our executive offices, our administrative employees are mostly working remotely, and we have limited the number of staff in our research and development laboratories and other facilities. The continued spread of the COVID-19 pandemic and the measures taken by the governments of countries have affected, and could continue to affect, our business and the business of our partners, including future disruptions to our supply chain and the manufacture or shipment of drug substance and finished drug product for Captisol, delays by us or our partners in the initiation or enrollment of patients in clinical trials, discontinuations by patients enrolled in clinical trials, difficulties launching or commercializing products and other related activities, which could delay ongoing clinical trials, increase development costs, reduce royalty revenues and have a material adverse effect on our business, financial condition and results of operations. Several of our partners have reported that their operations have been impacted including delays in research and development programs and deprioritizing clinical trials in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in the clinical trials being conducted by us or our partners. In addition, certain of our partners have reported negative impacts on product sales which will impact our royalty revenues. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of our partners are working to develop drugs to treat COVID-19. For example, we are supplying Captisol to partners, including Gilead for Veklury</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (remdesivir), the first FDA-approved treatment for COVID-19 for the treatment of patients with COVID-19 requiring hospitalization and, as a result, we have extended our Captisol supply agreement with Gilead until September 2030 and worked to increase our manufacturing of Captisol to meet this increased demand. We believe our existing production capacity, together with our planned expansion, will provide adequate supply of Captisol and do not expect any significant risk or disruption to our supply chain for the foreseeable future. In addition, certain of our OmniAb and Vernalis partners have initiated antibody discovery programs for the potential treatment of COVID-19. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, the businesses of our partners, our results of operations and our financial condition will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact, including the timing and extent of governments reopening or further restricting activities, and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. This standard includes our financial instruments, such as accounts receivable, investments that are generally of high credit quality, and commercial license rights. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The new guidance requires us to identify, analyze, document and support new methodologies for quantifying expected credit loss estimates for our financial instruments, using information such as historical experience and current economic conditions, plus the use of reasonable supportable forecast information. We adopted <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b">ASU 2016-13</span> on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance sheet of retained earnings to be recognized on the date of adoption with prior periods not restated. The cumulative-effect adjustment, net of tax, recorded on January 1, 2020, is approximately $5.2 million on our unaudited condensed consolidated balance sheet as of January 1, 2020. Results for periods after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported under previously applicable accounting standards. See additional disclosure on credit losses under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Short-term Investments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Accounts Receivable and Allowance for Credit Losses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Commercial License and Other Economic Rights&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which eliminates the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. Under the new standard the goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value, although it cannot exceed the total amount of goodwill allocated to that reporting unit. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which modifies the disclosure requirements on fair value measurements. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In November 2018, the FASB issued ASU 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements: Clarifying the Interaction between Topic 808 and Topic 606 (Topic 808)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when the counterparty is a customer for a good or service that is a distinct unit of account. The amendments also preclude entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. Depending on the amendment, adoption may be applied on a retrospective, modified retrospective or prospective basis. We adopted this standard on a prospective basis on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $5.8 million and $8.3 million, respectively. During the three and nine months ended September&#160;30, 2019, the amount recognized as revenue that was previously deferred was $1.0 million and $5.0 million, respectively. We expect to satisfy the performance obligations related to long-term deferred revenue within the next 3 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Promacta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,005&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,931&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,848&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments, excluding investment in Viking, consist of the following at September&#160;30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411,690&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,943&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,552&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,850)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,624)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">941,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">939,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as of September&#160;30, 2020 and December&#160;31, 2019, we recorded shares of Viking common stock we own at fair value of $33.9 million and $48.4 million, respectively, in &#8220;Short-term investments&#8221; in our consolidated balance sheets. We also own warrants to purchase up to 1.5 million shares of Viking's common stock at an exercise price of $1.50 per share. We recorded the warrants in &#8220;Short-term investments&#8221; in our consolidated balance sheet at fair value of $6.6 million and $9.9 million at September&#160;30, 2020 and December&#160;31, 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments on our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For available-for-sale debt securities with unrealized losses, the new credit losses standard (Topic 326) now requires allowances to be recorded instead of reducing the amortized cost of the investment. This standard limits the amount of credit losses to be recognized for available-for-sale debt securities to be the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the new credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">After five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invested in U.S.-dollar denominated investments. We held a total of 2 positions which were in an unrealized loss position as of September&#160;30, 2020. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities nor do we believe that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2020, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the surrounding novel coronavirus (COVID-19) pandemic on our business and recorded an adjustment of $(0.1)&#160;million and $0.2&#160;million, of allowance for credit losses, respectively, as of September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59,869)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50,203)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,279)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,929)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,224)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1) Accumulated amortization for complete technology includes immaterial amount of foreign currency translation adjustments for the complete technology acquired from the Vernalis acquisition.<br/></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial License and Other Economic Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,644)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,052</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Palvella</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,492)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,508</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,820)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,782</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,464)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,834</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,208)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal or research and development expenses of $21.5 million and credit loss adjustments of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$6.0 million as of September&#160;30, 2020.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal or research and development expenses as of December&#160;31, 2019.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license and other economics rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis in April 2013 and April 2015, CorMatrix in May 2016, Palvella in December 2018, and Dianomi in January 2019. Commercial license rights acquired are accounted for as financial assets and other economic rights are accounted for as funded research and developments as further discussed below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In May 2017, we entered into a Royalty Agreement with Aziyo pursuant to which we will receive royalties from certain marketed products that Aziyo acquired from CorMatrix. We account for the Aziyo commercial license right as a financial asset, and in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we amortize the commercial license right using the effective interest method whereby we forecast expected cash flows over the term of the arrangement to arrive at an annualized effective interest. The annual effective interest associated with the forecasted cash flows from the Royalty Agreement with Aziyo as of September&#160;30, 2020 is 23%. Revenue is calculated by multiplying the carrying value of the commercial license right by the effective interest. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2018, we entered into a development funding and royalties agreement with Palvella. Pursuant to the agreement, we may receive up to $8.0 million of milestone payments upon the achievement by Palvella of certain corporate, financing and regulatory milestones for PTX-022, a product candidate being developed to treat pachyonychia congentia. In addition to the milestone payments, Palvella will pay us tiered royalties from 5.0% to 9.8% based on any aggregate annual worldwide net sales of any PTX-022 products, subject to Palvella&#8217;s right to reduce the royalty rates by making payments in certain circumstances. We paid Palvella an upfront payment of $10.0 million, which Palvella is required to use to fund the development of PTX-022. We are not obligated to provide additional funding to Palvella for the development or commercialization of PTX-022. We determined the economic rights related to Palvella should be characterized as a funded research and development arrangement, thus we account for it in accordance with ASC 730-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Research and Development Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and reduce our asset as the funds are expended by Palvella. As of September&#160;30, 2020, the fund has been fully expended by Palvella and our cost basis for the asset has been reduced to zero, we will recognize milestones and royalties as revenue when earned. During the second quarter of 2020, we recorded a $3.0&#160;million milestone from Palvella under contract revenue, which has been included in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We recorded a $5.5 million pre-tax reserve for credit losses upon adoption of the new credit losses on January 1, 2020. We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the nine months ended September&#160;30, 2020, we further considered the current and expected future economic and market conditions surrounding novel coronavirus (COVID-19) pandemic and recorded an additional $0.5 million reserve for credit losses in other expense, net, in our condensed consolidated statement of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See further detail described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, of Notes to Consolidated Financial Statements in our 2019 Annual Report.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Assets</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol manufacturing ramp up fee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investment receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (loss) Per Share</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2020, all of the 0.70 million and 0.65 million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2019, all of the 0.70 million weighted average shares of outstanding equity awards as of September&#160;30, 2019 were anti-dilutive due to the net loss for the period</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4 - Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6 - Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"/><td style="width:45.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,549&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,330&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,694&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198429695800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">936,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">939,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">338,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">936,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the first quarter of 2020, we paid a $1.8&#160;million contingent liability on development milestones to former Crystal shareholders. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the third quarter of 2020, we paid a $0.5&#160;million contingent liability based on revenue milestones to Icagen.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div>There were no triggering events identified and no indication of impairment of our goodwill, indefinite-lived intangible assets, or long-lived assets during the three and nine months ended September&#160;30, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198429737560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Taurus Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 9, 2020, we acquired Taurus, which discovers and develops novel antibodies from immunized cows and cow-derived libraries. The purchase price of $5.1 million included $4.6 million in cash, and a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021.  We also issued nontransferable CVRs for up to $4.5 million tied to partnered and internal research and development and for up to $25.0 million as a 25% share of post-clinical Taurus product revenues (including milestone payments) received by us. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of Taurus met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $5.1 million consideration transferred, we recognized (1) $0.05 million of tangible assets acquired, and (2) $5.0 million of core completed technology intangibles acquired. The core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. We account for the CVRs in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the CVRs are recognized as of the acquisition date. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">xCella Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 8, 2020, we acquired xCella, an antibody discovery company. We paid $7.1 million in cash (including a $0.5 million holdback to satisfy indemnification obligations which will be settled by September 2021), and issued earnout rights for up to $5.0 million tied to our use of the xCella technology for partnered research and development and for up to $25.75 million as a 25% share of any future milestone payments we received under a certain existing xCella partner arrangement. We evaluated this acquisition in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, to discern whether the assets and operations of xCella met the definition of a business. We concluded that substantially all of the fair value of the gross assets acquired is concentrated in the acquired core technology. Accordingly, we accounted for this transaction as an asset acquisition. Of the $7.1 million consideration transferred, we recognized (1) $0.2 million of tangible assets acquired, (2) $(0.1) million of liabilities assumed, (3) $7.8 million of core completed technology acquired, and (4) $(0.8) million of deferred tax liability. The core technology is being amortized on a straight-line basis over the estimated useful life of 15 years. We account for the earnout rights in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, when the contingency is resolved and the liability becomes payable. None of the earnout rights are recognized as of the acquisition date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Icagen Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 1, 2020, we acquired the core assets, including its partnered programs and ion channel technology from Icagen and certain of its affiliates. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $19.9 million included $15.1 million cash consideration paid upon acquisition, and a contingent earn-out payment of up to $25.0&#160;million of cash payments based on certain revenue milestones with an estimated fair value of $4.8 million. The fair value of the earn-out liability was determined using a probability weighted income approach incorporating the estimated future cash flows from expected future milestones. These cash flows were then discounted to present value using a discount rate based on the market participants' cost of debt reflective of Icagen. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 2, Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, for </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">further discussion. The liability will be periodically assessed based on events and circumstances related to the underlying milestones, and any change in fair value will be recorded in our consolidated statements of operations. The carrying amount of the liability may fluctuate significantly and actual amount paid may be materially different than the carrying amount of the liability. There was no change in the fair value of the continent liabilities during the second quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Icagen have been included in our results of operations since the date of acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preliminary allocation of the purchase price consisted of (1) $1.8 million of fair value of tangible assets acquired, (2) $(0.8) million of liabilities assumed, (3) $12.8 million of acquired intangibles, (4) $(3.7) million of deferred revenue in connection with assumed performance obligations under a collaboration agreement, (5) $0.8 million of deferred tax asset associated with the deferred revenue, and (6) $9.0 million of goodwill, the majority of which is deductible for tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acquired intangibles include $11.1 million of customer relationships and $1.7 million of core technology. The fair values of the customer relationships were based on a discounted cash flow analysis incorporating the estimated future cash flows from these relationships during the contractual term. These cash flows were then discounted to present value using a discount rate of 17%. The fair value of the customer relationships is being amortized on a straight-line basis over the weighted average estimated useful life of 9.6 years The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 17%. The fair value of the core technology is being amortized on a straight-line basis over the estimated useful life of 10 years. The total acquired intangibles are being amortized on a straight-line basis over the estimated useful life of 9.7 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The estimated fair values of assets acquired and liabilities assumed, including deferred tax assets and liabilities, and purchased intangibles are provisional. The accounting for these amounts falls within the measurement period and therefore we may adjust these provisional amounts to reflect new information obtained about facts and circumstances that existed as of the acquisition date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Ab Initio Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 23, 2019, we acquired privately-held Ab Initio Biotherapeutics, Inc., an antigen-discovery company located in South San Francisco, California. The acquisition was accounted for as a business combination and we applied the acquisition method of accounting. Accordingly, we recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. We did not incur any material acquisition related costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The purchase price of $12.0 million included $11.86 million cash consideration paid upon acquisition, net of cash acquired, and $0.15 million cash holdback for potential indemnification claims, which was paid during the third quarter of 2020. As the acquisition is not considered significant, pro forma information has not been provided. The results of Ab Initio have been included in our results of operations since the date of acquisition. </span></div>The allocation of the purchase price consisted of (1) $0.03 million of fair value of tangible assets acquired, (2) $(0.08)&#160;million of liabilities assumed, (3) $7.40&#160;million of acquired technologies, (4) $(0.15)&#160;million of deferred tax liability in connection with the acquired intangibles, and (5) $4.81&#160;million of goodwill, none of which is deductible for tax purposes. The fair value of the core technology was based on the discounted cash flow method that estimated the present value of the potential royalties, milestones, and collaboration revenue streams derived from the licensing of the related technologies. These projected cash flows were discounted to present value using a discount rate of 12%. The fair value of the core technology is being amortized on a straight-line basis over the weighted average estimated useful life of the approximately 20 years.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198429690184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. As of September&#160;30, 2020, the &#8220;if-converted value&#8221; did not exceed the principal amount of the 2023 Notes. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees. The portion of these costs allocated to the liability component totaling $13.7 million is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we repurchased $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted (1) a gain of $0.7&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September&#160;30, 2020; (2) a $32.7 million reduction in debt discount, and (3) a $2.7&#160;million reduction to additional paid in capital, net of tax, related to the reacquisition of the equity component in our condensed consolidated balance sheet as of September&#160;30, 2020. After the repurchases, approximately $515.6&#160;million in principal amount of the 2023 Notes remain outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, in connection with the repurchases of $234.4&#160;million in principal of the 2023 Notes for $203.8&#160;million in cash, including accrued interest of $0.6&#160;million, during the quarter ended March 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">515,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198449628584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2020 was 42.3% and 37.1%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2020 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory rates than the U.S. and tax deductions related to stock award activities offset by tax deductions related to foreign derived intangible income tax credits. The effective tax rate for the three and nine months ended September&#160;30, 2019 was 23.2% and 20.9%, respectively. The variances from the U.S. federal statutory tax rate of 21% for the three months ended September&#160;30, 2019 were primarily attributable to the mix of earnings in the jurisdictions with lower statutory tax rates than the U.S..<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431044744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of Notes to Consolidated Financial Statements in our 2019 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"/><td style="width:40.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,053)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,313,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, outstanding options to purchase 1.6 million shares were exercisable with a weighted average exercise price per share of $72.60.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2020, 56,079 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, we repurchased $73.3 million of our common stock under our stock repurchase programs as discussed below. We did not have any share repurchases during the second and third quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market </span></div>repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. Authorization to repurchase $253.5 million of our common stock remained available as of September&#160;30, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198465536840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 9, 2019, CyDex received a Paragraph IV certification Notice Letter from Alembic Global Holdings SA (&#8220;Alembic&#8221;) stating that Alembic had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&#174; prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or U.S. Patent No. 10,040,872 (&#8220;the &#8217;872 patent&#8221;), and alleging that these patents, each of which relates to Captisol&#174;, are invalid, unenforceable, and/or would not be infringed by Alembic&#8217;s ANDA product. On May 23, 2019, CyDex filed a complaint against Alembic, Alembic Pharmaceuticals, Ltd., and Alembic Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware, asserting that the filing of Alembic&#8217;s ANDA constitutes infringement of each of the &#8217;088 patent and the &#8217;582 patent. On July 29, 2019, Alembic filed an answer and counterclaims seeking declarations of non-infringement and invalidity as to each of the asserted patents and, on August 19, 2019, CyDex filed an answer to Alembic&#8217;s counterclaims. On April 7, 2020, the Court ordered that the Scheduling Order be amended such that, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter alia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the fact discovery cut off was set for November 2, 2020, the close of expect discovery was set for March 22, 2021, and that May 17, 2021 would remain the first day of a five-to-six-day bench trial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 16, 2019, CyDex received a Paragraph IV certification Notice Letter from Lupin Ltd. (&#8220;Lupin&#8221;) stating that Lupin had submitted an ANDA to the FDA, seeking approval to manufacture, offer to sell, and sell a generic version of EVOMELA&#174; prior to the expiration of any of the &#8217;077 patent; the &#8217;088 patent, the &#8217;582 patent, or the &#8217;872 patent, and alleging that these patents, each of which relates to Captisol&#174;, are invalid, unenforceable, and/or would not be infringed by Lupin&#8217;s ANDA product. CyDex filed a complaint on October 29, 2019, alleging patent infringement against Lupin. Lupin filed an answer on December 11, 2019 and counterclaimed for declaratory judgments of invalidity and non-infringement as to all four patents and CyDex filed its answer to Lupin&#8217;s counterclaims on January 2, 2020. Fact discovery is ongoing. The Court&#8217;s scheduling order sets close of discovery on May 7, 2021 and a five day bench trial starting on December 13, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the US District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198429790056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMTU4_6e2e7d5b-569a-4112-af29-1a3087e4b64c">seven</span> years, some of which include options to extend the leases for up to <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl81OC9mcmFnOjFjMjM2OGRlZGEyMzQ0OTZhYTI5YjEwNTU4YmY2YTE4L3RleHRyZWdpb246MWMyMzY4ZGVkYTIzNDQ5NmFhMjliMTA1NThiZjZhMThfMjI5_55733a26-80e9-4395-8c9c-5fd85e05d7b3">seven</span> years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. For leases with a term of 12 months or less, we elected to not recognize lease assets and lease liabilities and expense the leases over a straight-line basis for the term of those leases.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431255272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Assets Held for Sale</a></td>
<td class="text">Assets Held for Sale<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 10 - Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, we entered into an agreement to divest Vernalis (R&amp;D) Limited in October 2020. As a result of meeting the criteria to classify the disposal group as held for sale under generally accepted accounting principles, Vernalis (R&amp;D) Limited was classified as held for sale as of September&#160;30, 2020. Assets classified as held for sale are recorded at the lower of their carrying amount or fair value less costs to sell and are not depreciated or amortized. Classification of our disposal group held for sale occurs when sufficient authority to sell the disposal group has been obtained, the disposal group is available for immediate sale and its sale is probable within one year. If at any time these criteria are no longer met, the disposal group would be reclassified as held and used. We evaluate the held for sale classification during each reporting period. The disposal group did not meet the requirements for presentation as discontinued operations and are included in income from continuing operations for the three and nine months ended September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any assets held for sale as of December&#160;31, 2019. The following table presents the carrying amounts of major classes of assets and liabilities related to assets held for sale with respect to the Vernalis (R&amp;D) Limited divestiture as of September&#160;30, 2020.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:75.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities related to assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431852104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Events<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfenex Acquisition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, we completed the acquisition of Pfenex for $437.5&#160;million in cash, plus one non-transferable CVR per share representing the right to receive an aggregate contingent payment of $78&#160;million in cash if a certain specified milestone is achieved. The acquisition was funded using cash on hand. We are currently evaluating the accounting impact of this transaction and anticipate using ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, but the initial purchase price allocation is not yet complete.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Vernalis Research Operations</span></div>On October 11, 2020, we and our wholly-owned subsidary Vernalis Limited, a company incorporated in England (&#8220;Seller&#8221;), entered into an Agreement for the Sale and Purchase of the Entire Issued Share Capital of Vernalis (R&amp;D) Limited (the &#8220;Purchase and Sale Agreement&#8221;) with HitGen UK Ltd, a company incorporated in England (&#8220;Buyer&#8221;), and HitGen Inc., a company incorporated in China (&#8220;HitGen&#8221;), pursuant to which Ligand and Seller agreed to sell the entire issued share capital of Vernalis (R&amp;D) Limited, a company incorporated in England and a wholly-owned subsidiary of Seller (&#8220;Vernalis&#8221;), which constitutes the sale of the Vernalis business operations including the Vernalis Design Platform.  Under the terms of the Purchase and Sale Agreement, at the closing of the transaction, Buyer will pay $25.0&#160;million in cash, subject to a working capital adjustment. In addition, Buyer will pay to Ligand any net receipts pursuant to completed collaboration licenses and a share of any net receipts pursuant to ongoing research collaboration agreements. The closing is expected to occur in the fourth quarter of 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434240040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2019 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications and Prior Period Immaterial Error</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the second quarter of 2020, we began to include our investment in Viking in &#8220;short-term investments&#8221; in the condensed consolidated balance sheet, and present &#8220;gain (loss) from short-term investments&#8221; in the condensed consolidated statements of operations to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in &#8220;other income, net&#8221;. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and nine months ended September&#160;30, 2019 have been reclassified to conform to the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available for sale debt securities. This standard includes our financial instruments, such as accounts receivable, investments that are generally of high credit quality, and commercial license rights. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. The new guidance requires us to identify, analyze, document and support new methodologies for quantifying expected credit loss estimates for our financial instruments, using information such as historical experience and current economic conditions, plus the use of reasonable supportable forecast information. We adopted <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNTc1M2MzNzkxOTQ4MDdhMjA4MWM0YjVkNGQxM2YyL3NlYzo3YzU3NTNjMzc5MTk0ODA3YTIwODFjNGI1ZDRkMTNmMl8zNC9mcmFnOmE0NzUzOTM4YWUzZDRhMjU5ODljZDFkNzMyZjAzZGUwL3RleHRyZWdpb246YTQ3NTM5MzhhZTNkNGEyNTk4OWNkMWQ3MzJmMDNkZTBfMjc2MDE_c33c1541-3114-4d1b-9629-8b74d41c9f5b">ASU 2016-13</span> on January 1, 2020, using a modified retrospective transition method, which requires a cumulative-effect adjustment, if any, to the opening balance sheet of retained earnings to be recognized on the date of adoption with prior periods not restated. The cumulative-effect adjustment, net of tax, recorded on January 1, 2020, is approximately $5.2 million on our unaudited condensed consolidated balance sheet as of January 1, 2020. Results for periods after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported under previously applicable accounting standards. See additional disclosure on credit losses under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Short-term Investments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Accounts Receivable and Allowance for Credit Losses&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Commercial License and Other Economic Rights&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Test for Goodwill Impairment, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which eliminates the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment. Under the new standard the goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value, although it cannot exceed the total amount of goodwill allocated to that reporting unit. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework&#8212;Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which modifies the disclosure requirements on fair value measurements. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In November 2018, the FASB issued ASU 2018-18, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements: Clarifying the Interaction between Topic 808 and Topic 606 (Topic 808)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new standard clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under Topic 606,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when the counterparty is a customer for a good or service that is a distinct unit of account. The amendments also preclude entities from presenting consideration from transactions with a collaborator that is not a customer together with revenue recognized from contracts with customers. We adopted this standard on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. Depending on the amendment, adoption may be applied on a retrospective, modified retrospective or prospective basis. We adopted this standard on a prospective basis on January 1, 2020, and the adoption did not have a material impact on our condensed consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Not Yet Adopted</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance simplifies accounting for convertible instruments by removing major separation models required under current GAAP. This standard removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020 and adoption must be as of the beginning of the Company&#8217;s annual fiscal year. We are currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on our condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we own. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a sales-based royalty to be recorded when the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues are adjusted for in the period in which they become known, typically the following quarter. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contract revenue includes service revenue, license fees and future contingent milestone based payments. We recognize service revenue for contracted R&amp;D services performed for our customers over time. We measure our progress using an input method based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time we estimate it will take us to complete the activities, or costs we incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make estimates and use judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include contingent milestone based payments in the estimated transaction price when there is a basis to reasonably estimate the amount of the payment.  These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone based payment is sales-based, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the&#160;transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development based milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon or after the development milestone or regulatory approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when control of Captisol material is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. We consider a performance obligation satisfied once we have transferred control of the product, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. We have elected to recognize the cost for freight and shipping when or after </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">control over Captisol material has transferred to the customer as an expense in cost of Captisol. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. We use an observable price to determine the stand-alone selling price for separate performance obligations or a cost plus margin approach when one is not available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry a contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three and nine months ended September&#160;30, 2020, the amount recognized as revenue that was previously deferred was $5.8 million and $8.3 million, respectively. During the three and nine months ended September&#160;30, 2019, the amount recognized as revenue that was previously deferred was $1.0 million and $5.0 million, respectively. We expect to satisfy the performance obligations related to long-term deferred revenue within the next 3 years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period until the last tranche vests. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (loss) Per Share</a></td>
<td class="text">Net Income (loss) Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September&#160;30, 2020, all of the 0.70 million and 0.65 million, respectively, weighted average shares of outstanding equity awards as of September&#160;30, 2020 were anti-dilutive due to the net loss for the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2019, all of the 0.70 million weighted average shares of outstanding equity awards as of September&#160;30, 2019 were anti-dilutive due to the net loss for the period</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the applicable conversion price of the respective notes. It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4 - Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6 - Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434184424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.982%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Promacta</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,005&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,931&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,848&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments, excluding investment in Viking, consist of the following at September&#160;30, 2020 and December 31, 2019 (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated fair value</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411,690&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47,943&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">210,552&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,850)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">250,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,624)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">941,174&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">939,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">After five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities in an unrealized loss position (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,018&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.509%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.512%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">242,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59,869)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50,203)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,279)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,929)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,224)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt 2px 36pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(1) Accumulated amortization for complete technology includes immaterial amount of foreign currency translation adjustments for the complete technology acquired from the Vernalis acquisition.<br/></span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license and other economic rights consist of the following (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,644)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8,052</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,196</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Palvella</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,492)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,508</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,820)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,782</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,386</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,464)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,834</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,208)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal or research and development expenses of $21.5 million and credit loss adjustments of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;$6.0 million as of September&#160;30, 2020.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal or research and development expenses as of December&#160;31, 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol manufacturing ramp up fee</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term investment receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total other assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,704&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total accrued liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,752&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,215&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"/><td style="width:45.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.405%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,028&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,549&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,330&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,694&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431270888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297,704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">936,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">939,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295,275&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">338,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">936,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">998,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,935&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,007&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.&#160;Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Investment in warrants, which we received as a result of Viking&#8217;s partial repayment of the Viking note receivable and our purchase of Viking common stock and warrants in April 2016, are classified as level 1 as the fair value is determined using quoted market prices in active markets for the same securities. The change of the fair value is recorded in "Gain (loss) from short-term investments" in our condensed consolidated statement of operations. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Crystal contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on development or regulatory milestones as defined in the merger agreement with Crystal. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the first quarter of 2020, we paid a $1.8&#160;million contingent liability on development milestones to former Crystal shareholders. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the third quarter of 2020, we paid a $0.5&#160;million contingent liability based on revenue milestones to Icagen.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431278424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:68.885%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.542%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">515,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying value of equity component of the 2023 Notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431121448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"/><td style="width:40.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,053)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,313,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.929%"><tr><td style="width:1.0%"/><td style="width:40.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.929%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,306&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,053)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,313,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431300344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Assets Held for Sale (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale</a></td>
<td class="text">The following table presents the carrying amounts of major classes of assets and liabilities related to assets held for sale with respect to the Vernalis (R&amp;D) Limited divestiture as of September&#160;30, 2020.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:75.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.019%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities related to assets held for sale</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198438259672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>position </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from milestone method revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 8,300,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,910,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Additional allowance for credit losses recorded related to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod', window );">Increase (decrease) to allowance for credit loss during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,549,000<span></span>
</td>
<td class="nump">8,330,000<span></span>
</td>
<td class="nump">8,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction of remaining performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants | Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative-effect adjustment from adoption of ASU 2016-13, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,200,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Viking Therapeutics, Inc. | Common Stock | Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Fair value of equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=lgnd_PalvellaMember', window );">Palvella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from milestone method revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements | Aziyo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent', window );">Effective interest rate for forecasted cash flows (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Up-front payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,298,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights | Palvella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset</a></td>
<td class="nump">$ 8,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Up-front payment</a></td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Royalty Agreements | Palvella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CollaborationArrangementRoyaltyRate', window );">Royalty rate (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Viking Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Outstanding warrants to purchase shares of Viking's common stock (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Royalty Agreements | Palvella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CollaborationArrangementRoyaltyRate', window );">Royalty rate (as a percent)</a></td>
<td class="nump">9.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CollaborationArrangementRoyaltyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement, Royalty Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CollaborationArrangementRoyaltyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights, Increase (Decrease) to Allowance for Credit Loss during Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ForecastedCashFlowsEffectiveInterestRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forecasted Cash Flows, Effective Interest Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ForecastedCashFlowsEffectiveInterestRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-10-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_PalvellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_PalvellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434929912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 41,848<span></span>
</td>
<td class="nump">$ 24,808<span></span>
</td>
<td class="nump">$ 116,429<span></span>
</td>
<td class="nump">$ 93,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,005<span></span>
</td>
<td class="nump">9,767<span></span>
</td>
<td class="nump">22,751<span></span>
</td>
<td class="nump">35,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,923<span></span>
</td>
<td class="nump">7,602<span></span>
</td>
<td class="nump">16,809<span></span>
</td>
<td class="nump">16,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">1,515<span></span>
</td>
<td class="nump">4,577<span></span>
</td>
<td class="nump">3,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">280<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
<td class="nump">1,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_PromactaMember', window );">Promacta</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">23,389<span></span>
</td>
<td class="nump">6,849<span></span>
</td>
<td class="nump">68,966<span></span>
</td>
<td class="nump">24,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,454<span></span>
</td>
<td class="nump">8,192<span></span>
</td>
<td class="nump">24,712<span></span>
</td>
<td class="nump">32,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,341<span></span>
</td>
<td class="nump">4,548<span></span>
</td>
<td class="nump">15,280<span></span>
</td>
<td class="nump">12,990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">3,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">960<span></span>
</td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">4,766<span></span>
</td>
<td class="nump">15,425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 995<span></span>
</td>
<td class="nump">$ 727<span></span>
</td>
<td class="nump">$ 2,873<span></span>
</td>
<td class="nump">$ 1,493<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_PromactaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_PromactaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431957048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLossAbstract', window );"><strong>Equity Securities, FV-NI [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">$ 6,581<span></span>
</td>
<td class="nump">$ 9,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract', window );"><strong>Debt and Equity Securities, FV-NI [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">299,291<span></span>
</td>
<td class="nump">941,174<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">933<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(2,624)<span></span>
</td>
<td class="num">(2,118)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Estimated fair value</a></td>
<td class="nump">297,704<span></span>
</td>
<td class="nump">939,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">68,226<span></span>
</td>
<td class="nump">411,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">68,327<span></span>
</td>
<td class="nump">411,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">27,125<span></span>
</td>
<td class="nump">63,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">27,227<span></span>
</td>
<td class="nump">63,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">47,943<span></span>
</td>
<td class="nump">210,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">48,003<span></span>
</td>
<td class="nump">210,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">4,484<span></span>
</td>
<td class="nump">4,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">415<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(2,624)<span></span>
</td>
<td class="num">(1,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,275<span></span>
</td>
<td class="nump">3,072<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">151,513<span></span>
</td>
<td class="nump">250,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">151,717<span></span>
</td>
<td class="nump">250,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLossAbstract', window );"><strong>Equity Securities, FV-NI [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain', window );">Gross unrealized gains</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Estimated fair value</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available for Sale and Equity Securities, FV-NI, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Accumulated Gross Unrealized Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Accumulated Gross Unrealized Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198450965128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 121,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">21,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost', window );">After five years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">143,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">121,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">21,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue', window );">After five years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 143,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198432835512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">$ (400)<span></span>
</td>
<td class="num">$ (19,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(400)<span></span>
</td>
<td class="num">(19,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">8,018,000<span></span>
</td>
<td class="nump">137,947,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">8,018,000<span></span>
</td>
<td class="nump">137,947,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">5,011,000<span></span>
</td>
<td class="nump">58,584,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">5,011,000<span></span>
</td>
<td class="nump">58,584,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="nump">3,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">$ 3,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,363,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,363,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198441248952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 102,136<span></span>
</td>
<td class="nump">$ 95,229<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">326,718<span></span>
</td>
<td class="nump">305,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">257,317<span></span>
</td>
<td class="nump">242,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(59,869)<span></span>
</td>
<td class="num">(50,203)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,279)<span></span>
</td>
<td class="num">(1,180)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">29,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(14,929)<span></span>
</td>
<td class="num">(13,224)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">38,298<span></span>
</td>
<td class="nump">38,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(21,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Commercial license rights | Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">$ 10,602<span></span>
</td>
<td class="nump">$ 10,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434715448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 38,298<span></span>
</td>
<td class="nump">$ 38,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(27,464)<span></span>
</td>
<td class="num">(18,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,834<span></span>
</td>
<td class="nump">20,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="num">(21,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="num">(6,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,644)<span></span>
</td>
<td class="num">(5,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,052<span></span>
</td>
<td class="nump">12,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Palvella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="num">(7,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(7,820)<span></span>
</td>
<td class="num">(5,216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,782<span></span>
</td>
<td class="nump">$ 5,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_PalvellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_PalvellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198451847272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_RampUpFeeAssetNoncurrent', window );">Captisol manufacturing ramp up fee</a></td>
<td class="nump">$ 9,215<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAndReceivablesNet', window );">Long-term investment receivable</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity investment</a></td>
<td class="nump">813<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">$ 13,704<span></span>
</td>
<td class="nump">$ 2,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RampUpFeeAssetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ramp-up Fee Asset, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RampUpFeeAssetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAndReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAndReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198433658840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 4,840<span></span>
</td>
<td class="nump">$ 1,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">1,226<span></span>
</td>
<td class="nump">1,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">3,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">1,437<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,919<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 14,498<span></span>
</td>
<td class="nump">$ 9,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198433474872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 7,740<span></span>
</td>
<td class="nump">$ 6,297<span></span>
</td>
<td class="nump">$ 20,752<span></span>
</td>
<td class="nump">$ 18,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">3,094<span></span>
</td>
<td class="nump">2,481<span></span>
</td>
<td class="nump">8,510<span></span>
</td>
<td class="nump">7,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 4,646<span></span>
</td>
<td class="nump">$ 3,816<span></span>
</td>
<td class="nump">$ 12,242<span></span>
</td>
<td class="nump">$ 11,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198450964376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198432905512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Summary of computation of basic and diluted net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding (shares)</a></td>
<td class="nump">16,082,000<span></span>
</td>
<td class="nump">18,770,000<span></span>
</td>
<td class="nump">16,222,000<span></span>
</td>
<td class="nump">19,586,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Restricted stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">728,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (shares)</a></td>
<td class="nump">16,082,000<span></span>
</td>
<td class="nump">18,770,000<span></span>
</td>
<td class="nump">16,222,000<span></span>
</td>
<td class="nump">20,349,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)</a></td>
<td class="nump">7,028,000<span></span>
</td>
<td class="nump">11,549,000<span></span>
</td>
<td class="nump">8,330,000<span></span>
</td>
<td class="nump">8,694,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198360642040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities at Fair Value (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingentValueRight </div>
<div>contingentValueRightSeries</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShortTermInvestmentsFairValueDisclosure', window );">Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 939,989,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,869,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,425,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,910,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998,324,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,869,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,017,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities', window );">Repayments of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingentValueRightSeries</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingentValueRight</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingentValueRight</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember', window );">Crystal contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,659,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember', window );">CyDex contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember', window );">Metabasis contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,935,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember', window );">Icagen contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment for contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShortTermInvestmentsFairValueDisclosure', window );">Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,274,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,073,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,869,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,425,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,910,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,408,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Crystal contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | CyDex contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Metabasis contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Icagen contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShortTermInvestmentsFairValueDisclosure', window );">Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,791,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,791,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,935,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Crystal contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | CyDex contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Metabasis contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,935,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Icagen contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShortTermInvestmentsFairValueDisclosure', window );">Short-term investments, excluding Viking</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investment in warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,007,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Crystal contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,659,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | CyDex contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Metabasis contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Icagen contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ContingentLiabilitiesFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ContingentLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Liabilities, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ContingentLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders and Other Contingency Payments, Investing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShortTermInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-Term Investments, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShortTermInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198437206920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 09, 2020</div></th>
<th class="th"><div>Sep. 08, 2020</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Jul. 23, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,857,000<span></span>
</td>
<td class="nump">$ 11,840,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="nump">50,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right for Internal Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Contingent Value Right on Product Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember', window );">Taurus | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationConsiderationTransferredHoldback', window );">Holdback from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Milestone Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues', window );">Proportion of milestone payments (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Fair value of contingent earn-out payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred tax assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_AbInitioBiotherapeuticsIncMember', window );">Ab Initio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,000.00)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability acquired in connection with the acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,810,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate', window );">Cash holdback for potential indemnification claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_AbInitioBiotherapeuticsIncMember', window );">Ab Initio | Core Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average estimated useful life of finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate', window );">Discount rate used to value intangible assets acquired (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationConsiderationTransferredHoldback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationConsiderationTransferredHoldback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_TaurusBiosciencesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_ContingentValueRightOnProductRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_AbInitioBiotherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_AbInitioBiotherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198437936968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 659,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">$ 2,745,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 234,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 234,400,000<span></span>
</td>
<td class="nump">515,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="nump">203,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Increase (decrease) in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to additional paid in capital, equity component of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrant derivative in connection with Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434006280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 515,560,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(60,587,000)<span></span>
</td>
<td class="num">(111,041,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">454,973,000<span></span>
</td>
<td class="nump">638,959,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying value of equity component of the 2023 Notes</a></td>
<td class="nump">55,339,000<span></span>
</td>
<td class="nump">101,422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 464,958,000<span></span>
</td>
<td class="nump">$ 647,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198451846872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">42.30%<span></span>
</td>
<td class="nump">23.20%<span></span>
</td>
<td class="nump">37.10%<span></span>
</td>
<td class="nump">20.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198437955272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares) | shares</a></td>
<td class="nump">1,956,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares) | shares</a></td>
<td class="nump">480,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="num">(113,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(10,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares) | shares</a></td>
<td class="nump">2,313,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 77.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">90.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (USD per share) | $ / shares</a></td>
<td class="nump">23.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">72.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 82.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares) | shares</a></td>
<td class="nump">147,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">104,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(50,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares) | shares</a></td>
<td class="nump">201,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 125.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">89.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (USD per share) | $ / shares</a></td>
<td class="nump">122.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 107.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431900760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 73,287,000<span></span>
</td>
<td class="nump">$ 181,188,000<span></span>
</td>
<td class="nump">$ 33,717,000<span></span>
</td>
<td class="nump">$ 151,585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198433756376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civilComplaint</div>
</th>
<th class="th">
<div>Oct. 29, 2019 </div>
<div>patent</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember', window );">Lupin Patent Infringement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber', window );">Number of patents allegedly infringed upon | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity | civilComplaint</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of entity's patents that another entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_LupinPatentInfringementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198431143928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198451850184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Assets Held for Sale - Summary (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable, net</a></td>
<td class="nump">$ 2,581,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">2,871,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property and equipment, net</a></td>
<td class="nump">2,445,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">5,246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Total assets held for sale</a></td>
<td class="nump">13,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">463,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">1,697,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,464,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">5,084,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">653,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Total liabilities related to assets held for sale</a></td>
<td class="nump">$ 10,361,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121558832&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140198434449672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 11, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,857<span></span>
</td>
<td class="nump">$ 11,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Vernalis | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ExpectedProceedsFromDivestitureOfBusinesses', window );">Expected proceeds from divestiture of business</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Pfenex Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ExpectedProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected Proceeds from Divestiture of Businesses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ExpectedProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=lgnd_VernalisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=lgnd_VernalisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>60
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MCQYMW0:!>]##&GK8'+I!XPX/.*(>'4:'P,<"!W'[)'!$_QTFM#ERTRZN/!N
M'XT\2A[NG(CN=>0+TRLN#1&P1"EM]=%#ER=\.;&J\(?D0ED\<OTPP[<BT"X
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M("6B$5.N\3,LCOPT?DA]BVQ*]@M<9$@9^5GY !(7 2SLT+@MM$_D A9=*A>
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MG[1#OU<6P8&M>F\6P0W+\\&%_<=F$>T5.F?U'5D$ '5D$0 2RB*XK39<600
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M735\:Q]^D9-#0I^O;*O>_!L]3+;Q653N^J&MIX-!0:V:\?_B<0K$T0%P'OP
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M:&5E=#@N>&ULS7U;D]M&DNY?06CE674$F@+!NRPKHM6R/=IC6PJW;)V-C7T
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M%45+PWY5^[)J!L%;'%FV.]U<D%0*(%G\9(3@K$CII*$7@!1 8T8WVZ0A.7L
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MY'_I; SA6UEP<CI&$EIMWFOR#(+7:I6TCC:Y[(4)S&I_7L[5U+GZ&Z/X6.C
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MYFQ[V7^)_?CQG+QTPO(%[M-&J B8AS,2M?0NCNG=(IR0=_;&4+7[^:X.?;^
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M0#J+I@P?Y"P0N%50S.EO"#R^!\ 8;PGP$9 7D5N[(#H"*^7JQU\!E< ?DA(
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MF79G2KA6S,]^$+Z0CAU76Q^.,B0(S#1MV&MG\R8+D'&GJ@8Q>AI=JJL5':4
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M$D5/ :UXFG$+O.$APR1"6 /E!TPYG&$V?$13EJ49F,V\ R"'PA[GD'#G?*Q
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M9Z?)</K'"=DN-IC"$K>K.&SX^X N.+"]LI:.DY!@_.*L?@!02P,$%     @
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M(AV2=J--Y\ADDA%Z2AD*/# K-0#[:CU-X%!!F;U)#0X;>X^70A*);\!*5S,
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M/4H&L,@NI+7$&0[K[#Y PPP4UW]Q]IF?#/39A8JI&F_"TYEME ?T(:9ZK8>
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M4(PS1?-6:?'=HM#@HKX:.+HR&$_T-F^2K3WD=GJ8['G[SYR%=%OE7O_N?L0
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M\L(X)5MTHKV"SE0A)V,@%L.(H(+\*",.8X_HQH![>>ZS=]C>=)*]EA!1$&<
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M^ @X(]S&6\@\!7\0$]X(1"OKB$$%K\L?MD:<][RUPX>T"7%'= 7U( #^8Y+
M'(ETZTY.0#J+I@P#<A8(/"HHYO0W!!Y?[C''1P)\!.1%Y%8NB([ 2KCZ\2B@
M$MV&+0-PH=C-%'%%"_8[V5);K9YX#M165N:PCP1[',1^,IU>K0(E[(780>&=
M_QM 9!.< -8.HC8@RR431W:=6$L-79"RV9;.@W"-KD!^GI'<NC<J[42A\%]F
M58)&"O6ETZ#!O,_[QZ=(SQ4XX19,UC<#3@$6A/FTN!/R;*&ZJ99JY!JW'MPD
M^7]#7#2#Y'"9_0>^"<W+0BDJ"S[<5<+UI;D6[,#JX=?A+)[WZR>C'RQ-);'^
M7 =*GS]>_/C#?'SU"MJ90KL:4TO#';W,0F.*CJCD5C:%-;G"=/FLMR@\H0&!
M.?#(M8Q$NG69+M&8\^BWVT^_A"[[[Q>W[^[[XO?6K!0MKC'!'K8W2FU48_(Z
MQUCEJJ3?LQ'N4@U"@4S';%$70HDY-1.0E13K5AJLH +2-QEKMC(+;6_1L<(2
MO;D-V>4ZFA,\QBWOIM7A&-,%T$LV ";%!VYK1NA0L$(7%4^!TQ>30X7Z],7W
M?U>GF])D*?,AVLGJ'*XF;0>WY\F@TO^+]']3I/U:V_1DD8[[D]-%NG7I 5?"
MH+5W#GV2O>Q\]>8&C+[MT^<>0%KX -[.MO\^N U?S7?;P_\>WDN+VR7UY4L<
MC?O324_8\#T_#+PI^1OZPGAO<GY=*PF@H U87QID9#T@!NT_56[^!%!+ P04
M    " !V@6913J_R1A\#  !N!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q]5=MNVS ,_17"V$,#>/4]ER()T*8K-F ;BK;;'H8]*#:3"),E3Y*3
M=5\_2G;=;&CSDE 4>7A(BO3\H/1/LT.T\+L6TBR"G;7-1129<H<U,^>J04DW
M&Z5K9NFHMY%I-++*.]4B2N-X'-6,RV Y][I;O9RKU@HN\5:#:>N:Z<<K%.JP
M")+@27''MSOK%-%RWK MWJ/]TMQJ.D4#2L5KE(8K"1HWB^ RN;C*G;TW^,KQ
M8(YD<)FLE?KI#A^J11 [0BBPM Z!T=\>5RB$ R(:OWK,8 CI'(_E)_0;GSOE
MLF8&5TI\XY7=+8)I !5N6"OLG3J\QSZ?PN&52AC_"X?.=D(1R]985??.=*ZY
M[/[9[[X.1P[3^!6'M'=(/>\ND&=YS2Q;SK4Z@';6A.8$GZKW)G)<NJ;<6TVW
MG/SL<J7D'K7E:X%PCY(K#9^510-G#XQT9C2/+(5QQE'90UYUD.DKD#/XI*3=
M&7@G*ZS^]8^(WL Q?>)XE9X$O,?F'+(XA#1.XQ-XV9!SYO&R5_"N<6WAFIM2
M*--JA.^7:V,UO8\?)\#S 3SWX/EK9&ELJI:JJ3:P8EH_<KF%KTRT5%,F*UBI
MMJ'7>,=<D4FXX9+)TAE=:LWD%NG%6_-2U4_&=<-[81I6XB*@Z32H]Q@L'W8(
M&R5H\EP ZSK:CQ__0^&Y[*;:C\>:1A8L.5"5LZ='P"6I5&N(N1E=T MI+-9K
MU$,[X!K+7I,X33*#6\TIH88)8+5JI765^ ^70AE+F([5&RB2(BS&,4F3(@[C
M.(8ODESI5?[!"BIJE(<A,J5HO4][?.^ZR8UIJ8P(I3)V!&?C."RF$Q*2) GC
M/!G!@[+$2"BY?6M1U] X?\J;R$G/J6&/OCYO("_R<#;)2!IGTW!6S)X;N7>-
M=#[XJ^7VD<+5U$U\,4E*K BS;$9"$B=AGJ9PP[A^QCA1E+./N$<!Z<C1&1.=
M8NKHY),PG<;PTC.-CG9 C7KK-YT!7[IN'0S:89E>=CODV;S;Q)^8WG)I0."&
M7./S21& [K9;=["J\1MEK2SM)R_NZ(. VAG0_4910OW!!1@^,<N_4$L#!!0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;)55VV[C-A#]E8$0%+N
M$LF2[&13VX"3M-T"&VR0I-N'H@^T-+;8Y45+4O'Z[SND+G8+)VA?;)&<.7/.
M<&8XWVGSU=:(#KY+H>PBJIUKKI/$EC5*9B]T@XI.-MI(YFAIMHEM#+(J.$F1
M9&DZ2R3C*EK.P]Z#6<YUZP17^&# ME(RL[]!H7>+:!(-&X]\6SN_D2SG#=OB
M$[K?F@=#JV1$J;A$9;E68'"SB%:3ZYO"VP>#+QQW]N@;O)*UUE_]XM=J$:6>
M$ HLG4=@]/>"MRB$!R(:WWK,: SI'8^_!_2?@W;2LF86;[7XG5>N7D17$52X
M8:UPCWKW$7L]4X]7:F'#+^QZVS2"LK5.R]Z9&$BNNG_VO<_#?W'(>H<L\.X"
M!99WS+'EW.@=&&]-:/XC2 W>1(XK?RE/SM I)S^W7%F+SL)'%!70%<,3$PCO
MGME:H'T_3QR%\(9)V</=='#9*W ?X%XK5UOX2558_=,_(6HCOVS@=Y.]"?B$
MS07D:0Q9FJ5OX.6CWCS@Y:_@W7%;$D.N6JS@<X.&^>*PP%0%=-9HRP3\8G3;
M6/ACM;;.4-W\^4;@8@Q<A,#%:T*HG:J6DJLW<,N,V7.UA974K:+TT]X]^XO2
M?RL874C8Z&_&$_O$V9H+[CB=/*)@CK@[#:?N[M25O4G,=_VU;5B)BXC:VJ)Y
MP6CY7"-!"FI93]/Y<H!PZMDZ.BP'">P@008)Y4$".T@01Q+,04)O40\2K"^_
M'7<U&=F&.M<;^7A?T"@FN(5WCS\PV?QX]YZR(KF'J:BMK>.N-4AX/BX5C4.Y
M1C-6SL6)O3Y_U[ JRTZ#P1+YBQ<;@Z*!> 99/+V:P&=B0,):8TC_P#F+KRXG
M\&!H/AJW#R+Q6\L;FEBN<\_BHI@.14:I$DCC XR?$^=Z<]Y:'+"F<5;,X%D[
M*KZ3*3F#21Y/BORX%(Z(-VP?KN@,BEGNMXTO[^.<3^+9ATNXPPV2B(J4OB"U
M@*<X*^"35MMSAT:"_A?9 6)/%-.KHL^$&.V/0\RF>2_A_UPV*4OC?#:!4SV6
M' TVB68;QK>%H+J;<>/N^$*LNL%X,.^>EWMFMIP:7>"&7-.+RVG47<6P<+H)
M8W*M'0W=\%G3*X?&&]#Y1FLW+'R \=U<_@U02P,$%     @ =H%F4?A(/EY3
M"   ;R<  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&ULQ5IM;^,V$OXK
MA-'BLD <6V^.%20!$B?>NKAT@[C9?BCZ@9%H6[>2J)*4DQ3WXSN49%&V:%H7
M='T+;&Q+,\-Y?69(Z?*5LF]\18A ;TF<\JO>2HCL8C#@P8HDF)_1C*1P9T%9
M@@7\9,L!SQC!8<&4Q -[.!P-$AREO>O+XMHCN[ZDN8BCE#PRQ/,DP>S]EL3T
M]:IG]387GJ+E2L@+@^O+#"_)G(CG[)'!KT$M)8P2DO*(IHB1Q57OQKJ8>9YD
M*"B^1N25-[XC:<H+I=_DCUEXU1M*C4A, B%%8/A8DPF)8RD)]/BS$MJKUY2,
MS>\;Z=/">##F!7,RH?%O42A65[UQ#X5D@?-8/-'7GTAE4*%@0&->_$6O%>VP
MAX*<"YI4S*!!$J7E)WZK'-%@L*T]#';%8.\PN-X>!J=B<+JNX%8,[B[#^1X&
MKV+P=E4:[6$850RCKBN<5PSG76T85PSCK@Q^Q> 7Z5#&KPC^'1;X^I+15\0D
M-4B37XH,*K@AYE$JDWTN&-R-@$]<WV(><407Z)$13E*!RQ1,0S0OTU_>FT?+
M-%I$ 4X%N@D"FJ<B2I?HD<91$!&.^N@7S!B6:8M.[HC 4<P_70X$Z"=7&025
M+K>E+O8>72ST0%.QXN@^#4FHX9^8^9U#_%,SOV_@'X!?:^?:&^?>VD:!=R0X
M0XYUBNRA-7Z>WZ&3'W1NF9BES$D&4H92BCVLI&241S)2/Z !XBL,L2O_:J3?
MF:7_G*<MZ1HI]YUUM/Q*REZ-IM_5WL__H*8_'? =!M\-K4.^FW7/$E\K92OY
MG+JRG4*LLT?L(X..R,3[*7J,9>'*FK[_,X\R:%4"_?YO($<S01+^AV$QMU[,
M+19S]RS60(6Y@)4P"SEZSD(LB"X!S,)RWE]BG%THH;7,4B0X:F0Y#R1Y(<R@
MO%<K[QG7>R)KDN8$>G=  >C^(B%:,)H W,8$ !C\E!"QHB$0%(2Z$BY7&!4K
MR %C?>V-A_+?Y6#=+*,VG374T$W;=&-'0_=9L^Z.O"V7C&J7C(PNF>*(H36.
MP2N _P321KPC3H*<01EJ2V4R:FDR\L96V[*.=+,VG>];^RT[KRT[-UKV2RZS
M1EJUP12.(MGQ4)["M!@7X8\IY_5]]-_ZJ\[N<CFOH:>]8[&)8LN&<6W#V&C#
MA)$P$H66T'T9B:$F0B0HPFMHO?@E)GT8@_L<QP0&OQ=Q('+CEJ=W8V:BV++
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M2 Y4$$81A\7 NG&OIZZC"0;QC<!6U,9(N_+(V).>W"8#R]$[@@QBJ26P^MO
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M4MBE<S^M0UQ4(88=(4;P34F[-["2&68M^*0??]N#]TFN1K/PK-DB["7<8#&
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MH?]0)1W?69!PE*F<K$0NPIC+D 7H"U<Z5?X*L7"!9OQ6"Z--/5^[D1C>X?Z
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M@7'W#"TT+5Q7Z\*#Q! Q,"3NB\F0:>&KJPXA!I;D)6$Y+;QUD"+$4)+ ##M
MBDQ)71,2* ^&?@2FWR?!KD6@\\]5&D>R;FB_K@>'8#D80A)8$LYX49,QN]-$
MR*.Y+Y.1EJH?A6%Q*K,5\0K%*U[]_H$7:F_@=0TY' .!VP:Z-@S=' =ZW9CK
M^DG+)],0N<"_9#(.N7R*>+,-8&W<WV[54,^&J7?@1"F\U2=L4[XK^V9819;Y
M_ESJB<M"3T =-;2TG?[2:>AGP_0[-)WN'I'F ;L0VQ#0A@GX?)$V;6FA5:39
MAI4VS,IR\+N+--LPT![W-_(&=#8,NJ>+M&GA>6<QAB#F&(@Y,,1>0Z1-6V+
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M<.9&>:3I/EP^[8T")]TH-VZ4*QIL/.I V4H%7.X=G,/B3MBY K>)5"+3:J[
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MZP;J_PUC\N5$#]"^?5G\#U!+ P04    " !V@691!4^^C?$#   3#@  &0
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MH)!N2)'(.[:_I65 KO(7L$3H7[0O;2T#!860+"W!P""-L^,_>2P340/@T06
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M#2FA&\!9 P\<\.,)Y#B0+-?;TS63L-G5MQ&<VBA7!C"_84R>!FK'6YT#9S\
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MZ,OA%K_%0)H%^'XMA#Y,S&W??-W-_P%02P,$%     @ =H%F45$5!O'? @
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M&YZ/OR\?)SOO^!UG!W_L%K]02P,$%     @ =H%F42;ZAZ>U 0  W!L  !,
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MCD'ZZO-1.^V,LE]ZA^O]T';5S<.Q;KG^CK_.^*1_80X!DD."Y$A <MR Y)B
MY+@%R7$'DN,>) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M
M(:M (:M (:M (:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$
M(:M$(:M$(:M$(6N"0M8$A:P)"ED3%+(F*&1-4,B:_"=9W[5>_?7_IG:-:U4V
M1W_6_=2;?P)02P$"% ,4    " !V@691!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ':!9E'ALA+A
M[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( ':!9E&97)PC$ 8  )PG   3              "  <L!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ =H%F4:_<\)-<!0  C!4
M !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( ':!9E%)" G;' <  !H?   8              " @9X-  !X
M;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !V@691V*/=P\\"
M  !S"0  &               @('P%   >&PO=V]R:W-H965T<R]S:&5E=#,N
M>&UL4$L! A0#%     @ =H%F42I+)EG^!@  91\  !@              ("!
M]1<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( ':!9E$O
M)T8O/@,  ,<)   8              " @2D?  !X;"]W;W)K<VAE971S+W-H
M965T-2YX;6Q02P$"% ,4    " !V@691&$)C7%\+   K30  &
M    @(&=(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @
M=H%F4;-1^LNK"0  S2H  !@              ("!,BX  'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+ 0(4 Q0    ( ':!9E&'?)9.A"H  /&%   8
M          " @1,X  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M    " !V@691@]3-3',*  ""'   &               @('-8@  >&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ =H%F4?:PJ&]_"@  3R(
M !D              ("!=FT  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q0
M2P$"% ,4    " !V@691G?4/QPT+  !6'@  &0              @($L>
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( ':!9E'OIXV;
M7 ,  /,(   9              " @7"#  !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL4$L! A0#%     @ =H%F4?#'*SYQ!0  T0L  !D
M ("! X<  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !V
M@6916@AM\90'  "M$P  &0              @(&KC   >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( ':!9E$N"TA4L 0  $4+   9
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M970Q.2YX;6Q02P$"% ,4    " !V@691/RHDVVP)  !@&0  &0
M    @(&7Q0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (
M ':!9E%.K_)&'P,  &X&   9              " @3K/  !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL4$L! A0#%     @ =H%F4:(]EQ,[ P  %PD  !D
M             ("!D-(  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"
M% ,4    " !V@691:2MG95(#  !#!P  &0              @($"U@  >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( ':!9E'X2#Y>4P@
M &\G   9              " @8O9  !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&UL4$L! A0#%     @ =H%F4;?S7+0)!0  RA@  !D              ("!
M%>(  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !V@691
MIJY(TH@%  "R&P  &0              @(%5YP  >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;%!+ 0(4 Q0    ( ':!9E'P. >0O (  -$'   9
M      " @13M  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%
M  @ =H%F4<4X?]%&!   N10  !D              ("!!_   'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !V@691R)>?JO #   9$
M&0              @(&$]   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+
M 0(4 Q0    ( ':!9E$X-..$Z ,  )</   9              " @:OX  !X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ =H%F437KB438
M @  L0<  !D              ("!ROP  'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6Q02P$"% ,4    " !V@691%$^C!$,#  #3"0  &0
M@('9_P  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( ':!
M9E'VQ=T=,P,  (\*   9              " @5,# 0!X;"]W;W)K<VAE971S
M+W-H965T,S,N>&UL4$L! A0#%     @ =H%F433TX",Z P  2PL  !D
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M=#,X+GAM;%!+ 0(4 Q0    ( ':!9E'O/(>C%@,  )<(   9
M  " @6(E 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @
M=H%F44>V+]5= @  UP8  !D              ("!KR@! 'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"% ,4    " !V@691A^'8^RD$  ")$0  &0
M            @(%#*P$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4
M Q0    ( ':!9E$%3[Z-\0,  !,.   9              " @:,O 0!X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ =H%F43=GBHN+ @
M608  !D              ("!RS,! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6Q02P$"% ,4    " !V@691Z/C@=MP!  !+!   &0              @(&-
M-@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( ':!9E&6
M/R^U(0,  .D)   9              " @: X 0!X;"]W;W)K<VAE971S+W-H
M965T-#4N>&UL4$L! A0#%     @ =H%F45$5!O'? @  L0@  !D
M     ("!^#L! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
M" !V@691*.3*$T@"  !J"P  #0              @ $./P$ >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( ':!9E&7BKL<P    !,"   +              "
M 8%! 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ':!9E$7?H&]PP,  /$>   /
M              "  6I" 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !V
M@691_2S5I:X!  #!&P  &@              @ %:1@$ >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !V@691)OJ'I[4!  #<&P  $P
M            @ % 2 $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     -@ V
+ +$.   F2@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>263</ContextCount>
  <ElementCount>411</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2116102 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2119103 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2121104 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2125105 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2127106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2131107 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2133108 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - Assets Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AssetsHeldforSale</Role>
      <ShortName>Assets Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2317302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2322303 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2328304 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2336305 - Disclosure - Assets Held for Sale (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AssetsHeldforSaleTables</Role>
      <ShortName>Assets Held for Sale (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/AssetsHeldforSale</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2414411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2415412 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2418413 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2420414 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2423415 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2424416 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2426417 - Disclosure - Income Tax - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxNarrativeDetails</Role>
      <ShortName>Income Tax - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2429418 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2430419 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2432420 - Disclosure - Commitment and Contingencies: Legal Proceedings - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Assets Held for Sale - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails</Role>
      <ShortName>Assets Held for Sale - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lgnd-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SubsequentEvent</ParentRole>
      <Position>46</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20200930.htm">lgnd-20200930.htm</File>
    <File>exhibit102ligandcydexg.htm</File>
    <File>exhibit25ligand-cvragr.htm</File>
    <File>lgnd-20200930.xsd</File>
    <File>lgnd-20200930_cal.xml</File>
    <File>lgnd-20200930_def.xml</File>
    <File>lgnd-20200930_lab.xml</File>
    <File>lgnd-20200930_pre.xml</File>
    <File>lgnd_93020exhibit311.htm</File>
    <File>lgnd_93020exhibit312.htm</File>
    <File>lgnd_93020exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20200930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20200930.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 263,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20200930_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 548,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 10
   },
   "keyCustom": 51,
   "keyStandard": 360,
   "memberCustom": 36,
   "memberStandard": 37,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ligand.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119103 - Disclosure - Acquisitions",
     "role": "http://www.ligand.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121104 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125105 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127106 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131107 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133108 - Disclosure - Leases",
     "role": "http://www.ligand.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - Assets Held for Sale",
     "role": "http://www.ligand.com/role/AssetsHeldforSale",
     "shortName": "Assets Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - Subsequent Event",
     "role": "http://www.ligand.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322303 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328304 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336305 - Disclosure - Assets Held for Sale (Tables)",
     "role": "http://www.ligand.com/role/AssetsHeldforSaleTables",
     "shortName": "Assets Held for Sale (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i4a8257a98db24ffaa95e5892f684fd01_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities in an Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0ee0d788eb77400190e92faa6bb87523_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License and Other Economic Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0ee0d788eb77400190e92faa6bb87523_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:RampUpFeeAssetNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Other Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:RampUpFeeAssetNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414411 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415412 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:ShortTermInvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418413 - Disclosure - Fair Value Measurements - Assets and Liabilities at Fair Value (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:ShortTermInvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420414 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i2e34c2fcfbd848bc8a11abaa9cd8b79e_D20200909-20200909",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423415 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "ia05bcc7e288f4c2dbd1a0909d128fe6a_I20180531",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "iee3cabb8282246d9b2d4d3044cdde963_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424416 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "iee3cabb8282246d9b2d4d3044cdde963_I20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426417 - Disclosure - Income Tax - Narrative (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxNarrativeDetails",
     "shortName": "Income Tax - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "ib9901cc55d3a41d6a022e1bace11721c_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429418 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "ib9901cc55d3a41d6a022e1bace11721c_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430419 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i8183957e6f4e449b8b14bffaa3391716_I20190911",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "ia89ff6c0983c400999c69d63e6050433_D20191029-20191029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432420 - Disclosure - Commitment and Contingencies: Legal Proceedings - Narrative (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "ia89ff6c0983c400999c69d63e6050433_D20191029-20191029",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainContingencyPatentsAllegedlyInfringedUponNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "patent",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ligand.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Assets Held for Sale - Summary (Details)",
     "role": "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails",
     "shortName": "Assets Held for Sale - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i0dbd91e819fd450fbfa34b2e4ae9dda6_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.ligand.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "ia8fa3962729945ee8b1a302fab16a100_D20201011-20201011",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lgnd:ExpectedProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i976bd4ac4dab4daaa9b66449f1d49eca_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i7a970afb914d41ce990cb1157db7eb2e_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i6e5afa73d23643e3be7e8f54eef93bd5_D20190101-20190331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116102 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20200930.htm",
      "contextRef": "i084c958f709b4a00b5002d47e6069f43_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 74,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AbInitioBiotherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ab Initio Biotherapeutics, Inc.",
        "label": "Ab Initio Biotherapeutics, Inc. [Member]",
        "terseLabel": "Ab Initio"
       }
      }
     },
     "localname": "AbInitioBiotherapeuticsIncMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedLeasePurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Lease Purchases",
        "label": "Accrued Lease Purchases",
        "terseLabel": "Accrued financing lease payment"
       }
      }
     },
     "localname": "AccruedLeasePurchases",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "label": "Adjustments to Additional Paid in Capital, Foreign Currency Translation Adjustment",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization of Other Economic Rights",
        "label": "Amortization of Other Economic Rights",
        "verboseLabel": "Amortization of commercial license and other economic rights"
       }
      }
     },
     "localname": "AmortizationOfOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AziyoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "AziyoMember",
        "terseLabel": "Aziyo"
       }
      }
     },
     "localname": "AziyoMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationConsiderationTransferredHoldback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Holdback",
        "label": "Business Combination, Consideration Transferred, Holdback",
        "terseLabel": "Holdback from acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredHoldback",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "terseLabel": "Fair value of contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "label": "Business Combination, Contingent Consideration, Liability, Percentage of Acquiree Revenues",
        "terseLabel": "Proportion of milestone payments (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentageOfAcquireeRevenues",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Discount Rate",
        "terseLabel": "Discount rate used to value intangible assets acquired (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsDiscountRate",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets",
        "terseLabel": "Tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Additional allowance for credit losses recorded related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CollaborationArrangementRoyaltyRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaboration Arrangement, Royalty Rate",
        "label": "Collaboration Arrangement, Royalty Rate",
        "terseLabel": "Royalty rate (as a percent)"
       }
      }
     },
     "localname": "CollaborationArrangementRoyaltyRate",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "label": "Commercial License and Other Economic Rights, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights, Increase (Decrease) to Allowance for Credit Loss during Period",
        "label": "Commercial License and Other Economic Rights, Increase (Decrease) to Allowance for Credit Loss during Period",
        "terseLabel": "Increase (decrease) to allowance for credit loss during period"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "label": "CommercialLicenseRights",
        "terseLabel": "Commercial license and other economic rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ContingentLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Liabilities, Fair Value Disclosure",
        "label": "Contingent Liabilities, Fair Value Disclosure",
        "terseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "ContingentLiabilitiesFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ContingentValueRightForInternalResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Value Right for Internal Research and Development",
        "label": "Contingent Value Right for Internal Research and Development [Member]",
        "terseLabel": "Contingent Value Right for Internal Research and Development"
       }
      }
     },
     "localname": "ContingentValueRightForInternalResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContingentValueRightOnProductRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent Value Right on Product Revenues",
        "label": "Contingent Value Right on Product Revenues [Member]",
        "terseLabel": "Contingent Value Right on Product Revenues"
       }
      }
     },
     "localname": "ContingentValueRightOnProductRevenuesMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Senior Notes due 2019",
        "label": "Convertible Senior Notes due 2019 [Member]",
        "terseLabel": "2019 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2019Member",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember",
        "terseLabel": "Crystal contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionofLiabilityForContingentValueRightsCompanyCrystalMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember",
        "verboseLabel": "CyDex contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionofLiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI",
        "totalLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Gain, before Tax",
        "totalLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTotalLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available for Sale and Equity Securities, FV-NI, Amortized Cost",
        "label": "Debt Securities, Available for Sale and Equity Securities, FV-NI, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Amortized Cost",
        "terseLabel": "After five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Fair Value",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Years, Fair Value",
        "terseLabel": "After five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Current",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Accumulated Gross Unrealized Gain",
        "label": "Equity Securities, FV-NI, Accumulated Gross Unrealized Gain",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAccumulatedGrossUnrealizedGain",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Accumulated Gross Unrealized Loss",
        "label": "Equity Securities, FV-NI, Accumulated Gross Unrealized Loss",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIAccumulatedGrossUnrealizedLoss",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ExpectedProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected Proceeds from Divestiture of Businesses",
        "label": "Expected Proceeds from Divestiture of Businesses",
        "terseLabel": "Expected proceeds from divestiture of business"
       }
      }
     },
     "localname": "ExpectedProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ForecastedCashFlowsEffectiveInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "label": "Forecasted Cash Flows, Effective Interest Rate, Percent",
        "terseLabel": "Effective interest rate for forecasted cash flows (as a percent)"
       }
      }
     },
     "localname": "ForecastedCashFlowsEffectiveInterestRatePercent",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Icagen",
        "label": "Icagen [Member]",
        "terseLabel": "Icagen"
       }
      }
     },
     "localname": "IcagenMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Increase (decrease) in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IncreaseDecreaseInOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) in Other Economic Rights",
        "label": "Increase (Decrease) in Other Economic Rights",
        "negatedTerseLabel": "Other economic rights"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Liabilities Related to Assets Held-for-sale, Not Part of Disposal Group, Current",
        "label": "Liabilities Related to Assets Held-for-sale, Not Part of Disposal Group, Current",
        "terseLabel": "Liabilities related to assets held for sale"
       }
      }
     },
     "localname": "LiabilitiesRelatedToAssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "LongTermPortionofLiabilityForContingentValueRightsCompanyIcagen",
        "label": "LongTermPortionofLiabilityForContingentValueRightsCompanyIcagen [Member]",
        "terseLabel": "Icagen contingent liabilities"
       }
      }
     },
     "localname": "LongTermPortionofLiabilityForContingentValueRightsCompanyIcagenMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember",
        "terseLabel": "Metabasis contingent liabilities"
       }
      }
     },
     "localname": "LongTermPortionofLiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LupinPatentInfringementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lupin Patent Infringement",
        "label": "Lupin Patent Infringement [Member]",
        "terseLabel": "Lupin Patent Infringement"
       }
      }
     },
     "localname": "LupinPatentInfringementMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "verboseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Milestone Payments",
        "label": "Milestone Payments [Member]",
        "terseLabel": "Milestone Payments"
       }
      }
     },
     "localname": "MilestonePaymentsMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_PalvellaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Palvella",
        "label": "Palvella [Member]",
        "terseLabel": "Palvella"
       }
      }
     },
     "localname": "PalvellaMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders and Other Contingency Payments, Investing Activities",
        "label": "Payments to Contingent Value Right Holders and Other Contingency Payments, Investing Activities",
        "terseLabel": "Repayments of related party debt"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersAndOtherContingencyPaymentsInvestingActivities",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pfenex Inc.",
        "label": "Pfenex Inc. [Member]",
        "terseLabel": "Pfenex Inc."
       }
      }
     },
     "localname": "PfenexIncMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PromactaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Promacta",
        "label": "Promacta [Member]",
        "terseLabel": "Promacta"
       }
      }
     },
     "localname": "PromactaMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RampUpFeeAssetNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ramp-up Fee Asset, Noncurrent",
        "label": "Ramp-up Fee Asset, Noncurrent",
        "terseLabel": "Captisol manufacturing ramp up fee"
       }
      }
     },
     "localname": "RampUpFeeAssetNoncurrent",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShortTermInvestmentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Short-Term Investments, Fair Value Disclosure",
        "label": "Short-Term Investments, Fair Value Disclosure",
        "terseLabel": "Short-term investments, excluding Viking"
       }
      }
     },
     "localname": "ShortTermInvestmentsFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_TaurusBiosciencesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Taurus Biosciences, LLC",
        "label": "Taurus Biosciences, LLC [Member]",
        "terseLabel": "Taurus"
       }
      }
     },
     "localname": "TaurusBiosciencesLLCMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_VernalisMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vernalis",
        "label": "Vernalis [Member]",
        "terseLabel": "Vernalis"
       }
      }
     },
     "localname": "VernalisMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20200930",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r63",
      "r121"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r130",
      "r137",
      "r216",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r130",
      "r137",
      "r216",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r130",
      "r137",
      "r216",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r321",
      "r323",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r533",
      "r535"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r321",
      "r323",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r533",
      "r535"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r187",
      "r299",
      "r302",
      "r482",
      "r532",
      "r534"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r187",
      "r299",
      "r302",
      "r482",
      "r532",
      "r534"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r310",
      "r321",
      "r323",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r533",
      "r535"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r310",
      "r321",
      "r323",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r481",
      "r533",
      "r535"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r134",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r373",
      "r374",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r19",
      "r35",
      "r190",
      "r191"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium (discount) on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r22",
      "r23",
      "r49"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r22",
      "r23",
      "r49"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r68",
      "r69",
      "r70",
      "r521",
      "r543",
      "r547"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r67",
      "r70",
      "r71",
      "r127",
      "r128",
      "r129",
      "r409",
      "r538",
      "r539"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average estimated useful life of finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r36",
      "r361"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r358",
      "r359",
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "negatedLabel": "Adjustments to additional paid in capital, equity component of convertible debt",
        "verboseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Other tax adjustments"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r324",
      "r326",
      "r363",
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r265",
      "r276",
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Warrant derivative in connection with Notes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r107",
      "r438"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r119",
      "r175",
      "r179",
      "r185",
      "r212",
      "r405",
      "r410",
      "r426",
      "r498",
      "r519"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r62",
      "r119",
      "r212",
      "r405",
      "r410",
      "r426"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current",
        "terseLabel": "Assets held for sale",
        "totalLabel": "Total assets held for sale"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails",
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r195",
      "r224"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1": {
       "order": 1.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r200",
      "r201",
      "r513"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r193",
      "r196",
      "r224",
      "r504"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r328",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r416",
      "r417"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r320",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r320",
      "r322",
      "r383",
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r395",
      "r396",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred in acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r394",
      "r397",
      "r400"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Asset",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r393",
      "r397",
      "r400"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination.",
        "label": "Business Combination, Indemnification Assets, Amount as of Acquisition Date",
        "terseLabel": "Cash holdback for potential indemnification claims"
       }
      }
     },
     "localname": "BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "negatedTerseLabel": "Deferred revenue acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred tax assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedLabel": "Deferred tax liability acquired in connection with the acquired intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r385",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r111",
      "r112",
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r17",
      "r42",
      "r109"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r101",
      "r109",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r101",
      "r427"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "netLabel": "Outstanding warrants to purchase shares of Viking's common stock (shares)",
        "verboseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r55",
      "r259",
      "r506",
      "r525"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r256",
      "r257",
      "r258",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r34",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,091 and 16,823 shares issued and outstanding at September\u00a030, 2020 and December\u00a031, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r76",
      "r79",
      "r508",
      "r529"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r286",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r286",
      "r288",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r286",
      "r287",
      "r300"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized from milestone method revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r29",
      "r499",
      "r516",
      "r549"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r311",
      "r319",
      "r548"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r29",
      "r31",
      "r32",
      "r499",
      "r500",
      "r516"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying value of equity component of the 2023 Notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r52",
      "r277",
      "r280",
      "r282"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r437",
      "r439"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r53",
      "r122",
      "r277",
      "r281",
      "r282",
      "r283",
      "r436",
      "r437",
      "r439",
      "r515"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r436",
      "r439"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r436",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r197",
      "r224",
      "r231",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r208",
      "r229",
      "r234"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 months or greater"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r208",
      "r229"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "12 months or greater"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r208",
      "r229",
      "r234"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r208",
      "r229"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of deferred tax"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r205",
      "r225",
      "r234"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r206",
      "r226"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r207",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Abstract]"
       }
      }
     },
     "localname": "DebtSecuritiesTradingAndEquitySecuritiesFvNiAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Deposits Assets, Noncurrent",
        "terseLabel": "Deposits"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r107",
      "r173"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r299",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r248",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Assets Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r320",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r80",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r143",
      "r146",
      "r151",
      "r152",
      "r153",
      "r156",
      "r157",
      "r509",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Summary of computation of basic and diluted net income (loss) per share",
        "verboseLabel": "Earnings Per Share, Basic and Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r80",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r146",
      "r151",
      "r152",
      "r153",
      "r156",
      "r157",
      "r509",
      "r530"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r154",
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net Income (loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r142",
      "r158",
      "r216",
      "r276",
      "r284",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r210",
      "r486",
      "r488",
      "r490",
      "r492",
      "r494",
      "r496"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Viking Therapeutics, Inc."
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r43",
      "r176",
      "r211"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r425"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiCost",
       "weight": 1.0
      },
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "netLabel": "Fair value of equity securities",
        "terseLabel": "Estimated fair value",
        "verboseLabel": "Investment in warrants"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails_1": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.",
        "label": "Equity Securities, FV-NI, Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Securities, FV-NI, Gain (Loss) [Abstract]",
        "terseLabel": "Equity Securities, FV-NI [Abstract]"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r26",
      "r30",
      "r209",
      "r517",
      "r551",
      "r552",
      "r553"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r423",
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r419",
      "r454",
      "r455",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r422",
      "r424"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r311",
      "r312",
      "r317",
      "r319",
      "r419",
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r311",
      "r312",
      "r317",
      "r319",
      "r419",
      "r455"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r419",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r454",
      "r455",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r203",
      "r204",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r228",
      "r230",
      "r233",
      "r234",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "negatedTerseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r240",
      "r242",
      "r245",
      "r246",
      "r483",
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r245",
      "r484"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "terseLabel": "Up-front payment",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r240",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r245",
      "r483"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingencyPatentsAllegedlyInfringedUponNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of entity's patents that another entity has allegedly infringed.",
        "label": "Gain Contingency, Patents Allegedly Infringed upon, Number",
        "terseLabel": "Number of patents allegedly infringed upon"
       }
      }
     },
     "localname": "GainContingencyPatentsAllegedlyInfringedUponNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedLabel": "Gain from sale of Promacta license"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets.",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "terseLabel": "Gain from sale of Promacta license"
       }
      }
     },
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r85",
      "r107",
      "r194"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Loss from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r107",
      "r270",
      "r271"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Gain on debt extinguishment",
        "terseLabel": "Gain (loss) on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r235",
      "r236",
      "r497"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r202",
      "r512"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at amortized cost (held-to-maturity), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r124",
      "r175",
      "r178",
      "r181",
      "r184",
      "r186"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r320",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r375",
      "r377",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r141",
      "r142",
      "r174",
      "r368",
      "r376",
      "r378",
      "r531"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r103",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r58",
      "r505",
      "r527"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities, net of acquisition:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r153"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r239",
      "r243"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r77",
      "r172",
      "r435",
      "r438",
      "r510"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r99",
      "r102",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r23",
      "r24",
      "r49"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r18",
      "r60"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r84",
      "r171"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r48",
      "r119",
      "r180",
      "r212",
      "r406",
      "r410",
      "r411",
      "r426"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r41",
      "r119",
      "r212",
      "r426",
      "r501",
      "r523"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r50",
      "r119",
      "r212",
      "r406",
      "r410",
      "r411",
      "r426"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r9",
      "r11",
      "r14",
      "r249",
      "r252"
     ],
     "calculation": {
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "totalLabel": "Total liabilities related to assets held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r268",
      "r500",
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestmentsAndReceivablesNet": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.",
        "label": "Long-term Investments and Receivables, Net",
        "terseLabel": "Long-term investment receivable"
       }
      }
     },
     "localname": "LongTermInvestmentsAndReceivablesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r53",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r101",
      "r104",
      "r108"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in ) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r14",
      "r72",
      "r74",
      "r78",
      "r108",
      "r119",
      "r131",
      "r135",
      "r136",
      "r137",
      "r138",
      "r141",
      "r142",
      "r150",
      "r175",
      "r178",
      "r181",
      "r184",
      "r186",
      "r212",
      "r426",
      "r507",
      "r528"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss):"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.",
        "label": "Notes Receivable, Fair Value Disclosure",
        "terseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "NotesReceivableFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r175",
      "r178",
      "r181",
      "r184",
      "r186"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r16",
      "r126",
      "r168",
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r49"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Total other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesOtherAssetsDetails",
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r65",
      "r66",
      "r68"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment for contingent liability"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r98",
      "r105"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for bond conversion"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r89",
      "r91",
      "r125"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchase"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r90",
      "r399"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash acquired",
        "terseLabel": "Cash payments for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r328",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September\u00a030, 2020 and December\u00a031, 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications and Prior Period Immaterial Error"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r94",
      "r105"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r89",
      "r91"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r94",
      "r98",
      "r125"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfIntangibleAssets": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Proceeds from Sale of Intangible Assets",
        "terseLabel": "Proceeds from sale of Promacta license"
       }
      }
     },
     "localname": "ProceedsFromSaleOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r92",
      "r353"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r72",
      "r74",
      "r100",
      "r119",
      "r131",
      "r141",
      "r142",
      "r175",
      "r178",
      "r181",
      "r184",
      "r186",
      "r212",
      "r404",
      "r407",
      "r408",
      "r413",
      "r414",
      "r426",
      "r511"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r27",
      "r28",
      "r250",
      "r524"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r318",
      "r445",
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r318",
      "r445",
      "r447",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repurchase/ Repayment of Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r365",
      "r554"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r17",
      "r25",
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r37",
      "r284",
      "r361",
      "r522",
      "r542",
      "r547"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r142",
      "r216",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374",
      "r538",
      "r540"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r177",
      "r182",
      "r183",
      "r187",
      "r188",
      "r189",
      "r298",
      "r299",
      "r482"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r309"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Expected timing of satisfaction of remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyAgreementsMember": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Agreements [Member]",
        "terseLabel": "Royalty Agreements"
       }
      }
     },
     "localname": "RoyaltyAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r12",
      "r13",
      "r14",
      "r253",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts of Major Classes of Assets and Liabilities Related to Assets Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AssetsHeldforSaleTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r240",
      "r244",
      "r483"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseandOtherEconomicRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r44",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r328",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r331",
      "r342",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r56",
      "r117",
      "r159",
      "r160",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r333",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r325",
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r115",
      "r328",
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r346",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r30",
      "r502",
      "r503",
      "r518"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r550",
      "r551",
      "r552",
      "r553"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r57",
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r142",
      "r158",
      "r216",
      "r276",
      "r284",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r158",
      "r482"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r33",
      "r34",
      "r276",
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r33",
      "r34",
      "r276",
      "r284",
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r33",
      "r34",
      "r284",
      "r327",
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r33",
      "r34",
      "r276",
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of common stock (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r33",
      "r34",
      "r276",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r34",
      "r39",
      "r40",
      "r119",
      "r192",
      "r212",
      "r426"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r119",
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r212",
      "r216",
      "r284",
      "r358",
      "r359",
      "r360",
      "r373",
      "r374",
      "r402",
      "r403",
      "r412",
      "r426",
      "r428",
      "r429",
      "r433",
      "r539",
      "r540"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Cumulative-effect adjustment from adoption of ASU 2016-13, net of tax"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r284",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r434",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r434",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r434",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r434",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r448",
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Core Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r299",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r299",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r203",
      "r204",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesinanUnrealizedLossPositionDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized gain (loss) on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r145",
      "r153"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (shares)",
        "totalLabel": "Shares used to compute diluted income per share (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average shares outstanding (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r143",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "verboseLabel": "Restricted stock (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=121558832&loc=d3e400-110220"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498348-110258"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r555": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r556": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r557": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r558": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r559": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0000886163-20-000122-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-20-000122-xbrl.zip
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MLE)'N U6^//FI/ 5K.8'F5_)W$IBX-;P7;>Z0AZ^;^1PM 5?@T8Z%E.0PY&
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M&E<[."QX&(QPCN8+Y^]39%>.9QS>A6<PD0&=@Q*3"&0-;B699>,%0*\)L95
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M7=O@'9E(-@+H^91!UU#I,-64WG7$D/[>C\$ _*YPG?2TQ2CXR),7M3QIC82
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M16-.)2KPIIGPM+:@9D!)?4!MF^4;C;3V$?^+Z_LC2<KQ@]DRBA])4@_ =GT
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MX02!D@2RR_!I<7)CE@P'$6P-CZ?"S$1=?%JQB0@9W\\-9[U[L9K[@U]/_MQ
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M=1$#K2+%D 3U/#*VV-C8*G_^X51C!X],GD^W3FQ+A#06*<2B"2P&I@230I&
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M(X7TLRX#T!M<!/]]($<'E1^&%IAT8,R]#7GLY"W3=N' -K-3DURH[:N+X,!
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M/D:G*)8.!%I4"AME#);!(6+80C#.# ":) <1:DPDC! =F#4"O'AI4Z5J28D
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MC-!$<QXQEA9I7(83N,H"\&S<>!U,$"0:XAQAS'%EG V1*R:Q1,+S$A3!*PO
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MTBNFI%%*3!O<"ARB,MJ",9OJME'L5?212N&1H*A$2F)%)'.AI1C0#\(B6D[
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MG>&PX2>[QKRE>>C\V1#_PV_]JS3,0=GQ=NL_OD=MO\7^X;'MQYDHXKO[/S]
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M;S5.Q?(,L3SAKN<^*&(E&"]*^S#!07NM0)G,OXHD),:,L,QPZO: -6%@.B_
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MX7'@G"OJLL6B8TB 3F93)F@.U+(0M;/&<+.QR71;S*)TOS;57!$"6$BY?R6
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MKWCTI:=FWKXU">X\;?+)ZM+;ZC+<8FJ4*L--PW 3*<G:>B:]A<"PS!ZS#FS
M_(5$R4RD:$O78"K:3*Q15DS5X*H&M]CZJ\IO4_#;A",L4DJY91J(33)K<!C
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M>/E#/S%,M_7Q-'_LJ"QMO;(C'Q9X"P&5%1%#-NZ*)\-2P@2EF@A%1.+B,C4
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M-$[.!)QCOAJESK\\1Q/*G@IZ5TK#VZW?4G G,Q U"7D:)$P%P^:=L]Q^L\Q
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MKY(;M0)\V<<V/ >IK-', QCA44!7$($E:7,TL=H@U@O@<S8(X$JRD!R1+)5
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MXYW//H:M'<94&_B="Z]O#CG?J8N56Y<S.)M"K\ U4.><U^6$!8 /J&@J'7$
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MO:@K3E%G<UY4I:+BP:! D,LI1LHRJLB4$A>#!59H2F84SMM@8(4".&HXUJI
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M4Q,", <V*(;J44)IX;C81_LG:>L!R;! */<*-37KN4QX:W!R>.CZ^)#!3>&
M;% &H&SHI6P]XJI<.6O]A/O&\ #AC? 8_/QDL=UA,A38E@^=HXG)6S46Y'%#
MQ\;RD<D;AZSKC@?IR>277V-G<-QU9T\Z1TW'FR]=-&X/>\>_GG;B\*!X=+;I
MR*LSSCTQ?O[X\G9SZ8*A?G2-JVVKK[],M]FUU[[U6 ';4O-;/?;;UX2!^VGL
MS1[[G?P>W\VU8R_=>H4/-> .F?H/XRS45SH+I[M!:[(1G//^W'54YMS=U_F
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MPI3=P( 9G@"+=0:3",8=(_>/H-5OG3;V\C3[[MGN]N%GFQSV)$I$2+ (-'E
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MJP23V^WUQV&;T7[L9 ]DXO_4IM;XW1IS\1"<ATF\!V8LCWHTU:./;52_-M?
MKXX %$"&K4[><@$.&XVD'L3%#8]V#BWUFLV6WG3CJ=G\&;V)A:M.X:*9MQB/
M!=0Z7-*KSN";Q@2H)SOV^S :F(S14*YZ_VS2CCYXSBRX-;?68QQOQ8[G:RQ)
MPU[]ZGE$DQD>S_AX5?,?FXW)6@^T&H[OPT>[(]N^T\VB!M0(%O^W5@_LY+^_
M?O?GSC8BYA\P\S"Z\7VF!-J9=1+N1*8Z5RG226'CN,78"8QIX"I*+$WB[">;
M/7-GU9T."([MQ^W8_+O?O9IGF[7[#7#8?<EV#HP?[!PM'#$L*G#MK,KU(2F"
MI?2(265\THDK!KXLOHESK^?:;+0TF0Q-&LQZCL^LW\^6>1:6R8<X13CXR+;5
MAG_ZOM=RC0FW7$[H7G<00;L]I9NY9#/R2^U>YF!'DY/4:+/,EQ^&Q\?9&,AN
M;0M\I-3R>=]NJXE!9.[]#238MYXZ!P+&EY>UUEJO9V'U=I)D\F$,L/X8B3F#
MJ=IJ8JGO8\["NB(E+7-_"RYI\MEGDM)&(^ "AGC2[=>JY%4= @*=^J_35A@<
MC8]*S'RJR09_A:<?L0Y&.QQ<_Y&9!'-?[\$^^MDWFH=$U(7)F?EZU)NFZAU&
MY$ 1?44VP5A?V?:I/>NO_?/<*X%E-+ZY@8=??/-;4-Q5?[S%)1<6M%%^T0IE
MF-;&^L2=8=9*S[WV6BHG TF- 0"?B6$K:VW.F2-,.><5^%0Q&6T,M@EC9@D8
M[&EML51\+;@O'=2IUZTV&:HFD'V'R3R7C3D'"^A\6.:#/XIAV([O4CV\T4F=
M;F=D$.[#LWYI=_W7%V:>[&WOPCVW\-Z7/^ __^/=UF>K ]'6"N2I3> =2H.<
M3QX)282G7 7FP6L';6M/,E?TAO$J\;OVP,LC4/2,%(YR/6LOH#\8^T:IFPW6
MK$S^WLJN47<(3PK]?[RZ-J$:=-(A4,B(3)N$X/I,S91FZW,\/F]0GO3CJ_$W
M_PJM_DG;GKUJ=>HQUA^Z>&)GT#T949(Q&[S6,..*FZ/;CPAKHR:L"V>+FK])
MOH&YNO;/>(/<\V]2TWM]\J;!$K$AR"(&*YA8S&#-K6[[DUJI/ZVL_*!+KSB[
MVJCO93K%.?'9*W#7;U%4=57G89+MQLCY:7@2$9K+\<3EGO!L&,Q7WE9I;HBY
MBQ"N0@/+U_9DT((UJ^!&PQR";"*-/7M\DI- 4XR+Z&?YL\\]EU(%9LY56^[\
M^D]4JN!V[WV7X&YPP9"HB4F!"YQ<LBSWQ^8VFA"L?&@AU/<@SW^<O(U-8M'4
MX5F1"@5_D+WM _%I__WQNX]OON]NOS\^R)4)Z-[QWG:[=4#_^+'[Z][QI^W?
M?URJ4+"?/9YV>^_7 W&P_^9T[]=/K8/]0W9 #_"[C__^\FE_]_2 ?OJZM[V7
M=EN3.L]GNU]V^&?F(U%.",2XC$V*G6.6(6$2B0$4IU!L;=.L4W(YGGN_2OY+
M4XNE$%PAN+L0'-Q :IL4,='Q:'4^:<\U=8)3%X*WMZO%DO.,@NT?%6Y; +?A
M*;?MGGV..$;EN$?,.8:X@>^,I [D"%O&O)<TR5SM))<]_==S8;<7T,3D/]W.
M(:KWZUN=;[&IP3"S=;^(!B:WZ@AUQ4P^=4>HYV3%C0/8>7GW875W)HO;W^J$
MF3/!JU-VZI&([VQJU.UM_\X^*Q;R\02&9""Y9#U5R-C<PE$$YY52!HN4&\""
MT,VIUN@2U= K4%ZHO5)0O#@43\R7O1];_+-+FGM&)*(1H,Q5(,@E9Y"V.E"F
M!(L1S\U\F2..7T#([<U?P];@;,8\642$[;EVJ5PBF^0\936KMEM7ZYBAK<)2
M][0UZ@"2@&5Q^6@NHR0"2VF.C* <.:US:3!# U9KFYI<KB%1>D6O"D#O;VD4
M@"[2C*BC(-)&)Y)S"#,-S@#E"3GL#9(Z$.HU%E++M4TE'NP*E$ZM=S$AMF.=
MQM@OT8QG8#F,%^MBLEUAICLPT][K"Z:#Q; Z01,4.<D-K+5 EB:/J"::>.,9
M#6YMD[!Y-40I08KE0^B\3(>"T/D@]+SMX%AB0)<,68YS)V#MD-92(FZ3]4F3
MA"/+]:7-$B'T!80?ZHS@$G)82L/AUML@,]G[NZV^SV?\.[$[+-QU3^[Z<,&Z
MD)HGFG/^N0L1OK"(# =C0QJ2B%312 [<1=;%P^V+$II86B#/9Q.D /E1@7S>
M"%$N6"4E1T$ZBWA,'&E#-()EI20%:QHW89WI90+R8X<P[G)L;JO7LNTYM BZ
M_/7)NQ;M=P>YP<+,D:D+!QT?OUO;Z*@5 T$*W6$^:97GXOI,H55.'ISGS*R*
MBGI<6[-HI?MII7.)T[O?/UL5 \ZUAJ1B#G$*YJ55F")JB(@FZB 3S\&K=84O
M-TU_4(>U!Z'F>32X+)19*'-YK/I"F?>ES%E#GGZV7AOAC4/$&XJX]P%9HRE*
M$6/J?6)8Y&CB.A-J!1CSBG:55_3I>IJ21'>L@['E?6\80S6N_CE3LV:)RF&,
M1CDSR/T\^2^U(,;N%T_AO\_>81.9 T,%F]R[#^?>?4XCEH ];7(T$/L,JF",
M9; ]7=Y2#*,4PRC%,);BW'TIAE&*891B&$LW-R^P&$;W.!<.K4O4E;(7Y53X
M*D1OWQR?M+MG,;YOFJ3,.#BO5RHL<2C@9[*[[[_#9^"9O__X]/&-@+'A@X\'
M9._XW\<'^_#]E[WCBV$)N"_X/']\W_OQ%OPB3_:V8>S[7\]VX;F?OOQ!#XX_
M'<'WK5WZ:;8$QNEGITS45H(WQ$7.%$@1N> Y,L'0P!S!2OFU3;ZN^;S2HTOY
MBT)TR_/>RQ5S+40W9Z+#$Z+3F#EJK4:>4@Q$IQG21EGD'"&>T>0M)SF)PFCY
M7(CN!1P2^:W73;G31-..+<9R6N29FW*C*.;LNKZ-A=[N16]G,W8<"Q0,.2Q1
M)+F,F>,66><9XH$R863B*IA,;Y0^F-[*89*E!? CF"@%P/,$\-0^X<IC+IA'
MS%N;N\H$Y B5R"D1-#6,!!,R@ E[<!W"<M;D+B;(UG%N5]*ONJ=-G\R,E-BK
MVDU?I7M:)"5[_7'.K];%!4<ML&)-7;9=J.KN5#5S=/7T<[3!*BX]"I93Q 61
MR"JEX+N0HJ825LRM;7+\X"26<JQD:8'YT&.K!9AS ^;4AK!&)VF90DIJ!Z8_
MT\@XPE$,PBEIK6-&KVTR398(F"\@B/%^TC)[;$,,CEJ]W ZT=RZ3K'A$RV=
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M5#ZP /C96" %P(L \-0HP0%'IL *D2YO;P8OD/;.(VXPM\3F6KV^3JKB=(D
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M/K*]^(OMQS!;I?'=2?ZZU0D[G5Q"L_4M_M8&8/\&D^//GJ?8/ZAF]][V(9@
M+'*2:R!H(A&GB2&@'1!@(JUPC&F7TL]K=C^82^]=,+Y>:50O=75E1<Z?5XU?
MY-O<6&B\&;NKQ^YGQE[%[_G[7&:\5]E3VPO]?)8QCFJ6]2O;"16@!XU_4X56
M+_I!M]>O6O#7^F_>]H\F-\H?@+_ 1=W##HPP5/ 4"^_;LWD\*(^M@H' -5V
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M=W_'@E=]Z[9!@-NMP=D\0F2KMH'T<+_U$<CCS\D2%M/YSOPQ6\M$$R%Q;O<
M:MDCGN [S;!"A'.?F#"">=#3XG(5K2</+Z\J_A[NSA;\+3O^?LPT'=#$ =!0
M2(DAS@Q&1AN"4J*2)4:<IF)MDU]N-K4T^'M4##\?R_SA'G"!\;+#>.KN@ML5
ML!0281X2XIHPY)(E*%C%'%,JZKQ-*RZ? EX:&*\@!!_N'!<(+CL$IYZPXSDG
M B!H4Z[*%[1&.AJ.N($E#S8EQ31HTI_E*:[(3NS$V04$'Z_H1NR5Y][OY;[.
M!,%@2/Y5&/;.HNU=20#NYP3@[D( ^[! I(#]YV!OS9;@U(K#VGID!'SA1ACD
M1(PH2EASH/MHC0>P;TS\UI&LE,CRU:BYE]-94/,L4#-35C%B&D,BB#EE$:=4
M(<>T1311)8*(S(9LI4YS^1>+FI<$L'NY@P5@SP)@4S?0DL2% !M4>!-SF["
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M3&3ININ<,.V 7Q-EG!BNM+#!2VJ5IC1*#^/Y6:'[(B>/)B?[6^+=_A_@3QS
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MY\$[.+A@2-3$I, %3BY9QAV-W$83@KV!=XHY](24-#THEX+4@0 1T9 [%.@
M/AJA%%%%N7.&<.-B-H?4NL+%2RNT]#QHB:M\C"5B'A+CDDK#'$^<JT HHT+[
M3$L$Y)R10DM+1$O?=\?E>;8^:XI!@:2$\IDDQ(T(2&.=3_ F$YA3)!FYMLG6
ML6*%E@HM/0M:THDK1^$VFC,>%74T4 =,%0(F'E-1:&E)::DUH25LO5=>&#"0
M)$6<TX1RG3AD-*')8H>Q#6N;ALEU94@AID),SX*8!%&:&FXH<X;'( T)25@'
MEI(14=AX/3$5]EDX^^Q-C2+%5(C):H29RP=8J4 Z4 M&D;34>\YQ9&N;A)8
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M*\QB,"(7P-#K1!1/M%#<BZ:X1\@U*A0W)XH[U[$%R QCECO],@&^*%ASQL>
M6")1.LX"+.7:IB3K'.O"<87C7C+'+; 33.&XN7/<3/F48+QVWB$B T8\Q8@<
M%0S11(CQ0C'J_=S:OQ22*R3WG$GNH5UE"I/-F\EFDM:H5$9QDY +N9:;)02Y
M2!F*AG/!);/.SZ>53&&QPF+/F<4>(:NO$-S<"&ZF4Y^F./J8D#"4(JZL1%;R
M@*CR^<AIB#):,-6,7F?/)_OCL4OO/ $T_].RKM6NLUM?W2NW[[;IRK>XQ\QZ
M,EBQT!VZ=KRTH ]Y0AEE&64991GE D;YV%GB3U6F[77OK)_3P;/5!N/.Y=K:
M4QWR#.NTL8?4:7N@>[/Z'LQ*.BDQ>.VMTSA(PJ5AVO)HI+>&,"<QNV?YJKJ#
MYNL)K&8LL^*K/,Q7>3?;:$X[#.X)QBC@*!%G*2#+O4<Y(5<J&321;H7K^19*
M6DE*8@F3++XZ"L$YEUJ8*' (PEB1-':%DI:.DJ9YY=2KE+ 1B <5$.@2C*R*
M'IF4B(_ 2UCA0DF%DI;@U>X2RC4Q.IMR.:O$B?,Z$J&3I833R+A7/TL +^2S
M0/*9)H,'ER@17"/ME04&L@:9  S$# G:>N5<(FN;&C_X2'8AGD(\CT(\QD2'
M=0*WC"K.6#0"""@D8Y5RF'E>B.<)B6>:IJU(] Z+@"A)!O%\ ,4131"6E KF
MB>8:%^(IQ/-\B"=B+22HRT1-Y,(Q"RX8<UIXI30X:.E^A:0*'2V0CF93JH,"
ME6&QSVZ8R4DZ$EG'#/($Z(8G+U5:Y6YMA916DI243HX:HZ+TA!OGM G$&8Y%
M%%Q)<<^:E(64%DI*,S6S!-BP3C$4L,W,I/.Q-FF1)HHJRTQBN9MS(:5"2D_^
M:G<J#I! 7@-0$P<SWRF+J6*>BF1(9%Z:!Z3Y%69:)#/-Y#0S*J3"GB I(D&<
MAH1<)!X9:;GR3@:1S26Z+L4*MIDOO+22O&0\3@HXB44E. ;%BW$$R?:8Z)0K
M5Q9>6E9>FEI,3!K!64H(+".>&U919(R4\",XXM9HQY5>/EYZ ;G&K\^VX_>?
M)(Z54LF+./_*$Y8<8.$CY88HFZ)C6@7*K,%2FY(<L&2$-MLQT_#D.=$>I80#
MXM@JI!UUR!"+"1>6)NE+O?/5!S&&1??)2LFPYH1ZG:BT@:=HO>5>Z0+BI0/Q
M-,-'2D*%(A0ESC7B.KM)-CB41%!<:D:5G%]HN8!X:4$<J/#,\V"5"CS:W*71
M6^4((SR%0''9FGY"N$YS8I*@4F#MD#0JYL(3#KE@*6(*LQ"5LIC+M4V!'^Q
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MJT]^4)PDT2:PL+;)^(/KQQ:P+BU8:0*4AL I" ,G@%MK)7>$BVB3]>P&T[F
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M;KAG)@8E'KFWZ;6B&L>#E R'L#$>#B>HV8#&*L/_#+Z@C]V:4U8;<FV$E@G
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M!I*99 $)9K.,>5*HU>]TC.U7SN[)F$L05OF/QKQ&#N>/3LQ.7\N]=T?16\D
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M3AW X-Z7)UC4/>R2ZA@.E_C%JKJ >G46ONB[B&&GE,P!K&RI5%-[L6G/O[M
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M3&UHN=@&>A5!K6*?<SE>3"3(>FCC\A;7:#QM!H_D^V-,^YAYW&^Y_'/<X@]
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MK$RC@/48(U<&-;I1!KSQK\/0Z6PD:<"?X)'@."3]_B4,AA57>OW7_N[KMUO
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MAV;O!T"="N[KW4$6NMZ )C[)(RF++#,\)XH&342F)5$.RX*B5S)0Z0N;+=N
MAM@#D0,57CJ#?#\YO%#P347JZE I1D<31ZQJ5X_!<@=N&0)L9O,]B1>C;8W&
M=\\DMUQ_,'U+F7)7.0[+[2YO9NYDPN>'2 ?*U+KJ+#>"Q=7)OVA*A_&8 @"W
M4/LE$2.&50!Y&)(S&W_QL!Z=?@D44P0I_8L8"(YP@Y@14%TZ.0N[]1-\%VZ
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MSK'IJA%6RTP:)XI,Q6"TF?> ;95G\G]"IT2L#Z83'MH?=N,]/6.*T5:SIP8
MPLIDO*6[V^N/L#"T15H?QG8(&AL5Y^LOB)7/E *7;JODY<@GTZ)ACDIOZLU
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MA(N-]%##)8T2]F[+!:ESU-M:G"\ZRX%7Z93LW6/Z8^.;YYS*X"\@91>.20R
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M5,+%Q6WI/.CN9$D=5HII80(\H\D#;T(@F210?L/7*A:"1(L6A@AYEXQKVS[
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M*%F-GWMT:(DT8@5VNW*Q#[L%%Q D>S7/8#\B?F3WIQJAY-E%]-8KLR28BB1
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M2.14R<'$G78GA]9R#\M'+/O":Q[PT#&5G/M_.\X'3/*^X?H%JXW]B9\L.9Q
MZ^"<F9T/N?MMA]PZ-&.WUW=Z)77UNBB".?$#CV05T-0!S>[Z@.;VM _+,\1_
M;&%0_1W8H.$%;#I"U[WFGNGS0[);!^3IN_M), !E>3=^@A6,8?,4\76(H3CT
M:,@2X;DOR(::I?*U_N$-:MI@W;T.(IH<O?0&5&6"7U)4F<6SXBQJ=3Z/+('_
M]_7XZL\U^M.KS%_Q-Z_6Z777_KE>\]:_NF'8;K/6;+2>?%B:;7^K85_13O!N
M($ 7G-#__:'YPP+2VNO&[-[Q-,X:[RL"C*W8:YO8OR,]PK'RY'RPK=FN>DT6
M,S[UP]\4@3J_4B7S H>I/3KCY;\ED)C9\I6WQ=KKN/)#D<MHM)\+](']^C]B
MI;253$5O#CY!9Y+($5SR639+7[]Z=7=W5X-YUL;Q[:O+9#B!*SY])?VQ2%YA
MX>ZK7J_C=9JO8+J>UV]ZC7:CWO#:S5;GE=_M]QL-7]XWO-HDF_[PMT;-^S^O
MQ.(=],0<\IVU)1+Y91?9)RR6 1/_@TS&&!WA!N*"? *7^3A/,\>KNYA^6^?P
M,+KI"')/!]FNHV'-=7X)QC0<%I2+H<QIK2G^456XJR[$GR3JY9%S67B0G)M\
MP,,X+P+[^<&<>\93I[\LUI>K T=3-$#'.,#\/U/G2@6U5  !AGV//O_>Q3]5
MCK!Q[BWX.-[=*PQE:@"?<CE09!;O\>)?%K9B)2F>E:2H\X\-_-&K>Z\$_$](
MU'Y//50XAUH+C<;S%1HW<@9J,.*C]+3 8$FQA6QP553>^3F(TR'U]DR53"@"
MXQQX3K>4$E[]>XB)8M%:3%:2HI(41E(T6%)DE'U2EA3-2E(D3G\'2:%2>4J2
MXI=?KKY%4#0J05$)BH,*BJ8M*(:W"<@*+2A:YRDHKJBD>HP\]CLEK7[F!&PC
M0#9(BX',[K >9ENKXW>1CR? @U-,B*>\P \T8OJ?R-\,/,E0-2\2"0=&20QK
MY4QANKS<7L0T*Q%3B9A=18R:3Z/-4N*B+"#:^Q<0AZ@^HJC]UE*"718%"S07
MO1:/E1F74RS"A17?4&;U%\QT M9V*,\,_HG> <7+)!=J_[OR*)X/QWWKI=Y[
MI7G6NX5AYW"G7,!!2,VSG3/FV<($T$ [F&;$]H!.U%/ID>\H4=:Y3M,<;WIL
M<H'%Y]R-8E-Z9YGM/PZSF.X];Z6K<BNSPGS+?.$?0?9W$!B__=/Y)6.9H'YS
M;+Y*L_SFTK5?B:)G+XK(OFC9]L4TB.),L"A"-]FY&A@FD_X7!=7_&-MBDYOA
M VU@GB *52)F)%'21\4P8-M;E450"85OM B,AW$X]^7]V+#T=PA#'$Z]  ;V
MIPHUYX:Q!#<P=F-1)] ,?H5;MJ@46$$';DWAW)3"$:8E$DY"50?IJH)U<WDK
MAVHJ.!.O_30SJ<R-,V+G<!SY_]-O IFJF34]E8?0],[V?L:)F.(>8(E/"5R=
MP0SNZW?W<+V1/^XC0F2ASPXLAS07S/2?<ZQ:\)KBPFN]$"^)1[RVS_\B]Y[P
MXQFRWLQZZT:U,(!=UN;'C4@&(I+IQ<?[4 +G<K<IT)L:%GM5C'5>C-4PC'6F
MP?H-C/7>%%=5C%4QUM,RELZ<:YYMZER)L=('KBSV=VW+>5Z/T):N:H:;O&:[
M_B#+]>N=4V.Y0QR<5_<>L05';P;5=4_; E2CJ)HMM;;1B,/_RD62 0//%UT+
M7OWB7\9-^V]^RD'( LN$XIJA(J#"XRL@PN"_?_[\"SH]J%^(_&]JBH,E"S]K
M'!#^(D[R%Q&-<S&6+U_#"R^=*V"B6 %JX3]\]-'XSL\,X^S<3*1$\(\7P?IG
M"7R5 4S1#6S!F,!;6[Q&\*KQ=);(B>JZ@T[AJ<3W;[?\*L6')G'H4SR9"VGA
M_6U?OT)4Y?>(JLPX*"]N8=YX&K_&&>.BKQFFD"C%@,=H%1Z&X5MGR?"$V>=@
M'58!QE"X#_?'Y=?,WL3KC.(0*7 '^&/AT_2>(O#PBJJ7'EL[I<:[P(-[W>SH
MTS05MX<K3S0L^?T__J:T*UX3]^ ].9(19!&=R4\*G[#J**@$L%P7^V"=_!%,
M8>LZR>9:8( 5M:#;U-/NLX1TRW+&F^N__WKYY;?/[VX>/=4=5_C :\^NB+=7
MH1)OWB';=EH 2DJ-153$R$Q\3)E%7K_9<M6+"(:2X%"(P.[G<'M2OTV_!$#+
M/?805Y61N! 09R G(AQIF':RD-4#U-0MCQ#:"\<3>3:)$UC=DZ+5[%92_&85
MB>^CR+C?K_7:S5UJC%NU;KOS]+7 O5JSVWCZ81NU3N?IAVW4^OWM"I<?,VJ[
M7>MZZU_=7STTT]^!C(&W8!V]?GISX*!K^A4, 8HI=EA?W]7#<_H[\?/\W,[V
M5?K*^0"FUP2&^V><R C.>5Q:XY;,^8B3/MBCZK:!>^,U/.N0H\/1>WQ*I_9L
M3NR4#J7PRO^.>/6?$HD]$3 U@[UGG)5Z-0GD:-E#7QW@X0_P+>K/ET9_WC:X
MLGQTNWF5GIWAV5]O>+["7@3PGTDV#?_V_P%02P,$%     @ =H%F46LW>U"J
M$0  ",,  !$   !L9VYD+3(P,C P.3,P+GAS9.T]VW+CMI+O^0JN7C9;M1I+
MENRQ7?&<\LAVXEJ/K;(].3E/*8B$))Q0@ *2MI6OWVZ0%"F1!"^61.9(5:F)
M3*(O0%_0W;CPIW^\SVSCE4J'"7[9ZG[JM S*36$Q/KEL?7^Y;9^U_O'EAQ]^
M^J]V^[>O3_?&M3"]&>6N,9"4N-0RWI@[-?YI4></8RS%S/BGD'^P5])N?U%
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M[LH$UU%V>^X&Z.B=WGF_F]CZD"KDX+'ADS:0MJKE1-2#!B']@Y-4 U=M#BN
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M2!YW.T;LK?:6'M;LC-[^ 1,2,^,$:6F^$M$EI44TA8$7B69FP6FFCX694D3
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M7;D2\BM%MM>+\W*U,?:AZG@Q@ABC3AF9"8YDYDDRT"1XUL(9D86"?">FNE]
MNMNKAY1X;D2& ]B@H4<]7<XA+?\Y7I[\<+98SDYQ?@WU2@DQ>E&(QHSKF)@&
M2[X^ALBL-X[<0Y/08Q_7^G%P0\I>-YY,FMNFS>QR0\H/N*I%^C1[8O),.V%1
M)<^<Y!1KA)P9$,&)^8F[*'40FF\UW>R/94CY[Y;SSX&MU#AC/LK96XXBL"#
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M<^S,MR?.Q_L9N'\U#,4Y@+D(9NOMV!I+8#YX\GN22CX5#>BA!]VVJX9Y=@Y
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M94C:Y2X]7AX#-J25N3M'FEKI$-RY$<A>5HM<W'1JK07$3+&U!JR>K6(A&L=
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M8H2\.'L?A%',&:_ &0'1=^EC\D2<^SI &UZW>L^-UU1+IU?3? EC%)T0G-O
MA$_(M/&.>:T5@^"]1A.4REU*.W>#.Z0,?$\>WG6C#F#<9I[X0U@7'RA<F(]3
M5=!REOXU4M(G<"(Q*3@I)45#L0)Y@25E;@)74*#+P?*G@!Q2(G\HI-O+D WS
M &F.M5@()O7(RFQZ@>W5DJ#%LV4-2C_-OCF4%*?6#[^:SV'Z&2^*C*Q)VD"(
MS(;:E*7&(B'QVD8/D5!SY*9+6FE_Z$/:=C@D+0]L](YAY[4S_ O"XFQ^:=8=
M',OU#]K?+=P"X+[N^=I7?%I5A3;3Q.7C.NEC'=@N6KFH<J+/W:Q765Y_=(_
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MS>5_=)/_DA#U2Z2)\F]_^O]02P,$%     @ =H%F41]WX>@-;0  >Q\% !4
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ML&!YLE8$'II$CQHU.&@"Z!&[FE5DWN*6T 3?_$5H@K#MSB?-H.V_#4K[*MV
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MHI..AW)3RDDVP(6W'!2OXW0T!'AF8!U=MM@W8U:D>@OD-)7B%8IN<-F-"[O
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MC,MDD\(MTU;IH=((W>FSJ'4=50@HW:7ZZNM"AF=ZCIDH96B9(X-X8RR]I4)
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M"ZU$=OKT:54W%4.0GV ZD.'+X(O_\8_N^*),\4-QE)GJJTM&E;74E-:V,9<
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MI%4\:?X%J9.,H%8:1XPI*=HLYU+0@ )S5&;I3 AUJ@8W@WER7*NHI2JYBG-
M173E=8#A-">O'^%#*-96T47)<BE9=5^ZE_@G'_)G_.DHXQKQ=[-"&]8QSD:9
M&+X,4*;'9ZV)E302(Z,&0T6.=3K+M+6 D^/A031;(?]AME]_ACCOZ?WZ^_MN
M)R<#FGE'* B*5D+,9108)9$&KR5#8+)**OTJ,"?'G)TE7J,\KN='HP_Y'\53
MZH\_#*<=)-Y/BIR0M5=02XOW4IT]_[O1_ ]'G>2#2BD"D3+@T6TM)R[)3+B/
M+I:R<"FK)$+LB/ODN+5//=8HFEL%?]'"Z^.PBWMK7L;,.L+HK+.,Z,GX,KL>
M-T\'*A$?K!,L&Y=%E=UJ*[1/@W*MZJQ"$_9R<77].CS_[KN]XIJ4WEV^!]=)
M:"4![>-@--70XC5:?%_$IFD0%B6FA2)2246"C(XH<$HF+@4+5:91MH+^Y(BX
M?YU6*&J\?Q'/>[W!G\7$Q.]?#"%UQV4Q':=\5%0%8MATZ ]GQ+NHB>%9H4!]
MT*Q*E<(V8)\8[5K06(OU+[,K]@__^>8E<XNYX^@L0_?[=/3X2JRK6SUTE)%*
M(U3D1);XGMB,*\@*#5:7>!940UIJB; NL:$-."?#J@-IJ,5&2=,5(#Z(?C0O
M%2S%B*-9'Y#N=UC$^TIS$(0>2Q%A LH@E41Q7283>^;0[LSX>B1!3=!*)=^,
M31L^^+1X4U/J*P*N.]\&K(KE38=KE@ISQJEU3@C"8D0I0!(DF-)=+%MOHQ19
M0Y6^M_>!.AFZM*Z!%?38-:&RAS\:#&?ER\5]^#I-*O\T^.E[XY^%QIU(#01>
MQDU#9H6_* /.$W$43*#<>FI-LS/HX8>=C.JK2'>%^G>.G;\N$H:WN'>EY=F[
ML]%P+G/-8C8D2P.X>F#$90O$"ZJLB:),O*RQ0SP$[&2H4D43*ZBR=1![SN7+
MRQ)M\+VW73S61H "F'8E?14'_<%E-\YB#FLL\1Q#BEDP$J/@1 8:B8]<D^BE
MMS)$EHQKN(?L .-D*+-GC:P@T]:Q\$V@+QO;7P:K%_,2W<+IW1 :Z!WI<$<M
M/>^ RC(PW#IB50A$!!:<#]:#T6U2;1N03Y*(U;6Y@J8[Q\J?]\?=U.U-BG%_
M'7]X]:,D7D J79K+\(')+%?N0W[EA^6:LCB+T_$$SR^+;]DQ-ALMA,17S&E\
MV3)NVJ71G'.>&@F.T^7MKZ4\K3;0GPQ9#Z?3%<S<.;C^.5Y FI01Y6O%-2L-
M-2Y:8Y0C6JC2(AQ?)FM+4(Q3K;WBS*0ZY=,- >ZKL+IV>E8-?1RZ!'LT''<^
M%;=E6D](%?<*[06BBJ6 '/<D.)=)3CQ[%ZD/K F3\$-OL B_6V;0K:<>K,"Z
MBCX'N\JUQ92\*Q"+BJ\&,#8HKFZNYO8+ZQZNH=Y! \LZW$%\%;7)0@X"K28"
MLDRPY7A269$EH;I,<8LB.M[$YC@.+:ZI?6Y?B9M(K67EO4-)74XNYT# IXA&
M!"XF:%O:NT0$XA/1D!E/PC#5*/FZD?IN/7E_YMY.LA^T(;@6<^^G0/R/&T <
M0RLB&T#7)7@B3:#$4K E^9"[E)6%1ME:S31X\\F/4(-;"ZY"AOH]<;C??[[S
M_XV^:DG&F6XY4D.9QZ)0%Q0!EDKI:5O.(#*3DH+@=7("-L!XDO93;5U52%*_
M!^HUT!O%_4W@UFQULR'>PW3 J:;_YCQK37G[W<I6PE942"&E):*,%)/4<&*Y
M$,29G) EB6I>93+E47#M@?XZQTJU3716@6+SN\SG7X<P#3F,%J: RXIR8XFB
M)3P6,R)27J!1X)SW.1LFJLPG6H-G_T',JGI<+I-I00D5ZE!GUP&EB^4R,)5X
MX&6RN 9MR@O"B$V QI[B6H "D>MT[%J+Z+3YT8XB6O9W7Y0P.@R_>30-RSJG
M.R<HH7&3U$2;B(RUWA,+S! GT(50E@9&F^0C-7*:5@$X26NY%6FW6!4W=1NO
MQB]?<7(9XISX34"V'I9LBF[_0<O=%3G8EQ;:CFXV!IL"U49S3P*4J63,6Q(2
M6F(^2W"!.B9ID_:PCX$J]T1&#\24383?^K" ?W5_#N9'6Z#"!6XIX4K38OS@
M2JTML:1@\-#TTK)F.4<W/G3/H;4Z,A^T(+"VNSQ^]+WOT.OY.10C@X\F9J(4
MY-*YE!)/T8O2,M+,);-,-LLYO?VY)Z>^'<16PQ>$GA]#^EA6]V7H^Z-9#3[Z
MQS=_,]V&D@T0 3>?F!CZ(P;A>B6 9*.9R%G)Y*KDG3>'>)*68&5-5:B9OXEG
M\;8T0%0S,GH7TF&"G[64> ]7=M! Y?UF$7@UDD.*DF1G$1EH30)%C-/>IB)I
M:7*5&<+[XL0#0<K#46(3P5>@PJS=QSL87PS2;)()+"XE!7?*:5XR\SC@H1@3
M"18 3T:94HC@)*\R*V(]I/T'FW95V,KF*CM+N^7K]Q>3RTEOVH)R5H\W2R'^
MD)^GP;>I>*>A><A11L1GI2B!T#+*3/I(J*8JNLB<-:W=RC<!=))F1A5MM-@)
MI0F^Q6O2 &';T:=FT X0>FI=I1OP90=]M!VX;H;4\,R4$9$((R0>L(Z3X(,O
MD1:#VVM.D9M38,Q]$:@C(,PF:M@S49ZG_Y[,1J[-#T\?HJ=@ _&"<\2*YI@/
MEA%@P!*7SO)&_0?;.9R6P.TW=E)#N9L<3KMHIL)-ZHXE*[__7/T!T_?/\FB%
M9HY0JQ@NC7'BHL[$4@4)7,J95^FO5'%-)VE4'1L7*C0,6XWL1J"T";Z:H9^'
M !XF$'0TC&C$U!W562%X\"!.FG)B,FJ2DG-$1@IHK*"OS((*U,84G*X2K3X,
MW1Z(,3U:MFVBQ0HLF_9O+Z)!.4]E4\Z&Q<5-2<<*P CC&8BD.A+/58G-,,,5
M=4R)*DTV[L&T_R!5NPI<U3V_!>E7,.[F YY];VE\HY<ZTY BT;GTBBU7@S8;
M04S..@#G-.DJ5>-K\)RT4=6&#BHTJIS&\#,,1[C:SS#\WHW3#N<KT(Z^X$>.
M5O]J_OHT64M-XZG-Q1RLW&!WE@R.3,45CKI6U^0,95(R1DJK12)YV?6U=83;
MA)YWUHS3*C56QT_7ARL6CINMFVBV DOG_;+G1D .90B:9"1YIHIQ(8AC5A,T
M!)2ER91JQAHTNX5B_T;7X10Z:$L;%4RRTM)HT)_:C(M$>9HL!%46I$/Q3-"X
M8-238!CCR?/L994HV1TD3Y@BNVFEP@[RN^^5]E6?+P#&;\M?+^XTE&0>,CHI
M :(LS8$"L8IKPJ)54?K(?:A2_;0.T$G;[JUHH<7^W_?A6A3S-$!6TQ1?#^TP
MAG4[*FS BQWDOZ?]8S';70MNF,2MC+M(I-*.6!$8L33BB6CP'/15(D+[9L8#
M-NR^B;&)V&O$""\&P_$7&%[.LJIN5NJ!-B9R9@E+96Y&<!DQTE3&F"70-$<!
MJDJ(<"VD_5LB;2EN.3;8CM0KV*$[S[_[//;#\4L_GA7_,,D#D[B:F,LMMO.E
M?)2A]12#2C2:&'R5^OYVEW'2QLP!-;YV/,7??EV2]%O\]O"3WSM+R/<_^[W#
MCFOZ^[)$EN:_!^IE-"%(RHUT1EL-X)VP  :B%;+5^>^(Y3P!_CP!_M1Z!Y\G
MP)\GP!^*?.<)\.<)\.<)\.<)\.<)\.<)\.<)\.<)\.<)\ <['<\3X,\3X(^
M<N<)\.<)\,<UBOL\ 7[?/#SQ68=[T]AY OQY OQY OQY OQY OQY OQY OQY
M OQY OQY OQY OQ-+I\GP!\-9<X3X,\3X!\=$<\3X,\3X(_BH#U/@#]/@#]/
M@&]$MO,$^/,$^/,$^/,$^$-K\3P!_CP!_CP!_CP!_CP!?F.,)VD_U=;5>0+\
M<4SE/D^ /T^ /T^ /T^ /T^ /T^ /T^ /T^ /T^ /T^ /T^ /T^ /T^ /T^
M7V+(>0+\>0+\>0+\>0+\0YT6SA/@ZVGJ/ %^G\'/\P3X\P3XHZ'$>0+\>0+\
M>0+\>0)\/6V<)\"?)\"?)\ ?'V/.$^#/$^!;CYV<)\"W6;)RG@!_ D;5L7'A
M/ '^/ '^/ '^/ '^T;#M/ '^/ '^/ '^/ %^%3W.$^#/$^#/$^#/$^ ?%5W/
M$^#/$^!/9KSW>0+\>0+\>0+\>0+\>0+\>0+\>0+\>0+\88AQG@!_G@#?^@3X
M(YF@/1^F%WY^'DR&<3&I^3;Z^E.TUZ XZ"3M)I)9FJ8-&E((/!B;H]0T6BY9
M8BS0+" (27>:IKT&SXY#;[HC__7K$+[.+V;F#WE[U?TP:!9<"I08+4O7@F)6
MHU%.J&$FHQT6#31)6-IXAWD(6$OC06<W4W<[\5]-T2W%U_A_Z8O_T?'9J&B4
M)=G@VS[=3@*83#(KO8QH#"I6Z82Q!=;];\.M,FG-R,]JVJH0+5@CCYEGDX5&
M)S=%M$QD*IY-(-ZQ7(80":&=<D)4N<6Y#]2^6JY6)4IK4C^&)JOH'J=)''\8
MS@(LLUK=E*/5X!W)P#B17 GB.00"CDIM0HPR-XE\-TH'7 7@4%&#]C0[:%'"
M+2>'SO%<!]5@$2)K JKME/.U:/:?9;Z[HNYJO24I[XT"PACF4U($I$>2BYQ*
MGQ=4FE>2>VJ,;S1TY1A5?T^Z^)XTOXEPZW7,FCN8.AN3E$Y$RU3:E0I#7)2<
M.":4%,E'E^H8FC=1[#>WNR7-K.Z!M858V^YE\/_]_(:BZ"Y""&6>2A)ET@J/
MD4@7 PDAXD'(F,^6:\9]LSX4MS_W $6$VTMXT(YXVFX7\NH[NA17W1,\<,A(
M-"(2\T3J$(E#;YXP'R6-P"(#UDA1MS[VT>II>^&TV#UUBF2^H.E,F46O$DD#
MC<ZAV:=9Z0PLB;=&$,Z9EC[Z:)8OV-;HZNYG/UJ%[2BF%AM\S7J3X#K1>?=7
M-_K!4#5M,A<R_H<B%.04L1F$!QW0:<^--';[<Q^MMG803XMM-J90WODQ#+N^
M5T8ICU[X;^/N:-"[:L8MN<QH>4&("$[ASAP@(:&"Q>5EP_UR%>,:M=WSD,=L
M?K0JP+;/MT4 ;>Y 7VT*.8N@*0F<(:(4./&)2P)9JI"54,HT'>BYXN,?O3)W
M%UK;Y]\2HOE"%\GK5L6<<NGCH361)B8$QB+)RG"3C= Y-!VMN/XI^U-J6RJX
M1Z/;RZ_M]W,^+^\UP-5](XO*:8H^;AD$+*%<:PMT>5.6H+EE-,9F([KO?/3C
M5N%NDFK[A7S7Q7U^/.@OEN4HI=E9W.,5,D>"U,2%!(0B=V2,WJ,KT^R0O/W!
MCUMGNTBI;6/T)G\6L,JAL0@Y%9OYYM>+F4XI6& ID20!2::I19)9/+P!:!1X
M=&N=-GX=FS__<>M_#S)?:PD?2<K%=4+)"S01OPZ&^+,#Y5W<!^6@R1>-9;24
M@9&S#\%&W.F!H=,$P6BD))IV#!D".>Z4@7$?J+;F=C[_CA]7[K1>#X;%<[BN
M>7Q[=4'JK#'&!DNBU(Y(FR4)Z D2RZG+TD:5=.7AG0U0[EQ_O?2(EQ#&-PJ#
M+P?#<?=?D%X,1N.I3CL437I+ ;UL&TO+&)J)0S>9)"^EY$G%V*A/RN;UV!L"
MW7]PHAZ[[I1;UU1:C18J]^.-<=82!M+?AX/1Z(_^$'RO+.#O*/;?(0^&4#)-
M!),A.)Z(@C)CD..Y-.V:&#T3QGD1DJCR/K:"_@G3L8)Z:S2BV'(196SZ]2(T
MFM827&F\:$HY.Z@22LP$ .T($]&:8/:8.'H+_9FC;:JWPAR[]4*ZO9P. "3+
MN2-94'R7!',$-_XRT!&<\S*S$.HT36D(\"DQK14EM>B3+W#.&LE>XWG]_7VW
M[,B%\<_#:.J-=IA4D)UQ1*C,RE110X(HKJ@,.AOM0"]?H+?9P/=^<*=,HM:5
M4Z$]_"J,Q>3L:,45/E\2%5"YN/A$/(N*&&HE.M3&J53%4%L':/]$:5]]#?BQ
ML>Q;3^E8!O6?[]_<;_UU@E)2YX@KMU02&;T@#E\+DEU4W$L?-&UV@[+YLT^(
M%?N0?MMQ_,W@%A%UC!9<)X4')B_SD[RA)#!*"6=.1N4B. @5R%*>_;3)LK'T
M]V2N=#A/WG/AB-%0AO<4>YP951K@E\YAQHHZC4-6@3DABK0F\PI6QVTC^LO0
M3PN29DT-EK%>"2%+)C5D3<#3,AD!66R35T09\%$:R;Q+-7BR#=A3-FNK*Z_%
M0073?7(I3+ DGE7(RT9Z,P#; 8,O#.5 N#:6R(06F055!H,IJ3BH4N/<Z-3:
M'<L!RA6K*WQP.&VU;3]O![]A>#4IXSA017"OQN,[E_'%(FC"H^<)-.[:UE>D
MX;%&R1\#02MHN&UKON6%W8ZZ@J%)!6T)Y&*XN&DZ86+(31:%$HEJUBS%IR;*
M,W7WI.&VTY.V6E@'M* ,/1X25<F4*;.VO/.!:*8]<\(XJRN>ZF>R[:J3ZI[)
M,NA9!;67DH:(C@+5H510&TEL";L8HW7(2HL@ZO3Y>!C;OAH3',K;V%TAAVY6
ML%C7NN:RP3*3A,^$4EHZ^ M-G.4._7U%K=*1:E6EGO7(FI:WKO:&_<HW$?^Q
M-WYNLI9SO_)M^I5OQ)*:':"W4?&QTQ9?:S,=$ 8V22(IY<1QYXD$*F6"$-"W
M?YITW;)?^=&P=1/-5F#I2[CT_?02O@U&W:L&A5&P&%Q@)$*I/Y5.$A\Y2DBZ
M*$$&GEF5@=>KP#SRUM0;J?>.F;>C;JHT,1]^&PS1[[UMC"SJIZAG62A<K>>J
M^$7HJ%#%T2\*2LL8188J637WHGK"#&I/6Q6VGM)Y'8U?7/1'_^VJ4H<I80UG
M0*+0?E8Z&:C)A%$?C>-,*%6E1_%*-$^:.KMJIT*>Z')T9-'N)=J@H'30]2*5
M^(@C/C!*@-&0&#BMS%Z2^9X\:5K03X4,BW>3\<3W7D_Z:=%W1EJJ5)3EIA^(
M3-00;_ T!>HTE4Q["U7R^):!/&&F[*23"C'.VY-BG&$LR(S;7+:\]-?P>#("
M)\PF'4$R\+[*J(U3FMNS"SNVU\;:/(DC*=Z]BMKE5>4:X>>B7!I?CG=^7'[\
M\T"UO3L@/6CI;UL27JX,ME8&*JV4T4NCE#?>(K%]E#(8T&RGRN!V9'T<'"X[
MPNWKT(_%?RU3%8Z1R _#/6(V;RCK)4H+YTH8C$:9@N0L6&VX58(:*HM5EBM2
M^F'@^RR(+_T@DXJ6&)\,'E62$I]D)B)$IYE!5SB?7D'\]2/*[M+M3P:3T6J5
MW$AVN)6!&VAV5)8,6>'$K!%@H"D0ER1W.DJ1W)Z+\;9<R;%GIF["S^95>_M0
M>XW!"/?>@CZTJ+<P&GVY\'W&W^%?7HR6%MD)@:J08R8ZE>$!B1EBP1I"$PM9
M*FE]W$-"=<NK.L#8]<.R;J-\B7U2ILH-SBZ+6RSJP_#MH/\5ALN+HUH+7(8N
MG90#D8Y%8D52Q'HM)#42G;@J(TJKKNK\/AP+92K$B.]?7",A=[1F0J3@23*9
MEW8(G'@3-3%6)9:R2LF(_;.^$?8SM_>K_@KQZIN@1[<$^F:-TS3Z/Q/\8?'0
MOL/+[JCD[$V&\'Y2%/<A7_W5E8"CQ24P :70,92;/TLLPU5RRIBUC&HOJE@Y
MU5?V5"SYP]/BZ"R993.M(Z(.0AI!;!:,2"\XGD,\$,ZX,9H:+9;;WAZ#Z;*\
MC,/NYT? LZJV_$8D.3K*+UMB'2YB=B%D8H#BP24\KLLF0;2A64G<9**MDBC=
M[C+.E#\:DAR)?=Y)B@8?O"$!RJ08&]"G4 PQ<XG'*<J5UNG[M0W8,WWWK/ *
M)GB34@NE(OH'TI)$32)2IX3OD0.B,C,L.LZ9J3(\_=&6/.UB_+:MD&,O>0+M
MO7+:D^!+,Y+$+7%1(?\C9&N$ICY7J:=[A"5/&ZF]8<G3)N(_]MJ1)FLYESQM
M4_*T$4MJ%I%LH^)CIZV508'6ELCI#$<>%/%E@AGDF%,9TBIEE>/U^.FZ9<G3
MT;!U$\WNJ^2):TV5A4P4#^@4)<N)YTP3;T*"8'6THM(]U\F5/&VDWB8E3YOH
M9N\E3SHD!]0:XI@I,Q9QR3YY3W3F62-"B'4N2$^YY&D7!K6GK;V5/,G <8E4
M$14,\CNX2 (-##?FZ$4H/0E3E=[ZIUCRM!MU=M7.VG#9D62?_WTP2']V>SW\
M!]/I6&\2?@3^=?&CWN"'];]V\:OGHQ&,#S52:AN(!\W0W5FF2UFY*6DPV>5D
M.)4Q<6<3URQZYKC4H,Q.6;G;@-TYP-$=P]ON=TC+#[B.#$5ELDY2D2 ])3+B
M5]:P1 )NU]Q10(NUR@[8!-RN>_[R![^'\9M^[$U*GZF%.J[BK"8%&TOMDY))
ME<V&H4@D;C99>*0$MXQ5"?ML G+_)T3K'%K>^:OIJ((YNL#3@1"TB]D09LIY
M!RSC4:<3450X901PXZIP90%@_SRHIZ9!"S*N8"_>0_QIV\%.9HY9ES/)43DB
M-7X56-;$@8/$2W3=5DE4>PC8"7.C59U4N%^]!]^-/+=Y<V _NVR+T7()* Y;
M>@-+Q8BS&;=.CP:'+;W/997Z^<VA/DU>M:&W"I>D3433R=RD;($1)E0NDWXU
M\<$"D9D#9<9')ZID834!=\)L:ETW%6KNKV^/[^'^[(Y/1&>"M:4#:IE/QW@@
M06B!>ZJQ8$0VE0KRFT/<UY5[=5NXDE:.Z,)]W:)^__G.__=@^*+G1Z/IC8D2
MC L7*+X5"=\/;CAQ3C"BRM1YST+RK$J:] 88#W4Q7XLES0_%G;2U7UO]&NA[
M?PGS2&43N#6OY3?$>[";]SKZ;\ZSUI1W!)R+P&/0P D> 8E(875I))X(4\ES
M*;7EILI8J:/@VL/7YD=)M4UT5H%B']'KP(,X?8%XT1_T!E]_SN]%3.1>:F>(
M*_<KTG!%/-H698/G5H5H3)W14^L '558<G=-#BJHH4(TL@Q,@++&Q0VK-]H$
MBJX*/E<3274DP3I+8I92</ TL%J=BF\!.6TZ["3V&A?;D]%X< G#3]";AB9&
M%]UO"VC"*D:EB$3JTFJ9:D^<5I18IKR(R4J>JVP4]V Z;7*TI8P*P<FWW5B.
MX_[7YU^','7LKOH:>Y]YZ9T0?$8O04KT5J5%O:9$HU9&N5@ECV8MHM/F2#N*
M:#&H.!J..R_*;34,O_GA^&=9Y]36XIYFYKPDFO$R31XR"<IZ8H%Z$")YW:C+
M$'[^#5+@=\N$6 ?@1#WL5N3=X@Y1\'R";Y-AO/ CN&+E,L0Y]9N W,!Y;D2.
MQNCVZRJWH\C!OK30HO&Q&5ACP"L:(N&*62(MX&[I.9#,C:$\12Y=DP/F,5!E
MC:=[0*9L(ORVIX]^AA[@*I_WT\NN[P\NNXNT8I^2"@:7&46I@P5/O(Z>\ 3,
MV$C1OW\PT^V^!^S/@*BHBT'+@ESK@AY)AN1U#NC,0H)%IMRK."A+CI^Z7R\.
MEARY(;J#YD7N(LFEE$@;K=&1&R]IE)#0,.5@7399:"-<3#NE1&Z(<P_9D%RG
MD"EW!'0L!8UZ.L,-?7DOP+D$5.@J(92:V9#3#>2.J)^O%/75!3A5N'@5 W$L
M&B*5B<0%1PFJ72?G/+Y4MM$.O>&#C\KUVXX7MS;NFG*O$%-\,,/*2&YEPA,L
M3BO9N ?B%1?$4&EMSM[+O.\79,]9;_75NFG6VR8Z:=O"VSQUZL404G<\;3J7
M_GLR&D\#()T 2FF+IE (908%]2@J%SGQ# \@KAUHWVSV<4N 3I!/!]/7?C,M
MW\.X$Y2/:*9XE(R,1$((Q%LMRL D=+:4Y,KE/>]2".L$.55!'Q6R);?([V2)
M)L&8(\:5:L4D [&9&F*Y$]$IRGG8]SEW\+S<8V)5&WIK,:_RH;UU]2;JT85*
M5B1"(:-LC+,$WQ1+LN,Y42.E27[70^]\NK6E@;7SC?:2AJLTYS9&]$!*5V>I
M>22!X_D+!H QR66T57IR/-(TW&T<MLI:>8QIN(G))**-)#-=7 O'B76B#"OU
MGIDDT<,XI^&VRY(=TG WT=81I$0V@7M.PZVE_QUS([=1WA%PCH= 7;DA$4Y8
M(H/PQ+OLB/",)LM]Y%"E3>]1<*W%--Q]4FT3G56@V/I\'<LH.K"T9'N4?)V@
MT=G =1/E +(37%3JD_:($Z<VTF7CQ*E-%-%BU'SMK;Y7,3-5QKM#1"\T>CSP
M)9[ZADD&A@D&ODFR_RDG3FUC$[4B[X,E3C4!^=03IS92Y%;I,-MHX6")4QY=
M5L,E:C66O.&L!?$\&I*E2#XS(Z!1!?=CH,JFB5-[8,H&PF_[6NWYO[H_!\_[
MZ<5@^,Z/A]T?BXYHF4:=F2"X]#+9.R1B(462LM4Q<<A2+?GC:R*&:QYPK(E3
M&^EBT+(@6[08II@^^MYWZ/7\' J3E"6;#$E:SOOFV>CPW0273 3I%6V6:G'[
M<T].E3N(;5]YC2%Z%AV51&GERT@;W)28RD3;E*-WSHNL&ZGRD>4U;JW3-@1Y
M[)T?IS<=!VWLN +!0?,3'Y+(4@ZBE]99#TXHZJ2-.4"2SK' C"K;]&[#TN^7
MS;XX@C\93B"][?K0[4V[YBY2(<ODH"\PO+SQJP.Q:"N,!^79[E)=8F(,,EL7
MH@7G)"1J+;41C&:&*2:MVHF)N\IWCUR=_R0/AI\O_!#PTP MK,MO:,Q//^MP
M#&V*[-"\W$J"2VS,020IM7,B,IEX<L8E:1@+*BB0TN[*QJ88=S"DI@@_W$)X
M?8<KE=7,&UT2&2F1:+(35UJNH3'!9;)1R* :65/W/67GB;&]Z=] 6BVC5S_*
ME_ >QA_R%_^C$XO?$:@A7%"TE**1N"9;)L"AE93Q2*.T2E[19C#WG!_2&@ON
MS&VMIYRVG<(5,I@%2GV01N 10XPK,P-+NF6(61 $!C$*[_GV;\%>\C;JJ+@]
MH1U+7L:;/AXN\!F7,?W<M^4?%#64:!?3H*)%*B(-@10CF'AD*Q&XF&1H2%E7
M:N6X%M.^[QA:5/B=AHWM"+["W>,::'.WNPFXF@D4]Z([3+I$:[ILQI$=%+%W
MMC@J+-76$F]*5J4,B00E) F:FBQU=M%427TX $L>2'0X#$DVD7\%<GS"+1,_
M\*+$VN [] ;?"L:Y";3H:,48,RD' K%4=3BJ20!3KM5M\+CPI&.5NHD&V [1
M,+@U;0[JJJ+&J /HP]#W$.'S=(FB+IG996+Q;9"*,1Z*X<:FHX(EQY>%&THR
M:$<=9U*%*CWP&Z$[)<:TKXZU.\R11,U?^^[P/WUO N4_L^UY-)I<?IMVU3I0
M?*D1IH-&EC:7VG),2;((3 D6RD5ZH@%-:88_9$%[[G+<*::TJ?SVQ;57?MC'
M;T?3,>@PBW8=B&+W03DHLQK+:#ED;J1-K@RJIT*:X*SD3NG ++/)JJ!W(E1#
M:6W"HRN.O@,_F@QG:8;;L&#U!^VLPP;XEC0 WI:&]"&+8"1EUB7+K1*6Z\!1
M.[[S(-*=Y3?UT=N3XOSCZLAR%=8EB2KCA+=@E?),!@=>4($[ID8!4_05TFJ)
MWD6]LUQG]Y;X=S<OC<97?[K#'K;+X^KH99NU+NG-&8\[$+/!)) Y",\Y!7PS
MC S">&E7ZZWA@W>L8UA\W+R\]=;3YFC2A_ZG,E5U6%*@^^G]H#]<?#O=1&\$
M5%FTR5M*9"I]IK3)Q!GKB$W:1*'0@<A59G:TNHJ=;V:F&*[UU!V5:"XBN*HS
ME9G%8&+)&#>22 !-'%61Z&! )G2W5*K2D_U!9 ?(XS\8_^[<V;2JMK:O:3Y?
M#(;C<A?_IO\=YE7$*[!V>,##0%A&E*$H!LLX.GL\$1&S8L8 N.5RW7698,T>
MN'_&M*RG064A5XBHO1^,881O!'2_EZ-]%4*EA=$Z1)*H5$0RB1YY$ Z_0@M,
M!^D3KQ)0>QC:J1"FDC(J]*QY]3^3[OCG]5STU]_?=SO<1F-*W0O5 F:80K">
M4%I0<1YD:M)B>6."K )S:I386> 56M&L77''Q!A X"'I72K)!TJ18"-N:TYZ
M%C*C8/=KC)P:'=H1?85A?#<LK?O6SI1FGBI/LC.(TB3$*YP@D:E4FG'*9* &
M09K!>\HF:P4%MEVQ\&(P#9R56XE[P794<-P&-**X+G55P5AB*=>$\^0IGI:0
M66YDN#9]XOZ)4T-=@]JRKF"_SG*+[X<(2;A,T4CBV2)$,(EXQ31NN!SP_9 4
MC],:FTX#;"=%G%HZJ3)(YEYT6J>4<W3$.5K0*49"]H8H1!O0U(HF5K%CGB!9
M6M1$BZ;NO%COYRSH/;C>#:?XIJW>_F/0PV>,%FW@KOXD_ES\NYGG7T[M..Y^
MGRZQ@\*AG*'Q9W2,)27"$J<\)][0)/&%"%&)1D=3!7!/T?PY"D6WN,'-,DPG
M(Q3*J/2F#]W^]#KR_:1HXD->M<#1F]%H NDC#)]'=#>' --+R$X,WOIL#?$Y
M:A3J+!5#D,R%CEI!,,$UXFH[>)XL/0^@SK:WTNV6\!HU\LK'BU5_\AF&Y37+
MQFD:M2<"T..5W +Q3%(2+94J "3KFK4?K87PS-I#JKSM]KCWKF".3XLH>'9(
M,NFGUE D05!/%-42[22>-&]VQ#=XV)-E5]N*:+$Q[CKVOQ["_TR*V8"H_>CB
M?J-C-+<Z.D)*RK)W:$<PCF(*:$=$EPE3(KE$E4X-VS&TA>C)4NX@*KW+2[U[
MA<75A63'>1."D.A/9?3 <?N4Q 4EB;8J6^NC9*)**><-#$^13[NJXBXKS,XC
MF)&QQ9G_1W=\L9@ /)7/;#X+KL8:%RE)!NDJ$YZ\SJ$M&:PS6J)EF7F5B,C]
ML)XR=UI4V%TZV5WI--\*7P^N_>4Q?C7JXL?/*V=G8OOY&O?2?KSM/%/O'$<!
M$,,AE"'"G@3%#,%#6QMT7W E5=BV$^JG3,;]J?LN5]W._9=;$.-\DC(+ 2)3
M1'FT,Z4 E)Z5FBC'./=! M2)&[>V@KW-/S@:YAY&^<=2KW^U^M]_7GWY'UU\
M9X?QXN?;4M<W:U29O#$J<U(&QI?;&D&"YX: \T(J2P4U=7-Q[X5WJ$[!!Z+.
M.@*WI\(:/>Y79:7?Q;OHQ=< ;-6I"IN@/=!,A0IJ7\>L:CH[.-' &>5D29.R
M"4'S8B4S1]$?#Z"TL Q2E>[W1T"PAP8I'!N_-E%535Z]Z7^;C$=3";!%(UZ3
M611:D<1Y&0B@!''"1)++K.GL0$E:I;/-/9@.Z(RTK\UUO-E1%35F#Z^ QN?0
MJ')*"AN)2T$12<LASQ&:2-0G:K-RNDJC@7LP/366;*.*/>TE8M$UV 7EHC)$
MI4)@(Z"TA*:$0XS9@&8TA7VQ1#Q-EFRCBAKS@:]/X*OHR8WA13EEEP,C*MB
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MVGD7--"\W*9V#4/;0G2FZ:'5W':-Q]:+>!,]_F)Q%#"13.13H>%10$O5.(-
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MH#D+)AD6* @M7L7,,>SE\8,_^JFSH*VM3W&I\S<D4QQU/K;\FYW/NC8A6+^
MJ6B^"&\TEJQM4)%B*D[_D,N$$T(.'F(YW 9]G!EN>5)/-CKLK"]+'R$*FX+6
M7H0HK4N^./I'.9=PL!OK(39\-9WB;/H7O,YE//D UWB,^1X^I+/E=N!:,YIU
M,HH21"Y<:J0-'D7()G(OD[#2Y\&C"#O9:YY,'$6Z;8_JWW:;,*Z_)K <= QH
M:9/3*O" 4%!"5LY'$]4&"SY$V\F.'VYO;F#RM<,DWO7(_NWZ&.8U^PK!C=?9
M"J>D-CY 3)$C[1U92!N#?FC?[>@/NOQ_&Z?X[UL*<7[^HQXH'&'7]4=TO];_
M&*8UNP7OT=0]-H#3'G/(D=CIO/.>=O[H!H^@ZV"G+L((FY_4M]7V(5WVF:L4
M+.VXN0J:!*]$M)$V%!$Y3W+=>#V)'MQ_Z/=#.6D-+=":8FKR)477,5$,90I3
M5AA0X'WD;90?MP#J7#NRJ(.:?AR_2O^^'4[P]>V4GDT3>?K+9#RE 7-)*ZER
M3!7M:V%GO27!D6+($@L-U@G9Y-+5+F!G*,[M@Q,/"DWZM'^#]SHK.&_&-W$X
M6B0PJW-(2CQ&TR%]SJ+2KB[^ UM;E>LD6>+%,.WJY<-B ^/ULA;2BF>P23OZ
M W$^$_:T]$[O=4Q_?L$J,[1\D3^M]UA_&E;1V;GR\%7YSOR!SY)8CY04HZ2D
MF C/@C>1(5+FBK0!:"C[U33M_Z%/G!)-;=SB+N7]P2_>9PB(SD4GB)JH:."V
MMF3+CF7CBZ%0$ZQOLGIL G.R.OH6"T-GZY[[[=^V@:PT&XT+8$KVK%!&PG2(
M@<QD+7V5("KO;$EMKFELQG.V\O?.?MY!G&/LW4)&]2&L50WV'L":"OIN0W:>
M4O=>_+>;$QV,?U)V\%HKZB0P(XVJ0OWS%^2TW6%( G51]+]GP(H=9?&G)<4A
M-F]/AE6-=Q**.^-8E4PC4#DR\((SC)Z#3R"L;M/A<!.:LX>:QWKK<0X<8>J&
M&>L\GYXN[%K)SF.V8+)BL6Z(.M6+(9 "L\DHK[D3RC3II+4%S[.)&/JP=X/\
M8A.LQ0G+-^;O ;!EY+ 3X7DBB%[\N0='NCNCP>:Q&V@ SVD^U/*;&!FMC\B"
M%)(9;0ND;(++_AFQ94=D<1ZR'.*#OH^QWA<<X9^_CM)RMRLV AJ76=!86\DK
M&BF%34P [:?)TDZXWK)HRU'5VH-/'R/T;/=Q3T9K$"(0D/$-?IC!;"%4 -<P
MJF)EB+-7H_PJY_G@X;I*[EV/I[4OVNNO],V7\12N?YF,;[],Z1'7M_4VTER6
MKQZYWF*^^K(\;9W.)P$J"46*P)P!7R\L%A9RE PBUR4$'EP,+9:*TPSOV00P
M%\B&!G)C!P&^<^MV']@MHZ0C<9\G=KI$*HW/QX,& =JQ\)V)V451BQV-KEW1
M#(L::,&1-A59>W!"D[#MHNB[(YA[QNP]Q/U]1XQ_QPD9;3A=QC[6!UTR1&9L
MO:B9BV%>2<M25K7FSVJSWKAP2\!X_[FGCQ=/XHMQ/X9L$$3>&_Z\_^*P#!-\
M2X'0B122D2SS4F/<DA@D;1G&%*7**!#;KS@/<3V;L*U/^S?0WWP$WFI'W0/@
MR2*K30C/$T/UZM?].=/!*:W#G(U O4,?,R;&;0Q,!Z$9@%0LUPIH4W)J]&;K
M3*S9$;J<ES2'^*(U61;?T-9;7G^M)=COQK/-._+J;8TO20,W3%7Y1=J'"_/H
M)"O6%Y&2H9BC24%K%]!GCG6Z<^ QAK5TX*'J5<L_KO^),,7__9__!U!+ P04
M    " !V@691A1=_*GP2  #7+0  %    &QG;F0M,C R,# Y,S!?9S$N:G!G
M[5<'6%/;ECXA"4'*I0B"@ 1!I00(! &I$3%4O30I@D@-$$.O$>E>42)*1T6O
M=$0009 J(E(55$!#$5$PH#21T'LR!Z_7.W/?G9GW9N:;F>][_/E6LO8^Z^S_
MK+W7V?L/HY\Q#' 9ZAKH A (!$@ /P#C(]<*CD1P!8#CQP%I  !8 !A$'6 "
M/4ZP87B1 ,! 'P+Z-K=^W?H%1 " Z_6D,(  ^]C!MA9H@/#DMWNWL8UM;&,;
MV]C&/RF.$YP=\1Z.<L<( 0$>>+ #G@#]IBAX0>50D #[X=<E)7[SH<J* )"4
M](?_A[I@N;4UXK:ZV,8VMK&-;6SCGQL8>055-7DE-7EE404%-25Y-8SJ7_:!
M.@0@ ,Z (X '/,!O.> 8V X /Q[ EBAA?&3;ZQX0X*.&1GOYRSFZ>#OAY9R]
M/=$D1Q^T@IP\&M# DGP<G8GX %$GO!O!2U-BYM$3"5&"BZ:$E=)Q^>,^.GAW
M@GZ(']X\Y.<3SB%$9U47":P6!ZL&28WDZ>.)#W 4)7EZ>/FKD33%OHVN!OI;
MW6@Q+0T_%U<ULZ.ZWR/ EJ;8]V<)#@Z6"U:4\_9S0RNHJJJBY3%H#$86C)#U
M/^L5X$B2]?(7_S[ 4;R_LQ_!)X#@[26ZU79T\@X,T!0+#"2XJ+DZNBHYN;@H
MR3HY*KK(*BBX.,HZNB@JR+HH*KJH*"D<PK@J.(E]IW=Q_L'N$^CG\8W;Q1F-
M]\![XKT"_,'94$"+H?]G.<$I^D'ZE],/Y@C&J.GXX1T#\$=!T]I:9%EY)5EY
MY1._+[*<,D99 _VG. WTGQ[T_V"VM#1<G-6<MY[)V^\W>G.\[W]OM3T(6O]6
M6/^6)]C]FP,2@-6W8\<.#?2_YO[;R4!_+S[0^U&JX)VB_PO8)MDFV2;9)MDF
MV2;9)OG_1?*'W,5[@1HW&!2SC'> #H" PYGA, 0SG)D%@6!AY68#-08K'R<7
M.[< G^!N 3X!?B$1B;U">_;OX1<0DQ/;+RF%DD$)BJ(5T=(8"6F4]-8@$ 0+
M"^L.5EXV-EYI80%AZ7\8C : FP4@0*2A$#& B1L"Y88PF@$D $#@D&_X_=\!
MA D*@S,C6':PLH$!%5P $P0*98)!X7 8#+P:!EX'8-QPGKT*VLP[31T18KZ\
MF*C$+!;Q(P^>\IEUT_8I.OE%[V#=Q2^P6W#_ 0E)*>F#2LHJAU35=([B=/7T
M#0S-3UA86EF?M'%VP;NZN1/.^ <$!@63SH:<_^5"S,5+L>2DY)34M&O7;Z1G
MY^3FY=\IN%M85OZPHK*JNJ:VL:FYI;7MV?/VUV\H/;U]_6\'/E)'1C]]'AN?
MF)R=FU]87%I>65W;R@L"0"&_XR_SX@;S8H+!H##$5EX0IN"M &X8?*\",X^V
M*<+1=Z<8)HJ%]TABUH.G.\05S6A\3G[=K+OV'?RX?W8KM6^9_7V)1?^7,ON1
MV!]Y#0#L4 BX>%!N  NLZ9(E,YG(TJBBZ_>^?*ZM]GR@(Z0_/9[IDO',!/;0
M2IR_>8:] Z.W=-?*'SY(2V ^E]QO97<8SFOZCQO?_$U2D1VQ.V@@K_.6FC(=
M*Y>Z\%.JSW*(9FIS/^:X5Y(RPB\SW<$VNVZYA3\]9>W"4.).?4^75$N96S($
M)GVA:*UYA0UFA%AM"<>K.9OWC5Z"7U&V53%",:H846#NW+2,.?;+:ZC3MWQ
M*]LP9@!B5Q\P@-.*#&"\W";U&C5BE3<P?FTV@P'@TH'5UOKLDFO$26D/,#X7
M@N-+"K7(8NLLVV/9USE4[G9=\='K2*6";#(@>6]3Q_YU0*4%18GM7)#3X9]&
M- +I@=JAOA\K79$#2R.$5B,'9![@W8<LV-!]L[!I2.W\DMSNX"^DE@ 1/]_W
MH?8R:OVX+D3I2K-_JZZ.[ML2R;Y0\6*.H-GATC3WO!NC>O&?V],.==:C7KY
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MJ>;WR?T,./W(AWQ5N1UN%V([*M<JX%5>\OFR7!?RL_R^>J$)^=LL8RPB<91
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MKT[T:0YP9G'"DB"F$G)&B58 +(8$Z?^@. UHR -*39-+^S7_>(BI+?F?S1B
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M+<M7RP>:+V:4,Q9(RF&&"88HX0IF(<.0:46N(KT_XVY5R 9'/#7MOVN(:(S
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M /SPY=,KDRM:!Q(X:G8;_NUTM6=.!]:^#9E-'( &K-]:4$-N''D:=*U[?;;
ML*;(;R.,R\..W [#FH?CIACVM_8XPJJ.Q#[O'XF=\I>G"281"C'$:4HAX@F!
M!&,,%4K26&0)39E5FRN70:=F<WXZ&0=PH\W-35GI7_._Z?]S.,VPI=_BD&D
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M]YOC=#3*R!E-YZ0\SE\Z>V4/?^CK[X_2Q*ZWZQ*]RJN21*MU(=^KC::2Y2Q
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M2X5!$F>4ZDEC$42""$A3+B##2._-(X$1#IV<CF[C3\U*K.'#"C_8"0!J"6Y
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M5JJ<<9FD*HP8Q(KIW0Y7 C(4!E )SM)8"L*H4_/WRT-.S9C8( 9F.H'0F&_
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MZ'_>5NA$BD<!#DV>(D$092*&3&L5*+26,:UR9":I4[BM;X134TL_%QH<V(D
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M,'+:<5;_@%8?$:D_HNZPX;XE(V\39TGK$]&O^A>]:E"PK)T2;OQT!7 [4O(
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MV!IWTKS(\TPF(H'$5'%'*D&0Y:* N8@H18)G66K%7[>+,C5.VTE9E?7BE9S
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M.92R,/'.,=)+51'!)$X$S1@G>L6R390X>/+4=MJ-<*"6SCX-XA"N?DZ_"83
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MI9K\$P$5CF7.249,60,'\G<<?VH,7PL(GHS#;[$"HA9[O[T%G"YY99VL5^7
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MQSWO'P/[DZ"!408=[B*6&[XPH4]Z"][T.!0RR^-,Y3"/N(!UH6:*""PHBZG
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M=#7]<[%<SI6@C.A%!!9Q*B"BL8 DD0KRW.0L1"+%C+O4;[09U&E%&<&LK!/
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MZH^EZ<#W4RY%59/-^,'=F.;6V;.CI1'G)+0Q>]!*>@;VE:2Z"H"=!K-N[[P
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MS$,-!R%;Y9JD.42,IT1B+(PCXQ8DZ"#-Z8,9-5"P;GK2U&.R^AXRD4^=ZPM
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MN6S.")?RWGP%W>?Q6;>U:MGBB_E-DPWA>=H31-:$:+IOSPW8LZ@^!^K;9-?
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MPV.#AMTPTG!6M#<!MP24]]U\X2?_W_CSTJ6RP7M(.J,CE3%&]QF_TF@791)
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M9[1ZQM#3N:U>=-2 NW^?J]60R6>7B_-N-OXG)+3:U#%/RU!2GXA46I1)M>B
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M0Z),JFSDY2HQVMD<8E:XCT,T5?RIK=0,G,VJH/A'][Q#== $E&Z)7XD(]VQ
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M^\]C]-_7S$@.40N?2?0211-2)DX91700,0G%5!95IM@]2=7 Q_^]8Z@_%;2
MIQ@O+RXG)7!Y+%&R9HS*)&G0@ACI,00%--,A4""Z3.@+X**,5?)?.U,X< %
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MG7(1- 61!I;,4M(?X//E+)X7CA_N8:.0E39"*5+RJ>BD!R ^"ETZLKL,P@)
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MPI;(;A&V(8XG1[26UE--J0Y5'/'ZD*V6W6@*LOOH[TC(OISVU)[Z\O/GR5*
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MNRH5C8]2-.SF>DIL]:.4@9W[YR5Q##.4[N*JR&5IX4$)C<9<$VTBK@[K/;'
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MBS6X3G"68_H C#">H30ECL1S58)&9KBBCBE1I?O4$S2U",I#E;]YNZ$G330
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MD1=#;MYC%K5SVC5YUO$<8>-F@"?#U:#ZZ<(S/<'1G7<DF]49X;JK*R4G%)(
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M,;^@CZG=6VN1Y#HR.VH$861M0C:D*^<R9!68TCG;Y)O4?$_ V[C-Y2_4GHZ
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MRXMWTX*3D-"BJ /1 W/$*Z-$)!I& 9VE@S );E2;!4-'$#WN.+!F<#Z9'CO
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M@J=40F!(L;2Z)3[5S$1,TI*-)9"EMDR)F"&4PD%3MI2+";JTV1=R+C,3]T'
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MRN+O[2]ZI(JQQY=V51D^#DY-Y=V^1W7S@_J?&);X__X__S]02P,$%     @
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M:_OL7UW2[@Q(_^JT2[PZ+7F-'?KQPU9C[]#;#=S1JU]5^Y*T3\XO!MT3LKC
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M93,"B#]*(CA3G H24 \N*2(CX)M&.KDE@9AY3&NJIB@2T1L&\RZ,J>&:#\K
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MF'2MFA:QU *-Q1 '@_=$%VH\EAK>9@8EJ4H P[1-$CT/<, J8*L](Q9#[B<
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M.3,P7V-A;"YX;6Q02P$"% ,4    " !V@691'W?AZ UM  !['P4 %0
M        @ %OO0( ;&=N9"TR,#(P,#DS,%]D968N>&UL4$L! A0#%     @
M=H%F4847?RI\$@  URT  !0              ( !KRH# &QG;F0M,C R,# Y
M,S!?9S$N:G!G4$L! A0#%     @ =H%F43P4B-(   $ "< * !4
M     ( !73T# &QG;F0M,C R,# Y,S!?;&%B+GAM;%!+ 0(4 Q0    ( ':!
M9E'G>S5!<(\  -.0!@ 5              "  9 ]! !L9VYD+3(P,C P.3,P
M7W!R92YX;6Q02P$"% ,4    " !V@6911KD7J>$(  !*0   &
M    @ $SS00 ;&=N9%\Y,S R,&5X:&EB:70S,3$N:'1M4$L! A0#%     @
M=H%F47@C0UG;"   G4$  !@              ( !2M8$ &QG;F1?.3,P,C!E
M>&AI8FET,S$R+FAT;5!+ 0(4 Q0    ( ':!9E$GY2]9Q 8  !HL   8
M          "  5O?! !L9VYD7SDS,#(P97AH:6)I=#,R,2YH=&U02P4&
/  P #  N P  5>8$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
